UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. 4)
Filed by the
Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
☒ |
Preliminary Proxy Statement |
☐ |
Confidential, for Use of the Commission Only (as permitted by
Rule 14a-6(e)(2)) |
☐ |
Definitive Proxy Statement |
☐ |
Definitive Additional Materials |
☐ |
Soliciting Material under Rule 14a-12 |
EAST RESOURCES ACQUISITION COMPANY
(Name of Registrant as Specified in its Charter)
N/A
(Name of Person(s)
Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check all boxes that apply):
☒ |
Fee paid previously with preliminary materials |
☐ |
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules
14a-6(i)(1) and 0-11 |
PRELIMINARY PROXY STATEMENTSUBJECT TO COMPLETION DATED
APRIL 21, 2023
EAST RESOURCES ACQUISITION COMPANY
7777 NW Beacon Square Boulevard
Boca Raton, Florida 33487
Dear Stockholder:
On August 30, 2022, East Resources Acquisition Company, a Delaware corporation (ERES), LMA Merger Sub, LLC, a Delaware
limited liability company and wholly owned subsidiary of ERES (LMA Merger Sub), Abacus Merger Sub, LLC, a Delaware limited liability company and wholly owned subsidiary of ERES (Abacus Merger Sub), Longevity Market Assets,
LLC, a Florida limited liability company (LMA), and Abacus Settlements, LLC, a Florida limited liability company (Abacus and, together with LMA, the Companies), entered into an Agreement and Plan of Merger, as
amended on October 14, 2022 and April 20, 2023 (as it may be further amended, supplemented or otherwise modified from time to time in accordance with its terms, the Merger Agreement), pursuant to which, subject to the satisfaction or
waiver of certain conditions precedent in the Merger Agreement, (i) LMA Merger Sub will merge with and into LMA, with LMA surviving such merger (the LMA Merger) and (ii) Abacus Merger Sub will merge with and into Abacus, with
Abacus surviving such merger (the Abacus Merger and, together with the LMA Merger, the Mergers and, along with the transactions contemplated in the Merger Agreement, the Business Combination) and the Companies
will become direct wholly owned subsidiaries of ERES.
As part of the Business Combination, the holders of the issued and outstanding
limited liability company interests of each of the Companies will receive aggregate consideration of approximately $531.8 million, payable in a number of newly issued shares of ERES Class A common stock, par value $0.0001 per share
(ERES Class A Common Stock), with a value ascribed to each share of ERES Class A Common Stock of $10.00 (the Stock Consideration) and, to the extent the Aggregate Transaction Proceeds (as defined herein) exceed
$200.0 million, at the election of the Company Members (as defined herein), up to $20.0 million of the aggregate consideration will be payable in cash to the Company Members (the Cash Consideration and, together with the Stock
Consideration, the Aggregate Merger Consideration).
At the effective time of the LMA Merger (the LMA Effective
Time), each limited liability company interest in LMA that is issued and outstanding as of immediately prior to the closing of the LMA Merger (the LMA Closing) will be cancelled and converted into the right to receive a portion of
the Aggregate Merger Consideration. At the effective time of the Abacus Merger (the Abacus Effective Time, and together with the LMA Effective Time, the Effective Time), each limited liability company interest in Abacus that
is issued and outstanding as of immediately prior to the closing of the Abacus Merger (the Abacus Closing and, together with the LMA Closing, the Closing) will be cancelled and converted into the right to receive a portion of
the Aggregate Merger Consideration.
ERES expects to issue 53.2 million shares of ERES Class A Common Stock to the Company
Members in connection with the Closing (assuming that the Cash Consideration equals zero). The Company Members as of immediately prior to the Closing will hold, in the aggregate, approximately 82% of ERES Class A Common Stock immediately
following the Closing (assuming that no shares of ERES Class A Common Stock are validly redeemed and that the Cash Consideration equals zero). ERES units, ERES Class A Common Stock and ERES public warrants are currently publicly traded on
The Nasdaq Capital Market (Nasdaq). In connection with the Closing, ERES intends to change its name to Abacus Life, Inc. (the Post-Combination Company). We anticipate that the Post-Combination Companys common stock and
public warrants will be listed on Nasdaq under the symbols ABL and ABLLW, respectively. The Post-Combination Company will not have units traded following the Closing, and ERESs units will be delisted and deregistered
following the Closing.
See the section entitled The Business Combination of the attached
proxy statement for further information on the consideration being paid to the Company Members in the Mergers.
ERES will hold a special
meeting of stockholders in lieu of the 2022 annual meeting of its stockholders (the Special Meeting) to consider matters relating to the proposed Business Combination. ERES and the Companies cannot complete the Business Combination
unless ERESs stockholders consent to the approval of the Merger Agreement and the transactions contemplated thereby. ERES is sending you this proxy statement to ask you to vote in favor of these and the other matters described in this proxy
statement.
The Special Meeting will be held at [●], on [●], 2023, in virtual format at
https://www.cstproxy.com/eastresources/2023.
YOUR VOTE IS VERY IMPORTANT, REGARDLESS OF THE NUMBER OF UNITS OR SHARES OF COMMON STOCK
YOU OWN.
To ensure your representation at the Special Meeting, please complete and return the enclosed proxy card or submit your
proxy by following the instructions contained in this proxy statement and on your proxy card. Please submit your proxy promptly whether or not you expect to attend the meeting. Submitting a proxy now will NOT prevent you from being able to vote in
person (which would include presence at a virtual meeting) at the meeting. If you hold your shares in street name, you should instruct your broker, bank or other nominee how to vote in accordance with the voting instruction form you
receive from your broker, bank or other nominee.
The ERES board of directors has unanimously approved the Merger Agreement and the
transactions contemplated thereby and recommends that ERES stockholders vote FOR the approval of the Merger Agreement, FOR the issuance of ERES Class A Common Stock to be issued as the Stock Consideration
and FOR the other matters to be considered at the Special Meeting.
This proxy
statement provides you with detailed information about the proposed Business Combination. It also contains or references information about ERES and the Companies and certain related matters. You are encouraged to read this proxy statement carefully.
In particular, you should read the Risk Factors section beginning on page 34 for a discussion of the risks you should consider in evaluating the proposed Business Combination and
how the Business Combination will affect you.
If you have any questions regarding the accompanying proxy statement, you may contact
Morrow Sodali LLC, ERESs proxy solicitor, toll free at (800) 662-5200.
Sincerely,
Terrence M. Pegula
Chief Executive Officer, President and
Chairman
Neither the U.S. Securities and Exchange Commission nor any state securities commission has approved or disapproved of the
Mergers, the issuance of shares of ERES Class A Common Stock in connection with the Mergers or the other transactions described in this proxy statement, or passed upon the adequacy or accuracy of the disclosure in this proxy statement. Any
representation to the contrary is a criminal offense.
This proxy statement is dated [●], 2023, and is first being mailed to
stockholders of ERES on or about [●], 2023.
EAST RESOURCES ACQUISITION COMPANY
7777 NW Beacon Square Boulevard
Boca Raton, Florida 33487
NOTICE OF
SPECIAL
MEETING IN LIEU OF THE 2022 ANNUAL MEETING OF STOCKHOLDERS
TO BE HELD ON [●], 2023
TO THE STOCKHOLDERS OF EAST RESOURCES ACQUISITION COMPANY:
NOTICE IS HEREBY GIVEN that a special meeting in lieu of the 2022 annual meeting of stockholders of East Resources Acquisition Company, a
Delaware corporation (ERES), will be held at [●], on [●], 2023, in virtual format at https://www.cstproxy.com/eastresources/2023 (the Special Meeting). You are cordially invited to attend the Special Meeting,
which will be held for the following purposes:
(1) The Business Combination ProposalTo consider and vote upon a
proposal (the Business Combination Proposal) to approve the Agreement and Plan of Merger, dated as of August 30, 2022 and amended as of October 14, 2022 and April 20, 2023 (as it may be further amended, supplemented or
otherwise modified from time to time in accordance with its terms, the Merger Agreement), by and among ERES, LMA Merger Sub, LLC, a Delaware limited liability company and wholly owned subsidiary of ERES (LMA Merger Sub),
Abacus Merger Sub, LLC, a Delaware limited liability company and wholly owned subsidiary of ERES (Abacus Merger Sub and, together with LMA Merger Sub, Merger Subs), Longevity Market Assets, LLC, a Florida limited liability
company (LMA), and Abacus Settlements, LLC, a Florida limited liability company (Abacus and, together with LMA, the Companies), and the transactions contemplated thereby, pursuant to which, subject to the
satisfaction or waiver of certain conditions precedent in the Merger Agreement, (i) LMA Merger Sub will merge with and into LMA, with LMA surviving such merger (the LMA Merger) and (ii) Abacus Merger Sub will merge with and
into Abacus, with Abacus surviving such merger (the Abacus Merger and, together with the LMA Merger, the Mergers and, along with the transactions contemplated in the Merger Agreement, the Business Combination) and
the Companies will become direct wholly owned subsidiaries of ERES. A copy of the Merger Agreement is attached to this proxy statement as Annex A-1, a copy of the First Amendment to the Agreement and
Plan of Merger, dated as of October 14, 2022, (the Amendment) is attached to this proxy statement as Annex A-2 and a copy of the Second Amendment to the Agreement and Plan of Merger,
dated as of April 20, 2023 (the Second Amendment) is attached to this proxy statement as Annex A-3;
(2) The
Charter Approval ProposalTo consider and vote upon a proposal (the Charter Approval Proposal) to adopt the Second Amended and Restated Certificate of Incorporation of ERES (the Proposed Charter) in the form
attached hereto as Annex B;
(3) The Governance ProposalTo consider and act upon, on a non-binding advisory basis, a separate proposal (the Governance Proposal) with respect to certain governance provisions in the Proposed Charter in accordance with the U.S. Securities and Exchange
Commission requirements;
(4) The Director Election ProposalTo consider and for holders of ERES Class B Common
Stock (as defined herein) to vote upon a proposal (the Director Election Proposal) to elect seven directors to serve on the Board of Directors of the Post-Combination Company (the
Board) until the 2023 annual meeting of stockholders, in the case of Class I directors, the 2024 annual meeting of stockholders, in the case of Class II directors, and the 2025 annual meeting of stockholders, in the case of
Class III directors, and, in each case, until their respective successors are duly elected and qualified;
(5) The Nasdaq
ProposalTo consider and vote upon a proposal (the Nasdaq Proposal) to approve, for purposes of complying with applicable listing rules of Nasdaq, the issuance of shares of ERES Class A Common Stock to the Company Members
pursuant to the Merger Agreement;
(6) The Incentive Plan ProposalTo consider and vote upon a proposal (the
Incentive Plan Proposal) to approve and adopt the Incentive Plan (as defined herein) in the form attached hereto as Annex G; and
(7) The Adjournment ProposalTo consider and vote upon a proposal (the Adjournment Proposal and, each of the
Business Combination Proposal, the Charter Approval Proposal, the Governance Proposal, the Nasdaq Proposal, the Director Election Proposal, the Incentive Plan Proposal and the Adjournment Proposal, each a Proposal and collectively, the
Proposals) to approve the adjournment of the Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with,
the approval of the Business Combination Proposal, the Charter Approval Proposal, the Director Election Proposal, the Nasdaq Proposal or the Incentive Plan Proposal.
These items of business are described in the attached proxy statement, which we encourage you to read in its entirety before voting. Only
holders of record of ERES Class A Common Stock and ERES Class B Common Stock (collectively, ERES Common Stock) at the close of business on [●], 2023 (the ERES Record Date) are entitled to notice of the Special
Meeting and to vote and have their votes counted at the Special Meeting and any adjournments or postponements of the Special Meeting.
Pursuant to ERESs Amended and Restated Certificate of Incorporation, ERES will provide holders of its Class A Common Stock
(Public Shares, and such holders, Public Stockholders) with the opportunity to redeem their Public Shares for cash equal to their pro rata share of the aggregate amount on deposit in the Trust Account (as defined herein),
which holds the proceeds of the ERES IPO and additional funds deposited by East Sponsor, LLC, a Delaware limited liability company (the Sponsor), in connection with the extension of the date by which ERES must complete an initial
business combination, as of two business days prior to the consummation of the transactions contemplated by the Business Combination Proposal (including interest earned on the funds held in the Trust Account and not previously released to ERES to
pay its taxes). For illustrative purposes, based on funds in the Trust Account of approximately $[●] million on [●], 2023, the ERES Record Date, the estimated per Public Share redemption price would have been approximately $[●],
excluding additional interest earned, if any, on the funds held in the Trust Account and not previously released to ERES to pay taxes. Public Stockholders may elect to redeem their shares even if they vote for the Business Combination Proposal.
Public Stockholders, together with any other person with whom such Public Stockholder is acting in concert or as a group (as defined in Section 13(d)(3) of the Exchange Act (as defined herein)), will be restricted from seeking
redemption rights with respect to more than 20% of the Public Shares without the consent of ERES. Accordingly, all Public Shares in excess of 20% held by a Public Stockholder, together with any affiliate of such Public Stockholder or any other
person with whom such Public Stockholder is acting in concert or as a group, will not be redeemed for cash without the consent of ERES. The Sponsor and ERESs directors and officers have agreed to waive their redemption rights in
connection with the consummation of the Business Combination with respect to any shares of ERES Class A Common Stock they may hold. These waivers were made at the time of the ERES IPO for no additional consideration. As of the date of this
proxy, and due to the redemption of 24,781,028 Public Shares in connection with the stockholder vote in July 2022 and the redemption of 6,862,925 Public Shares in connection with the stockholder vote in January 2023 to approve the extension of the
date by which ERES must complete an initial business combination, the Sponsor (including ERESs directors, officers and Initial Stockholders (as defined herein) and their permitted transferees) owns approximately 75% of the issued and
outstanding ERES Common Stock, consisting of the Founder Shares (as defined herein). Founder Shares will be excluded from the pro rata calculation used to determine the per Public Share redemption price. The Sponsor and ERES directors and officers
have agreed to vote any shares of ERES Common Stock owned by them in favor of each of the proposals presented at the Special Meeting.
After careful consideration, ERESs board of directors (the ERES Board) has determined that the Business Combination
Proposal, the Charter Approval Proposal, the Governance Proposal, the Nasdaq Proposal, the Director Election Proposal, the Incentive Plan Proposal and the Adjournment Proposal are fair to and in the best interests of ERES and its stockholders and
unanimously recommends that you vote or give instruction to vote FOR the Business Combination Proposal, FOR the Charter Approval Proposal, FOR the Governance Proposal, FOR
the Nasdaq Proposal, FOR the Director Election Proposal, FOR the Incentive Plan Proposal and, if presented, FOR the Adjournment Proposal.
The approval of each of the Business Combination Proposal, the Governance Proposal, the
Nasdaq Proposal, the Incentive Plan Proposal and the Adjournment Proposal, if presented, requires the affirmative vote (in person or by proxy) of the holders of a majority of the shares of ERES Common Stock entitled to vote and actually cast thereon
at the Special Meeting, voting as a single class. The approval of the Charter Approval Proposal requires the affirmative vote (in person or by proxy) of (i) the holders of a majority of the ERES Class B Common Stock then outstanding and
entitled to vote, voting separately as a single class, (ii) the holders of a majority of the shares of ERES Class A Common Stock then outstanding and entitled to vote, voting separately as a single class, and (iii) the holders of a majority of
the shares of ERES Class A Common Stock and ERES Class B Common Stock then outstanding and entitled to vote, voting together as a single class. The approval of the Director Election Proposal requires the affirmative vote (in person or by proxy) of
the holders of a plurality of the outstanding shares of ERES Class B Common Stock entitled to vote and actually cast thereon at the Special Meeting.
Consummation of the Business Combination is conditioned on the approval of the Business Combination Proposal, the Charter Approval Proposal,
the Nasdaq Proposal and the Incentive Plan Proposal at the Special Meeting, subject to the terms of the Merger Agreement. The Mergers are not conditioned on stockholders of ERES approving any of the Governance Proposal, the Director Election
Proposal or the Adjournment Proposal. If the Business Combination Proposal is not approved, the other Proposals (except the Adjournment Proposal) will not be presented to the stockholders for a vote. The proxy statement accompanying this notice
explains the Merger Agreement and the transactions contemplated thereby, as well as the Proposals to be considered at the Special Meeting. Please review the proxy statement carefully.
All ERES stockholders are cordially invited to attend the Special Meeting in virtual format. ERES stockholders may attend, vote and examine
the list of ERES stockholders entitled to vote at the Special Meeting by visiting and entering the control number found on their proxy card, voting instruction form or notice included in their proxy materials. The Special Meeting will be held in
virtual meeting format only. You will not be able to attend the Special Meeting physically. To ensure your representation at the Special Meeting, you are urged to complete, sign, date and return the enclosed proxy card as soon as possible. If your
shares are held in an account at a brokerage firm or bank, you must instruct your broker or bank on how to vote your shares.
Your vote is
important regardless of the number of shares you own. Whether you plan to attend the Special Meeting or not, please sign, date and return the enclosed proxy card as soon as possible in the envelope provided. If your shares are held in street
name or are in a margin or similar account, you should contact your broker to ensure that votes related to the shares you beneficially own are properly counted.
If you have any questions or need assistance voting your shares, please call Morrow Sodali LLC, ERESs proxy solicitor, toll free at
(800) 662-5200.
Thank you for your participation. We look forward to your continued support.
|
|
|
|
|
By Order of the Board of Directors |
|
|
|
|
|
|
|
Terrence M. Pegula |
|
|
Chief Executive Officer, President and Chairman |
[●], 2023
IF YOU RETURN YOUR SIGNED PROXY CARD WITHOUT AN INDICATION OF HOW YOU WISH TO VOTE, YOUR SHARES WILL BE VOTED IN FAVOR OF EACH OF THE
PROPOSALS. TO EXERCISE YOUR REDEMPTION RIGHTS, YOU MUST ELECT TO HAVE ERES REDEEM YOUR SHARES FOR A PRO RATA PORTION OF THE FUNDS HELD IN THE TRUST ACCOUNT AND TENDER YOUR SHARES TO ERESS TRANSFER AGENT AT LEAST TWO (2) BUSINESS DAYS
PRIOR TO THE VOTE AT THE SPECIAL MEETING. YOU MAY TENDER YOUR SHARES BY EITHER DELIVERING YOUR SHARE
CERTIFICATE TO THE TRANSFER AGENT OR BY DELIVERING YOUR SHARES ELECTRONICALLY USING THE DEPOSITORY TRUST COMPANYS DWAC (DEPOSIT AND WITHDRAWAL AT CUSTODIAN) SYSTEM. IF THE BUSINESS
COMBINATION IS NOT COMPLETED, THEN THESE SHARES WILL NOT BE REDEEMED FOR CASH. IF YOU HOLD THE SHARES IN STREET NAME, YOU WILL NEED TO INSTRUCT THE ACCOUNT EXECUTIVE AT YOUR BANKS OR BROKERS TO WITHDRAW THE SHARES FROM YOUR ACCOUNT IN ORDER TO
EXERCISE YOUR REDEMPTION RIGHTS. SEE ERESS SPECIAL MEETING OF STOCKHOLDERSREDEMPTION RIGHTS FOR MORE SPECIFIC INSTRUCTIONS.
BASIS OF PRESENTATION AND GLOSSARY
As used in this proxy statement, unless otherwise noted or the context otherwise requires, references to:
Abacus are to Abacus Settlements, LLC, a Florida limited liability company;
Abacus Interests are to the issued and outstanding limited liability company interests in Abacus;
Abacus Members are to holders of Abacus Interests;
Abacus Merger Sub are to Abacus Merger Sub, LLC, a Delaware limited liability company and wholly owned subsidiary of ERES;
Aggregate Transaction Proceeds are to an amount equal to: (a) the aggregate cash proceeds available for release
to ERES from the Trust Account in connection with the Business Combination; plus (b) the PIPE Investment Amount (as defined in the Merger Agreement) (while ERES continues to opportunistically seek to raise a PIPE investment, at this
time, it has no committed PIPE Investment Amount); minus (c) the aggregate amount of cash proceeds required to satisfy the redemption of any Public Shares by ERES stockholders; minus (d) the costs and expenses incurred by
ERES and Merger Subs in connection with the Business Combination; minus (e) the costs and expenses incurred by the Companies in connection with the Business Combination; minus (f) the aggregate amount of cash proceeds
required to repay in full the loans made by the Sponsor to ERES as of the Effective Time;
Amended and Restated Bylaws
are to the proposed Amended and Restated Bylaws of ERES in the form attached hereto as Annex C;
Business
Combination are to the Mergers and the other transactions contemplated by the Merger Agreement;
Class A Common Stock or ERES Class A Common Stock are to the
shares of ERESs Class A common stock, par value $0.0001 per share, prior to the Business Combination, and to shares of the Post-Combination Companys common stock, par value $0.0001 per share,
after the Business Combination;
Class B Common Stock or ERES Class B
Common Stock are to the shares of ERESs Class B common stock, par value $0.0001 per share;
Code
are to the Internal Revenue Code of 1986, as amended;
Common Stock or ERES Common Stock are to the
ERES Class A Common Stock and ERES Class B Common Stock, collectively;
Companies are to Abacus and
LMA, collectively;
Company Members are to the holders of LMA Interests and Abacus Interests prior to the closing of
the Business Combination;
DGCL are to the Delaware General Corporation Law, as may be amended from time to time;
ERES are to East Resources Acquisition Company, a Delaware corporation;
ERES IPO or Initial Public Offering are to the initial public offering by ERES, which closed on
July 27, 2020;
ERES public warrants or public warrants are to the warrants issued as part of the ERES
IPO, with each unit offered consisting of one share of Class A common stock and one-half of one public warrant. Each whole public warrant issued is eligible to purchase one share of Class A Common Stock at a price of $11.50,
iv
regardless of whether the holder has previously redeemed their ERES Class A Common Stock purchased in connection with the ERES IPO;
ERES Record Date are to [●], 2023;
Exchange Act are to the Securities Exchange Act of 1934, as amended;
Existing Charter are to the Amended and Restated Certificate of Incorporation of ERES, dated July 23, 2020, as amended
by that certain Certificate of Amendment, dated July 25, 2022;
Extension Note are to the note dated July 25,
2022, entered into by and between ERES and the Sponsor in connection with the extension of the business combination deadline;
Extension Warrants are to the warrants that are issuable at the closing of the Business Combination if the Sponsor elects
to exercise its option to convert up to $1,500,000 of the unpaid principal balance of the Extension Note into that number of warrants equal to the principal amount of the Extension Note so converted divided by $1.50;
Founder Shares are to the shares of ERES Class B Common Stock and ERES Class A Common Stock issued upon the
automatic conversion thereof at the time of ERESs initial business combination as provided herein. The 8,625,000 Founder Shares are held of record by the Initial Stockholders as of the ERES Record Date;
GAAP are to generally accepted accounting principles in the United States, as applied on a consistent basis;
Initial Stockholders are to holders of the Founder Shares prior to the Business Combination;
Investment Company Act are to the Investment Company Act of 1940, as amended;
LMA are to Longevity Market Assets, LLC, a Florida limited liability company;
LMA Interests are to the issued and outstanding limited liability company interests in LMA;
LMA Members are to the holders of LMA Interests;
LMA Merger Sub are to LMA Merger Sub, LLC, a Delaware limited liability company and wholly owned subsidiary of ERES;
Merger Subs are to Abacus Merger Sub and LMA Merger Sub;
Nasdaq are to The Nasdaq Capital Market;
Post-Combination Company are to ERES following the consummation of the
Mergers and the other transactions contemplated by the Merger Agreement;
Private Placement Warrants are to the
warrants issued by ERES to the Sponsor in a private placement simultaneously with the closing of the ERES IPO;
Proposed
Charter are to the Second Amended and Restated Certificate of Incorporation of ERES proposed under the Charter Approval Proposal;
Public Shares are to shares of ERES Class A Common Stock sold as part of the units in the ERES IPO (whether they were
purchased in the ERES IPO or thereafter in the open market);
v
Public Stockholders are to the holders of the Public Shares;
SEC are to the U.S. Securities and Exchange Commission;
Second Extension Note are to the note dated January 23, 2023, entered into by and between ERES and the Sponsor in
connection with the extension of the business combination deadline;
Second Extension Warrants are
to the warrants that are issuable at the closing of the Business Combination if the Sponsor elects to exercise its option to convert up to $500,000 of the unpaid principal balance of the Second Extension Note into that number of warrants equal to
the principal amount of the Second Extension Note so converted divided by $1.50;
Securities Act are to the
Securities Act of 1933, as amended;
Sponsor are to East Sponsor, LLC, a Delaware limited liability company;
Trust Account are to the trust account established by ERES at Continental Stock Transfer & Trust Company for the
benefit of ERESs stockholders;
Working Capital Loans or Working Capital Note are to the loans
made to ERES by the Sponsor, members of ERES founding team or any of their affiliates in order to finance transaction costs in connection with a business combination; and
Units or ERES units are to the units publicly offered as part of the ERES IPO and the units later
available through the consummation of the full exercise of the underwriter over-allotment option. Each unit consists of one share of Class A common stock and one-half of one public warrant.
Unless specified otherwise, amounts in this proxy statement are presented in United States (U.S.) dollars.
Defined terms in the financial statements contained in this proxy statement have the meanings ascribed to them in the financial statements.
vi
TRADEMARKS, TRADE NAMES AND SERVICE MARKS
ERES, the Companies and their respective subsidiaries own or have rights to trademarks, trade names and service marks that they use in
connection with the operation of their business. In addition, their names, logos and website names and addresses are their trademarks or service marks. Other trademarks, trade names and service marks appearing in this proxy statement are the
property of their respective owners. Solely for convenience, in some cases, the trademarks, trade names and service marks referred to in this proxy statement are listed without the applicable
®, M and SM symbols, but ERES, the Companies and their respective subsidiaries will assert, to the fullest extent under applicable law, their rights to these trademarks, trade names and
service marks.
vii
QUESTIONS AND ANSWERS
The questions and answers below highlight only selected information from this proxy statement and only briefly address some commonly asked
questions about the Business Combination and the Mergers, the Special Meeting in lieu of the 2022 annual meeting and the Proposals to be presented at the Special Meeting. The following questions and answers do not include all the information that is
important to ERES stockholders. You are urged to carefully read this entire proxy statement, including the Annexes and the other documents referred to herein, to fully understand the Business Combination and the voting procedures for the Special
Meeting.
QUESTIONS AND ANSWERS ABOUT THE BUSINESS COMBINATION
Q: |
WHAT IS THE BUSINESS COMBINATION? |
A: |
ERES, LMA Merger Sub, a wholly owned subsidiary of ERES, Abacus Merger Sub, a wholly owned subsidiary of ERES,
and Abacus and LMA have entered into the Merger Agreement, pursuant to which Abacus Merger Sub will merge with and into Abacus, with Abacus surviving the Abacus Merger as a wholly owned subsidiary of ERES and LMA Merger Sub will merge with and into
LMA, with LMA surviving the LMA Merger as a wholly owned subsidiary of ERES. In connection with the closing of the Mergers (the Closing), ERES will be renamed Abacus Life, Inc. |
ERES will hold the Special Meeting to, among other things, obtain the approvals required for the Business Combination and the other
transactions contemplated by the Merger Agreement, and you are receiving this proxy statement in connection with such meeting. See the section entitled The Merger Agreement. In addition, a copy of the Merger Agreement is
attached to this proxy statement as Annex A-1, a copy of the Amendment is attached to this proxy statement as Annex A-2 and a copy of the Second Amendment
is attached to this proxy statement as Annex A-3. We urge you to carefully read this proxy statement, including the Annexes and the other documents referred to herein, in their entirety.
Q: |
WHY AM I RECEIVING THIS DOCUMENT? |
A: |
ERES is sending this proxy statement to its stockholders to help them decide how to vote their shares of ERES
Common Stock with respect to the matters to be considered at the Special Meeting. The Business Combination cannot be completed unless ERESs stockholders approve the Business Combination Proposal, the Charter Approval Proposal, the Nasdaq
Proposal and the Incentive Plan Proposal set forth in this proxy statement for their approval. Information about the Special Meeting, the Business Combination and the other business to be considered by stockholders at the Special Meeting is
contained in this proxy statement. This document constitutes a proxy statement of ERES. It is a proxy statement because the board of directors of ERES is soliciting proxies using this proxy statement from its stockholders. |
Q: |
WHAT WILL COMPANY MEMBERS RECEIVE IN THE BUSINESS COMBINATION? |
A: |
As part of the Business Combination, the Company Members will receive aggregate merger consideration of
$531.8 million, payable in newly issued shares of ERES Class A Common Stock at a price of $10.00 per share, with the Company Members having the option to elect to receive a portion of the aggregate merger consideration of up to
$20.0 million in cash consideration under certain circumstances. |
At the Effective Time, the limited liability
company interests in each of LMA and Abacus issued and outstanding immediately prior to the Closing will be cancelled and converted into the right to receive a portion of the aggregate merger consideration.
The total number of shares of ERES Class A Common Stock expected to be issued to the Company Members in connection with the Closing is
approximately 53.2 million, and the Company Members as of immediately prior to the Closing will hold, in the aggregate, approximately 82% of the fully diluted shares of ERES Class A Common Stock immediately following the Closing (assuming
that no shares of ERES
viii
Class A Common Stock are validly redeemed). See the section entitled The Merger AgreementMerger Consideration.
Q: |
WHEN DO YOU EXPECT THE BUSINESS COMBINATION TO BE COMPLETED? |
A: |
It is currently anticipated that the Business Combination will be consummated promptly following the Special
Meeting, which is set for [●], 2023; however, such meeting could be adjourned, as described herein. Neither ERES nor the Companies can assure you of when or if the Business Combination will be completed and it is possible that factors outside
of the control of both parties could result in the Business Combination being completed at a different time or not at all. ERES must first obtain the approval of its stockholders for certain of the Proposals set forth in this proxy statement for
their approval, and ERES and the Companies must also first obtain certain necessary regulatory approvals and satisfy other closing conditions. See the section entitled The Merger AgreementConditions to the Business
Combination. |
Q: |
WHAT HAPPENS IF THE BUSINESS COMBINATION IS NOT COMPLETED? |
A: |
If the Business Combination is not completed, Company Members will not receive any consideration for their
limited liability company interests in the Companies. Instead, the Companies will remain independent companies. See the sections entitled The Merger AgreementTermination and Risk Factors.
|
Q: |
HOW WILL ERES BE MANAGED AND GOVERNED FOLLOWING THE BUSINESS COMBINATION? |
A: |
Following the Closing, the Post-Combination Companys executive officers are expected to be the current
management team of the Companies. See the section entitled Management of the Post-Combination Company Following the Business Combination for more information. |
ERES is, and after the Closing will continue to be, managed by its board of directors. Following the Closing, the size of our board of
directors will be seven directors.
Following the Closing, we expect that a majority of the directors will be independent under applicable
Nasdaq listing rules. See the section entitled Management of the Post-Combination Company Following the Business Combination for more information.
Q: |
WHAT EQUITY STAKE WILL CURRENT ERES STOCKHOLDERS, THE INITIAL STOCKHOLDERS, AND THE COMPANY MEMBERS HOLD IN
ERES FOLLOWING THE CLOSING? |
A: |
The following table illustrates varying ownership levels in the
Post-Combination Company immediately following the Closing, assuming (i) no Public Shares are redeemed, (ii) 50% of Public Shares are redeemed and (iii) 100% of Public Shares are redeemed, each on a
shares outstanding and fully diluted basis, in each case assuming that the Cash Consideration equals zero. The numbers of shares and percentage interests set forth below are based on a number of assumptions. If the actual
facts differ from our assumptions, the |
ix
|
number of shares and percentage interests set forth below will be different. For more information, see the section entitled Unaudited Pro Forma Condensed Combined Financial
Information. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
No Redemption Scenario(1) |
|
|
50% Redemption Scenario(2) |
|
|
100% Redemption Scenario(3) |
|
|
|
Outstanding Shares |
|
|
Outstanding Ownership |
|
|
Fully Diluted Shares(4) |
|
|
Fully Diluted Ownership |
|
|
Outstanding Shares |
|
|
Outstanding Ownership |
|
|
Fully Diluted Shares(4) |
|
|
Fully Diluted Ownership |
|
|
Outstanding Shares |
|
|
Outstanding Ownership |
|
|
Fully Diluted Shares(4) |
|
|
Fully Diluted Ownership |
|
Current public ERES stockholders |
|
|
2,856,047 |
|
|
|
4.42 |
% |
|
|
20,106,047
|
|
|
|
21.08 |
% |
|
|
1,428,024 |
|
|
|
2.26 |
% |
|
|
18,678,024 |
|
|
|
19.90 |
% |
|
|
0 |
|
|
|
0.00 |
% |
|
|
17,250,000 |
|
|
|
18.67 |
% |
Initial Stockholders |
|
|
8,625,000 |
|
|
|
13.34 |
% |
|
|
17,078,333
|
|
|
|
17.91 |
% |
|
|
8,625,000 |
|
|
|
13.64 |
% |
|
|
17,078,333 |
|
|
|
18.19 |
% |
|
|
8,625,000 |
|
|
|
13.96 |
% |
|
|
17,078,333 |
|
|
|
18.49 |
% |
Current Company Members(5) |
|
|
53,175,000 |
|
|
|
82.24 |
% |
|
|
53,175,000 |
|
|
|
55.76 |
% |
|
|
53,175,000 |
|
|
|
84.10 |
% |
|
|
53,175,000 |
|
|
|
56.65 |
% |
|
|
53,175,000 |
|
|
|
86.04 |
% |
|
|
53,175,000 |
|
|
|
57.57 |
% |
Incentive Plan(6) |
|
|
0 |
|
|
|
0.00 |
% |
|
|
3,232,802 |
|
|
|
3.39 |
% |
|
|
0 |
|
|
|
0.00 |
% |
|
|
3,161,401 |
|
|
|
3.37 |
% |
|
|
0 |
|
|
|
0.00 |
% |
|
|
3,090,000 |
|
|
|
3.35 |
% |
Warrant Pool |
|
|
0 |
|
|
|
0.00 |
% |
|
|
1,780,000 |
|
|
|
1.87 |
% |
|
|
0 |
|
|
|
0.00 |
% |
|
|
1,780,000 |
|
|
|
1.90 |
% |
|
|
0 |
|
|
|
0.00 |
% |
|
|
1,780,000 |
|
|
|
1.93 |
% |
Pro forma Class A Common Stock at December 31, 2022 |
|
|
64,656,047 |
|
|
|
100 |
% |
|
|
95,372,182 |
|
|
|
100 |
% |
|
|
63,228,024 |
|
|
|
100 |
% |
|
|
93,872,758 |
|
|
|
100 |
% |
|
|
61,800,000 |
|
|
|
100 |
% |
|
|
92,373,333 |
|
|
|
100 |
% |
(1) |
This presentation assumes that no Public Stockholders exercise their right to have their Public Shares converted
into their pro rata share of the Trust Account. |
(2) |
This presentation assumes that (i) Public Stockholders exercise their rights to have 50% of all outstanding
Public Shares converted into their pro rata share of the Trust Account and (ii) such redeeming Public Stockholders continue to hold public warrants following exercise of their redemption rights. |
(3) |
This presentation assumes that (i) Public Stockholders exercise their rights to have 100% of all
outstanding Public Shares converted into their pro rata share of the Trust Account and (ii) such redeeming Public Stockholders continue to hold public warrants following exercise of their redemption rights. |
(4) |
(a) This presentation assumes that (i) Public Stockholders exercise the 17,250,000 public warrants,
(ii) the Initial Stockholders exercise the 7,120,000 Private Placement Warrants, (iii) the 1,780,000 warrants in the warrant pool are exercised, (iv) the Sponsor exercises its option to convert up to $1,500,000 of the unpaid principal
balance on the Extension Note to 1,000,000 Extension Warrants and exercises such warrants, (v) the Sponsor exercises its option to convert up to $500,000 of the unpaid principal balance on the Second Extension Note to 333,333 Second Extension
Warrants and exercises such warrants and (vi) all shares underlying the Incentive Plan are issued. |
(b) The
presentation includes shares that may be issued but are not presently outstanding and, as such, differ from the share counts shown or assumed in the sections entitled Summary Unaudited Pro Forma Condensed Combined Financial Information,
Unaudited Historical Comparative and Pro Forma Combined Per Share Data of ERES and the Companies, Unaudited Pro Forma Condensed Combined Financial Information and Comparative Historical and Unaudited Pro Forma Combined
Per Share Financial Information, which sections are limited to shares that are presently issued and outstanding.
(5) |
Includes 4,569,922 shares of incentive units related to a non-pro rata distribution to one of the existing
owners of the Companies, which will be subject to forfeiture as included in Annex I. |
(6) |
Reflects shares expected to be reserved for issuance under the Incentive Plan (assuming the Incentive Plan
Proposal is approved). |
The following table further illustrates the impact on relative fully diluted ownership levels of
the Post-Combination Company for each source of dilution, namely the issuance of Class A Common Stock under (i) the 17,250,000 public warrants, (ii) the 7,120,000 Private Placement Warrants, (iii) the 1,780,000 warrants under the
warrant pool granted to the Post-Combination Company, (iv) the 1,000,000 Extension Warrants, (v) the 333,333 Second Extension Warrants and (vi) the Incentive Plan.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
No Redemption Scenario(1) |
|
|
50% Redemption Scenario(2) |
|
|
100% Redemption Scenario(3) |
|
|
|
Number of Shares |
|
|
Fully Diluted Ownership(4) |
|
|
Number of Shares |
|
|
Fully Diluted Ownership(4) |
|
|
Number of Shares |
|
|
Fully Diluted Ownership(4) |
|
Current Stockholders |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current ERES Public Stockholders |
|
|
2,856,047 |
|
|
|
2.99 |
% |
|
|
1,428,024 |
|
|
|
1.52 |
% |
|
|
0 |
|
|
|
0.00 |
% |
Initial Stockholders |
|
|
8,625,000 |
|
|
|
9.04 |
% |
|
|
8,625,000 |
|
|
|
9.19 |
% |
|
|
8,625,000 |
|
|
|
9.34 |
% |
Total Current Stockholders |
|
|
11,481,047 |
|
|
|
12.04 |
% |
|
|
10,053,024 |
|
|
|
10.71 |
% |
|
|
8,625,000 |
|
|
|
9.34 |
% |
Shares Issued Upon Exercise of Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ERES Public Warrants |
|
|
17,250,000 |
|
|
|
18.09 |
% |
|
|
17,250,000 |
|
|
|
18.38 |
% |
|
|
17,250,000 |
|
|
|
18.67 |
% |
ERES Sponsor Private Warrants |
|
|
7,120,000 |
|
|
|
7.47 |
% |
|
|
7,120,000 |
|
|
|
7.58 |
% |
|
|
7,120,000 |
|
|
|
7.71 |
% |
Extension Warrants |
|
|
1,000,000 |
|
|
|
1.05 |
% |
|
|
1,000,000 |
|
|
|
1.07 |
% |
|
|
1,000,000 |
|
|
|
1.08 |
% |
Second Extension Warrants |
|
|
333,333 |
|
|
|
0.35 |
% |
|
|
333,333 |
|
|
|
0.36 |
% |
|
|
333,333 |
|
|
|
0.36 |
% |
Warrant Pool |
|
|
1,780,000 |
|
|
|
1.74 |
% |
|
|
1,780,000 |
|
|
|
1.83 |
% |
|
|
1,780,000 |
|
|
|
1.93 |
% |
Total Shares Issued Upon Exercise of Warrants |
|
|
27,483,333 |
|
|
|
28.82 |
% |
|
|
27,483,333 |
|
|
|
29.28 |
% |
|
|
27,483,333 |
|
|
|
29.75 |
% |
Current Company Members(5) |
|
|
53,175,000 |
|
|
|
55.76 |
% |
|
|
53,175,000 |
|
|
|
56.65 |
% |
|
|
53,175,000 |
|
|
|
57.57 |
% |
Incentive Plan(6) |
|
|
3,232,802 |
|
|
|
3.39 |
% |
|
|
3,161,401 |
|
|
|
3.37 |
%% |
|
|
3,090,000 |
|
|
|
3.35 |
% |
Pro Forma Class A Common Stock at December 31, 2022 |
|
|
95,372,182 |
|
|
|
100.00 |
% |
|
|
93,872,758 |
|
|
|
100.00 |
% |
|
|
92,373,333 |
|
|
|
100.00 |
% |
(1) |
This presentation assumes that no Public Stockholders exercise their right to have their Public Shares
converted into their pro rata share of the Trust Account. |
x
(2) |
This presentation assumes that (i) Public Stockholders exercise their rights to have 50% of all outstanding
Public Shares converted into their pro rata share of the Trust Account and (ii) such redeeming Public Stockholders continue to hold public warrants following exercise of their redemption rights. |
(3) |
This presentation assumes that (i) Public Stockholders exercise their rights to have 100% of all outstanding
Public Shares converted into their pro rata share of the Trust Account and (ii) such redeeming Public Stockholders continue to hold public warrants following exercise of their redemption rights. |
(4) |
(a) This presentation assumes that (i) Public Stockholders exercise the 17,250,000 public warrants, (ii) the
Initial Stockholders exercise the 7,120,000 Private Placement Warrants, (iii) the 1,780,000 warrants in the warrant pool are exercised, (iv) the Sponsor exercises its option to convert up to $1,500,000 of the unpaid principal balance on the
Extension Note to 1,000,000 Extension Warrants and exercises such warrants, (v) the Sponsor exercises its option to convert up to $500,000 of the unpaid principal balance on the Second Extension Note to 333,333 Second Extension Warrants and
exercises such warrants and (vi) all shares underlying the Incentive Plan are issued. |
(b) |
The presentation includes shares that may be issued but are not presently outstanding and, as such, differ from
the share counts shown or assumed in the sections entitled Summary Unaudited Pro Forma Condensed Combined Financial Information, Unaudited Historical Comparative and Pro Forma Combined Per Share Data of ERES and the
Companies, Unaudited Pro Forma Condensed Combined Financial Information and Comparative Historical and Unaudited Pro Forma Combined Per Share Financial Information, which sections are limited to shares that are
presently issued and outstanding. |
(5) |
Includes 4,569,922 shares of incentive units related to a non-pro rata distribution to one of the existing
owners of the Companies, which will be subject to forfeiture as included in Annex I. |
(6) |
Reflects shares expected to be reserved for issuance under the Incentive Plan (assuming the Incentive Plan
Proposal is approved). |
In addition to the changes in percentage ownerships depicted above, variations in redemptions
and dilutive equity issuances will also affect the per share value as illustrated in the table below.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
No Redemption Scenario(1) |
|
|
50% Redemption Scenario(2) |
|
|
100% Redemption Scenario(3) |
|
|
|
Number of Shares |
|
|
Value per Share(4) |
|
|
Number of Shares |
|
|
Value per Share(4) |
|
|
Number of Shares |
|
|
Value per Share(4) |
|
Base Scenario at December 31,
2022(5) |
|
|
64,656,047 |
|
|
$ |
8.68 |
|
|
|
63,228,024 |
|
|
$ |
8.64 |
|
|
|
61,800,000 |
|
|
$ |
8.60 |
|
Fully Diluted Scenario at December 31,
2022(6) |
|
|
95,372,182 |
|
|
$ |
9.20 |
|
|
|
93,872,758 |
|
|
$ |
9.19 |
|
|
|
92,373,333 |
|
|
$ |
9.18 |
|
(1) |
This presentation assumes that no Public Stockholders exercise their right to have their Public Shares
converted into their pro rata share of the Trust Account. |
(2) |
This presentation assumes that (i) Public Stockholders exercise their rights to have 50% of all
outstanding Public Shares converted into their pro rata share of the Trust Account and (ii) such redeeming Public Stockholders continue to hold public warrants following exercise of their redemption rights. |
(3) |
This presentation assumes that (i) Public Stockholders exercise their rights to have 100% of all
outstanding Public Shares converted into their pro rata share of the Trust Account and (ii) such redeeming Public Stockholders continue to hold public warrants following exercise of their redemption rights. |
(4) |
Based on the Post-Combination Company Equity Values set forth below. |
(5) |
Reflects current Public Shares and Founder Shares outstanding, plus shares to be issued to
current Company Members upon the consummation of the Business Combination, including the 4,569,922 shares of incentive units related to a non-pro rata distribution to one of the existing owners of the Companies, which will be subject to forfeiture
as included in Annex I. |
(6) |
(a) This presentation assumes that (i) Public Stockholders exercise the 17,250,000 public warrants,
(ii) the Initial Stockholders exercise the 7,120,000 Private Placement Warrants, (iii) the 1,780,000 warrants in the warrant pool are exercised, (iv) the Sponsor exercises its option to convert up to $1,500,000 of the unpaid principal
balance on the Extension Note to 1,000,000 Extension Warrants and exercises such warrants, |
xi
|
(v) the Sponsor exercises its option to convert up to $500,000 of the unpaid principal balance on the Second Extension Note to 333,333 Second Extension Warrants and exercises such warrants
and (vi) all shares underlying the Incentive Plan are issued. |
(b) The presentation includes shares that may be issued
but are not presently outstanding and, as such, differ from the share counts shown or assumed in the sections entitled Summary Unaudited Pro Forma Condensed Combined Financial Information, Unaudited Historical Comparative and Pro
Forma Combined Per Share Data of ERES and the Companies, Unaudited Pro Forma Condensed Combined Financial Information and Comparative Historical and Unaudited Pro Forma Combined Per Share Financial Information, which
sections are limited to shares that are presently issued and outstanding.
|
|
|
|
|
|
|
|
|
|
|
|
|
Post-Combination Company Equity Value (in millions): |
|
|
|
|
|
|
|
No Redemption Scenario |
|
|
50% Redemption Scenario |
|
|
100% Redemption Scenario |
|
Base Scenario at December 31,
2022(7) |
|
$ |
560.91 |
|
|
$ |
546.33 |
|
|
$ |
531.75 |
|
Fully Diluted Scenario at December 31, 2022(8) |
|
$ |
876.97 |
|
|
$ |
862.39 |
|
|
$ |
847.81 |
|
(7) |
Assumes a deemed equity value of $10.00 per share for the Class A Common Stock issued to the current Company
Members, plus the amount remaining in the Trust Account after deductions for payments to redeeming stockholders. |
(8) |
(a) Assumes that (i) Public Stockholders exercise the 17,250,000 public warrants, (ii) the Initial
Stockholders exercise the 7,120,000 Private Placement Warrants, (iii) the 1,780,000 warrants in the warrant pool are exercised, (iv) the Sponsor exercises its option to convert up to $1,500,000 of the unpaid principal balance on the
Extension Note to 1,000,000 Extension Warrants and exercises such warrants, (v) the Sponsor exercises its option to convert up to $500,000 of the unpaid principal balance on the Second Extension Note to 333,333 Second Extension Warrants and
exercises such warrants and (vi) all shares underlying the Incentive Plan are issued. |
(b) Includes shares that may
be issued but are not presently outstanding and, as such, differs from the share counts shown or assumed in the sections entitled Summary Unaudited Pro Forma Condensed Combined Financial Information, Unaudited Historical
Comparative and Pro Forma Combined Per Share Data of ERES and the Companies, Unaudited Pro Forma Condensed Combined Financial Information and Comparative Historical and Unaudited Pro Forma Combined Per Share Financial
Information, which sections are limited to shares that are presently issued and outstanding.
If a Public Stockholder exercises its
redemption rights, such exercise will not result in the loss of any warrants that it may hold. We cannot predict the ultimate value of the ERES public warrants following the consummation of the Business Combination, but assuming that 100%, or
2,856,047 shares of Class A Stock held by our Public Stockholders were redeemed, the 17,250,000 retained outstanding ERES public warrants would have an aggregate value of $1.73 million based on a price per ERES public warrant of $0.10 on
April 20, 2023, the most recent practicable date prior to the date of this proxy statement.
Q: |
FOLLOWING THE BUSINESS COMBINATION, WILL ERESS SECURITIES CONTINUE TO TRADE ON A STOCK EXCHANGE?
|
A: |
Yes. Upon the Closing, we intend to change our name from East Resources Acquisition Company to
Abacus Life, Inc., and our common stock and warrants will be listed following the closing under the symbols ABL and ABLLW, respectively. ERESs units will be delisted and deregistered following the Closing.
|
xii
QUESTIONS AND ANSWERS ABOUT THE SPECIAL MEETING
Q: |
WHEN AND WHERE IS THE SPECIAL MEETING? |
A: |
The Special Meeting will be held at [●], on [●], 2023, in virtual format at
https://www.cstproxy.com/eastresources/2023. ERES stockholders may attend, vote and examine the list of ERES stockholders entitled to vote at the Special Meeting by visiting and entering the control number found on their proxy card, voting
instruction form or notice included in their proxy materials. In light of public health concerns regarding the coronavirus (COVID-19) pandemic, the Special Meeting will be held in virtual meeting
format only. You will not be able to attend the Special Meeting physically. |
Q: |
WHAT AM I BEING ASKED TO VOTE ON AND WHY IS THIS APPROVAL NECESSARY? |
A: |
The stockholders of ERES are being asked to vote on the following: |
|
|
|
A proposal to adopt the Merger Agreement and the transactions contemplated thereby. See the section entitled
Proposal No. 1The Business Combination Proposal. |
|
|
|
A proposal to adopt the Proposed Charter in the form attached hereto as Annex B. See the
section entitled Proposal No. 2The Charter Approval Proposal. |
|
|
|
A proposal with respect to certain governance provisions in the Proposed Charter, which are being separately
presented in accordance with SEC requirements and which will be voted upon on a non-binding advisory basis. See the section entitled Proposal No. 3The Governance
Proposal. |
|
|
|
A proposal for Class B Common Stock holders to elect seven directors to serve on the Board until the 2023
annual meeting of stockholders, in the case of Class I directors, the 2024 annual meeting of stockholders, in the case of Class II directors, and the 2025 annual meeting of stockholders, in the case of Class III directors, and, in
each case, until their respective successors are duly elected and qualified. See the section entitled Proposal No. 4The Director Election Proposal. |
|
|
|
A proposal to approve, for purposes of complying with applicable listing rules of Nasdaq, the issuance of shares
of ERES Class A Common Stock to the Company Members pursuant to the Merger Agreement. See the section entitled Proposal No. 5The Nasdaq Proposal. |
|
|
|
A proposal to approve and adopt the Incentive Plan in the form attached hereto as Annex G. See the
section entitled Proposal No. 6The Incentive Plan Proposal. |
|
|
|
A proposal to approve the adjournment of the Special Meeting to a later date or dates, if necessary, to permit
further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the Business Combination Proposal, the Charter Approval Proposal, the Director Election Proposal, the
Nasdaq Proposal or the Incentive Plan Proposal. See the section entitled Proposal No. 7The Adjournment Proposal. |
ERES will hold the Special Meeting to consider and vote upon these Proposals. This proxy statement contains important information about the
proposed Mergers and the other matters to be acted upon at the Special Meeting.
Stockholders should read this proxy statement carefully,
including the Annexes and the other documents referred to herein.
Consummation of the Business Combination is conditioned on the approval
of each of the Business Combination Proposal, the Charter Approval Proposal, the Nasdaq Proposal and the Incentive Plan Proposal, subject to the terms of the Merger Agreement. If the Business Combination Proposal is not approved, the other
Proposals, except the Adjournment Proposal, will not be presented to stockholders for a vote.
The vote of stockholders is important.
Stockholders are encouraged to vote as soon as possible after carefully reviewing this proxy statement.
xiii
Q: |
I AM AN ERES WARRANT HOLDER. WHY AM I RECEIVING THIS PROXY STATEMENT? |
A: |
Upon consummation of the Mergers, the ERES warrants shall, by their terms, entitle the holders to purchase
Class A Common Stock at a purchase price of $11.50 per share. This proxy statement includes important information about the Companies and the business of the Companies and its subsidiaries following consummation of the Mergers. As holders of
ERES warrants will be entitled to purchase Class A Common Stock of the Post-Combination Company upon consummation of the Mergers, ERES urges you to read the information contained in this proxy statement carefully. |
Q: |
WHO ARE THE COMPANIES? |
A: |
Abacus and LMA comprise a leading, vertically integrated alternative asset manager specializing in buying,
trading, holding and servicing life insurance products as financial investment assets. Abacus was formed in 2004 as a New York limited liability company and LMA was formed in 2017 as a Florida limited liability company. In 2016, Abacus was licensed
in Florida as a life settlement broker and became a Florida limited liability company. The Companies are not insurance companies or insurance agents, brokers or producers, are not licensed or regulated as insurance companies or insurance agents,
brokers or producers and therefore do not underwrite insurable risks or sell new insurance policies for their own account. See the section entitled Information About the Post-Combination Company Following the Business Combination.
|
Q: |
WHY IS ERES PROPOSING THE BUSINESS COMBINATION? |
A: |
ERES was organized to effect a merger, capital stock exchange, asset acquisition, stock purchase,
reorganization or similar business combination with one or more businesses. |
On July 27, 2020, ERES completed
the ERES IPO at a price per unit of $10.00, with each unit consisting of one share of Class A Common Stock and one-half of one public warrant, each whole public warrant eligible to purchase one share of
Class A Common Stock at a price of $11.50, raising total gross proceeds of $300,000,000. On the same date, ERES also completed a private placement of warrants to its Sponsor, raising total gross proceeds of $8,000,000. On August 25, 2021,
the underwriter in the ERES IPO fully exercised its over-allotment option, resulting in the offering of an additional 4,500,000 units and 900,000 Private Placement Warrants. Following the closing of the over-allotment option, an aggregate of $345,000,000 was placed in ERESs Trust Account. On July 25, 2022, ERESs stockholders approved an amendment to its Existing Charter (the Extension
Amendment) that extended the date by which ERES must consummate its initial business combination from July 27, 2022 to January 27, 2023. In connection with the Extension Amendment, ERES issued the Extension Note in the aggregate
principal amount of up to $1,924,356.46 to the Sponsor, pursuant to which the Sponsor agreed to loan ERES up to $1,924,356.46 in connection with the Extension Amendment. Also in connection with the Extension Amendment, stockholders holding
24,781,028 shares of Class A Common Stock exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account. As a result, approximately $97,939,800.60 remained in the Trust Account after paying such redeeming
holders, prior to the Sponsors deposit of additional funds in connection with the Extension Amendment. On January 20, 2023, ERESs stockholders approved an amendment to its Existing Charter (the Second Extension Amendment)
that extended the date by which ERES must consummate its initial business combination from January 27, 2023 to July 27, 2023. In connection with the Second Extension Amendment, ERES issued the Second Extension Note in the aggregate principal amount
of up to $565,497.31 to the Sponsor, pursuant to which the Sponsor agreed to loan ERES up to $565,497.31 in connection with the Second Extension Amendment. Also in connection with the Second Extension Amendment, stockholders holding 6,862,925 shares
of Class A Common Stock exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account. As a result, approximately $29,102,648.33 remained in the Trust Account after paying such redeeming holders, prior to the
Sponsors deposit of additional funds in connection with the Second Extension Amendment.
Based on its due diligence
investigations of the Companies and the industry in which they operate, including the financial and other information provided by the Companies in the course of their negotiations in connection with the Merger Agreement, ERES believes that the
Business Combination with the Companies
xiv
is advisable and in the best interests of ERES and its stockholders. See the section entitled The Business CombinationERES Reasons for Approval of the Business
Combination.
Q: |
DID THE ERES BOARD OBTAIN A THIRD-PARTY VALUATION OR FAIRNESS
OPINION IN DETERMINING WHETHER OR NOT TO PROCEED WITH THE MERGERS? |
A: |
Yes. The ERES Board engaged Northland Securities, Inc. (Northland) to provide an opinion
(a) as to the fairness, from a financial point of view, of the consideration to be paid by ERES to the Company Members to ERES and its unaffiliated Public Stockholders and (b) that the Companies had an aggregate fair market value equal to
at least 80% of the balance of the funds in ERESs Trust Account (excluding deferred underwriting commissions and taxes payable and subject to proportionate adjustments related to Nasdaqs 80% test). On August 29, 2022, Northland
rendered its oral opinion to the ERES Board, which was subsequently confirmed in writing by delivery of Northlands written opinion dated the same date, based upon and subject to the assumptions, limitations and qualifications contained in its
opinion, and other factors Northland considers relevant, that (i) the consideration to be paid by ERES to the Company Members pursuant to the Merger Agreement was fair, from a financial point of view, to ERES and its unaffiliated Public
Stockholders and (ii) the Companies had an aggregate fair market value equal to at least 80% of the balance of funds in ERESs Trust Account (excluding deferred underwriting commissions and taxes payable and subject to proportionate
adjustments related to Nasdaqs 80% test). |
Q: |
WHY IS ERES PROVIDING STOCKHOLDERS WITH THE OPPORTUNITY TO VOTE ON THE BUSINESS COMBINATION?
|
A: |
We are seeking approval of the Business Combination for purposes of complying with applicable Nasdaq listing
rules requiring stockholder approval of issuances of more than 20% of a listed companys issued and outstanding common stock. In addition, pursuant to the Existing Charter, we must provide all Public Stockholders with the opportunity to redeem
all or a portion of their Public Shares upon the consummation of an initial business combination (as defined in our Existing Charter) either in conjunction with a tender offer or in conjunction with a stockholder vote to approve such initial
business combination. If we submit the proposed initial business combination to the stockholders for their approval, our Existing Charter requires us to conduct a redemption offer in conjunction with the proxy solicitation (and not in conjunction
with a tender offer) pursuant to the applicable SEC proxy solicitation rules. |
Q: |
DO THE COMPANY MEMBERS NEED TO APPROVE THE BUSINESS COMBINATION? |
A: |
Yes. In connection with the execution of the Merger Agreement, each Company Member delivered written consent
approving the Merger Agreement and the related agreements and transactions contemplated thereby. The execution and delivery of written consents by all of the Company Members constituted approval at the time of such delivery. Additionally,
concurrently with the execution of the Merger Agreement, ERES, Abacus, LMA and the Company Members entered into the Company Support Agreement (the Company Support Agreement). The Company Support Agreement provides, among other things,
that each Company Member agrees to vote or cause to be voted, at any meeting of the members of the applicable company (and at any adjournment or postponement thereof), however called, and in any written actions by consent of the members of the
applicable company, the membership interests held by such Company Members in favor of the Business Combination, on the terms and subject to the conditions set forth in the Company Support Agreement. The Company Members collectively own 100% of the
limited liability company interests in the Companies. |
Q: |
DO I HAVE REDEMPTION RIGHTS? |
A: |
If you are a holder of Public Shares, you have the right to demand that ERES redeem such shares for a pro rata
portion of the cash held in the Trust Account, which holds the proceeds, less redemptions, of the ERES IPO, as of two business days prior to the consummation of the transactions contemplated by the Business Combination Proposal (including interest
earned on the funds held in the Trust Account and not previously released to ERES to pay taxes) upon the Closing. |
xv
Notwithstanding the foregoing, a holder of Public Shares, together with any affiliate of
such holder or any other person with whom such holder is acting in concert or as a group (as defined in Section 13(d)(3) of the Exchange Act) will be restricted from seeking redemption with respect to more than 20% of the Public
Shares without the consent of ERES. Accordingly, all Public Shares in excess of 20% held by a Public Stockholder, together with any affiliate of such stockholder or any other person with whom such holder is acting in concert or as a
group, will not be redeemed without the consent of ERES.
Under ERESs Existing Charter, the Mergers may be consummated
only if ERES has at least $5,000,001 of net tangible assets after giving to all holders of Public Shares that properly demand redemption of their shares their pro rata portion of cash held in the Trust Account.
Q: |
WILL HOW I VOTE AFFECT MY ABILITY TO EXERCISE REDEMPTION RIGHTS? |
A: |
No. You may exercise your redemption rights whether you vote your Public Shares for or against, or whether you
abstain from voting on, the Business Combination Proposal or any other Proposal described in this proxy statement. As a result, the Business Combination Proposal can be approved by stockholders who will redeem their Public Shares and no longer
remain stockholders and the Mergers may be consummated even though the funds available from the Trust Account and the number of Public Stockholders are substantially reduced as a result of redemptions by Public Stockholders. |
Q: |
HOW DO I EXERCISE MY REDEMPTION RIGHTS? |
A: |
If you are a holder of Public Shares and wish to exercise your redemption rights, you must demand that ERES
redeem your shares for cash no later than the second business day preceding the vote on the Business Combination Proposal by delivering your stock to ERESs transfer agent physically or electronically using the Depository Trust Companys
DWAC (Deposit and Withdrawal at Custodian) system. Any holder of Public Shares will be entitled to demand that such holders Public Shares be redeemed for a pro rata portion of the amount then in the Trust Account (which, for illustrative
purposes, was approximately $[●] million, or approximately $[●] per Public Share, as of [●], 2023, the ERES Record Date). Such amount, including interest earned, if any, on the funds held in the Trust Account and not previously
released to ERES to pay its taxes, will be paid promptly upon consummation of the Mergers. However, under Delaware law, the proceeds held in the Trust Account could be subject to claims that could take priority over those of ERESs Public
Stockholders exercising redemption rights, regardless of whether such holders vote for or against the Business Combination Proposal. Therefore, the per Public Share distribution from the Trust Account in such a situation may be less than originally
anticipated due to such claims. Your vote on any Proposal will have no impact on the amount you will receive upon exercise of your redemption rights. |
Any request for redemption, once made by a holder of Public Shares, may be withdrawn at any time up to the time the vote is taken with respect
to the Business Combination Proposal at the Special Meeting. If you deliver your Public Shares for redemption to ERESs transfer agent and later decide prior to the Special Meeting not to elect redemption, you may request that ERESs
transfer agent return the Public Shares (physically or electronically).
If a holder of Public Shares properly makes a request for
redemption and the Public Shares are delivered to ERESs transfer agent as described herein, then, if the Mergers are consummated, ERES will redeem those shares for a pro rata portion of funds deposited in the Trust Account. If you exercise
your redemption rights, then you will be exchanging your Public Shares for cash and you will cease to have any rights as an ERES stockholder (other than the right to receive the redemption amount) upon consummation of the Mergers.
For a discussion of the material U.S. federal income tax considerations for holders of Public Shares with respect to the exercise of these
redemption rights, see the section entitled Material U.S. Federal Income Tax ConsequencesMaterial U.S. Federal Income Tax Consequences of the Redemption of Public Shares.
xvi
Q: |
WHAT ARE THE U.S. FEDERAL INCOME TAX CONSEQUENCES OF EXERCISING MY REDEMPTION RIGHTS?
|
A: |
The U.S. federal income tax consequences of exercising redemption rights that may be relevant to holders of
shares of ERES Class A Common Stock are discussed in more detail in the section entitled Material U.S. Federal Income Tax ConsiderationsMaterial U.S. Federal Income Tax Consequences of the Redemption of ERES Public
Stockholders. The discussion of the U.S. federal income tax consequences contained in this proxy statement is intended to provide only a general discussion and is not a complete analysis or description of all of the U.S. federal
income tax considerations that are applicable to holders of shares of ERES Class A Common Stock in respect of the exercise of their redemption rights, nor does it address any tax considerations arising under U.S. state or local or non-U.S. tax laws.
All holders considering exercising their redemption rights are urged to consult their tax advisor on the tax consequences to them of such an exercise of redemption rights, including the applicability and effect of U.S. federal, state, local and
non-U.S. tax laws. |
Q: |
DO I HAVE APPRAISAL RIGHTS IF I OBJECT TO THE PROPOSED BUSINESS COMBINATION? |
A: |
No. Neither ERES stockholders nor its unit or warrant holders have appraisal rights in connection with the
Business Combination under the DGCL. See the section entitled Appraisal Rights. |
Q: |
WHAT HAPPENS TO THE FUNDS DEPOSITED IN THE TRUST ACCOUNT AFTER CONSUMMATION OF THE BUSINESS COMBINATION?
|
A: |
Following the closing the ERES IPO, an amount equal to $345,000,000.00 ($10.00 per unit) of the net proceeds
from the ERES IPO and the sale of the Private Placement Warrants was placed in the Trust Account. As of [●], 2023, funds in the Trust Account totaled approximately $[●] in cash. Taking into account the Sponsors monthly
contributions pursuant to the Second Extension Note, and without giving effect to any requests for redemption in connection with the Special Meeting being held in connection with the Business Combination, the amount expected to be held in the Trust
Account on [●], 2023, is $[●]. Prior to June 2022, the funds in the Trust Account were comprised entirely of U.S. government treasury obligations with a maturity of 185 days or less or of money market funds meeting certain conditions
under Rule 2a-7 under the Investment Company Act, which invest only in direct U.S. government treasury obligations. These funds will remain in the Trust Account, except for the withdrawal of interest to pay
taxes, if any, until the earliest of (1) the completion of a business combination (including the Closing) and (2) the redemption of all of the Public Shares if ERES is unable to complete a business combination by July 27, 2023 (or if
such date is further extended at a duly called extraordinary general meeting, such later date), subject to applicable law. |
With respect to the regulation of special purpose acquisition companies like ERES (SPACs), on March 30, 2022, the SEC issued
proposed rules (the SPAC Rule Proposals) relating to, among other items, disclosures in business combination transactions involving SPACs and private operating companies; the condensed financial statement requirements applicable to
transactions involving shell companies; the use of projections by SPACs in SEC filings in connection with proposed business combination transactions; the potential liability of certain participants in proposed business combination transactions; and
the extent to which SPACs could become subject to regulation under the Investment Company Act, including a proposed rule that would provide SPACs a safe harbor from treatment as an investment company if they satisfy certain conditions that limit a
SPACs duration, asset composition, business purpose and activities.
With regard to the SECs investment company proposals
included in the SPAC Rule Proposals, while the funds in the Trust Account have, since the ERES IPO, been held only in U.S. government treasury bills with a maturity of 185 days or less or in money market funds investing solely in U.S. Treasuries, to
mitigate the risk of being viewed as operating an unregistered investment company (including pursuant to the subjective
xvii
test of Section 3(a)(1)(A) of the Investment Company Act), on June 22, 2022, ERES instructed Continental Stock Transfer & Trust Company, the trustee managing the Trust Account,
to hold all funds in the Trust Account in cash until the earlier of the consummation of the Business Combination and the liquidation of ERES.
On July 25, 2022, ERES entered into the Extension Note with the Sponsor, pursuant to which the Sponsor agreed to contribute to ERES as a
loan $0.033 for each Public Share that was not redeemed in connection with the stockholder vote to approve the extension of the date by which ERES must complete an initial business combination from July 27, 2022 to January 27, 2023 (which extension
was approved at the special meeting of ERES on July 25, 2022), for each month until the earlier of (i) the date of consummation of ERESs initial business combination and (ii) the date of liquidation of ERES. Such contributions
will be deposited into the Trust Account. Additionally, in connection with the stockholder approval of such extension in July 2022, certain stockholders elected to redeem an aggregate of 24,781,028 Public Shares, or approximately 71.83% of the then
outstanding Public Shares. Such redemption demands have been completed and such shares have been redeemed and, in relation thereto, we paid cash from the Trust Account in the aggregate amount of approximately $248,087,256.06, or approximately $10.01
per share, to redeeming stockholders. As a result, approximately $97,939,800.60 remained in the Trust Account after paying such redeeming holders.
On January 23, 2023, ERES entered into the Second Extension Note with the Sponsor, pursuant to which the Sponsor agreed to contribute to ERES
as a loan $0.033 for each Public Share that was not redeemed in connection with the stockholder vote to approve the extension of the date by which ERES must complete an initial business combination from January 27, 2023 to July 27, 2023 (which
extension was approved at the special meeting of ERES on January 20, 2023), for each month until the earlier of (i) the date of consummation of ERESs initial business combination and (ii) the date of liquidation of ERES. Such contributions
will be deposited into the Trust Account. Additionally, in connection with the stockholder approval of such extension in January 2023, certain stockholders elected to redeem an aggregate of 6,862,925 Public Shares, or approximately 70.61% of the
then outstanding Public Shares. Such redemption demands have been completed and such shares have been redeemed and, in relation thereto, we paid cash from the Trust Account in the aggregate amount of approximately $69,932,074.88, or approximately
$10.19 per share, to redeeming stockholders. As a result, approximately $29,102,648.33 remained in the Trust Account after paying such redeeming holders. As of [●], 2023, there is $[●] remaining in the Trust Account.
After consummation of the Mergers, the funds in the Trust Account will be used to pay holders of the Public Shares who exercise redemption
rights, to pay fees and expenses incurred in connection with the Mergers and for the Post-Combination Companys working capital and general corporate purposes.
Q: |
WHAT HAPPENS IF THE MERGERS ARE NOT CONSUMMATED? |
A: |
If ERES does not complete the Mergers with the Companies for whatever reason, ERES would search for another
target business with which to complete a business combination. If ERES does not complete the Mergers with the Companies or another target business by July 27, 2023 (the Completion Window), ERES must redeem 100% of the outstanding
Public Shares, at a per Public Share price, payable in cash, equal to the amount then held in the Trust Account including interest earned, if any, on the funds held in the Trust Account and not previously released to ERES to pay taxes (less up to
$100,000 of interest to pay dissolution expenses) divided by the number of outstanding Public Shares. The Initial Stockholders have no redemption rights in the event a business combination is not effected in the Completion Window, and, accordingly,
their Founder Shares will be worthless. Additionally, in the event of such liquidation, there will be no distribution with respect to ERESs outstanding warrants. Accordingly, the warrants will expire worthless. |
xviii
Q: |
WILL ERES SEEK TO AMEND THE EXISTING CHARTER TO EXTEND THE BUSINESS COMBINATION DEADLINE IF THE PROPOSED
BUSINESS COMBINATION WITH THE COMPANIES OR AN ALTERNATIVE BUSINESS COMBINATION IS NOT COMPLETED BY THE COMPLETION WINDOW ENDING ON JULY 27, 2023? |
While ERES is using its best efforts to complete the Business Combination with the Companies on or before the expiration of the Completion
Window, the ERES Board cannot guarantee that an additional extension will not be necessary. However, at this time, the ERES Board does not believe that an additional extension beyond the Completion Window will be necessary to complete the Business
Combination.
Q: |
HOW DOES THE SPONSOR INTEND TO VOTE ON THE PROPOSALS? |
A: |
As of the date of this proxy statement, and due to the redemption of 24,781,028 Public Shares in connection
with the stockholder vote in July 2022 and the redemption of 6,862,925 Public Shares in connection with the stockholder vote in January 2023 to approve the extension of the date by which ERES must complete an initial business combination, the
Sponsor (including ERESs directors, officers and Initial Stockholders and their permitted transferees) owns approximately 75% of the issued and outstanding ERES Common Stock, consisting of the Founder Shares. The Sponsor has agreed to vote any
shares of ERES Common Stock held by it as of the ERES Record Date in favor of each of the Proposals presented at the Special Meeting. |
Q: |
WHAT CONSTITUTES A QUORUM AT THE SPECIAL MEETING? |
A: |
A majority of the voting power of the issued and outstanding common stock of ERES entitled to vote at the
Special Meeting must be present, in person (which would include presence at a virtual meeting) or represented by proxy, at the Special Meeting to constitute a quorum and in order to conduct business at the Special Meeting. Abstentions and broker non-votes will be counted as present for the purpose of determining a quorum. The holders of the Founder Shares, who currently own approximately 75% of the issued and outstanding shares of ERES Common Stock, will
count towards this quorum. In the absence of a quorum, the chairman of the Special Meeting has power to adjourn the Special Meeting. As of the ERES Record Date for the Special Meeting, 5,740,524 shares of ERES Common Stock would be required to
achieve a quorum. |
Q: |
WHAT VOTE IS REQUIRED TO APPROVE EACH PROPOSAL AT THE SPECIAL MEETING? |
A: |
The Business Combination Proposal: The affirmative vote (in person or by proxy) of the holders of a
majority of the shares of Class A Common Stock and Class B Common Stock entitled to vote and actually cast thereon at the Special Meeting, voting as a single class, is required to approve the Business Combination Proposal. Accordingly, a
stockholders failure to vote by proxy or to vote in person (which would include presence at a virtual meeting) at the Special Meeting, as well as an abstention from voting and a broker non-vote with
regard to the Business Combination Proposal, will have no effect on the Business Combination Proposal. ERES stockholders must approve the Business Combination Proposal in order for the Mergers to occur. |
The Charter Approval Proposal: The affirmative vote (in person or by proxy) of (i) the holders of a majority of the shares of Class
B Common Stock then outstanding and entitled to vote, voting separately as a single class, (ii) the holders of a majority of the shares of Class A Common Stock then outstanding and entitled to vote, voting separately as a single class, and
(iii) the holders of a majority of the shares of ERES Common Stock then outstanding and entitled to vote, voting together as a single class, is required to approve the Charter Approval Proposal. Accordingly, a stockholders failure to vote by
proxy or to vote in person (which would include presence at a virtual meeting) at the Special Meeting, as well as an abstention from voting and a broker non-vote with regard to the Charter Approval Proposal, will have the same effect as a vote
AGAINST such Proposal. The Mergers are conditioned on the approval of the Charter Approval Proposal, subject to the terms of the Merger Agreement. If the Business Combination Proposal is not approved, the Charter Approval Proposal
will not be presented to the stockholders for a vote.
xix
The Governance Proposal: The affirmative vote (in person or by proxy) of the holders
of a majority of the shares of Class A Common Stock and Class B Common Stock entitled to vote and actually cast thereon at the Special Meeting, voting as a single class, is required to approve the Governance Proposal. Accordingly, a
stockholders failure to vote by proxy or to vote in person (which would include presence at a virtual meeting) at the Special Meeting, as well as an abstention from voting and a broker non-vote with
regard to the Governance Proposal, will have no effect on the Governance Proposal. The Mergers are not conditioned on the approval of the Governance Proposal. If the Business Combination Proposal is not approved, the Governance Proposal will not be
presented to the stockholders for a vote.
The Director Election Proposal: The affirmative vote (in person or by proxy) of the
holders of a plurality of the outstanding shares of Class B Common Stock entitled to vote and actually cast thereon at the Special Meeting, voting as a single class, is required to approve the Director Election Proposal. Accordingly, a
stockholders failure to vote by proxy or to vote in person (which would include presence at a virtual meeting) at the Special Meeting, as well as an abstention from voting and a broker non-vote with
regard to the Director Election Proposal, will have no effect on the election of directors. The Mergers are not conditioned on the approval of the Director Election Proposal. If the Business Combination Proposal is not approved, the Director
Election Proposal will not be presented to the stockholders for a vote.
The Nasdaq Proposal: The affirmative vote (in person or by
proxy) of the holders of a majority of the shares of Class A Common Stock and Class B Common Stock entitled to vote and actually cast thereon at the Special Meeting, voting as a single class, is required to approve the Nasdaq Proposal.
Accordingly, a stockholders failure to vote by proxy or to vote in person (which would include presence at a virtual meeting) at the Special Meeting, as well as an abstention from voting and a broker
non-vote with regard to the Nasdaq Proposal, will have no effect on the Nasdaq Proposal. The Mergers are conditioned on the approval of the Nasdaq Proposal, subject to the terms of the Merger Agreement. If the
Business Combination Proposal is not approved, the Nasdaq Proposal will not be presented to the stockholders for a vote.
The Incentive
Plan Proposal: The affirmative vote (in person or by proxy) of the holders of a majority of the shares of Class A Common Stock and Class B Common Stock entitled to vote and actually cast thereon at the Special Meeting, voting as a
single class, is required to approve the Incentive Plan Proposal. Accordingly, a stockholders failure to vote by proxy or to vote in person (which would include presence at a virtual meeting) at the Special Meeting, as well as an abstention
from voting and a broker non-vote with regard to the Incentive Plan Proposal, will have no effect on the Incentive Plan Proposal. The Mergers are conditioned on the approval of the Incentive Plan Proposal,
subject to the terms of the Merger Agreement. If the Business Combination Proposal is not approved, the Incentive Plan Proposal will not be presented to the stockholders for a vote.
The Adjournment Proposal: The affirmative vote (in person or by proxy) of the holders of a majority of the shares of Class A Common
Stock and Class B Common Stock entitled to vote and actually cast thereon at the Special Meeting, voting as a single class, is required to approve the Adjournment Proposal. Accordingly, a stockholders failure to vote by proxy or to vote
in person (which would include presence at a virtual meeting) at the Special Meeting, as well as an abstention from voting and a broker non-vote with regard to the Adjournment Proposal, will have no effect on
the Adjournment Proposal. The Mergers are not conditioned on the approval of the Adjournment Proposal.
As further discussed in the
section entitled Other AgreementsSponsor Support Agreement, the Sponsor has entered into a letter agreement with ERES and the Companies, a copy of which is attached as Annex D to this proxy statement (the
Sponsor Support Agreement), pursuant to which the Sponsor agreed to vote its shares in favor of the each of the Proposals presented at the Special Meeting.
xx
Q: |
DO ANY OF ERESS DIRECTORS OR OFFICERS OR THE SPONSOR OR ITS AFFILIATES HAVE INTERESTS IN THE BUSINESS
COMBINATION THAT MAY DIFFER FROM OR BE IN ADDITION TO THE INTERESTS OF ERES STOCKHOLDERS? |
A: |
Certain of ERESs executive officers and certain non-employee
directors, as well as our Sponsor and its affiliates, may have interests in the Mergers that may be different from, or in addition to, the interests of ERES stockholders generally. |
These interests include, among other things:
|
|
|
If the Business Combination with the Companies or another business combination is not consummated within the
Completion Window, ERES will cease all operations except for the purpose of winding up, redeeming 100% of the outstanding Public Shares for cash and, subject to the approval of its remaining stockholders and the ERES Board, dissolving and
liquidating. In such event, the 8,625,000 Founder Shares held by ERESs Initial Stockholders, which were acquired for an aggregate purchase price of $25,000, or approximately $0.003 per share, would be worthless because ERESs Initial
Stockholders are not entitled to participate in any redemption or distribution with respect to such shares. The Founder Shares had an aggregate market value of $[●] based upon the closing price of $[●] per share of ERES Class A
Common Stock on Nasdaq on the ERES Record Date. Certain Founder Shares are subject to time-based vesting provisions as described under Other AgreementsSponsor Support Agreement. |
|
|
|
The Sponsor purchased an aggregate of 8,900,000 Private Placement Warrants from ERES for an aggregate purchase
price of $8,900,000 (or $1.00 per warrant). These purchases took place on a private placement basis simultaneously with the consummation of the ERES IPO and associated exercise of the over-allotment option. A portion of the proceeds ERES received
from these purchases was placed in the Trust Account. Such warrants had an aggregate market value of approximately $[●] based upon the closing price of $[●] per public warrant on the Nasdaq on [●], 2023, the ERES Record Date. The
Private Placement Warrants will become worthless if ERES does not consummate a business combination within the Completion Window. The Sponsor paid an aggregate of $8,925,000 for its purchases of the Founder Shares and the Private Placement Warrants.
|
|
|
|
In order to finance transaction costs in connection with a business combination, the Sponsor, members of the ERES
founding team or any of their affiliates may, but are not obligated to, make Working Capital Loans as may be required (also referred to as Working Capital Note). In August 2021, the Sponsor committed to provide ERES up to an aggregate of
$1,500,000 in loans for working capital purposes. The Working Capital Note does not bear interest and is repayable in full upon consummation of a business combination. If ERES does not complete a business combination, the Working Capital Note shall
not be repaid and all amounts owed under it will be forgiven. The Working Capital Note is subject to customary events of default, the occurrence of which automatically trigger the unpaid principal balance of the Working Capital Note and all other
sums payable with regard to the Working Capital Note becoming immediately due and payable. As of December 31, 2022, there was a balance of $1,500,000 under this loan. On January 31, 2023, the Sponsor agreed to loan ERES up to an additional
$1,500,000 under the Working Capital Note. |
|
|
|
On July 25, 2022, ERES entered into the Extension Note with the Sponsor. Pursuant to the Extension Note, the
Sponsor has agreed that it will contribute to ERES as a loan (each loan being referred to herein as a Contribution) $0.033 for each Public Share that was not redeemed in connection with the stockholder vote to approve the extension of
the deadline by which ERES must complete its initial business combination, for each month until the earlier of (i) the date of the special meeting held in connection with the stockholder vote to approve the Business Combination and
(ii) the date of liquidation of ERES. The Extension Note does not bear interest and is repayable in full upon the earlier of (i) the date of the consummation of ERESs initial business combination and (ii) the date of ERESs
liquidation. At any time prior to payment in full of the principal balance of the Extension Note, the holder of the Extension Note (or a permitted assignee) will have the option, but not the obligation, to
|
xxi
|
convert up to $1,500,000 of the unpaid principal balance of the Extension Note into that number of Extension Warrants, each whole warrant exercisable for one share of ERES Class A Common
Stock equal to the principal amount of the Extension Note so converted divided by $1.50. The terms of the Extension Warrants will be identical to the terms of the Private Placement Warrants. The Sponsor will have the sole discretion whether to
continue extending for additional months, and if the Sponsor determines not to continue extending for additional months, its obligation to make additional Contributions will terminate. If this occurs, ERES would wind up ERESs affairs and
redeem 100% of the outstanding Public Shares in accordance with the procedures set forth in the Existing Charter. The maturity date of the Extension Note may be accelerated upon the occurrence of an Event of Default (as defined therein). Any
outstanding principal under the Extension Note may be prepaid at any time by ERES, at its election and without penalty, provided, however, that the Sponsor shall have a right to first convert such principal balance as described in Section 17 of
the Extension Note upon notice of such prepayment. If the Business Combination is not completed and ERES winds up, there will not be sufficient assets to repay the Extension Note and it will be worthless. As of December 31, 2022, there was a balance
of $1,924,356 under this loan. |
|
|
|
On January 23, 2023, ERES entered into the Second Extension Note with the Sponsor. Pursuant to the Second
Extension Note, the Sponsor agreed to contribute to ERES as a loan $0.033 for each Public Share that was not redeemed in connection with the stockholder vote to approve the extension of the date by which ERES must complete an initial business
combination, for each month until the earlier of (i) the date of consummation of ERESs initial business combination and (ii) the date of liquidation of ERES. The Second Extension Note does not bear interest and is repayable in full upon the
earlier of (i) the date of the consummation of ERESs initial business combination and (ii) the date of ERESs liquidation. At any time prior to payment in full of the principal balance of the Second Extension Note, the holder of the
Second Extension Note (or a permitted assignee) will have the option, but not the obligation, to convert up to $500,000 of the unpaid principal balance of the Second Extension Note into that number of Second Extension Warrants, each whole warrant
exercisable for one share of ERES Class A Common Stock equal to the principal amount of the Second Extension Note so converted divided by $1.50. The terms of the Second Extension Warrants will be identical to the terms of the Private Placement
Warrants. The Sponsor will have the sole discretion whether to continue extending for additional months, and if the Sponsor determines not to continue extending for additional months, its obligation to make additional Contributions will terminate.
If this occurs, ERES would wind up ERESs affairs and redeem 100% of the outstanding Public Shares in accordance with the procedures set forth in the Existing Charter. The maturity date of the Second Extension Note may be accelerated upon the
occurrence of an Event of Default (as defined therein). Any outstanding principal under the Second Extension Note may be prepaid at any time by ERES, at its election and without penalty, provided, however, that the Sponsor shall have a right to
first convert such principal balance as described in Section 17 of the Second Extension Note upon notice of such prepayment. If the Business Combination is not completed and ERES winds up, there will not be sufficient assets to repay the Second
Extension Note and it will be worthless. As of April 17, 2023, there was a balance of $282,748.65 under this loan. |
|
|
|
ERESs directors and officers, and their affiliates are entitled to reimbursement of out-of-pocket expenses incurred by them in connection with certain activities on ERESs behalf, such as identifying and investigating possible business targets and
business combinations. However, if ERES fails to consummate a business combination within the Completion Window, they will not have any claim against the Trust Account for reimbursement. Accordingly, ERES may not be able to reimburse these expenses
if the Business Combination or another business combination is not consummated within the Completion Window. As of December 31, 2022, $0 was outstanding in out-of-pocket
expense reimbursements. Additionally, two affiliates of the Sponsor are each entitled to $10,000 per month for office space, utilities, administrative and support services provided to ERESs management team, which commenced on July 24,
2020 and will continue through the earlier of consummation of the Business Combination and ERESs liquidation. For the years ended December 31, 2022 and |
xxii
|
December 31, 2021, the ERES incurred and paid an aggregate of $240,000 and $240,000 in connection with these agreements, respectively. |
|
|
|
The continued indemnification of current directors and officers and the continuation of directors and
officers liability insurance. |
|
|
|
In the event of the liquidation of the Trust Account, the Sponsor has agreed to indemnify and hold harmless ERES
against any and all losses, liabilities, claims, damages and expenses to which ERES may become subject as a result of any claim by (i) any third party for services rendered or products sold to ERES or (ii) a prospective target business
with which ERES has entered into an acquisition agreement, provided that such indemnification of ERES by the Sponsor shall apply only to the extent necessary to ensure that such claims by a third party for services rendered or products sold to ERES
or a target do not reduce the amount of funds in the Trust Account to below (i) $10.00 per share of ERES Class A Common Stock or (ii) such lesser amount per share of ERES Class A Common Stock held in the Trust Account due to
reductions in the value of the trust assets as of the date of the liquidation of the Trust Account, in each case, net of the amount of interest earned on the property in the Trust Account, which may be withdrawn to pay taxes and expenses related to
the administration of the Trust Account, except as to any claims by a third party (including a target) who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under ERESs indemnity of the
underwriters of the ERES IPO against certain liabilities, including liabilities under the Securities Act. If ERES consummates the Business Combination, on the other hand, ERES will be liable for all such claims. |
|
|
|
Pursuant to the Sponsor Support Agreement, the Sponsor has agreed, subject to certain exceptions, not to transfer
(i) 15% of the shares of the Post-Combination Companys common stock received by the Sponsor in connection with the Closing until the date that is 180 days after the Closing Date and (ii) the remaining 85% of the shares of the
Post-Combination Companys common stock received by the Sponsor in connection with the Closing until the date that is 24 months after the Closing Date. |
|
|
|
Subject to certain limited exceptions, the Private Placement Warrants will not be transferable until 30 days
following the completion of the Business Combination. |
|
|
|
There will be no finders fees, reimbursements or cash payments made by ERES to the Sponsor or ERESs
officers or directors, or ERESs or any of their affiliates, for services rendered to ERES prior to or in connection with the completion of the Business Combination, other than payment of the amount described above for office space, utilities,
administrative and support services described above and repayments of the loans under the Working Capital Note, the Extension Note and the Second Extension Note to our Sponsor as described above. The Sponsor and ERESs officers and directors or
any of their respective affiliates will also be reimbursed for any out-of-pocket expenses incurred in connection with ERESs formation, the ERES IPO and activities
on ERESs behalf such as identifying potential target businesses and performing due diligence on suitable business combinations. There is no cap or ceiling on the reimbursement of
out-of-pocket expenses incurred by such persons in connection with activities on our behalf. |
xxiii
|
|
|
Our Sponsor, officers and directors would hold the following number of shares of common stock in the Post-Combination Company, on a fully diluted basis, at the closing of the Business Combination: |
|
|
|
|
|
|
|
|
|
Name of Person/Entity |
|
Number of Shares of Common Stock(1) |
|
|
Value of Shares(2) |
|
East Sponsor, LLC |
|
|
17,068,333 |
|
|
$ |
170,683,330 |
|
Terrence M. Pegula |
|
|
17,068,333 |
|
|
$ |
170,683,330 |
|
Gary L. Hagerman, Jr. |
|
|
1,000 |
|
|
$ |
10,000 |
|
John P. Sieminski |
|
|
2,500 |
|
|
$ |
25,000 |
|
James S. Morrow |
|
|
0 |
|
|
$ |
0 |
|
William A. Fustos |
|
|
22,000 |
|
|
$ |
220,000 |
|
Thomas W. Corbett, Jr. |
|
|
10,000 |
|
|
$ |
100,000 |
|
Benjamin Wingard(3) |
|
|
4,000 |
|
|
$ |
40,000 |
|
Jacob Long |
|
|
5,000 |
|
|
$ |
50,000 |
|
Adam Gusky |
|
|
2,452 |
|
|
$ |
24,520 |
|
|
(1) |
(a) Assumes that (i) Public Stockholders exercise the 17,250,000 public warrants, (ii) the
Initial Stockholders exercise the 7,120,000 Private Placement Warrants, (iii) the 1,780,000 warrants in the warrant pool are exercised, (iv) the Sponsor exercises its option to convert up to $1,500,000 of the unpaid principal balance on
the Extension Note to 1,000,000 Extension Warrants and exercises such warrants, (v) the Sponsor exercises its option to convert up to $500,000 of the unpaid principal balance on the Second Extension Note to 333,333 Second Extension Warrants and
exercises such warrants and (vi) all shares underlying the Incentive Plan are issued. |
(b) Includes shares
that may be issued but are not presently outstanding and, as such, differs from the share counts shown or assumed in the sections entitled Summary Unaudited Pro Forma Condensed Combined Financial Information, Unaudited Historical
Comparative and Pro Forma Combined Per Share Data of ERES and the Companies, Unaudited Pro Forma Condensed Combined Financial Information and Comparative Historical and Unaudited Pro Forma Combined Per Share Financial
Information, which sections are limited to shares that are presently issued and outstanding.
|
(2) |
Assumes a value of $10.00 per share, the deemed value of the Class A Common Stock in the Business
Combination. |
|
(3) |
Benjamin Wingard was a named executive officer for the purposes of the Annual Report on Form 10-K
for fiscal year ended December 31, 2022, filed by ERES on April 18, 2023. Mr. Wingard resigned from ERES effective January 31, 2023. |
|
|
|
Certain of our officers and directors presently have, and any of them in the future may have additional,
fiduciary or contractual obligations to other entities pursuant to which such officer or director is or will be required to present business combination opportunities to such entity. Accordingly, in the future, if any of our officers or directors
becomes aware of a business combination opportunity which is suitable for an entity to which he or she has then-current fiduciary or contractual obligations, he or she will honor his or her fiduciary or contractual obligations to present such
opportunity to such entity. We do not believe, however, that any fiduciary duties or contractual obligations of our officers would materially undermine our ability to complete our business combination. The Existing Charter provides that we renounce
our interest in any corporate opportunity offered to any director or officer unless such opportunity is expressly offered to such person solely in his or her capacity as a director or officer of our company and such opportunity is one we are legally
and contractually permitted to undertake and would otherwise be reasonable for us to pursue, and to the extent such person is permitted to refer that opportunity to us without violating another legal obligation. This waiver allows our Sponsor and
its affiliates to allocate opportunities based on a combination of the objectives and fundraising needs of the target, as well as the investment objectives of the entity. However, we do not believe that the waiver of the corporate opportunities
doctrine otherwise had a material impact on our search for an acquisition target. |
xxiv
|
|
|
Following the completion of the Business Combination, Adam Gusky and Thomas W. Corbett, Jr. will be members of
the board of directors of the Post-Combination Company. As such, in the future, Mr. Gusky and Mr. Corbett, Jr. will receive any cash fees, stock options or stock awards that the board of directors of the Post-Combination Company determines to pay to its directors. |
|
|
|
Given the interests described above, our Sponsor and its affiliates may earn a positive rate of return on their
investment, even if the Post-Combination Company common stock trades below the price initially paid for the ERES units in the ERES IPO, and the Public Stockholders may experience a negative rate of return
following the completion of the Business Combination. Thus, our Sponsor and its affiliates may have more of an economic incentive for us to, rather than liquidate if we fail to complete our initial business combination by the Completion Window,
enter into an initial business combination on potentially less favorable terms with a potentially less favorable, riskier, weaker-performing or financially unstable business, or an entity lacking an
established record of revenues or earnings, than would be the case if such parties had paid the full offering price for their Founder Shares. |
|
|
|
Our Sponsor, directors and officers beneficially own Founder Shares and warrants that will be worthless and have
incurred reimbursable expenses that may not be reimbursed or repaid if the Business Combination is not approved. As of the date of this proxy statement, the Sponsor has invested an aggregate of approximately $14,132,105 (consisting of $25,000 for
the Founder Shares, $8,900,000 for the Private Placement Warrants, $3,000,000 for the aggregate principal amount of the Working Capital Note, $1,924,356 for the Extension Note and $282,749 for the Second Extension Note). Assuming a value of $10.00
per share, the deemed value of the Class A Common Stock in the Business Combination, the aggregate market value with respect to the common stock, fully diluted, based on Founder Shares and warrants in ERES held by our Sponsor, directors and
officers, would be approximately $170,783,330. Thus, the aggregate market value of our Sponsors Founder Shares and Private Placement Warrants, together with the aggregate outstanding principal amount of the foregoing loans and the foregoing
reimbursable expenses, would be approximately $184,915,435. |
|
The ERES Board was aware of and considered these interests to the extent such interests existed at the time,
among other matters, in approving the Merger Agreement and in recommending that the Business Combination be approved by the stockholders of ERES. See the section entitled The Business CombinationInterests of ERESs
Directors and Executive Officers and the Sponsor and its Affiliates in the Business Combination. The ERES Board concluded that the Merger Agreement and the Business Combination are fair from a financial point of view to and in the best
interests of ERES and its stockholders. In view of the wide variety of factors considered by the ERES Board in connection with its evaluation, negotiation and recommendation of the business combination and related transactions and the complexity of
these matters, the ERES Board did not consider it practical to, nor did it attempt to, quantify, rank or otherwise assign relative weights to the specific factors that it considered in reaching its decision. Rather, the ERES Board based its
evaluation, negotiation and recommendation of the business combination on the totality of the information presented to and considered by it. The ERES Board evaluated the reasons described above with the assistance of ERES outside advisors. In
considering the factors described above and any other factors, individual members of the ERES Board may have viewed factors differently or given different weights to other or different factors. |
|
After careful consideration, the ERES Board unanimously (i) declared the advisability of the Business
Combination and the other transactions contemplated by the Merger Agreement and (ii) determined that the Business Combination and the other transactions contemplated by the Merger Agreement are in the best interests of the ERES stockholders.
|
Q: |
WHAT DO I NEED TO DO NOW? |
A: |
ERES urges you to carefully read and consider the information contained in this proxy statement, including the
Annexes and the other documents referred to herein, and to consider how the Mergers will affect you as |
xxv
|
a stockholder and/or warrant holder of ERES. Stockholders should then vote as soon as possible in accordance with the instructions provided in this proxy statement and on the enclosed proxy card.
|
Q: |
WHAT HAPPENS IF I SELL MY SHARES OF CLASS A COMMON STOCK BEFORE THE SPECIAL MEETING?
|
A: |
The ERES Record Date for the Special Meeting is earlier than the date that the Business Combination is expected
to be completed. If you transfer your shares of ERES Class A Common Stock after the ERES Record Date but before the Special Meeting, unless the transferee obtains from you a proxy to vote those shares, you will retain your right to vote at the
Special Meeting. However, you will not be able to seek redemption of your shares of ERES Class A Common Stock because you will no longer be able to tender them prior to the Special Meeting in accordance with the provisions described herein. If
you transferred your shares of ERES Class A Common Stock prior to the ERES Record Date, you have no right to vote those shares at the Special Meeting or redeem those shares for a pro rata portion of the proceeds held in the Trust Account.
|
A: |
If you are a holder of record of ERES Class A Common Stock on the ERES Record Date, you may vote in person
(which would include presence at a virtual meeting) at the Special Meeting or by submitting a proxy for the Special Meeting. You may submit your proxy by completing, signing, dating and returning the enclosed proxy card in the accompanying pre-addressed postage paid envelope. If you hold your shares in street name, which means your shares are held of record by a broker, bank or nominee, you should contact your broker to ensure that votes
related to the shares you beneficially own are properly counted. In this regard, you must provide the broker, bank or nominee with instructions on how to vote your shares or, if you wish to attend the meeting and vote in person (which would include
presence at a virtual meeting), obtain a proxy from your broker, bank or nominee. |
Q: |
IF MY SHARES ARE HELD IN STREET NAME BY A BROKER, BANK OR OTHER NOMINEE, WILL MY BROKER, BANK OR
OTHER NOMINEE VOTE MY SHARES FOR ME? |
A: |
If your shares are held in street name in a stock brokerage account or by a broker, bank or other
nominee, you must provide the record holder of your shares with instructions on how to vote your shares. Please follow the voting instructions provided by your broker, bank or other nominee. Please note that you may not vote shares held in
street name by returning a proxy card directly to ERES or by voting in person (which would include presence at a virtual meeting) at the Special Meeting unless you provide a legal proxy, which you must obtain from your
broker, bank or other nominee. Please submit your legal proxy to Proxy@continentalstock.com in order to receive a control number to vote at the virtual meeting. |
Under Nasdaq rules, brokers who hold shares in street name for a beneficial owner of those shares typically have the authority to
vote in their discretion on routine proposals when they have not received instructions from beneficial owners. However, brokers are not permitted to exercise their voting discretion with respect to the approval of matters that Nasdaq
determines to be non-routine without specific instructions from the beneficial owner. It is expected that all proposals to be voted on at the Special Meeting are
non-routine matters. Broker non-votes occur when a broker or nominee is not instructed by the beneficial owner of shares to vote on a particular proposal for
which the broker does not have discretionary voting power.
If you are an ERES stockholder holding your shares in street name
and you do not instruct your broker, bank or other nominee on how to vote your shares, your broker, bank or other nominee will not vote your shares on the Business Combination Proposal, the Charter Approval Proposal, the Governance Proposal, the
Director Election Proposal, the Nasdaq Proposal, the Incentive Plan Proposal or the Adjournment Proposal. Such broker non-votes will be the equivalent of a vote AGAINST the Charter Approval Proposal, but will have no effect on the
vote count for such other Proposals.
xxvi
Q: |
WHAT IF I ATTEND THE SPECIAL MEETING AND ABSTAIN OR DO NOT VOTE? |
A: |
For purposes of the Special Meeting, an abstention occurs when a stockholder attends the meeting in person
(which would include presence at a virtual meeting) and does not vote or returns a proxy with an abstain vote. |
If you are an ERES stockholder that attends the Special Meeting virtually and fails to vote on the Charter Approval Proposal, your failure to
vote will have the same effect as a vote AGAINST such Proposal.
If you are an ERES stockholder that attends the Special
Meeting virtually and fail to vote on the Business Combination Proposal, Governance Proposal, the Nasdaq Proposal, the Incentive Plan Proposal and the Adjournment Proposal, your failure to vote will have no effect on the Business Combination
Proposal, the Governance Proposal, the Nasdaq Proposal, the Incentive Plan Proposal or the Adjournment Proposal.
Q: |
WHAT WILL HAPPEN IF I RETURN MY PROXY CARD WITHOUT INDICATING HOW TO VOTE? |
A: |
If you sign and return your proxy card without indicating how to vote on any particular Proposal, the common
stock represented by your proxy will be voted FOR each of the Proposals presented at the Special Meeting. |
Q: |
MAY I CHANGE MY VOTE AFTER I HAVE MAILED MY SIGNED PROXY CARD? |
A: |
Yes. You may change your vote at any time before your proxy is exercised by doing any one of the following:
|
|
|
|
send another proxy card with a later date; |
|
|
|
notify ERESs Secretary in writing before the Special Meeting that you have revoked your proxy; or
|
|
|
|
attend the Special Meeting and vote electronically by visiting and entering the control number found on your
proxy card, instruction form or notice you previously received. |
If you are a stockholder of record of ERES and you
choose to send a written notice or to mail a new proxy, you must submit your notice of revocation or your new proxy to ERESs transfer agent, and it must be received at any time before the vote is taken at the Special Meeting. Any proxy that
you submitted may also be revoked by submitting a new proxy by mail, or online or by telephone, not later than 11:59 p.m. Eastern Time on [●], 2023, or by voting online at the Special Meeting. Simply attending the Special Meeting will not
revoke your proxy. If you have instructed a broker, bank or other nominee to vote your ERES shares, you must follow the directions you receive from your broker, bank or other nominee in order to change or revoke your vote.
Q: |
WHAT HAPPENS IF I FAIL TO TAKE ANY ACTION WITH RESPECT TO THE SPECIAL MEETING? |
A: |
If you fail to take any action with respect to the Special Meeting and the Business Combination is approved by
stockholders and consummated, you will become a stockholder of the Post-Combination Company. Failure to take any action with respect to the Special Meeting will not affect your ability to exercise your
redemption rights. If you fail to take any action with respect to the Special Meeting and the Business Combination is not approved, you will continue to be a stockholder and/or warrant holder of ERES while ERES searches for another target business
with which to complete a business combination. |
Q: |
WHAT SHOULD I DO IF I RECEIVE MORE THAN ONE SET OF VOTING MATERIALS? |
A: |
Stockholders may receive more than one set of voting materials, including multiple copies of this proxy
statement and multiple proxy cards or voting instruction cards. For example, if you hold your shares in more than one brokerage account, you will receive a separate voting instruction card for each brokerage account
|
xxvii
|
in which you hold shares. If you are a holder of record and your shares are registered in more than one name, you will receive more than one proxy card. Please complete, sign, date and return
each proxy card and voting instruction card that you receive in order to cast a vote with respect to all of your ERES shares. |
Q: |
WHO CAN HELP ANSWER MY QUESTIONS? |
A: |
If you have questions about the Mergers or if you need additional copies of the proxy statement or the enclosed
proxy card you should contact: |
Morrow Sodali LLC
333 Ludlow St., 5th Floor, South Tower
Stamford, Connecticut 06902
Stockholders may call toll free: (800) 662-5200
Banks and Brokers may call collect: (203) 658-9400
ERES.info@investor.morrowsodali.com
You may also obtain additional information about ERES from documents filed with the SEC by following the instructions in the
section entitled Where You Can Find More Information. If you are a holder of Public Shares and you intend to seek redemption of your Public Shares, you will need to deliver your stock (either physically or
electronically) to ERESs transfer agent at the address below prior to the vote at the Special Meeting. If you have questions regarding the certification of your position or delivery of your stock, please contact:
Continental Stock Transfer & Trust Company
1 State Street 30th Floor
New
York, New York 10004
xxviii
SUMMARY
This summary highlights selected information included in this proxy statement and does not contain all of the information that may be
important to you. You should read this entire document and its annexes and the other documents to which we refer before you decide how to vote. Each item in this summary includes a page reference directing you to a more complete description of that
item.
The Business Combination and the Merger Agreement (pages 187 and 210)
The terms and conditions of the Business Combination are contained in the Merger Agreement, the Amendment and the Second Amendment, copies of
which are attached to this proxy statement as Annex A-1, Annex A-2 and Annex A-3, respectively. We
encourage you to read the Merger Agreement carefully, as it is the legal document that governs the Business Combination.
On
August 30, 2022, ERES entered into the Merger Agreement with the Companies and the Merger Subs, pursuant to which, among other things and subject to the terms and conditions contained in the Merger Agreement, Abacus Merger Sub will merge with
and into Abacus, with Abacus surviving the Merger as a wholly owned subsidiary of ERES, and LMA Merger Sub will merge with and into LMA, with LMA surviving the Merger as a wholly owned subsidiary of ERES. In connection with the Closing, ERES will be
renamed Abacus Life, Inc.
ERES has agreed to provide its stockholders with the opportunity to redeem shares of Class A
Common Stock upon completion of the transactions contemplated by the Merger Agreement.
Below, please find an organizational chart
depicting the Companies and ERES current structure and corresponding ownership percentages:
1
Below, please find an organizational chart depicting the Post-Combination Companys intended structure
and corresponding ownership percentages (assuming that 50% of Public Shares are redeemed):
Merger Consideration; Conversion of Shares (page 210)
As part of the Business Combination, the Company Members will receive aggregate consideration of approximately $531.8 million, payable in
newly issued shares of ERES Class A Common Stock at a price of $10.00 per share (the Stock Consideration) and, to the extent the Aggregate Transaction Proceeds exceed $200.0 million, at the election of the Company Members, up
to $20.0 million of the aggregate consideration will be payable in cash to the Company Members (the Cash Consideration and, together with the Stock Consideration, the Aggregate Merger Consideration).
At the effective time of the LMA Merger (the LMA Effective Time), each LMA Interest that is issued and outstanding as of
immediately prior to the closing of the LMA Merger (the LMA Closing) will be cancelled and converted into the right to receive a portion of the Aggregate Merger Consideration. At the effective time of the Abacus Merger (the Abacus
Effective Time, and together with the LMA Effective Time, the Effective Time), each Abacus Interest that is issued and outstanding as of immediately prior to the closing of the Abacus Merger (the Abacus Closing) will be
cancelled and converted into the right to receive a portion of the Aggregate Merger Consideration.
2
ERES expects to be issue 53.2 million shares of ERES Class A Common Stock to the
Company Members in connection with the Closing (assuming that the Cash Consideration equals zero). The Company Members as of immediately prior to the Closing will hold, in the aggregate, approximately 82% of ERES Class A Common Stock
immediately following the Closing (assuming that no shares of ERES Class A Common Stock are validly redeemed).
Fractional
Shares. No fractional shares of ERES Class A Common Stock will be issued by virtue of the Business Combination or the other transactions contemplated by the Merger Agreement. Each person who would otherwise be entitled to a fraction of a
share of ERES Class A Common Stock (after aggregating all fractional shares of ERES Class A Common Stock that otherwise would be received by such holder) will instead have the number of shares of ERES Class A Common Stock issued to
such person rounded down in the aggregate to the nearest whole share of ERES Class A Common Stock.
Ownership of the Post-Combination Company (page 131)
As of April 21, 2023, the most recent practicable date
prior to the date of this proxy statement, there are 11,481,047 shares of ERES Common Stock issued and outstanding, including 8,625,000 shares of ERES Class B Common Stock, each of which will be converted into one share of the
Post-Combination Companys common stock at the Closing. As of April 21, 2023, the most recent practicable date prior to the date of this proxy statement, there are an aggregate of 27,483,333 warrants outstanding. Each whole warrant
entitles the holder thereof to purchase one share of Class A Common Stock. Therefore, as of April 21, 2023, the most recent practicable date prior to the date of this proxy statement (without giving effect to the Business Combination and
assuming no redemptions), assuming that (i) each share of ERES Class B Common Stock is converted into one share of ERES Class A Common Stock and (ii) each outstanding warrant is exercised and share of ERES Class A Common
Stock is issued as a result of such exercise, the ERES fully-diluted stock capital would be 38,964,380 shares of common stock.
It is anticipated that, upon the completion of the Business Combination, the ownership levels in the
Post-Combination Company will be as follows, assuming (i) no Public Shares are redeemed, (ii) 50% of Public Shares are redeemed and (iii) 100% of Public Shares are redeemed, each on a shares
outstanding and fully diluted basis. All scenarios assume that none of Aggregate Merger Consideration will be distributed to the Company Members in cash. For more information, see the section entitled Unaudited Pro Forma
Condensed Combined Financial Information.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
No Redemption Scenario(1) |
|
|
50% Redemption Scenario(2) |
|
|
100% Redemption Scenario(3) |
|
|
|
Outstanding Shares |
|
|
Outstanding Ownership |
|
|
Fully Diluted Shares(4) |
|
|
Fully Diluted Ownership |
|
|
Outstanding Shares |
|
|
Outstanding Ownership |
|
|
Fully Diluted Shares(4) |
|
|
Fully Diluted Ownership |
|
|
Outstanding Shares |
|
|
Outstanding Ownership |
|
|
Fully Diluted Shares(4) |
|
|
Fully Diluted Ownership |
|
Current public ERES stockholders |
|
|
2,856,047 |
|
|
|
4.42 |
% |
|
|
20,106,047 |
|
|
|
21.08 |
% |
|
|
1,428,024 |
|
|
|
2.26 |
% |
|
|
18,678,024 |
|
|
|
19.90 |
% |
|
|
0 |
|
|
|
0.00 |
% |
|
|
17,250,000 |
|
|
|
18.67 |
% |
Initial Stockholders |
|
|
8,625,000 |
|
|
|
13.34 |
% |
|
|
17,078,333
|
|
|
|
17.91 |
% |
|
|
8,625,000 |
|
|
|
13.64 |
% |
|
|
17,078,333
|
|
|
|
18.19 |
% |
|
|
8,625,000 |
|
|
|
13.96 |
% |
|
|
17,078,333
|
|
|
|
18.49 |
% |
Current Company Members(5) |
|
|
53,175,000 |
|
|
|
82.24 |
% |
|
|
53,175,000 |
|
|
|
55.76 |
% |
|
|
53,175,000 |
|
|
|
84.10 |
% |
|
|
53,175,000 |
|
|
|
56.65 |
% |
|
|
53,175,000 |
|
|
|
86.04 |
% |
|
|
53,175,000 |
|
|
|
57.57 |
% |
Incentive Plan(6) |
|
|
0 |
|
|
|
0.00 |
% |
|
|
3,232,802 |
|
|
|
3.39 |
% |
|
|
0 |
|
|
|
0.00 |
% |
|
|
3,161,401 |
|
|
|
3.37 |
% |
|
|
0 |
|
|
|
0.00 |
% |
|
|
3,090,000 |
|
|
|
3.35 |
% |
Warrant Pool |
|
|
0 |
|
|
|
0.00 |
% |
|
|
1,780,000 |
|
|
|
1.87 |
% |
|
|
0 |
|
|
|
0.00 |
% |
|
|
1,780,000 |
|
|
|
1.90 |
% |
|
|
0 |
|
|
|
0.00 |
% |
|
|
1,780,000 |
|
|
|
1.93 |
% |
Pro forma Class A Common Stock at December 31, 2022 |
|
|
64,656,047 |
|
|
|
100 |
% |
|
|
95,372,182 |
|
|
|
100 |
% |
|
|
63,228,024 |
|
|
|
100 |
% |
|
|
93,872,758 |
|
|
|
100 |
% |
|
|
61,800,000 |
|
|
|
100 |
% |
|
|
92,373,333 |
|
|
|
100 |
% |
(1) |
This presentation assumes that no Public Stockholders exercise their right to have their Public Shares converted
into their pro rata share of the Trust Account. |
(2) |
This presentation assumes that (i) Public Stockholders exercise their rights to have 50% of all outstanding
Public Shares converted into their pro rata share of the Trust Account and (ii) such redeeming Public Stockholders continue to hold public warrants following exercise of their redemption rights. |
(3) |
This presentation assumes that (i) Public Stockholders exercise their rights to have 100% of all outstanding
Public Shares converted into their pro rata share of the Trust Account and (ii) such redeeming Public Stockholders continue to hold public warrants following exercise of their redemption rights. |
3
(4) |
(a) This presentation assumes that (i) Public Stockholders exercise the 17,250,000 public warrants, (ii) the
Initial Stockholders exercise the 7,120,000 Private Placement Warrants, (iii) the 1,780,000 warrants in the warrant pool are exercised, (iv) the Sponsor exercises its option to convert up to $1,500,000 of the unpaid principal balance on the
Extension Note to 1,000,000 Extension Warrants and exercises such warrants, (v) the Sponsor exercises its option to convert up to $500,000 of the unpaid principal balance on the Second Extension Note to 333,333 Second Extension Warrants and
exercises such warrants and (vi) all shares underlying the Incentive Plan are issued. |
(b) The presentation includes
shares that may be issued but are not presently outstanding and, as such, differ from the share counts shown or assumed in the sections entitled Summary Unaudited Pro Forma Condensed Combined Financial Information, Unaudited
Historical Comparative and Pro Forma Combined Per Share Data of ERES and the Companies, Unaudited Pro Forma Condensed Combined Financial Information and Comparative Historical and Unaudited Pro Forma Combined Per Share
Financial Information, which sections are limited to shares that are presently issued and outstanding.
(5) |
Includes 4,569,922 shares of incentive units related to a non-pro rata distribution to one of the existing
owners of the Companies, which will be subject to forfeiture as included in Annex I. |
(6) |
Reflects shares expected to be reserved for issuance under the Incentive Plan (assuming the Incentive Plan
Proposal is approved). |
The numbers of shares and percentage interests set forth above are based on a number of
assumptions. If the actual facts differ from our assumptions, the numbers of shares and percentage interests set forth above will be different.
The following table further illustrates the impact on relative fully diluted ownership levels of the
Post-Combination Company for each source of dilution, namely the issuance of Class A Common Stock under (i) the 17,250,000 public warrants, (ii) the 7,120,000 Private Placement Warrants, (iii) the
1,780,000 warrants under the warrant pool granted to the Post-Combination Company, (iv) 1,000,000 Extension Warrants, (v) 333,333 Second Extension Warrants and (vi) the Incentive Plan.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
No Redemption Scenario(1) |
|
|
50% Redemption Scenario(2) |
|
|
100% Redemption Scenario(3) |
|
|
|
Number of Shares |
|
|
Fully Diluted Ownership(4) |
|
|
Number of Shares |
|
|
Fully Diluted Ownership(4) |
|
|
Number of Shares |
|
|
Fully Diluted Ownership(4) |
|
Current Stockholders |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current ERES Public Stockholders |
|
|
2,856,047 |
|
|
|
2.99 |
% |
|
|
1,428,024 |
|
|
|
1.52 |
% |
|
|
0 |
|
|
|
0.00 |
% |
Initial Stockholders |
|
|
8,625,000 |
|
|
|
9.04 |
% |
|
|
8,625,000 |
|
|
|
9.19 |
% |
|
|
8,625,000 |
|
|
|
9.34 |
% |
Total Current Stockholders |
|
|
11,481,047 |
|
|
|
12.04 |
% |
|
|
10,053,024 |
|
|
|
10.71 |
% |
|
|
8,625,000 |
|
|
|
9.44 |
% |
|
|
|
|
|
|
|
Shares Issued Upon Exercise of Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ERES Public Warrants |
|
|
17,250,000 |
|
|
|
18.09 |
% |
|
|
17,250,000 |
|
|
|
18.38 |
% |
|
|
17,250,000 |
|
|
|
18.67 |
% |
ERES Sponsor Private Warrants |
|
|
7,120,000 |
|
|
|
7.47 |
% |
|
|
7,120,000 |
|
|
|
7.58 |
% |
|
|
7,120,000 |
|
|
|
7.71 |
% |
Extension Warrants |
|
|
1,000,000 |
|
|
|
1.05 |
% |
|
|
1,000,000 |
|
|
|
1.07 |
% |
|
|
1,000,000 |
|
|
|
1.08 |
% |
Second Extension Warrants |
|
|
333,333 |
|
|
|
0.35 |
% |
|
|
333,333 |
|
|
|
0.36 |
% |
|
|
333,333 |
|
|
|
0.36 |
% |
Warrant Pool |
|
|
1,780,000 |
|
|
|
1.87 |
% |
|
|
1,780,000 |
|
|
|
1.90 |
% |
|
|
1,780,000 |
|
|
|
1.93 |
% |
|
|
|
|
|
|
|
Total Shares Issued Upon Exercise of Warrants |
|
|
27,483,333 |
|
|
|
28.82 |
% |
|
|
27,483,333 |
|
|
|
29.28 |
% |
|
|
27,483,333 |
|
|
|
29.75 |
% |
|
|
|
|
|
|
|
Current Company
Members(5) |
|
|
53,175,000 |
|
|
|
55.76 |
% |
|
|
53,175,000 |
|
|
|
56.65 |
% |
|
|
53,175,000 |
|
|
|
57.57 |
% |
|
|
|
|
|
|
|
Incentive
Plan(6) |
|
|
3,232,802 |
|
|
|
3.39 |
% |
|
|
3,161,401 |
|
|
|
3.37 |
% |
|
|
3,090,000 |
|
|
|
3.55 |
% |
|
|
|
|
|
|
|
Pro Forma Class A Common Stock at December 31, 2022 |
|
|
95,372,182 |
|
|
|
100.00 |
% |
|
|
93,872,758 |
|
|
|
100.00 |
% |
|
|
92,373,333 |
|
|
|
100.00 |
% |
(1) |
This presentation assumes that no Public Stockholders exercise their right to have their Public Shares
converted into their pro rata share of the Trust Account. |
(2) |
This presentation assumes that (i) Public Stockholders exercise their rights to have 50% of all outstanding
Public Shares converted into their pro rata share of the Trust Account and (ii) such redeeming Public Stockholders continue to hold public warrants following exercise of their redemption rights. |
4
(3) |
This presentation assumes that (i) Public Stockholders exercise their rights to have 100% of all outstanding
Public Shares converted into their pro rata share of the Trust Account and (ii) such redeeming Public Stockholders continue to hold public warrants following exercise of their redemption rights. |
(4) |
(a) This presentation assumes that (i) Public Stockholders exercise the 17,250,000 public warrants, (ii) the
Initial Stockholders exercise the 7,120,000 Private Placement Warrants, (iii) the 1,780,000 warrants in the warrant pool are exercised, (iv) the Sponsor exercises its option to convert up to $1,500,000 of the unpaid principal balance on the
Extension Note to 1,000,000 Extension Warrants and exercises such warrants, (v) the Sponsor exercises its option to convert up to $500,000 of the unpaid principal balance on the Second Extension Note to 333,333 Second Extension Warrants and
exercises such warrants and (vi) all shares underlying the Incentive Plan are issued. |
(b) The presentation includes
shares that may be issued but are not presently outstanding and, as such, differ from the share counts shown or assumed in the sections entitled Summary Unaudited Pro Forma Condensed Combined Financial Information, Unaudited
Historical Comparative and Pro Forma Combined Per Share Data of ERES and the Companies, Unaudited Pro Forma Condensed Combined Financial Information and Comparative Historical and Unaudited Pro Forma Combined Per Share
Financial Information, which sections are limited to shares that are presently issued and outstanding.
(5) |
Includes 4,569,922 shares of incentive units related to a non-pro rata distribution to one of the existing
owners of the Companies, which will be subject to forfeiture as included in Annex I. |
(6) |
Reflects shares expected to be reserved for issuance under the Incentive Plan (assuming the Incentive Plan
Proposal is approved). |
In addition to the changes in percentage ownerships depicted above, variations in redemptions
and dilutive equity issuances will also affect the per share value as illustrated in the table below.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
No Redemption Scenario(1) |
|
|
50% Redemption Scenario(2) |
|
|
100% Redemption Scenario(3) |
|
|
|
Number of Shares |
|
|
Value per Share(4) |
|
|
Number of Shares |
|
|
Value per Share(4) |
|
|
Number of Shares |
|
|
Value per Share(4) |
|
Base Scenario at December 31,
2022(5) |
|
|
64,656,047 |
|
|
$ |
8.68 |
|
|
|
63,228,024 |
|
|
$ |
8.64 |
|
|
|
61,800,000 |
|
|
$ |
8.60 |
|
Fully Diluted Scenario at December 31,
2022(6) |
|
|
95,372,182 |
|
|
$ |
9.20 |
|
|
|
93,872,758 |
|
|
$ |
9.19 |
|
|
|
92,373,333 |
|
|
$ |
9.18 |
|
(1) |
This presentation assumes that no Public Stockholders exercise their right to have their Public Shares
converted into their pro rata share of the Trust Account. |
(2) |
This presentation assumes that (i) Public Stockholders exercise their rights to have 50% of all
outstanding Public Shares converted into their pro rata share of the Trust Account and (ii) such redeeming Public Stockholders continue to hold public warrants following exercise of their redemption rights. |
(3) |
This presentation assumes that (i) Public Stockholders exercise their rights to have 100% of all
outstanding Public Shares converted into their pro rata share of the Trust Account and (ii) such redeeming Public Stockholders continue to hold public warrants following exercise of their redemption rights. |
(4) |
Based on the Post-Combination Company Equity Values set forth below. |
(5) |
Reflects current Public Shares and Founder Shares outstanding, plus shares to be issued to current
Company Members upon the consummation of the Business Combination, including the 4,569,922 shares of incentive units related to a non-pro rata distribution to one of the existing owners of the Companies, which will be subject to forfeiture as
included in Annex I. |
(6) |
(a) This presentation assumes that (i) Public Stockholders exercise the 17,250,000 public warrants, (ii) the
Initial Stockholders exercise the 7,120,000 Private Placement Warrants, (iii) the 1,780,000 warrants in the warrant pool are exercised, (iv) the Sponsor exercises its option to convert up to $1,500,000 of the unpaid principal balance on the
Extension Note to 1,000,000 Extension Warrants and exercises such warrants, |
5
|
(v) the Sponsor exercises its option to convert up to $500,000 of the unpaid principal balance on the Second Extension Note to 333,333 Second Extension Warrants and exercises such warrants
and (vi) all shares underlying the Incentive Plan are issued. |
(b) The presentation includes shares that may be issued but
are not presently outstanding and, as such, differ from the share counts shown or assumed in the sections entitled Summary Unaudited Pro Forma Condensed Combined Financial Information, Unaudited Historical Comparative and Pro Forma
Combined Per Share Data of ERES and the Companies, Unaudited Pro Forma Condensed Combined Financial Information and Comparative Historical and Unaudited Pro Forma Combined Per Share Financial Information, which sections
are limited to shares that are presently issued and outstanding.
Post-Combination Company Equity Value (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
No Redemption Scenario |
|
|
50% Redemption Scenario |
|
|
100% Redemption Scenario |
|
Base Scenario at December 31,
2022(7) |
|
$ |
560.91 |
|
|
$ |
546.33 |
|
|
$ |
531.75 |
|
Fully Diluted Scenario at December 31,
2022(8) |
|
$ |
876.97 |
|
|
$ |
862.39 |
|
|
$ |
847.81 |
|
|
(7) |
Assumes a deemed equity value of $10.00 per share for the Class A Common Stock issued to the current
Company Members, plus the amount remaining in the Trust Account after deductions for payments to redeeming stockholders. |
|
(8) |
(a) Assumes that (i) Public Stockholders exercise the 17,250,000 public warrants, (ii) the Initial
Stockholders exercise the 7,120,000 Private Placement Warrants, (iii) the 1,780,000 warrants in the warrant pool are exercised, (iv) the Sponsor exercises its option to convert up to $1,500,000 of the unpaid principal balance on the Extension
Note to 1,000,000 Extension Warrants and exercises such warrants, (v) the Sponsor exercises its option to convert up to $500,000 of the unpaid principal balance on the Second Extension Note to 333,333 Second Extension Warrants and exercises
such warrants and (vi) all shares underlying the Incentive Plan are issued. |
(b) Includes shares that may be
issued but are not presently outstanding and, as such, differs from the share counts shown or assumed in the sections entitled Summary Unaudited Pro Forma Condensed Combined Financial Information, Unaudited Historical Comparative
and Pro Forma Combined Per Share Data of ERES and the Companies, Unaudited Pro Forma Condensed Combined Financial Information and Comparative Historical and Unaudited Pro Forma Combined Per Share Financial Information,
which sections are limited to shares that are presently issued and outstanding.
Please see the section entitled
Unaudited Pro Forma Condensed Combined Financial Information for further information.
Recommendation of the ERES Board of Directors
(page 191)
The ERES Board has unanimously determined that the Business Combination, on the terms and conditions set forth in the
Merger Agreement, is advisable and in the best interests of ERES and its stockholders and has directed that the Proposals set forth in this proxy statement be submitted to its stockholders for approval at the Special Meeting on the date and at the
time and place set forth in this proxy statement. The ERES Board unanimously recommends that ERESs stockholders vote or give instruction to vote FOR the Business Combination Proposal, FOR the Charter
Approval Proposal, FOR the Governance Proposal, FOR the Nasdaq Proposal, FOR the Director Election Proposal, FOR the Incentive Plan Proposal and, if presented,
FOR the Adjournment Proposal. See the section entitled The Business CombinationERES Reasons for Approval of the Business Combination.
6
ERESs Special Meeting of Stockholders (page 81)
The Special Meeting will be held on [●], 2023, at [●], in virtual format at https://www.cstproxy.com/eastresources/2023. At the
Special Meeting, ERES stockholders will be asked to vote on the Business Combination Proposal, the Charter Approval Proposal, the Governance Proposal, the Nasdaq Proposal, the Director Election Proposal, the Incentive Plan Proposal and, if
presented, the Adjournment Proposal.
Stockholders will be entitled to vote or direct votes to be cast at the Special Meeting if they
owned shares of ERES Common Stock at the close of business on [●], 2023, the ERES Record Date. Stockholders are entitled to one vote for each share of ERES Common Stock owned at the close of business on the ERES Record Date. If
stockholders shares are held in street name or are in a margin or similar account, stockholders should contact their broker, bank or other nominee to ensure that votes related to the shares they beneficially own are properly
counted. On the ERES Record Date, there were 11,481,047 shares of ERES Common Stock outstanding, of which 2,856,047 were Public Shares and 8,625,000 were Founder Shares.
A quorum of ERES stockholders is necessary to hold a valid meeting. A quorum will be present at the Special Meeting if a majority of the
voting power of all outstanding shares of capital stock of ERES entitled to vote at the Special Meeting as of the ERES Record Date is represented in person (which would include presence at a virtual meeting) or by proxy. Abstentions and broker non-votes will be counted as present for the purpose of determining a quorum. The Initial Stockholders, who currently own approximately 75% of the issued and outstanding shares of ERES Common Stock, will count
towards this quorum. As of the ERES Record Date, 5,740,524 shares of ERES Common Stock would be required to achieve a quorum. ERES has entered into an agreement with the Sponsor and ERESs directors and officers, pursuant to which each agreed
to vote any shares of ERES Common Stock owned by them in favor of each of the Proposals presented at the Special Meeting. The Proposals presented at the Special Meeting will require the following votes:
The approval of each of the Business Combination Proposal, the Governance Proposal, the Nasdaq Proposal, the Incentive Plan Proposal and the
Adjournment Proposal, if presented, requires the affirmative vote (in person or by proxy) of the holders of a majority of the shares of ERES Common Stock entitled to vote and actually cast thereon at the Special Meeting, voting as a single class.
The approval of the Charter Approval Proposal requires the affirmative vote (in person or by proxy) of (i) the holders of a majority of the Class B Common Stock then outstanding and entitled to vote, voting separately as a single class,
(ii) the holders of a majority of the shares of ERES Class A Common Stock then outstanding and entitled to vote, voting separately as a single class, and (iii) the holders of a majority of the shares of ERES Common Stock then outstanding
and entitled to vote, voting together as a single class. The approval of the Director Election Proposal requires the affirmative vote (in person or by proxy) of the holders of a plurality of the outstanding shares of ERES Class B Common Stock
entitled to vote and actually cast thereon at the Special Meeting.
Consummation of the Business Combination is conditioned on the
approval of the Business Combination Proposal, the Charter Approval Proposal, the Nasdaq Proposal and the Incentive Plan Proposal at the Special Meeting, subject to the terms of the Merger Agreement. The Mergers are not conditioned on stockholders
of ERES approving any of the Governance Proposal, the Director Election Proposal or the Adjournment Proposal. If the Business Combination Proposal is not approved, the other Proposals (except the Adjournment Proposal) will not be presented to the
stockholders for a vote. The proxy statement accompanying this notice explains the Merger Agreement and the transactions contemplated thereby, as well as the Proposals to be considered at the Special Meeting.
ERESs Directors and Executive Officers and the Sponsor and its Affiliates Have Financial Interests in the Business Combination (page 201)
Certain of ERESs executive officers and certain non-employee directors, as well as our Sponsor
and its affiliates, may have interests in the Mergers that may be different from, or in addition to, the interests of ERES stockholders generally. These interests include, among other things:
|
|
|
If the Business Combination with the Companies or another business combination is not consummated within the
Completion Window, ERES will cease all operations except for the purpose of winding up, |
7
|
redeeming 100% of the outstanding Public Shares for cash and, subject to the approval of its remaining stockholders and the ERES Board, dissolving and liquidating. In such event, the 8,625,000
Founder Shares held by ERESs Initial Stockholders, which were acquired for an aggregate purchase price of $25,000, or approximately $0.003 per share, would be worthless because ERESs Initial Stockholders are not entitled to participate
in any redemption or distribution with respect to such shares. The Founder Shares had an aggregate market value of $[●] based upon the closing price of $[●] per share of ERES Class A Common Stock on Nasdaq on the ERES Record Date.
Certain Founder Shares are subject to time-based vesting provisions as described under Other AgreementsSponsor Support Agreement. |
|
|
|
The Sponsor purchased an aggregate of 8,900,000 Private Placement Warrants from ERES for an aggregate purchase
price of $8,900,000 (or $1.00 per warrant). These purchases took place on a private placement basis simultaneously with the consummation of the ERES IPO and associated exercise of the over-allotment option. A portion of the proceeds ERES received
from these purchases was placed in the Trust Account. Such warrants had an aggregate market value of approximately $[●] based upon the closing price of $[●] per public warrant on the Nasdaq on [●], 2023, the ERES Record Date. The
Private Placement Warrants will become worthless if ERES does not consummate a business combination within the Completion Window. The Sponsor paid an aggregate of $8,925,000 for its purchases of the Founder Shares and the Private Placement Warrants.
|
|
|
|
In order to finance transaction costs in connection with a business combination, the Sponsor, members of the ERES
founding team or any of their affiliates may, but are not obligated to, loan ERES funds as may be required. In August 2021, the Sponsor committed to provide ERES up to an aggregate of $1,500,000 in loans for working capital purposes. The Working
Capital Note does not bear interest and is repayable in full upon consummation of a business combination. If ERES does not complete a business combination, the Working Capital Note shall not be repaid and all amounts owed under it will be forgiven.
The Working Capital Note is subject to customary events of default, the occurrence of which automatically trigger the unpaid principal balance of the Working Capital Note and all other sums payable with regard to the Working Capital Note becoming
immediately due and payable. As of December 31, 2022, there was a balance of $1,500,000 under this loan. On January 31, 2023, the Sponsor agreed to loan ERES up to an additional $1,500,000 under the Working Capital Note. |
|
|
|
On July 25, 2022, ERES entered into the Extension Note with the Sponsor. Pursuant to the Extension Note, the
Sponsor has agreed that it will contribute to ERES as a loan (each loan being referred to herein as a Contribution) $0.033 for each Public Share that was not redeemed in connection with the stockholder vote to approve the extension of
the deadline by which ERES must complete its initial business combination, for each month until the earlier of (i) the date of the special meeting held in connection with the stockholder vote to approve the Business Combination and
(ii) the date of liquidation of ERES. The Extension Note does not bear interest and is repayable in full upon the earlier of (i) the date of the consummation of ERESs initial business combination and (ii) the date of ERESs
liquidation. At any time prior to payment in full of the principal balance of the Extension Note, the holder of the Extension Note (or a permitted assignee) will have the option, but not the obligation, to convert up to $1,500,000 of the unpaid
principal balance of the Extension Note into that number of Extension Warrants, each whole warrant exercisable for one share of ERES Class A Common Stock equal to the principal amount of the Extension Note so converted divided by $1.50. The
terms of the Extension Warrants will be identical to the terms of the Private Placement Warrants. The Sponsor will have the sole discretion whether to continue extending for additional months, and if the Sponsor determines not to continue extending
for additional months, its obligation to make additional Contributions will terminate. If this occurs, ERES would wind up ERESs affairs and redeem 100% of the outstanding Public Shares in accordance with the procedures set forth in the
Existing Charter. The maturity date of the Extension Note may be accelerated upon the occurrence of an Event of Default (as defined therein). Any outstanding principal under the Extension Note may be prepaid at any time by ERES, at its election and
without penalty, provided, however, that the Sponsor shall have a right to first |
8
|
convert such principal balance as described in Section 17 of the Extension Note upon notice of such prepayment. If the Business Combination is not completed and ERES winds up, there will not
be sufficient assets to repay the Extension Note and it will be worthless. As of December 31, 2022, there was a balance of $1,924,356 under this loan. |
|
|
|
On January 23, 2023, ERES entered into the Second Extension Note with the Sponsor. Pursuant to the Second
Extension Note, the Sponsor agreed to contribute to ERES as a loan $0.033 for each Public Share that was not redeemed in connection with the stockholder vote to approve the extension of the date by which ERES must complete an initial business
combination, for each month until the earlier of (i) the date of consummation of ERESs initial business combination and (ii) the date of liquidation of ERES. The Second Extension Note does not bear interest and is repayable in full upon the
earlier of (i) the date of the consummation of ERESs initial business combination and (ii) the date of ERESs liquidation. At any time prior to payment in full of the principal balance of the Second Extension Note, the holder of the
Second Extension Note (or a permitted assignee) will have the option, but not the obligation, to convert up to $500,000 of the unpaid principal balance of the Second Extension Note into that number of Second Extension Warrants, each whole warrant
exercisable for one share of ERES Class A Common Stock equal to the principal amount of the Second Extension Note so converted divided by $1.50. The terms of the Second Extension Warrants will be identical to the terms of the Private Placement
Warrants. The Sponsor will have the sole discretion whether to continue extending for additional months, and if the Sponsor determines not to continue extending for additional months, its obligation to make additional Contributions will terminate.
If this occurs, ERES would wind up ERESs affairs and redeem 100% of the outstanding Public Shares in accordance with the procedures set forth in the Existing Charter. The maturity date of the Second Extension Note may be accelerated upon the
occurrence of an Event of Default (as defined therein). Any outstanding principal under the Second Extension Note may be prepaid at any time by ERES, at its election and without penalty, provided, however, that the Sponsor shall have a right to
first convert such principal balance as described in Section 17 of the Second Extension Note upon notice of such prepayment. If the Business Combination is not completed and ERES winds up, there will not be sufficient assets to repay the Second
Extension Note and it will be worthless. As of April 17, 2023, there was a balance of $282,748.65 under this loan. |
|
|
|
ERESs directors and officers, and their affiliates are entitled to reimbursement of out-of-pocket expenses incurred by them in connection with certain activities on ERESs behalf, such as identifying and investigating possible business targets and
business combinations. However, if ERES fails to consummate a business combination within the Completion Window, they will not have any claim against the Trust Account for reimbursement. Accordingly, ERES may not be able to reimburse these expenses
if the Business Combination or another business combination is not consummated within the Completion Window. As of December 31, 2022, $0 was outstanding in out-of-pocket expense reimbursements. Additionally, two affiliates of the Sponsor are each
entitled to $10,000 per month for office space, utilities, administrative and support services provided to ERESs management team, which commenced on July 24, 2020 and will continue through the earlier of consummation of the Business
Combination and ERESs liquidation. For the year ended December 31, 2022 and December 31, 2021, the ERES incurred and paid an aggregate of $240,000 and $240,000 in connection with these agreements, respectively. |
|
|
|
The continued indemnification of current directors and officers and the continuation of directors and
officers liability insurance. |
|
|
|
In the event of the liquidation of the Trust Account, the Sponsor has agreed to indemnify and hold harmless ERES
against any and all losses, liabilities, claims, damages and expenses to which ERES may become subject as a result of any claim by (i) any third party for services rendered or products sold to ERES or (ii) a prospective target business
with which ERES has entered into an acquisition |
9
|
agreement, provided that such indemnification of ERES by the Sponsor shall apply only to the extent necessary to ensure that such claims by a third party for services rendered or products sold to
ERES or a target do not reduce the amount of funds in the Trust Account to below (i) $10.00 per share of ERES Class A Common Stock or (ii) such lesser amount per share of ERES Class A Common Stock held in the Trust Account due to
reductions in the value of the trust assets as of the date of the liquidation of the Trust Account, in each case, net of the amount of interest earned on the property in the Trust Account, which may be withdrawn to pay taxes and expenses related to
the administration of the Trust Account, except as to any claims by a third party (including a target) who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under ERESs indemnity of the
underwriters of the ERES IPO against certain liabilities, including liabilities under the Securities Act. If ERES consummates the Business Combination, on the other hand, ERES will be liable for all such claims. |
|
|
|
Pursuant to the Sponsor Support Agreement, the Sponsor has agreed, subject to certain exceptions, not to transfer
(i) 15% of the shares of the Post-Combination Companys common stock received by the Sponsor in connection with the Closing until the date that is 180 days after the Closing Date and (ii) the remaining 85% of the shares of the
Post-Combination Companys common stock received by the Sponsor in connection with the Closing until the date that is 24 months after the Closing Date. |
|
|
|
Subject to certain limited exceptions, the Private Placement Warrants will not be transferable until 30 days
following the completion of the Business Combination. |
|
|
|
There will be no finders fees, reimbursements or cash payments made by ERES to the Sponsor or ERESs
officers or directors, or ERESs or any of their affiliates, for services rendered to ERES prior to or in connection with the completion of the Business Combination, other than payment of the amount described above for office space, utilities,
administrative and support services described above and repayments of the loans under the Working Capital Note, the Extension Note and the Second Extension Note to our Sponsor as described above. The Sponsor and ERESs officers and directors or
any of their respective affiliates will also be reimbursed for any out-of-pocket expenses incurred in connection with ERESs formation, the ERES IPO and activities
on ERESs behalf such as identifying potential target businesses and performing due diligence on suitable business combinations. There is no cap or ceiling on the reimbursement of
out-of-pocket expenses incurred by such persons in connection with activities on our behalf. |
|
|
|
Our Sponsor, officers and directors would hold the following number of shares of common stock in the Post-Combination Company, on a fully diluted basis, at the closing of the Business Combination: |
|
|
|
|
|
|
|
|
|
Name of Person/Entity |
|
Number of Shares of Common Stock(1) |
|
|
Value of Shares(2) |
|
East Sponsor, LLC |
|
|
17,068,333 |
|
|
$ |
170,683,330 |
|
Terrence M. Pegula |
|
|
17,068,333 |
|
|
$ |
170,683,330 |
|
Gary L. Hagerman, Jr. |
|
|
1,000 |
|
|
$ |
10,000 |
|
John P. Sieminski |
|
|
2,500 |
|
|
$ |
25,000 |
|
James S. Morrow |
|
|
0 |
|
|
$ |
0 |
|
William A. Fustos |
|
|
22,000 |
|
|
$ |
220,000 |
|
Thomas W. Corbett, Jr. |
|
|
10,000 |
|
|
$ |
100,000 |
|
Benjamin Wingard(3) |
|
|
4,000 |
|
|
$ |
40,000 |
|
Jacob Long |
|
|
5,000 |
|
|
$ |
50,000 |
|
Adam Gusky |
|
|
2,452 |
|
|
$ |
24,520 |
|
|
(1) |
(a) Assumes that (i) Public Stockholders exercise the 17,250,000 public warrants, (ii) the Initial Stockholders
exercise the 7,120,000 Private Placement Warrants, (iii) the 1,780,000 warrants in the warrant pool are exercised, (iv) the Sponsor exercises its option to convert up to $1,500,000 of
|
10
|
the unpaid principal balance on the Extension Note to 1,000,000 Extension Warrants and exercises such warrants, (v) the Sponsor exercises its option to convert up to $500,000 of the unpaid
principal balance on the Second Extension Note to 333,333 Second Extension Warrants and exercise such options and (vi) all shares underlying the Incentive Plan are issued. |
(b) Includes shares that may be issued but are not presently outstanding and, as such, differs from the share counts shown or assumed in the
sections entitled Summary Unaudited Pro Forma Condensed Combined Financial Information, Unaudited Historical Comparative and Pro Forma Combined Per Share Data of ERES and the Companies, Unaudited Pro Forma Condensed
Combined Financial Information and Comparative Historical and Unaudited Pro Forma Combined Per Share Financial Information, which sections are limited to shares that are presently issued and outstanding.
|
(2) |
Assumes a value of $10.00 per share, the deemed value of the Class A Common Stock in the Business
Combination. |
|
(3) |
Benjamin Wingard was a named executive officer for purposes of the Annual Report on Form 10-K
for fiscal year ended December 31, 2022, filed by ERES on April 18, 2023. Mr. Wingard resigned from ERES effective January 31, 2023. |
|
|
|
Certain of our officers and directors presently have, and any of them in the future may have, additional
fiduciary or contractual obligations to other entities pursuant to which such officer or director is or will be required to present business combination opportunities to such entity. Accordingly, in the future, if any of our officers or directors
becomes aware of a business combination opportunity which is suitable for an entity to which he or she has then-current fiduciary or contractual obligations, he or she will honor his or her fiduciary or contractual obligations to present such
opportunity to such entity. We do not believe, however, that any fiduciary duties or contractual obligations of our officers would materially undermine our ability to complete our business combination. The Existing Charter provides that we renounce
our interest in any corporate opportunity offered to any director or officer unless such opportunity is expressly offered to such person solely in his or her capacity as a director or officer of our company and such opportunity is one we are legally
and contractually permitted to undertake and would otherwise be reasonable for us to pursue, and to the extent such person is permitted to refer that opportunity to us without violating another legal obligation. This waiver allows our Sponsor and
its affiliates to allocate opportunities based on a combination of the objectives and fundraising needs of the target, as well as the investment objectives of the entity. However, we do not believe that the waiver of the corporate opportunities
doctrine otherwise had a material impact on our search for an acquisition target. |
|
|
|
Following the completion of the Business Combination, Adam Gusky and Thomas W. Corbett, Jr. will be members of
the board of directors of the Post-Combination Company. As such, in the future, Mr. Gusky and Mr. Corbett, Jr. will receive any cash fees, stock options or stock awards that the board of directors of the Post-Combination Company determines to pay to
its directors. |
|
|
|
Given the interests described above, our Sponsor and its affiliates may earn a positive rate of return on their
investment, even if the Post-Combination Company common stock trades below the price initially paid for the ERES units in the ERES IPO, and the Public Stockholders may experience a negative rate of return following the completion of the Business
Combination. Thus, our Sponsor and its affiliates may have more of an economic incentive for us to, rather than liquidate if we fail to complete our initial business combination by the Completion Window, enter into an initial business combination on
potentially less favorable terms with a potentially less favorable, riskier, weaker-performing or financially unstable business, or an entity lacking an established record of revenues or earnings, than would be the case if such parties had paid the
full offering price for their Founder Shares. |
|
|
|
Our Sponsor, directors and officers beneficially own Founder Shares and warrants that will be worthless and have
incurred reimbursable expenses that may not be reimbursed or repaid if the Business Combination is not approved. As of the date of this proxy statement, the Sponsor has invested an
|
11
|
aggregate of approximately $14,132,105 (consisting of $25,000 for the Founder Shares, $8,900,000 for |
|
the Private Placement Warrants, $3,000,000 for the aggregate principal amount of the Working Capital Note, $1,924,356 for the Extension Note and $282,749 for the Second Extension Note). Assuming a value of $10.00 per share, the
deemed value of the Class A Common Stock in the Business Combination, the aggregate market value with respect to the common stock, fully diluted, based on Founder Shares and warrants in ERES held by our Sponsor, directors and officers, would be
approximately $170,783,330. Thus, the aggregate market value of our Sponsors Founder Shares and Private Placement Warrants, together with the aggregate outstanding principal amount of the foregoing loans and the foregoing reimbursable
expenses, would be approximately $184,915,435. |
The ERES Board was aware of and considered these interests to the extent
such interests existed at the time, among other matters, in approving the Merger Agreement and in recommending that the Business Combination be approved by the stockholders of ERES. See the section entitled The Business
CombinationInterests of ERESs Directors and Executive Officers and the Sponsor and its Affiliates in the Business Combination. On balance, the ERES Board concluded that the Merger Agreement and the Business Combination
are fair from a financial point of view to and in the best interests of ERES and its stockholders. In view of the wide variety of factors considered by the ERES Board in connection with its evaluation, negotiation and recommendation of the Business
Combination and related transactions and the complexity of these matters, the ERES Board did not consider it practical to, nor did it attempt to, quantify, rank or otherwise assign relative weights to the specific factors that it considered in
reaching its decision. Rather, the ERES Board based its evaluation, negotiation and recommendation of the Business Combination on the totality of the information presented to and considered by it. The ERES Board evaluated the reasons described above
with the assistance of ERES outside advisors. In considering the factors described above and any other factors, individual members of the ERES Board may have viewed factors differently or given different weights to other or different factors.
After careful consideration, the ERES Board unanimously (i) declared the advisability of the Business Combination and the other
transactions contemplated by the Merger Agreement and (ii) determined that the Business Combination and the other transactions contemplated by the Merger Agreement are in the best interests of the ERES stockholders.
The Companies Executive Officers Have Financial Interests in the Business Combination (page 201)
Certain of the Companies executive officers and directors may have financial interests in the Business Combination that may be different
from, or in addition to, the interests of Company Members. For a detailed discussion of the special interests that the Companies executive officers and directors may have in the Business Combination, please see the section entitled
The Business CombinationInterests of the Companies Directors and Executive Officers in the Business Combination.
Regulatory Approvals Required for the Business Combination (page 206)
Completion of the Business Combination is subject to approval under the
Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the HSR Act). Each of the Companies and ERES have agreed to use their respective
commercially reasonable efforts to take all actions necessary, proper or advisable under applicable laws to consummate the Business Combination as promptly as practicable, including all licenses, permits, clearances, consents, approvals,
authorizations, qualifications and government orders. ERES filed a Notification and Report Form with the Antitrust Division and the FTC on September 26, 2022, and the 30-day waiting period expired at
11:59 p.m., New York City time, on October 26, 2022.
In connection with the Business Combination, ERES must obtain regulatory
approval from the Florida Office of Insurance Regulation for the proposed change of control of Abacus.
The regulatory approvals to which
completion of the Business Combination are subject are described in more detail in the section of this proxy statement entitled The Business CombinationRegulatory Approvals Required for the Business Combination.
12
Appraisal Rights (page 208)
Holders of ERES Common Stock are not entitled to appraisal rights in connection with the Business Combination under Delaware law.
Conditions to Closing of the Business Combination (page 211)
Conditions to Each Partys Obligations.
The respective obligations of each of ERES, the Companies and the Merger Subs to complete the Business Combination are subject to the
satisfaction or waiver at or prior to the Closing of the following conditions:
|
|
|
there must not be in effect any order prohibiting or preventing the consummation of the Business Combination and
no law adopted, enacted or promulgated that makes consummation of the Business Combination illegal or otherwise prohibited; |
|
|
|
all waiting periods and any extensions thereof applicable to the transactions contemplated by the Merger
Agreement under the HSR Act, and any commitments or agreements (including timing agreements) with any governmental entity not to consummate the Business Combination before a certain date, must have expired or been terminated; |
|
|
|
the offer contemplated by this proxy statement must have been completed in accordance with the terms of the
Merger Agreement and this proxy statement; |
|
|
|
the approval of each of the Proposals set forth in this proxy statement must have been obtained in accordance
with the DGCL, ERESs organizational documents and the rules and regulations of Nasdaq; |
|
|
|
the approval of the Business Combination by the Company Members must have been obtained; |
|
|
|
ERES shall have received the approval of the Florida Office of Insurance Regulation with respect to the change of
control of Abacus contemplated under the Merger Agreement without certain conditions; |
|
|
|
ERES shall have at least $5,000,001 of net tangible assets immediately after the Mergers are effective; and
|
|
|
|
the ERES Common Stock to be issued in the Business Combination must have been approved by the Nasdaq, subject
only to official notice of issuance thereof. |
Conditions to Obligations of ERES and the Merger Subs.
The obligation of ERES and the Merger Subs to complete the Business Combination is also subject to the satisfaction, or waiver by ERES, of the
following conditions:
|
|
|
the representations and warranties of the Companies (other than fundamental representations), disregarding
qualifications contained therein relating to materiality, must be true and correct as of the date of the Closing (the Closing Date) as if made at and as of such time (or, if given as of an earlier date, as of such earlier date), except
that this condition will be satisfied unless any and all inaccuracies in such representations and warranties of the Companies, in the aggregate, would or would reasonably be expected to result in a Material Adverse Effect (as defined herein) with
respect to the Companies, and fundamental representations must be true and correct in all respects as of the Closing Date (or, if given as of an earlier date, such earlier date); |
|
|
|
the Companies must have performed in all material respects its obligations under the Merger Agreement required to
be performed by it at or prior to the Closing; |
13
|
|
|
ERES must have received a certificate executed and delivered by an authorized officer of the Companies confirming
that the conditions set forth in the immediately preceding bullet points have been satisfied; |
|
|
|
ERES and the Merger Subs (collectively, the Parent Parties) must have received a copy of the written
consent of the Company Members, which must remain in full force and effect; |
|
|
|
the Companies must have converted to Delaware limited liability companies at least five business days prior to
the Closing Date; and |
|
|
|
since the date of the Merger Agreement, a Material Adverse Effect with respect to the Companies must not have
occurred. |
Conditions to Obligations of the Companies.
The obligation of the Companies to complete the Business Combination is also subject to the satisfaction or waiver by the Companies of the
following conditions:
|
|
|
the representations and warranties of the Parent Parties (other than fundamental representations), disregarding
qualifications contained therein relating to materiality, must be true and correct as of the Closing Date as if made at and as of such time (or, if given as of an earlier date, as of such earlier date), except that this condition will be satisfied
unless any and all inaccuracies in such representations and warranties of the Parent Parties, in the aggregate, would or would reasonably be expected to result in a Material Adverse Effect with respect to the Parent Parties, and fundamental
representations must be true and correct in all respects as of the Closing Date (or, if given as of an earlier date, such earlier date); |
|
|
|
each of the Parent Parties must have performed in all material respects its obligations under the Merger
Agreement required to be performed by it at or prior to the Closing; |
|
|
|
the Companies must have received a certificate executed and delivered by an authorized officer of the Parent
Parties confirming that the conditions set forth in the immediately preceding bullet points have been satisfied; |
|
|
|
the proceeds from the Business Combination, consisting of (a) the aggregate cash proceeds available for
release to ERES from the Trust Account in connection with the Business Combination (after, for the avoidance of doubt, giving effect to any redemptions of shares of ERES Common Stock by stockholders of ERES but before release of any other funds);
plus (b) the PIPE Investment Amount, if any (while ERES continues to opportunistically seek to raise a PIPE investment, at this time, it has no committed PIPE Investment Amount); minus (c) the Parent Transaction Expenses; minus
(d) the Company Transaction Expenses; minus (e) the Working Capital Loan amount; and plus the Sponsor PIK Note Amount (terms as defined in the Merger Agreement), must be equal to or in excess of $1.0 million; and
|
|
|
|
the directors and executive officers of ERES must have been removed from their respective positions or tendered
their irrevocable resignations effective as of the Closing. |
No Solicitation (page 214)
The Companies. From the date of the Merger Agreement until the earlier of (x) the Effective Time or (y) the date on which the
Merger Agreement is terminated, other than in connection with the transaction contemplated by the Merger Agreement, the Companies agreed that they will not, and will not authorize or (to the extent within its control) permit any Companies
subsidiary or any of their or any Companies subsidiarys affiliates, directors, officers, employees, agents or representatives (including investment bankers, attorneys and accountants), in each case in such directors,
officers, employees, agents or representatives capacity in such role with the
14
Companies, to, directly or indirectly, (i) knowingly encourage, initiate, solicit, facilitate, offer or make any offers or proposals related to an acquisition proposal, (ii) engage in
any discussions or negotiations with respect to an acquisition proposal with, or provide any non-public information or data to, any person that has made, or informs the Companies that it is considering making,
an acquisition proposal, or (iii) enter into any agreement (whether or not binding) relating to an acquisition proposal. The Companies must give notice of any acquisition proposal to ERES as soon as practicable following their awareness of such
proposal, but in any event no later than two business days following such awareness.
ERES. From the date of the Merger Agreement
until the earlier of (x) the Effective Time or (y) the date on which the Merger Agreement is terminated, other than in connection with the transaction contemplated by the Merger Agreement, ERES agreed that it will not, and will not
authorize or (to the extent within its control) permit any of its affiliates, directors, officers, employees, agents or representatives (including investment bankers, attorneys and accountants), in each case in such directors, officers,
employees, agents or representatives capacity in such role with ERES, to, directly or indirectly, (i) knowingly encourage, initiate, solicit, facilitate, offer or make any offers or proposals related to an alternate business
combination, (ii) engage in any discussions or negotiations with respect to an alternate business combination with, or provide any non-public information or data to, any person that has made, or informs
ERES that it is considering making, an alternate business combination proposal, or (iii) enter into any agreement (whether or not binding) relating to an alternate business combination. ERES must give notice of any alternate business
combination to the Companies as soon as practicable following its awareness of such proposal, but in any event no later than two business days following such awareness.
Termination (page 216)
The Merger
Agreement may be terminated and the Business Combination abandoned at any time prior to the Closing, as follows:
|
|
|
in writing, by mutual consent of ERES, the Companies and the Company Members (collectively, the
Parties); |
|
|
|
by ERES or the Companies if any law or order permanently restraining, enjoining or otherwise prohibiting the
consummation of the Mergers has been enacted and has become final and non-appealable, except that a party may not terminate the Merger Agreement for this reason if it has breached in any material respect its
obligations set forth in the Merger Agreement in any manner that has proximately contributed to the enactment, issuance, promulgation or entry into such law or order; |
|
|
|
by the Companies (if not in breach such that a closing condition cannot be satisfied) if any representation or
warranty is not true and correct or if ERES has failed to perform any covenant or agreement made by any Parent Party in the Merger Agreement, such that the conditions to the obligations of ERES, as described in the section entitled
Conditions to Closing of the Business Combination above, could not be satisfied as of the Closing Date, and (i) are or cannot be cured within thirty days after written notice from the Companies of such breach is
received by the Parent Parties, or (ii) which breach, untruth or inaccuracy, by its nature, cannot be cured prior to the Outside Date (as defined in the Merger Agreement); |
|
|
|
by ERES (if not in breach such that a closing condition cannot be satisfied) if any representation or warranty is
not true and correct or if the Companies have failed to perform any covenant or agreement made by the Companies in the Merger Agreement, such that the conditions to the obligations of the Companies, as described in the section entitled
Conditions to Closing of the Business Combination above, could not be satisfied as of the Closing Date, and (i) are or cannot be cured within thirty days after written notice from ERES of such breach is received by the
Companies or (ii) which breach, untruth or inaccuracy, by its nature, cannot be cured prior to the Outside Date; |
15
|
|
|
by written notice by any Party if the Closing has not occurred on or prior to January 27, 2023 so long as
such Party is not then in breach of the Merger Agreement in a manner that contributed to the occurrence of the failure of a condition; |
|
|
|
by the Companies if ERESs board of directors changes its recommendation in favor of the Business
Combination; |
|
|
|
by ERES if the required approvals of the Companies have not been obtained or if the required approvals are
revoked, modified or no longer in full force and effect; or |
|
|
|
by ERES or the Companies if the approval of the Proposals is not obtained at the Special Meeting (including any
adjournments of such meeting). |
Other Agreements (page 218)
Sponsor Support Agreement.
In connection
with the execution of the Merger Agreement and pursuant to the terms of a Sponsor Support Agreement entered into among the Companies, ERES and the Sponsor, a copy of which is attached to this proxy statement as Annex D, the Sponsor has agreed
to vote any shares of ERES Common Stock held by it in favor of each of the Proposals presented at the Special Meeting. The Sponsor owns at least 75% of ERESs outstanding common stock entitled to vote thereon. The quorum and voting thresholds
at the Special Meeting and the Sponsor Support Agreement may make it more likely that ERES will consummate the Business Combination. In addition, pursuant to the terms of the Sponsor Support Agreement, the Sponsor has agreed to waive its redemption
rights with respect to any Founder Shares and any Public Shares held by the Initial Stockholders in connection with the completion of the Business Combination and has agreed not to transfer (i) 15% of the shares of the Post-Combination
Companys common stock received by the Sponsor in connection with the Closing until the date that is 180 days after the Closing and (ii) the remaining 85% of the shares of the Post-Combination Companys common stock received by the
Sponsor in connection with the Closing until the date that is 24 months after the Closing. See the section entitled Other AgreementsSponsor Support Agreement.
Company Support Agreement.
In
connection with the execution of the Merger Agreement, ERES, the Companies and the Company Members entered into the Company Support Agreement, a copy of which is attached to this proxy statement as Annex E. The Company Support Agreement
provides, among other things, that each Company Member agreed to vote, at any meeting of the applicable Company and in any written action by consent of the members of the applicable Company, all of the Abacus and LMA Interests (i) in favor of
the transactions and the adoption of the Merger Agreement and (ii) against certain measures and any other action that would reasonably be expected to interfere with the Mergers, subject to the terms and conditions set forth in the Company
Support Agreement. Each Company Member also agrees to be bound by certain other covenants and agreements related to the Mergers and be bound by certain transfer restrictions with respect to Abacus and LMA Interests, in each case, on the terms and
subject to the conditions set forth in the Company Support Agreement. See the section entitled Other AgreementsCompany Support Agreement.
Registration Rights Agreement.
The
Merger Agreement contemplates that, at the Closing, ERES and the Company Members will enter into an Amended and Restated Registration Rights Agreement, a copy of which is attached to this proxy statement as Annex F (the Registration
Rights Agreement), pursuant to which ERES will agree to register for resale, pursuant to Rule 415 under the Securities Act, certain shares of ERES Class A Common Stock and other equity securities of ERES that are held by the parties
thereto from time to time. See the section entitled Other AgreementsRegistration Rights Agreement.
16
Proposed Charter.
Pursuant to the terms of the Merger Agreement, in connection with the consummation of the Business Combination, ERES will amend the Existing
Charter to (a) change the number of authorized shares of ERESs capital stock, par value $0.0001 per share, from 221,000,000 shares, consisting of (i) 200,000,000 shares of the Class A Common Stock and 20,000,000 shares of the
Class B Common Stock and 1,000,000 shares of preferred stock, to 201,000,000 shares, consisting of (i) 200,000,000 shares of common stock and (ii) 1,000,000 shares of preferred stock, (b) eliminate certain provisions in our Existing
Charter relating to the Class B Common Stock, the initial business combination and other matters relating to ERESs status as a blank-check company that will no longer be applicable to us following
the Closing and (c) approve and adopt any other changes contained in the Proposed Charter, a copy of which is attached as Annex B to this proxy statement. In addition, we will amend our Existing Charter to change the name of the
corporation to Abacus Life, Inc.
For more information, see the section entitled Proposal Number 2The
Charter Approval Proposal.
ERES Nasdaq Listing (page 209)
The ERES Class A Common Stock, units and public warrants are listed on Nasdaq under the symbols ERES, ERESU and
ERESW, respectively. Following the Business Combination, the common stock of the Post-Combination Company (including the Class A Common Stock issuable in the Business Combination) and warrants
of the Post-Combination Company will be listed on Nasdaq under the symbols ABL and ABLLW, respectively. ERESs units will be delisted and deregistered following the Closing.
Summary Risk Factors
You should
consider all the information contained in this proxy statement in deciding how to vote for the Proposals presented in this proxy statement. In this section, we, us, our and Company refer to the
Companies prior to the Business Combination and to the Post-Combination Company following the Business Combination. In particular, you should consider the risk factors described in the section entitled
Risk Factors beginning on page . Such risks include, but are not limited to:
Risks
relating to the business of the Company, including that:
|
|
|
The Companys valuation of life insurance policies is uncertain as many life insurance policies values
are tied to their actual maturity date and any erroneous valuations could have a material adverse impact on the Companys business. |
|
|
|
The Company could fail to accurately forecast life expectancies. There may also be changes to life expectancy
resulting in people living longer in the future, which could result in a lower return on the Companys life settlement policies. |
|
|
|
The Companys policy acquisitions are limited by the market availability of life insurance policies that
meet the Companys eligibility criteria and purchase parameters, and failure to secure a sufficient number of quality life insurance policies could have a material adverse effect on the Companys business. |
|
|
|
The Company may experience increased competition from originating life insurance companies, life insurance
brokers, and investment funds which could have a material adverse effect on the Companys business. |
|
|
|
Historically, there has been a negative public perception of the life settlement industry that could affect the
value and/or liquidity of the Companys investments and the life settlement industry faces political opposition from life insurance companies which could have a material adverse effect on the Companys business. |
17
|
|
|
The Company or third parties the Company relies upon could fail to accurately evaluate, acquire, maintain, track,
or collect on life settlement policies, which could have a material adverse impact on the Companys revenues. |
|
|
|
There is a risk of fraud in the origination of the original life insurance policy or in subsequent sales of the
life insurance policy that could adversely affect the Companys returns which could have a material adverse impact on the Companys business. |
|
|
|
The Company may become subject to claims by life insurance companies, individuals and their families, or
regulatory authorities which could have a material adverse impact on the Companys business. |
|
|
|
Life settlements in which we invest are not currently regulated under the federal securities laws, but if deemed
to be securities would require further compliance with federal and state securities laws, which could result in significant additional regulatory burdens on the Company and limit the Companys investments, which could have an adverse impact on
the Companys business and results of operations. |
|
|
|
The Company faces privacy and cyber security risks related to its maintenance of proprietary information,
including information regarding life settlement policies and the related insureds, and any adverse impact related to such risks could have a material adverse impact on the Companys business. |
|
|
|
The Company is subject to U.S. privacy laws and regulations. Failure to comply with such obligations could lead
to regulatory investigations or actions; litigation; fines and penalties; disruptions of operations; reputational harm; loss of revenue or profits; and other adverse business consequences. |
|
|
|
The Companys business may be subject to additional or different government regulation in the future, which
could have a material adverse impact on the Companys business. |
|
|
|
There is currently no direct legal authority regarding the proper federal tax treatment of life settlements and
potential future rulings from the IRS may have significant tax consequences on the Company. |
|
|
|
There have been lawsuits in various states questioning whether a purchaser of a life insurance policy has the
requisite insurable interest in the policy which would permit the purchaser to collect the insurance benefits and an adverse finding in any of these lawsuits could have a material adverse effect on the Companys business.
|
|
|
|
The failure of the Company to accurately and timely track and pay premium payments on the life insurance policies
it holds could result in the lapse of such policies which would have a material adverse impact on the Companys business. |
|
|
|
The originating life insurance company may increase the cost of insurance premiums, which would adversely affect
the Companys returns. |
|
|
|
The Company may not be able to liquidate its life insurance policies which could have a material adverse effect
on the Companys business. |
|
|
|
The Company assumes the credit risk associated with life insurance companies and may not be able to realize the
full value of insurance company payouts which could have a material adverse effect on the Companys profits. |
|
|
|
The Companys success is dependent upon the services of its experienced management and talented employees.
If the Company is unable to retain management and/or key employees, its ability to compete could be harmed. |
|
|
|
The Companys intellectual property rights may not adequately protect the Companys business.
|
|
|
|
The Company may become subject to intellectual property disputes, which are costly and may subject the Company to
significant liability and increased costs of doing business. |
18
|
|
|
The ongoing COVID-19 pandemic, along with rising interest rates and
inflation, may disrupt the ability of the Company and its providers to originate life settlement policies which could have a material adverse impact on the Companys financial position. |
|
|
|
We have identified material weaknesses in our internal control over financial reporting. If our remediation of
the material weaknesses are not effective, or if we experience additional material weaknesses in the future or otherwise fail to maintain an effective system of internal controls in the future, we may not be able to accurately or timely report our
financial condition or results of operations. |
Risks relating to being a public company, including that:
|
|
|
The market price of shares of our common stock may be volatile or may decline regardless of our operating
performance. You may lose some or all of your investment. |
|
|
|
We do not intend to pay dividends on our common stock for the foreseeable future. |
|
|
|
If securities or industry analysts do not publish research or reports about our business or Business Combination
or publish negative reports, the market price of our common stock could decline. |
|
|
|
Our ability to timely raise capital in the future may be limited, or may be unavailable on acceptable terms, if
at all. Our failure to raise capital when needed could harm our business, operating results and financial condition. Debt issued to raise additional capital may reduce the value of our common stock. |
|
|
|
Our issuance of additional shares of common stock or convertible securities could make it difficult for another
company to acquire us, may dilute your ownership of us and could adversely affect our stock price. |
|
|
|
Future sales, or the perception of future sales, of our common stock by us or our existing stockholders in the
public market following the closing of the Business Combination could cause the market price for our common stock to decline. |
|
|
|
We are an emerging growth company. The reduced public company reporting requirements applicable to
emerging growth companies may make our common stock less attractive to investors. |
|
|
|
Our management has limited experience in operating a public company. |
Risks relating to the Business Combination, including that:
|
|
|
ERES stockholders will have a reduced ownership and voting interest after the Business Combination and will
exercise less influence over management. |
|
|
|
The market price of shares of the Post-Combination Companys common
stock after the Business Combination may be affected by factors different from those currently affecting the prices of shares of ERES Class A Common Stock. |
|
|
|
There can be no assurance that the Post-Combination Companys common
stock will be approved for listing on Nasdaq or that the Post-Combination Company will be able to comply with the continued listing standards of Nasdaq. |
|
|
|
The consummation of the Business Combination is subject to a number of conditions and if those conditions are not
satisfied or waived, the Merger Agreement may be terminated in accordance with its terms and the Business Combination may not be completed. |
|
|
|
The parties to the Merger Agreement may amend the terms of the Merger Agreement or waive one or more of the
conditions to the Business Combination, and the exercise of discretion by our directors and officers in agreeing to changes to the terms of or waivers of closing conditions in the Merger Agreement may result in a
|
19
|
conflict of interest when determining whether such changes to the terms of the Merger Agreement or waivers of conditions are appropriate and in the best interests of our stockholders.
|
|
|
|
Termination of the Merger Agreement could negatively impact ERES. |
|
|
|
The Companies will be subject to business uncertainties and contractual restrictions while the Business
Combination is pending. |
|
|
|
ERES directors and officers may have interests in the Business Combination different from the interests of ERES
stockholders. |
|
|
|
The Sponsor has interests in the Business Combination different from the interests of ERES stockholders.
|
|
|
|
ERES stockholders who redeem their Common Stock and/or previously redeemed their Common Stock in connection with
the Extension Amendment or the Second Extension Amendment may continue to hold any ERES public warrants or Private Placement Warrants that they own, which will result in additional dilution to non-redeeming ERES stockholders upon exercise of such
ERES public warrants or Private Placement Warrants, as applicable. |
|
|
|
Because the Companies will become a publicly traded company through the Business Combination rather than an
underwritten initial public offering, the scope of due diligence conducted may be different from that conducted by an underwriter in an underwritten initial public offering. |
|
|
|
The Business Combination will result in changes to the board of directors that may affect our strategy.
|
|
|
|
The Merger Agreement contains provisions that limit ERES from seeking an alternative business combination.
|
|
|
|
The unaudited pro forma condensed combined financial information included in this proxy statement is preliminary
and the actual financial condition and results of operations after the Business Combination may differ materially. |
|
|
|
ERES and the Companies will incur transaction costs in connection with the Business Combination.
|
|
|
|
ERESs stockholders will have their rights as stockholders governed by the
Post-Combination Companys organizational documents. |
|
|
|
The Sponsor has agreed to vote in favor of each of the Proposals presented at the Special Meeting, regardless of
how Public Stockholders vote. |
|
|
|
ERESs and the Companies ability to consummate the Business Combination, and the operations of the Post-Combination Company following the Business Combination, may be materially adversely affected by the recent coronavirus (COVID-19) pandemic. |
Risks relating to ownership of our Class A Common Stock following the Business Combination, including that:
|
|
|
Subsequent to the consummation of the Business Combination, the Post-Combination Company may be required to take
write-downs or write-offs, or the Post-Combination Company may be subject to restructuring, impairment or other charges that could have a significant negative effect on the Post-Combination Companys financial condition, results of operations
and the price of the Post-Combination Companys securities, which could cause you to lose some or all of your investment. |
|
|
|
Anti-takeover provisions in our governing documents and under Delaware
law could make an acquisition of us more difficult, limit attempts by our stockholders to replace or remove our current management and limit the market price of our common stock. |
|
|
|
ERES has identified a material weakness in its internal control over financial reporting as of December 31,
2022. If ERES is unable to develop and maintain an effective system of internal control |
20
|
over financial reporting, ERES may not be able to accurately report its financial results in a timely manner, which may adversely affect investor confidence in ERES and materially and adversely
affect its business and operating results. |
Risks relating to redemption, including that:
|
|
|
If third parties bring claims against ERES, the proceeds held in the Trust Account could be reduced and the per
share redemption amount received by stockholders may be less than $[●] per share. |
|
|
|
ERESs independent directors may decide not to enforce the indemnification obligations of the Sponsor,
resulting in a reduction in the amount of funds in the Trust Account available for distribution to our Public Stockholders. |
|
|
|
There is no guarantee that a Public Stockholders decision whether to redeem their Public Shares for a pro
rata portion of the Trust Account will put such stockholder in a better future economic position. |
|
|
|
If Public Stockholders fail to comply with the redemption requirements specified in this proxy statement, they
will not be entitled to redeem their Public Shares for a pro rata portion of the funds held in the Trust Account. |
|
|
|
If, before distributing the proceeds in the Trust Account to Public Stockholders, ERES files a bankruptcy
petition or an involuntary bankruptcy petition is filed against ERES that is not dismissed, the claims of creditors in such proceeding may have priority over the claims of ERESs stockholders and the per share amount that would otherwise be
received by ERESs stockholders in connection with ERESs liquidation may be reduced. |
|
|
|
If, after ERES distributes the proceeds in the Trust Account to Public Stockholders, ERES files a bankruptcy
petition or an involuntary bankruptcy petition is filed against ERES that is not dismissed, a bankruptcy court may seek to recover such proceeds, and ERES and the ERES Board may be exposed to claims of punitive damages. |
|
|
|
If you or a group of stockholders of which you are a part are deemed to hold an aggregate of more
than 20% of the Public Shares, you (or, if a member of such a group, all of the members of such group in the aggregate) will lose the ability to redeem all such shares in excess of 20% of the Public Shares. |
|
|
|
ERES may redeem your unexpired warrants prior to their exercise at a time that is disadvantageous to you, thereby
making your warrants worthless, and Private Placement Warrants have different cashless exercise rights than other warrants issued by ERES. |
|
|
|
There is uncertainty regarding the federal income tax consequences of the redemption to the holders of ERES
Class A Common Stock. |
|
|
|
A new 1% U.S. federal excise tax may be imposed upon us in connection with the redemptions by us of our Class A
Common Stock. |
|
|
|
Unlike some other blank check companies, ERES does not have a specified maximum redemption threshold, except that
in no event will ERES redeem the Public Shares in an amount that would cause ERESs net tangible assets to be less than $5,000,001. The absence of such a redemption threshold will make it easier for ERES to consummate the Business Combination
even if a substantial number of ERES stockholders redeem. |
Information about ERES (page 106)
ERES is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase,
reorganization or other similar business combination with one or more businesses. The ERES Class A Common Stock, units and public warrants are currently listed on Nasdaq under the symbols
21
ERES, ERESU and ERESW, respectively. The mailing address of ERESs principal executive office is 7777 NW Beacon Square Boulevard, Boca Raton, Florida
33487 and the telephone number of ERESs principal executive office is (561) 826-3620.
INFORMATION ABOUT
THE POST-COMBINATION COMPANY FOLLOWING THE BUSINESS COMBINATION (page 133)
Abacus and LMA comprise a leading vertically integrated
alternative asset manager specializing in investing in inforce life insurance products throughout the lifecycle of a life insurance policy. As an alternative asset manager, the Companies focus on originating, holding and servicing life insurance
policies. The Companies purchase life insurance policies from consumers seeking liquidity and actively manages those policies over time (via trading, holding and/or servicing). To date, the Companies have purchased over $2.9 billion in policy
value and have helped thousands of clients maximize the value of their life insurance.
The mailing address of each of the
Companies principal executive office is 2101 Park Center Drive, Suite 170, Orlando, Florida 32835 and the telephone number of each of the Companies principal executive office is 800-561-4148.
22
Summary Historical Financial Data For ERES
The summary historical financial information of ERES for the years ended December 31, 2022 and 2021 was derived from the audited consolidated
financial statements of ERES included elsewhere in this proxy statement. You should read the following summary financial information in conjunction with the sections titled Selected Historical Financial Information of ERES
and ERES Managements Discussion and Analysis of Financial Condition and Results of Operations and ERESs financial statements and related notes appearing elsewhere in this proxy statement.
|
|
|
|
|
|
|
|
|
|
|
For the year ended December 31, |
|
|
For the year ended December 31, |
|
|
|
2022 |
|
|
2021 |
|
Statement of Operations Data: |
|
|
|
|
|
|
|
|
Loss from operations |
|
$ |
(11,722,287 |
) |
|
$ |
(1,382,681 |
) |
Other income (expense) |
|
$ |
11,131,208 |
|
|
$ |
17,222,046 |
|
Net income (loss) |
|
$ |
(643,564 |
) |
|
$ |
15,839,365 |
|
Basic and diluted weighted average shares outstanding, Class A Common Stock subject to possible
redemption |
|
|
23,637,084 |
|
|
|
34,500,000 |
|
Basic and diluted net income (loss) per share, Class A Common Stock subject to possible
redemption |
|
$ |
(0.02 |
) |
|
$ |
0.37 |
|
Basic and diluted weighted average shares outstanding, Non-redeemable common stock |
|
|
8,625,000 |
|
|
|
8,625,000 |
|
Basic and diluted net income (loss) per share, Non-redeemable common stock |
|
$ |
(0.02 |
) |
|
$ |
0.37 |
|
|
|
|
Statement of Cash Flows Data: |
|
|
|
|
|
|
|
|
Net cash used in operating activities |
|
$ |
(2,602,281 |
) |
|
$ |
(1,236,555 |
) |
Net cash used in (provided by) investing activities |
|
$ |
246,498,623 |
|
|
$ |
|
|
Net cash used in (provided by) financing activities |
|
$ |
(244,662,900 |
) |
|
$ |
1,500,000 |
|
Net Change in Cash |
|
$ |
(766,558 |
) |
|
$ |
263,445 |
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31, |
|
|
|
2022 |
|
|
2021 |
|
Balance Sheet Data: |
|
|
|
|
|
|
|
|
Total Assets |
|
$ |
99,374,190 |
|
|
$ |
345,993,643 |
|
Total Liabilities |
|
$ |
18,780,609 |
|
|
$ |
29,231,054 |
|
Class A Common Stock subject to possible redemption |
|
$ |
98,983,437 |
|
|
$ |
345,000,000 |
|
Total Stockholders Deficit |
|
$ |
(18,389,856 |
) |
|
$ |
(28,237,411 |
) |
23
Summary Historical Financial Data For LMA
The summary historical statements of income data of LMA for the years ended December 31, 2022 and 2021 and the historical balance sheet data
as of December 31, 2022 and December 31, 2021 are derived from LMAs audited financial statements included elsewhere in this proxy statement.
LMAs historical results are not necessarily indicative of the results that may be expected in the future. The information below is only
a summary and should be read in conjunction with the section entitled LMA Managements Discussion and Analysis of Financial Condition and Results of Operations and the LMA financial statements, and the notes and schedules
related thereto, which are included elsewhere in this proxy statement.
|
|
|
|
|
|
|
|
|
|
|
As of and for the year ended December 31, 2022 |
|
|
As of and for the year-ended December 31, 2021 |
|
Statement of Income Data: |
|
|
|
|
|
|
|
|
Total revenue |
|
$ |
44,713,553 |
|
|
$ |
1,199,986 |
|
Total cost of revenue |
|
|
6,245,131 |
|
|
|
735,893 |
|
|
|
|
|
|
|
|
|
|
Gross profit |
|
|
38,468,422
|
|
|
|
464,093 |
|
Sales, general, administrative, and depreciation |
|
|
3,666,826
|
|
|
|
597,702 |
|
Change in fair value of debt |
|
|
90,719 |
|
|
|
|
|
Unrealized loss on investments |
|
|
1,045,623 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from operations |
|
|
33,665,255 |
|
|
|
(133,609 |
) |
Other (expense) income |
|
|
|
|
|
|
|
|
Other (expense) |
|
|
(347,013 |
) |
|
|
|
|
Interest (expense) |
|
|
(42,798 |
) |
|
|
|
|
Interest income |
|
|
1,474 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total other (expense) |
|
|
(388,337 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes |
|
|
33,276,917 |
|
|
|
(133,609 |
) |
Provision for Income taxes |
|
|
889,943 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net and Comprehensive Income (loss) |
|
$ |
32,386,975 |
|
|
$ |
(133,609 |
) |
|
|
|
|
|
|
|
|
|
Balance Sheet Data: |
|
|
|
|
|
|
|
|
Total assets |
|
$ |
59,094,847 |
|
|
$ |
1,840,218 |
|
Total liabilities |
|
|
30,945,150 |
|
|
|
1,073,325 |
|
Total members equity |
|
|
28,149,697 |
|
|
|
766,893 |
|
24
Summary Historical Financial Data For Abacus
The summary historical statements of income data of Abacus for the years ended December 31, 2022 and 2021 and the historical balance sheet
data as of December 31, 2022 and December 31, 2021 are derived from Abacus audited financial statements included elsewhere in this proxy statement.
Abacus historical results are not necessarily indicative of the results that may be expected in the future. The information below is
only a summary and should be read in conjunction with the section entitled Abacus Managements Discussion and Analysis of Financial Condition and Results of Operations and the Abacus financial statements, and the notes and
schedules related thereto, which are included elsewhere in this proxy statement.
|
|
|
|
|
|
|
|
|
|
|
As of and for the year ended December 31, 2022 |
|
|
As of and for the year-ended December 31, 2021 |
|
Statement of Income Data: |
|
|
|
|
|
|
|
|
Total revenue |
|
$ |
25,203,463 |
|
|
$ |
22,592,144 |
|
Total cost of revenue |
|
|
5,538,470 |
|
|
|
14,205,341 |
|
|
|
|
|
|
|
|
|
|
Gross profit |
|
|
8,642,458 |
|
|
|
8,386,803 |
|
Operating expenses |
|
|
8,686,590 |
|
|
|
7,449,688 |
|
|
|
|
|
|
|
|
|
|
Income from operations |
|
|
(44,132 |
) |
|
|
937,115 |
|
Other (expense) income |
|
|
|
|
|
|
|
|
Interest income |
|
|
2,199 |
|
|
|
10,870 |
|
Interest (expense) |
|
|
(8,817 |
) |
|
|
|
|
Consulting income |
|
|
273 |
|
|
|
50,000 |
|
Other income |
|
|
|
|
|
|
630 |
|
|
|
|
|
|
|
|
|
|
Total other (expense) income |
|
|
(6,345 |
) |
|
|
61,500 |
|
|
|
|
|
|
|
|
|
|
Income before income taxes |
|
|
(50,477 |
) |
|
|
998,615 |
|
Provision for income taxes |
|
|
2,018 |
|
|
|
1,200 |
|
|
|
|
|
|
|
|
|
|
Net Income |
|
$ |
(52,495 |
) |
|
$ |
997,415 |
|
|
|
|
|
|
|
|
|
|
Balance Sheet Data: |
|
|
|
|
|
|
|
|
Total assets |
|
$ |
3,215,812 |
|
|
$ |
5,291,997 |
|
Total liabilities |
|
|
1,204,675 |
|
|
|
2,569,002 |
|
Total members equity |
|
|
2,011,137 |
|
|
|
2,722,995 |
|
25
SUMMARY UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL
INFORMATION
The following summary unaudited pro forma condensed combined financial data (the summary pro forma data)
gives effect to the Business Combination and related transactions described in the section entitled Unaudited Pro Forma Condensed Combined Financial Information.
The LMA Merger is expected to be accounted for using the reverse recapitalization method of accounting, with no goodwill or other intangible
assets recorded in accordance with GAAP. Accordingly, for accounting purposes, the financial statements of the Post-Combination Company will represent a continuation of the financial statements of LMA with the acquisition being treated as the
equivalent of LMA issuing stock for the net assets of ERES, accompanied by a recapitalization. The net assets of ERES will be stated at historical cost, with no goodwill or other intangible assets recorded.
The Abacus Merger is expected to be accounted for using the acquisition method of accounting in accordance with GAAP. Accordingly, for
accounting purposes, the identified assets and liabilities of Abacus will be recorded at their estimated fair values as of the acquisition date. The excess of the purchase price over the estimated fair values of the net assets acquired, if
applicable, will be recognized as goodwill.
The summary unaudited pro forma condensed combined balance sheet data as December 31,
2022 gives pro forma effect to the Business Combination and related transactions as if they had occurred on December 31, 2022. The summary unaudited pro forma condensed combined statement of operations data for the year ended December 31,
2022 gives pro forma effect to the Business Combination and related transactions as if they had been consummated on January 1, 2022.
The summary pro forma data have been derived from, and should be read in conjunction with, the unaudited pro forma condensed combined
financial information of the Post-Combination Company appearing elsewhere in this proxy statement and the accompanying notes. The unaudited pro forma condensed combined financial information is based upon, and should be read in conjunction with, the
historical financial statements of ERES and related notes, the historical financial statements of LMA and related notes and the historical financial statements of Abacus and related notes included in this proxy statement. The summary pro forma data
have been presented for informational purposes only and are not necessarily indicative of what the Post-Combination Companys financial position or results of operations actually would have been had the Business Combination and related
transactions been completed as of the dates indicated. In addition, the summary pro forma data do not purport to project the future financial position or operating results of the Post-Combination Company.
The summary unaudited pro forma condensed combined financial information has been prepared assuming two redemption scenarios after giving
effect to the Transactions, as follows:
|
|
|
Assuming No Redemption No stockholders of Class A Common Stock exercise their redemption rights with
respect to their redeemable Class A Common Stock upon the Closing. |
|
|
|
Assuming Maximum Contractual Redemptions Stockholders representing 2.9 million shares of Class A
Common Stock exercise their redemption rights with respect to their redeemable Class A Common Stock upon the Closing for a total redemption price of $29.3 million, assuming that the redemption price is $10.00 per share.
|
If the actual facts are different than these assumptions, including as to the amount of ERES cash and net debt,
then the maximum number of redemptions and the amounts and shares outstanding in the unaudited pro forma condensed combined financial information will be different.
26
|
|
|
|
|
|
|
|
|
|
|
Year Ended |
|
|
|
December 31, 2022 |
|
Pro Forma Condensed Combined Statement of Operations Data |
|
Assuming No Redemptions |
|
|
Assuming Maximum Redemptions |
|
Revenue |
|
$ |
67,648 |
|
|
$ |
67,648 |
|
Net income (loss) |
|
$ |
(17,435 |
) |
|
$ |
(19,082 |
) |
Net income (loss) per share - basic and diluted |
|
$ |
(0.29 |
) |
|
$ |
(0.33 |
) |
Weighted average common shares outstanding - basic and diluted |
|
|
60,086,125 |
|
|
|
57,230,078 |
|
27
UNAUDITED HISTORICAL COMPARATIVE AND PRO FORMA COMBINED PER
SHARE DATA OF ERES AND THE COMPANIES
The following table sets forth selected historical comparative share information for ERES and
the Companies, and unaudited pro forma condensed combined per share information of the Post-Combination Company after giving effect to the Business Combination and related transactions, assuming two redemption scenarios as follows:
|
|
|
Assuming No RedemptionNo holders of ERES Class A Common Stock exercise their redemption rights with
respect to their redeemable ERES Class A Common Stock upon the Closing. In this scenario, ERES stockholders comprise 2.9 million shares of Class A Common Stock and contribute $29.3 million to the Post-Combination Company,
assuming that the redemption price is $10.00 per share. |
|
|
|
Assuming Maximum RedemptionStockholders representing 2.9 million shares of Class A Common Stock
exercise their redemption rights with respect to their redeemable Class A Common Stock upon the Closing, which represents 100% redemptions, for a total redemption price of $29.3 million, with the number of redemptions being determined by
assuming that the redemption price is $10.00 per share. |
The pro forma stockholders equity information reflects
the Business Combination and related transactions as if they had occurred on December 31, 2022. The weighted average shares outstanding and net income per share information for the year ended December 31, 2022 gives pro forma effect to the Business
Combination and related transactions as if they had occurred on January 1, 2022, the beginning of the earliest period presented.
If
the actual facts are different than these assumptions, including as to the amount of ERESs cash and net debt, then the maximum number of redemptions and the amounts and shares outstanding in the unaudited pro forma condensed combined financial
information will be different.
This information is only a summary and should be read together with the historical financial information
included elsewhere in this proxy statement, and the historical financial statements of ERES and related notes, historical financial statements of LMA and related notes, and historical financial statements of Abacus and related notes that are
included elsewhere in this proxy statement. The unaudited pro forma combined per share information of ERES and the Companies are derived from, and should be read in conjunction with, the unaudited pro forma condensed combined financial statements
and related notes included elsewhere in this proxy statement.
28
The unaudited pro forma combined earnings per share information below does not purport to
represent the earnings per share which would have occurred had ERES and the Companies been combined during the periods presented, nor earnings per share for any future date or period. The unaudited pro forma combined book value per share information
below does not purport to represent what the value of ERES, LMA and Abacus would have been had ERES and the Companies been combined during the periods presented.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Combined Pro Forma |
|
|
|
LMA (Historical) |
|
|
Abacus (Historical) |
|
|
ERES (Historical) |
|
|
No Redemptions |
|
|
Maximum Redemptions |
|
As of and for the Year Ended December 31, 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders equity (deficit) |
|
$ |
28,150 |
|
|
$ |
2,011 |
|
|
$ |
(18,389 |
) |
|
$ |
205,169 |
|
|
$ |
175,878 |
|
Net income (loss) |
|
$ |
32,387 |
|
|
$ |
(52 |
) |
|
$ |
(644 |
) |
|
$ |
(17,435 |
) |
|
$ |
(19,082 |
) |
Common shares outstanding as of December 31, 2022basic and diluted(1) |
|
|
5,000 |
|
|
|
400 |
|
|
|
9,718,972 |
|
|
|
60,086,125 |
|
|
|
57,230,078 |
|
Weighted average common shares outstandingbasic and diluted(1) |
|
|
5,000 |
|
|
|
400 |
|
|
|
23,637,084 |
|
|
|
60,086,125 |
|
|
|
57,230,078 |
|
Stockholders equity (deficit) per sharebasic and diluted(1) |
|
$ |
5,630.00 |
|
|
$ |
5,027.50 |
|
|
$ |
(1.89 |
) |
|
$ |
3.41 |
|
|
$ |
3.07 |
|
Net income (loss) per share attributable to common stockholdersbasic and diluted(1) |
|
$ |
6,477.39 |
|
|
$ |
(131.24 |
) |
|
$ |
0.02 |
|
|
$ |
(0.29 |
) |
|
$ |
(0.33 |
) |
(1) |
ERES shares and per share information are inclusive of common shares subject to possible redemption.
|
29
MARKET PRICE AND DIVIDEND INFORMATION
ERES
The ERES Class A Common Stock,
units and public warrants are listed on the Nasdaq under the symbols ERES, ERESU and ERESW, respectively.
The closing price of the ERES
Class A Common Stock, units and public warrants on August 29, 2022, the last trading day before announcement of the execution of the Merger Agreement, was $10.04, $10.07 and $0.17, respectively. As of [●], 2023, the ERES Record Date,
the most recent closing price for each of the ERES Class A Common Stock, units and public warrants was $[●], $[●] and $[●], respectively.
Holders of the ERES Class A Common Stock, units and public warrants should obtain current market quotations for their securities. The
market price of ERESs securities could vary at any time before the Business Combination.
Holders
As of April 21, 2023, there was one holder of record of ERESs units, one holder of record of ERES Class A Common Stock, two
holders of record of ERES Class B Common Stock and two holders of record of public warrants. The number of holders of record does not include a substantially greater number of street name holders or beneficial holders whose units,
Public Shares and public warrants are held of record by banks, brokers and other financial institutions.
Dividend Policy
ERES has not paid any cash dividends on ERES Common Stock to date and does not intend to pay cash dividends prior to the completion of the
Business Combination. The payment of cash dividends in the future will be dependent upon the Post-Combination Companys revenues and earnings, if any, capital requirements and general financial condition
subsequent to completion of the Business Combination, as well as the applicable provisions of the Proposed Charter, the Amended and Restated Bylaws and applicable law. The payment of any cash dividends subsequent to the Business Combination will be
within the discretion of the Post-Combination Companys board of directors at such time. The Post-Combination Companys ability to declare dividends may also
be limited by restrictive covenants pursuant to any debt financing agreements. In addition, the Post-Combination Companys board of directors is not currently contemplating and does not anticipate declaring any stock dividends in the
foreseeable future.
The Companies
Historical market price information regarding the Companies is not provided because there is no public market for the Companies
securities. See the sections entitled Abacus Managements Discussion and Analysis of Financial Condition and Results of Operations and LMA Managements Discussion and Analysis of Financial Condition and
Results of Operations.
30
CAUTIONARY NOTE REGARDING
FORWARD-LOOKING STATEMENTS
This proxy statement includes
forward-looking statements regarding, among other things, the plans, strategies and prospects, both business and financial, of ERES and the Companies. These statements are based on the beliefs and assumptions
of the management of ERES and the Companies. Although ERES and the Companies believe that their respective plans, intentions and expectations reflected in or suggested by these forward-looking statements are
reasonable, neither ERES and the Companies can assure you that either will achieve or realize these plans, intentions or expectations. Forward-looking statements are inherently subject to risks, uncertainties
and assumptions. Generally, statements that are not historical facts, including statements concerning possible or assumed future actions, business strategies, events or results of operations, and any statements that refer to projections, forecasts
or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. These statements may be preceded by, followed by or include the words
believes, estimates, expects, predicts, projects, forecasts, may, might, will, could, should, would,
seeks, plans, scheduled, possible, continue, potential, anticipates or intends or similar expressions; provided that the absence of these does not means
that a statement is not forward-looking. Forward-looking statements contained in this proxy statement include, but are not limited to, statements about the ability of ERES and the Companies prior to the
consummation of the Business Combination, and of the Post-Combination Company following the Business Combination, to:
|
|
|
meet the closing conditions to the Business Combination, including approval by stockholders of ERES and the
Company Members on the expected terms and schedule; |
|
|
|
realize the benefits expected from the proposed Business Combination and the transactions contemplated thereby;
|
|
|
|
anticipate any event, change or other circumstances that could give rise to the termination of the Merger
Agreement or any other agreement described in this proxy statement; |
|
|
|
obtain and/or maintain the listing of Post-Combination Company common stock on a securities exchange following
the Business Combination; |
|
|
|
achieve projections and anticipate uncertainties relating to the business, operations and financial performance
of ERES and the Companies prior to the Business Combination, and of the Post-Combination Company after the Business Combination, including: |
|
|
|
expectations with respect to financial and business performance, including financial projections and business
metrics and any underlying assumptions thereunder; |
|
|
|
expectations regarding product development and pipeline; |
|
|
|
expectations regarding market size; |
|
|
|
expectations regarding the competitive landscape; |
|
|
|
expectations regarding future acquisitions, partnerships or other relationships with third parties;
|
|
|
|
future capital requirements and sources and uses of cash, including the ability to obtain additional capital in
the future; and |
|
|
|
develop, design and sell services that are differentiated from those of competitors; |
|
|
|
retain and hire necessary employees; |
|
|
|
attract, train and retain effective officers, key employees or directors; |
|
|
|
enhance future operating and financial results; |
|
|
|
comply with laws and regulations applicable to its business; |
31
|
|
|
stay abreast of modified or new laws and regulations applying to its business, including privacy regulation;
|
|
|
|
anticipate the impact of, and response to, new accounting standards; |
|
|
|
anticipate the significance and timing of contractual obligations; |
|
|
|
maintain key strategic relationships with partners and customers; |
|
|
|
respond to uncertainties associated with product and service development and market acceptance;
|
|
|
|
successfully defend litigation; |
|
|
|
upgrade, maintain and secure information technology systems; |
|
|
|
access, collect and use personal data about consumers; |
|
|
|
acquire, maintain and protect intellectual property; |
|
|
|
anticipate rapid technological changes; |
|
|
|
meet future liquidity requirements and comply with restrictive covenants related to long-term indebtedness; |
|
|
|
maintain the listing on, or the delisting of ERESs or the Post-Combination Companys securities from,
Nasdaq or an inability to have our securities listed on the Nasdaq or another national securities exchange following the Business Combination; |
|
|
|
effectively respond to general economic and business conditions; |
|
|
|
obtain additional capital, including use of the debt market; and |
|
|
|
successfully deploy the proceeds from the Business Combination; |
Forward-looking statements are not guarantees of performance. You should not put undue reliance on
these statements which speak only as of the date hereof. You should understand that the following important factors, in addition to those discussed under the heading Risk Factors and elsewhere in this proxy statement, could affect
the future results of ERES and the Companies prior to the consummation of the Business Combination, and of the Post-Combination Company following the Business Combination, and could cause those results or
other outcomes to differ materially from those expressed or implied in the forward-looking statements in this proxy statement:
|
|
|
the Business Combination may not be completed in a timely manner or at all, which may adversely affect the price
of ERESs securities; |
|
|
|
the transaction may not be completed by ERESs business combination deadline; |
|
|
|
occurrence of an event, change or other circumstances that could give rise to the termination of the Merger
Agreement; |
|
|
|
inability to complete the Business Combination due to the failure to obtain approval of ERESs stockholders
or the Company Members, or to satisfy other closing conditions of the Business Combination; |
|
|
|
changes to the proposed structure of the Business Combination that may be required or appropriate as a result of
applicable laws or regulations or as a condition to obtaining regulatory approval of the Business Combination; |
|
|
|
ability to meet the Nasdaqs listing standards following the consummation of the Business Combination;
|
32
|
|
|
inability to recognize the anticipated benefits of the Business Combination, which may be affected by, among
other things, competition and the ability of the Post-Combination Company to grow and manage growth profitably, maintain relationships with customers and suppliers and retain its management and key employees; |
|
|
|
risks related to disruption of managements time from ongoing business operations due to the proposed
transactions; |
|
|
|
litigation, complaints and/or adverse publicity; |
|
|
|
changes in applicable laws or regulations; |
|
|
|
possibility that ERES or the Post-Combination Company may be adversely affected by other economic, business or
competitive factors; |
|
|
|
volatility in the markets caused by geopolitical and economic factors; |
|
|
|
privacy and data protection laws, privacy or data breaches, or the loss of data; |
|
|
|
the impact of changes in consumer spending patterns, consumer preferences, local, regional and national economic
conditions, crime, weather, demographic trends and employee availability; |
|
|
|
the impact of the COVID-19 pandemic on the financial condition and
results of operations of ERES and the Companies; |
|
|
|
any defects in new products or enhancements to existing products; and |
|
|
|
other risks and uncertainties detailed under the section entitled Risk Factors.
|
These and other factors that could cause actual results to differ from those implied by the forward-looking statements in this proxy statement are more fully described under the heading Risk Factors and elsewhere in this proxy statement. The risks described under the heading
Risk Factors are not exhaustive. Other sections of this proxy statement describe additional factors that could adversely affect the business, financial condition or results of operations of ERES and the Companies prior to the
Business Combination, and of the Post-Combination Company following the Business Combination. New risk factors emerge from time to time and it is not possible to predict all such risk factors, nor can ERES and
the Companies assess the impact of all such risk factors on the business of ERES and the Companies prior to the Business Combination, and on the Post-Combination Company following the Business Combination, or
the extent to which any factor or combination of factors may cause actual results to differ materially from those contained in any forward-looking statements. All
forward-looking statements attributable to ERES and the Companies or persons acting on their behalf are expressly qualified in their entirety by the foregoing cautionary statements. ERES and the Companies
prior to the Business Combination, and the Post-Combination Company following the Business Combination, undertake no obligations to update or revise publicly any
forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
In addition, statements of belief and similar statements reflect the beliefs and opinions of ERES and the Companies, as applicable, on the
relevant subject. These statements are based upon information available to ERES and the Companies, as applicable, as of the date of this proxy statement, and while such party believes such information forms a reasonable basis for such statements,
such information may be limited or incomplete, and statements should not be read to indicate that ERES and the Companies, as applicable, has conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These
statements are inherently uncertain and you are cautioned not to unduly rely upon these statements.
33
RISK FACTORS
In addition to the other information contained in this proxy statement, including the matters addressed under the heading Forward-Looking Statements, you should carefully consider the following risk factors in deciding how to vote on the Proposals presented in this proxy statement. In this section we,
us, our and Company refer to the Companies prior to the Business Combination and to the Post-Combination Company following the Business Combination.
Risks Related to the Business of the Companies
The
Companys valuation of life insurance policies is uncertain as many life insurance policies values are tied to their actual maturity date and any erroneous valuations could have a material adverse impact on the Companys business.
The valuation of life insurance policies involves inherent uncertainty (including, without limitation, the life expectancies of
insureds and future increases in premium costs to keep the policies in force). There is no guarantee that the value determined with respect to a particular life settlement policy by the Company will represent the value that will be realized by the
Company on the eventual disposition of the related investment or that would, in fact, be realized upon an immediate disposition of the investment. In addition, there can be no guarantee that such valuation accurately reflects the current present
value of such life insurance policy at its actual maturity. Uncertainties as to the valuation of life insurance policies held by the Company could require adjustments to reported net asset values and could have a material adverse impact on the
Companys business. Uncertainties as to the valuation may also result in the Company being less competitive in the market for originating new life settlement policies and could adversely affect the profits the Company realizes on life
settlements purchased and sold.
The Company could fail to accurately forecast life expectancies. There may also be changes to life expectancies
generally, resulting in people living longer in the future, which could result in a lower return on the Companys life settlement policies.
Prices for life insurance policies and annuities that may be obtained by the Company depend, in large measure, upon the life expectancy of the
underlying insureds. The returns of the Companys hold portfolio is almost entirely dependent upon how accurate the actual longevity of an insured is as compared to the Companys expectation for that insured. Life expectancies are
estimates of the expected longevity or mortality of an insured. In determining the life expectancy of an insured, the Company relies on medical underwriting conducted by various medical underwriting firms. The medical underwriting process underlying
life expectancy estimates is highly subjective, and mortality and longevity estimates are inherently uncertain. In addition, there can be no assurance that the applicable medical underwriting firm received accurate or complete information regarding
the health of an insured under a life insurance policy, or that such insureds health has not changed since the information was received. Different medical underwriting firms use different methods and may arrive at materially different
mortality estimates for the same individual based on the same information, thus causing a life insurance policys value to vary. Moreover, as methods of calculating mortality estimates change over time, a mortality estimate prepared by any
medical underwriting firm in connection with the acquisition of a life insurance policy may be different from a mortality estimate prepared by the same person at a later time. The valuation of the life insurance policies will vary depending on the
dates of the related mortality estimates and the medical underwriting firms that provide the supporting information.
Other factors,
including, but not limited to, better access to health care, better adherence to treatment plans, improved nutritional habits, improved lifestyle, an improved economic environment and a higher standard of living could also lead to increases in the
longevity of the insureds under the life insurance policies. In addition to other factors affecting the accuracy of life expectancy estimates, improvements in medicine, disease treatment, pharmaceuticals and other medical and health services may
enable insureds to live longer.
34
The actual longevity of an insured may be materially different than the predicted mortality
estimate. If the actual maturity date of life insurance policies are longer than projected, it would delay when the Company could expect to receive a return on its investment and the Company may be unable to meet its investment objectives and goals.
For example, a term life insurance policy in which the Company may invest have a stated expiration date on the date at which the underlying insured reaches a certain attained age and, beyond such date, the issuing insurance company may not be
obligated to pay the face value, but rather only the cash surrender value which is usually maintained at a low value by investors, if any, in accordance with the terms of such life insurance policy. Therefore, if the underlying insured survives to
the stated maturity date set forth in the terms of the life insurance policy, the issuing insurance company may only be obligated to pay an amount substantially less than the deface value, which could have an adverse effect on the performance of the
Company.
The medical underwriting and other firms that provide information for the Companys forecasts of life expectancies are
generally not regulated by the U.S. federal or state governments, with the exception of the states of Florida and Texas, which require life expectancy providers to register with their respective offices of insurance regulation. There can be no
assurance that this business will not become more broadly regulated and, if so, that any such regulation would not have a material adverse effect on the ability of the Company to establish appropriate life expectancies in connection with the
purchase or sale of policies.
The Companys policy acquisitions are limited by the market availability of life insurance policies that meet
the Companys eligibility criteria and purchase parameters, and failure to secure a sufficient number of quality life insurance policies could have a material adverse effect on the Companys business.
The life insurance policy secondary market has grown substantially in the past several years, however, as to whether and how it will continue
to develop is uncertain. There are only a limited number of life insurance policies available in the market from time to time. There can be no assurance that the Company will be able to source life insurance policies on terms acceptable to the
Company. As more investment funds flow into the market for life insurance policies, margins may be squeezed and the value of the collateral may become comparatively more expensive to purchase or subject to greater competition on the purchase side.
There can be no assurance that secondary market life insurance policies will be available to the Company on satisfactory or competitive terms.
The supply of life insurance policies available in the market may be reduced by, among other things: (i) improvement in the economy,
resulting in higher investment returns to insureds and other owners of life insurance policies from their investment portfolios; (ii) improvements in health insurance coverage, limiting the need of insureds to obtain funds to pay the cost of
their medical treatment by selling their life insurance policies; (iii) the entry into the market of less reputable third-party brokers who submit inaccurate or false life insurance policy information to the Company; (iv) the establishment
of new licensing requirements for market participants and a delay in complying or an inability to comply with such new requirements; or (v) refusal of the carrier that issued a life insurance policy to consent to its transfer. A change in the
availability of life insurance policies could adversely affect the Companys ability to execute its strategy and meet its objectives.
The
Company may experience increased competition from originating life insurance companies, life insurance brokers, and investment funds which could have a material adverse effect on the Companys business.
Life insurance companies have begun offering to repurchase their own in-force life insurance policies
from their current policyholders by offering enhanced cash surrender value payments above the amount of the net cash surrender value provided under the life insurance contracts terms and thus compete directly with the Company and
other life settlement providers. The life settlements industry has attacked the legal validity of the life insurance companies actions, and some state insurance regulators have declared that these repurchase offers are unlawful while other
state insurance regulators have approved them. To the extent that life insurance companies can seek to repurchase their own in-force life insurance policies, they present competition to the Company in
acquiring policies.
35
In addition, the Company is subject to significant competition from other life settlement
brokers and investment funds for the purchase of life settlement policies. Increased competition for life settlement policies may result in the Company being unable to access the number of life settlement policies that it desires for its business at
prices that it deems acceptable.
Historically, there has been a negative public perception of the life settlement industry that could affect the
value and/or liquidity of the Companys investments and the life settlement industry faces political opposition from life insurance companies which could have a material adverse effect on the Companys business.
Many regulators, lawmakers and other governmental authorities, as well as many insurance companies and insurance industry organizations, are
hostile to or otherwise concerned about certain aspects of the longevity-contingent asset markets. The life settlement industry and some of its participants have also been, and may continue to be, portrayed negatively in a number of widely read
publications and other forms of media. These opponents regularly contend that life settlement transactions are contrary to public policy by promoting financial speculation on human life and often involve elements of fraud and other wrongdoing.
Continued public opposition to the life settlement industry, as well as actual or alleged wrongdoing by participants in the industry, could have a material adverse effect on the Company and its investors, including on the value and/or liquidity of
the Companys investments.
In March 2010, the American Council of Life Insurers, an insurance carrier trade association, issued a
press release calling for a complete ban on life settlement securitization. While that effort was not successful, any such federal or state legislation, if passed, could have the effect of severely limiting or potentially prohibiting the continued
operation of the Companys life settlement purchasing operations. All of the foregoing could adversely affect the Companys ability to execute its investment strategy and meet its investment objective.
The Company or third parties the Company relies upon could fail to accurately evaluate, acquire, maintain, track, or collect on life settlement
policies, which could have a material adverse impact on the Companys revenues.
The Company relies on third party data for
tracking and servicing its life settlement policies. This includes the origination and servicing of life settlement policies by the servicing and tracking agent, market counterparties and other service providers, and the Company may not be in a
position to verify the risks or reliability of such third-party data and systems. Failures in the systems employed by the Company and other service providers, counterparties, and other parties could result in mistakes made in the evaluation,
acquisition, maintenance, tracking and collection of life settlement policies and other longevity-linked investments. This could result in the Company overpaying for life settlement policies it acquires or underpricing life settlement policies it
sells. In addition, disruptions in the Companys operations as a result of a failure in a third party system may cause the Company to suffer, among other things, financial loss, the disruption of its business, liability to third-parties,
regulatory intervention or reputational damage. Any of the foregoing failures or disruptions could have a material adverse effect on the Company.
There is a risk of fraud in the origination of the original life insurance policy or in subsequent sales of the life insurance policy that could
adversely affect the Companys returns which could have a material adverse impact on the Companys business.
The Company
faces the risk that an original owner of a life insurance policy, the related insured, the insurance agent involved in the issuance of such life insurance policy, or other party may have committed fraud, or misstated or failed to provide material
information in connection with the origination or subsequent sale of that life insurance policy. While most life insurance policies may not be challenged for fraud after the end of the two-year contestability
period, there may be situations where such fraud in connection with the issuance of a life insurance policy may survive the contestability period. If an issuing insurance company successfully challenges a life insurance policy acquired by the
Company on the grounds of fraud, the Company may lose its entire
36
investment in that life insurance policy. Furthermore, if the age of an insured was misstated, the Company may receive lower death benefits than expected. In addition, there may be information
directly relevant to the value of a life insurance policy, including, but not limited to, information relating to the insureds medical or financial condition, to which the Company will not have access. It is not possible to verify the accuracy
or completeness of each piece of information or the completeness of the overall information supplied by such parties. Any such misstatement or omission could cause the Company to rely on assumptions which turn out to be inaccurate. Additionally,
there can be no assurance that the seller of a life insurance policy in the tertiary market properly acquired that policy from the former owner, or that a former beneficiary or other interested party will not attempt to challenge the validity of the
transfer. The occurrence of any one or more of these factors could adversely affect the Companys performance and returns.
The Company may
become subject to claims by life insurance companies, individuals and their families, or regulatory authorities which could have a material adverse impact on the Companys business.
The secondary market for life insurance policies has been subjected to allegations of fraud and misconduct as reflected in certain litigated
cases. Some of these cases, some of which have been brought by regulatory authorities, involve allegations of fraud, breaches of fiduciary duty, bid rigging, non-disclosure of material facts and associated
misconduct in life settlement transactions. Cases have also been brought by the life insurance companies that challenge the legality of the original issuance of the life insurance policies based on lack of insurable interest, fraud and
misrepresentation grounds.
Further, both federal and U.S. state statutes safeguard an insureds private health information. In
addition, insureds frequently have an expectation of confidentiality even if they are not legally entitled to it. Even if the Company properly obtains and uses otherwise private health information, but fails to maintain the confidentiality of such
information, the Company may be the subject of complaints from the affected individuals, their families and relatives and, potentially, interested regulatory authorities. Because of the uncertainty of applicable laws, it is not possible to predict
the outcome of those disputes. It is also possible that, due to a misunderstanding regarding the scope of consents that a transaction party possesses, the Company may request and receive from health care providers information that it in fact did not
have a right to request or receive. If the Company finds itself to be the recipient of complaints for these acts, it is not possible to predict what the results will be. This uncertainty also increases the likelihood that a transaction party may
sell, or cause to be sold, life insurance policies in violation of applicable law, which could potentially result in additional costs related to defending claims or enduring regulatory inquiries, rescinding such transactions, possible legal damages
and penalties and probable reduced market value of the affected life insurance policies. Each of the foregoing factors may delay or reduce the return on the policies and adversely affect the Companys business and results of operations.
Life settlements in which we invest are not currently regulated under the federal securities laws, but if deemed to be securities would require further
compliance with federal and state securities laws, which could result in significant additional regulatory burdens on the Company, and limit the Companys investments, which could have an adverse impact on the Companys business and
results of operations.
The origination and trading in whole, non-variable life insurance
policies has traditionally been understood to not involve transactions in securities. However, on February 22, 2019, the United States Court of Appeals for the Fifth Circuit in a case captioned In the Matter of Living Benefits Asset Management,
LLC, vs. Kestrel Aircraft Company, Incorporated, case No. 18-10510, concluded that whole, non-variable life insurance policies, when offered for sale to an
investor, were securities for purposes of the Securities Act. If this same conclusion were to be reached in other circuits or at the Supreme Court, there would be significant changes to our industry and it would materially impact the Companys
ability to conduct its business.
The Eleventh Circuit Court of Appeals reached a similar conclusion with respect to fractionalized death
benefits payable under non-variable policies, but, the District of Columbia Circuit Court of Appeals reached a contrary result with respect to fractionalized death benefits.
37
It is possible that sales of life insurance policies, depending on the facts and
circumstances attending the particular transaction, or an investment or financing program of which the purchase or sale of a life insurance policy is a part, could implicate U.S. state and federal securities laws, including the Investment Company
Act.
On July 22, 2010, the SEC released a staff report that recommended that Congress clearly define life settlements to be
securities, so that the investors in life settlements transactions would be protected under the U.S. federal securities laws. Since that time, there have been a number of changes to the life settlements industry and, to date, the SEC has not made
another such recommendation to Congress. If the statutory definitions of security were to be amended to encompass life settlements involving non-variable life insurance policies, or if the Supreme
Court or other Circuit Courts were to conclude that non-variable life insurance policies are securities for purposes of the Securities Act, the Company could become subject to additional extensive regulatory requirements under the federal securities
laws. Those regulatory requirements would include the obligation to register sales and offerings of life settlements with the SEC as public offerings under the Securities Act. Also, if non-variable life insurance policies were to be considered
securities, the Companys ownership of those policies as a percentage of its assets or source of income could be limited as it would manage its business to avoid being required to register as an investment company pursuant to the
Investment Company Act. Those limitations could have an adverse effect on the Companys business and results of operations. Any legislation or court interpretations leading to that regulatory change or a change in the transactions that are
characterized as life settlement transactions could lead to significantly increased compliance costs and increased liability risk, and could adversely affect the Companys ability to acquire or sell life insurance policies in the future. This
could materially and adversely affect the Companys business, financial condition and results of operations, which in turn could materially and adversely affect the performance of the Company.
The Company cannot assure you as to the ultimate content, timing, or effect of changes, nor is it possible at this time to estimate the impact
of any such potential change in administration or new legislation on the Companys business, financial condition, or results of operations and consequently, any potential material and adverse effect on the performance of the Company.
Certain U.S. state laws specifically characterize life settlements as securities transactions. Thus, in some U.S. states, purchases and sales
of life insurance policies by the Company may be subject to applicable U.S. state blue sky laws or other U.S. state securities laws. The Company intends to comply with all applicable federal and state securities laws. However, this will not
necessarily exempt the Company from compliance with U.S. federal or state broker-dealer laws. The failure to comply with applicable securities laws in connection with the purchase or sale of life settlement policies could result in the Company being
subject to fines, administrative and civil sanctions and rescission of life settlement policy purchase or sales transactions. Each of the foregoing factors could materially and adversely affect the performance of the Company.
The Company faces privacy and cyber security risks related to its maintenance of proprietary information, including information regarding life
settlement policies and the related insureds, and any adverse impact related to such risks could have a material adverse impact on the Companys business.
The Company relies on data processing systems to price and close transactions, to evaluate investments, to monitor its portfolio and capital,
and to generate risk management and other reports that are critical to oversight of the Companys activities. Further, the Company relies on information systems to store sensitive information about the Company, its affiliates, and its
investments, including life settlement policies and information about the related insured individuals and others. While the Company is not aware of security breaches or proceedings related to the processing of information, the loss or improper
access, use or disclosure of the Companys proprietary information can adversely impact the Company. For example, the Company could suffer, among other things, financial loss, the disruption of its business, liability to third parties,
regulatory intervention or reputational damage. Any of the foregoing events could have a material adverse effect on the Company.
Additionally, the Company collects information related to life insurance, including nonpublic personal information (NPI) and
protected health information (PHI), and information from its website, such as contact
38
information and high-level policy information. The Company also collects information from its employees, such as standard HR information, and business contact information from third party
employees. The Company shares information with its service providers, and has entered into non-disclosure and business association agreements, where appropriate. Although the Company has, and believes that
each service provider has, procedures and systems in place that it believes are reasonably designed to protect such information and prevent data loss and security breaches, such measures cannot guarantee absolute security.
Furthermore, the techniques used to obtain unauthorized access to data, disable or degrade service, or sabotage systems change frequently with
increasing sophistication and may be difficult to detect for long periods of time. For example, hardware or software acquired from third parties may contain defects in design or other problems that could unexpectedly compromise information security.
Network connected services provided by third parties to the Company may be susceptible to compromise, leading to a breach of the Companys network and/or business interruptions. The Companys systems or facilities may be susceptible to
employee error or malfeasance, government surveillance, or other security threats.
The Company is subject to U.S. privacy laws and regulations.
Failure to comply with such obligations could lead to regulatory investigations or actions; litigation; fines and penalties; disruptions of operations; reputational harm; loss of revenue or profits; and other adverse business consequences.
Due to the type of information the Company collects, including personal, medical, and financial information on the underlying
insureds, and the nature of its services, the Company is subject to privacy laws. In the United States, federal, state and local governments have enacted numerous data privacy and security laws to address privacy, data protection and collection, and
the processing and disclosure of certain types of information. Obligations related to these laws are quickly changing, becoming increasingly stringent and creating regulatory uncertainty. In addition, these obligations may be subject to differing
applications and interpretations, which can result in inconsistency or conflict among jurisdictions. Among these laws, the Company is likely subject to the Telephone Consumer Protection Act ( TCPA), Controlling Assault of Non-Solicited Pornography and Marketing Act of 2003, the Gramm-Leach Bliley Act (GLBA) and the Health Insurance Portability and Accountability Act of 1996 (HIPAA).
The Company may be considered a financial institution under the GLBA, and is subject to the GLBA through the NPI it collects. The GLBA
regulates, among other things, the use of certain information about individuals (NPI) in the context of the provision of financial services. The GLBA includes both a Privacy Rule, which imposes obligations on financial institutions
relating to the use or disclosure of NPI, and a Safeguards Rule, which imposes obligations on financial institutions, and indirectly, their service providers, to implement and maintain physical, administrative and technological measures
to protect the security of NPI.
The Company has certain business components that are subject to HIPAA. HIPAA imposes privacy,
security and breach notification obligations on covered entities and business associates. Furthermore, HIPAA requires covered entities and business associates to develop and maintain policies with
respect to the protection of PHI. If in violation of HIPAA, the Company may be subject to significant civil, criminal and administrative fines and penalties and/or additional reporting and oversight obligations. HIPAA also authorizes state Attorneys
Generals to file suit on behalf of their residents. Courts may award damages, costs and attorneys fees related to violations of HIPAA in such cases. While HIPAA does not create a private right of action allowing individuals to sue the Company
in civil court for violations of HIPAA, its standards have been used as the basis for duty of care in state civil suits such as those for negligence or recklessness in the misuse or breach of PHI.
Because of the complexity of the various data privacy laws the Company may be subject to, compliance can be costly. The Company has taken
general steps to comply with data privacy and security laws. For example, the Company has implemented a number of policies, including policies regarding access controls, customer data privacy, secure data disposal, and incident response and risk
assessments. Despite these efforts, the Company may at times fail in its efforts due to the complexity and evolving nature of these laws. Failure to comply with
39
relevant data privacy laws could negatively impact the Companys operations, including subject the Company to possible government enforcement actions which could result in investigations,
fines, penalties, audits, inspection, litigation, additional reporting requirements and/or oversight.
The Companys business may be subject to
additional or different government regulation in the future, which could have a material adverse impact on the Companys business.
The Company is currently licensed and operating in 49 states. Increased regulation (whether promulgated under insurance laws or any other
applicable law) and regulatory oversight of and changes in law applicable to life settlements may restrict the ability of the Company to carry on its business as currently conducted. This could also impose additional administrative burdens on the
Company, including responding to examinations and other regulatory inquiries and implementing policies and procedures. Regulatory inquiries often are confidential in nature, may involve a review of an individuals or a firms activities or
may involve studies of the industry or industry practices, as well as the practices of a particular institution.
There is currently no direct legal
authority regarding the proper federal tax treatment of life settlements and potential future rulings from the IRS may have significant tax consequences on the Company.
There is no direct legal authority regarding the proper U.S. federal income tax treatment of life settlements, and the Company does not plan to
request a ruling from the IRS. Consequently, significant aspects of the tax treatment of the Companys assets are uncertain, and the IRS or a court might not agree with the Companys treatment of life settlements as prepaid financial
contracts that are not debt. If the IRS were successful in asserting an alternative treatment, the tax consequences of ownership and disposition of life settlements could be materially and adversely affected. In addition, in 2007, the U.S. Treasury
Department and the IRS released a notice requesting public comments on various issues regarding the U.S. federal income tax treatment of prepaid forward contracts and similar instruments. Any Treasury regulations or other guidance
promulgated after consideration of these issues could materially and adversely affect the tax consequences of an investment in life settlements, possibly with retroactive effect.
There have been lawsuits in various states questioning whether a purchaser of a life insurance policy has the requisite insurable interest
in the policy which would permit the purchaser to collect the insurance benefits and an adverse finding in any of these lawsuits could have a material adverse effect on the Companys business.
All states require that the initial purchaser of a new life insurance policy insuring the life of another individual have an insurable interest
in that individuals life at the time of the original issuance of the policy. An insurable interest is an economic stake in an event for which a person or entity purchases an insurance policy. An insurance policy may only be
initially purchased by a person or entity who has an insurable interest in the insured. For example, if a spouse purchases an insurance policy on his or her spouse or a company purchases an insurance policy on an employee. In addition, some states
may require that Company have an insurable interest in the insured. Whether an insurable interest exists in the context of the purchase of a life insurance policy is critical because in the absence of a valid insurable interest, life insurance
policies are unenforceable under the laws of most states. Where a life insurance policy has been issued to a policy holder without an insurable interest in the life of the insured, the life insurance company may not be required to pay the face value
under the policy and may also be entitled to retain the premiums paid. Generally, there are two forms of insurable interest in the life of an individual, familial and financial. Additionally, an individual is deemed to have an insurable interest in
his or her own life. Insurable interest is determined at the inception of the policy. The definition of exactly what constitutes insurable interest tends to vary by state. Some cases have also been initiated by life insurance companies,
challenging the legality of the original issuance of policies on insurable interest grounds and asserting that such policies constitute Stranger-Originated Life Insurance or STOLI, which is defined as a practice or plan to
initiate a life insurance policy for a third-party investor who, at the time of policy origination, has no insurable interest in the insured. Some states (such as Utah and New York) permit the heirs and beneficiaries of
40
an insured to recover the face value under such STOLI policies rather than the policy owner which lacked insurable interest.
While the Company does not believe it has invested in any STOLI polices, and has policies and procedures in place to identify potential STOLI
policies, there can be no guarantee that the Company will identify all STOLI policies. As such, the Company may acquire certain life insurance policies that may be deemed by an issuing insurance company to be STOLI policies, whether purposefully, if
the Company deems such life insurance policy to be an attractive investment even after taking into account the insurable interest risk, or inadvertently, where the true nature of such life insurance policy is not discovered prior to its acquisition
by the Company. Should an issuing insurance company successfully challenge the validity of a life insurance policy acquired by the Company, the Company will lose its investment in such life insurance policy. Furthermore, the Company will also suffer
losses if a family member of an insured is successful in asserting a claim that he or she, and not the Company, is entitled to the face value payable under a life insurance policy.
The failure of the Company to accurately and timely track and pay premium payments on the life insurance policies it holds could result in the lapse of
such policies which would have a material adverse impact on the Companys business.
In order to realize on its investment in
life insurance policies, the Company must ensure that the life insurance policies remain in force until they mature or are sold by the Company. Failure by the Company to pay premiums on the life insurance policies when due will result in termination
or lapse of the life insurance policies and will result in the loss of the Companys investment in such life insurance policies.
The originating life insurance company may increase the cost of insurance premiums, which would adversely affect the Companys returns.
For any life insurance policies that may be obtained by the Company, the Company will be responsible for maintaining the policies,
including paying insurance premiums. If a life insurance company increases the cost of insurance charged for any of the life insurance policies held by the Company, the amounts required to be paid for insurance premiums due for these life insurance
policies may increase, requiring the Company to incur additional costs for the life insurance policies which may reduce the value of such life insurance policies and consequently affect the returns available on such policies.
Life insurance companies have in the past materially increased the cost of insurance charges. There can be no assurance that life insurance
policies acquired by the Company will not be subject to cost of insurance increases. If any such life insurance policies are affected by a cost of insurance increase, the value of such life insurance policy may be materially reduced and the Company
may decide or may be forced to allow such life insurance policy to lapse, resulting in a loss to the Company.
In the event an insurance
company experiences significantly higher than anticipated expenses associated with operation and/or policy administration, or, in some instances, lower investment returns, the insurance company may have the right to increase the charges to each of
its policy owners, but not beyond guaranteed maximums. While the insurance companies did not specify the reason for the increases, it is generally believed that the low interest rate environment was a significant contributing factor in the decision
to raise the cost of insurance.
The Company may not be able to liquidate its life insurance policies which could have a material adverse effect on
the Companys business.
In the ordinary course of its business, the Company engages in the purchase and sale of life
insurance policies. The liquidation value of these life insurance policies is important where, for example, it becomes necessary to sell life insurance policies from the Companys hold portfolio in order to meet the Companys cash flow
needs, including the payment of future premiums.
41
In many cases liquidations may not be a viable option to meet the Companys liquidity
because of, among other things: (1) the lack of a market for such life insurance policies at the time; (2) the uncertainties surrounding the liquidation value of an individual life insurance policy; (3) the extensive amount of time
and effort it might take to sell a life insurance policy; (4) the effect excessive sales of life insurance policies may have on transactions and future cash flows; and (5) the tax consequences.
The Company assumes the credit risk associated with life insurance companies and may not be able to realize the full value of insurance company payouts
which could have a material adverse effect on the Companys profits.
The Company will assume the credit risk associated with
life insurance policies issued by various life insurance companies. The failure or bankruptcy of any such life insurance company could have a material adverse impact on the Companys ability to achieve its investment objectives. A life
insurance companys business tends to track general economic and market conditions that are beyond its control, including extended economic recessions, interest rate changes, the subprime lending market crisis or changes in investor perceptions
regarding the strength of insurers generally and the life insurance policies or annuities they offer. Adverse economic factors and volatility in the financial markets may have a material adverse effect on a life insurance companys business
obligation to pay the face value of policies.
The insolvency of any insurance company or a downgrade in the ratings of an insurance
company could have a material adverse impact on the value of the related life insurance policies, the collectability of the related face value, cash surrender value or other amounts agreed to be paid by such insurance company. In the event that a
life insurance carrier becomes insolvent or is placed into receivership, most state guaranty associations place a $300,000 or lower cap on face value for policies per insured. In addition to the limitations on the amount of coverage, which vary by
state, there are limitations on who may make claims under such coverage and the Company may not be eligible to make claims under U.S. state guarantee funds as most U.S. state guarantee fund laws were enacted with the stated goal of assisting
policyholders residing in such states. Even if available to the Company, guarantee fund coverage limits are typically smaller than the face values of some of the life insurance policies that the Company will acquire. There can be no assurance that
as more life settlement transactions are undertaken, legislators will not adopt additional restrictions on the availability of U.S. state guaranty funds.
The Companys success is dependent upon the services of its experienced management and talented employees. If the Company is unable to retain
management and/or key employees, its ability to compete could be harmed.
The success of the Company is dependent upon the talents
and efforts of highly skilled individuals employed by the Company and the Companys ability to identify and willingness to provide acceptable compensation to attract, retain and motivate experienced management, talented investment professionals
and other employees. There can be no assurance that the Companys management and professionals will continue to be associated with the Company, and the failure to attract or retain such professionals could have a material adverse effect on the
Companys ability to execute on its business plan. Competition in the financial services industry for qualified management and employees is intense and there is no guarantee that, if lost, the talents of the Companys professionals could
be replaced.
The Companys intellectual property rights may not adequately protect the Companys business.
To be successful, the Company must protect its technology, know-how and brand through means, such
as trademarks, trade secrets, patents, copyrights, service marks, contractual restrictions, and other intellectual property rights and confidentiality procedures. Despite the Companys efforts to implement these protections, they
may not adequately protect its business for a variety of reasons, including:
|
|
|
inability to successfully register or obtain patents and other intellectual property rights for important
innovations that sufficiently protect the full scope of such innovations; |
|
|
|
inability to maintain appropriate confidentiality and other protective measures to establish and maintain the
Companys trade secrets; |
42
|
|
|
uncertainty in, and evolution of, legal standards relating to the validity, enforceability and scope of
protection of intellectual property rights; |
|
|
|
potential invalidation of the Companys intellectual property rights through administrative processes or
litigation; and |
|
|
|
other practical, resource, or business limitations on the Companys ability to detect and prevent
infringement or misappropriation of our rights and to enforce our rights. |
Litigation may be necessary to enforce
the Companys intellectual property or proprietary rights, protect the Companys trade secrets, or determine the validity and scope of proprietary rights claimed by others. Any litigation, whether or not resolved in the Companys
favor, could result in significant expense to the Company, and divert the time and efforts of the Companys technical and management personnel. If the Company is unable to prevent third parties from infringing upon, violating or
misappropriating the Companys intellectual property or is required to incur substantial expenses defending the Companys intellectual property rights, the Companys business, financial condition and results of operations may be
materially adversely affected.
The Company may become subject to intellectual property disputes, which are costly and may subject the Company
to significant liability and increased costs of doing business.
The Company may in the future become subject to intellectual
property disputes. The Companys success depends, in part, on the Companys ability to operate without infringing, misappropriating or otherwise violating the intellectual property rights of third parties. However, the Company may not be
aware that its practices are infringing, misappropriating or otherwise violating third-party intellectual property rights, and such third parties may bring claims against the Company or its business partners alleging such infringement,
misappropriation or violation.
Any claims of intellectual property infringement, even those without merit, may be time-consuming and
expensive to resolve, divert managements time and attention, cause the Company to cease using or incorporating the asserted challenged intellectual property rights expose it to other legal liabilities, or require it to enter into licensing
agreements to obtain the right to use a third partys intellectual property. Although the Company carries general liability insurance, it may not cover potential claims of this type or may not be adequate to indemnify the Company for all
liability that may be imposed. The Company cannot predict the outcome of lawsuits and cannot ensure that the results of any such actions will not have an adverse effect on the Companys business, financial condition, or results of operations.
Even if the claims do not result in litigation or are resolved in the Companys favor, these claims, and the time and resources
necessary to resolve them, could divert the resources of the Companys management and harm the Companys business and results of operations.
The ongoing COVID-19 pandemic, along with rising interest rates and inflation, may disrupt the ability of the
Company and its providers to originate life settlement policies which could have a material adverse impact on the Companys financial position.
The COVID-19 pandemic disrupted the global economy in several ways, some of which are still unfolding. COVID-19, or any outbreak of contagious diseases and other adverse public health developments, particularly in the United States, could have a material and adverse effect on our business operations. These could
include disruptions or restrictions on our ability to source life settlement policies, as well as temporary closures of our facilities and the facilities of our third-party service providers. Any disruption or delay of our third-party service
providers would likely impact our operating results. In addition, a significant outbreak of contagious diseases in the human population could result in a widespread health crisis that could adversely affect the economies and financial markets of the
United States and throughout the world, resulting in an economic downturn that could affect demand for the life insurance policies and significantly impact the Companys operating results.
43
We have identified material weaknesses in our internal control over financial reporting. If our
remediation of the material weaknesses are not effective, or if we experience additional material weaknesses in the future or otherwise fail to maintain an effective system of internal controls in the future, we may not be able to accurately or
timely report our financial condition or results of operations.
In connection with the audit of our financial statements for
Abacus and LMA for the years ended December 31, 2022 and 2021, we identified the same material weakness in our internal control over financial reporting for both Abacus and LMA. A material weakness is a deficiency, or a combination of
deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis. The material
weaknesses for both entities related to members of executive management having access to post to the general ledger; members of finance having inappropriate information technology access to the general ledger; and journal entry users having the
ability to post to the general ledger without formal review or approval. The material weaknesses did not result in a misstatement to our financial statements.
We are taking steps to remediate the material weaknesses and, as it related to executive management and information technology access to the
general ledger, LMA and Abacus have already revoked the inappropriate privileges before 2022 year-end. We have also hired a new qualified accounting resource and are in the process of enhancing and formalizing our accounting, business operations and
information technology policies, procedures and controls. We have engaged outside resources to enhance our business documentation process, provide company-wide training and to help with managements self-assessment and testing of internal
controls. We are implementing a new accounting system in 2023 that will require the appropriate approval of journal entries in our accounting system and are currently working with outside advisors to ensure proper segregation of duties and put
mitigating controls in place. However, we are still in the process of implementing these steps and cannot assure investors that these measures will significantly improve or remediate the material weaknesses described above.
We may in the future discover additional material weaknesses in our system of internal financial and accounting controls and procedures that
could result in a material misstatement of our financial statements. Our internal control over financial reporting will not prevent or detect all errors and all fraud. A control system, no matter how well designed and operated, can provide only
reasonable, not absolute, assurance that the control systems objectives will be met. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud
will not occur or that all control issues and instances of fraud will be detected.
Risks Related to Being a Public Company
The market price of shares of our common stock may be volatile or may decline regardless of our operating performance. You may lose some or all of your
investment.
The trading price of our common stock following the Business Combination is likely to be volatile. The stock market
recently has experienced extreme volatility. This volatility often has been unrelated or disproportionate to the operating performance of particular companies. You may not be able to resell your shares at an attractive price due to a number of
factors such as those listed in Risks Related to the Companies Operations and Financial Condition and the following:
|
|
|
the impact of the COVID-19 pandemic on our financial condition and the
results of operations; |
|
|
|
our operating and financial performance and prospects; |
|
|
|
our quarterly or annual earnings or those of other companies in our industry compared to market expectations;
|
|
|
|
conditions that impact demand for our products and/or services; |
|
|
|
future announcements concerning our business, our clients businesses or our competitors businesses;
|
|
|
|
the publics reaction to our press releases, other public announcements and filings with the SEC;
|
44
|
|
|
the markets reaction to our reduced disclosure and other requirements as a result of being an
emerging growth company under the Jumpstart Our Business Startups Act (the JOBS Act); |
|
|
|
the size of our public float; |
|
|
|
coverage by or changes in financial estimates by securities analysts or failure to meet their expectations;
|
|
|
|
market and industry perception of our success, or lack thereof, in pursuing our growth strategy;
|
|
|
|
strategic actions by us or our competitors, such as acquisitions or restructurings; |
|
|
|
changes in laws or regulations which adversely affect our industry or us; |
|
|
|
privacy and data protection laws, privacy or data breaches, or the loss of data; |
|
|
|
changes in accounting standards, policies, guidance, interpretations or principles; |
|
|
|
changes in senior management or key personnel; |
|
|
|
issuances, exchanges or sales, or expected issuances, exchanges or sales of our capital stock;
|
|
|
|
changes in our dividend policy; |
|
|
|
adverse resolution of new or pending litigation against us; and |
|
|
|
changes in general market, economic and political conditions in the United States and global economies or
financial markets, including those resulting from inflation, natural disasters, terrorist attacks, acts of war and responses to such events. |
These broad market and industry factors may materially reduce the market price of common stock, regardless of our operating performance. In
addition, price volatility may be greater if the public float and trading volume of our common stock is low. As a result, you may suffer a loss on your investment.
In the past, following periods of market volatility, stockholders have instituted securities class action litigation. If we were involved in
securities litigation, it could have a substantial cost and divert resources and the attention of management from our business regardless of the outcome of such litigation.
We do not intend to pay dividends on our common stock for the foreseeable future.
We currently intend to retain all available funds and any future earnings to fund the development and growth of our business. As a result, we
do not anticipate declaring or paying any cash dividends on our common stock in the foreseeable future. Any decision to declare and pay dividends in the future will be made at the discretion of the Board and will depend on, among other things, our
business prospects, results of operations, financial condition, cash requirements and availability, certain restrictions related to our indebtedness, industry trends and other factors that the Board may deem relevant. Any such decision will also be
subject to compliance with contractual restrictions and covenants in the agreements governing our current and future indebtedness. In addition, we may incur additional indebtedness, the terms of which may further restrict or prevent us from paying
dividends on our common stock. As a result, you may have to sell some or all of your common stock after price appreciation in order to generate cash flow from your investment, which you may not be able to do. Our inability or decision not to pay
dividends could also adversely affect the market price of our common stock.
If securities or industry analysts do not publish research or reports
about our business or Business Combination or publish negative reports, the market price of our common stock could decline.
The
trading market for our common stock will be influenced by the research and reports that industry or securities analysts publish about us, our business or the Business Combination. We may be unable or slow to attract research coverage and if one or
more analysts cease coverage of us, the price and trading volume of our securities would likely be negatively impacted. If any of the analysts that may cover us change their recommendation regarding our securities adversely, or provide more
favorable relative recommendations about our competitors, the price of our securities would likely decline. If any analyst that may cover us ceases covering us or fails to regularly
45
publish reports on us, we could lose visibility in the financial markets, which could cause the price or trading volume of our securities to decline. If one or more of the analysts who cover us
downgrades our common stock or if our reporting results do not meet their expectations, the market price of our common stock could decline. Moreover, the market price of our common stock may decline as a result of the Business Combination if we do
not achieve the perceived benefits of the Business Combination as rapidly or to the extent anticipated by financial analysts, or the effect of the Business Combination on our financial results is not consistent with the expectations of financial
analysts. Accordingly, holders of our common stock following the consummation of the Business Combination may experience a loss as a result of a decline in the market price of such common stock. In addition, a decline in the market price of our
common stock following the consummation of the Business Combination could adversely affect our ability to issue additional securities and to obtain additional financing in the future.
Our ability to timely raise capital in the future may be limited, or may be unavailable on acceptable terms, if at all. Our failure to raise capital
when needed could harm our business, operating results and financial condition. Debt issued to raise additional capital may reduce the value of our common stock.
We have funded our operations since inception primarily through our origination, active management and holding of life settlement policies. We
cannot be certain when or if our operations will generate sufficient cash to fund our ongoing operations or the growth of our business.
We intend to continue to make investments to support our business and may require additional funds. Additional financing may not be available
on favorable terms, if at all. If adequate funds are not available on acceptable terms, we may be unable to invest in future growth opportunities, which could harm our business, operating results and financial condition. If we incur debt, the debt
holders could have rights senior to holders of common stock to make claims on our assets. The terms of any debt could restrict our operations, including our ability to pay dividends on our common stock. As a result, our stockholders bear the risk of
future issuances of debt securities reducing the value of our common stock.
Our issuance of additional shares of common stock or convertible
securities could make it difficult for another company to acquire us, may dilute your ownership of us and could adversely affect our stock price.
In connection with the proposed Business Combination, we intend to file a registration statement with the SEC on Form S-8 providing for the registration of shares of our common stock issued or reserved for issuance under the Incentive Plan. The Incentive Plan will provide for automatic increases in the shares reserved for grant or
issuance under the plan which could result in additional dilution to our stockholders. Subject to the satisfaction of vesting conditions and the expiration of any applicable lockup restrictions, shares registered under the registration statement on
Form S-8 will generally be available for resale immediately in the public market without restriction. From time to time in the future, we may also issue additional shares of our common stock or securities
convertible into common stock pursuant to a variety of transactions, including acquisitions. The issuance by us of additional shares of our common stock or securities convertible into our common stock would dilute your ownership of us and the sale
of a significant amount of such shares in the public market could adversely affect prevailing market prices of our common stock.
In the
future, we expect to obtain financing or to further increase our capital resources by issuing additional shares of our capital stock or offering debt or other equity securities, including senior or subordinated notes, debt securities convertible
into equity, or shares of preferred stock. Issuing additional shares of our capital stock, other equity securities, or securities convertible into equity may dilute the economic and voting rights of our existing stockholders, reduce the market price
of our common stock, or both. Debt securities convertible into equity could be subject to adjustments in the conversion ratio pursuant to which certain events may increase the number of equity securities issuable upon conversion. Preferred stock, if
issued, could have a preference with respect to liquidating distributions or a preference with respect to dividend payments that could limit our ability to pay dividends to the holders of our common stock. Our decision to issue securities in any
future offering will depend on market conditions and other factors beyond our control, which may adversely affect the amount, timing or nature of our future offerings. As a result, holders of our common stock bear the risk that our future offerings
46
may reduce the market price of our common stock and dilute their percentage ownership. See the section entitled Description of Capital Stock of the Post-Combination Company.
Future sales, or the perception of future sales, of our common stock by us or our
existing stockholders in the public market following the closing of the Business Combination could cause the market price for our common stock to decline.
The sale of substantial amounts of shares of our common stock in the public market, or the perception that such sales could occur, could harm
the prevailing market price of shares of our common stock. These sales, or the possibility that these sales may occur, also might make it more difficult for us to sell equity securities in the future at a time and at a price that we deem
appropriate.
Upon consummation of the Business Combination, we will have a total of 64,656,047 shares of common stock outstanding,
consisting of (i) 53,175,000 shares of common stock issued to the Company Members (assuming that the Cash Consideration equals zero), (ii) 2,856,047 shares of common stock held by ERESs Public Stockholders (assuming no redemptions by such
Public Stockholders) and (iii) 8,625,000 shares of common stock held by the Initial Stockholders.
In connection with the Business
Combination, pursuant to the Company Support Agreement, the Company Members have agreed, subject to certain exceptions, not to transfer (i) 15% of the shares of the Post-Combination Companys common stock received by such Company Member in
connection with the Closing until the date that is 180 days after the Closing Date (x) the remaining 85% of the shares of the Post-Combination Companys common stock received by such Company Member in connection with the Closing until the
date that is 24 months after the Closing Date. See the section entitled Other AgreementsCompany Support Agreement for a description of the Company Support Agreement.
Upon the expiration or waiver of the lock-ups described above, shares held by certain of our
stockholders will be eligible for resale, subject to, in the case of certain stockholders, volume, manner of sale and other limitations under Rule 144. In addition, pursuant to the Registration Rights Agreement, certain stockholders will have the
right, subject to certain conditions, to require us to register the sale of their shares of our common stock under the Securities Act. By exercising their registration rights and selling a large number of shares, these stockholders could cause the
prevailing market price of our common stock to decline. Following completion of the Business Combination, the shares covered by registration rights would represent approximately 86% of our outstanding common stock (assuming no shares of ERES Common
Stock are redeemed in connection with the Special Meeting). See the section entitled Other AgreementsRegistration Rights Agreement for a description of these registration rights.
As restrictions on resale end or if these stockholders exercise their registration rights, the market price of shares of our common stock
could drop significantly if the holders of these shares sell them or are perceived by the market as intending to sell them. These factors could also make it more difficult for us to raise additional funds through future offerings of our shares of
common stock or other securities.
In addition, the shares of our common stock reserved for future issuance under our equity incentive
plans will become eligible for sale in the public market once those shares are issued, subject to provisions relating to various vesting agreements, lock-up agreements and, in some cases, limitations on volume
and manner of sale applicable to affiliates under Rule 144, as applicable. The number of shares to be reserved for future issuance under the Incentive Plan is expected to equal 3,232,802, 3,161,401 or 3,090,000 shares of our common stock, assuming
no redemptions, 50% redemptions or 100% redemptions, respectively. We expect to file one or more registration statements on Form S-8 under the Securities Act to register shares of our common stock or
securities convertible into or exchangeable for shares of our common stock issued pursuant to our equity incentive plans. Any such Form S-8 registration statements will automatically become effective upon
filing. Accordingly, shares registered under such registration statements will be available for sale in the open market. The initial registration statement on Form S-8 is expected to cover approximately
3,232,802, 3,161,401 or 3,090,000 shares of our common stock, assuming no redemptions, 50% redemptions or 100% redemptions, respectively.
47
We are an emerging growth company. The reduced public company reporting requirements
applicable to emerging growth companies may make our common stock less attractive to investors.
We qualify as an
emerging growth company, as defined in the JOBS Act. While we remain an emerging growth company, we are permitted and plan to rely on exemptions from certain disclosure requirements that are applicable to other public companies that are
not emerging growth companies. These provisions include: (1) an exemption from compliance with the auditor attestation requirement in the assessment of our internal control over financial reporting pursuant to Section 404 of the Sarbanes-Oxley Act, (2) not being required to comply with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation or a supplement to the
auditors report providing additional information about the audit and the financial statements, (3) reduced disclosure obligations regarding executive compensation arrangements in our periodic reports, registration statements and proxy
statements and (4) exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. As a result, the information we provide will
be different than the information that is available with respect to other public companies that are not emerging growth companies.
In addition, Section 107 of the JOBS Act provides that an emerging growth company can take advantage of the exemption from complying with
new or revised accounting standards provided in Section 7(a)(2)(B) of the Securities Act as long as we are an emerging growth company. An emerging growth company can therefore delay the adoption of certain accounting standards until those
standards would otherwise apply to private companies. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging
growth companies, but any such election to opt out is irrevocable. We have elected to irrevocably opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or
private companies, we will adopt the new or revised standard at the time public companies adopt the new or revised standard. This may make comparison of our financial statements with another emerging growth company that has not opted out of using
the extended transition period difficult or impossible because of the potential differences in accounting standards used.
We cannot
predict whether investors will find our common stock less attractive if we rely on these exemptions. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock. The market
price of our common stock may be more volatile.
We will remain an emerging growth company until the earliest of: (1) the last day of
the fiscal year following the fifth anniversary of the date of the completion of the ERES IPO, (2) in which we have total annual gross revenue of at least $1.235 billion, (3) the date on which we have, during the immediately preceding
three-year period, issued more than $1.0 billion in non-convertible debt securities, or (4) the end of any fiscal year in which the market value of our common
stock held by non-affiliates is at least $700 million as of the end of the second quarter of that fiscal year.
Our management has limited experience in operating a public company.
Our executive officers have limited experience in the management of a publicly traded company. Our management team may not successfully or
effectively manage its transition to a public company that will be subject to significant regulatory oversight and reporting obligations under federal securities laws. Their limited experience in dealing with the increasingly complex laws pertaining
to public companies could be a disadvantage in that it is likely that an increasing amount of their time may be devoted to these activities which will result in less time being devoted to the management and growth of the Post-Combination Company. We may not have adequate personnel with the appropriate level of knowledge, experience and training in the accounting policies, practices or internal controls over financial reporting
required of public companies in the United States. The development and implementation of the standards and controls necessary for the Post-Combination Company to achieve the level of accounting standards
required of a public company in the United States may require costs greater than expected. It is possible that the Post-Combination Company will be required to expand its employee base and hire additional
employees to support its operations as a public company which will increase its operating costs in future periods.
48
Risks Related to the Business Combination
ERES stockholders will have a reduced ownership and voting interest after the Business Combination and will exercise less influence over management.
Upon the issuance of the Stock Consideration to the Company Members, current ERES stockholders percentage ownership will
be diluted. Assuming no Public Stockholders exercise their redemption rights and excluding any shares issuable pursuant to ERESs outstanding warrants or shares to be reserved for issuance under the Incentive Plan, current ERES
stockholders percentage ownership in the Post-Combination Company following the issuance of the Stock Consideration to the Company Members would be approximately 17.76%. Additionally, of the expected
members of the Board after the completion of the Business Combination, only two will be either current directors or executive officers of ERES and two will be either current managers or executive officers of the Companies. The percentage of the Post-Combination Companys common stock that will be owned by current ERES stockholders as a group will vary based on the number of Public Shares for which the holders thereof request redemption in connection
with the Business Combination. To illustrate the potential ownership percentages of current ERES stockholders (including the Sponsor and directors of ERES), under different redemption levels, based on the number of issued and outstanding shares of
ERES Common Stock and the issued and outstanding LMA Interests and Abacus Interests on April 21, 2023, and based on the Stock Consideration, current ERES stockholders, as a group, will own (1) if there are redemptions of 50% of all
outstanding Public Shares, approximately 15.90% of the Post-Combination Companys common stock expected to be outstanding immediately after the Business Combination or (2) if there are redemptions of
the maximum number of outstanding Public Shares, approximately 13.96% of the Post-Combination Companys common stock expected to be outstanding immediately after the Business Combination (in each case,
excluding any shares issuable pursuant to ERESs outstanding warrants or shares to be reserved for issuance under the Incentive Plan). Because of this, current ERES stockholders, as a group, will have less influence on the board of directors,
management and policies of the Post-Combination Company than they now have on the board of directors, management and policies of ERES.
Public Stockholders will experience additional dilution to the extent the Post-Combination Company issues additional shares of Common Stock
after the Closing if the outstanding warrants are exercised or pursuant to the shares reserved for issuance under the Incentive Plan. For fully diluted ownership information, see the section entitled Q: WHAT EQUITY STAKE WILL CURRENT ERES
STOCKHOLDERS, THE INITIAL STOCKHOLDERS, AND THE COMPANY MEMBERS HOLD IN ERES FOLLOWING THE CLOSING?
The market price of shares of the Post-Combination Companys common stock after the Business Combination may be affected by factors different from those currently affecting the prices of shares of ERES Class A Common Stock.
Upon completion of the Business Combination, holders of the LMA Interests and the Abacus Interests will become holders of shares of the Post-Combination Companys common stock. Prior to the Business Combination, ERES has had limited operations. Upon completion of the Business Combination, the
Post-Combination Companys results of operations will depend upon the performance of the Companies businesses, which are affected by factors that are different from those currently affecting the
results of operations of ERES.
There can be no assurance that the Post-Combination Companys common
stock will be approved for listing on Nasdaq or that the Post-Combination Company will be able to comply with the continued listing standards of Nasdaq.
In connection with the closing of the Business Combination, we intend to list the Post-Combination
Companys common stock and warrants on Nasdaq under the symbols ABL and ABLLW, respectively. The Post-Combination Companys continued eligibility for listing may depend on the
number of our shares that are
49
converted. If, after the Business Combination, Nasdaq delists the Post-Combination Companys shares from trading on its exchange for failure to meet
the listing standards, the Post-Combination Company and its stockholders could face significant material adverse consequences including:
|
|
|
a limited availability of market quotations for the Post-Combination
Companys securities; |
|
|
|
reduced liquidity for the Post-Combination Companys securities;
|
|
|
|
a determination that the Post-Combination Companys common stock is
a penny stock which will require brokers trading in the Post-Combination Companys common stock to adhere to more stringent rules, possibly resulting in a reduced level of trading activity in
the secondary trading market for shares of the Post-Combination Companys common stock; |
|
|
|
a limited amount of analyst coverage; and |
|
|
|
a decreased ability to issue additional securities or obtain additional financing in the future.
|
The consummation of the Business Combination is subject to a number of conditions and if those conditions are not satisfied or
waived, the Merger Agreement may be terminated in accordance with its terms and the Business Combination may not be completed.
The
Merger Agreement is subject to a number of conditions which must be fulfilled in order to complete the Business Combination. Those conditions include: approval of the Merger Agreement by the Company Members, approval of the Proposals required to
effect the Business Combination by ERES stockholders, as well as receipt of certain requisite regulatory approvals, absence of orders prohibiting completion of the Business Combination, approval of the shares of Class A Common Stock to be
issued to the Company Members for listing on Nasdaq, the resignation of specified ERES executive officers and directors, the accuracy of the representations and warranties by both parties (subject to the materiality standards set forth in the Merger
Agreement) and the performance by both parties of their covenants and agreements. These conditions to the closing of the Business Combination may not be fulfilled in a timely manner or at all, and, accordingly, the Business Combination may not be
completed. In addition, the parties can mutually decide to terminate the Merger Agreement at any time, before or after stockholder approval, or ERES or the Companies may elect to terminate the Merger Agreement in certain other circumstances. See the
section entitled The Merger AgreementTermination.
The parties to the Merger Agreement may amend the terms of the
Merger Agreement or waive one or more of the conditions to the Business Combination, and the exercise of discretion by our directors and officers in agreeing to changes to the terms of or waivers of closing conditions in the Merger Agreement may
result in a conflict of interest when determining whether such changes to the terms of the Merger Agreement or waivers of conditions are appropriate and in the best interests of our stockholders.
In the period leading up to the Closing, other events may occur that, pursuant to the Merger Agreement, would require us to agree to amend the
Merger Agreement, to consent to certain actions or to waive certain closing conditions or other rights that we are entitled to under the Merger Agreement. Such events could arise because of changes in the course of the Companies business, a
request by the Companies to undertake actions that would otherwise be prohibited by the terms of the Merger Agreement or the occurrence of other events that would have a material adverse effect on the Companies business and would entitle us to
terminate the Merger Agreement. In any of such circumstances, it would be in our discretion, acting through the ERES Board, to grant our consent or waive our rights. The existence of the financial and personal interests of the directors and officers
described elsewhere in this proxy statement may result in a conflict of interest on the part of one or more of the directors or officers between what he or she may believe is best for ERES and our stockholders and what he or she may believe is best
for himself or herself or his or her affiliates in determining whether or not to take the requested action.
For example, it is a
condition to ERESs obligation to close the Business Combination that the Companies representations and warranties be true and correct as of the Closing in all respects subject to the applicable
50
materiality standards as set forth in the Merger Agreement. However, if the ERES Board determines that any such breach is not material to the business of the Companies, then the ERES Board may
elect to waive that condition and close the Business Combination. The parties will not waive the condition that ERESs stockholders approve the Business Combination.
As of the date of this proxy statement, we do not believe there will be any material changes or waivers that our directors and officers would
be likely to make after stockholder approval of the Business Combination has been obtained. While certain changes could be made without further stockholder approval, if there is a change to the terms of the Business Combination that would have a
material impact on the stockholders, we will be required to circulate a new or amended proxy statement or supplement thereto and resolicit the vote of our stockholders with respect to the Business Combination Proposal.
Termination of the Merger Agreement could negatively impact ERES.
If the Business Combination is not completed for any reason, including as a result of the Company Members declining to adopt the Merger
Agreement or ERES stockholders declining to approve the Proposals required to effect the Business Combination, the ongoing businesses of ERES may be adversely impacted and, without realizing any of the anticipated benefits of completing the Business
Combination, ERES would be subject to a number of risks, including the following:
|
|
|
ERES may experience negative reactions from the financial markets, including negative impacts on the stock price
of shares of ERES Class A Common Stock (including to the extent that the current market price reflects a market assumption that the Business Combination will be completed); |
|
|
|
ERES will have incurred substantial expenses and will be required to pay certain costs relating to the Business
Combination, whether or not the Business Combination is completed; and |
|
|
|
since the Merger Agreement restricts the conduct of ERESs business prior to completion of the Business
Combination, ERES may not have been able to take certain actions during the pendency of the Business Combination that would have benefitted it as an independent company, and the opportunity to take such actions may no longer be available. See the
section entitled The Merger AgreementCovenants and Agreements. |
If the Merger Agreement is
terminated and the ERES Board seeks another merger or business combination, ERES stockholders cannot be certain that ERES will be able to find another acquisition target that would constitute a business combination or that such other merger or
business combination will be completed. See the section entitled The Merger AgreementTermination.
The Companies will be
subject to business uncertainties and contractual restrictions while the Business Combination is pending.
Uncertainty about the
effect of the Business Combination on the Companies employees and customers may have an adverse effect on the Companies and consequently on ERES. These uncertainties may impair the Companies ability to attract, retain and motivate key
personnel until the Business Combination is completed and could cause customers and others that deal with the Companies to seek to change existing business relationships with the Companies. Retention of certain employees may be challenging during
the pendency of the Business Combination as certain employees may experience uncertainty about their future roles. If key employees depart because of issues relating to the uncertainty and difficulty of integration or a desire not to remain with the
business, our business following the Business Combination could be negatively impacted. In addition, the Merger Agreement restricts the Companies from making certain expenditures and taking other specified actions without the consent of ERES until
the Business Combination occurs. These restrictions may prevent the Companies from pursuing attractive business opportunities that may arise prior to the completion of the Business Combination. See the section entitled The Merger
AgreementCovenants and Agreements.
51
ERES directors and officers and the Sponsor and its affiliates may have interests in the Business
Combination different from the interests of ERES stockholders.
Executive officers of ERES negotiated the terms of the Merger
Agreement with their counterparts at the Companies, and the ERES Board determined that entering into the Merger Agreement was in the best interests of ERES and its stockholders, declared the Merger Agreement advisable and recommended that ERES
stockholders approve the Proposals required to effect the Business Combination. In considering these facts and the other information contained in this proxy statement, you should be aware that ERESs executive officers and directors, as well as
our Sponsor and its affiliates, may have financial interests in the Business Combination that may be different from, or in addition to, the interests of ERES stockholders. The ERES Board was aware of and considered these interests, among other
matters, in reaching the determination to approve the terms of the Business Combination and in recommending to ERESs stockholders that they vote to approve the Business Combination. These interests include, among other things:
|
|
|
If the Business Combination with the Companies or another business combination is not consummated within the
Completion Window, ERES will cease all operations except for the purpose of winding up, redeeming 100% of the outstanding Public Shares for cash and, subject to the approval of its remaining stockholders and the ERES Board, dissolving and
liquidating. In such event, the 8,625,000 Founder Shares held by ERESs Initial Stockholders, which were acquired for an aggregate purchase price of $25,000, or approximately $0.003 per share, would be worthless because ERESs Initial
Stockholders are not entitled to participate in any redemption or distribution with respect to such shares. The Founder Shares had an aggregate market value of $[●] based upon the closing price of $[●] per share of ERES Class A
Common Stock on Nasdaq on the ERES Record Date. Certain Founder Shares are subject to time-based vesting provisions as described under Other AgreementsSponsor Support Agreement. |
|
|
|
The Sponsor purchased an aggregate of 8,900,000 Private Placement Warrants from ERES for an aggregate purchase
price of $8,900,000 (or $1.00 per warrant). These purchases took place on a private placement basis simultaneously with the consummation of the ERES IPO and associated exercise of the over-allotment option. A portion of the proceeds ERES received
from these purchases was placed in the Trust Account. Such warrants had an aggregate market value of approximately $[●] based upon the closing price of $[●] per public warrant on the Nasdaq on [●], 2023, the ERES Record Date. The
Private Placement Warrants will become worthless if ERES does not consummate a business combination within the Completion Window. The Sponsor paid an aggregate of $8,925,000 for its purchases of the Founder Shares and the Private Placement Warrants.
|
|
|
|
In order to finance transaction costs in connection with a business combination, the Sponsor, members of the ERES
founding team or any of their affiliates may, but are not obligated to, loan ERES funds as may be required. In August 2021, the Sponsor committed to provide ERES up to an aggregate of $1,500,000 in loans for working capital purposes. The Working
Capital Note does not bear interest and is repayable in full upon consummation of a business combination. If ERES does not complete a business combination, the Working Capital Note shall not be repaid and all amounts owed under it will be forgiven.
The Working Capital Note is subject to customary events of default, the occurrence of which automatically trigger the unpaid principal balance of the Working Capital Note and all other sums payable with regard to the Working Capital Note becoming
immediately due and payable. As of December 31, 2022, there was a balance of $1,500,000 under this loan. On January 31, 2023, the Sponsor agreed to loan ERES up to an additional $1,500,000 under the Working Capital Note.
|
|
|
|
On July 25, 2022, ERES entered into the Extension Note with the Sponsor. Pursuant to the Extension Note, the
Sponsor has agreed that it will contribute to ERES as a loan (each loan being referred to herein as a Contribution) $0.033 for each Public Share that was not redeemed in connection with the stockholder vote to approve the extension of
the deadline by which ERES must complete its initial business combination, for each month until the earlier of (i) the date of the special meeting held in connection with the stockholder vote to approve the Business Combination and
(ii) the date of liquidation of ERES. The Extension Note does not bear interest and is repayable in full upon the earlier |
52
|
of (i) the date of the consummation of ERESs initial business combination and (ii) the date of ERESs liquidation. At any time prior to payment in full of the principal
balance of the Extension Note, the holder of the Extension Note (or a permitted assignee) will have the option, but not the obligation, to convert up to $1,500,000 of the unpaid principal balance of the Extension Note into that number of Extension
Warrants, each whole warrant exercisable for one share of ERES Class A Common Stock equal to the principal amount of the Extension Note so converted divided by $1.50. The terms of the Extension Warrants will be identical to the terms of the
Private Placement Warrants. The Sponsor will have the sole discretion whether to continue extending for additional months, and if the Sponsor determines not to continue extending for additional months, its obligation to make additional Contributions
will terminate. If this occurs, ERES would wind up ERESs affairs and redeem 100% of the outstanding Public Shares in accordance with the procedures set forth in the Existing Charter. The maturity date of the Extension Note may be accelerated
upon the occurrence of an Event of Default (as defined therein). Any outstanding principal under the Extension Note may be prepaid at any time by ERES, at its election and without penalty, provided, however, that the Sponsor shall have a right to
first convert such principal balance as described in Section 17 of the Extension Note upon notice of such prepayment. If the Business Combination is not completed and ERES winds up, there will not be sufficient assets to repay the Extension
Note and it will be worthless. As of December 31, 2022, there was a balance of $1,924,356 under this loan. |
|
|
|
On January 23, 2023, ERES entered into the Second Extension Note with the Sponsor. Pursuant to the Second
Extension Note, the Sponsor agreed to contribute to ERES as a loan $0.033 for each Public Share that was not redeemed in connection with the stockholder vote to approve the extension of the date by which ERES must complete an initial business
combination, for each month until the earlier of (i) the date of consummation of ERESs initial business combination and (ii) the date of liquidation of ERES. The Second Extension Note does not bear interest and is repayable in full upon the
earlier of (i) the date of the consummation of ERESs initial business combination and (ii) the date of ERESs liquidation. At any time prior to payment in full of the principal balance of the Second Extension Note, the holder of the
Second Extension Note (or a permitted assignee) will have the option, but not the obligation, to convert up to $500,000 of the unpaid principal balance of the Second Extension Note into that number of Second Extension Warrants, each whole warrant
exercisable for one share of ERES Class A Common Stock equal to the principal amount of the Second Extension Note so converted divided by $1.50. The terms of the Second Extension Warrants will be identical to the terms of the Private Placement
Warrants. The Sponsor will have the sole discretion whether to continue extending for additional months, and if the Sponsor determines not to continue extending for additional months, its obligation to make additional Contributions will terminate.
If this occurs, ERES would wind up ERESs affairs and redeem 100% of the outstanding Public Shares in accordance with the procedures set forth in the Existing Charter. The maturity date of the Second Extension Note may be accelerated upon the
occurrence of an Event of Default (as defined therein). Any outstanding principal under the Second Extension Note may be prepaid at any time by ERES, at its election and without penalty, provided, however, that the Sponsor shall have a right to
first convert such principal balance as described in Section 17 of the Second Extension Note upon notice of such prepayment. If the Business Combination is not completed and ERES winds up, there will not be sufficient assets to repay the Second
Extension Note and it will be worthless. As of April 17, 2023, there was a balance of $282,748.65 under this loan. |
|
|
|
ERESs directors and officers, and their affiliates are entitled to reimbursement of out-of-pocket expenses incurred by them in connection with certain activities on ERESs behalf, such as identifying and investigating possible business targets and
business combinations. However, if ERES fails to consummate a business combination within the Completion Window, they will not have any claim against the Trust Account for reimbursement. Accordingly, ERES may not be able to reimburse these expenses
if the Business Combination or another business combination is not consummated within the Completion Window. As of December 31, 2022, $0 was outstanding in out-of-pocket expense reimbursements. Additionally, two affiliates of the Sponsor are each
entitled to $10,000 per month for |
53
|
office space, utilities, administrative and support services provided to ERESs management team, which commenced on July 24, 2020 and will continue through the earlier of consummation
of the Business Combination and ERESs liquidation. For the years ended December 31, 2022 and December 31, 2021, the ERES incurred and paid an aggregate of $240,000 and $240,000 in connection with these agreements, respectively.
|
|
|
|
The continued indemnification of current directors and officers and the continuation of directors and
officers liability insurance. |
|
|
|
In the event of the liquidation of the Trust Account, the Sponsor has agreed to indemnify and hold harmless ERES
against any and all losses, liabilities, claims, damages and expenses to which ERES may become subject as a result of any claim by (i) any third party for services rendered or products sold to ERES or (ii) a prospective target business
with which ERES has entered into an acquisition agreement, provided that such indemnification of ERES by the Sponsor shall apply only to the extent necessary to ensure that such claims by a third party for services rendered or products sold to ERES
or a target do not reduce the amount of funds in the Trust Account to below (i) $10.00 per share of ERES Class A Common Stock or (ii) such lesser amount per share of ERES Class A Common Stock held in the Trust Account due to
reductions in the value of the trust assets as of the date of the liquidation of the Trust Account, in each case, net of the amount of interest earned on the property in the Trust Account, which may be withdrawn to pay taxes and expenses related to
the administration of the Trust Account, except as to any claims by a third party (including a target) who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under ERESs indemnity of the
underwriters of the ERES IPO against certain liabilities, including liabilities under the Securities Act. If ERES consummates the Business Combination, on the other hand, ERES will be liable for all such claims. |
|
|
|
Pursuant to the Sponsor Support Agreement, the Sponsor has agreed, subject to certain exceptions, not to transfer
(i) 15% of the shares of the Post-Combination Companys common stock received by the Sponsor in connection with the Closing until the date that is 180 days after the Closing Date and (ii) the remaining 85% of the shares of the
Post-Combination Companys common stock received by the Sponsor in connection with the Closing until the date that is 24 months after the Closing Date. |
|
|
|
Subject to certain limited exceptions, the Private Placement Warrants will not be transferable until 30 days
following the completion of the Business Combination. |
|
|
|
There will be no finders fees, reimbursements or cash payments made by ERES to the Sponsor or ERESs
officers or directors, or ERESs or any of their affiliates, for services rendered to ERES prior to or in connection with the completion of the Business Combination, other than payment of the amount described above for office space, utilities,
administrative and support services described above and repayments of the loans under the Working Capital Note, the Extension Note and the Second Extension Note as described above. The Sponsor and ERESs officers and directors or any of their
respective affiliates will also be reimbursed for any out-of-pocket expenses incurred in connection with ERESs formation, the ERES IPO and activities on
ERESs behalf such as identifying potential target businesses and performing due diligence on suitable business combinations. There is no cap or ceiling on the reimbursement of
out-of-pocket expenses incurred by such persons in connection with activities on our behalf. |
54
|
|
|
Our Sponsor, officers and directors would hold the following number of shares of common stock in the Post-Combination Company, on a fully diluted basis, at the closing of the Business Combination: |
|
|
|
|
|
|
|
|
|
Name of Person/Entity |
|
Number of Shares of Common Stock(1) |
|
|
Value of Shares(2) |
|
East Sponsor, LLC |
|
|
17,068,333 |
|
|
$ |
170,683,330 |
|
Terrence M. Pegula |
|
|
17,068,333 |
|
|
$ |
170,683,330 |
|
Gary L. Hagerman, Jr. |
|
|
1,000 |
|
|
$ |
10,000 |
|
John P. Sieminski |
|
|
2,500 |
|
|
$ |
25,000 |
|
James S. Morrow |
|
|
0 |
|
|
$ |
0 |
|
William A. Fustos |
|
|
22,000 |
|
|
$ |
220,000 |
|
Thomas W. Corbett, Jr. |
|
|
10,000 |
|
|
$ |
100,000 |
|
Benjamin Wingard(3) |
|
|
4,000 |
|
|
$ |
40,000 |
|
Jacob Long |
|
|
5,000 |
|
|
$ |
50,000 |
|
Adam Gusky |
|
|
2,452 |
|
|
$ |
24,520 |
|
|
(1) |
(a) Assumes that (i) Public Stockholders exercise the 17,250,000 public warrants, (ii) the Initial Stockholders
exercise the 7,120,000 Private Placement Warrants, (iii) the 1,780,000 warrants in the warrant pool are exercised, (iv) the Sponsor exercises its option to convert up to $1,500,000 of the unpaid principal balance on the Extension Note to 1,000,000
Extension Warrants and exercises such warrants, (v) the Sponsor exercise its option to convert up to $500,000 of the unpaid principal balance on the Second Extension Note to 333,333 Second Extension Warrants and exercises such warrants and (vi) all
shares underlying the Incentive Plan are issued. |
(b) Includes shares that may be issued but are not presently
outstanding and, as such, differs from the share counts shown or assumed in the sections entitled Summary Unaudited Pro Forma Condensed Combined Financial Information, Unaudited Historical Comparative and Pro Forma Combined Per
Share Data of ERES and the Companies, Unaudited Pro Forma Condensed Combined Financial Information and Comparative Historical and Unaudited Pro Forma Combined Per Share Financial Information, which sections are limited
to shares that are presently issued and outstanding.
|
(2) |
Assumes a value of $10.00 per share, the deemed value of the Class A Common Stock in the Business
Combination. |
|
(3) |
Benjamin Wingard was a named executive officer for the purposes of the Annual Report on Form 10-K
for fiscal year ended December 31, 2022, filed by ERES on April 18, 2023. Mr. Wingard resigned from ERES effective January 31, 2023. |
|
|
|
Certain of our officers and directors presently have, and any of them in the future may have additional,
fiduciary or contractual obligations to other entities pursuant to which such officer or director is or will be required to present business combination opportunities to such entity. Accordingly, in the future, if any of our officers or directors
becomes aware of a business combination opportunity which is suitable for an entity to which he or she has then-current fiduciary or contractual obligations, he or she will honor his or her fiduciary or contractual obligations to present such
opportunity to such entity. We do not believe, however, that any fiduciary duties or contractual obligations of our officers would materially undermine our ability to complete our business combination. The Existing Charter provides that we renounce
our interest in any corporate opportunity offered to any director or officer unless such opportunity is expressly offered to such person solely in his or her capacity as a director or officer of our company and such opportunity is one we are legally
and contractually permitted to undertake and would otherwise be reasonable for us to pursue, and to the extent such person is permitted to refer that opportunity to us without violating another legal obligation. This waiver allows our Sponsor and
its affiliates to allocate opportunities based on a combination of the objectives and fundraising needs of the target, as well as the investment objectives of the entity. However, we do not believe that the waiver of the corporate opportunities
doctrine otherwise had a material impact on our search for an acquisition target. |
55
|
|
|
Following the completion of the Business Combination, Adam Gusky and Thomas W. Corbett, Jr. will be members of
the board of directors of the Post-Combination Company. As such, in the future, Mr. Gusky and Mr. Corbett, Jr. will receive any cash fees, stock options or stock awards that the board of directors of the Post-Combination Company determines to
pay to its directors. |
|
|
|
Given the interests described above, our Sponsor and its affiliates may earn a positive rate of return on their
investment, even if the Post-Combination Company common stock trades below the price initially paid for the ERES units in the ERES IPO, and the Public Stockholders may experience a negative rate of return following the completion of the Business
Combination. Thus, our Sponsor and its affiliates may have more of an economic incentive for us to, rather than liquidate if we fail to complete our initial business combination by the Completion Window, enter into an initial business combination on
potentially less favorable terms with a potentially less favorable, riskier, weaker-performing or financially unstable business, or an entity lacking an established record of revenues or earnings, than would be the case if such parties had paid the
full offering price for their Founder Shares. |
|
|
|
Our Sponsor, directors and officers beneficially own Founder Shares and warrants that will be worthless and have
incurred reimbursable expenses that may not be reimbursed or repaid if the Business Combination is not approved. As of the date of this proxy statement, the Sponsor has invested an aggregate of approximately $14,132,105 (consisting of $25,000 for
the Founder Shares, $8,900,000 for the Private Placement Warrants, $3,000,000 for the aggregate principal amount of the Working Capital Note, $1,924,356 for the Extension Note and $282,749 for the Second Extension Note). Assuming a value of $10.00
per share, the deemed value of the Class A Common Stock in the Business Combination, the aggregate market value with respect to the common stock, fully diluted, based on Founder Shares and warrants in ERES held by our Sponsor, directors and
officers, would be approximately $170,783,330. Thus, the aggregate market value of our Sponsors Founder Shares and Private Placement Warrants, together with the aggregate outstanding principal amount of the foregoing loans and the foregoing
reimbursable expenses, would be approximately $184,915,435. |
See the section entitled The Business
CombinationInterests of ERESs Directors and Executive Officers and the Sponsor and its Affiliates in the Business Combination.
The Sponsor has interests in the Business Combination different from the interests of ERES stockholders.
When considering the ERES Boards recommendation that our stockholders vote in favor of the approval of the Business Combination Proposal
and the other Proposals described in this proxy statement, our stockholders should be aware that the Sponsor has interests in the Business Combination that may be different from, in addition to, or conflict with the interests of our stockholders in
general. For instance, the 8,625,000 Founder Shares held by the Initial Stockholders which were acquired for an aggregate purchase price of $25,000 prior to the completion of the ERES IPO and the 8,900,000 Private Placement Warrants the Sponsor
purchased from ERES for an aggregate purchase price of $8,900,000 (or $1.00 per warrant) purchased concurrently with the closing of the ERES IPO will expire worthless if ERES does not consummate a business combination within the Completion Window.
For a more complete description of these interests, see the section entitled The Business CombinationInterests of ERESs Directors and Executive Officers and the Sponsor and its Affiliates in the Business
Combination.
Public Stockholders who redeem their Common Stock and/or previously redeemed their Common Stock in connection with the
Extension Amendment or the Second Extension Amendment may continue to hold any ERES public warrants that they own, which will result in additional dilution to non-redeeming Public Stockholders upon exercise of such ERES public warrants or Private
Placement Warrants, as applicable.
Public Stockholders who redeem their Common Stock and/or previously redeemed their Common Stock
in connection with the Extension Amendment or the Second Extension Amendment may continue to hold any public
56
warrants they owned prior to redemption, which will result in additional dilution to non-redeeming holders upon exercise of such public warrants. Assuming (i) all redeeming Public Stockholders
acquired ERES units in the IPO and continue to hold the public warrants that were included in the units and (ii) maximum redemption of Common Stock held by the redeeming Public Stockholders, 17,250,000 public warrants would be retained by redeeming
Public Stockholders with a value of approximately $1.73 million based on the market price of $0.10 per warrant based on the closing price of the public warrants on Nasdaq on April 20, 2023. As a result of exercising their redemption
rights, the redeeming Public Stockholders would receive their pro rata portion of the Trust Account and continue to hold public warrants with an aggregate market value of approximately $1.73 million while non-redeeming Public Stockholders would
experience additional dilution in their percentage ownership and voting interest of the Post-Combination Company upon the exercise of the ERES public warrants held by redeeming Public Stockholders or upon the exercise of the Private Placement
Warrants.
Because the Companies will become a publicly traded company through the Business Combination rather than an underwritten initial
public offering, the scope of due diligence conducted may be different from that conducted by an underwriter in an underwritten initial public offering.
The Companies will effectively become a publicly listed company upon the completion of the Business Combination. The Business Combination and
the transactions described in this proxy statement differ from an underwritten initial public offering. In a traditional underwritten initial public offering, underwriters typically conduct a certain amount of due diligence on the company being
taken public in order to establish a due diligence defense against liability claims under federal securities laws. Because ERES is already a publicly listed company, an underwriter has not been engaged. The due diligence conducted by management and
the ERES Board may be different than the due diligence undertaken by an underwriter in a traditional initial public offering. The Sponsor may have an inherent conflict of interest because its shares and warrants will be worthless if an initial
business combination is not completed with the Companies or another company before July 27, 2023. Therefore, there could be a heightened risk of an incorrect valuation of the Companies business, which could cause potential harm to
investors.
The Business Combination will result in changes to the board of directors that may affect our strategy.
If the parties complete the Business Combination and the Director Election Proposal is approved, the composition of the Board will change from
the current board of directors to boards of managers of ERES and the Companies, respectively. The Board of the Post-Combination Company will be divided into three classes and will consist of the directors
elected pursuant to the Director Election Proposal, each of which will serve an initial term ending in either 2023, 2024 or 2025, and thereafter will serve a three-year term. This new composition of the Post-Combination Company board of directors may affect our business strategy and operating decisions upon the completion of the Business Combination.
The Merger Agreement contains provisions that limit ERES from seeking an alternative business combination.
The Merger Agreement contains provisions that prohibit ERES from seeking alternative business combinations during the pendency of the Business
Combination. Further, if ERES is unable to obtain the requisite approval of its stockholders, either party may terminate the Merger Agreement. See the section entitled The Merger AgreementTermination.
The unaudited pro forma condensed combined financial information included in this proxy statement is preliminary and the actual financial condition and
results of operations after the Business Combination may differ materially.
The unaudited pro forma financial information included
in this proxy statement is presented for illustrative purposes only and is not necessarily indicative of what our actual financial position or results of operations would
57
have been had the Business Combination been completed on the date(s) indicated. The preparation of the pro forma financial information is based upon available information and certain assumptions
and estimates that ERES and the Companies currently believe are reasonable. However, the final reverse recapitalization accounting adjustments may differ materially from the pro forma adjustments reflected in this proxy statement. Accordingly, the
Post-Combination Companys business, assets, cash flows, results of operations and financial condition may differ significantly from those indicated by the unaudited pro forma condensed combined financial statements included in this proxy
statement. See the section entitled Unaudited Pro Forma Condensed Combined Financial Information.
ERES and the Companies
will incur transaction costs in connection with the Business Combination.
Each of ERES and the Companies has incurred and expects
that it will incur significant, non-recurring costs in connection with consummating the Business Combination. ERES and the Companies may also incur additional costs to retain key employees. ERES and the
Companies will also incur significant legal, financial advisor, accounting, banking and consulting fees, fees relating to regulatory filings and notices, SEC filing fees, printing and mailing fees and other costs associated with the Business
Combination. ERES and the Companies estimate that they will incur $18.4 million in aggregate transaction costs (this excludes any deferred underwriting fee to Wells Fargo). Some of the transaction costs are payable regardless of whether the Business
Combination is completed. See the section entitled The Business CombinationTerms of the Business Combination.
ERESs stockholders will have their rights as stockholders governed by the Post-Combination Companys
organizational documents.
As a result of the completion of the Business Combination, holders of shares of ERES Common Stock will
become holders of shares of the Post-Combination Companys common stock, which are expected to be governed by the Post-Combination Companys organizational
documents. As a result, there will be differences between the rights currently enjoyed by ERES stockholders and the rights that ERES stockholders who become stockholders of the Post-Combination Company will
have as stockholders of the Post-Combination Company.
The Sponsor has agreed to vote in favor of each of
the Proposals presented at the Special Meeting, regardless of how Public Stockholders vote.
Pursuant to the Sponsor Support
Agreement, the Sponsor has agreed to vote any shares of ERES Common Stock it holds in favor of each of the Proposals presented at the Special Meeting, regardless of how Public Stockholders vote. Accordingly, the agreement by the Sponsor to vote in
favor of the each of the Proposals presented at the Special Meeting will increase the likelihood that ERES will receive the requisite stockholder approval for the Business Combination and the transactions contemplated thereby. See the
section entitled Other AgreementsSponsor Support Agreement.
ERESs and the Companies ability to
consummate the Business Combination, and the operations of the Post-Combination Company following the Business Combination, may be materially adversely affected by the recent coronavirus (COVID-19) pandemic.
The COVID-19 pandemic has resulted,
and other infectious diseases could result, in a widespread health crisis that has and could continue to adversely affect the economies and financial markets worldwide, which may delay or prevent the consummation of the Business Combination, and the
business of the Companies or Post-Combination Company following the Business Combination could be materially and adversely affected. The extent of such impact will depend on future developments, which are
highly uncertain and cannot be predicted.
The parties will be required to consummate the Business Combination even if the Companies,
their business, financial condition and results of operations are materially affected by COVID-19. The disruptions posed by COVID-19 have continued, and other matters of
global concern may continue, for an extensive period
58
of time, and if the Companies are unable to recover from business disruptions due to COVID-19 or other matters of global concern on a timely basis, the
Companies ability to consummate the Business Combination and the Post-Combination Companys financial condition and results of operations following the Business Combination may be materially
adversely affected. Each of the Companies and the Post-Combination Company may also incur additional costs due to delays caused by COVID-19, which could adversely affect
the Post-Combination Companys financial condition and results of operations.
Risks Related to Ownership
of Our Class A Common Stock Following the Business Combination
Subsequent to the consummation of the Business Combination, the Post-Combination Company may be required to take write-downs or write-offs, or the
Post-Combination Company may be subject to restructuring, impairment or other charges that could have a significant negative effect on the Post-Combination
Companys financial condition, results of operations and the price of the Post-Combination Companys securities, which could cause you to lose some or all of your investment.
Although ERES has conducted due diligence on the Companies, this diligence may not surface all material issues that may be present with the
Companies business. Factors outside of ERESs and outside of the Companies control may, at any time, arise. As a result of these factors, the Post-Combination Company may be forced to later write-down or write-off assets, restructure its operations, or incur impairment or other charges that could result in the
Post-Combination Company reporting losses. Even if ERESs due diligence successfully identified certain risks, unexpected risks may arise, and previously known risks may materialize in a manner not
consistent with our preliminary risk analysis. Even though these charges may be non-cash items and therefore not have an immediate impact on the Post-Combination
Companys liquidity, the fact that the Post-Combination Company reports charges of this nature could contribute to negative market perceptions about the
Post-Combination Company or its securities. In addition, charges of this nature may cause the Post-Combination Company to be unable to obtain future financing on
favorable terms or at all.
Anti-takeover provisions in our governing documents and under Delaware law could
make an acquisition of us more difficult, limit attempts by our stockholders to replace or remove our current management and limit the market price of our common stock.
The Proposed Charter, the Amended and Restated Bylaws and Delaware law contain or will contain provisions that could have the effect of
rendering more difficult, delaying, or preventing an acquisition deemed undesirable by the Board. Among other things, the Proposed Charter and/or the Amended and Restated Bylaws will include the following provisions:
|
|
|
a staggered board, which means that the Board will be classified into three classes of directors with staggered three-year terms and directors will only be able to be removed from office for cause; |
|
|
|
limitations on convening special stockholder meetings, which could make it difficult for our stockholders to
adopt desired governance changes; |
|
|
|
a prohibition on stockholder action by written consent, which means that our stockholders will only be able to
take action at an annual meeting of stockholders and will not be able to take action by written consent for any matter; |
|
|
|
a forum selection clause, which means certain litigation against us can only be brought in Delaware;
|
|
|
|
the authorization of undesignated preferred stock, the terms of which may be established and shares of which may
be issued without further action by our stockholders; and |
|
|
|
advance notice procedures, which apply for stockholders to nominate candidates for election as directors or to
bring matters before an annual meeting of stockholders. |
These provisions, alone or together, could delay or prevent
hostile takeovers and changes in control or changes in our management. As a Delaware corporation, we are also subject to provisions of Delaware law,
59
including Section 203 of the DGCL, which prevents interested stockholders, such as certain stockholders holding more than 15% of our outstanding common stock, from engaging in certain
business combinations unless (i) prior to the time such stockholder became an interested stockholder, the board of directors approved the transaction that resulted in such stockholder becoming an interested stockholder, (ii) upon
consummation of the transaction that resulted in such stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the common stock, or (iii) following board approval, such business combination receives the
approval of the holders of at least two-thirds of our outstanding common stock not held by such interested stockholder at an annual or special meeting of stockholders.
Any provision of the Proposed Charter, the Amended and Restated Bylaws or Delaware law that has the effect of delaying, preventing or
deterring a change in control could limit the opportunity for our stockholders to receive a premium for their shares of our common stock and could also affect the price that some investors are willing to pay for our common stock.
ERES has identified a material weakness in its internal control over financial reporting as of December 31, 2022. If ERES is unable to develop and
maintain an effective system of internal control over financial reporting, ERES may not be able to accurately report its financial results in a timely manner, which may adversely affect investor confidence in ERES and materially and adversely affect
its business and operating results.
On April 12, 2021, the staff of the SEC issued a public statement entitled
Staff Statement on Accounting and Reporting Considerations for Warrants Issued by Special Purpose Acquisition Companies (SPACs) (the Statement). In the Statement, the SEC staff, among other things, expressed its
view that certain terms and conditions common to warrants issued by SPACs, such as ERES, may require such warrants to be classified as liabilities on the SPACs balance sheet as opposed to equity. ERES previously accounted for its outstanding
warrants as components of equity instead of as derivative liabilities. Following the issuance of the Statement, ERESs management and audit committee concluded that in light of the Statement, it was appropriate to restate ERESs previously
issued audited financial statements as of December 31, 2020, as of July 27, 2020, for the period from May 22, 2020 through December 31, 2020 and for the period ended September 30, 2020.
Additionally, in light of recent guidance from the staff of the SEC, ERES reevaluated its application of Accounting Standards Codification
(ASC) 480-10-S99-3A on the classification of redeemable shares of common stock that were issued as part of the units
sold in the ERES IPO. Historically, a portion of the Public Shares was classified as permanent equity to maintain net tangible assets greater than $5,000,000 on the basis that ERES would consummate its initial business combination only if it has net
tangible assets of at least $5,000,001. Pursuant to such re-evaluation, ERESs management determined that the Public Shares include certain provisions that require classification of the Public Shares as
temporary equity regardless of the minimum net tangible assets required to complete ERESs initial business combination. ERESs management and audit committee concluded that in light of this change it was appropriate to restate ERESs
previously issued audited financial statements as of July 27, 2020, for the period from May 22, 2020 through December 31, 2020, ERESs unaudited quarterly financial statements as of September 30, 2020 included in ERESs
quarterly report on Form 10-Q filed with the SEC on November 16, 2020, ERESs unaudited quarterly financial statements as of March 31, 2021 included in ERESs quarterly report on Form 10-Q filed with the SEC on July 16, 2021, and ERESs unaudited quarterly financial statements as of June 30, 2021 included in ERESs quarterly report on Form
10-Q filed with the SEC on August 17, 2021.
In connection with these restatements, ERES
identified material weaknesses in its internal controls over financial reporting due to the ability to apply the nuances of the complex accounting standards and preparation of financial statements in accordance with GAAP. A material weakness is a
deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of ERESs annual or interim financial statements will not be prevented, or
detected and corrected on a timely basis. Effective internal controls are necessary for us to provide reliable financial reports and prevent fraud.
60
ERES continues to evaluate steps to remediate the material weakness. These remediation measures may be time consuming and costly and there is no assurance that these initiatives will ultimately
have the intended effects. If ERES identifies any new material weaknesses in the future, any such newly identified material weakness could limit ERESs ability to prevent or detect a misstatement of ERESs accounts or disclosures that
could result in a material misstatement of ERESs annual or interim financial statements. In such case, ERES may be unable to maintain compliance with securities law requirements regarding timely filing of periodic reports in addition to
applicable stock exchange listing requirements, investors may lose confidence in ERESs financial reporting and ERESs stock price may decline as a result. ERES cannot assure you that the measures it has taken to date, or any measures it
may take in the future, will be sufficient to avoid potential future material weaknesses.
Risks Related to Redemption
If third parties bring claims against us, the proceeds held in the Trust Account could be reduced and the per share redemption amount received by
stockholders may be less than $[●] per share.
Our placing of funds in the Trust Account may not
protect those funds from third-party claims against us. Although we have sought and will continue to seek to have all vendors, service providers, prospective target businesses, including the Companies, or
other entities with which we do business execute agreements with us waiving any right, title, interest or claim of any kind in or to any monies held in the Trust Account for the benefit of our Public Stockholders, such parties may not execute such
agreements, or even if they execute such agreements they may not be prevented from bringing claims against the Trust Account, including, but not limited to, fraudulent inducement, breach of fiduciary responsibility or other similar claims, as well
as claims challenging the enforceability of the waiver, in each case in order to gain advantage with respect to a claim against our assets, including the funds held in the Trust Account. If any third party refuses to execute an agreement waiving
such claims to the monies held in the Trust Account, our management will perform an analysis of the alternatives available to it and will only enter into an agreement with a third party that has not executed a waiver if management believes that such
third partys engagement would be significantly more beneficial to us than any alternative. Marcum LLP, our independent registered public accounting firm, did not execute agreements with us waiving such claims to the monies held in the Trust
Account.
Examples of possible instances where we may engage a third party that refuses to execute a waiver include the engagement of a third-party consultant whose particular expertise or skills are believed by management to be significantly superior to those of other consultants that would agree to execute a waiver or in cases where management is
unable to find a service provider willing to execute a waiver. In addition, there is no guarantee that such entities will agree to waive any claims they may have in the future as a result of, or arising out of, any negotiations, contracts or
agreements with us and will not seek recourse against the Trust Account for any reason. Upon redemption of our Public Shares, if we are unable to complete our initial business combination within the prescribed timeframe, or upon the exercise of a
redemption right in connection with our initial business combination, we will be required to provide for payment of claims of creditors that were not waived that may be brought against us within the 10 years following redemption. Accordingly, the
per share redemption amount received by Public Stockholders could be less than the $[●] per share as of the ERES Record Date, due to claims of such creditors. Our Sponsor has agreed that it will be liable to us if and to the extent any claims
by a vendor for services rendered or products sold to us, or a prospective target business, with which we have discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (i) $10.00 per Public Share
or (ii) such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay
taxes. This liability will not apply with respect to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under our indemnity of the underwriters of the ERES IPO
against certain liabilities, including liabilities under the Securities Act. Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, then our Sponsor will not be responsible to the extent of any liability
for such third party claims. We have not independently verified whether our Sponsor has sufficient funds to satisfy its indemnity obligations and
61
believe that our Sponsors only assets are our securities. We have not asked our Sponsor to reserve for such indemnification obligations. Therefore, we cannot assure you that our Sponsor
would be able to satisfy those obligations. As a result, if any such claims were successfully made against the Trust Account, the funds available for our initial business combination and redemptions could be reduced to less than $[●] per
Public Share. In such event, we may not be able to complete our initial business combination, and you would receive such lesser amount per share in connection with any redemption of your Public Shares. None of our officers will indemnify us for
claims by third parties including, without limitation, claims by vendors and prospective target businesses.
ERESs independent directors may
decide not to enforce the indemnification obligations of our Sponsor, resulting in a reduction in the amount of funds in the Trust Account available for distribution to our Public Stockholders.
In the event that the proceeds in the Trust Account are reduced below the lesser of (i) $10.00 per Public Share or (ii) such lesser amount
per share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay taxes, and our Sponsor asserts that it is
unable to satisfy its obligations or that it has no indemnification obligations related to a particular claim, our independent directors would determine whether to take legal action against our Sponsor to enforce its indemnification obligations.
While we currently expect that our independent directors would take legal action on our behalf against our Sponsor to enforce its
indemnification obligations to us, it is possible that our independent directors in exercising their business judgment may choose not to do so if, for example, the cost of such legal action is deemed by the independent directors to be too high
relative to the amount recoverable or if the independent directors determine that a favorable outcome is not likely. If our independent directors choose not to enforce these indemnification obligations, the amount of funds in the Trust Account
available for distribution to our Public Stockholders may be reduced below $[●] per share.
There is no guarantee that a Public
Stockholders decision whether to redeem their Public Shares for a pro rata portion of the Trust Account will put such stockholder in a better future economic position.
No assurance can be given as to the price at which a Public Stockholder may be able to sell the shares of our Class A Common Stock in the
future following the completion of the Business Combination. Certain events following the consummation of any business combination, including the Business Combination, may cause an increase in our stock price, and may result in a lower value
realized now than an ERES stockholder might realize in the future had the stockholder not elected to redeem such stockholders Public Shares. Similarly, if a Public Stockholder does not redeem his, her or its shares, such stockholder will bear
the risk of ownership of our Class A Common Stock after the consummation of the Business Combination, and there can be no assurance that a stockholder can sell his, her or its shares of our Class A Common Stock in the future for a greater
amount than the redemption price set forth in this proxy statement. A Public Stockholder should consult his, her or its own tax and/or financial advisor for assistance on how this may affect its individual situation.
If Public Stockholders fail to comply with the redemption requirements specified in this proxy statement, they will not be entitled to redeem their
Public Shares for a pro rata portion of the funds held in the Trust Account.
To exercise their redemption rights, holders are
required to deliver their stock, either physically or electronically using the Depository Trust Companys DWAC System, to ERESs transfer agent two business days prior to the vote at the Special Meeting. If a holder properly seeks
redemption as described in this proxy statement and the Business Combination with the Companies is consummated, ERES will redeem these Public Shares for a pro rata portion of funds deposited in the Trust Account and the holder will no longer own
such Public Shares following the Business Combination. See the section entitled ERESs Special Meeting of StockholdersRedemption Rights for additional information on how to exercise your redemption rights.
62
If, before distributing the proceeds in the Trust Account to our Public Stockholders, we file a
bankruptcy petition or an involuntary bankruptcy petition is filed against us that is not dismissed, the claims of creditors in such proceeding may have priority over the claims of our stockholders and the per share amount that would otherwise be
received by our stockholders in connection with our liquidation may be reduced.
If, before distributing the proceeds in the Trust
Account to our Public Stockholders, we file a bankruptcy petition or an involuntary bankruptcy petition is filed against us that is not dismissed, the proceeds held in the Trust Account could be subject to applicable bankruptcy law, and may be
included in our bankruptcy estate and subject to the claims of third parties with priority over the claims of our stockholders. To the extent any bankruptcy claims deplete the Trust Account, the per share amount that would otherwise be received by
our stockholders in connection with our liquidation may be reduced.
If, after we distribute the proceeds in the Trust Account to our Public
Stockholders, we file a bankruptcy petition or an involuntary bankruptcy petition is filed against us that is not dismissed, a bankruptcy court may seek to recover such proceeds, and we and our board may be exposed to claims of punitive damages.
If, after we distribute the proceeds in the Trust Account to our Public Stockholders, we file a bankruptcy petition or an
involuntary bankruptcy petition is filed against us that is not dismissed, any distributions received by stockholders could be viewed under applicable debtor/creditor and/or bankruptcy laws as either a preferential transfer or a
fraudulent conveyance. As a result, a bankruptcy court could seek to recover all amounts received by our stockholders. In addition, the ERES Board may be viewed as having breached its fiduciary duty to our creditors and/or having acted
in bad faith, thereby exposing itself and us to claims of punitive damages, by paying Public Stockholders from the Trust Account prior to addressing the claims of creditors.
If you or a group of stockholders of which you are a part are deemed to hold an aggregate of more than 20% of the Public Shares, you (or, if
a member of such a group, all of the members of such group in the aggregate) will lose the ability to redeem all such shares in excess of 20% of the Public Shares.
A Public Stockholder, together with any of his, her or its affiliates or any other person with whom it is acting in concert or as a
group (as defined in Section 13(d)(3) of the Exchange Act), will be restricted from redeeming in the aggregate his, her or its Public Shares or, if part of such a group, the groups Public Shares, in excess of 20% of the Public
Shares without the consent of ERES. Your inability to redeem any such excess Public Shares could resulting in you suffering a material loss on your investment in ERES if you sell such excess Public Shares in open market transactions. ERES cannot
assure you that the value of such excess Public Shares will appreciate over time following the Business Combination or that the market price of the Public Shares will exceed the per-share redemption price.
However, ERESs stockholders ability to vote all of their Public Shares (including such excess shares) for or against the
Business Combination Proposal is not restricted by this limitation on redemption.
ERES may redeem your unexpired warrants prior to their exercise
at a time that is disadvantageous to you, thereby making your warrants worthless, and Private Placement Warrants have different cashless exercise rights than other warrants issued by ERES.
We have the ability to redeem the outstanding warrants underlying the ERES units sold in the ERES IPO at any time after they become exercisable
and prior to their expiration, at a price of $0.01 per warrant if, among other things, the last reported sale price of the Class A Common Stock for any 20 trading days within a 30-trading day period
ending on the third trading day prior to the date on which we send the notice of redemption to the warrant holders equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like).
The Class A Common Stock has never traded above $18.00 per share. 90 days after the warrants become exercisable, we may redeem the outstanding warrants at a price equal to a number of shares of Class A Common Stock as set forth in the table under
the section Description of the
63
Securities of the Post-Combination CompanyWarrantsPublic Stockholders Warrants. If and when the warrants become redeemable by us, we may exercise our redemption
right. Redemption of the outstanding warrants as described above could force you to: (i) exercise your warrants and pay the exercise price therefor at a time when it may be disadvantageous for you to do so; (ii) sell your warrants at the then-current market price when you might otherwise wish to hold your warrants; or (iii) accept the nominal redemption price which, at the time the outstanding warrants are called for redemption, we expect would
be substantially less than the market value of your warrants. We have no obligation to notify holders of warrants that they have become eligible for redemption. In the event we decide to redeem the warrants, we shall fix a date for the redemption
(the Redemption Date) and are required to mail notice of such redemption not less than 30 days prior to the Redemption Date. The warrants may be exercised any time after notice of redemption is given and prior to the Redemption Date.
Redemption may occur at a time when the warrants are out-of-the-money, in which case you would lose any potential
embedded value from a subsequent increase in the value of the Class A Common Stock had your warrants remained outstanding.
The
Private Placement Warrants are identical to the public warrants except that (i) the Private Placement Warrants and the Class A Common Stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable
or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions, (ii) the Private Placement Warrants will be exercisable on a cashless basis at the election of such holder, whereas public warrants
will only be exercisable on a cashless basis at ERESs election and (iii) none of the Private Placement Warrants will be redeemable by us.
If we elect to redeem the public warrants on a cashless basis, or if the holders of the Private Placement Warrants elect to exercise their
Private Placement Warrants on a cashless basis, then ERES will not receive any cash proceeds from the exercise of such warrants.
There is
uncertainty regarding the federal income tax consequences of the redemption to the holders of ERES Class A Common Stock.
There is some uncertainty regarding the federal income tax consequences to holders of ERES Class A Common Stock that exercise their
redemption rights. The uncertainty of tax consequences relates primarily to the individual circumstances of the taxpayer and include (i) whether the redemption will be treated as a corporate distribution potentially taxable as a dividend, or a
sale, that would potentially give rise to capital gain or capital loss and (ii) whether such capital gain is long-term or short-term.
Whether the redemption qualifies for sale treatment, resulting in taxation as capital gain rather than treatment as a corporate distribution, will depend largely on whether the holder owns (or is deemed to own) any shares of Class A Common
Stock following the redemption, and if so, the total number of shares of ERES Class A Common Stock treated as held by the holder both before and after the redemption relative to all shares of ERES voting stock outstanding both before and after
the redemption. The redemption generally will be treated as a sale, rather than a distribution, if the redemption (i) is substantially disproportionate with respect to the holder, (ii) results in a complete
termination of the holders interest in ERES or (iii) is not essentially equivalent to a dividend with respect to the holder. Due to the personal and subjective nature of certain of such tests and the absence of clear
guidance from the IRS, there is uncertainty as to how a holder who elects to exercise its redemption rights will be taxed in connection with the exercise of redemption rights. See the section entitled Material
U.S. Federal Income Tax ConsequencesMaterial Tax Consequences of a Redemption of Public Shares.
A new 1% U.S. federal excise tax may be imposed upon us in connection with the redemptions by us of our Class A Common Stock.
On August 16, 2022, President Biden signed into law the Inflation Reduction Act of 2022 (the IRA), which, among other things,
imposes a new U.S. federal 1% excise tax on certain repurchases (including redemptions) of stock by publicly traded domestic corporations and certain domestic subsidiaries of publicly traded foreign corporations. This excise tax is imposed on the
repurchasing corporation itself, not its stockholders
64
from which shares are repurchased. Generally, the amount of the excise tax is 1% of the fair market value of the shares repurchased at the time of the repurchase. For the purposes of calculating
the excise tax, the repurchasing corporation is permitted to net the fair market value of certain new stock issuances against the fair market value of the stock repurchases that occur in the same taxable year. The U.S. Treasury Department, the IRS
and other standard-setting bodies are expected to issue guidance on how the excise tax provisions of the IRA will be applied. The IRA excise tax applies to repurchases that occur after December 31, 2022.
Any repurchase or redemption of our Class A Common Stock that occurs after December 31, 2022, in connection with the Business
Combination may be subject to the excise tax. Whether and to what extent we would be subject to the excise tax in connection with the Business Combination would depend on a number of factors, including (i) the fair market value of the
redemptions and repurchase in connection with the Business Combination, (ii) the structure of the Business Combination, (iii) the nature and amount of any PIPE or other equity issuances in connection with the Business Combination (or
otherwise issued not in connection with the Business Combination but issued within the same taxable year of the Business Combination) (while ERES continues to opportunistically seek to raise a PIPE investment, at this time, it has no committed PIPE
Investment Amount) and (iv) the regulations and other guidance issued by the U.S. Treasury Department and the IRS. Since the excise tax would be payable by us and not by the redeeming holder, we have yet to determine the mechanics of any
required payment of the excise taxes.
Unlike some other blank check companies, ERES does not have a specified maximum redemption threshold, except
that in no event will ERES redeem the Public Shares in an amount that would cause ERESs net tangible assets to be less than $5,000,001. The absence of such a redemption threshold will make it easier for ERES to consummate the Business
Combination even if a substantial number of ERES stockholders redeem.
Unlike some other blank check companies, ERES does not have
a specified maximum redemption threshold, except that we will not redeem Public Shares in an amount that would cause our net tangible assets to be less than $5,000,001. Some other blank check companies structures disallow the consummation of a
business combination if the holders of such companies public shares elect to redeem or convert more than a specified percentage of the shares sold in such companies initial public offering. Because we have no such maximum redemption
threshold, we may be able to consummate the Business Combination even though a substantial number of our Public Stockholders have redeemed their shares.
However, the Merger Agreement provides that the obligation of the Companies to consummate the Business Combination is subject to ERES having
cash on hand and any additional cash received from financing activities equal to or in excess of $1.0 million (without, for the avoidance of doubt, taking into account any transaction expenses) and after distribution of the Trust Account,
deducting all amounts to be paid pursuant to the redemption of Public Shares and after giving effect to any financing. In the event the aggregate cash consideration we would be required to pay for all shares of Class A Common Stock that are
validly submitted for redemption plus the required amount of required funds pursuant to the Merger Agreement exceed the aggregate amount of cash available to us, we will not complete the Business Combination or redeem any shares, all shares of
Class A Common Stock submitted for redemption will be returned to the holders thereof, and we instead may search for an alternate business combination.
65
UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL
INFORMATION
Introduction
ERES
and the Companies are providing the following unaudited pro forma condensed combined financial information to aid you in your analysis of the financial aspects of the Business Combination. The unaudited pro forma condensed combined financial
information has been prepared in accordance with Article 11 of Regulation S-X and should be read in conjunction with the accompanying notes.
The unaudited pro forma condensed combined balance sheet as of December 31, 2022 combines the audited balance sheet of ERES as of
December 31, 2022, the audited balance sheet of LMA as of December 31, 2022, and the audited balance sheet of Abacus as of December 31, 2022, giving effect to the Business Combination as if it had been consummated on December 31,
2022.
The unaudited pro forma condensed combined statement of operations for the year ended December 31, 2022 combines the audited
statement of operations of ERES for the year ended December 31, 2022, the audited statement of operations of LMA for the year ended December 31, 2022, and the audited statement of operations of Abacus for the year ended December 31,
2022, giving effect to the Business Combination as if it had been consummated on January 1, 2022, the beginning of the earliest period presented.
The unaudited pro forma condensed combined financial information was derived from, and should be read in conjunction with, the following
historical financial statements and the accompanying notes, which are included elsewhere in this proxy statement/prospectus:
|
|
|
The historical audited financial statements of ERES as of and for year ended December 31, 2022;
|
|
|
|
The historical audited financial statements of LMA as of and for the year ended December 31, 2022; and
|
|
|
|
The historical audited financial statements of Abacus as of and for the year ended December 31,
2022. |
The foregoing historical financial statements have been prepared in accordance with GAAP. The unaudited pro forma
condensed combined financial information has been prepared based on the aforementioned historical financial statements and the assumptions and adjustments as described in the notes to the unaudited pro forma condensed combined financial information.
The pro forma adjustments reflect transaction accounting adjustments related to the Business Combination, which is discussed in further detail below. The unaudited pro forma condensed combined financial statements are presented for illustrative
purposes only and do not purport to represent the Post-Combination Companys consolidated results of operations or consolidated financial position that would actually have occurred had the Business Combination been consummated on the dates
assumed or to project the Post-Combination Companys consolidated results of operations or consolidated financial position for any future date or period.
The unaudited pro forma condensed combined financial information should also be read together with Managements Discussion and
Analysis of Financial Condition and Results of Operations of ERES,
Managements Discussion and Analysis of Financial Condition and
Results of Operations of LMA, Managements Discussion and Analysis of Financial Condition and Results of Operations of Abacus, and other financial information included elsewhere in this proxy statement/prospectus.
Description of the Business Combination
On August 30, 2022, ERES entered into the Merger Agreement with the Companies and Merger Subs, pursuant to which, among other things and
subject to the terms and conditions contained in the Merger Agreement, Abacus Merger Sub will merge with and into Abacus, with Abacus surviving the Merger as a wholly owned subsidiary of ERES, and LMA Merger Sub will merge with and into LMA, with
LMA surviving the Merger as a wholly owned subsidiary of ERES. In connection with the Closing of the Merger, ERES will be renamed Abacus Life, Inc.
66
On October 14, 2022, ERES entered into the First Amendment to the Merger Agreement
with the Companies and Merger Subs, which modified certain terms and conditions contained within the Merger Agreement.
On April 20,
2023, ERES entered into the Second Amendment to the Merger Agreement with the Companies and Merger Subs, which modified certain terms and conditions contained within the Merger Agreement.
Accounting for the Business Combination
The Business Combination will be accounted for as a reverse recapitalization with ERES in accordance with GAAP. Under this method of
accounting, ERES has been treated as the acquired company for financial reporting purposes. This determination was primarily based on the LMA stockholders having a relative majority of the voting power of the Post-Combination Company,
the LMA stockholders having the authority to appoint a majority of directors on the Board of Directors, and senior management of LMA comprising the majority of the senior management of the Post-Combination Company. LMA was then determined to be the
acquirer for financial reporting purposes based on the relative size of LMA as compared to Abacus, represented by their revenue, equity, gross profit and net income. Accordingly, for accounting purposes, the financial statements of the
combined entity will represent a continuation of the financial statements of LMA with the LMA Merger being treated as the equivalent of LMA issuing stock for the net assets of ERES, accompanied by a recapitalization. The net assets of ERES will be
stated at historical cost, with no goodwill or other intangible assets recorded.
The Abacus Merger will be accounted for using the
acquisition method of accounting. Under the acquisition method of accounting, the assets and liabilities of Abacus will be recorded at estimated fair value as of the acquisition date. The excess of the purchase price over the estimated fair values
of the net assets acquired, if applicable, will be recognized as goodwill. For purposes of the unaudited pro forma condensed combined balance sheet, the purchase consideration has been allocated to the assets acquired and liabilities assumed of
Abacus based upon managements preliminary estimate of their fair values, subject to further revision as additional information becomes available and additional analyses are performed. Differences may occur between these preliminary estimates
and the final accounting, expected to be completed after the Closing of the Business Combination, and these differences could have a material impact on the accompanying unaudited pro forma condensed combined financial information and the
Companys future results of operations and financial position.
Basis of Pro Forma Presentation
The historical financial information has been adjusted to give pro forma effect to the transaction accounting required for the Business
Combination. The adjustments in the unaudited pro forma condensed combined financial information have been identified and presented to provide relevant information necessary for an accurate understanding of the Post-Combination Company upon Closing.
The unaudited pro forma condensed combined financial information is for illustrative purposes only. The financial results may have been
different had ERES and the Companies always been combined. You should not rely on the unaudited pro forma condensed combined financial information as being indicative of the historical results that would have been achieved had ERES and the Companies
always been combined or the future results that the Post-Combination Company will experience.
The Companies are related parties, although
they were determined not to be under common control. As such, an adjustment was applied to the statement of operations for the year ended December 31, 2022 to remove activity that would be considered intercompany activity and eliminated upon
consolidation. This activity represented revenue for Abacus and cost of sales for LMA in the amount of $2.3 million. The Companies have not had any historical relationship with ERES prior to the Business Combination. Accordingly, no pro forma
adjustments were required to eliminate activities between the Companies and ERES.
67
The unaudited pro forma condensed combined financial information has been prepared
assuming two alternative levels of redemptions of Class A Common Stock into cash:
|
|
|
Assuming No Redemptions. This presentation assumes: |
|
|
|
No stockholders of Class A Common Stock exercise their redemption rights with respect to their redeemable
Class A Common Stock upon Closing. In this scenario, ERES stockholders comprise 2.9 million shares of Class A Common Stock and contribute $29.3 million to the Post-Combination Company, assuming $10.00 per share.
|
|
|
|
Assuming Maximum Contractual Redemptions. |
|
|
|
This presentation assumes: Stockholders representing 2.9 million shares of Class A Common Stock
exercise their redemption rights with respect to their redeemable Class A Common Stock upon Closing, which represents 100% redemptions, for a total redemption price of $29.3 million, assuming that the redemption price is $10.00 per share.
|
If the actual facts are different than these assumptions, then the amounts and shares outstanding in the unaudited pro
forma condensed combined financial information will be different.
68
Unaudited Pro Forma Condensed Combined Balance Sheet
As of December 31, 2022
(in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) ERES Historical |
|
|
(2) ERES- January 20 Redemptions |
|
|
(3) Subtotal (1) + (2) |
|
|
(4) LMA Historical |
|
|
(5) Transaction Adjustments Assuming No Redemptions |
|
|
(6) Pro Forma Combined ERES
and LMA Assuming No Redemptions (3) + (4) + (5) |
|
|
(7) Abacus Historical |
|
|
(8) Transaction Adjustments - Abacus Acquisition |
|
|
(9) Pro Forma Combined Assuming No Redemptions (6) + (7) + (8) |
|
|
(10) Transaction Adjustments Assuming Maximum Redemptions |
|
|
Pro Forma Combined Assuming Maximum Redemptions (9) + (10) |
|
ASSETS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
|
86 |
|
|
|
|
|
|
|
86 |
|
|
|
30,053 |
|
|
|
29,291 |
(B) |
|
|
43,427 |
|
|
|
1,459 |
|
|
|
|
|
|
|
44,886 |
|
|
|
(29,291 |
)(I) |
|
|
33,595 |
|
Accounts receivable |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10 |
|
|
|
(16,003 |
) (C) |
|
|
10 |
|
|
|
|
|
|
|
|
|
|
|
10 |
|
|
|
18,000 |
(J) |
|
|
10 |
|
Related party receivable |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
198 |
|
|
|
|
|
|
|
198 |
|
|
|
403 |
|
|
|
|
|
|
|
601 |
|
|
|
|
|
|
|
601 |
|
Due from affiliates |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,905 |
|
|
|
(2,905 |
) (C) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other receivables |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
122 |
|
|
|
|
|
|
|
122 |
|
|
|
|
|
|
|
122 |
|
Prepaid expenses and other current assets |
|
|
65 |
|
|
|
|
|
|
|
65 |
|
|
|
117 |
|
|
|
|
|
|
|
182 |
|
|
|
232 |
|
|
|
|
|
|
|
414 |
|
|
|
|
|
|
|
414 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current assets |
|
|
151 |
|
|
|
|
|
|
|
151 |
|
|
|
33,283 |
|
|
|
10,383 |
|
|
|
43,817 |
|
|
|
2,216 |
|
|
|
|
|
|
|
46,033 |
|
|
|
(11,291 |
) |
|
|
34,742 |
|
Property and equipment, net |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
19 |
|
|
|
|
|
|
|
19 |
|
|
|
72 |
|
|
|
|
|
|
|
91 |
|
|
|
|
|
|
|
91 |
|
Intangible assets, net |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
149 |
|
|
|
31,000 |
(H) |
|
|
31,149 |
|
|
|
|
|
|
|
31,149 |
|
Goodwill |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
156,788 |
(H) |
|
|
156,788 |
|
|
|
|
|
|
|
156,788 |
|
Operating
right-of-use assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
77 |
|
|
|
|
|
|
|
77 |
|
|
|
301 |
|
|
|
|
|
|
|
378 |
|
|
|
|
|
|
|
378 |
|
Life settlement policies, at cost |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8,716 |
|
|
|
|
|
|
|
8,716 |
|
|
|
|
|
|
|
|
|
|
|
8,716 |
|
|
|
|
|
|
|
8,716 |
|
Life settlement policies, at fair value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13,809 |
|
|
|
|
|
|
|
13,809 |
|
|
|
|
|
|
|
|
|
|
|
13,809 |
|
|
|
|
|
|
|
13,809 |
|
Available-for-sale
securities, at fair value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,000 |
|
|
|
|
|
|
|
1,000 |
|
|
|
|
|
|
|
|
|
|
|
1,000 |
|
|
|
|
|
|
|
1,000 |
|
Other investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,300 |
|
|
|
|
|
|
|
1,300 |
|
|
|
|
|
|
|
|
|
|
|
1,300 |
|
|
|
|
|
|
|
1,300 |
|
Due from members and affiliates |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
|
|
|
|
|
|
|
1 |
|
|
|
|
|
|
|
1 |
|
State security deposit |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
207 |
|
|
|
|
|
|
|
207 |
|
|
|
|
|
|
|
207 |
|
Certificate of deposit |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
263 |
|
|
|
|
|
|
|
263 |
|
|
|
|
|
|
|
263 |
|
Other assets, at fair value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
891 |
|
|
|
|
|
|
|
891 |
|
|
|
7 |
|
|
|
|
|
|
|
898 |
|
|
|
|
|
|
|
898 |
|
Cash and marketable securities held in Trust Account |
|
|
99,223 |
|
|
|
(69,932 |
) (A) |
|
|
29,291 |
|
|
|
|
|
|
|
(29,291 |
) (B) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets |
|
|
99,374 |
|
|
|
(69,932 |
) |
|
|
29,442 |
|
|
|
59,095 |
|
|
|
(18,908 |
) |
|
|
69,629 |
|
|
|
3,216 |
|
|
|
187,788 |
|
|
|
260,633 |
|
|
|
(11,291 |
) |
|
|
249,342 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES, CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDERS EQUITY
(DEFICIT) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accrued expenses |
|
|
9,228 |
|
|
|
|
|
|
|
9,228 |
|
|
|
|
|
|
|
|
|
|
|
9,228 |
|
|
|
542 |
|
|
|
|
|
|
|
9,770 |
|
|
|
|
|
|
|
9,770 |
|
Accounts payable |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
40 |
|
|
|
|
|
|
|
40 |
|
|
|
37 |
|
|
|
|
|
|
|
77 |
|
|
|
|
|
|
|
77 |
|
Operating lease liability-current portion |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
48 |
|
|
|
|
|
|
|
48 |
|
|
|
215 |
|
|
|
|
|
|
|
263 |
|
|
|
|
|
|
|
263 |
|
Due to members and affiliates |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
264 |
|
|
|
|
|
|
|
264 |
|
|
|
1 |
|
|
|
|
|
|
|
265 |
|
|
|
|
|
|
|
265 |
|
Contract liabilitiesdeposits on pending settlements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
322 |
|
|
|
|
|
|
|
322 |
|
|
|
|
|
|
|
322 |
|
Accrued transaction costs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
908 |
|
|
|
(908 |
) (C) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other current liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
42 |
|
|
|
|
|
|
|
42 |
|
|
|
|
|
|
|
|
|
|
|
42 |
|
|
|
|
|
|
|
42 |
|
Income taxes payable |
|
|
53 |
|
|
|
|
|
|
|
53 |
|
|
|
|
|
|
|
|
|
|
|
53 |
|
|
|
|
|
|
|
|
|
|
|
53 |
|
|
|
|
|
|
|
53 |
|
Note payable to related party |
|
|
4,924 |
|
|
|
|
|
|
|
4,924 |
|
|
|
|
|
|
|
|
|
|
|
4,924 |
|
|
|
|
|
|
|
|
|
|
|
4,924 |
|
|
|
|
|
|
|
4,924 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
69
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) ERES Historical |
|
|
(2) ERES- January 20 Redemptions |
|
|
(3) Subtotal (1) + (2) |
|
|
(4) LMA Historical |
|
|
(5) Transaction Adjustments Assuming No Redemptions |
|
|
(6) Pro Forma Combined ERES
and LMA Assuming No Redemptions (3) + (4) + (5) |
|
|
(7) Abacus Historical |
|
|
(8) Transaction Adjustments - Abacus Acquisition |
|
|
(9) Pro Forma Combined Assuming No Redemptions (6) + (7) + (8) |
|
|
(10) Transaction Adjustments Assuming Maximum Redemptions |
|
|
Pro Forma Combined Assuming Maximum Redemptions (9) + (10) |
|
Total current liabilities |
|
|
14,205 |
|
|
|
|
|
|
|
14,205 |
|
|
|
1,302 |
|
|
|
(908 |
) |
|
|
14,599 |
|
|
|
1,117 |
|
|
|
|
|
|
|
15,716 |
|
|
|
|
|
|
|
15,716 |
|
Long-term debt at fair value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
28,250 |
|
|
|
|
|
|
|
28,250 |
|
|
|
|
|
|
|
|
|
|
|
28,250 |
|
|
|
18,000 |
(J) |
|
|
46,250 |
|
Operating lease liability-noncurrent portion |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
29 |
|
|
|
|
|
|
|
29 |
|
|
|
88 |
|
|
|
|
|
|
|
117 |
|
|
|
|
|
|
|
117 |
|
Deferred tax liability |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,364 |
|
|
|
|
|
|
|
1,364 |
|
|
|
|
|
|
|
7,857 |
(H) |
|
|
9,221 |
|
|
|
|
|
|
|
9,221 |
|
Deferred underwriting fee payable |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward purchase agreement liability |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant liability |
|
|
4,576 |
|
|
|
|
|
|
|
4,576 |
|
|
|
|
|
|
|
(2,415 |
) (G) |
|
|
2,161 |
|
|
|
|
|
|
|
|
|
|
|
2,161 |
|
|
|
|
|
|
|
2,161 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities |
|
|
18,781 |
|
|
|
|
|
|
|
18,781 |
|
|
|
30,945 |
|
|
|
(3,323 |
) |
|
|
46,403 |
|
|
|
1,205 |
|
|
|
7,857 |
|
|
|
55,465 |
|
|
|
18,000 |
|
|
|
73,465 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commitments and Contingencies |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class A Common Stock subject to possible redemption |
|
|
98,983 |
|
|
|
(69,932 |
) (A) |
|
|
29,051 |
|
|
|
|
|
|
|
(29,051 |
) (D) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shareholders equity (deficit) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class A common stock / Common units |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
50 |
|
|
|
|
(D) |
|
|
6 |
|
|
|
4 |
|
|
|
(4 |
)(H) |
|
|
6 |
|
|
|
|
(I) |
|
|
6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(45 |
) (E) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
(F) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class B common stock |
|
|
1 |
|
|
|
|
|
|
|
1 |
|
|
|
|
|
|
|
(1 |
) (F) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional Paid-in Capital |
|
|
24 |
|
|
|
|
|
|
|
24 |
|
|
|
660 |
|
|
|
(11,887 |
) (C) |
|
|
20,308 |
|
|
|
80 |
|
|
|
181,862 |
(H) |
|
|
202,250 |
|
|
|
(29,291 |
)(I) |
|
|
172,959 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
29,051 |
(D) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
45 |
(E) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,415 |
(G) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Retained earnings/(accumulated deficit) |
|
|
(18,415 |
) |
|
|
|
|
|
|
(18,415 |
) |
|
|
25,487 |
|
|
|
(6,113 |
) (C) |
|
|
959 |
|
|
|
1,927 |
|
|
|
(1,927 |
) (H) |
|
|
959 |
|
|
|
|
|
|
|
959 |
|
Accumulated other comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,053 |
|
|
|
|
|
|
|
1,053 |
|
|
|
|
|
|
|
|
|
|
|
1,053 |
|
|
|
|
|
|
|
1,053 |
|
Noncontrolling interest |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
900 |
|
|
|
|
|
|
|
900 |
|
|
|
|
|
|
|
|
|
|
|
900 |
|
|
|
|
|
|
|
900 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total shareholders equity (deficit) |
|
|
(18,390 |
) |
|
|
|
|
|
|
(18,390 |
) |
|
|
28,150 |
|
|
|
13,466 |
|
|
|
23,226 |
|
|
|
2,011 |
|
|
|
179,931 |
|
|
|
205,168 |
|
|
|
(29,291 |
) |
|
|
175,877 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and shareholders equity (deficit) |
|
|
99,374 |
|
|
|
(69,932 |
) |
|
|
29,442 |
|
|
|
59,095 |
|
|
|
(18,908 |
) |
|
|
69,629 |
|
|
|
3,216 |
|
|
|
187,788 |
|
|
|
260,633 |
|
|
|
(11,291 |
) |
|
|
249,342 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
70
Unaudited Pro Forma Condensed Combined Statement of Operations
Year Ended December 31, 2022
(in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) ERES Historical |
|
|
(2) LMA Historical |
|
|
(3) Transaction Adjustments Assuming No Redemptions |
|
|
(4) Pro Forma Combined ERES and LMA Assuming No Redemptions (1) + (2) +
(3) |
|
|
(5) Abacus Historical |
|
|
(6) Transaction Adjustments - Abacus Acquisition |
|
|
(7) Pro Forma Combined Assuming No Redemptions (4) + (5) + (6) |
|
|
(8) Transaction Adjustments Assuming Maximum Redemptions |
|
|
Pro Forma Combined Assuming Maximum Redemptions (7) + (8) |
|
Revenue |
|
|
|
|
|
|
44,713 |
|
|
|
(2,268 |
) (AA) |
|
|
42,445 |
|
|
|
25,203 |
|
|
|
|
|
|
|
67,648 |
|
|
|
|
|
|
|
67,648 |
|
Cost of sales |
|
|
|
|
|
|
6,245 |
|
|
|
(2,268 |
) (AA) |
|
|
3,977 |
|
|
|
16,561 |
|
|
|
|
|
|
|
20,538 |
|
|
|
|
|
|
|
20,538 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit |
|
|
|
|
|
|
38,468 |
|
|
|
|
|
|
|
38,468 |
|
|
|
8,642 |
|
|
|
|
|
|
|
47,110 |
|
|
|
|
|
|
|
47,110 |
|
Formation and operating costs |
|
|
11,722 |
|
|
|
|
|
|
|
|
|
|
|
11,722 |
|
|
|
|
|
|
|
|
|
|
|
11,722 |
|
|
|
|
|
|
|
11,722 |
|
Sales and marketing |
|
|
|
|
|
|
2,596 |
|
|
|
|
|
|
|
2,596 |
|
|
|
|
|
|
|
|
|
|
|
2,596 |
|
|
|
|
|
|
|
2,596 |
|
General and administrative expenses |
|
|
|
|
|
|
1,066 |
|
|
|
20,550 |
(EE) |
|
|
21,616 |
|
|
|
8,674 |
|
|
|
|
|
|
|
30,290 |
|
|
|
|
|
|
|
30,290 |
|
Loss (gain) on change in fair value of debt |
|
|
|
|
|
|
91 |
|
|
|
|
|
|
|
91 |
|
|
|
|
|
|
|
|
|
|
|
91 |
|
|
|
|
|
|
|
91 |
|
Unrealized loss (gain) on investments |
|
|
|
|
|
|
1,046 |
|
|
|
|
|
|
|
1,046 |
|
|
|
|
|
|
|
|
|
|
|
1,046 |
|
|
|
|
|
|
|
1,046 |
|
Other operating expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,599 |
(HH) |
|
|
5,599 |
|
|
|
|
|
|
|
5,599 |
|
Depreciation |
|
|
|
|
|
|
4 |
|
|
|
|
|
|
|
4 |
|
|
|
12 |
|
|
|
|
|
|
|
16 |
|
|
|
|
|
|
|
16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating expenses |
|
|
11,722 |
|
|
|
4,803 |
|
|
|
20,550 |
|
|
|
37,075 |
|
|
|
8,686 |
|
|
|
5,599 |
|
|
|
51,360 |
|
|
|
|
|
|
|
51,360 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from operations |
|
|
(11,722 |
) |
|
|
33,665 |
|
|
|
(20,550 |
) |
|
|
1,393 |
|
|
|
(44 |
) |
|
|
(5,599 |
) |
|
|
(4,250 |
) |
|
|
|
|
|
|
(4,250 |
) |
|
|
|
|
|
|
|
|
|
|
Other income (expense): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in fair value of warrant liability |
|
|
9,336 |
|
|
|
|
|
|
|
(9,660 |
) (CC) |
|
|
(324 |
) |
|
|
|
|
|
|
|
|
|
|
(324 |
) |
|
|
|
|
|
|
(324 |
) |
Change in fair value of forward purchase agreement liability |
|
|
600
|
|
|
|
|
|
|
|
|
|
|
|
600
|
|
|
|
|
|
|
|
|
|
|
|
600
|
|
|
|
|
|
|
|
600
|
|
Interest (expense) |
|
|
10 |
|
|
|
(43 |
) |
|
|
|
|
|
|
(33 |
) |
|
|
(9 |
) |
|
|
|
|
|
|
(42 |
) |
|
|
(2,160 |
) (II) |
|
|
(2,202 |
) |
Interest income |
|
|
|
|
|
|
2 |
|
|
|
|
|
|
|
2 |
|
|
|
3 |
|
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
5 |
|
Interest earned on marketable securities held in Trust Account |
|
|
672 |
|
|
|
|
|
|
|
(672 |
)(BB) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consulting income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other income/(expense) |
|
|
513 |
|
|
|
(347 |
) |
|
|
(6,113 |
) (DD) |
|
|
(5,947 |
) |
|
|
|
|
|
|
|
|
|
|
(5,947 |
) |
|
|
|
|
|
|
(5,947 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total other income |
|
|
11,131 |
|
|
|
(388 |
) |
|
|
(16,445 |
) |
|
|
(5,702 |
) |
|
|
(6 |
) |
|
|
|
|
|
|
(5,708 |
) |
|
|
(2,160 |
) |
|
|
(7,868 |
) |
|
|
|
|
|
|
|
|
|
|
Net income before provision for income taxes |
|
|
(591 |
) |
|
|
33,277 |
|
|
|
(36,995 |
) |
|
|
(4,309 |
) |
|
|
(50 |
) |
|
|
(5,599 |
) |
|
|
(9,958 |
) |
|
|
(2,160 |
) |
|
|
(12,118 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Provision for)/Benefit from income taxes |
|
|
(53 |
) |
|
|
(890 |
) |
|
|
160 |
(FF) |
|
|
(8,806 |
) |
|
|
(2 |
) |
|
|
1,331 |
(FF) |
|
|
(7,477 |
) |
|
|
513 |
(FF) |
|
|
(6,964 |
) |
|
|
|
|
|
|
|
|
|
|
|
(8,023 |
) (GG) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income / (loss) |
|
|
(644 |
) |
|
|
32,387 |
|
|
|
(44,858 |
) |
|
|
(13,115 |
) |
|
|
(52 |
) |
|
|
(4,268 |
) |
|
|
(17,435 |
) |
|
|
(1,647 |
) |
|
|
(19,082 |
) |
Net income attributable to noncontrolling interest |
|
|
|
|
|
|
705 |
|
|
|
|
|
|
|
705 |
|
|
|
|
|
|
|
|
|
|
|
705 |
|
|
|
|
|
|
|
705 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income / (loss) attributable to members / shareholders |
|
|
(644 |
) |
|
|
31,682 |
|
|
|
(44,858 |
) |
|
|
(13,820 |
) |
|
|
(52 |
) |
|
|
(4,268 |
) |
|
|
(18,140 |
) |
|
|
(1,647 |
) |
|
|
(19,787 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted weighted average shares outstanding, Class A common stock subject to
possible redemption |
|
|
23,637,084 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted net income per share, Class A common stock subject to possible
redemption |
|
|
0.02 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted weighted average shares outstanding, Non- redeemable common stock |
|
|
8,625,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted net income per share, Non-redeemable
common stock |
|
|
0.02 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted weighted average shares outstanding, Class A common stock |
|
|
|
|
|
|
5,000 |
|
|
|
|
|
|
|
|
|
|
|
400 |
|
|
|
|
|
|
|
60,086,125 |
|
|
|
|
|
|
|
57,230,078 |
|
Basic and diluted net loss per share, Class A common stock |
|
|
|
|
|
|
6,477.39 |
|
|
|
|
|
|
|
|
|
|
|
(131.24 |
) |
|
|
|
|
|
|
(0.29 |
) |
|
|
|
|
|
|
(0.33 |
) |
71
NOTES TO UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION
1. Basis of Presentation
The pro forma
adjustments have been prepared as if the Business Combination had been consummated on December 31, 2022, in the case of the unaudited pro forma condensed combined balance sheet, and, in the case of the unaudited pro forma condensed combined
statement of operations, as if the Business Combination had been consummated on January 1, 2022, the beginning of the earliest period presented in the unaudited pro forma condensed combined statement of operations.
The LMA Merger is expected to be accounted for using the reverse recapitalization method of accounting, with no goodwill or other intangible
assets recorded in accordance with GAAP. Accordingly, for accounting purposes, the financial statements of the Post-Combination Company will represent a continuation of the financial statements of LMA with the acquisition being treated as the
equivalent of LMA issuing stock for the net assets of ERES, accompanied by a recapitalization. The net assets of ERES will be stated at historical cost, with no goodwill or other intangible assets recorded.
The Abacus Merger is expected to be accounted for using the acquisition method of accounting in accordance with GAAP. Accordingly, for
accounting purposes, the identified assets and liabilities of Abacus will be recorded at their estimated fair values as of the acquisition date. The excess of the purchase price over the estimated fair values of the net assets acquired, if
applicable, will be recognized as goodwill.
The pro forma adjustments represent managements estimates based on information
available as of the date of this proxy statement/prospectus and are subject to change as additional information becomes available and additional analyses are performed. Management considers this basis of presentation to be reasonable under the
circumstances.
One-time direct and incremental transaction costs anticipated to be incurred
prior to, or concurrent with, Closing are reflected in the unaudited pro forma condensed combined balance sheet as a direct reduction to the Post-Combination Companys additional paid-in capital
and are assumed to be cash settled.
2. Adjustments and Assumptions to the Unaudited Pro Forma Condensed Combined Balance Sheet as of December 31,
2022
The adjustments included in the unaudited pro forma condensed combined balance sheet as of December 31, 2022 are as follows:
|
(A) |
On January 20, 2023, ERES held a stockholder vote to extend the date by which they must consummate a
business combination, and ERES stockholders were able to redeem their shares at this time. The stockholders voted to approve the extension; concurrent with the vote, 6.9 million stockholders opted to redeem their shares for a pro rata portion
of the funds in the Trust Account. As a result, $69.9 million, or approximately $10.19 per share, was removed from the Trust Account to pay such redeeming holders. |
|
(B) |
Represents the reclassification of $29.3 million in cash and marketable securities held in the Trust
Account that become available in conjunction with the Business Combination. |
|
(C) |
Represents transaction costs of $18.0 million. The transaction costs were allocated between the LMA Merger
and Abacus Merger on a relative fair value basis given the consideration allocated to each entity, as shown below. Transaction costs associated with the LMA Merger were considered to be chargeable against the proceeds of the merger; transaction
costs associated with the Abacus Merger were expensed in line with ASC 805 guidance. |
|
|
|
|
|
|
|
|
|
Value Conveyed |
|
Amount (in thousands) |
|
|
Percent of Total |
|
LMA Merger |
|
|
350,350 |
|
|
|
65.9 |
% |
Abacus Merger |
|
|
181,400 |
|
|
|
34.1 |
% |
Total Purchase Consideration |
|
$ |
531,750 |
|
|
|
100.0 |
% |
72
In July 2022, ERESs underwriter communicated their intention to withdraw their
involvement with the transaction and forfeit the $12.1 million in deferred underwriting fees due upon Closing. As such, this adjustment also reflects the elimination of this liability.
|
(D) |
Reflects the reclassification of $28.0 million and 2.9 million shares of Class A common stock
subject to possible redemption to permanent equity. |
|
(E) |
Represents the issuance of 48.6 million shares of Class A Common Stock to the existing
Companies stockholders at Closing as consideration for the reverse recapitalization. One of the existing stockholders in the Companies also received an additional 4.6 million incentive shares, which are subject to forfeiture, in
accordance with the terms of the Merger Agreement. The expense associated with this non-pro rata distribution is reflected at adjustments (DD) and (MM). |
|
(F) |
Reflects the issuance of shares in the Post-Combination Company to the Sponsor, involving the conversion from
Class B Common Stock to Class A Common Stock. |
|
(G) |
Represents the reclassification of ERESs public warrants from liability to equity, based on an initial
accounting analysis performed related to the appropriate classification. As part of this analysis, it was determined that the public warrants do not meet any of the conditions to be classified as a liability under ASC 480, are considered indexed to
the Post-Combination Companys own stock pursuant to ASC 815-40, and meet all of the criteria for equity classification within ASC 815-40. |
|
(H) |
Reflects the purchase price allocation adjustments to record Abacus assets and liabilities at estimated
fair value based on the consideration conveyed of $181.4 million, as detailed below. Consideration conveyed was allocated between the Companies based on relative values derived through both the discounted cash flow method within the income
approach and the guideline public company method within the market approach. Within the discounted cash flow method, the present values of cash flows reasonably expected to be produced by the Companies from their operations were summed to produce an
estimate of the Companies business enterprise values on a controlling, marketable basis. The cash flows used in the discounted cash flow analysis were discounted at the weighted average cost of capital of 14.5% for LMA and 15.5% for Abacus.
The discounted cash flow method resulted in a business enterprise value range of $310.0 million to $390.0 million for LMA and $180.0 million to $200.0 million for Abacus. Within the market approach, we applied the guideline
public company method, which employs market multiples derived from market prices of stocks of companies that are engaged in the same or similar lines of business as the Companies and that are actively traded on a free and open market. The guideline
public company method resulted in a business enterprise value range of $350.0 million to $390.0 million for LMA and $160.0 million to $180.0 million for Abacus. Management determined concluded on a business enterprise value of
$180.0 million for Abacus and $350.0 million for LMA. |
The preliminary purchase price was allocated among the
identified assets to be acquired, based on a preliminary analysis. All valuation procedures related to existing assets as no new assets were identified as a result of procedures performed. Goodwill was recognized as a result of the acquisition,
which represents the excess fair value of consideration over the fair value of the underlying net assets, largely arising from the extensive industry expertise that has been established by Abacus. This was considered appropriate based on the
determination that the Abacus Merger would be accounted for as a business acquisition under ASC 805. The estimates of fair value are based upon preliminary valuation assumptions believed to be reasonable but which are inherently uncertain and
unpredictable; and, as a result, actual results may differ from estimates.
73
|
|
|
|
|
Net Assets Identified |
|
Fair
Value |
|
Intangibles |
|
|
31,000 |
|
Goodwill |
|
|
156,788 |
|
Current assets |
|
|
2,216 |
|
Non-current assets |
|
|
1,000 |
|
Deferred tax liabilities |
|
|
(7,857 |
) |
Accrued expenses |
|
|
(542 |
) |
Other liabilities |
|
|
(1,205 |
) |
|
|
|
|
|
Total Fair Value |
|
$ |
181,400 |
|
|
|
|
|
|
Value Conveyed |
|
Amount (in thousands) |
|
Purchase Consideration |
|
|
180,000 |
|
Plus: Cash |
|
|
1,400 |
|
|
|
|
|
|
Total Purchase Consideration |
|
$ |
181,400 |
|
Intangible assets were comprised of the following:
|
|
|
|
|
|
|
|
|
|
|
Asset type |
|
Fair value |
|
|
Useful Life |
|
|
Valuation methodology |
Customer RelationshipsAgents |
|
|
12,100 |
|
|
|
5 years |
|
|
Multi-period excess-earnings method |
Customer RelationshipFinancing Entities |
|
|
11,300 |
|
|
|
8 years |
|
|
Multi-period excess-earnings method |
Internally Developed and Used TechnologyAPA |
|
|
1,400 |
|
|
|
3 years |
|
|
Relief from royalty method |
Internally Developed and Used TechnologyMarket Place |
|
|
200 |
|
|
|
2 years |
|
|
Replacement cost method |
Trade Name |
|
|
900 |
|
|
|
Indefinite |
|
|
Relief from royalty method |
Non-Compete Agreements |
|
|
2,400 |
|
|
|
2 years |
|
|
With and without method |
State Insurance Licenses |
|
|
2,700 |
|
|
|
Indefinite |
|
|
Replacement cost method |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31,000 |
|
|
|
|
|
|
|
|
(I) |
Represents the $29.3 million redemption of 2.9 million shares of Class A Common Stock subject to
possible redemption, at an assumed redemption price of $10.00 per share, inclusive of related interest earned on funds held in the Trust Account. |
|
(J) |
Represents the incremental amount to be issued under the promissory note with the Sponsor under the maximum
redemption scenario. The initial issuance occurred on July 24, 2022 in the amount of $1.9 million. |
3. Adjustments and
Assumptions to the Unaudited Pro Forma Condensed Combined Statement of Operations for the Year ended December 31, 2022
The
adjustments included in the unaudited pro forma condensed combined statement of operations for the year ended December 31, 2022 are as follows:
|
(AA) |
Reflects the elimination of activity between LMA and Abacus for the year ended December 31, 2022 that,
following the Business Combination, would be considered intercompany activity and eliminated upon consolidation. This activity was historically recorded as revenue for Abacus and as cost of sales for LMA. |
|
(BB) |
Reflects the elimination of interest earned on marketable securities held in the Trust Account.
|
|
(CC) |
Represents the elimination of the change in fair value of the ERESs public warrants for the year ended
December 31, 2022 as a result of the reclassification of these warrants, as presented at adjustment (G). This adjustment is expected to result in a permanent difference between book and taxable income, and as such, no income tax benefit has
been reflected herein related to this adjustment. |
74
|
(DD) |
Reflects the portion of nonrecurring transaction costs expected to be expensed as incurred based on the nature
of the costs, as noted at adjustment (C). This adjustment is expected to result in a permanent difference between book and taxable income, and as such, no income tax benefit has been reflected herein related to this adjustment.
|
|
(EE) |
Reflects recurring compensation expense due to a non-pro rata
distribution to one of the existing owners of the Companies, which vests in two equal tranches over the period of 25 months and 30 months, respectively, following Closing and which is subject to forfeiture prior to vesting. The negotiations related
to the draft Restriction Agreement governing these shares, attached to this proxy statement as Annex I, were considered to be concluded as of January 12, 2023, and this was determined to be the grant date of these incentive shares. The
compensation expense amount was calculated using ERESs closing stock price on the grant date. This adjustment is expected to result in a permanent difference between book and taxable income, and as such, no income tax benefit has been
reflected herein related to this adjustment. |
|
(FF) |
Represents the pro forma adjustment to taxes as a result of adjustments to the income statement for the year
ended December 31, 2022, which was calculated using the statutory income tax rate of 26.5%. Adjustments that were expected to result in permanent differences between book and taxable income, as noted herein, were not included in the calculation
of the tax impact of pro forma adjustments. |
|
(GG) |
Reflects the tax impact of transitioning the Companies from pass-through entities for tax purposes to taxable
entities for the year ended December 31, 2022. |
|
(HH) |
Reflects the incremental amortization expense related to intangibles. These intangibles include customer
relationships, internally developed and used technology and non-compete agreements, which were previously not present within Abacus historical financial statements and were adjusted to fair
value based on the purchase price allocation. The amortization expense for intangibles was calculated on a straight-line basis using the estimated remaining useful lives of the assets, which varied among the different intangibles.
|
|
(II) |
Reflects the interest expense related to the incremental issuance under the promissory note with the Sponsor,
in the maximum redemption scenario, which is subject to a fixed interest rate of 12%, for the year ended December 31, 2022. The incremental issuance under the maximum redemption scenario is noted at adjustment (K). |
4. Earnings per Share Information
The
pro forma weighted average shares calculations have been performed for the year ended December 31, 2022 using the historical weighted average shares outstanding, and the issuance of additional shares in connection with the Business Combination,
assuming the transaction occurred on January 1, 2022. As the Business Combination is being reflected as if it had occurred at the beginning of the periods presented, the calculation of weighted average share outstanding for both basic and
diluted earnings per share assumes that the shares issuable relating to the Business Combination have been outstanding for the entire periods presented. If the maximum number of shares are redeemed, this calculation is retroactively adjusted to
eliminate such shares for the entire periods.
|
|
|
|
|
|
|
|
|
|
|
Year Ended |
|
|
|
December 31, 2022 |
|
(In thousands, except share and per share data) |
|
Assuming No Redemptions |
|
|
Assuming Maximum Redemptions |
|
Pro forma net income |
|
$ |
(17,435 |
) |
|
$ |
(19,082 |
) |
Pro forma weighted average Class A Common Stock outstandingbasic and diluted |
|
|
60,086,125 |
|
|
|
57,230,078 |
|
Pro forma Class A Common Stock income per share |
|
$ |
(0.29 |
) |
|
$ |
(0.33 |
) |
75
The above calculation excludes the effects of potentially dilutive shares from the
computation of diluted net income per share as the effect would have an antidilutive impact under the treasury stock method. Therefore, the weighted average number of common shares outstanding used to calculate both basic and diluted net profit per
share attributable to common stockholders of the Post-Combination Company is the same. The above excludes the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net profit
per share attributable to common stockholders for the periods indicated because including them would have had an antidilutive effect:
|
|
|
|
|
|
|
As of December 31, 2022 |
|
Private Placement Warrants |
|
|
8,900,000 |
|
Public Warrants |
|
|
17,250,000 |
|
76
COMPARATIVE HISTORICAL AND UNAUDITED PRO FORMA COMBINED PER
SHARE
FINANCIAL INFORMATION
The following table sets forth selected historical comparative share information for ERES and the Companies, and unaudited pro forma
condensed combined per share information of the combined company after giving effect to the Business Combination and related transactions, assuming two redemption scenarios as follows:
|
|
|
Assuming No Redemption No stockholders of Class A Common Stock exercise their redemption rights with
respect to their redeemable Class A Common Stock upon the Closing. |
|
|
|
Assuming Maximum Contractual Redemption Stockholders representing 2.9 million shares of Class A
Common Stock exercise their redemption rights with respect to their redeemable Class A Common Stock upon the Closing for a total redemption price of $29.3 million, assuming that the redemption price is $10.00 per share.
|
The pro forma stockholders equity information reflects the Business Combination and related transactions as if
they had occurred on December 31, 2022. The weighted average shares outstanding and net income per share information for the year ended December 31, 2022 gives pro forma effect to the Business Combination and related transactions as if
they had occurred on January 1, 2022, the beginning of the earlier period presented.
If the actual facts are different than these
assumptions, including as to the amount of ERES cash and net debt, then the maximum number of redemptions and the amounts and shares outstanding in the unaudited pro forma condensed combined financial information will be different.
This information is only a summary and should be read together with the historical financial information included elsewhere in this proxy
statement/prospectus, and the historical financial statements of ERES and related notes, historical financial statements of LMA and related notes, and historical financial statements of Abacus and related notes that are included elsewhere in this
proxy statement/prospectus. The unaudited pro forma combined per share information of ERES and the Companies are derived from, and should be read in conjunction with, the unaudited pro forma condensed combined financial statements and related notes
included elsewhere in this proxy statement/prospectus.
The unaudited pro forma combined earnings per share information below does not
purport to represent the earnings per share which would have occurred had ERES and the Companies been combined during the periods presented, nor earnings per share for any future date or period. The unaudited pro forma combined book value per share
information below does not purport to represent what the value of ERES, LMA and Abacus would have been had ERES and the Companies been combined during the periods presented.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Combined Pro Forma |
|
|
|
LMA |
|
|
Abacus |
|
|
ERES |
|
|
No |
|
|
Maximum |
|
As of and for the Year Ended December 31, 2022 |
|
(Historical) |
|
|
(Historical) |
|
|
(Historical) |
|
|
Redemptions |
|
|
Redemptions |
|
Stockholders equity (deficit) |
|
$ |
28,150 |
|
|
$ |
2,011 |
|
|
$ |
(18,389 |
) |
|
$ |
205,169 |
|
|
$ |
175,878 |
|
Net income (loss) |
|
$ |
32,387 |
|
|
$ |
(52 |
) |
|
$ |
(644 |
) |
|
$ |
(17,435 |
) |
|
$ |
(19,082 |
) |
|
|
|
|
|
|
Common shares outstanding as of December 31, 2022 basic and diluted (1) |
|
|
5,000 |
|
|
|
400 |
|
|
|
9,718,972 |
|
|
|
60,086,125 |
|
|
|
57,230,078 |
|
|
|
|
|
|
|
Weighted average common shares outstanding basic and diluted (1) |
|
|
5,000 |
|
|
|
400 |
|
|
|
23,637,084 |
|
|
|
60,086,125 |
|
|
|
57,230,078 |
|
Stockholders equity (deficit) per share basic and diluted |
|
$ |
5,630.00 |
|
|
$ |
5,027.50 |
|
|
$ |
(1.89 |
) |
|
$ |
3.41 |
|
|
$ |
3.07 |
|
Net income (loss) per share attributable to common stockholders basic and diluted |
|
$ |
6,477.39 |
|
|
$ |
(131.24 |
) |
|
$ |
0.02 |
|
|
$ |
(0.29 |
) |
|
$ |
(0.33 |
) |
(1) |
ERES share count and income/(loss) per share is inclusive of common shares subject to possible redemption.
|
77
ERESS SPECIAL MEETING OF STOCKHOLDERS
General
ERES is furnishing this proxy
statement to ERESs stockholders as part of the solicitation of proxies by the ERES Board for use at the Special Meeting of ERES stockholders in lieu of the 2022 annual meeting of ERES stockholders to be held on [●], 2023, and at any
adjournment or postponement thereof. This proxy statement provides ERESs stockholders with information they need to know to be able to vote or instruct their vote to be cast at the Special Meeting.
Date, Time and Place of Special Meeting
The Special Meeting in lieu of the 2022 annual meeting of stockholders will be held at [●], on [●], 2023,
at https://www.cstproxy.com/eastresources/2023, in virtual format.
Voting Power; Record Date
You will be entitled to vote or direct votes to be cast at the Special Meeting if you owned shares of ERES Common Stock at the close of
business on [●], 2023, the ERES Record Date. You are entitled to one vote for each share of ERES Common Stock that you owned as of the close of business on the ERES Record Date. If your shares are held in street name or are in a
margin or similar account, you should contact your broker, bank or other nominee to ensure that votes related to the shares you beneficially own are properly counted. On the ERES Record Date, there were 11,481,047 shares of ERES Common Stock
outstanding, of which 2,856,047 were Public Shares and 8,625,000 were Founder Shares.
Purpose of the Special Meeting
At the Special Meeting, ERES is asking holders of ERES Common Stock to vote on the following Proposals:
(1) The Business Combination ProposalTo consider and vote upon a proposal to approve the Merger Agreement and the transactions
contemplated thereby;
(2) The Charter Approval ProposalTo consider and vote upon a proposal to adopt the Proposed Charter in
the form attached hereto as Annex B;
(3) The Governance ProposalTo consider and act upon, on a non-binding advisory basis, a separate proposal with respect to certain governance provisions in the Proposed Charter in accordance with the U.S. Securities and Exchange Commission requirements;
(4) The Director Election ProposalTo consider and vote upon a proposal to elect seven directors to serve on the Board of the Post-Combination Company until the 2023 annual meeting of stockholders, in the case of Class I directors, the 2024 annual meeting of stockholders, in the case of Class II directors, and the 2025 annual
meeting of stockholders, in the case of Class III directors, and, in each case, until their respective successors are duly elected and qualified;
(5) The Nasdaq ProposalTo consider and vote upon a proposal to approve, for purposes of complying with applicable listing rules
of Nasdaq, the issuance of shares of ERES Class A Common Stock to the Company Members pursuant to the Merger Agreement;
(6) The
Incentive Plan ProposalTo consider and vote upon a proposal to approve and adopt the Incentive Plan in the form attached hereto as Annex G; and
78
(7) The Adjournment ProposalTo consider and vote upon a proposal to
approve the adjournment of the Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the
Business Combination Proposal, the Charter Approval Proposal, the Director Election Proposal, the Nasdaq Proposal or the Incentive Plan Proposal.
Vote
of the Sponsor, Directors and Officers
ERES has entered into an agreement with the Sponsor and ERESs directors and officers,
pursuant to which each agreed to vote any shares of ERES Common Stock owned by them in favor of each of the Proposals presented at the Special Meeting.
The Sponsor and ERESs directors and officers have waived any redemption rights, including with respect to any Public Shares purchased in
the ERES IPO or in the aftermarket, in connection with an initial business combination. The Founder Shares held by the Initial Stockholders have no redemption rights upon our liquidation and will be worthless if no business combination is effected
by us within the Completion Window.
Quorum and Required Vote for Proposals for the Special Meeting
A quorum of ERES stockholders is necessary to hold a valid meeting. A quorum will be present at the Special Meeting if a majority of the voting
power of all outstanding shares of capital stock of ERES entitled to vote at the Special Meeting as of the ERES Record Date is represented in person (which would include presence at a virtual meeting) or by proxy. Abstentions and broker non-votes will be counted as present for the purpose of determining a quorum. The Initial Stockholders, who currently own approximately 75% of the issued and outstanding shares of ERES Common Stock, will count
towards this quorum. As of the ERES Record Date, 5,740,524 shares of ERES Common Stock would be required to achieve a quorum.
The
approval of each of the Business Combination Proposal, the Governance Proposal, the Nasdaq Proposal, the Incentive Plan Proposal and, if presented, the Adjournment Proposal, requires the affirmative vote (in person or by proxy) of the holders of a
majority of the shares of Class A Common Stock and Class B Common Stock entitled to vote and actually cast thereon at the Special Meeting, voting as a single class. Accordingly, a stockholders failure to vote by proxy or to vote in
person (which would include presence at a virtual meeting) at the Special Meeting, as well as an abstention from voting and a broker non-vote with regard to each of the Business Combination Proposal, the
Governance Proposal, the Nasdaq Proposal, the Incentive Plan Proposal or, if presented, the Adjournment Proposal, will have no effect on the Business Combination Proposal, the Governance Proposal, the Nasdaq Proposal, the Incentive Plan Proposal or
the Adjournment Proposal. The Sponsor and its directors and officers have agreed to vote their shares of ERES Common Stock in favor of each of the Proposals presented at the Special Meeting.
The approval of the Charter Approval Proposal requires the affirmative vote of (i) the holders of a majority of the Class B Common
Stock then outstanding and entitled to vote, voting separately as a single class, (ii) the holders of a majority of the ERES Class A Common Stock then outstanding and entitled to vote, voting separately as a single class, and (iii) the holders
of a majority of the shares of ERES Common Stock then outstanding and entitled to vote, voting together as a single class. Accordingly, a stockholders failure to vote by proxy or to vote in person (which would include presence at a virtual
meeting) at the Special Meeting, as well as an abstention from voting and a broker non-vote with regard to the Charter Approval Proposal, will have the same effect as a vote AGAINST such
Proposal.
Directors are elected by a plurality of the votes cast by the holders of Class B Common Stock present in person
(which would include presence at a virtual meeting) or represented by proxy at the Special Meeting and entitled to vote thereon. This means that the seven director nominees who receive the most affirmative votes will be elected. Stockholders may not
cumulate their votes with respect to the election of directors. Accordingly, a stockholders failure to vote by proxy or to vote in person (which would include presence at a virtual meeting) at the Special Meeting, as well as an abstention from
voting and a broker non-vote with regard to election of directors, will have no effect on the election of directors.
79
Consummation of the Business Combination is conditioned on the approval of the Business
Combination Proposal, the Charter Approval Proposal, the Nasdaq Proposal and the Incentive Plan Proposal at the Special Meeting, subject to the terms of the Merger Agreement. The Mergers are not conditioned on the Governance Proposal, the Director
Election Proposal or the Adjournment Proposal. If the Business Combination Proposal is not approved, the other Proposals (except the Adjournment Proposal) will not be presented to the stockholders for a vote.
It is important for you to note that in the event that the Business Combination Proposal, the Charter Approval Proposal, the Nasdaq Proposal
and the Incentive Plan Proposal do not receive the requisite vote for approval, ERES will not consummate the Business Combination. If ERES does not consummate the Business Combination and fails to complete an initial business combination within the
Completion Window, it will be required to dissolve and liquidate the Trust Account by returning the then remaining funds in such account to its Public Stockholders.
Recommendation of ERES Board of Directors
The
ERES Board unanimously determined that the Merger Agreement and the transactions contemplated thereby, including the Mergers, were advisable for, fair to, and in the best interests of ERES and its stockholders. Accordingly, the ERES Board
unanimously recommends that its stockholders vote FOR each of the Business Combination Proposal, the Charter Approval Proposal, the Governance Proposal, the Director Election Proposal, the Nasdaq Proposal, the Incentive Plan Proposal and
the Adjournment Proposal.
In considering the recommendation of the ERES Board to vote in favor of approval of the Proposals,
stockholders should keep in mind that the Sponsor and its affiliates and ERESs directors and officers have interests in such Proposals that are different from or in addition to (and which may conflict with) those of ERES stockholders.
Stockholders should take these interests into account in deciding whether to approve the Proposals presented at the Special Meeting, including the Business Combination Proposal. These interests include, among other things:
|
|
|
If the Business Combination with the Companies or another business combination is not consummated within the
Completion Window, ERES will cease all operations except for the purpose of winding up, redeeming 100% of the outstanding Public Shares for cash and, subject to the approval of its remaining stockholders and the ERES Board, dissolving and
liquidating. In such event, the 8,625,000 Founder Shares held by ERESs Initial Stockholders, acquired for an aggregate purchase price of $25,000, or approximately $0.003 per share, would be worthless because ERESs Initial Stockholders
are not entitled to participate in any redemption or distribution with respect to such shares. The Founder Shares had an aggregate market value of $[●] based upon the closing price of $[●] per share of ERES Class A Common Stock on
Nasdaq on the ERES Record Date. Certain Founder Shares are subject to time-based vesting provisions as described under Other AgreementsSponsor Support Agreement. |
|
|
|
The Sponsor purchased an aggregate of 8,900,000 Private Placement Warrants from ERES for an aggregate purchase
price of $8,900,000 (or $1.00 per warrant). These purchases took place on a private placement basis simultaneously with the consummation of the ERES IPO and associated exercise of the over-allotment option. A portion of the proceeds ERES received
from these purchases was placed in the Trust Account. Such warrants had an aggregate market value of approximately $[●] based upon the closing price of $[●] per public warrant on the Nasdaq on [●], 2023, the ERES Record Date. The
Private Placement Warrants will become worthless if ERES does not consummate a business combination within the Completion Window. The Sponsor paid an aggregate of $8,925,000 for its purchases of the Founder Shares and the Private Placement Warrants.
|
|
|
|
In order to finance transaction costs in connection with a business combination, the Sponsor, members of the ERES
founding team or any of their affiliates may, but are not obligated to, loan ERES funds as may be required. In August 2021, the Sponsor committed to provide ERES up to an aggregate of $1,500,000 in loans for working capital purposes. The Working
Capital Note does not bear interest and is repayable in full upon consummation of a business combination. If ERES does not complete a business combination, the Working Capital Note shall not be repaid and all amounts owed under it will
|
80
|
be forgiven. The Working Capital Note is subject to customary events of default, the occurrence of which automatically trigger the unpaid principal balance of the Working Capital Note and all
other sums payable with regard to the Working Capital Note becoming immediately due and payable. As of December 31, 2022, there was a balance of $1,500,000 under this loan. On January 31, 2023, the Sponsor agreed to loan ERES up to an additional
$1,500,000 under the Working Capital Note. |
|
|
|
On July 25, 2022, ERES entered into the Extension Note with the Sponsor. Pursuant to the Extension Note, the
Sponsor has agreed that it will contribute to ERES as a loan (each loan being referred to herein as a Contribution) $0.033 for each Public Share that was not redeemed in connection with the stockholder vote to approve the extension of
the deadline by which ERES must complete its initial business combination, for each month until the earlier of (i) the date of the special meeting held in connection with the stockholder vote to approve the Business Combination and
(ii) the date of liquidation of ERES. The Extension Note does not bear interest and is repayable in full upon the earlier of (i) the date of the consummation of ERESs initial business combination and (ii) the date of ERESs
liquidation. At any time prior to payment in full of the principal balance of the Extension Note, the holder of the Extension Note (or a permitted assignee) will have the option, but not the obligation, to convert up to $1,500,000 of the unpaid
principal balance of the Extension Note into that number of Extension Warrants, each whole warrant exercisable for one share of ERES Class A Common Stock equal to the principal amount of the Extension Note so converted divided by $1.50. The
terms of the Extension Warrants will be identical to the terms of the Private Placement Warrants. The Sponsor will have the sole discretion whether to continue extending for additional months, and if the Sponsor determines not to continue extending
for additional months, its obligation to make additional Contributions will terminate. If this occurs, ERES would wind up ERESs affairs and redeem 100% of the outstanding Public Shares in accordance with the procedures set forth in the
Existing Charter. The maturity date of the Extension Note may be accelerated upon the occurrence of an Event of Default (as defined therein). Any outstanding principal under the Extension Note may be prepaid at any time by ERES, at its election and
without penalty, provided, however, that the Sponsor shall have a right to first convert such principal balance as described in Section 17 of the Extension Note upon notice of such prepayment. If the Business Combination is not completed and
ERES winds up, there will not be sufficient assets to repay the Extension Note and it will be worthless. As of December 31, 2022, there was a balance of $1,924,356 under this loan. |
|
|
|
On January 23, 2023, ERES entered into the Second Extension Note with the Sponsor. Pursuant to the Second
Extension Note, the Sponsor agreed to contribute to ERES as a loan $0.033 for each Public Share that was not redeemed in connection with the stockholder vote to approve the extension of the date by which ERES must complete an initial business
combination, for each month until the earlier of (i) the date of consummation of ERESs initial business combination and (ii) the date of liquidation of ERES. The Second Extension Note does not bear interest and is repayable in full upon the
earlier of (i) the date of the consummation of ERESs initial business combination and (ii) the date of ERESs liquidation. At any time prior to payment in full of the principal balance of the Second Extension Note, the holder of the
Second Extension Note (or a permitted assignee) will have the option, but not the obligation, to convert up to $500,000 of the unpaid principal balance of the Second Extension Note into that number of Second Extension Warrants, each whole warrant
exercisable for one share of ERES Class A Common Stock equal to the principal amount of the Second Extension Note so converted divided by $1.50. The terms of the Second Extension Warrants will be identical to the terms of the Private Placement
Warrants. The Sponsor will have the sole discretion whether to continue extending for additional months, and if the Sponsor determines not to continue extending for additional months, its obligation to make additional Contributions will terminate.
If this occurs, ERES would wind up ERESs affairs and redeem 100% of the outstanding Public Shares in accordance with the procedures set forth in the Existing Charter. The maturity date of the Second Extension Note may be accelerated upon the
occurrence of an Event of Default (as defined therein). Any outstanding principal under the Second Extension Note may be prepaid at any time by ERES, at its election and without penalty, provided, however, that the Sponsor shall have a right to
first convert such principal balance as |
81
|
described in Section 17 of the Second Extension Note upon notice of such prepayment. If the Business Combination is not completed and ERES winds up, there will not be sufficient assets to repay
the Second Extension Note and it will be worthless. As of April 17, 2023, there was a balance of $282,748.65 under this loan. |
|
|
|
ERESs directors and officers, and their affiliates are entitled to reimbursement of out-of-pocket expenses incurred by them in connection with certain activities on ERESs behalf, such as identifying and investigating possible business targets and
business combinations. However, if ERES fails to consummate a business combination within the Completion Window, they will not have any claim against the Trust Account for reimbursement. Accordingly, ERES may not be able to reimburse these expenses
if the Business Combination or another business combination is not consummated within the Completion Window. As of December 31, 2022, $0 was outstanding in out-of-pocket expense reimbursements. Additionally, two affiliates of the Sponsor are each
entitled to $10,000 per month for office space, utilities, administrative and support services provided to ERESs management team, which commenced on July 24, 2020 and will continue through the earlier of consummation of the Business
Combination and ERESs liquidation. For the years ended December 31, 2022 and December 31, 2021, the ERES incurred and paid an aggregate of $240,000 and $240,000 in connection with these agreements, respectively.
|
|
|
|
The continued indemnification of current directors and officers and the continuation of directors and
officers liability insurance. |
|
|
|
In the event of the liquidation of the Trust Account, the Sponsor has agreed to indemnify and hold harmless ERES
against any and all losses, liabilities, claims, damages and expenses to which ERES may become subject as a result of any claim by (i) any third party for services rendered or products sold to ERES or (ii) a prospective target business
with which ERES has entered into an acquisition agreement, provided that such indemnification of ERES by the Sponsor shall apply only to the extent necessary to ensure that such claims by a third party for services rendered or products sold to ERES
or a target do not reduce the amount of funds in the Trust Account to below (i) $10.00 per share of ERES Class A Common Stock or (ii) such lesser amount per share of ERES Class A Common Stock held in the Trust Account due to
reductions in the value of the trust assets as of the date of the liquidation of the Trust Account, in each case, net of the amount of interest earned on the property in the Trust Account, which may be withdrawn to pay taxes and expenses related to
the administration of the Trust Account, except as to any claims by a third party (including a target) who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under ERESs indemnity of the
underwriters of the ERES IPO against certain liabilities, including liabilities under the Securities Act. If ERES consummates the Business Combination, on the other hand, ERES will be liable for all such claims. |
|
|
|
Pursuant to the Sponsor Support Agreement, the Sponsor has agreed, subject to certain exceptions, not to transfer
(i) 15% of the shares of the Post-Combination Companys common stock received by the Sponsor in connection with the Closing until the date that is 180 days after the Closing Date and (ii) the remaining 85% of the shares of the
Post-Combination Companys common stock received by the Sponsor in connection with the Closing until the date that is 24 months after the Closing Date. |
|
|
|
Subject to certain limited exceptions, the Private Placement Warrants will not be transferable until 30 days
following the completion of the Business Combination. |
|
|
|
There will be no finders fees, reimbursements or cash payments made by ERES to the Sponsor or ERESs
officers or directors, or ERESs or any of their affiliates, for services rendered to ERES prior to or in connection with the completion of the Business Combination, other than payment of the amount described above for office space, utilities,
administrative and support services described above and repayments of the loans under the Working Capital Note, the Extension Note and the Second Extension Note as described above. The Sponsor and ERESs officers and directors or any of their
respective affiliates will also be reimbursed for any out-of-pocket expenses incurred in connection with ERESs formation, the ERES IPO and activities on
ERESs behalf such as identifying potential target |
82
|
businesses and performing due diligence on suitable business combinations. There is no cap or ceiling on the reimbursement of
out-of-pocket expenses incurred by such persons in connection with activities on our behalf. |
|
|
|
Our Sponsor, officers and directors would hold the following number of shares of common stock in the Post-Combination Company, on a fully diluted basis, at the closing of the Business Combination: |
|
|
|
|
|
|
|
|
|
Name of Person/Entity |
|
Number of Shares of Common Stock(1) |
|
|
Value of Shares(2) |
|
East Sponsor, LLC |
|
|
17,068,333 |
|
|
$ |
170,683,333 |
|
Terrence M. Pegula |
|
|
17,068,333 |
|
|
$ |
170,683,333 |
|
Gary L. Hagerman, Jr. |
|
|
1,000 |
|
|
$ |
10,000 |
|
John P. Sieminski |
|
|
2,500 |
|
|
$ |
25,000 |
|
James S. Morrow |
|
|
0 |
|
|
$ |
0 |
|
William A. Fustos |
|
|
22,000 |
|
|
$ |
220,000 |
|
Thomas W. Corbett, Jr.. |
|
|
10,000 |
|
|
$ |
100,000 |
|
Benjamin Wingard(3) |
|
|
4,000 |
|
|
$ |
40,000 |
|
Jacob Long |
|
|
5,000 |
|
|
$ |
50,000 |
|
Adam Gusky |
|
|
2,452 |
|
|
$ |
24,520 |
|
(1) |
(a) Assumes that (i) Public Stockholders exercise the 17,250,000 public warrants, (ii) the Initial Stockholders
exercise the 7,120,000 Private Placement Warrants, (iii) the 1,780,000 warrants in the warrant pool are exercised, (iv) the Sponsor exercises its option to convert up to $1,500,000 of the unpaid principal balance on the Extension Note to 1,000,000
Extension Warrants and exercises such warrants, (v) the Sponsor exercises its option to convert up to $500,000 of the unpaid principal balance on the Second Extension Note to 333,333 Second Extension Warrants and exercise such warrants and (vi) all
shares underlying the Incentive Plan are issued. |
(b) Includes shares that may be issued but are not presently
outstanding and, as such, differs from the share counts shown or assumed in the sections entitled Summary Unaudited Pro Forma Condensed Combined Financial Information, Unaudited Historical Comparative and Pro Forma Combined Per
Share Data of ERES and the Companies, Unaudited Pro Forma Condensed Combined Financial Information and Comparative Historical and Unaudited Pro Forma Combined Per Share Financial Information, which sections are limited
to shares that are presently issued and outstanding.
(2) |
Assumes a value of $10.00 per share, the deemed value of the Class A Common Stock in the Business
Combination. |
(3) |
Benjamin Wingard was a named executive officer for the purposes of the Annual Report on Form 10-K
for fiscal year ended December 31, 2022, filed by ERES on April 18, 2023. Mr. Wingard resigned from ERES effective January 31, 2023. |
|
|
|
Certain of our officers and directors presently have, and any of them in the future may have additional,
fiduciary or contractual obligations to other entities pursuant to which such officer or director is or will be required to present business combination opportunities to such entity. Accordingly, in the future, if any of our officers or directors
becomes aware of a business combination opportunity which is suitable for an entity to which he or she has then-current fiduciary or contractual obligations, he or she will honor his or her fiduciary or contractual obligations to present such
opportunity to such entity. We do not believe, however, that any fiduciary duties or contractual obligations of our officers would materially undermine our ability to complete our business combination. The Existing Charter provides that we renounce
our interest in any corporate opportunity offered to any director or officer unless such opportunity is expressly offered to such person solely in his or her capacity as a director or officer of our company and such opportunity is one we are legally
and contractually permitted to undertake and would otherwise be reasonable for us to pursue, and to the extent such person is permitted to refer that opportunity to us without violating another legal obligation. This waiver allows our Sponsor and
its affiliates to allocate opportunities based on a combination of the objectives and fundraising needs of the target, as well as the investment objectives of the entity. However, we do not believe that the waiver of the corporate opportunities
doctrine otherwise had a material impact on our search for an acquisition target. |
83
|
|
|
Following the completion of the Business Combination, Adam Gusky and Thomas W. Corbett, Jr. will be members of
the board of directors of the Post-Combination Company. As such, in the future, Mr. Gusky and Mr. Corbett, Jr. will receive any cash fees, stock options or stock awards that the board of directors of the Post-Combination Company determines to pay to
its directors. |
|
|
|
Given the interests described above, our Sponsor and its affiliates may earn a positive rate of return on their
investment, even if the Post-Combination Company common stock trades below the price initially paid for the ERES units in the ERES IPO, and the Public Stockholders may experience a negative rate of return following the completion of the Business
Combination. Thus, our Sponsor and its affiliates may have more of an economic incentive for us to, rather than liquidate if we fail to complete our initial business combination by the Completion Window, enter into an initial business combination on
potentially less favorable terms with a potentially less favorable, riskier, weaker-performing or financially unstable business, or an entity lacking an established record of revenues or earnings, than would be the case if such parties had paid the
full offering price for their Founder Shares. |
|
|
|
Our Sponsor, directors and officers beneficially own Founder Shares and warrants that will be worthless and have
incurred reimbursable expenses that may not be reimbursed or repaid if the Business Combination is not approved. As of the date of this proxy statement, the Sponsor has invested an aggregate of approximately $14,132,105 (consisting of $25,000 for
the Founder Shares, $8,900,000 for the Private Placement Warrants, $3,000,000 for the aggregate principal amount of the Working Capital Note, $1,924,356 for the Extension Note and $282,749 for the Second Extension Note). Assuming a value of $10.00
per share, the deemed value of the Class A Common Stock in the Business Combination, the aggregate market value with respect to the common stock, fully diluted, based on Founder Shares and warrants in ERES held by our Sponsor, directors and
officers, would be approximately $170,783,330. Thus, the aggregate market value of our Sponsors Founder Shares and Private Placement Warrants, together with the aggregate outstanding principal amount of the foregoing loans and the foregoing
reimbursable expenses, would be approximately $184,915,435. |
The ERES Board was aware of and considered these interests
to the extent such interests existed at the time, among other matters, in approving the Merger Agreement and in recommending that the Business Combination be approved by the stockholders of ERES. See the section entitled The Business
CombinationInterests of ERESs Directors and Executive Officers and the Sponsor and its Affiliates in the Business Combination. On balance, the ERES Board concluded that the Merger Agreement and the Business Combination are fair
from a financial point of view to and in the best interests of ERES and its stockholders. In view of the wide variety of factors considered by the ERES Board in connection with its evaluation, negotiation and recommendation of the business
combination and related transactions and the complexity of these matters, the ERES Board did not consider it practical to, nor did it attempt to, quantify, rank or otherwise assign relative weights to the specific factors that it considered in
reaching its decision. Rather, the ERES Board based its evaluation, negotiation and recommendation of the business combination on the totality of the information presented to and considered by it. The ERES Board evaluated the reasons described above
with the assistance of ERES outside advisors. In considering the factors described above and any other factors, individual members of the ERES Board may have viewed factors differently or given different weights to other or different factors.
After careful consideration, the ERES Board unanimously (i) declared the advisability of the Business Combination and the other
transactions contemplated by the Merger Agreement and (ii) determined that the Business Combination and the other transactions contemplated by the Merger Agreement are in the best interests of the ERES stockholders.
Abstentions and Broker Non-Votes
Abstentions are considered present for the purposes of establishing a quorum and will have the same effect as a vote AGAINST
the Charter Approval Proposal. Broker non-votes are considered present for the purposes of establishing a quorum and will have the effect of a vote AGAINST the Charter Approval Proposal.
Abstentions and broker non-votes will have no effect on the Business Combination Proposal, the Governance Proposal, the Director Election Proposal, the Nasdaq Proposal, the Incentive Plan Proposal and the
Adjournment Proposal.
84
In general, if your shares are held in street name and you do not instruct your
broker, bank or other nominee on a timely basis on how to vote your shares, your broker, bank or other nominee, in its sole discretion, may either leave your shares unvoted or vote your shares on routine matters, but not on any non-routine matters. None of the Proposals at the Special Meeting are routine matters. As such, without your voting instructions, your brokerage firm cannot vote your shares on any Proposal to be voted on at the
Special Meeting.
Certain Engagements in Connection with the Business Combination and Related Transactions
Aviditi Financial, LLC (Aviditi) was engaged by ERES to act as exclusive strategic and financial advisor to ERES in
connection with the Business Combination and will receive compensation in connection therewith. Aviditi was also engaged to act as PIPE advisor. While ERES continues to opportunistically seek to raise a PIPE investment, at this time, it has no
committed PIPE Investment Amount. Wells Fargo Securities, LLC (Wells Fargo) was engaged by ERES to serve as the sole book-running manager for the ERES IPO and was entitled to receive deferred underwriting fees of $12.075 million.
However, Wells Fargo has agreed to waive its entitlement to any deferred underwriting fees. Northland was engaged by ERES to provide a fairness opinion in connection with the Merger and will receive fees and certain expense reimbursements in
connection therewith.
Aviditi (together with its affiliates) is a financial institution engaged in various activities, which may include
investment banking, advisory and other financial and non-financial activities and services. In addition, Aviditi and its respective affiliates may provide investment banking and other advisory services to ERES, the Companies and their respective
affiliates in the future, for which they would expect to receive customary compensation.
In addition, in the ordinary course of its
business activities, Aviditi and its respective affiliates, officers, directors and employees may make or hold a broad array of investments and actively trade debt and equity securities (or related derivative securities) and financial instruments
(including bank loans) for their own accounts. Such investments and securities activities may involve securities and/or instruments of ERES or the Companies, or their respective affiliates.
Wells Fargo (together with their respective affiliates) is a full service financial institution engaged in various activities, which may
include sales and trading, commercial and investment banking, advisory, investment management, investment research, principal investing, hedging, market making, brokerage and other financial and non-financial
activities and services. Wells Fargo (together with their respective affiliates) may provide investment banking and other commercial dealings to ERES, the Companies and their respective affiliates in the future, for which they would expect to
receive customary compensation.
In addition, in the ordinary course of its business activities, Wells Fargo and their respective
affiliates, officers, directors and employees may make or hold a broad array of investments and actively trade debt and equity securities (or related derivative securities) and financial instruments (including bank loans) for their own accounts and
for the accounts of their customers. Such investments and securities activities may involve securities and/or instruments of ERES or the Companies, or their respective affiliates. Wells Fargo and their respective affiliates may also make investment
recommendations and/or publish or express independent research views in respect of such securities or financial instruments and may hold, or recommend to clients that they acquire, long and/or short positions in such securities and instruments.
Voting Your SharesStockholders of Record
ERES stockholders may vote electronically at the Special Meeting by attending virtually or by proxy. ERES recommends that you submit your proxy
even if you plan to attend the Special Meeting. If you vote by proxy, you may change your vote by submitting a later dated proxy before the deadline or by voting electronically at the Special Meeting.
85
If your shares are owned directly in your name with our transfer agent, Continental, you are
considered, with respect to those shares, the stockholder of record. If your shares are held in a stock brokerage account or by a bank or other nominee or intermediary, you are considered the beneficial owner of shares held in
street name and are considered a non-record (beneficial) stockholder.
If
you are an ERES stockholder of record, you may use the enclosed proxy card to tell the persons named as proxies how to vote your shares. If you properly complete, sign and date your proxy card, your shares will be voted in accordance with your
instructions. The named proxies will vote all shares at the Special Meeting for which proxies have been properly submitted and not revoked. If you sign and return your proxy card but do not mark your card to tell the proxies how to vote, your shares
will be voted for each of the Proposals presented at the Special Meeting.
Your shares will be counted for purposes of determining a
quorum if you vote:
|
|
|
by submitting a properly executed proxy card or voting instruction form by mail; or |
|
|
|
electronically at the Special Meeting. |
Abstentions will be counted for determining whether a quorum is present for the Special Meeting.
Voting instructions are printed on the proxy card or voting information form you received. Either method of submitting a proxy will enable
your shares to be represented and voted at the Special Meeting.
Voting Your SharesBeneficial Owners
If your shares are held in an account at a brokerage firm, bank or other nominee, then you are the beneficial owner of shares held in
street name and this proxy statement is being sent to you by that broker, bank or other nominee. The broker, bank or other nominee holding your account is considered to be the stockholder of record for purposes of voting at the Special
Meeting. As a beneficial owner, you have the right to direct your broker, bank or other nominee regarding how to vote the shares in your account by following the instructions that the broker, bank or other nominee provides you along with this proxy
statement. Your broker, bank or other nominee may have an earlier deadline by which you must provide instructions to it as to how to vote your shares. As a beneficial owner, if you wish to vote at the Special Meeting, you will need to bring to the
Special Meeting a legal proxy from your broker, bank or other nominee authorizing you to vote those shares. That is the only way we can be sure that the broker, bank or nominee has not already voted your shares of ERES Common Stock.
Revoking Your Proxy
If you are a
stockholder and you give a proxy, you may revoke it at any time before it is exercised by doing any one of the following:
|
|
|
you may send another proxy card with a later date; |
|
|
|
you may notify ERESs Secretary in writing before the Special Meeting that you have revoked your proxy; or
|
|
|
|
you may attend the Special Meeting and vote electronically by visiting and entering the control number found on
your proxy card, instruction form or notice you previously received. Attendance at the Special Meeting will not, in and of itself, revoke a proxy. |
If your shares are held in street name or are in a margin or similar account, you should contact your broker for information on
how to change or revoke your voting instructions.
86
No Additional Matters
The Special Meeting has been called only to consider the approval of the Business Combination Proposal, the Charter Approval Proposal, the
Governance Proposal, the Director Election Proposal, the Nasdaq Proposal, the Incentive Plan Proposal and the Adjournment Proposal. Under ERESs bylaws, other than procedural matters incident to the conduct of the Special Meeting, no other
matters may be considered at the Special Meeting if they are not included in this proxy statement, which serves as the notice of the Special Meeting.
Who Can Answer Your Questions About Voting Your Shares
If you are a stockholder and have any questions about how to vote or direct a vote in respect of your shares of ERES Common Stock, you may call
Morrow Sodali LLC, ERESs proxy solicitor, at (800) 662-5200.
Redemption Rights
Holders of Public Shares may seek to redeem their shares for cash, regardless of whether they vote for or against, or abstain from voting on,
the Business Combination Proposal. Any stockholder holding Public Shares may demand that ERES redeem such shares for a pro rata portion of the Trust Account (which was approximately $[●] per Public Share as of [●], 2023, the ERES Record
Date), calculated as of two business days prior to the anticipated consummation of the Business Combination. If a holder properly seeks redemption as described in this section and the Business Combination with the Companies is consummated, ERES
will redeem these shares for a pro rata portion of funds deposited in the Trust Account and the holder will no longer own those shares following the Business Combination.
Notwithstanding the foregoing, a holder of Public Shares, together with any affiliate of his or any other person with whom he is acting in
concert or as a group (as defined in Section 13(d)(3) of the Exchange Act), will be restricted from seeking redemption rights with respect to more than 20% of the Public Shares without the consent of ERES. Accordingly, all Public
Shares in excess of 20% held by a Public Stockholder, together with any affiliate of such holder or any other person with whom such holder is acting in concert or as a group, will not be redeemed for cash without the consent of ERES.
The Sponsor and ERESs directors and officers will not have redemption rights with respect to any shares of ERES Common Stock owned
by them, directly or indirectly in connection with the Business Combination.
Public Stockholders may seek to redeem their Public Shares
for cash, regardless of whether they vote for or against, or abstain from voting on, the Business Combination Proposal. Holders may demand redemption by delivering their Public Shares, either physically or electronically using the Depository Trust
Companys DWAC System, to ERESs transfer agent no later than the second business day preceding the vote on the Business Combination Proposal. If you hold the shares in street name, you will have to coordinate with your broker to have your
shares certificated or delivered electronically. Certificates that have not been tendered (either physically or electronically) in accordance with these procedures will not be redeemed for cash. There is a nominal cost associated with this tendering
process and the act of certificating the shares or delivering them through the DWAC system. The transfer agent will typically charge the tendering broker $80.00 and it would be up to the broker whether or not to pass this cost on to the redeeming
stockholder. In the event the proposed Business Combination is not consummated this may result in an additional cost to Public Stockholders for the return of their Public Shares.
Any request to redeem such Public Shares, once made, may be withdrawn at any time up to the vote on the Business Combination Proposal.
Furthermore, if a holder of a Public Share delivered its certificate in connection with an election of its redemption and subsequently decides prior to the applicable date not to elect to exercise such rights, it may simply request that the transfer
agent return the certificate (physically or electronically).
87
If the Business Combination is not approved or completed for any reason, then ERESs
Public Stockholders who elected to exercise their redemption rights will not be entitled to redeem their Public Shares for a pro rata portion of the Trust Account, as applicable. In such case, ERES will promptly return any Public Shares delivered by
Public Stockholders.
The closing price of ERES Class A Common Stock on [●], 2023, the ERES Record Date, was $[●].
The cash held in the Trust Account on such date was approximately $[●] million (approximately $[●] per Public Share). Prior to exercising redemption rights, stockholders should verify the market price of ERES Class A Common Stock as they
may receive higher proceeds from the sale of their ERES Class A Common Stock in the public market than from exercising their redemption rights if the market price per share is higher than the redemption price. ERES cannot assure its stockholders
that they will be able to sell their shares of ERES Class A Common Stock in the open market, even if the market price per share is higher than the redemption price stated above, as there may not be sufficient liquidity in its securities when its
stockholders wish to sell their shares.
If a holder of Public Shares exercises its redemption rights, then it will be exchanging its
shares of ERES Class A Common Stock for cash and will no longer own those Public Shares. You will be entitled to receive cash for these Public Shares only if you properly demand redemption no later than the second business day preceding the vote on
the Business Combination Proposal by delivering your stock certificate (either physically or electronically) to ERESs transfer agent prior to the vote at the Special Meeting, and the Business Combination is consummated.
Appraisal Rights
Stockholders,
unitholders and warrant holders of ERES do not have appraisal rights in connection the Business Combination under the DGCL.
Proxy Solicitation Costs
ERES is soliciting proxies on behalf of the ERES Board. This solicitation is being made by mail but also may be made by telephone or
in person. ERES and its directors, officers and employees may also solicit proxies in person, by telephone or by other electronic means. ERES will bear the cost of the solicitation.
ERES has hired Morrow Sodali LLC to assist in the proxy solicitation process. ERES will pay that firm a fee of $25,000 plus disbursements.
Such payment will be made from non-Trust Account funds.
ERES will ask banks, brokers and other
institutions, nominees and fiduciaries to forward the proxy materials to their principals and to obtain their authority to execute proxies and voting instructions. ERES will reimburse them for their reasonable expenses.
The Initial Stockholders
As of
[●], 2023, the ERES Record Date, the Initial Stockholders of record were entitled to vote an aggregate of 8,625,000 Founder Shares that were issued prior to the ERES IPO. Such shares currently constitute approximately 75% of the outstanding
shares of ERES Common Stock. The Initial Stockholders have agreed to vote the Founder Shares, as well as any shares of ERES Class A Common Stock acquired in the aftermarket, in favor of each of the Proposals presented at the Special Meeting. The
Founder Shares have no right to participate in any redemption distribution and will be worthless if no business combination is effected by ERES.
Upon consummation of the Business Combination, under the Sponsor Support Agreement, certain Founder Shares (or shares of common stock issuable
upon conversion thereof) will be subject to (i) certain lock-up restrictions and (ii) certain time-based vesting provisions. See the section entitled
Other AgreementsSponsor Support Agreement for more information.
88
Purchases of ERES Shares
At any time prior to the Special Meeting, during a period when they are not then aware of any material nonpublic information regarding ERES or
its securities, the Sponsor, the Companies, the Company Members and/or their respective affiliates may purchase shares from institutional and other investors who vote, or indicate an intention to vote, against the Business Combination Proposal, or
execute agreements to purchase shares from such investors in the future, or they may enter into transactions with such investors and others to provide them with incentives to acquire shares of ERES Class A Common Stock or vote their shares in favor
of the Business Combination Proposal. The purpose of such share purchases and other transactions would be to increase the likelihood of satisfaction of the requirements to consummate the Business Combination where it appears that such requirements
would otherwise not be met. While the exact nature of any such incentives has not been determined as of the date of this proxy statement, they might include, without limitation, arrangements to protect such investors or holders against potential
loss in value of their shares, including the granting of put options and, with the Companies consent, the transfer to such investors or holders of shares or warrants owned by the Sponsor for nominal value.
Entering into any such arrangements may have a depressive effect on ERES Class A Common Stock. For example, as a result of these arrangements,
an investor or holder may have the ability to effectively purchase shares at a price lower than market and may therefore be more likely to sell the shares he owns, either prior to or immediately after the Special Meeting.
If such transactions are effected, the consequence could be to cause the Business Combination to be approved in circumstances where such
approval could not otherwise be obtained. Purchases of shares by the persons described above would allow them to exert more influence over the approval of the Business Combination Proposal and other Proposals and would likely increase the chances
that such Proposals would be approved.
No agreements dealing with the above arrangements or purchases have been entered into as of the
date of this proxy statement by the Sponsor, the Companies, the Company Members or any of their respective affiliates. ERES will file a Current Report on Form 8-K to disclose arrangements entered into or
significant purchases made by any of the aforementioned persons that would affect the vote on the Business Combination Proposal or the satisfaction of any closing conditions. Any such report will include descriptions of any arrangements entered into
or significant purchases by any of the aforementioned persons.
89
PROPOSAL NO. 1THE BUSINESS COMBINATION PROPOSAL
Overview
Holders of ERES Common
Stock are being asked to approve the Merger Agreement and the transactions contemplated thereby, including the Business Combination. ERES stockholders should carefully read this proxy statement in its entirety for more detailed information
concerning the Merger Agreement, a copy of which is attached as Annex A-1 to this proxy statement, the Amendment, a copy of which is attached as Annex A-2
to this proxy statement, and the Second Amendment, a copy of which is attached as Annex A-3 to this proxy statement. Please see the sections entitled The Business Combination and The Merger Agreement
in this proxy statement for additional information regarding the Business Combination and a summary of certain terms of the Merger Agreement. You are urged to carefully read the Merger Agreement in its entirety before voting on this Proposal.
Vote Required for Approval
This
Business Combination Proposal (and consequently, the Merger Agreement and the transactions contemplated thereby, including the Business Combination) will be adopted and approved only if at least a majority of the votes cast by the stockholders
present in person (which would include presence at a virtual meeting) or represented by proxy at the Special Meeting and entitled to vote thereon are FOR the Business Combination Proposal.
Failure to vote by proxy or to vote in person (which would include presence at a virtual meeting) at the Special Meeting, abstentions and
broker non-votes will have no effect on the Business Combination Proposal.
The Business
Combination is conditioned upon the approval of the Business Combination Proposal, subject to the terms of the Merger Agreement. If the Business Combination Proposal is not approved, the other Proposals (except the Adjournment Proposal, as described
below) will not be presented to the stockholders for a vote.
The Sponsor has agreed to vote any shares of ERES Common Stock owned by the
Sponsor in favor of the Business Combination Proposal. See the section entitled Other AgreementsSponsor Support Agreement for more information.
Recommendation of the Board of Directors
THE ERES
BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT THE ERES STOCKHOLDERS VOTE FOR THE APPROVAL OF THE BUSINESS COMBINATION PROPOSAL.
90
PROPOSAL NO. 2THE CHARTER APPROVAL PROPOSAL
Overview
Our stockholders are being
asked to adopt the Proposed Charter in the form attached hereto as Annex B, which, in the judgment of the ERES Board, is necessary to adequately address the needs of the Post-Combination Company.
The following is a summary of the key changes effected by the Proposed Charter, but this summary is qualified in its entirety by reference to
the full text of the Proposed Charter, a copy of which is included as Annex B:
|
|
|
Changes to Authorized Capital Stockthe Existing Charter authorized the issuance of
221,000,000 total shares, consisting of (a) 220,000,000 shares of common stock, of which (i) 200,000,000 shares were Class A Common Stock and (ii) 20,000,000 shares were Class B Common Stock, and (b) 1,000,000 shares of preferred
stock. The Proposed Charter authorizes the issuance of 201,000,000 total shares, consisting of (a) 200,000,000 shares of common stock and (b) 1,000,000 shares of preferred stock, and eliminates the Class B Common Stock and any rights of holders
thereof; and |
|
|
|
Removal of Blank Check Company Provisionseliminates various provisions applicable only
to blank check companies, including business combination requirements. |
Reasons for the Amendments
Each of these amendments was negotiated as part of the Business Combination. The ERES Boards reasons for proposing each of these
amendments to the Existing Charter is set forth below.
Changes to Authorized Capital Stock
Our Existing Charter authorizes 221,000,000 shares, consisting of (a) 220,000,000 shares of common stock, including (i) 200,000,000 shares of
Class A Common Stock and (ii) 20,000,000 shares of Class B Common Stock, and (b) 1,000,000 shares of preferred stock. The Proposed Charter provides that ERES will be authorized to issue 201,000,000 shares, consisting of (a) 200,000,000
shares of common stock and (b) 1,000,000 shares of preferred stock. Upon the conversion of the ERES Class B Common Stock to ERES Class A Common Stock and the elimination of the blank check provisions in our Existing Charter, the ERES Board
determined that there was no longer a need to continue with two series of common stock and, therefore, this amendment eliminates the ERES Class B Common Stock.
Removal of Blank Check Company Provisions
Our Existing Charter contains various provisions applicable only to blank check companies. This amendment eliminates certain provisions related
to our status as a blank check company, which is desirable because these provisions will serve no purpose following the Business Combination. For example, these proposed amendments remove the requirement to dissolve the Post-Combination Company and allow it to continue as a corporate entity with perpetual existence following consummation of the Business Combination. Perpetual existence is the usual period of existence for
corporations and we believe it is the most appropriate period for the Post-Combination Company following the Business Combination. In connection with the Business Combination, all shares of Class B Common
Stock will automatically be converted into shares of Class A Common Stock, pursuant to the terms of the Proposed Charter. Upon the conversion of the Class B Common Stock to Class A Common Stock, the ERES Board determined that there
will no longer be a need to continue with two series of common stock and, therefore, this amendment eliminates the Class B Common Stock. In addition, certain other provisions in our Existing Charter require that proceeds from the ERES IPO be
held in the Trust Account until a business combination or liquidation of merger has occurred. These provisions cease to apply once the Business Combination is consummated.
91
Vote Required for Approval
If the Business Combination Proposal is not approved, the Charter Approval Proposal will not be presented at the Special Meeting. The Charter
Approval Proposal will be approved and adopted only if: (i) the holders of a majority of the ERES Class B Common Stock then outstanding and entitled to vote, voting separately as a single class, (ii) the holders of a majority of the ERES
Class A Common Stock outstanding and entitled to vote, voting separately as a single class, and (iii) the holders of a majority of the ERES Common Stock then outstanding and entitled to vote, voting together as a single class, vote
FOR the Charter Approval Proposal.
Failure to vote by proxy or to vote in person (which would include presence at
a virtual meeting) at the Special Meeting, abstentions and broker non-votes will have the same effect as a vote AGAINST the Charter Approval Proposal.
The Business Combination is conditioned upon the approval of the Charter Approval Proposal, subject to the terms of the Merger Agreement.
Notwithstanding the approval of the Charter Approval Proposal, if the Business Combination is not consummated for any reason, the actions contemplated by the Charter Approval Proposal will not be effected. The ERES Board shall abandon the Charter
Approval Proposal in the event the Business Combination is not consummated.
A copy of the Proposed Charter, as will be in effect assuming
approval of the Charter Approval Proposal and upon consummation of the Business Combination and filing with the Secretary of State of the State of Delaware, is attached to this proxy statement as Annex B.
The Sponsor agreed to vote the Founder Shares and any Public Shares owned by the Sponsor in favor of the Charter Approval Proposal. See the
section entitled Other AgreementsSponsor Support Agreement for more information.
Recommendation of the Board of
Directors
THE ERES BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT THE ERES STOCKHOLDERS VOTE FOR THE APPROVAL OF THE CHARTER APPROVAL
PROPOSAL.
92
PROPOSAL NO. 3THE GOVERNANCE PROPOSAL
Overview
Our stockholders are also being
asked to vote on a separate proposal with respect to certain governance provisions in the Proposed Charter, which are separately being presented in accordance with SEC guidance and which will be voted upon on a
non-binding advisory basis. In the judgment of the ERES Board, these provisions are necessary to adequately address the needs of the Post-Combination Company.
Accordingly, regardless of the outcome of the non-binding advisory vote on these proposals, the Companies and ERES intend that the Proposed Charter in the form set forth on Annex B will take effect at
consummation of the Business Combination, assuming adoption of the Charter Approval Proposal.
Proposal 3A: Changes to Authorized Capital Stock
See the section entitled Proposal No. 2The Charter Approval ProposalReasons for the
AmendmentsChanges to Authorized Capital Stock for a description and reasons for the amendment.
Proposal 3B: Removal of Blank Check
Company Provisions
See the section entitled Proposal No. 2The Charter Approval
ProposalReasons for the AmendmentsRemoval of Blank Check Company Provisions for a description and reasons for the amendment.
Vote Required for Approval
If the
Business Combination Proposal is not approved, the Governance Proposal will not be presented at the Special Meeting. The approval of the Governance Proposal requires the affirmative vote of the majority of the votes cast by the stockholders present
in person (which would include presence at a virtual meeting) or represented by proxy at the Special Meeting and entitled to vote thereon.
Failure to vote by proxy or to vote in person (which would include presence at a virtual meeting) at the Special Meeting, abstentions and
broker non-votes will have no effect on the Governance Proposal.
The Business Combination is not
conditioned upon the approval of the Governance Proposal.
As discussed above, a vote to approve the Governance Proposal is an advisory
vote, and therefore, is not binding on ERES, the Companies or their respective boards of directors or equivalent governing bodies. Accordingly, regardless of the outcome of the non-binding advisory vote, ERES
and the Companies intend that the Proposed Charter, in the form set forth on Annex B and containing the provisions noted above, will take effect at consummation of the Business Combination, assuming adoption of the Charter Approval Proposal.
The Sponsor has agreed to vote any shares of ERES Common Stock owned by the Sponsor in favor of the Governance Proposal. See the
section entitled Other AgreementsSponsor Support Agreement for more information.
Recommendation of the Board of
Directors
THE ERES BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT THE ERES STOCKHOLDERS VOTE FOR THE APPROVAL OF THE GOVERNANCE
PROPOSAL.
93
PROPOSAL NO. 4THE DIRECTOR ELECTION PROPOSAL
Overview
Assuming the Business
Combination Proposal, the Charter Approval Proposal, the Nasdaq Proposal and the Incentive Plan Proposal are approved at the Special Meeting, Class B Common Stock holders are being asked to elect seven directors to the Board, effective upon the
closing of the Business Combination, with each Class I director having a term that expires at the Post-Combination Companys annual meeting of stockholders in 2023, each Class II director having
a term that expires at the Post-Combination Companys annual meeting of stockholders in 2024 and each Class III director having a term that expires at the
Post-Combination Companys annual meeting of stockholders in 2025, or, in each case, until their respective successors are duly elected and qualified, or until their earlier resignation, removal or death.
The election of these directors is contingent upon approval of the Business Combination Proposal, the Charter Approval Proposal, the Nasdaq Proposal and the Incentive Plan Proposal.
The ERES Board has nominated Adam Gusky and Sean McNealy to serve as the Class I directors, Cornelius Michiel van Katwijk, Mary Beth
Schulte and Karla Radka to serve as the Class II directors and Thomas W. Corbett, Jr. and Jay Jackson to serve as the Class III directors.
Vote Required for Approval
If a quorum
is present, directors are elected by a plurality of the votes cast by holders of the Class B Common Stock present in person (which would include presence at a virtual meeting) or represented by proxy at the Special Meeting and entitled to vote
thereon. This means that the seven director nominees who receive the most affirmative votes will be elected. Votes marked FOR a nominee will be counted in favor of that nominee. Proxies will have full discretion to cast votes for
other persons in the event any nominee is unable to serve.
Failure to vote by proxy or to vote in person (which would include presence at
a virtual meeting) at the Special Meeting, abstentions and broker non-votes will have no effect on the Director Election Proposal.
The Business Combination is not conditioned upon the approval of the Director Election Proposal. Notwithstanding the approval of each of the
seven director nominees to the Board in the Director Election Proposal, if the Business Combination is not consummated for any reason, the actions contemplated by the Director Election Proposal will not be effected.
The Sponsor has agreed to vote any shares of ERES Common Stock owned by the Sponsor in favor of the Director Election Proposal. See the
section entitled Other AgreementsSponsor Support Agreement for more information.
Recommendation of the Board of
Directors
THE ERES BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT THE HOLDERS OF CLASS B COMMON STOCK VOTE FOR THE ELECTION OF EACH
OF THE DIRECTOR NOMINEES TO THE BOARD IN THE DIRECTOR ELECTION PROPOSAL.
94
PROPOSAL NO. 5THE NASDAQ PROPOSAL
Overview
Immediately prior to and in
connection with the Business Combination, we intend to effect (subject to customary terms and conditions, including the closing of the Business Combination) the issuance and/or sale of up to 53.2 million shares of ERES Class A Common
Stock to the Company Members pursuant to the Merger Agreement.
For more information, see the full text of the Merger Agreement, the
Amendment and the Second Amendment, copies of which are attached to this proxy statement as Annex A-1, Annex A-2 and Annex A-3, respectively.
The discussion herein is qualified in its entirety by reference to such documents.
Why ERES Needs Stockholder Approval for Purposes of Nasdaq
Listing Rule 5635
We are seeking stockholder approval in order to comply with Nasdaq Listing Rule 5635(a), (b) and (d).
Under Nasdaq Listing Rule 5635(a), stockholder approval is required prior to the issuance of securities in connection with the acquisition of
another company if such securities are not issued in a public offering and: (i) have, or will have upon issuance, voting power equal to or in excess of 20% of the voting power outstanding before the issuance of such securities (or securities
convertible into or exercisable for common stock); or (ii) the number of shares of common stock to be issued is or will be equal to or in excess of 20% of the number of shares of common stock outstanding before the issuance of the stock or
securities.
Under Nasdaq Listing Rule 5635(b), stockholder approval is required prior to the issuance of securities when the issuance or
potential issuance will result in a change of control of the registrant. Although Nasdaq has not adopted any rule on what constitutes a change of control for purposes of Rule 5635(b), Nasdaq has previously indicated that the
acquisition of, or right to acquire, by a single investor or affiliated investor group, as little as 20% of the common stock (or securities convertible into or exercisable for common stock) or voting power of an issuer could constitute a change of
control.
Under Nasdaq Listing Rule 5635(d), stockholder approval is required for a transaction other than a public offering involving the
sale, issuance or potential issuance by an issuer of common stock (or securities convertible into or exercisable for common stock) at a price that is less than the greater of book or market value of the stock if the number of shares of common stock
to be issued is or may be equal to 20% or more of the common stock, or 20% or more of the voting power, outstanding before the issuance.
As described above, ERES will issue shares of Class A Common Stock to the Company Members as set forth in the Merger Agreement.
Stockholder approval of the Nasdaq Proposal is also a condition to the closing under the Merger Agreement.
Vote Required for Approval
If the
Business Combination Proposal is not approved, the Nasdaq Proposal will not be presented at the Special Meeting. The approval of the Nasdaq Proposal requires the affirmative vote of a majority of the votes cast by the stockholders present in person
(which would include presence at a virtual meeting) or represented by proxy at the Special Meeting and entitled to vote thereon.
Failure
to vote by proxy or to vote in person (which would include presence at a virtual meeting) at the Special Meeting, abstentions and broker non-votes will have no effect on the Nasdaq Proposal.
The Business Combination is conditioned upon the approval of the Nasdaq Proposal, subject to the terms of the Merger Agreement.
Notwithstanding the approval of the Nasdaq Proposal, if the Business Combination is not consummated for any reason, the actions contemplated by the Nasdaq Proposal will not be effected.
95
The Sponsor has agreed to vote any shares of ERES Common Stock owned by the Sponsor in favor
of the Nasdaq Proposal. See the section entitled Other AgreementsSponsor Support Agreement for more information.
Recommendation of the Board of Directors
THE ERES
BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT THE ERES STOCKHOLDERS VOTE FOR THE APPROVAL OF THE NASDAQ PROPOSAL.
96
PROPOSAL NO. 6THE INCENTIVE PLAN PROPOSAL
Overview
At the Special Meeting,
ERESs stockholders will be asked to approve the adoption of the Abacus Life, Inc. 2023 Long-Term Equity Compensation Incentive Plan (the Incentive Plan). The ERES Board will approve the Incentive Plan prior to the Special Meeting,
subject to stockholder approval at the Special Meeting. The Incentive Plan will become effective, if at all, upon the receipt of stockholder approval. If the Incentive Plan is not approved by the ERESs stockholders, or if the Merger Agreement
is terminated prior to the consummation of the Business Combination, the Incentive Plan will not become effective. No awards may be granted under the Incentive Plan as of 10 years after its effective date, and the Incentive Plan will terminate
thereafter once all awards have been satisfied, exercised, entirely forfeited or expire. The Board in its discretion may terminate the Incentive Plan at any time with respect to any shares of Abacus Lifes common stock for which awards have not
theretofore been granted.
The Incentive Plan is described in more detail below. A copy of the Incentive Plan is attached as Annex
G to this proxy statement.
The Incentive Plan
The purpose of the Incentive Plan is to provide a means through which Abacus Life and its affiliates may attract, retain and motivate persons
who make (or are expected to make) important contributions by providing these individuals with equity ownership opportunities and/or equity-linked compensatory opportunities. Equity awards and equity-linked compensatory opportunities are intended to
motivate high levels of performance and align the interests of directors, employees and consultants with those of stockholders by giving directors, employees and consultants the perspective of an owner with an equity or equity-linked stake in Abacus
Life and provide a means of recognizing their contributions to our success. The ERES Board believes that equity awards are necessary for Abacus Life to remain competitive in its industry and are essential to recruiting and retaining highly qualified
employees.
Summary of the Incentive Plan
This section summarizes certain principal features of the Incentive Plan. The summary is qualified in its entirety by reference to the complete
text of the Incentive Plan, a copy of which is attached as Annex G to this proxy statement. We urge our stockholders to carefully read the entire Incentive Plan before voting on this proposal.
Eligibility and Administration
Our
employees, consultants and directors may be eligible to receive awards under the Incentive Plan. Immediately following the consummation of the Business Combination, Abacus Life is expected to have 80 employees, four (4) non-employee directors
and no other individual service providers who may be eligible to receive awards under the Incentive Plan.
The Incentive Plan
provides that it will be administered by a committee of, and appointed by, the board of directors of Abacus Life that shall be composed of two or more independent directors, and which shall be subject to the limitations imposed under the Incentive
Plan, Section 16 of the Exchange Act, stock exchange rules and other applicable laws. Following the closing of the Business Combination, we expect the compensation committee of the board of directors will be appointed to administer the Incentive
Plan.
The committee will have the authority to take all actions and make all determinations under the Incentive Plan, to construe the
Incentive Plan and award agreements and to prescribe rules and regulations relating to the administration of the Incentive Plan as it deems necessary or advisable. The committee will also have the
97
authority to determine which eligible directors, employees and consultants receive awards, grant awards and set the terms and conditions of all awards under the Incentive Plan, including any
vesting and vesting acceleration provisions, subject to the conditions and limitations in the Incentive Plan.
Shares Available for Awards
The aggregate number of shares that may be issued under the Plan shall be equal to 5% of the issued and outstanding common stock of the
Post-Combination Company. The aggregate number of shares with respect to which incentive stock options may be granted under the Incentive Plan shall be equal to 5% of the issued and outstanding common stock of the Post-Combination Company. The
aggregate fair market value on the date of grant of an award made to a non-employee director during a calendar year shall be determined by the committee and shall not exceed $75,000 per calendar year.
If an award under the Incentive Plan is forfeited, expires unexercised or is settled for cash, any shares subject to such award may, to the
extent of such forfeiture, expiration or cash settlement, immediately be used again for new grants under the Incentive Plan. Any shares that are the subject of awards under the Incentive Plan which are exchanged for awards that do not involve shares
shall also again immediately become available to be issued pursuant to awards granted under the Incentive Plan. If shares are withheld to satisfy tax obligations with respect to an option or a stock appreciation right, such shares shall not again be
available for issuance under the Incentive Plan. If shares are tendered in payment of an option price of an option or the exercise price of a stock appreciation right, such shares shall not be available for issuance under the Incentive Plan.
Awards granted under the Incentive Plan upon the assumption of, or in substitution for, awards authorized or outstanding under a
qualifying equity plan maintained by an entity with which we enter into a merger or similar corporate transaction will not reduce the shares available for grant under the Incentive Plan, nor shall such shares subject to substitute awards again be
available for grant under the Incentive Plan to the extent of any forfeiture, expiration, or cash settlement under an award.
Awards
The Incentive Plan provides for the grant of stock options, stock appreciation rights (SARs), restricted stock awards, performance
awards, phantom stock awards, restricted stock unit awards (RSUs) and stock awards. Certain awards under the Incentive Plan may constitute or provide for payment of nonqualified deferred compensation under Section 409A of the
Code, which may impose additional requirements on the terms and conditions of such awards. All awards under the Incentive Plan will be evidenced by award agreements, which will detail the terms and conditions of awards, including any applicable
vesting and payment terms and post-termination exercise limitations. Awards other than cash awards generally will be settled in shares of Abacus Life common stock, but the applicable award agreement may provide for cash settlement of any award. A
brief description of each award type follows.
|
|
|
Stock Options and SARs. Stock options provide for the purchase of shares of Abacus Lifes common
stock in the future at an exercise price set on the grant date. Incentive stock options, in contrast to non-qualified stock options, may provide tax deferral beyond exercise and favorable capital gains tax treatment to their holders if certain
holding period and other requirements of the Code are satisfied. SARs entitle their holder, upon exercise, to receive from us an amount equal to the appreciation of the shares subject to the award between the grant date and the exercise date. Unless
otherwise determined by the committee, the exercise price of a stock option or SAR may not be less than 100% of the fair market value of the underlying share on the grant date (or 110% in the case of incentive stock options granted to certain
significant stockholders), except with respect to certain substitute awards granted in |
|
connection with a corporate transaction. Unless otherwise determined by the committee, the term of a stock option or SAR may not be longer than ten years (or five years in the case of incentive stock options granted to certain
significant stockholders). |
98
|
|
|
Restricted Stock. Restricted stock is an award of non-transferable shares of Abacus Lifes common
stock that are subject to certain vesting conditions and other restrictions. |
|
|
|
Performance Awards. A Performance Award under the Incentive Plan is an award of rights subject to vesting
and transferability restrictions generally based upon the attainment of performance goals as the committee may determine, payment of which may be made in cash or shares of Abacus Lifes common stock, as specified in the holders
Performance Award agreement. The Incentive Plan provides that a performance goal may be based on one or more business criteria that apply to the holder, one or more of our business units, or us as a whole. |
|
|
|
Phantom Stock. Phantom Stock Awards under the Incentive Plan are awards of rights to receive the
value of shares of Abacus Lifes common stock that are subject to certain vesting conditions. Following the end of the vesting period for a Phantom Stock Award (or at such other time as may be provided in a Phantom Stock Award agreement), the
holder of a Phantom Stock Award will be entitled to receive payment of cash, Abacus Lifes common stock, or a combination thereof as determined by the committee, in an amount not exceeding the maximum value of the Phantom Stock Award, based on
the then vested value of the award. |
|
|
|
Restricted Stock Units. RSUs are contractual promises to deliver shares of Abacus Lifes common stock
in the future or an equivalent in cash and other consideration determined by the committee, which may also remain forfeitable unless and until specified conditions are met and may be accompanied by the right to receive the equivalent value of
dividends paid on shares of Abacus Lifes common stock prior to the delivery of the underlying shares (i.e., dividend equivalent rights). The terms and conditions applicable to RSUs will be determined by the committee, subject to the conditions
and limitations contained in the Incentive Plan. |
|
|
|
Stock Awards. Stock awards are awards of fully vested shares of Abacus Lifes common stock.
|
|
|
|
Dividend Equivalents. Dividend equivalents represent the right to receive the equivalent value of
dividends paid on shares of Abacus Lifes common stock and may be granted alone or in tandem with awards other than stock options or SARs. Dividend equivalents are credited as of the dividend record dates during the period between the date an
award is granted and the date such award vests, is exercised, is distributed or expires, as determined by the committee. |
Certain
Transactions
The committee has broad discretion to take action under the Incentive Plan, as well as make adjustments to the terms and
conditions of existing and future awards, to prevent the dilution or enlargement of intended benefits and facilitate necessary or desirable changes in the event of certain transactions and events affecting Abacus Lifes common stock, such as
stock dividends (other than ordinary cash dividends), stock splits, spinoffs, recapitalizations, mergers, acquisitions, combinations, exchange of shares, consolidations and other corporate transactions. In addition, in the event of certain
non-reciprocal transactions with our stockholders known as equity restructurings, the committee will make equitable adjustments to the Incentive Plan and outstanding awards.
No Repricing
Except in connection with
certain changes in our capital structure, stockholder approval will be required for any amendment that reduces the exercise price of any stock option or SAR, or cancels any stock option or SAR that has an exercise price that is greater than the
then-current fair market value of Abacus Lifes common stock in exchange for cash, other awards or stock options or SARs with an exercise price per share that is less than the exercise price per share of the original stock options or SARs.
99
Transferability
An Incentive Stock Option is not transferable other than by will or the laws of descent and distribution, and may be exercised during the
employees lifetime only by the employee or such employees guardian or legal representative. All other awards under the Incentive Plan are not transferable other than by will or the laws of descent and distribution, pursuant to a
qualified domestic relations order, or with the consent of the committee (as to certain family transfers, or otherwise).
Plan Amendment and
Termination
The Board may amend or terminate the Incentive Plan at any time; however, no amendment may impair the rights of a
participant with respect to an award outstanding under the Incentive Plan without the consent of the affected participant. Further, the board of directors may not, without the consent of the stockholders, amend the Incentive Plan to increase the
maximum aggregate number of shares that may be issued under the Incentive Plan or change the class of individuals eligible to receive awards under the Incentive Plan or amend or eliminate the restrictions on repricing of awards. No awards may be
granted under the Incentive Plan after its termination.
Material U.S. Federal Income Tax Consequences
The following is a general summary under current law of the principal U.S. federal income tax consequences related to awards under the
Incentive Plan. Deductions described below may be limited by Section 162(m) of the Code. This summary deals with the general federal income tax principles that apply and is provided only for general information. Phantom Stock, and certain other
awards that may be granted pursuant to the Incentive Plan, could be subject to additional taxes unless they are designed to comply with certain restrictions set forth in Section 409A of the Code and guidance promulgated thereunder. Some kinds of
taxes, such as state, local and foreign income taxes and federal employment taxes, are not discussed. This summary is not intended as tax advice to participants, who should consult their own tax advisors.
|
|
|
Restricted Stock. The recipient of a Restricted Stock award generally will not realize taxable income at
the time of grant, and we generally will not be entitled to a deduction at that time, assuming that the restrictions constitute a substantial risk of forfeiture for federal income tax purposes. When the risk of forfeiture with respect to the stock
subject to the award lapses, the holder generally will realize ordinary income in an amount equal to the fair market value of the shares of Abacus Lifes common stock at such time less the amount paid for the stock (if any), and, subject to
Section 162(m), we will be entitled to a corresponding deduction. All dividends and distributions (or the cash equivalent thereof) with respect to a Restricted Stock award paid to the holder before the risk of forfeiture lapses generally will also
be compensation income to the holder when paid and, subject to Section 162(m) as discussed below, deductible as such by us. Notwithstanding the foregoing, the holder of a Restricted Stock award may elect under Section 83(b) of the Code to be taxed
at the time of grant of the Restricted Stock award based on the fair market value of the shares of Abacus Lifes common stock on the date of the award less the amount paid for the stock (if any), in which case (a) subject to Section 162(m), we
will be entitled to a deduction at the same time and in the same amount, (b) dividends paid to the recipient during the period the forfeiture restrictions apply will be taxable as dividends and will not be deductible by us and (c) there will be no
further federal income tax consequences when the risk of forfeiture lapses. Such election must be made not later than 30 days after the grant of the Restricted Stock award, and is irrevocable. |
|
|
|
Restricted Stock Unit Awards. The grant of a Restricted Stock Unit Award (RSU Award) under the
Incentive Plan generally will not result in the recognition of any U.S. federal taxable income by the recipient or a deduction for us at the time of grant. At the time an RSU Award is settled the recipient will generally recognize ordinary income
and, subject to Section 162(m) of the Code, we will be entitled to a corresponding deduction. Generally, the measure of the income and the deduction will be based on the number of shares of common stock issued in settlement of the RSU Award
multiplied by the value of Abacus Lifes common stock at the time the RSU Award is settled. |
100
|
|
|
Stock Awards. The recipient of a Stock Award generally will realize taxable ordinary income at the time of
grant in an amount equal to the fair market value of the shares of Abacus Lifes common stock on the date of the award, and, subject to Section 162(m) of the Code, we will be entitled to a corresponding deduction. |
|
|
|
Incentive Stock Options. Incentive Stock Options are subject to special federal income tax treatment. No
federal income tax is imposed on the optionee upon the grant or the exercise of an Incentive Stock Option if the optionee does not dispose of the shares acquired pursuant to the exercise within the two-year period beginning on the date the option
was granted or within the one-year period beginning on the date the option was exercised (collectively, the holding period). In such event, we would not be entitled to any deduction for federal income tax purposes in connection with the
grant or exercise of the option or the disposition of the shares so acquired. With respect to an Incentive Stock Option, the difference between the fair market value of the stock on the date of exercise and the exercise price must generally be
included as an item of adjustment for purposes of the optionees alternative minimum taxable income for the year in which such exercise occurs. However, if the optionee exercises an Incentive Stock Option and disposes of the shares received in
the same year and the amount realized is less than the fair market value of the shares on the date of exercise, then the amount included in alternative minimum taxable income will not exceed the amount realized over the adjusted basis of the shares.
|
|
|
Upon disposition of the shares received upon exercise of an Incentive Stock Option after the holding period,
any appreciation of the shares above the exercise price should constitute long-term capital gain. If an optionee disposes of shares acquired pursuant to his or her exercise of an Incentive Stock Option prior to the end of the holding period, the
optionee will be treated as having received, at the time of disposition, compensation taxable as ordinary income. In such event, and subject to Section 162(m) of the Code, we may claim a deduction for compensation paid at the same time and in the
same amount as compensation is treated as received by the optionee. The amount treated as compensation is the excess of the fair market value of the shares at the time of exercise (or in the case of a sale in which a loss would be recognized, the
amount realized on the sale if less) over the exercise price; any amount realized in excess of the fair market value of the shares at the time of exercise would be treated as short-term or long-term capital gain, depending on the holding period of
the shares. |
|
|
|
Non-statutory Stock Options and Stock Appreciation Rights. Generally, no federal income tax is imposed on
the optionee upon the grant of a Non-statutory Stock Option or a SAR, and we are not entitled to a tax deduction by reason of such grant. Generally, upon the exercise of a Non-statutory Stock Option, the optionee generally will be treated as
receiving compensation taxable as ordinary income in the year of exercise in an amount equal to the excess of the fair market value of the shares of stock at the time of exercise over the option price paid for such shares. In the case of the
exercise of a SAR, the holder generally will be treated as receiving compensation taxable as ordinary income in the year of exercise in an amount equal to the cash received or the fair market value of the shares distributed to the optionee. Upon the
exercise of a Non-statutory Stock Option or a SAR, and subject to Section 162(m) of the Code, we may claim a deduction for compensation paid at the same time and in the same amount as compensation income is recognized by the optionee assuming any
federal income tax reporting requirements are satisfied. |
|
|
|
Performance Awards, Phantom Stock Awards and Stock Awards. An individual who has been granted a
Performance Award, a Phantom Stock Award or a Stock Award generally will not realize taxable income at the time of grant, and we will not be entitled to a deduction at that time. Whether such an award is paid in cash or shares of Abacus Lifes
common stock, the individual generally will have taxable compensation and, subject to Section 162(m) of the Code, we generally will have a corresponding deduction. The measure of such income and deduction will be based on the amount of any cash paid
and the fair market value of any shares of Abacus Lifes common stock either at the time the award is paid or at the time any restrictions on the shares subsequently lapse, depending on the nature, if any, of the restrictions imposed and
whether the individual elects to be taxed without regard to any such restrictions. |
101
|
|
|
Section 162(m). Generally, Section 162(m) of the Code precludes a public corporation from taking a
deduction for annual compensation in excess of $1,000,000 paid to its covered employees (as defined in Section 162(m) of the Code). |
Section 409A of the Code
Certain types
of awards under the Incentive Plan may constitute, or provide for, a deferral of compensation subject to Section 409A of the Code. Unless certain requirements set forth in Section 409A of the Code are complied with, holders of such awards may be
taxed earlier than would otherwise be the case (e.g., at the time of vesting instead of the time of payment) and may be subject to an additional 20% penalty tax (and, potentially, certain interest, penalties and additional state taxes). To the
extent applicable, the Incentive Plan and awards granted under the Incentive Plan are intended to be structured and interpreted in a manner intended to either comply with or be exempt from Section 409A of the Code and the Department of Treasury
regulations and other interpretive guidance that may be issued under Section 409A of the Code. To the extent determined necessary or appropriate by the committee, the Incentive Plan and applicable award agreements may be amended to further comply
with Section 409A of the Code or to exempt the applicable awards from Section 409A of the Code.
New Plan Benefits
ERESs directors and executive officers may be considered to have an interest in the approval of the Incentive Plan because they may in
the future receive awards under the Incentive Plan; however, the benefits or amounts that may be received or allocated to directors, officers and employees under the Incentive Plan will be determined at the discretion of the plan administrator and
are not currently determinable. Nevertheless, the ERES Board believes that it is important to provide incentives and rewards for superior performance and the retention of executive officers and experienced directors by adopting the Incentive Plan.
Vote Required for Approval
If the
Business Combination Proposal is not approved, the Incentive Plan Proposal will not be presented at the Special Meeting. The Incentive Plan Proposal requires the affirmative vote of a majority of the issued and outstanding common stock represented
in person or by proxy at the meeting (which would include presence at a virtual meeting) and entitled to vote thereon.
Failure to vote by
proxy or to vote in person (which would include presence at a virtual meeting) at the Special Meeting, abstentions and broker non-votes will have no effect on the Incentive Plan Proposal.
The Sponsor has agreed to vote the ERES Common Stock owned by the Sponsor in favor of the Incentive Plan Proposal, if presented. See the
section entitled Other AgreementsSponsor Agreement for more information.
Recommendation of the Board of Directors
THE ERES BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT THE ERES STOCKHOLDERS VOTE FOR THE APPROVAL OF THE INCENTIVE PLAN PROPOSAL.
102
PROPOSAL NO. 7THE ADJOURNMENT PROPOSAL
The Adjournment Proposal, if adopted, will allow the ERES Board to adjourn the Special Meeting to a later date or dates, if necessary, to
permit further solicitation of proxies if, based upon the tabulated vote at the time of the Special Meeting, there are not sufficient votes to approve the Business Combination Proposal, the Charter Approval Proposal, the Director Election Proposal,
the Nasdaq Proposal or the Incentive Plan Proposal. In no event will the ERES Board adjourn the Special Meeting or consummate the Business Combination beyond the date by which it may properly do so under the Existing Charter and Delaware law.
Consequences if the Adjournment Proposal is not Approved
If the Adjournment Proposal is not approved by stockholders, the ERES Board may not be able to adjourn the Special Meeting to a later date in
the event that there are insufficient votes for the approval of the Business Combination Proposal, the Charter Approval Proposal, the Governance Proposal, the Director Election Proposal, the Nasdaq Proposal or the Incentive Plan Proposal, or we
determine that one or more of the closing conditions under the Merger Agreement is not satisfied or waived. If ERES does not consummate the Business Combination and fails to complete an initial business combination by July 27, 2023 (subject to
the requirements of law), ERES will be required to dissolve and liquidate its Trust Account by returning the then remaining funds in such account to its Public Stockholders.
Vote Required for Approval
The approval
of the Adjournment Proposal requires the affirmative vote of the majority of the votes cast by the stockholders present in person (which would include presence at a virtual meeting) or represented by proxy at the Special Meeting and entitled to vote
at thereon.
Failure to vote by proxy or to vote in person (which would include presence at a virtual meeting) at the Special Meeting,
abstentions and broker non-votes will have no effect on the Adjournment Proposal.
The Business
Combination is not conditioned upon the approval of the Adjournment Proposal.
The Sponsor has agreed to vote any shares of ERES Common
Stock owned by the Sponsor in favor of the Adjournment Proposal, if presented. See the section entitled Other AgreementsSponsor Support Agreement for more information.
Recommendation of the Board of Directors
THE ERES
BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT THE ERES STOCKHOLDERS VOTE FOR THE APPROVAL OF THE ADJOURNMENT PROPOSAL.
103
INFORMATION ABOUT ERES
In this section we, us, our or the Company refer to ERES prior to the Business
Combination and to the Post-Combination Company following the Business Combination.
Introduction
We are a blank check company incorporated in Delaware on May 22, 2020 for the purpose of effecting a merger, capital stock exchange, asset
acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies.
Company History
In June 2020,
the Sponsor purchased 8,625,000 Founder Shares for an aggregate purchase price of $25,000, or approximately $0.003 per share. Prior to the initial investment in the Company of $25,000 by our Sponsor, the Company had no assets, tangible or
intangible. The per share price of the Founder Shares was determined by dividing the amount of cash contributed to the Company by the number of Founder Shares issued. The number of Founder Shares issued was determined based on the expectation that
the Founder Shares would represent 20% of the outstanding shares of ERES Common Stock upon completion of the ERES IPO.
The registration
statement for our IPO was declared effective on July 22, 2020. On August 2, 2020, we consummated the ERES IPO of 30,000,000 units, with each unit consisting of one share of Class A Common Stock and one-half of one redeemable warrant.
Each whole public warrant entitles the holder thereof to purchase one share of Class A Common Stock at a price of $11.50 per share, subject to certain adjustments. The units were sold at a price of $10.00 per unit, generating gross proceeds to
us of $300,000,000. On August 25, 2020, the underwriter in the ERES IPO fully exercised its over-allotment option, resulting in the offering of an additional 4,500,000 units. Simultaneously with the consummation of the ERES IPO, we consummated
the private placement of an aggregate of 900,000 Private Placement Warrants to our Sponsor at a price of $1.00 per Private Placement Warrant, generating total proceeds of $900,000. As a result, $345,000,000 was placed into the Trust Account.
Our units began trading on July 24, 2020 on Nasdaq under the symbol ERESU. On September 14, 2020, the securities
comprising the units began separate trading. The Class A Common Stock and warrants trade on Nasdaq under the symbols ERES and ERESW, respectively.
On July 25, 2022, ERESs stockholders approved the Extension Amendment. The Extension Amendment extended the date by which ERES must
consummate its initial business combination from July 27, 2022 to January 27, 2023. In connection with the Extension Amendment, on July 25, 2022, ERES issued the Extension Note in the aggregate principal amount of up to $1,924,356.46
to the Sponsor, pursuant to which the Sponsor loaned ERES $1,924,356.46 to deposit into the Trust Account, at a rate of $0.033 per share each month for each Class A Common Stock that was not redeemed in connection with the extension of
ERESs termination date from July 27, 2022 to January 27, 2023.
On January 20, 2023, ERESs stockholders
approved the Second Extension Amendment. The Second Extension Amendment extends the date by which ERES must consummate its initial business combination from January 27, 2023 to July 27, 2023. If ERESs initial business combination is not
consummated by July 27, 2023, then ERESs existence will terminate, and ERES will distribute amounts in the Trust Account as provided in ERESs Amended and Restated Certificate of Incorporation. In connection with the Second Extension
Amendment, ERES issued the Second Extension Note in the aggregate principal amount of up to $565,497.31 to the Sponsor, pursuant to which the Sponsor agreed to loan ERES up to $565,497.31 into the Trust Account, at a rate of $0.033 per share each
month for each Class A Common Stock that was not redeemed in connection with the extension of ERESs termination date from January 27, 2023 to July 27, 2023.
104
Redemption Rights for Holders of Public Shares
We are providing our Public Stockholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of the
Business Combination at a per share price, payable in cash, equal to (i) the aggregate amount then on deposit in the Trust Account as of two business days prior to the closing, including interest earned on the funds held in the Trust Account
and not previously released to us to pay our taxes, divided by (ii) the number of then-outstanding Public Shares, subject to the limitations described herein. The amount in the Trust Account as of
[●], 2023, the ERES Record Date, was approximately $[●] per Public Share. The per share amount we will distribute to stockholders who properly redeem their shares will not be reduced by any deferred underwriting commissions that we pay
to the underwriters or another Financial Industry Regulatory Authority (FINRA) member. There will be no redemption rights upon the completion of the Business Combination with respect to our warrants. The redemption rights will include
the requirement that any beneficial owner on whose behalf a redemption right is being exercised must identify itself in order to validly redeem its shares. Our Sponsor, officers and directors have entered into a letter agreement with us pursuant to
which they have agreed to waive their redemption rights with respect to any Founder Shares they hold and any Public Shares they may acquire in connection with the completion of the Business Combination. These waivers were made at the time of the
ERES IPO for no additional consideration.
Limitation on Redemption Rights
Notwithstanding the foregoing redemption rights, if we seek stockholder approval of the Business Combination and we do not conduct redemptions
in connection with the Business Combination pursuant to the tender offer rules, our Existing Charter provides that a holder of the Public Shares, together with any affiliate of his or any other person with whom he is acting in concert or as a
group (as defined in Section 13(d)(3) of the Exchange Act), will be restricted from seeking redemption rights with respect to more than an aggregate of 20% of the Public Shares without prior consent, which we refer to as the
20% threshold. Accordingly, all Public Shares in excess of the 20% threshold beneficially owned by a Public Stockholder or group will not be redeemed for cash without our prior consent.
We believe this restriction will discourage stockholders from accumulating large blocks of shares, and subsequent attempts by such holders to
use their ability to exercise their redemption rights against the Business Combination as a means to force us or our management to purchase their shares at a significant premium to the then-current market
price or on other undesirable terms. Absent this provision, a Public Stockholder holding more than an aggregate of 20% of the Public Shares could threaten to exercise its redemption rights against the Business Combination if such holders
shares are not purchased by us, our Sponsor or our management at a premium to the then-current market price or on other undesirable terms. By limiting our stockholders ability to redeem no more than 20%
of the Public Shares, we believe we will limit the ability of a small group of stockholders to unreasonably attempt to block our ability to complete the Business Combination, particularly in connection with a business combination with a target that
requires as a closing condition that we have a minimum net worth or a certain amount of cash. However, we will not be restricting our stockholders ability to vote all of their shares (including such shares in excess of the 20% threshold) for
or against the Business Combination.
Submission of Business Combination to a Stockholder Vote
The Special Meeting of ERES stockholders to which this filing relates is to solicit your approval of the Business Combination. Unlike many
other blank check companies, ERESs Public Stockholders are not required to vote against the Business Combination in order to exercise their redemption rights. If the Business Combination is not completed, then Public Stockholders who elected
to exercise their redemption rights will not be entitled to receive such payments. Our Sponsor, officers and directors have agreed to vote any shares of ERES Common Stock purchased during or after the ERES IPO in favor of approving the Business
Combination.
105
Permitted Purchases of Our Securities
If we seek stockholder approval of the Business Combination and we do not conduct redemptions in connection with the Business Combination
pursuant to the tender offer rules, our Sponsor, directors, executive officers, advisors or their affiliates may purchase shares or public warrants in privately negotiated transactions or in the open market either prior to or following the
completion of the Business Combination. There is no limit on the number of shares our Sponsor, directors, officers, advisors or their affiliates may purchase in such transactions, subject to compliance with applicable law and Nasdaq rules. However,
they have no current commitments, plans or intentions to engage in such transactions and have not formulated any terms or conditions for any such transactions. None of the funds in the Trust Account will be used to purchase shares or public warrants
in such transactions. If they engage in such transactions, they will be restricted from making any such purchases when they are in possession of any material non-public information not disclosed to the seller
or if such purchases are prohibited by Regulation M under the Exchange Act.
In the event that our Sponsor, directors, officers, advisors
or their affiliates purchase shares in privately negotiated transactions from Public Stockholders who have already elected to exercise their redemption rights, such selling stockholders would be required to revoke their prior elections to redeem
their shares. We do not currently anticipate that such purchases, if any, would constitute a tender offer subject to the tender offer rules under the Exchange Act or a going-private transaction subject to the going-private rules under the Exchange Act; however, if the purchasers determine at the time of any such purchases that the purchases are subject to such rules, the purchasers will comply with such rules.
The purpose of any such purchases of shares could be to (i) vote such shares in favor of the Business Combination and thereby increase
the likelihood of obtaining stockholder approval of the Business Combination or (ii) to satisfy a closing condition in an agreement with a target that requires us to have a minimum net worth or a certain amount of cash at the closing of the
Business Combination, where it appears that such requirement would otherwise not be met. The purpose of any such purchases of public warrants could be to reduce the number of public warrants outstanding or to vote such warrants on any matters
submitted to the warrant holders for approval in connection with our initial business combination. Any such purchases of our securities may result in the completion of the Business Combination that may not otherwise have been possible.
In addition, if such purchases are made, the public float of our Class A Common Stock or public warrants may be reduced and
the number of beneficial holders of our securities may be reduced, which may make it difficult to maintain or obtain the quotation, listing or trading of our securities on a national securities exchange.
Our Sponsor, officers, directors and/or their affiliates anticipate that they may identify the stockholders with whom our Sponsor, officers,
directors or their affiliates may pursue privately negotiated purchases by either the stockholders contacting us directly or by our receipt of redemption requests submitted by stockholders (in the case of Class A Common Stock) following our
mailing of proxy materials in connection with the Business Combination. To the extent that our Sponsor, officers, directors, advisors or their affiliates enter into a private purchase, they would identify and contact only potential selling
stockholders who have expressed their election to redeem their shares for a pro rata share of the Trust Account or vote against the Business Combination, whether or not such stockholder has already submitted a proxy with respect to the Business
Combination, but only if such shares have not already been voted at the stockholder meeting related to the Business Combination. Our Sponsor, executive officers, directors, advisors or any of their affiliates will select which stockholders to
purchase shares from based on a negotiated price and number of shares and any other factors that they may deem relevant, and will only purchase shares if such purchases comply with Regulation M under the Exchange Act and the other federal securities
laws. Our Sponsor, officers, directors and/or their affiliates will be restricted from making purchases of shares if the purchases would violate Section 9(a)(2) of, or Rule 10b-5 under, the Exchange Act.
We expect any such purchases will be reported pursuant to Section 13 and Section 16 of the Exchange Act to the extent such purchases are subject to such reporting requirements.
106
Redemption of Public Shares and Liquidation if no Business Combination
Our Existing Charter provides that we will have only 36 months from the closing of the ERES IPO to complete a business combination. If we are
unable to complete a business combination within such 36-month period, we will: (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more
than ten business days thereafter subject to lawfully available funds therefor, redeem 100% of the Public Shares in consideration of a per-share price, payable in cash, equal to the quotient obtained by
dividing (A) the aggregate amount then on deposit in the Trust Account, including interest not previously released to us to pay our taxes and expenses related to the administration of the Trust Account (less up to $100,000 of such net interest
to pay dissolution expenses), by (B) the total number of then outstanding Public Shares, which redemption will completely extinguish the rights of the Public Stockholders (including the right to receive further liquidating distributions, if
any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the our board of directors in accordance with applicable law, dissolve and
liquidate, subject in each case to our obligations under the DGCL to provide for claims of creditors and other requirements of applicable law. There will be no redemption rights or liquidating distributions with respect to our warrants, which will
expire worthless if we fail to complete the Business Combination within the 30-month time period.
Pursuant to a letter agreement with us, our Sponsor, officers and directors have waived their rights to liquidating distributions from the
Trust Account with respect to any Founder Shares held by them if we fail to complete the Business Combination by July 27, 2023. However, if our Sponsor, officers or directors acquire Public Shares after the ERES IPO, they will be entitled to
liquidating distributions from the Trust Account with respect to such Public Shares if we fail to complete the Business Combination by July 27, 2023. For discussion of any such transactions please refer to the section entitled Certain
Relationships and Related Party Transactions.
Furthermore, pursuant to the letter agreement, our Sponsor, officers and
directors have agreed, that they will not propose any amendment to our Existing Charter that would modify the substance or timing of our obligation to redeem 100% of our Public Shares unless we provide our Public Stockholders with the opportunity to
redeem their Public Shares upon approval of any such amendment at a per share price, payable in cash, equal to (i) the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and
not previously released to us to pay our taxes divided by (ii) the number of then-outstanding Public Shares. However, we may not redeem our Public Shares in an amount that would cause our net tangible
assets to be less than $5,000,001 upon completion of the Business Combination (so that we are not subject to the SECs penny stock rules). If this optional redemption right is exercised with respect to an excessive number of Public
Shares such that we cannot satisfy the net tangible asset requirement, we would not proceed with the amendment or the related redemption of our Public Shares at such time.
We expect that all costs and expenses associated with implementing our plan of dissolution, as well as payments to any creditors, will be
funded from amounts remaining out of the approximately $[●] of proceeds held outside the Trust Account (as of the ERES Record Date), although there is no assurance that there will be sufficient funds for such purpose. However, if those funds
are not sufficient to cover the costs and expenses associated with implementing our plan of dissolution, to the extent that there is any interest accrued in the Trust Account not required to pay taxes on interest income earned on the Trust Account
balance, we may request the trustee to release to us an additional amount of up to $100,000 of such accrued interest to pay those costs and expenses.
If we were to expend all of the net proceeds of the ERES IPO and the sale of the Private Placement Warrants, other than the proceeds deposited
in the Trust Account, and without taking into account interest, if any, earned on the Trust Account and any tax payments of expenses for the dissolution of the trust, the per share redemption amount received by stockholders upon our dissolution
would be approximately $[●]. The proceeds deposited in the Trust Account could, however, become subject to the claims of our creditors which would have higher priority than the claims of our Public Stockholders. There is no assurance that the
actual per share redemption amount received by stockholders will not be substantially less than $[●]. Under Section 281(b) of the
107
DGCL, our plan of dissolution must provide for all claims against us to be paid in full or make provision for payments to be made in full, as applicable, if there are sufficient assets. These
claims must be paid or provided for before we make any distribution of our remaining assets to our stockholders. While we intend to pay such amounts, if any, there is no assurance that we will have funds sufficient to pay or provide for all
creditors claims.
Although we have sought and will continue to seek to have all vendors, service providers, prospective target
businesses or other entities with which we do business execute agreements with us waiving any right, title, interest and claim of any kind in or to any monies held in the Trust Account for the benefit of our Public Stockholders, there is no
guarantee that they will execute such agreements or even if they execute such agreements that they would be prevented from bringing claims against the Trust Account including but not limited to fraudulent inducement, breach of fiduciary
responsibility or other similar claims, as well as claims challenging the enforceability of the waiver, in each case in order to gain an advantage with respect to a claim against our assets, including the funds held in the Trust Account. If any
third party refuses to execute an agreement waiving such claims to the monies held in the Trust Account, our management will perform an analysis of the alternatives available to it and will only enter into an agreement with a third party that has
not executed a waiver if management believes that such third partys engagement would be significantly more beneficial to us than any alternative. Examples of possible instances where we may engage a third party that refuses to execute a waiver
include the engagement of a third party consultant whose particular expertise or skills are believed by management to be significantly superior to those of other consultants that would agree to execute a waiver or in cases where management is unable
to find a service provider willing to execute a waiver. Marcum LLP, our independent registered public accounting firm will not execute an agreement with us waiving such claims to the monies held in the Trust Account.
In addition, there is no guarantee that such entities will agree to waive any claims they may have in the future as a result of, or arising
out of, any negotiations, contracts or agreements with us and will not seek recourse against the Trust Account for any reason. In order to protect the amounts held in the Trust Account, our Sponsor has agreed that it will be liable to us if and to
the extent any claims by a third party for services rendered or products sold to us, or a prospective target business with which we have discussed entering into a written letter of intent, confidentiality or other similar agreement or business
combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share or (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust
Account, if less than $10.00 per Public Share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business that executed a waiver of
any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under our indemnity of the underwriters of the ERES IPO against certain liabilities, including liabilities under
the Securities Act. However, we have not asked our Sponsor to reserve for such indemnification obligations, nor have we independently verified whether our Sponsor has sufficient funds to satisfy its indemnity obligations and we believe that our
Sponsors only assets are securities of ERES. Therefore, we cannot assure you that our Sponsor would be able to satisfy those obligations. As a result, if any such claims were successfully made against the Trust Account, the funds available for
the Business Combination and redemptions could be reduced to less than $[●] per Public Share. In such event, we may not be able to complete the Business Combination, and you would receive such lesser amount per share in connection with any
redemption of your Public Shares. None of our officers or directors will indemnify us for claims by third parties including, without limitation, claims by vendors and prospective target businesses.
In the event that the proceeds in the Trust Account are reduced below the lesser of (i) $10.00 per Public Share or (ii) the actual
amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, due to reductions in value of the trust assets, in each case net of the amount of interest which may be withdrawn to pay taxes, and our Sponsor
asserts that it is unable to satisfy its indemnification obligations or that it has no indemnification obligations related to a particular claim, our independent directors would determine whether to take legal action against our Sponsor to enforce
its indemnification obligations. While we currently
108
expect that our independent directors would take legal action on our behalf against our Sponsor to enforce its indemnification obligations to us, it is possible that our independent directors in
exercising their business judgment may choose not to do so if, for example, the cost of such legal action is deemed by the independent directors to be too high relative to the amount recoverable or if the independent directors determine that a
favorable outcome is not likely. We have not asked our Sponsor to reserve for such indemnification obligations and there is no assurance that our Sponsor would be able to satisfy those obligations. Accordingly, there is no assurance that due to
claims of creditors the actual value of the per share redemption price will not be less than $[●] per Public Share.
We seek to
reduce the possibility that our Sponsor has to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (other than our independent auditor), prospective target businesses or other entities with
which we do business execute agreements with us waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Our Sponsor will also not be liable as to any claims under our indemnity of the underwriters of the
ERES IPO against certain liabilities, including liabilities under the Securities Act. We have access to approximately $[●] of proceeds from the ERES IPO (as of the ERES Record Date) with which to pay any such potential claims (including costs
and expenses incurred in connection with our liquidation, currently estimated to be no more than approximately $100,000).
In the event
that we liquidate and it is subsequently determined that the reserve for claims and liabilities is insufficient, stockholders who received funds from our Trust Account could be liable for claims made by creditors. In the event that our offering
expenses exceed our estimate of $[●], we may fund such excess with funds from the funds not to be held in the Trust Account. In such case, the amount of funds we intend to be held outside the Trust Account would decrease by a corresponding
amount. Conversely, in the event that the offering expenses are less than our estimate of $[●], the amount of funds we intend to be held outside the Trust Account would increase by a corresponding amount.
Under the DGCL, stockholders may be held liable for claims by third parties against a corporation to the extent of distributions received by
them in a dissolution. The pro rata portion of our Trust Account distributed to our Public Stockholders upon the redemption of our Public Shares in the event we do not complete an initial business combination by July 27, 2023 may be considered a
liquidating distribution under Delaware law. Delaware law provides that if a corporation complies with certain procedures set forth in Section 280 of the DGCL intended to ensure that it makes reasonable provision for all claims against it,
including a 60-day notice period during which any third-party claims can be brought against the corporation, a 90-day period
during which the corporation may reject any claims brought, and an additional 150-day waiting period before any liquidating distributions are made to stockholders, any liability of stockholders with respect to
a liquidating distribution is limited to the lesser of such stockholders pro rata share of the claim or the amount distributed to the stockholder, and any liability of the stockholder would be barred after the third anniversary of the
dissolution.
Furthermore, if the pro rata portion of our Trust Account distributed to our Public Stockholders upon the redemption of
our Public Shares in the event we do not complete an initial business combination by July 27, 2023, is not considered a liquidating distribution under Delaware law and such redemption distribution is deemed to be unlawful, then pursuant to
Section 174 of the DGCL, the statute of limitations for claims of creditors could then be six years after the unlawful redemption distribution, instead of three years, as in the case of a liquidating distribution. If we are unable to complete
an initial business combination by July 27, 2023, we will be required to: (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter subject to
lawfully available funds therefor, redeem 100% of the Public Shares in consideration of a per-share price, payable in cash, equal to the quotient obtained by dividing (A) the aggregate amount then on
deposit in the Trust Account, including interest not previously released to us to pay our taxes and expenses related to the administration of the Trust Account (less up to $100,000 of such net interest to pay dissolution expenses), by (B) the
total number of then outstanding Public Shares, which redemption will completely extinguish the rights of the Public Stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law and (iii) as
promptly as reasonably possible following such
109
redemption, subject to the approval of the remaining stockholders and the our board of directors in accordance with applicable law, dissolve and liquidate, subject in each case to our obligations
under the DGCL to provide for claims of creditors and other requirements of applicable law. Accordingly, it is our intention to redeem our Public Shares as soon as reasonably possible following July 27, 2023 and, therefore, we do not intend to
comply with those procedures. As such, our stockholders could potentially be liable for any claims to the extent of distributions received by them (but no more) and any liability of our stockholders may extend well beyond the third anniversary of
such date.
Because we will not be complying with Section 280, Section 281(b) of the DGCL requires us to adopt a plan, based on
facts known to us at such time that will provide for our payment of all existing and pending claims or claims that may be potentially brought against us within the subsequent 10 years.
However, because we are a blank check company, rather than an operating company, and our operations are limited to searching for prospective
target businesses to acquire, the only likely claims to arise would be from our vendors (such as lawyers, investment bankers, etc.) or prospective target businesses. As described above, pursuant to the obligation contained in our underwriting
agreement, we have sought and will continue to seek to have all vendors, service providers, prospective target businesses or other entities with which we do business execute agreements with us waiving any right, title, interest or claim of any kind
in or to any monies held in the Trust Account. As a result of this obligation, the claims that could be made against us are significantly limited and the likelihood that any claim that would result in any liability extending to the Trust Account is
remote.
Further, our Sponsor may be liable only to the extent necessary to ensure that the amounts in the Trust Account are not reduced
below (i) $10.00 per Public Share or (ii) such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, due to reductions in value of the trust assets, in each case net of the amount
of interest withdrawn to pay taxes and will not be liable as to any claims under our indemnity of the underwriters of the ERES IPO against certain liabilities, including liabilities under the Securities Act. In the event that an executed waiver is
deemed to be unenforceable against a third party, our Sponsor will not be responsible to the extent of any liability for such third-party claims.
If we file a bankruptcy petition or an involuntary bankruptcy petition is filed against us that is not dismissed, the proceeds held in the
Trust Account could be subject to applicable bankruptcy law, and may be included in our bankruptcy estate and subject to the claims of third parties with priority over the claims of our stockholders. To the extent any bankruptcy claims deplete the
Trust Account, there is no assurance that we will be able to return $[●] per share to our Public Stockholders. Additionally, if we file a bankruptcy petition or an involuntary bankruptcy petition is filed against us that is not dismissed, any
distributions received by stockholders could be viewed under applicable debtor/creditor and/or bankruptcy laws as either a preferential transfer or a fraudulent conveyance. As a result, a bankruptcy court could seek to
recover some or all amounts received by our stockholders. Furthermore, our board of directors may be viewed as having breached its fiduciary duty to our creditors and/or may have acted in bad faith, thereby exposing itself and our company to claims
of punitive damages, by paying Public Stockholders from the Trust Account prior to addressing the claims of creditors. There is no assurance that claims will not be brought against us for these reasons.
Our Public Stockholders will be entitled to receive funds from the Trust Account only (i) in the event of the redemption of our Public
Shares if we do not complete an initial business combination by July 27, 2023, subject to applicable law, (ii) in connection with a stockholder vote to approve an amendment to our Existing Charter to modify the substance or timing of our
obligation to redeem 100% of our Public Shares if we have not consummated an initial business combination by July 27, 2023 or with respect to any other material provisions relating to stockholders rights or
pre-initial business combination activity or (iii) our completion of an initial business combination, and then only in connection with those shares of our common stock that such stockholder properly
elected to redeem, subject to the limitations described herein. In no other circumstances will a stockholder have any right or interest of any kind to or in the Trust Account. In the event we seek stockholder approval in connection with the Business
Combination, a stockholders voting in connection with an initial
110
business combination alone will not result in a stockholders redeeming its shares to us for an applicable pro rata portion of the Trust Account. Such stockholder must have also exercised
its redemption rights as described above. These provisions of our Existing Charter, like all provisions of our Existing Charter, may be amended with a stockholder vote.
Voting Restrictions in Connection with the Special Meeting
Pursuant to the terms of the Sponsor Support Agreement, the Sponsor and ERESs directors and officers have agreed to vote any Founder
Shares held by them and any Public Shares purchased during or after the ERES IPO in favor of each of the Proposals presented at the Special Meeting. See the section entitled Other AgreementsSponsor Support Agreement for
more information. The Initial Stockholders own approximately 75% of ERESs outstanding common stock entitled to vote thereon. The quorum and voting thresholds at the Special Meeting and the Sponsor Support Agreement may make it more likely that
ERES will consummate the Business Combination.
Facilities
We currently maintain our executive offices at 7777 NW Beacon Square Boulevard, Boca Raton, Florida 33487 and our telephone number is
(561) 826-3620. Our executive offices are provided to us by the Sponsor. On July 24, 2020, we began paying two affiliates of the Sponsor up to $10,000 each per month for office space and administrative
support to the Company. We consider our current office space adequate for our current operations.
Upon completion of the Business
Combination or our liquidation, we will cease paying these monthly fees. No compensation of any kind, including finders and consulting fees, will be paid by ERES to our Sponsor, executive officers and directors, or any of their respective
affiliates, for services rendered prior to or in connection with the completion of a Business Combination. However, these individuals will be reimbursed for any
out-of-pocket expenses incurred in connection with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable
business combinations. Additionally, in connection with the successful completion of our Business Combination, we may determine to provide a payment to our Sponsor, officers, directors, advisors or our or their affiliates; however any such payment
would not be made from the proceeds of the ERES IPO held in the Trust Account and we currently do not have any agreement or arrangement with any such party to do so. Our audit committee will review on a quarterly basis all payments that were made to
our Sponsor, officers, directors or our or their affiliates.
Employees
We currently have no employees and six officers. Members of our management team are not obligated to devote any specific number of hours to our
matters but they intend to devote as much of their time as they deem necessary to our affairs until we have completed the Business Combination. The amount of time they will devote in any time period will vary based on whether a target business has
been selected for the Business Combination and the stage of the business combination process we are in.
Legal Proceedings
There is no material litigation, arbitration or governmental proceeding currently pending against us or any members of our management team in
their capacity as such.
111
MANAGEMENT OF ERES
In this section we, us, our or the Company refer to ERES prior to the Business
Combination and to the Post-Combination Company following the Business Combination.
Directors and
Executive Officers
ERESs current directors and executive officers are as follows:
|
|
|
|
|
Name |
|
Age |
|
Title |
Terrence M. Pegula |
|
72 |
|
Chairman, Chief Executive Officer and President |
Gary L. Hagerman, Jr. |
|
45 |
|
Chief Financial Officer and Treasurer |
John P. Sieminski |
|
64 |
|
General Counsel and Secretary |
Adam Gusky |
|
48 |
|
Chief Investment Officer |
Jacob Long |
|
35 |
|
Vice President, Operations |
James S. Morrow |
|
51 |
|
Director |
William A. Fustos |
|
65 |
|
Director |
Thomas W. Corbett, Jr. |
|
73 |
|
Director |
Thomas A. Lopus |
|
64 |
|
Director |
Terrence M. Pegula, Chairman, Chief Executive Officer and President
Mr. Pegula currently serves as our Chairman, Chief Executive Officer and President. Mr. Pegula is one of the most experienced Chief
Executive Officers in the Appalachian Basin, with over 40 years of success forming multiple oil & gas companies. Mr. Pegula has a proven operating and investing track record in the energy sector. In 2010, he sold assets of East
Resources, Inc. to Royal Dutch Shell plc (Shell) for $4.7 billion. In 2014, he was the majority owner of assets sold by HG Energy, LLC (HG Energy) to American Energy Partners, LP (American Energy Partners)
for $1.75 billion. At the respective times that both divestures occurred, East Resources, Inc. was not burdened with significant debt. Mr. Pegula has experience operating all segments of the value-chain, including upstream, midstream,
processing and local distribution company assets. Mr. Pegula is currently the Owner and Vice President of East Management Services, LP (East Management Services), an affiliate of our Sponsor. Mr. Pegula also currently owns
entities operating small assets in Texas, Colorado and Wyoming. Mr. Pegula also owns the Buffalo Sabres professional hockey team and the Buffalo Bills professional football team.
Mr. Pegula graduated from the Pennsylvania State University in 1973 with a degree in Petroleum and Natural Gas Engineering. In 2007, he
was the recipient of the Universitys prestigious C. Drew Stahl Distinguished Achievement Award in Petroleum & Natural Gas Engineering. In 2011, he was appointed by Pennsylvania Governor Tom Corbett to his Marcellus Shale Advisory
Commission and was also named Penn States Philanthropist of the Year in recognition of his past support and for the gift that provided the funds for the University to construct the Pegula Ice Arena and develop an NCAA Division I hockey
program. In 2014, he received Penn States Distinguished Alumni Award. In 2018, he was appointed by Pennsylvania Governor Tom Wolf to Penn States Board of Trustees, on which he still serves. Finally, in 2020, he was appointed by the
Department of Energy Secretary Dan Brouillette to serve on the National Petroleum Council. Mr. Pegula is well-qualified to serve on our Board due to his extensive experience in investment and management of oil and gas companies.
Gary L. Hagerman, Jr., Chief Financial Officer and Treasurer
Mr. Hagerman currently serves as our Chief Financial Officer and Treasurer. Gary served as a director from June 2020 to September 2021.
Mr. Hagerman joined East Management Services, an affiliate of our Sponsor, in August of 2015 as the Chief Accounting Officer after spending the prior twelve years at Pittsburgh-based
112
accounting firm Sobol Veltum & Associates working as the manager overseeing all audit and assurance, tax and advisory services provided to the entities owned by Terrence and Kim Pegula.
In January of 2018, he was promoted to Chief Financial Officer of East Management Services, JKLM Energy and all the other companies owned and operated by the Pegulas. Mr. Hagerman holds a B.S. degree in Accounting from West Liberty State
College and is a licensed CPA in Pennsylvania and West Virginia.
John P. Sieminski, General Counsel and Secretary
Mr. Sieminski currently serves as our General Counsel and Secretary. Mr. Sieminski joined East Resources, Inc. in April of 2008 as
the companys first General Counsel after spending over seventeen years in private law practice with two law firms in Pittsburgh, Pennsylvania. Mr. Sieminski played key contract negotiation, due diligence and overall transactional
administrative roles in East Resources, Inc.s issuance of convertible debt instruments to Kohlberg Kravis & Roberts & Co. (KKR) in 2009, with a deal value of $330 million, the sale of Easts
Pennsylvania, New York and Greater Rocky Mountain assets to Shell in 2010, and the sale of West Virginia and Ohio producing assets to affiliates of American Energy Partners in 2014 with a deal value of $1.75 billion. Mr. Sieminski has been
involved in the formation and management of multiple entities owned by Terrence and Kim Pegula in the areas of oil & gas, professional sports, investments, real estate and entertainment. Mr. Sieminski is currently the General Counsel
and Secretary of East Management Services, JKLM Energy and East Asset Management, all affiliates of our Sponsor. Mr. Sieminski received a B.A. in psychology from The Pennsylvania State University and a Juris Doctor from Duquesne University
School of Law in Pittsburgh, where he was a member of the Law Review. He is actively involved in JKLM Energys activities as an executive board member of the Marcellus Shale Coalition.
Adam Gusky, Chief Investment Officer
Mr. Gusky currently serves as our Chief Investment Officer. Mr. Gusky has served as the Chief Investment Officer of East Management
Services, an affiliate of our Sponsor since the inception of East Management Services in 2010. At East Resources, Inc., Mr. Gusky was responsible for all financial due diligence for acquisitions, and he was in charge of the reserve-based
lending facility. He also developed and implemented the corporate hedging strategy. Mr. Gusky currently serves on the board of directors of Rand Capital Corporation, a publicly traded business development company, where East Asset Management
made a control investment. Mr. Gusky received his B.A. in History and his MBA from Duke University.
Jacob Long, Vice President,
Operations
Mr. Long currently serves as our Vice President of Operations. Mr. Long has served as Operations Manager and
Vice President of Operations for JKLM Energy, an affiliate of the Company, since January 2016, overseeing the development of 38 deep, high-pressured Utica wells in north-central Pennsylvania. Mr. Long concurrently managed the West Texas
exploration program and legacy oil production in Colorado. Prior to JKLM Energy, Mr. Long worked at HG Energy in various management roles related to production, reservoir and A&D evaluation for conventional and unconventional assets. He was
also a part of the team for the 2014 sale to American Energy Partners. Mr. Long holds a B.S. degree in Petroleum Engineering from Marietta College.
James S. Morrow, Director
Mr. Morrow currently serves as a Director. Mr. Morrow is a veteran portfolio manager with over 20 years of experience.
Mr. Morrow has served as Chief Executive Officer of Callodine Capital Management, LP (Callodine) since founding Callodine in 2018. Prior to this, Mr. Morrow spent 19 years at Fidelity Investments Inc. (Fidelity)
where he managed $40 billion of assets across multiple equity-income strategies, including a $3-5 billion energy portfolio. Prior to Fidelity, Mr. Morrow worked in distressed debt for Chase
Manhattan Bank. Mr. Morrow received his Bachelor of Science in Finance from the University of Buffalo and his MBA from the University of Chicago. Mr. Morrows extensive experience as an investment manager makes him well-qualified to
serve on our Board.
113
William A. Fustos, Director
Mr. Fustos currently serves as a Director. Mr. Fustos has worked in the oil and gas industry for more than 35 years, first with
Texaco as a reservoir engineer, and then with several independent oil companies. In 1994, he formed Fustos Energy Services, an engineering firm whose work included reservoir engineering consulting along with a contract well servicing business. In
1998, he joined East Resources, Inc. as Vice President of Operations, eventually holding the position of Chief Operating Officer. As COO, Mr. Fustoss duties included supervision and oversight of all the operational and strategic
activities of East Resources, Inc. He was elected a Director of the Marcellus Shale Coalition in 2009, an industry organization founded to lead the oil and gas industrys regulatory and political efforts in Pennsylvania. He has served as chair
of Penn States Corporate Relations Subcommittee, the College of Earth and Mineral Sciences Development Council and in 2012, was the recipient of Penn States prestigious C. Drew Stahl Distinguished Achievement Award in
Petroleum & Natural Gas Engineering. Since 2017, Mr. Fustos has served as a member of the board of directors for HG Energy II, LLC, a large independent upstream oil and gas company based in Parkersburg, WV. Also since 2017,
Mr. Fustos has served on the board of Penn Hills Resources, LLC. He graduated from Penn State in 1979 with a degree in Petroleum and Natural Gas Engineering and has been licensed as a Professional Engineer in the Commonwealth of Pennsylvania.
Mr. Fustos is well-qualified to serve on our Board due to his extensive experience in the oil and gas industry and his service on the boards of several other oil and gas companies.
Thomas W. Corbett, Jr., Director
Mr. Corbett currently serves as a Director. Mr. Corbett has been the principal member of Corbett Consulting, LLC since 2015 and, from
2011 to 2015, served as the Governor of Pennsylvania. He has also served as the states Attorney General and as the US Attorney for the Western District of Pennsylvania. Mr. Corbett received a B.A. in political science from Lebanon Valley
College and a Juris Doctor from St. Marys University Law School. He was a member of the board of directors for Composites Consolidation Company LLC from 2015 to 2016 and was a member of the board for Animal Friends of Pittsburgh until 2019. He
currently serves on the board of the Variety Club, The Childrens Charity Pittsburgh. Mr. Corbett is well-qualified to serve on our Board due to his extensive leadership and risk management experience, as well as his service on other
public company boards.
Thomas A. Lopus, Director
Mr. Lopus currently serves as a Director. Mr. Lopus has worked in the oil and gas industry for 17 years in various roles. From June
2016 to June 2019, he served as the Director of Operations for Range Resources Corporation. He also served as a Senior Vice PresidentOil & Gas Assets for Pardee Resources Company. Prior to that Mr. Lopus served as the Appalachian
Business Manager for J-W Operating Company from January 2019 to December 2012. Mr. Lopus received a B.S. in Petroleum and Natural Gas Engineering from Penn State University. He was a member of the board
of directors for Linn Energy from 2006 to 2008. In 2012, he was awarded the Industry Executive Leader award from the Northeast US Oil and Gas Awards and was a founding member of the Marcellus Shale Coalition from 2008 to 2016. Mr. Lopus is
well-qualified to serve on our Board due to his extensive experience in the oil and gas industry.
Number and Terms of Office of Officers and Directors
We currently have five directors. Our Board is divided into three classes with only one class of directors being elected in each
year and each class (except for those directors appointed prior to our first annual meeting of stockholders) serving a three-year term. The term of office of the first class of directors, consisting of James S. Morrow, will expire at our first
annual meeting of stockholders. The term of office of the second class of directors, consisting of Thomas A. Lopus and William A. Fustos, will expire at the second annual meeting of stockholders. The term of office of the third class of directors,
consisting of Terrence M. Pegula and Thomas W. Corbett, Jr., will expire at the third annual meeting of stockholders.
114
Under the Existing Charter, holders of our Founder Shares will have the right to elect all
of our directors prior to consummation of our initial business combination and holders of our Public Shares will not have the right to vote on the election of directors during such time. These provisions of the Existing Charter may only be amended
if approved by holders of at least 90% of our outstanding common stock entitled to vote thereon. Subject to any other special rights applicable to the stockholders, any vacancies on our Board may be filled by the affirmative vote of a majority of
the directors present and voting at the meeting of our board or by a majority of the holders of our Founder Shares.
Our officers are
appointed by the Board and serve at the discretion of the Board, rather than for specific terms of office. Our Board is authorized to appoint persons to the offices set forth in our bylaws as it deems appropriate. Our bylaws provide that our
officers may consist of one or more Chief Executive Officer, a Chief Financial Officer, a Secretary and such other officers (including without limitation, a Chairman of the Board, Chief Operating Officer, Presidents, Vice Presidents, Partners,
Managing Directors and Senior Managing Directors) and such other offices as may be determined by the Board.
Director Independence
Nasdaq listing standards require that a majority of our board of directors be independent. An independent director is defined
generally as a person other than an officer or employee of the company or its subsidiaries or any other individual having a relationship which in the opinion of the companys board of directors, would interfere with the directors exercise
of independent judgment in carrying out the responsibilities of a director. Our Board has determined that William A. Fustos, Thomas A. Lopus and Thomas W. Corbett, Jr. are independent directors. Our independent directors have regularly scheduled
meetings at which only independent directors are present.
Officer and Director Compensation
None of our officers or directors has received any cash compensation for services rendered to us. No compensation of any kind, including
finders and consulting fees, will be paid to our Sponsor, officers and directors, or any of their respective affiliates, for services rendered prior to or in connection with the completion of our initial business combination. However, these
individuals will be reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf such as identifying potential target businesses and
performing due diligence on suitable business combinations. Additionally, in connection with the successful completion of our initial business combination, we may determine to provide a payment to our Sponsor, officers, directors, advisors or our or
their affiliates; however any such payment would not be made from the proceeds of the ERES IPO held in the Trust Account and we currently do not have any agreement or arrangement with any such party to do so. Our audit committee reviews on a
quarterly basis all payments that were or are to be made to our Sponsor, officers or directors, or our or their affiliates.
After the
completion of the Business Combination, directors or members of our management team who remain with us may be paid consulting or management fees from the Post-Combination Company. All of these fees will be fully disclosed to stockholders, to the
extent then known, in the tender offer materials or proxy solicitation materials furnished to our stockholders in connection with the Business Combination. We have not established any limit on the amount of such fees that may be paid by the
Post-Combination Company to our directors or members of management. It is unlikely the amount of such compensation will be known at the time of the Business Combination, because the directors of the
Post-Combination Company will be responsible for determining officer and director compensation. Any compensation to be paid to our officers will be determined, or recommended to the Board for determination,
either by a compensation committee constituted solely by independent directors or by a majority of independent directors on our board of directors.
Following a business combination, to the extent we deem it necessary, we may seek to recruit additional managers to supplement the incumbent
management team of the target business. We cannot assure you that we
115
will have the ability to recruit additional managers, or that additional managers will have the requisite skills, knowledge or experience necessary to enhance the incumbent management.
Committees of the Board of Directors
Our
Board has two standing committees: an audit committee and a compensation committee. Each committee operates under a charter approved by our board with the composition and responsibilities described below. The charter of each committee is available
on our website.
Audit Committee
We
have established an audit committee of the Board. William A. Fustos, Thomas A. Lopus and Thomas W. Corbett, Jr. serve as members of our audit committee. Under Nasdaq listing standards and applicable SEC rules, we are required to have at least three
members of the audit committee, all of whom must be independent. Under Nasdaq listing standards and applicable SEC rules, our audit committee must have one independent member at the time of listing, a majority of independent members within 90 days
of listing, and consist of all independent members within one year of listing. Mr. Fustos meets the independent director standard under Nasdaqs listing standard and under Rule 10A-3(b)(1) of the
Exchange Act, and serves as chairman of the audit committee.
Each member of the audit committee is financially literate and our Board has
determined that Mr. Fustos qualifies as an audit committee financial expert as defined in applicable SEC rules.
We have
adopted an audit committee charter, which details the principal functions of the audit committee, including:
|
|
|
the appointment, compensation, retention, replacement and oversight of the work of the independent auditors and
any other independent registered public accounting firm engaged by us; |
|
|
|
pre-approving all audit and permitted
non-audit services to be provided by the independent auditors or any other registered public accounting firm engaged by us, and establishing pre-approval policies and
procedures; |
|
|
|
reviewing and discussing with the independent auditors all relationships the auditors have with us in order to
evaluate their continued independence; |
|
|
|
setting clear hiring policies for employees or former employees of the independent auditors;
|
|
|
|
setting clear policies for audit partner rotation in compliance with applicable laws and regulations;
|
|
|
|
obtaining and reviewing a report, at least annually, from the independent auditors describing (i) the
independent auditors internal quality-control procedures and (ii) any material issues raised by the most recent internal quality-control review, or peer review, of the audit firm, or by any inquiry or investigation by governmental or
professional authorities within the preceding five years respecting one or more independent audits carried out by the firm and any steps taken to deal with such issues; |
|
|
|
reviewing and approving any related party transaction required to be disclosed pursuant to Item 404 of Regulation
S-K promulgated by the SEC prior to us entering into such transaction; and |
|
|
|
reviewing with management, the independent auditors and our legal advisors, as appropriate, any legal, regulatory
or compliance matters, including any correspondence with regulators or government agencies and any employee complaints or published reports that raise material issues regarding our financial statements or accounting policies and any significant
changes in accounting standards or rules promulgated by the Financial Accounting Standards Board, the SEC or other regulatory authorities. |
116
Compensation Committee
We have established a compensation committee of the Board. William A. Fustos and Thomas A. Lopus serve as members of our compensation
committee. Under Nasdaq listing standard and applicable SEC rules, our compensation committee must have one independent member at the time of listing, a majority of independent members within 90 days of listing, and consist of all independent
members within one year of listing. Mr. Fustos meets the independent director standard under Nasdaq listing standards, and will serve as chairman of the compensation committee.
We have adopted a compensation committee charter, which details the principal functions of the compensation committee, including:
|
|
|
reviewing and approving on an annual basis the corporate goals and objectives relevant to our Chief Executive
Officers compensation, evaluating our Chief Executive Officers performance in light of such goals and objectives and determining and approving the remuneration (if any) of our Chief Executive Officer based on such evaluation;
|
|
|
|
reviewing and approving on an annual basis the compensation of all of our other officers; |
|
|
|
reviewing on an annual basis our executive compensation policies and plans; |
|
|
|
implementing and administering our incentive compensation equity-based remuneration plans; |
|
|
|
assisting management in complying with our proxy statement and annual report disclosure requirements;
|
|
|
|
approving all special perquisites, special cash payments and other special compensation and benefit arrangements
for our officers and employees; |
|
|
|
if required, producing a report on executive compensation to be included in our annual proxy statement; and
|
|
|
|
reviewing, evaluating and recommending changes, if appropriate, to the remuneration for directors.
|
Notwithstanding the foregoing, as indicated above, no compensation of any kind, including finders, consulting or
other similar fees, will be paid to any of our existing stockholders, officers, directors or any of their respective affiliates, prior to, or for any services they render in order to complete the consummation of a business combination. Accordingly,
it is likely that prior to the consummation of an initial business combination, the compensation committee will only be responsible for the review and recommendation of any compensation arrangements to be entered into in connection with such initial
business combination.
The Existing Charter also provides that the compensation committee may, in its sole discretion, retain or obtain
the advice of a compensation consultant, legal counsel or other adviser and will be directly responsible for the appointment, compensation and oversight of the work of any such adviser. However, before engaging or receiving advice from a
compensation consultant, external legal counsel or any other adviser, the compensation committee will consider the independence of each such adviser, including the factors required by Nasdaq and the SEC.
Director Nominations
We do not have a
standing nominating committee. In accordance with Rule 5605(e)(2) of the Nasdaq Rules, a majority of the independent directors may recommend a director nominee for selection by the Board. The Board believes that the independent directors can
satisfactorily carry out the responsibility of properly selecting or approving director nominees without the formation of a standing nominating committee. As we do not have a standing nominating committee, we do not have a nominating committee
charter in place.
117
Our Board will consider candidates for nomination who have a high level of personal and
professional integrity, strong ethics and values and the ability to make mature business judgments. In general, in identifying and evaluating nominees for director, our Board will also consider experience in corporate management such as serving as
an officer or former officer of a publicly held company, experience as a board member of another publicly held company, professional and academic experience relevant to our business, leadership skills, experience in finance and accounting or
executive compensation practices, whether candidate has the time required for preparation, participation and attendance at Board meetings and committee meetings, if applicable, independence and the ability to represent the best interests of our
stockholders.
Compensation Committee Interlocks and Insider Participation
None of our officers currently serves, and in the past year none of them has served, as a member of the compensation committee of any entity
that has one or more officers serving on our Board.
Code of Ethics
We have adopted a Code of Ethics applicable to our directors, officers and employees. The Code of Ethics will be available on our website
https://www.eastresources.com. We will also post any amendments to or waivers of our Code of Ethics on our website.
Section 16(a) Beneficial
Ownership Reporting Compliance
Section 16(a) of the Exchange Act requires our officers, directors and persons who
beneficially own more than ten percent of our common stock to file reports of ownership and changes in ownership with the SEC. These reporting persons are also required to furnish us with copies of all Section 16(a) forms they file. Based
solely upon a review of such forms, we believe that all reporting requirements for fiscal year 2022 were complied with by each person who at any time during the 2022 fiscal year was a director or an executive officer or held more than 10% of our
common stock.
Corporate Governance Guidelines
Our Board has adopted corporate governance guidelines in accordance with the corporate governance rules of Nasdaq that serve as a flexible
framework within which our Board and its committees operate. These guidelines cover a number of areas including board membership criteria and director qualifications, director responsibilities, board agenda, roles of the Chairman of the Board, Chief
Executive Officer and presiding director, meetings of independent directors, committee responsibilities and assignments, board member access to management and independent advisors, director communications with third parties, director compensation,
director orientation and continuing education, evaluation of senior management and management succession planning. A copy of our corporate governance guidelines is posted on our website.
Conflicts of Interest
Certain of our
officers and directors presently have, and any of them in the future may have additional, fiduciary or contractual obligations to other entities pursuant to which such officer or director is or will be required to present business combination
opportunities to such entity. Accordingly, in the future, if any of our officers or directors becomes aware of a business combination opportunity which is suitable for an entity to which he or she has then-current fiduciary or contractual
obligations, he or she will honor his or her fiduciary or contractual obligations to present such opportunity to such entity. We do not believe, however, that any fiduciary duties or contractual obligations of our officers would materially undermine
our ability to complete our business combination. The Existing Charter provides that we renounce our interest in any corporate opportunity offered to any director or officer unless such opportunity is expressly offered to such person solely in his
or her capacity as
118
a director or officer of our company and such opportunity is one we are legally and contractually permitted to undertake and would otherwise be reasonable for us to pursue, and to the extent such
person is permitted to refer that opportunity to us without violating another legal obligation. This waiver allows our Sponsor and its affiliates to allocate opportunities based on a combination of the objectives and fundraising needs of the target,
as well as the investment objectives of the entity. However, we do not believe that the waiver of the corporate opportunities doctrine otherwise had a material impact on our search for an acquisition target.
Our Board has consented to the participation of our officers and directors in the formation of, or becoming an officer or director of, any
other special purpose acquisition company with a class of securities registered under the Exchange Act prior to our entering into a definitive agreement regarding our initial business combination.
Notwithstanding the foregoing, we may pursue an acquisition opportunity jointly with our Sponsor, or one or more of its affiliates, which we
refer to as an Affiliated Joint Acquisition. Such entities may co-invest with us in the target business at the time of our initial business combination, or we could raise additional proceeds to
complete the acquisition by issuing to such entity a class of equity or equity-linked securities. Each of our officers and directors presently has, and any of them in the future may have, additional fiduciary or contractual obligations to other
entities pursuant to which such officer or director is or will be required to present a business combination opportunity to such entity. Accordingly, if any of our officers or directors becomes aware of a business combination opportunity which is
suitable for an entity to which he or she has then-current fiduciary or contractual obligations, he or she will honor his or her fiduciary or contractual obligations to present such opportunity to such other entity. We do not believe, however, that
the fiduciary duties or contractual obligations of our officers or directors will materially affect our ability to complete our business combination. In addition, we may pursue an Affiliated Joint Acquisition opportunity with an entity to which an
officer or director has a fiduciary or contractual obligation. Any such entity may co-invest with us in the target business at the time of our initial business combination, or we could raise additional
proceeds to complete the acquisition by issuing to such entity a class of equity or equity-linked securities. The Existing Charter provides that we renounce our interest in any corporate opportunity offered to any director or officer unless such
opportunity is expressly offered to such person solely in his or her capacity as a director or officer of our company and such opportunity is one we are legally and contractually permitted to undertake and would otherwise be reasonable for us to
pursue, and to the extent such person is permitted to refer that opportunity to us without violating another legal obligation. This waiver allows our Sponsor and its affiliates to allocate opportunities based on a combination of the objectives and
fundraising needs of the target, as well as the investment objectives of the entity. However, we do not believe that the waiver of the corporate opportunities doctrine otherwise had a material impact on our search for an acquisition target. In
addition, the Company and its affiliates, including our officers and directors who are affiliated with the Company, may sponsor or form other blank check companies similar to ours during the period in which we are seeking an initial business
combination. Any such companies may present additional conflicts of interest in pursuing an acquisition target. However, we do not believe that any such potential conflicts would materially affect our ability to complete our initial business
combination.
Potential investors should also be aware of the following other potential conflicts of interest:
|
|
|
None of our officers or directors is required to commit his or her full time to our affairs in particular and,
accordingly, each of them may have conflicts of interest in allocating his or her time among various business activities. |
|
|
|
In the course of their other business activities, our officers and directors may become aware of investment and
business opportunities which may be appropriate for presentation to us as well as the other entities with which they are affiliated. Our officers and directors may have conflicts of interest in determining to which entity a particular business
opportunity should be presented. |
|
|
|
Our Sponsor, officers and directors have agreed to waive their redemption rights with respect to any shares of
ERES Common Stock held by them in connection with the consummation of our initial business combination. Additionally, our Sponsor, officers and directors have agreed to waive their |
119
|
redemption rights with respect to any Founder Shares held by them if we fail to consummate our initial business combination within the Completion Window. These waivers were made at the time of
the ERES IPO for no additional consideration. If we do not complete our initial business combination within such applicable time period, the proceeds of the sale of the Private Placement Warrants held in the Trust Account will be used to fund the
redemption of our Public Shares, and the Private Placement Warrants will expire worthless. With certain limited exceptions, the Founder Shares will not be transferable, assignable by our Sponsor until the earlier of: (A) one year after the
completion of our initial business combination or (B) subsequent to our initial business combination, (x) if the last sale price of our Class A Common Stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock
dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after our initial business combination, or
(y) the date on which we complete a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of our stockholders having the right to exchange their shares of common stock for cash, securities
or other property. With certain limited exceptions, the Private Placement Warrants and the Class A Common Stock underlying such warrants, will not be transferable, assignable or salable by our Sponsor or its permitted transferees until
30 days after the completion of our initial business combination. Since our Sponsor, officers and directors may directly or indirectly own Common Stock and warrants following the ERES IPO, our officers and directors may have a conflict of
interest in determining whether a particular target business is an appropriate business with which to complete our initial business combination. |
|
|
|
Our officers and directors may have a conflict of interest with respect to evaluating a particular business
combination if the retention or resignation of any such officers and directors was included by a target business as a condition to any agreement with respect to our initial business combination. |
|
|
|
Our Sponsor, officers or directors may have a conflict of interest with respect to evaluating a business
combination and financing arrangements as we may obtain loans from our Sponsor or an affiliate of our Sponsor or any of our officers or directors to finance transaction costs in connection with an intended initial business combination. Up to
$2,000,000 of such loans may be convertible into warrants at a price of $1.50 per warrant at the option of the lender. Such warrants would be identical to the Private Placement Warrants, including as to exercise price, exercisability and exercise
period. |
The conflicts described above may not be resolved in our favor.
In general, officers and directors of a corporation incorporated under the laws of the State of Delaware are required to present business
opportunities to a corporation if:
|
|
|
the corporation could financially undertake the opportunity; |
|
|
|
the opportunity is within the corporations line of business; and |
|
|
|
it would not be fair to our company and its stockholders for the opportunity not to be brought to the attention
of the corporation. |
Accordingly, as a result of multiple business affiliations, our officers and directors may have
similar legal obligations relating to presenting business opportunities meeting the above-listed criteria to multiple entities. Furthermore, the Existing Charter provides that we renounce our interest in any corporate opportunity offered to any
director or officer unless such opportunity is expressly offered to such person solely in his or her capacity as a director or officer of our company and such opportunity is one we are legally and contractually permitted to undertake and would
otherwise be reasonable for us to pursue, and to the extent the director or officer is permitted to refer that opportunity to us without violating another legal obligation. This waiver allows our Sponsor and its affiliates to allocate opportunities
based on a combination of the objectives and fundraising needs of the target, as well as the investment objectives of the entity. However, we do not believe that the waiver of the corporate opportunities doctrine otherwise had a material impact on
our search for an acquisition target.
120
We are not prohibited from pursuing an initial business combination with a company that is
affiliated with our Sponsor, officers or directors, subject to certain approvals and consents. In the event we seek to complete our initial business combination with such a company, we, or a committee of independent directors, would obtain an
opinion from an independent investment banking firm which is a member of FINRA, or from an independent accounting firm, that such an initial business combination is fair to our company from a financial point of view.
We cannot assure you that any of the above mentioned conflicts will be resolved in our favor.
In the event that we submit our initial business combination to our Public Stockholders for a vote, the Sponsor has agreed to vote any shares
of ERES Common Stock owned by it in favor of our initial business combination and our officers and directors have also agreed to vote any shares of ERES Common Stock purchased during or after the ERES IPO in favor of our initial business
combination.
Limitation on Liability and Indemnification of Officers and Directors
The Existing Charter provides that our officers and directors will be indemnified by us to the fullest extent authorized by Delaware law, as it
now exists or may in the future be amended. In addition, the Existing Charter provides that our directors will not be personally liable for monetary damages to us or our stockholders for breaches of their fiduciary duty as directors, unless they
violated their duty of loyalty to us or our stockholders, acted in bad faith, knowingly or intentionally violated the law, authorized unlawful payments of dividends, unlawful stock purchases or unlawful redemptions, or derived an improper personal
benefit from their actions as directors.
We will enter into agreements with our officers and directors to provide contractual
indemnification in addition to the indemnification provided for in the Existing Charter. Our bylaws also will permit us to secure insurance on behalf of any officer, director or employee for any liability arising out of his or her actions,
regardless of whether Delaware law would permit such indemnification. We will purchase a policy of directors and officers liability insurance that insures our officers and directors against the cost of defense, settlement or payment of a
judgment in some circumstances and insures us against our obligations to indemnify our officers and directors.
These provisions may
discourage stockholders from bringing a lawsuit against our directors for breach of their fiduciary duty. These provisions also may have the effect of reducing the likelihood of derivative litigation against officers and directors, even though such
an action, if successful, might otherwise benefit us and our stockholders. Furthermore, a stockholders investment may be adversely affected to the extent we pay the costs of settlement and damage awards against officers and directors pursuant
to these indemnification provisions.
We believe that these provisions, the directors and officers liability insurance and the
indemnity agreements are necessary to attract and retain talented and experienced officers and directors.
Insofar as indemnification for
liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling us pursuant to the foregoing provisions, we have been informed that in the opinion of the SEC such indemnification is against public policy
as expressed in the Securities Act and is therefore unenforceable.
121
SELECTED HISTORICAL FINANCIAL INFORMATION OF ERES
The selected historical financial information of ERES for the years ended December 31, 2022 and 2021 was derived from the audited consolidated
financial statements of ERES included elsewhere in this proxy statement. You should read the following summary financial information in conjunction with the section titled ERES Managements Discussion and Analysis of
Financial Condition and Results of Operations and ERESs financial statements and related notes appearing elsewhere in this proxy statement.
|
|
|
|
|
|
|
|
|
|
|
For the year ended December 31, |
|
|
For the year ended December 31, |
|
|
|
2022 |
|
|
2021 |
|
Statement of Operations Data: |
|
|
|
|
|
|
|
|
Loss from operations |
|
$ |
(11,722,287 |
) |
|
$ |
(1,382,681 |
) |
Other income (expense) |
|
$ |
11,131,208 |
|
|
$ |
17,222,046 |
|
Net income (loss) |
|
$ |
(643,564 |
) |
|
$ |
15,839,365 |
|
Basic and diluted weighted average shares outstanding, Class A common stock subject to possible
redemption |
|
|
23,637,084 |
|
|
|
34,500,000 |
|
Basic and diluted net income (loss) per share, Class A common stock subject to possible
redemption |
|
$ |
(0.02 |
) |
|
$ |
0.37 |
|
Basic and diluted weighted average shares outstanding, Non-redeemable common stock |
|
|
8,625,000 |
|
|
|
8,625,000 |
|
Basic and diluted net income (loss) per share, Non-redeemable common stock |
|
$ |
(0.02 |
) |
|
$ |
0.37 |
|
|
|
|
Statement of Cash Flows Data: |
|
|
|
|
|
|
|
|
Net cash used in operating activities |
|
$ |
(2,602,281 |
) |
|
$ |
(1,236,555 |
) |
Net cash used in investing activities |
|
$ |
246,498,623 |
|
|
$ |
|
|
Net cash provided by financing activities |
|
$ |
(244,662,900 |
) |
|
$ |
1,500,000 |
|
Net Change in Cash |
|
$ |
(766,558 |
) |
|
$ |
263,445 |
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31, |
|
|
|
2022 |
|
|
2021 |
|
Balance Sheet Data: |
|
|
|
|
|
|
|
|
Total Assets |
|
$ |
99,374,190 |
|
|
$ |
345,993,643 |
|
Total Liabilities |
|
$ |
18,780,609 |
|
|
$ |
29,231,054 |
|
Class A common stock subject to possible redemption |
|
|
98,983,437 |
|
|
|
345,000,000 |
|
Total Stockholders Deficit |
|
$ |
(18,389,856 |
) |
|
$ |
(28,237,411 |
) |
122
ERES MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND RESULTS OF OPERATIONS
The following discussion and analysis of ERESs financial condition and results of
operations should be read in conjunction with ERESs financial statements and the notes thereto contained elsewhere in this proxy statement. Certain information contained in the discussion, including, but not limited to, those described under
the heading Risk Factors and analysis set forth below includes forward-looking statements that involve risks and uncertainties. References in this section to ERES, we,
us and our are intended to mean the business and operations of ERES.
Overview
We are a blank check company formed under the laws of the State of Delaware on May 22, 2020 for the purpose of effecting a merger, capital
stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses. We intend to effectuate our initial business combination using cash from the proceeds of the ERES IPO and the sale
of the Private Placement Warrants, our capital stock, debt or a combination of cash, stock and debt.
On August 30, 2022, ERES
entered into the Merger Agreement with the Companies. If (i) the Merger Agreement is adopted and the transactions contemplated thereby, including the Mergers, are approved by ERESs stockholders and (ii) the Mergers are subsequently
completed, Abacus Merger Sub will merge with and into Abacus, with Abacus surviving the Merger as a wholly owned subsidiary of ERES and LMA Merger Sub will merge with and into LMA, with LMA surviving the Merger as a wholly owned subsidiary of ERES.
We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete
a Business Combination will be successful.
Results of Operations
We have neither engaged in any operations (other than searching for a business combination after the ERES IPO) nor generated any revenues to
date. Our only activities from May 22, 2020 (inception) through December 31, 2022 were organizational activities, those necessary to prepare for the Initial Public Offering, described below, and, subsequent to the Initial Public Offering,
identifying a target company for a Business Combination and completing such Business Combination. We do not expect to generate any operating revenues until after the completion of the Mergers. We generate
non-operating income in the form change in fair value of warrant liability, change in fair value of forward purchase agreements (prior to the termination of the forward purchase agreement on December 2,
2022), interest income from bank, and, until June 2022 when all investments in the Trust Account were liquidated to thereafter be held in cash as further explained in Note 1 to the financial statements, we also generated interest income on
marketable securities held in the Trust Account. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.
For the year ended December 31, 2022, we had a net loss of $643,564, which consists of operating costs of $11,722,287, offset by a change in
fair value of warrant liability of $9,335,550, a change in fair value of the forward purchase agreement liability of $600,000, interest earned from bank of $10,031, interest earned on marketable securities held in the Trust Account of $672,439 and
income tax expense of $52,485.
For the year ended December 31, 2021, we had a net income of $15,839,365, which consists of
operating costs of $1,382,681, offset by a change in fair value of warrant liability of $15,899,200, a change in fair value of the forward purchase agreement liability of $1,300,000, interest earned from bank of $62 and interest earned on marketable
securities held in the Trust Account of $22,784.
123
Liquidity and Capital Resources
On July 27, 2020, we consummated the ERES IPO of 30,000,000 Units at a price of $10.00 per unit, generating gross proceeds of
$300,000,000. Simultaneously with the closing of the initial public offering, we consummated the sale of 8,000,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant in a private placement to our stockholders, generating
gross proceeds of $8,000,000.
On August 25, 2020, the underwriters exercised their over-allotment option in full, resulting in an
additional 4,500,000 units issued for total gross proceeds of $45,000,000. In connection with the underwriters exercise of their over-allotment option, we also consummated the sale of an additional 900,000 Private Placement Warrants at $1.00
per Private Placement Warrant, generating total proceeds of $900,000. A total of $45,000,000 was deposited into the Trust Account, bringing the aggregate proceeds held in the Trust Account to $345,000,000.
Following the ERES IPO, the full exercise of the over-allotment option and the sale of the Private Placement Warrants, a total of $345,000,000
was placed in the Trust Account and we had $912,561 of cash held outside of the Trust Account, after payment of costs related to the initial public offering, and available for working capital purposes. We incurred $19,840,171 in transaction costs,
including $6,900,000 in cash underwriting fees, $12,075,000 of deferred underwriting fees and $865,171 of other offering costs.
For
the period ended December 31, 2022, cash used in operating activities was $2,602,281. Net loss of $643,564 was affected by non-cash charges for the change in fair value of warrant liability of $9,335,550, change in fair value of forward purchase
agreement liability of $600,000, interest earned on marketable securities held in the trust account of $672,439, gain on deferred underwriting fee waiver of $513,188 and changes in operating assets and liabilities, which used $9,162,460 of cash in
operating activities.
For the period ended December 31, 2021, cash used in operating activities was $1,236,555. Net income of
$15,839,365 was affected by non-cash charges for the change in fair value of warrant liability of $15,899,200, change in fair value of forward purchase agreement liability of $1,300,000, interest earned on
marketable securities held in the Trust Account of $22,784 and changes in operating assets and liabilities, which used $90,353 of cash in operating activities.
As of December 31, 2022 and December 31, 2021, we had cash and marketable securities held in the Trust Account of $99,222,704 and
$345,048,888, respectively. We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account to complete our initial business combination. We may withdraw interest to
pay franchise and income taxes. During the period ended December 31, 2022 we withdrew $335,723 of interest earned on the Trust Account. During the period ended December 31, 2021, we did not withdraw any interest earned on the Trust Account. To the
extent that our capital stock or debt is used, in whole or in part, as consideration to complete our initial business combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the
target business or businesses, make other acquisitions and pursue our growth strategies.
As of December 31, 2022 and December 31,
2021, we had cash of $86,572 and $853,130, respectively, outside of the Trust Account. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective
target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure,
negotiate and complete a business combination.
In order to fund working capital deficiencies or finance transaction costs in
connection with an initial business combination, the Sponsor, an affiliate of the Sponsor, or our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete a business combination, we would repay such
loaned amounts. In the event that a business combination does not close, we may use a portion of the working
124
capital held outside the Trust Account to repay such loaned amounts but no proceeds from our Trust Account would be used for such repayment. Up to $2,000,000 of such loans may be convertible into
warrants, at a price of $1.50 per warrant at the option of the lender. The warrants would be identical to the Private Placement Warrants, including as to exercise price, exercisability and exercise period. The terms of such loans by our officers and
directors, if any, have not been determined and no written agreements exist with respect to such loans. The loans would be repaid upon consummation of a business combination, without interest.
On February 15, 2021, the Sponsor committed to provide us an aggregate of $500,000 in loans for working capital purpose.
On July 25, 2022, in connection with the approval of the Extension Amendment Proposal, we issued the Extension Note in the principal
amount of up to $1,924,356 and an additional working capital note of up to $1,500,000. Both notes bear no interest and are repayable in full upon the earlier of (a) the date of the consummation of our initial business combination, or
(b) our date of the liquidation.
On January 23, 2023, in connection with the approval of the Second Extension Amendment Proposal, we
issued the Second Extension Note in the principal amount of up to $565,497.31 and increased the additional working capital note to up to $3,000,000. Both notes bear no interest and are repayable in full upon the earlier of (a) the date of the
consummation of our initial business combination, or (b) our date of the liquidation.
Until the consummation of a business
combination, we will be using the funds not held in the Trust Account for identifying and evaluating prospective acquisition candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target
business to acquire, and structuring, negotiating and consummating a business combination. We may need to raise additional capital through loans or additional investments from our Sponsor, stockholders, officers, directors, or third parties. Our
officers, directors and Sponsor may, but are not obligated to, loan us funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet our working capital needs. Accordingly, we may not be able to
obtain additional financing. If we are unable to raise additional capital, we may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of
a potential transaction and reducing overhead expenses. In addition, we may have to liquidate if the business combination is not completed before July 27, 2023.
We cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all, or that it will
complete a Business Combination prior to the expiration of the Completion Window. These conditions raise substantial doubt about the our ability to continue as a going concern through one year from the issuance of these financial statements. These
financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should we be unable to continue as a going concern.
Going Concern
In connection with our
assessment of going concern considerations in accordance with Financial Accounting Standard Boards Accounting Standards Update (ASU) 2014-15, Disclosures of Uncertainties about an
Entitys Ability to Continue as a Going Concern, management has determined that if we are unable to complete a business combination by July 27, 2023, then we will cease all operations except for the purpose of liquidating. The
liquidity condition and date for mandatory liquidation and subsequent dissolution raise substantial doubt about our ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should we be
required to liquidate after July 27, 2023.
Off-Balance Sheet Financing Arrangements
We have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements
as of December 31, 2022. We do not participate in transactions that create relationships with unconsolidated entities
125
or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance
sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.
Contractual Obligations
We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than an agreement to
pay two affiliates of the Sponsor a monthly fee of $10,000 each for office space and administrative support to us. We began incurring these fees on July 24, 2020 and will continue to incur these fees monthly until the earlier of the completion
of the initial business combination and our liquidation. For the years ended December 31, 2022 and December 31, 2021, we incurred and paid an aggregate of $240,000 and $240,000 in connection with these agreements, respectively.
The underwriters are entitled to a deferred fee of $0.35 per unit, or $12,075,000 in the aggregate. Wells Fargo Securities, LLC, as the sole
book running manager for our initial public offering, has agreed to waive its entitlement to any deferred underwriting fees.
On
July 2, 2020, we entered into a forward purchase agreement pursuant to which East Asset Management, an affiliate of the Sponsor, has agreed to purchase an aggregate of up to 5,000,000 forward purchase units, consisting of one forward purchase
shares and one-half of one forward purchase warrants, for $10.00 per unit, or an aggregate maximum amount of $50,000,000, in a private placement that will close simultaneously with the closing of a business
combination. On and effective as of December 2, 2022, we and East Asset Management entered into an agreement to terminate the forward purchase agreement, pursuant to which the parties agreed that no payments or deliveries are due by either party in
respect of the forward purchase agreement and the forward purchase agreement is in no further force and effect.
In addition, in order
to finance transaction costs in connection with an intended initial business combination, our Sponsor or an affiliate of our Sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we
complete an initial business combination, we would repay such loaned amounts. In the event that the initial business combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such loaned amounts
but no proceeds from our Trust Account would be used for such repayment. As of December 31, 2022, our Sponsor has loaned to us an aggregate of $1,500,000 for working capital purposes. The Working Capital Note does not bear interest and is repayable
in full upon consummation of a business combination. If we do not complete a business combination, the Working Capital Note need not be repaid and all amounts owed under it will be forgiven. The Working Capital Note is subject to customary events of
default, the occurrence of which automatically trigger the unpaid principal balance of the Working Capital Note and all other sums payable with regard to the Working Capital Note becoming immediately due and payable. We do not expect to seek loans
from parties other than our Sponsor or an affiliate of our Sponsor as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our trust account.
On July 25, 2022, in connection with the Extension Amendment, we entered into the Extension Note with our Sponsor, and on January 23, 2023, in
connection with the Second Extension Amendment, we entered into the Second Extension Note with our Sponsor. Pursuant to the Extension Note, the Sponsor agreed that it will contribute to us as a loan of $0.033 for each public share that was not
redeemed in connection with the stockholder vote to approve the Extension Amendment, for each month until the earlier of (i) the date of the special meeting held in connection with the stockholder vote to approve a business combination and
(ii) January 27, 2023 if we failed to complete a business combination by such date. Pursuant to the Second Extension Note, the Sponsor agreed that it will contribute to us as a loan of $0.033 for each public share that was not redeemed in
connection with the stockholder vote to approve the Second Extension Amendment, for each month until the earlier of (i) the date of the special meeting held in connection with the stockholder vote to
126
approve a business combination and (ii) July 27, 2023 if we fail to complete a business combination by such date. As of December 31, 2022, there was a balance of $1,924,356 under the First
Extension Note. As of April 17, 2023, there was a balance of $282,748.65 under the Second Extension Note.
The Extension Note and the
Second Extension Note do not bear interest and are repayable in full upon the earlier of (i) the date of the consummation of our initial business combination and (ii) the date of our liquidation. At any time prior to payment in full of the principal
balance of the Extension Note, the holder of the Extension Note (or a permitted assignee) will have the option, but not the obligation, to convert up to $1,500,000 of the unpaid principal balance of the Extension Note into that number of warrants,
each whole warrant exercisable for one share of our Class A Common Stock, equal to the principal amount of the Extension Note so converted divided by $1.50. At any time prior to payment in full of the principal balance of the Second Extension Note,
the holder of the Second Extension Note (or a permitted assignee) will have the option, but not the obligation, to convert up to $500,000 of the unpaid principal balance of the Second Extension Note into that number of warrants, each whole warrant
exercisable for one share of our Class A Common Stock, equal to the principal amount of the Second Extension Note so converted divided by $1.50. The terms of the warrants resulting from conversion of the Extension Note and the Second Extension Note
will be identical to the terms of the Private Placement Warrants. Our Sponsor will have the sole discretion whether to continue extending for additional months, and if it determines not to continue extending for additional months, its obligation to
make additional contributions will terminate. If this occurs, we would wind up our affairs and redeem 100% of the outstanding Class A Common Stock in accordance with the procedures set forth in our charter. The maturity date of the Extension Note
and the Second Extension Note may be accelerated upon the occurrence of an Event of Default (as defined therein). We may prepay any outstanding principal under the Extension Note and the Second Extension Note at any time, at our election and without
penalty, provided, however, our Sponsor shall have a right to first convert such principal balance as described in Section 17 of each of the Extension Note and the Second Extension Note upon notice of such prepayment. If a business combination is
not completed and we liquidate, there will not be sufficient assets to repay the Extension Note and the Second Extension Note and they will be worthless.
Critical Accounting Policies and Estimates
The preparation of Condensed Consolidated financial statements and related disclosures in conformity with accounting principles generally
accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and
income and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following critical accounting policies:
Derivative Financial Instruments.
We
evaluate its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, Derivatives and Hedging. Our derivative instruments are
recorded at fair value and re-valued at each reporting date, with changes in the fair value reported in the Condensed Consolidated Statement of Operations. Derivative assets and liabilities are classified on
the Condensed Consolidated balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within
12 months of the Condensed Consolidated balance sheet date. We have determined the warrants and the forward contract for additional warrants are derivatives. As the financial instruments meet the definition of a derivative, the warrants and the
forward contract for additional warrants are measured at fair value at issuance and at each reporting date in accordance with ASC 820, Fair Value Measurement, with changes in fair value recognized in the Condensed Consolidated Statement of
Operations in the period of change.
Class A Common Stock Subject to Possible Redemption.
We account for our shares of Class A Common Stock subject to possible redemption in accordance with the guidance in ASC Topic
480 Distinguishing Liabilities from Equity. Shares of Class A Common Stock subject
127
to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that
are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) is classified as temporary equity. At all other times, common stock is classified as stockholders
equity. Our common stock features certain redemption rights that are considered to be outside of our control and subject to occurrence of uncertain future events. Accordingly, all shares of Class A Common Stock subject to possible redemption
are presented as temporary equity, outside of the stockholders equity section of our balance sheet.
Net income (loss) per Common Share.
We apply the two-class method in calculating earnings (loss) per share. Net income (loss) per common
share, basic and diluted, for common stock subject to possible redemption is calculated by dividing the proportionate share of income on marketable securities held by the Trust Account, net of applicable franchise and income taxes, by the weighted
average number of common stock subject to possible redemption outstanding over the period. Net income (loss) is allocated evenly on a pro rata basis between Class A Common Stock and Class B Common Stock on weighted average number of shares
of common stock outstanding over the period. Remeasurement associated with the redeemable shares of Class A Common Stock is excluded from earnings (loss) per share as the redemption value approximates its fair value. The calculation of diluted
income (loss) per common share does not consider the effect of the warrants issued since the exercise of the warrants are contingent upon the occurrence of future events. However, the diluted earnings (loss) per share calculation includes the shares
subject to forfeiture from the first day of the interim period in which the contingency on such shares was resolved.
Recent accounting standards.
In August 2020, the Financial Accounting Standards Board issued Accounting Standards Update (ASU) 2020-06, DebtDebt with Conversion and Other Options (Subtopic 470-20) and Derivatives and HedgingContracts in Entitys Own Equity (Subtopic 815-40) (ASU 2020-06) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models
that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entitys own equity. The
new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entitys own equity. ASU 2020-06 amends the diluted earnings per
share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2022 for public
business entities that meet the definition of a Securities SEC filer, excluding entities eligible to be smaller reporting companies as defined by the SEC and should be applied on a full or modified retrospective basis, with early adoption permitted
beginning on January 1, 2021. We plan to adopt the standard on January 1, 2024, and we are currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of
operations or cash flows.
Management does not believe that any other recently issued, but not yet effective, accounting standards, if
currently adopted, would have a material effect on our Condensed Consolidated financial statements.
Quantitative and Qualitative Disclosures About
Market Risk
As of December 31, 2022, we were not subject to any market or interest rate risk. Following the consummation of our
initial public offering, and prior to June 2022, at which time the assets in the trust account were liquidated to thereafter be held in cash (as described previously in this proxy statement), the net proceeds of our initial public offering,
including amounts in the Trust Account, were invested in U.S. government treasury bills, notes or bonds with a maturity of 185 days or less or in certain money market funds that invest solely in U.S. treasuries. Due to the short-term nature of these
investments, there was no associated material exposure to interest rate risk.
128
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
OF ERES AND THE POST-COMBINATION COMPANY
The following table and accompanying footnotes
set forth information known to ERES regarding (i) the actual beneficial ownership of ERES Class A Common Stock and ERES Class B Common Stock, as of April 21, 2023 and (ii) expected beneficial ownership of the Post-Combination Company immediately following consummation of the Business Combination, assuming no Public Shares of ERES are redeemed, and alternatively that all Public Shares of ERES are redeemed, by:
|
|
|
each person who is, or is expected to be, the beneficial owner of more than 5% of the outstanding shares of
common stock of ERES or the Post-Combination Company, as applicable; |
|
|
|
each of ERESs current directors and executive officers; |
|
|
|
each person who will become a director or executive officer of the
Post-Combination Company; and |
|
|
|
all directors and officers of ERES, as a group, and of the
Post-Combination Company, as a group. |
The beneficial ownership of ERES
Common Stock is based on 2,856,047 shares Class A Common Stock issued and outstanding and 8,625,000 shares of Class B Common Stock issued and outstanding as of April 21, 2023.
The expected beneficial ownership of shares of the Post-Combination Companys common stock on a
fully diluted basis, assuming no Public Shares of ERES are redeemed, has been determined based upon the following: (i) no Public Stockholder has exercised its redemption rights to receive cash from the Trust Account in exchange for its Public
Shares; (ii) 8,625,000 shares of common stock have been issued pursuant to the conversion of Class B Common Stock; (iii) there will be an aggregate of 64,656,047 shares of the Post-Combination
Companys common stock issued and outstanding at the Closing and (iv) an aggregate of up to 27,483,333 shares of common stock underlying warrants that will become exercisable 30 days following the Closing, including (1) 26,150,000 shares
of common stock underlying ERESs public and private warrants and the warrant pool and (2) up to 1,000,000 shares of common stock underlying the Extension Warrants and up to 333,333 shares of common stock underlying the Second Extension
Warrants.
The expected beneficial ownership of shares of the Post-Combination Companys
common stock on a fully diluted basis, assuming all Public Shares of ERES have been redeemed, has been determined based on the following: (i) Public Stockholders have exercised their redemption rights with respect to 2,856,047 shares of
Class A Common Stock in the Assuming Maximum Redemption of Public Shares column; (ii) 8,625,000 shares of common stock have been issued pursuant to the conversion of Class B Common Stock; (iii) there will be an aggregate
of 61,800,000 shares of the Post-Combination Companys common stock issued and outstanding at the Closing and (iv) an aggregate of up to 27,483,333 shares of common stock underlying warrants that will
become exercisable 30 days following the Closing, including (1) 26,150,000 shares of common stock underlying ERESs public and private warrants and the warrant pool and (2) 1,000,000 shares of common stock underlying the Extension Warrants and
up to 333,333 shares of common stock underlying the Second Extension Warrants.
Beneficial ownership for the purposes of the following
table is determined in accordance with the rules and regulations of the SEC. A person is a beneficial owner of a security if that person has or shares voting power, which includes the power to vote or to direct the voting of
the security, or investment power, which includes the power to dispose of or to direct the disposition of the security or has the right to acquire such powers within 60 days.
129
Unless otherwise noted in the footnotes to the following table, and subject to applicable
community property laws, the persons and entities named in the table have sole voting and investment power with respect to their beneficially owned common stock.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Before the Business Combination |
|
|
After the Business Combination |
|
|
|
Class A |
|
|
Class B |
|
|
Assuming No Redemption |
|
|
Assuming Maximum Redemption of Public Shares |
|
|
|
Number of Shares Beneficially Owned(2) |
|
|
Percentage of Class |
|
|
Number of Shares Beneficially Owned(2) |
|
|
Percentage of Class |
|
|
Number of Shares Beneficially Owned |
|
|
Percentage of Class |
|
|
Number of Shares Beneficially Owned |
|
|
Percentage of Class |
|
Name of Beneficial Owner Principal Stockholders: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
East Sponsor, LLC(1) |
|
|
|
|
|
|
|
|
|
|
8,615,000 |
|
|
|
99.88 |
% |
|
|
17,068,333 |
|
|
|
17.90 |
% |
|
|
17,068,333 |
|
|
|
18.48 |
% |
Directors and Named Executive Officers of
ERES:(3) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Terrence Pegula |
|
|
|
|
|
|
|
|
|
|
8,615,000 |
|
|
|
99.88 |
% |
|
|
17,068,333 |
|
|
|
17.90
|
%
|
|
|
17,068,333 |
|
|
|
18.48 |
% |
Gary L. Hagerman, Jr. |
|
|
1,000 |
|
|
|
* |
|
|
|
|
|
|
|
|
|
|
|
1,000 |
|
|
|
* |
|
|
|
1,000 |
|
|
|
* |
|
John P. Sieminski |
|
|
2,500 |
|
|
|
* |
|
|
|
|
|
|
|
|
|
|
|
2,500 |
|
|
|
* |
|
|
|
2,500 |
|
|
|
* |
|
James S. Morrow |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0 |
|
|
|
* |
|
|
|
0 |
|
|
|
* |
|
William A. Fustos |
|
|
22,000 |
|
|
|
* |
|
|
|
|
|
|
|
|
|
|
|
22,000 |
|
|
|
* |
|
|
|
22,000 |
|
|
|
* |
|
Thomas W. Corbett, Jr. |
|
|
|
|
|
|
|
|
|
|
10,000 |
|
|
|
* |
|
|
|
10,000 |
|
|
|
* |
|
|
|
10,000 |
|
|
|
* |
|
Benjamin Wingard(4) |
|
|
4,000 |
|
|
|
* |
|
|
|
|
|
|
|
|
|
|
|
4,000 |
|
|
|
* |
|
|
|
4,000 |
|
|
|
* |
|
Jacob Long |
|
|
5,000 |
|
|
|
* |
|
|
|
|
|
|
|
|
|
|
|
5,000 |
|
|
|
* |
|
|
|
5,000 |
|
|
|
* |
|
Adam Gusky |
|
|
2,452 |
|
|
|
* |
|
|
|
|
|
|
|
|
|
|
|
2,452 |
|
|
|
* |
|
|
|
2,452 |
|
|
|
* |
|
Directors and Executive Officers of ERES as a Group (10 Individuals) |
|
|
36,952 |
|
|
|
1.29% |
|
|
|
8,625,000 |
|
|
|
100 |
% |
|
|
17,115,285 |
|
|
|
17.95 |
% |
|
|
17,115,285 |
|
|
|
18.53 |
% |
Directors and Executive Officers of the Post-Combination Company: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
[●] |
|
|
|
[●] |
|
|
|
[●] |
|
|
|
[●] |
% |
|
|
[●] |
|
|
|
[●] |
% |
|
|
[●] |
|
|
|
[●] |
% |
Directors and Executive Officers of the Post-Combination Company as a Group
([●] Individuals) |
|
|
[●] |
|
|
|
[●] |
|
|
|
[●] |
|
|
|
[●] |
% |
|
|
[●] |
|
|
|
[●] |
% |
|
|
[●] |
|
|
|
[●] |
% |
5% Holders of the Post-Combination Company: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
East Sponsor, LLC is the record holder of the shares reported herein. East Asset Management, LLC is the
managing member of East Sponsor, LLC. Trusts controlled by Terrence M. Pegula are the sole members of East Asset Management, LLC. As such, Mr. Pegula may be deemed to have or share beneficial ownership of the Class B common stock held directly by
East Sponsor, LLC. Mr. Pegula disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly. |
(2) |
Interests shown consist solely of Founder Shares, classified as shares of Class B Common Stock. Such
shares are convertible into shares of Class A Common Stock on a one-for-one basis, subject to adjustment. |
(3) |
Unless otherwise noted, the business address of each of the following entities or individuals is c/o East
Resources Acquisition Company, 7777 NW Beacon Square Boulevard, Boca Raton, Florida 33487. |
(4) |
Benjamin Wingard was a named executive officer for purposes of the Annual Report on Form 10-K for
fiscal year ended December 31, 2022, filed by ERES on April 18, 2023. Mr. Wingard resigned from ERES effective January 31, 2023. |
ERESs Initial Stockholders beneficially own approximately 75% of the issued and outstanding shares of ERES Common Stock as of the ERES
Record Date. Because of this ownership block, the Initial Stockholders may be able to effectively exercise influence the outcome of all matters requiring approval by our stockholders, including the election of directors, amendments to our Existing
Charter and approval of significant corporate transactions, including approval of the Business Combination.
130
The Sponsor and ERESs directors and officers agreed at the time of the ERES IPO
(A) to vote any Founder Shares or Public Shares owned by them in favor of the Business Combination Proposal and (B) to waive, for no additional consideration, their redemption rights with respect to any Founder Shares and any Public Shares
held by them in connection with the completion of the Business Combination.
131
INFORMATION ABOUT THE POST-COMBINATION COMPANY FOLLOWING THE
BUSINESS COMBINATION
References in this section to the Companies, we, Abacus, us,
or our generally refer to Abacus Settlements, LLC d/b/a Abacus Life, Longevity Market Assets, LLC and their consolidated subsidiaries, collectively.
Our Mission
Abacus Mission: To
educate every life insurance policy owner that their life insurance is personal property and, like any other asset they own, has a market value that can be monetized by selling into the secondary market.
Abacus Overview
Abacus is a leading
vertically integrated alternative asset manager specializing in investing in inforce life insurance products throughout the lifecycle of a life insurance policy. Traditionally, life insurance policies are owned by individuals to insure their lives.
Consistent with our mission, we educate policyholders regarding the potential to sell their policies to investors, often at a significant premium to the current cash surrender value. As an alternative asset manager, we purchase life insurance
policies from consumers seeking liquidity and actively manage these policies over time via trading, holding and/or servicing. To date, we have purchased over $2.9 billion in policy value and have helped thousands of clients maximize the value
of their life insurance.
As one of the leading buyers of life insurance policies in the U.S. for the last 18 years, we sit at the
heart of the life settlements industry. We leverage our strong market position, highly efficient origination platform and proprietary technology to drive our revenue and profitability. Abacus and its executive team have deep experience in the life
settlement industry. Using this experience, the Company has established policies and guidelines with respect to its purchase of universal life, whole life and convertible term life insurance policies. Currently, the Company principally invests in
non-variable universal life insurance policies, with approximately eighty-nine percent (89%) of the insurance policies, measured by face value, acquired by the Company in fiscal year 2021 being non-variable universal life policies, but the Company
retains the discretion to invest in whole life or convertible term life insurance policies. These guidelines focus on the age of the insured, whether the insured is a man or a woman, the duration of the underlying life insurance policy, the expected
mortality risk of the underlying life insurance policy, the projected internal rate of return of the investment in the underlying life insurance policy and the amount of the death benefit of the underlying life insurance policy. The Company excludes
making investments in life insurance policies based on certain types of the primary health impairment associated with the underlying insured to ensure that all policies are purchased in accordance with established industry standards and state law
requirements. The Companys guidelines are designed to allow the Company to target the life insurance policies that it believes have the most upside potential to generate attractive risk-adjusted returns to the Company through either its hold
or trade portfolio. Our proven policy origination process first locates policies and screens them for eligibility for a life settlement. This process includes verifying that the policy is in force, obtaining consents and disclosures and submitting
cases for life expectancy estimates, which is a process known as origination services. We generate fees on the policies we originate, which are sourced from three channels: (i) a large and growing network of financial advisors and agents,
(ii) an on-going direct-to-consumer marketing campaign and (iii) a number of traditional life settlements
intermediaries that submit policies to us on behalf of an advisor or client. Once identified, we utilize our proprietary heat-map technology platform to determine the initial risk and viability of
policies. Thereafter, a purchased policy is actively managed, whereby we consistently monitor the policy risk to optimize revenue by choosing to either (x) trade the policy to a third-party institutional investor (i.e., receive a
trade spread) or (y) hold the policy over time (i.e., pay premiums and receive payout). Additionally, we service policies on behalf of third parties for which we receive fees as a percentage of the values of the policies. Our multi-faceted and
dynamic revenue model is made possible by the fact that we sit at the heart of the entire life settlements industry.
Our revenue
generation platform and economic model is best summarized below:
|
1. |
Origination Fees (on average, 2% of face value of acquired policies) |
|
2. |
Active Management (spreads for traded policies and realized returns for held policies)
|
132
|
3. |
Third Party Portfolio Servicing (on average, 0.5% of total asset value) |
We are currently a leader in the life settlements industry. The Company has approximately 20% market share based on Abacus 2021 capital
invested/total industry capital invested and data compiled in a 2021 report by The Deal and Life Settlements Report, a U.S. life settlements industry news source. Data for the report was aggregated from each state based on 2021 annual reporting. We
have a proven track record of growth and strong asset returns. We are currently operational in 49 states, which is a key differentiator in an industry with high barriers to entry given the significant regulatory requirements. Our business is
supported by a total of approximately 59 employees and an innovative leadership team members, each of whom has an average of over 20 years of experience in the U.S. life settlements industry.
Our outstanding operations and execution team are led by a seasoned management team. Jay Jackson (CEO) has worked in the investment industry
for over 25 years (including at a family office, major investment firms and alternative asset managers) and pioneered the origination process and trading platform for our firm. Bill McCauley (CFO) has over
20-years of experience and has held Senior Finance positions for some of the largest insurance carriers (including Transamerica, MassMutual and John Hancock). In addition, we have three Managing Partners (Todd
Sean McNealy, Kevin Scott Kirby and Matthew Ganovsky) that co-founded Abacus in 2004 and helped build the institutional and broker market for the entire industry. In summary, our
leaders are innovators and have directly contributed to the development of the broader life settlements industry.
We have grown our
origination business by nearly four times since 2016 and have serviced approximately $950 million in policies since October 2021. With a previous $150 million capital base from a top alternative asset manager, we have acquired nearly 1,600
policies over the past three years via our active portfolio management strategy. Within our traded portfolio, we acquired 1,245 policies and generated a 22% realized return. Within our hold portfolio, we acquired 238 policies with a 12% projected
annual return and held an additional 71 policies to maturity yielding a 102% realized return. These returns demonstrate our ability to originate policies and drive meaningful economics with a scaled capital base.
Abacus Settlements, LLC was formed as a New York limited liability company in 2004 and LMA was formed in 2017 as a Florida limited liability
company. In 2016, the Abacus Settlements, LLC was licensed in Florida as life settlement brokers and became a Florida limited liability company. We are not an insurance company, are not licensed or regulated as an insurance company and therefore do
not underwrite insurable risks for our own account.
Our Industry / Opportunity
Large Addressable Market with Meaningful Growth Potential
We operate within a large, growing and currently underpenetrated market. The U.S. life insurance industry is an approximately $13 trillion
market, which is almost three times the size of the entire real estate industry in the Americas. Notably, given the scale of the overall life insurance industry, more than 90% of life insurance policies will never end up paying a claim.
Approximately 75% of policyholders over the age of 65 will either cancel or allow their coverage to lapse, forfeiting the right to ever receive a payout. The life settlements industry helps solve this problem by allowing policyholders the
opportunity to monetize their otherwise underutilized asset.
133
The combination of the large U.S. life insurance market and the high percentage of policies
that never pay a claim creates a considerable opportunity for Abacus and the broader life settlements industry. Specifically, the scale of the life settlements market opportunity is $233 billion each year. However, in 2021, the life settlements
industry only captured $4 billion, or approximately 2% of the annual market of lapsed life insurance policies. We believe there is a significant opportunity to increase this market penetration, primarily by driving awareness and education
regarding the ability to monetize life insurance policies by utilizing Abacus services.
Life insurance is often a senior citizens largest asset and one that can be used to alleviate
retirement challenges, but it is rarely treated in this way. This can be partially attributed to the fact that almost half of all financial advisors are not aware that selling a life insurance policy is an option for their clients. We help financial
advisors and their clients understand that a life insurance policy is personal property and selling it for a fair market value is a legitimate, safe and viable choice to create more options for the future. While less than 1% of financial advisors
and agents currently transact in the life settlements market, based on research conducted by the Life Insurance Settlement Association, the primary industry trade association for the U.S. life settlements industry, of which the Company is a
long-standing member, we believe approximately 90% of senior citizens who let their life insurance policies lapse, or surrendered their policies, would have considered this alternative if they had been made aware of it before lapsing or surrendering
their policies. The reference to this study can be found at the Life Insurance Settlement Association - https://www.lisa.org/life-settlements-industry-will-grow-as-more-seniors-are-informed-of-their-options-say-experts-at-lisa-conference/.
Selling a life insurance policy is a valuable transaction and for those consumers who transact, the benefits can be substantial. On average,
life settlements companies pay sellers nearly eight times more than the current cash value of a policy. Selling a life insurance policy not only alleviates the requirement for a policyholder to pay premiums but creates a meaningful and immediate
monetization event. Sellers use these proceeds in a variety of ways, including to support their retirement, transfer wealth and pay medical bills.
Generally Uncorrelated Alternative Asset Class with Institutional Investment Grade Counterparts
While selling life insurance policies at a fair market value can have significantly positive impacts on a persons life, it is a mutually
beneficial transaction. The underlying life insurance policy is a highly attractive asset that has minimal payout risk and generally uncorrelated returns.
The counterparties to these transactions are generally high-quality investment grade insurance companies. In fact, 95% of our carriers have an
A Rating or better. Additionally, these life insurance policies are cash backed by the carriers, which means they are required to pay policy claims ahead of any other contractual obligation, including senior debt. We do not believe that
there has ever been a life insurance policy issued that did not ultimately pay a claim at mortality due to the illiquidity of a carrier.
134
In addition to counterparty quality, this is a largely
a-cyclical asset class. A life insurance policy is sometimes described as a mortality-driven zero-coupon bond because its underlying value will appreciate
over time as it approaches maturity (i.e., as the policyholder ages). This is best demonstrated when comparing our historical risk-adjusted returns relative to other benchmark asset classes.
Our stockholders will have the opportunity to gain access to this unique asset class, which has
historically been reserved for firms that can either directly originate policies or large institutional investors that can deploy meaningful amounts of capital.
We are at the Heart of the Life Settlements Industry
Abacus Origination Model
Our Origination Process is core to our entire business and drives our economics. We average approximately 2% of face value in
origination fees on policies and have spent the last 20 years developing three high quality origination channels (Agents / Advisors, Direct to Consumer (DTC), and Life Settlements (LS) Brokers).
An example of our target market includes policyholders averaging 75 years old whose insurance needs have changed, rendering their life
insurance policy no longer necessary. We then focus our origination process on these targeted individuals, developing processes and procedures for identifying and screening policies that have the most potential return for the least projected cost.
135
We have three distinct origination channels to reach this target market.
|
1. |
Financial Advisor or AgentOur largest origination channel involves working directly with
financial advisors to facilitate the sale of client policies. Since our founding, we have been at the forefront of developing this market and are now ingrained in a network of over 30,000 financial advisors. We are currently on multiple national
platforms, we present at conferences, and we develop marketing tools specifically to help advisors efficiently present the benefits of this product to their clients. As we highlighted earlier, 49% of financial advisors are unaware this financial
option exists and less than 1% have completed a life settlement transaction. This origination channel has driven our four times growth over the last six years, and we believe it will continue to be a priority for our future growth.
|
|
2. |
Direct to ConsumerWe have been building this channel for several years and have focused
heavily on increasing broad consumer awareness and education regarding the ability to monetize life insurance policies by utilizing Abacus services. We have been active in a variety of common direct-to-consumer advertisement channels, including radio and television advertisements in particular. In addition, we have created a unique Policy Value Calculator whereby individuals can
receive an instant valuation on their life insurance policies. The direct-to-consumer channel has historically driven origination on smaller face value policies through
our financial advisor or agent channel, thereby expanding the scope of policies we are able to value and acquire. |
|
3. |
Traditional Life Settlements IntermediariesWithin this channel, we engage with life
settlements intermediaries or brokers who submit policies to us on behalf of an advisor or client, for which the life settlement intermediary earns a commission. We intend to slowly reduce our reliance on these intermediaries over time and focus our
efforts on building out the technology required to gain access to and educate both the financial advisor and direct-to-consumer channels. |
Abacus currently has a dedicated 45-person origination team with 16 sales members assigned by channel.
We intend to continue to fuel origination growth by expanding our team and outreach. In order to drive awareness across all origination channels, we plan to expand our marketing and launch national television advertising campaigns. Additionally, we
believe the Business Combination and our partnership with ERES will be a meaningful factor in driving awareness and trust, ultimately driving more origination.
Abacus Policy Acquisition Process
A life settlement transaction is the process by which a third-party intermediary acquires an existing life insurance policy for an amount
greater than its current cash surrender value. Upon closing of the life settlement transaction, the insured receives an immediate cash payment, and the third-party intermediary receives ownership of the policy. Thus, the third-party intermediary
becomes the beneficiary of the insureds claim payout but is now solely responsible for all future premium payments. Our company functions as this third-party intermediary.
The process of acquiring a policy is highly regulated and policyholder friendly. Unique licenses are mandatory to operate and significant
disclosures are required to be made available to consumers. We originate
136
these policies through three distinct channels (i.e., financial advisors / agents, direct-to-consumer and
traditional life settlements intermediaries). We first screen each policy to ensure it is eligible for a life settlement, including verifying the policy is in force, obtaining appropriate consents and disclosures, and submitting cases for medical
underwriting and life expectancy estimates. In connection with this process, we use our proprietary analytics and risk-rating systems to determine an estimated market value for each individual policy.
The Company has established policies and guidelines with respect to its purchase of life insurance policies. These guidelines focus on the age
of the insured, the sex of the insured, the duration of the underlying life insurance policy, the expected mortality risk of the underlying life insurance policy, the projected internal rate of return of the investment in the underlying life
insurance policy and the amount of the death benefit of the underlying life insurance policy. The Company excludes making investments in life insurance policies based on certain types of the primary health impairment associated with the underlying
insured to ensure that all policies are purchased in accordance with established industry standards and state law requirements.
Following
the origination, underwriting and valuation processes, we formally present our proposed purchase price to the policyholder or advisor. If agreed upon, the settlement closing process begins. Appropriate closing documents are reviewed by our in-house counsel, and we send funds to an independent escrow agent. Simultaneously, change of ownership and beneficiary documentation is sent to the underlying insurance carrier. Once the changes are confirmed by
the carrier, the escrow agent sends the proceeds to the appropriate party, and we become responsible for the underlying insurance policy (i.e., paying premiums and receiving claim). The proceeds from the escrow agent will also include the
commission(s) we owe to the broker and / or agent as well as our fee for completing the origination services.
While the transaction
is deemed closed, it is important to note that the policy owner may generally rescind the life settlement contract within 30 days from execution of the agreement or 15 days from the receipt of cash proceeds by the owner. As such, revenue is not
recorded until this rescission process is over.
Once the transaction is closed, the policy enters our active portfolio management whereby
we determine whether a policy should be sold to a third-party institutional investor or held on our balance sheet.
Proprietary Technology Platforms
Support Our Business
We have and continue to develop a comprehensive suite of technology products that helps drive origination,
underwriting and trading. Specifically, we have created:
|
1. |
Risk Rating Heat MapUsing the large amount of data we have gathered over time, we have
developed a proprietary risk-rating platform that measures the risk of life insurance contracts on a range from 15 (lowhigh risk, respectively). This risk score is calculated on a wide range of factors, including (i) duration and
extension risk, (ii) policy face value and purchase type, (iii) policy type, (iv) carrier rating, (v) life expectancy (LE) and LE extension ratios, (vi) age and age on LE date and (vii) survival probability.
We believe this platform is a key differentiating factor relative to our competitors as it gives us a meaningful advantage when valuing and purchasing life insurance policies. |
137
|
2. |
Policy Value CreatorOur Policy Value Calculator drives origination by using
proprietary data to instantly value policies for both individuals and financial advisors. This easy-to-use online tool only requires four pieces of information:
(i) gender, (ii) age, (iii) face value and (iv) policy type. These data points then generate a valuation range that advisors and individuals can use to quickly assess the current value of their policy. This product helps educate
consumers and bridges the gap between our specific offering and the $233 billion annual market of lapsed policies. |
|
3. |
Innovations in InsurTechMore recently, we have begun developing
Abacusmarketplace.com, which we anticipate being a blockchain tertiary trading, servicing and valuation platform. Given we will be able to see a large suite of data gathered by this website, we believe it will help us maintain our
leading market position and keep us at the heart of the life settlements industry. We expect to add the ability for investors to directly purchase policies in January 2023. Abacusmarketplace.com is still in the early stages of development and we do
not currently expect that Abacusmarketplace.com will have a material impact on the Companys future financial results. |
Active Portfolio Management Strategy
With meaningful support from our proprietary risk rating heat map, we consistently evaluate policies (at origination and throughout the
lifecycle) to generate essentially uncorrelated risk adjusted returns. Upon acquiring a policy, we have the option to either (i) trade that policy to a third-party institutional investor (i.e., generating a spread on each trade) or
(ii) hold that policy on our balance sheet until maturity (i.e., paying the premiums over time and receiving the final claim / payout). This process is predicated on driving the best economics for Abacus.
138
|
1. |
Traded PortfolioOur traded portfolio returns are driven by (i) the spread we generate
by selling policies to third-party institutional investors and (ii) our ability to quickly recycle capital. Our trade spreads average 20% and we have historically recycled capital 3.6 times per year. These two metrics are driven by our ability
to effectively originate new policies (supply) and the underlying market interest for the policies (demand). |
|
|
|
|
|
|
|
2. |
Hold PortfolioRelative to our traded portfolio, our hold portfolio has the prospect to
generate a higher estimated annual return than our traded portfolio but requires approximately a 3 to 4 times greater capital investment, which is driven by the need to hold policies, rather than recycle the policies in trading, and to fund premium
payments during the holding period for a policy. To the extent that we are not able to commit the required capital, we then focus efforts more on our traded portfolio. Our origination platform and proprietary risk rating heat map has allowed us to
hold only what we determine to be the highest quality policies which have our lowest risk ratings. Of the 71 policies we have held to maturity ($37 million in face value), we have achieved a 102% realized return. We currently have an additional
238 policies with a projected 12% annual return ($317 million in face value). We anticipate growing the size of our hold portfolio over time as we scale our capital base. We believe there is a unique opportunity to securitize a basket of
high-quality policies to sell to a third-party investor for a realized profit much sooner than contracts may actually expire. |
|
|
|
|
|
|
Policy Servicing
In addition to generating economics on the polices we directly originate and actively manage, we have a dynamic platform to service bundles of
policies for a variety of third-party institutions. We generate revenue by charging a base servicing fee of approximately 0.5% of total asset value of the portfolio. We have experience servicing a large number of policies for highly sophisticated
institutions, including policies for KKR and Apollo. Beyond our fees, servicing policies at scale supports our data analytics and keeps us at the heart of the life settlements industry. We have a sophisticated team of professionals solely focused on
servicing these policies.
Prospects for Future Growth
Continued Maturation of the Life Settlements Industry
As described above, there is $233 billion in policy value that lapses on an annual basis. However, the life settlements industry captured
only approximately 2% of the potential market in 2021, which leaves significant runway for future growth for industry participants. The total face value of life insurance policies is expected to grow from approximately $6 billion in 2022 to
approximately $8 billion in 2028, which is a 5% compounded
139
annual growth rate. Given our position at the heart of the life settlements industry, we believe that we are well positioned to capitalize on this anticipated market growth.
Focus on Growing our Origination Process
Our ability to originate policies is essential to scale our business over time. In order to support this expected growth, we continue to invest
in our technology and marketing infrastructure. In general, we expect our efforts will continue to focus on driving education and awareness of life settlements. In order to meet this growing demand, we have increased our total employee headcount by
23% over the last twelve months and we anticipate a 50% increase in our headcount by 2024.
Continued Innovation in Technology
Using technology to improve our analytics, market liquidity and velocity of capital use is a key priority. Certain key technology elements are:
|
1. |
Analytics (Abacus Analytics)the standard pricing and valuation platform for policy
valuation and portfolio assessment that we believe will allow us to obtain visibility into every transaction in the industry. |
|
2. |
Liquidity (Abacusmarketplace.com)tertiary trading, servicing and valuation platform
(planning to add direct purchase in January 2023). Abacusmarketplace.com is a proprietary technology platform that has been designed in order to facilitate tertiary trading, servicing and valuation for the life settlement industry. This platform is
intended to increase the trading volume for the entire industry by removing intermediaries and improving the efficiency and security of the transactions. The Company expects to realize future revenue through licensing agreements with
Abacusmarketplace.com. However, Abacusmarketplace.com is still in the early stages of development, and we do not currently expect that Abacusmarketplace.com will have a material impact on the Companys future financial results. With blockchain
technology, we expect that there will be increased comfort that the documents are secure on a private blockchain, which we believe will facilitate faster closing times. The blockchain technology to be used is still in the early stages of development
and is currently not a material part of the Companys business. We believe that Abacusmarketplace.com could be a leader in the industry and will allow an investor to fully understand how it may impact future business strategies and financial
results. |
|
3. |
Velocity (Lapetus Life Event Solutions, AgingIQ and BlockCerts)key partnerships and tools
that complement and enhance our core analytics platforms. |
|
a. |
Lapetus Life Event Solutionspartnership between Abacus and Lapetus Solutions, Inc. to build and develop
current life expectancy tables based on our 18 years of data. This information includes tens of thousands of unique datapoints, aiding more accurate predictions of mortality experience related to several demographics including age, income and
location. |
|
b. |
AgingIQlifespan prediction tool utilizing our mortality database. This tool explores how people can
extend their lifespans and healthspans by adjusting current lifestyle related decisions (financial, healthy living and education). |
|
c. |
BlockCertspartnership utilizing BlockCerts Web 4.0 technology to lead the next generation of life
insurance and annuity purchases using blockchain capabilities. The resulting benefit includes cost reductions, enhanced data security and a competitive edge in the origination marketplace. |
Access to Capital Markets Provides More Attractive Financing
We believe that as a publicly traded company, we will have access to a lower cost of capital, which will optimize our per policy revenue and
allow us to fund additional investment in infrastructure. Additionally, as discussed in more detail below, we plan to begin increasing our balance sheet hold portfolio, which we believe will drive higher long-term returns.
140
Transitioning Our Business Model as Our Capital Base Scales
As our capital base scales, we aim to increase the proportion of policies that we hold on our balance sheet so that the policies we hold and
the policies we trade each comprise 50% of our business model. One of the most obvious benefits to a larger hold portfolio is that it increases the predictability of returns (i.e., held policies will likely increase in value over time, largely
independent of trading market conditions). Additionally, with a larger hold portfolio, there is a unique opportunity to begin securitizing policies. In the long-term, we believe securitized portfolios can drive an even lower cost of capital and can
be sold in scale to third parties at a significant multiple.
Proven Ability to Deploy Capital and Scale
Over the past few years, we managed a $150 million capital base via a joint venture with a large alternative asset manager. This joint
venture will terminate at the Closing. Under US GAAP the financial results of the entire joint venture are not included in our financial statements as the joint venture is not under common control and neither Abacus nor LMA have a direct ownership
interest or investment in the joint venture. The financial impacts of the joint venture recognized in the financial statements solely relate to the services provided by Abacus and LMA to the joint venture and are discussed in the respective related
party transaction notes in the financial statements. However, our track record shows our ability to operate and generate highly attractive returns. The joint venture produced $21.6 million and $27.4 million in revenue and $16.2 million and $22.5
million in net income for fiscal year ended December 31, 2021 and December 31, 2020, respectively. We believe that becoming a publicly traded company will allow us to more effectively deploy capital to scale our business.
Over the past six years, we have grown our total originations by approximately four times. Within our traded portfolio we have acquired 1,245
policies for a total face value of $1.9 billion, generating a 22% realized return per policy. Within our hold portfolio, we have acquired 309 policies, with 238 policies currently on our balance sheet with a projected annual return of 12% and
71 policies that have matured and generated a realized return of 102%.
Beyond our traded and hold portfolios, we have serviced
approximately $950 million in policies over the last twelve months (including assets for KKR and Apollo). Additionally, we have underwritten and valued approximately $520 million of policies on behalf of third parties.
It is currently expected that the Company will require approximately thirty-five million dollars ($35,000,000) to fund its operations over the
next twelve (12) months. The Company believes that its funds from operations will provide sufficient funds to continue its operations for the foreseeable future.
Our Employees
As of October 14, 2022, we
had 61 employees (60 full-time and one part-time), none of whom are subject to any collective bargaining agreement or represented by a labor union. All of our employees are based in the United States. To date, we have not experienced any work
stoppages and we consider our employee relations to be good. We believe that our employees are critical to our long-term success, and in 2019, we were ranked a top 3 place to work in Orlando based on employee reviews.
The core of our business is driven by our ability to successfully originate new policies. We have built a highly experienced 45-person team dedicated solely on the origination and policy acquisition process. Specifically, we have a (i) 16-person sales team, (ii)
10-person team of acquisition managers and case processors, (iii) 15-person team focused on policy evaluation and closing processes (i.e., contracts, legal and
accounting) and (iv) four-person team supporting our broad marketing and information technology efforts. In addition, we have a 14-person team that supports our active portfolio management and portfolio
servicing efforts. Specifically, we have (a) three actuarial review and financial analysts, (b) three contract and accounting professionals, (c) six servicing specialists and (d) two institutional traders. While our employees
have a wide range of roles and responsibilities, we have spent the last 18 years building a highly efficient model.
141
Customers
As of December 31, 2021, we have served over 3,000 customers with operations in 49 states. Abacus maintains a broad customer base with a
balance of policy origination across three distinct channels described above.
Our customers include institutional investors seeking to
invest in life settlement assets as well as life settlement policy sellers. During the years ended December 31, 2021 and 2020, our largest origination customer based on revenue accounted for 33% and 35% of our revenue, respectively, and our ten
largest customers together accounted for 80% and 81% of our revenue, respectively.
In May of 2019, Abacus owners and certain executives
of Abacus formed a joint venture with KKR called Nova Trading and Nova Holding (funds that KKR invested money in and Abacus provided investment and trading services). These related party funds are collectively called the Nova Funds.
Following the Business Combination, Abacus does not intend to continue its relationship with the Nova Funds or provide management services to the Nova Funds. While the Company does not intend to continue its joint-venture relationship with the Nova
Funds after the expiration of this joint venture following the Business Combination, the Company expects to retain KKR as a client. For the fiscal years ended December 31, 2021 and December 31, 2020, the Nova Funds generated
$21.6 million and $27.4 million in revenue and $16.2 million and $22.5 million in net income, respectively. For the percent of revenue that the Nova Funds contributed to Abacus, please refer to the footnote disclosures on
page F-115-F-116 of the Abacus Audited Financials for fiscal years ended December 31, 2021 and December 31, 2020.
Intellectual Property
Our business depends, in part, on our ability to develop and maintain the proprietary aspects of its core technology. We rely on
patents and trademarks to protect our intellectual property.
As of October 14, 2022, we own one pending United States patent application
relating to market-linked investment vehicles secured by non-correlated or low-correlated assets, and we have been issued a federal registration for our Abacus
Settlements trademark. We also hold various domain names for websites that we use in our business. Additionally, we have developed and maintain proprietary software for our internal use to aid in pricing, valuation and risk analysis of
Life Settlement Policies.
Regulatory Overview
We are subject to various laws, regulations and licensing requirements in the United States which may expose us to liability, increase costs or
have other adverse effects that could harm our business. These laws and regulations include, but are not limited to, data privacy and data localization, healthcare, insurance, copyright or similar laws, anti-spam, consumer protection, employment and
taxation. Compliance with such laws can require changes to our business practices and significant management time and effort. Additionally, as we continue to develop and improve consumer-facing products and services, and as those offerings grow in
popularity, the risk that additional laws and regulations will impact our business will continue to increase. We believe that we are in material compliance with all such laws, regulations and licensing requirements.
Data Privacy Laws and Regulations.
Because we receive, use, transmit, disclose and store personal data, we are subject to numerous state and federal laws and regulations that
address privacy, data protection and the collection, storing, sharing, use, transfer, disclosure and protection of certain types of data. We are subject to the TCPA which restricts the making of telemarketing calls and the use of automatic telephone
dialing systems. Violators of the TCPA face regulatory enforcement action, substantial civil penalties, injunctions, and in some states, private lawsuits for damages.
142
Privacy and data security regulation in the U.S. is rapidly evolving. For example,
California enacted the California Consumer Privacy Act (CCPA), which came into force in 2020. The CCPA and related regulations give California residents expanded rights to access and request deletion of their personal information, opt
out of certain personal information sharing and receive detailed information about how their personal information is used and shared. The CCPA allows for the California Attorney General to impose civil penalties for violations, as well as providing
a private right of action for certain data breaches. California voters also recently passed the California Privacy Rights Act (CPRA), which will take effect on January 1, 2023. The CPRA significantly modifies the CCPA, including by
imposing additional obligations on covered companies and expanding California consumers rights with respect to certain personal information. The CCPAs restrictions on sales of personal information may restrict our use of
cookies and similar technologies for advertising purposes, as well as increasing our compliance costs and potential liability. The CCPA excludes information covered by the Gramm-Leach-Bliley Act, the Drivers Privacy Protection Act, the Fair
Credit Reporting Act and the California Financial Information Privacy Act from the CCPAs scope, but the CCPAs definition of personal information is broad and may encompass other information that we maintain.
The CCPA likely marked the beginning of a trend toward more stringent privacy legislation in the U.S., and multiple states have enacted or
proposed similar laws. For example, in 2020, Nevada enacted SB 220 which restricts the selling of personal information and, in 2021, Virginia passed the Consumer Data Protection Act which is set to take effect on January 1, 2023 and
creates new privacy rights for Virginia residents. There is also discussion in Congress of new comprehensive federal data protection and privacy law to which we likely would be subject if it is enacted.
Various regulators are interpreting existing state consumer protection laws to impose evolving standards for the online collection, use,
dissemination and security of other personal data. Courts may also adopt the standards for fair information practices which concern consumer notice, choice, security and access. Consumer protection laws require us to publish statements that describe
how we handle personal information and choices individuals may have about the way we handle their personal data.
Our failure to
comply with these privacy laws or regulations could expose us to significant fines and penalties imposed by regulators and has in the past and could in the future expose us to legal claims by buyers, or other relevant stakeholders. Some of these
laws, such as the CCPA, permit individual or class action claims for certain alleged violations, increasing the likelihood of such legal claims. Similarly, many of these laws require us to maintain an online privacy policy, terms of service and
other informational pages that disclose our practices regarding the collection, processing and disclosure of personal information. If these disclosures contain any information that a court or regulator finds to be inaccurate, we could also be
exposed to legal or regulatory liability. Any such proceedings or violations could force us to spend money in defense or settlement of these proceedings, result in the imposition of monetary liability or demanding injunctive relief, divert
managements time and attention, increase our costs of doing business and materially adversely affect our reputation.
Insurance Laws and
Regulations.
We operate as a life settlement producer in 49 states. We have a strong track record with each state in which we are
licensed and have not had any reportable incidents. Our in-house counsel and compliance staff reviews every life insurance policy we consider acquiring for compliance with applicable state regulations. We file
an annual report with each state in which it operates and each state has the ability to request an audit at its discretion. Currently, 42 states have regulations that support the sale of life insurance policies to a third party, like our Company.
Each state also has its own policyholder-facing disclosure requirements that we comply with in the ordinary course of its business.
We
focus on acquiring and trading non-variable, non-fractionalized life insurance policies. These life insurance policies are deemed to be personal property of the owner
based upon the Supreme Court decision Grigsby v. Russell in 1911. Furthermore, non-variable, non-fractionalized life insurance policies are not deemed
143
to be considered securities under the federal securities laws, and so the Company is not required to register as an investment adviser or an investment company under the Investment Advisers Act
of 1940, as amended or the Investment Company Act, respectively.
The Company may, in the future, purchase some amount of variable life
insurance policies or interests in the death benefit of underlying life insurance policies. The Company has recently acquired a limited purpose broker dealer, which the Company intends to license to engage in transactions for variable and
fractionalized life insurance policies. Abacus expects that any transactions in variable or fractionalized life insurance policies will represent less than twenty percent (20%) of the life insurance policies acquired by the Company at any time. The
Company does not, and does not in the future intend to, engage in any life insurance securitization.
Facilities
Our corporate headquarters is located at 2101 Park Center Drive, Suite 170, Orlando, Florida 32835 and our telephone number is 800-561-4148. The headquarters consists of 6,812 square feet of Class A office space pursuant to a lease that expires in June 2024. We also sublease
additional office space in Orlando, Florida, which consists of approximately 3,000 square feet of space pursuant to a sublease that expires in October 2023. We believe our facilities are adequate and suitable for our current needs and that, should
it be needed, suitable additional or alternative space will be available to accommodate our operations.
Legal Proceedings
We are not currently a party to any material legal proceedings. However, in the ordinary course of business we may be subject from time to time
to various claims, lawsuits and other legal and administrative proceedings. Some of these claims, lawsuits and other proceedings may involve highly complex issues that are subject to substantial uncertainties, and could result in damages, fines,
penalties, non-monetary sanctions or relief. We intend to recognize provisions for claims or pending litigation when we determine that an unfavorable outcome is probable and the amount of loss can be
reasonably estimated. Due to the inherent uncertain nature of litigation, the ultimate outcome or actual cost of settlement may materially vary from estimates. Additionally, any such claims, lawsuits and proceedings, whether or not successful, could
damage our reputation and business.
144
SELECTED HISTORICAL FINANCIAL INFORMATION OF ABACUS
The selected historical statements of income data of Abacus for the period from January 1, 2022 to December 31, 2022 and from January 1,
2021 to December 31, 2021 and the historical balance sheet data as of December 31, 2022 and December 31, 2021 are derived from Abacus audited financial statements included elsewhere in this proxy statement.
Abacus historical results are not necessarily indicative of the results that may be expected in the future. The information below is
only a summary and should be read in conjunction with the section entitled Abacus Managements Discussion and Analysis of Financial Condition and Results of Operations and the Abacus financial statements, and the notes and
schedules related thereto, which are included elsewhere in this proxy statement.
|
|
|
|
|
|
|
|
|
|
|
As of and for the year ended December 31, 2022 |
|
|
As of and for the year-ended December 31, 2021 |
|
Statement of Income Data: |
|
|
|
|
|
|
|
|
Total revenue |
|
$ |
25,203,463 |
|
|
$ |
22,592,144 |
|
Total cost of revenue |
|
|
5,538,470 |
|
|
|
14,205,341 |
|
|
|
|
|
|
|
|
|
|
Gross profit |
|
|
8,642,458 |
|
|
|
8,386,803 |
|
Operating expenses |
|
|
8,686,590
|
|
|
|
7,449,688 |
|
|
|
|
|
|
|
|
|
|
Income from operations |
|
|
(44,132
|
)
|
|
|
937,115 |
|
Other (expense) income |
|
|
|
|
|
|
|
|
Interest income |
|
|
2,199 |
|
|
|
11,500 |
|
Interest (expense) |
|
|
(8,817 |
) |
|
|
|
|
Consulting income |
|
|
273 |
|
|
|
50,000 |
|
Other income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total other (expense) income |
|
|
(6,345 |
) |
|
|
61,500 |
|
|
|
|
|
|
|
|
|
|
Income before income taxes |
|
|
(50,477 |
) |
|
|
998,615 |
|
Provision for income taxes |
|
|
2,018 |
|
|
|
1,200 |
|
|
|
|
|
|
|
|
|
|
Net Income |
|
$ |
(52,495 |
) |
|
$ |
997,415 |
|
|
|
|
|
|
|
|
|
|
Balance Sheet Data: |
|
|
|
|
|
|
|
|
Total assets |
|
$ |
3,215,812 |
|
|
$ |
5,291,997 |
|
Total liabilities |
|
|
1,204,675 |
|
|
|
2,569,002 |
|
Total members equity |
|
|
2,011,137 |
|
|
|
2,722,995 |
|
145
SELECTED HISTORICAL FINANCIAL INFORMATION OF LMA
The selected historical statements of income data of LMA for the period from January 1, 2022 to December 31, 2022 and from
January 1, 2021 to December 31, 2021 and the historical balance sheet data as of December 31, 2022 and December 31, 2021 are derived from LMAs audited financial statements included elsewhere in this proxy statement.
LMAs historical results are not necessarily indicative of the results that may be expected in the future. The information below is only
a summary and should be read in conjunction with the section entitled LMA Managements Discussion and Analysis of Financial Condition and Results of Operations and the LMA financial statements, and the notes and schedules
related thereto, which are included elsewhere in this proxy statement.
|
|
|
|
|
|
|
|
|
|
|
As of and for the year ended December 31, 2022 |
|
|
As of and for the year-ended December 31, 2021 |
|
Statement of Income Data: |
|
|
|
|
|
|
|
|
Total revenue |
|
$ |
44,713,553 |
|
|
$ |
1,199,986 |
|
Total cost of revenue |
|
|
6,245,131 |
|
|
|
735,893 |
|
|
|
|
|
|
|
|
|
|
Gross profit |
|
|
38,468,422 |
|
|
|
464,093 |
|
Sales, general, administrative, and depreciation |
|
|
3,666,826 |
|
|
|
597,702 |
|
(Gain) on change in fair value of debt |
|
|
90,719 |
|
|
|
|
|
Unrealized loss on investments |
|
|
1,045,623 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from operations |
|
|
33,665,255 |
|
|
|
(133,609 |
) |
Other (expense) income |
|
|
|
|
|
|
|
|
Other (expense) |
|
|
(347,013 |
) |
|
|
|
|
Interest (expense), net |
|
|
(41,324 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total other (expense) |
|
|
(388,337 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes |
|
|
33,276,917 |
|
|
|
(133,609 |
) |
Provision for Income taxes |
|
|
889,943 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net and Comprehensive Income (loss) before non-controlling interest |
|
$ |
32,386,975 |
|
|
$ |
(133,609 |
) |
|
|
|
|
|
|
|
|
|
Less: Comprehensive income and net income attributable to non-controlling interest |
|
|
704,699 |
|
|
|
(148,155 |
) |
|
|
|
|
|
|
|
|
|
Comprehensive income attributable Longevity Market Assets, LLC |
|
$ |
31,682,275 |
|
|
$ |
14,546 |
|
|
|
|
|
|
|
|
|
|
Balance Sheet Data: |
|
|
|
|
|
|
|
|
Total assets |
|
$ |
59,094,847 |
|
|
$ |
1,840,218 |
|
Total liabilities |
|
|
30,945,150 |
|
|
|
1,073,325 |
|
Total members equity |
|
|
28,149,697 |
|
|
|
766,893 |
|
146
LMA MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND RESULTS OF OPERATIONS
The following discussion and analysis provides information that management believes is
relevant to an assessment and understanding of Longevitys financial condition and results of operations. This discussion should be read in conjunction with Longevitys financial statements and related notes thereto that appear elsewhere
in this proxy statement.
In addition to historical financial analysis, this discussion and analysis contains forward-looking
statements based upon current expectations that involve risks, uncertainties and assumptions, as described under the heading Cautionary Note Regarding Forward-Looking Statements. Actual results and timing of selected events may differ
materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth under Risk Factors or elsewhere in this proxy statement. Unless the context otherwise requires, references in
this LMA Managements Discussion and Analysis of Financial Condition and Results of Operations to we, us, our, and LMA are intended to mean the business and operations of Longevity
Market Assets, LLC.
Overview
LMA directly acquires life insurance policies in a mutual beneficial transaction for both us and the underlying insured. With meaningful
support from our proprietary risk rating heat map, we consistently evaluate policies (at origination and throughout the lifecycle) to generate essentially uncorrelated risk adjusted returns. Additionally, we provide a range of services for owners of
life settlement assets.
Upon acquiring a policy, we have the option to either (i) trade that policy to a third-party institutional
investor (i.e., generating a spread on each trade) or (ii) hold that policy on our balance sheet until maturity (i.e., paying the premiums over time and receiving the final claim / payout). This process is predicated on driving the best
economics for LMA and we categorize this revenue as Trading or Active management revenue.
Additionally, LMA
provides a wide range of services to owners and purchasers of life settlements assets (i.e., acquired policies). More specifically, LMA provides consulting, valuation, actuarial services and perform administrative work involved in keeping a policy
in force and at the premium level most advantageous to the owner. We have experience servicing a large number of policies for highly sophisticated institutions, including policies for large institutional life settlement funds. We generate revenue on
these services by charging a base servicing fee of approximately 0.5% of total asset value of the portfolio. We categorize this revenue as Servicing or Portfolio servicing revenue.
In 2021, we shifted our focus from a service based only business model and began directly acquiring life insurance policies. Our first
purchase under the expanded model was in June 2021, and the revenue related to that purchase is included in the Active Management line item in the accompanying financial statements for the period ended December 31, 2022. We have seen rapid growth in
this segment as we have continued to dedicate capital and resources towards our marketing and diversified origination channels. Such items are appropriately reflected in the operating expenses section of the accompanying financial statements for the
period ended December 31, 2022.
LMA was formed as Abacus Life Services, LLC in the state of Florida in February 2017. Subsequently,
in
February 2022, we changed our name to Longevity Market Assets, LLC. We are headquartered in Orlando, Florida.
Our Business Model
As mentioned in the
above Overview section, LMA generates revenue in two main ways. The first is through our active portfolio management strategy (Active management revenue), whereby we can (i) generate
147
a spread on traded policies, (ii) hold policies on our balance sheet (paying premiums over time and receiving the payout / claim), or (iii) generate unrealized gains or losses on
policies purchased by our structured note offerings: LMATT Series 2024, Inc., LMATT Growth Series 2.2024, Inc. and LMATT Growth and Income Series 1.2026, Inc using the proceeds from the debt offering with the intention to hold to maturity. The
second is through our portfolio and policy servicing activities (Portfolio servicing revenue), whereby we provide a range of services to life settlement asset owners.
Active management revenue derives from buying and selling policies; and the receipt of death benefits proceeds on policies we hold where the
insured dies. Of the purchased policies, some are purchased with the intent to hold to maturity, while others are held for trading to be sold for a gain. We elected to account for each investment in life settlement contracts using either the
investment method or the fair value method. Once the accounting method is elected for each policy, it cannot be changed. LMA accounts for life settlement policies purchased that we intend to hold to maturity at fair value and life settlement
policies that we intend to trade in the near term at cost plus premiums paid. At the time that this election was made, this was the result of a cost-benefit analysis: because of our intention to hold the instruments for a relatively short period, we
believed that the investment method provided a more cost effective method of accounting for the instruments and did not believe that, in the course of the short period, the fair value would differ materially from the accumulated cost. For the life
settlement policies accounted for under the fair value method, these policies are part of the collateral consideration for the market linked structured notes issued under LMX Series, LLC and LMA Series, LLC subsidiaries where quarterly valuations
are a condition of the private placement memorandum. Given that there is a valuation requirement stipulated in the notes, management has elected to use the fair value method for these policies as the information is readily available and also
captures the change in fair value within the income statement when those changes occur as opposed to when the policies mature given managements intention to hold them to maturity. For policies held at fair value, changes in fair value are
reflected in operations in the period the change is calculated. Under the investment method, investments in contracts are recorded at investment price plus all initial direct costs. Continuing costs (e.g., policy premiums, statutory interest and
direct external costs, if any) to keep the policy in force are capitalized. Gains/losses on sales of such are recorded at the time of sale or maturity. Under the fair value method, we record the initial investment of the transaction price and
remeasure the investment at fair value at each subsequent reporting period. Changes in fair value are reported in revenue when they occur including those related to life insurance proceeds (policy maturities) and premium payments. Upon sale of a
life settlement contract, we record revenue (gain/loss) for the difference between the agreed-upon purchase price with the buyer, and the carrying value of the contract.
Generating Portfolio servicing revenue involves the provision of services to one affiliate by common ownership, and third parties, which own
life insurance policies. Portfolio servicing revenue is derived from services related to maintaining these settled policies pursuant to agreement with investors in settled policies (Service Agreement(s)). Additionally, also included in
servicing revenue are fees for limited consulting services related to the evaluation of policies that we perform for third-parties. Portfolio servicing revenue is recognized ratably over the life of the Service Agreements, which range from one month
to ten years. The duties performed by the company under these arrangements are considered a single performance obligation that is satisfied ratably as the customer simultaneously receives and consumes the benefit provided by us. As such, revenue is
recognized for services provided for the corresponding month.
Portfolio servicing revenue also consists of revenue related to consulting
engagements. We provide services for the owners of life settlement contracts who are often customers of the servicing business line, or customers of Abacus, an affiliated entity. These consulting engagements are comprised of valuation, actuarial
services and overall policy assessments related to life settlement contracts and are short-term in nature. The performance obligations are typically identified as separate services with a specific deliverable or a group of deliverables to be
provided in tandem, as agreed to in the engagement letter or contract. Each service provided under a contract is considered as a performance obligation and revenue is recognized at a point in time when the deliverable or group of deliverables is
transferred to the customer.
148
Key Factors Affecting Our Performance
The markets for our consulting and portfolio servicing are affected by economic, regulatory and legislative changes, technological developments
and increased competition from established and new competitors. We believe that the primary factors in selecting LMA include reputation, the ability to provide measurable increases to stockholder value and return on investment, global scale, quality
of service and the ability to tailor services to each clients specific needs. In that regard, with our ability to leverage the technology developed by the Companies, we are focused on developing and implementing data and analytic solutions for
both internal operations and for maintaining industry standards and meeting client needs.
Results of Operations
The following tables set forth our results of operations for the periods presented. The period-to-period comparison of financial results is not indicative of future results:
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31, |
|
|
|
2022 |
|
|
2021 |
|
Portfolio Servicing Revenue |
|
|
|
|
|
|
|
|
Related party servicing revenue |
|
$ |
818,300 |
|
|
$ |
699,884 |
|
Portfolio servicing revenue |
|
|
652,672 |
|
|
|
380,102 |
|
|
|
|
|
|
|
|
|
|
Total portfolio servicing revenue |
|
|
1,470,973 |
|
|
|
1,079,986 |
|
|
|
|
|
|
|
|
|
|
Active management revenue |
|
|
|
|
|
|
|
|
Investment income from life insurance policies held using investment method |
|
|
37,828,829 |
|
|
|
120,000 |
|
Change in fair value of life insurance policies (policies held using fair value method) |
|
|
5,413,751 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total active management revenue |
|
|
43,242,581 |
|
|
|
120,000 |
|
|
|
|
|
|
|
|
|
|
Total Revenue |
|
|
44,713,553 |
|
|
|
1,199,986 |
|
Cost of revenues (excluding depreciation stated below) |
|
|
6,245,131 |
|
|
|
735,893 |
|
|
|
|
|
|
|
|
|
|
Gross profit |
|
|
38,468,422 |
|
|
|
464,093 |
|
Operating expenses |
|
|
|
|
|
|
|
|
Sales and marketing |
|
|
2,596,140 |
|
|
|
|
|
General, administrative and other |
|
|
1,066,403 |
|
|
|
101,406 |
|
Unrealized loss on investments |
|
|
1,045,623 |
|
|
|
|
|
Change in fair value of debt |
|
|
90,719 |
|
|
|
|
|
Other operating expense |
|
|
|
|
|
|
493,849 |
|
Depreciation expense |
|
|
4,282 |
|
|
|
2,447 |
|
|
|
|
|
|
|
|
|
|
Total operating expenses |
|
|
4,803,168 |
|
|
|
597,702 |
|
|
|
|
|
|
|
|
|
|
Operating income |
|
|
33,665,255 |
|
|
|
(133,609 |
) |
Other (expense) / income |
|
|
|
|
|
|
|
|
Other (expense) |
|
|
(347,013 |
) |
|
|
|
|
Interest (expense) |
|
|
(42,798 |
) |
|
|
|
|
Interest income |
|
|
1,474 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income before tax |
|
|
33,276,917 |
|
|
|
(133,609 |
) |
Income tax expense |
|
|
(889,943 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
|
32,386,975 |
|
|
|
(133,609 |
) |
Net income attributable to noncontrolling interest |
|
|
704,699 |
|
|
|
(148,155 |
) |
|
|
|
|
|
|
|
|
|
Net income attributable to Longevity Market Assets |
|
$ |
31,682,275 |
|
|
$ |
14,546 |
|
|
|
|
|
|
|
|
|
|
149
Revenue
Related Party Services
We have a
related-party relationship with Nova Trading (US), LLC (Nova Trading), a Delaware limited liability company and Nova Holding (US) LP, a Delaware limited partnership (Nova Holding and collectively with Nova Trading, the
Nova Funds) as the owners of LMA jointly own 11% of the Nova Funds. We enter into service agreements with the owners of life settlement contracts and are responsible for maintaining the policies, managing processing of claims in the
event of death of the insured and ensuring timely payment of optimized premiums computed to derive maximum return on maturity of the policy. We neither assume the ownership of the contracts nor undertake the responsibility to make the associated
premium payments. The duties that we perform under these arrangements are considered a single performance obligation that is satisfied over time and revenue is recognized for services provided for the corresponding time period. We earn servicing
revenue related to policy and administrative services on behalf of Nova Funds portfolio (the Nova Portfolio). The servicing fee is equal to 50 basis points (0.50%) times the monthly invested amount in policies held by Nova Funds divided
by 12.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years ended December 31, |
|
|
$ Change |
|
|
|
|
|
|
2022 |
|
|
2021 |
|
|
% Change |
|
Related party servicing revenue |
|
$ |
818,300 |
|
|
$ |
699,884 |
|
|
$ |
118,416 |
|
|
|
17 |
% |
Related party servicing revenue increased by $118,416, or 17%, for the year ended December 31, 2022
compared to the year ended December 31, 2021. The increase in related party servicing revenue is primarily attributable to the increase in size of the Nova Portfolio, both in policy count and invested dollars. Total policy count for the Nova
Portfolio was 392 and 231 for the periods ended December 31, 2022 and December 31, 2021, respectively. This translated to total invested dollars of $155,451,161 and $76,016,669 as of December 31, 2022 and December 31, 2021, respectively.
Portfolio servicing revenue
We
engage in short term agreements typically for the owners of life settlement contracts who are often customers of the servicing business line or customers of Abacus, an affiliated entity. These consulting engagements involve valuation, actuarial
services and overall policy assessments related to life settlement contracts. The fees for these consulting engagements are contractually fixed. Each service provided under a contract is considered a performance obligation and revenue is recognized
at the point in time that the obligation is satisfied.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years ended December 31, |
|
|
|
|
|
|
|
|
|
2022 |
|
|
2021 |
|
|
$ Change |
|
|
% Change |
|
Portfolio servicing revenue |
|
$ |
652,672 |
|
|
$ |
380,102 |
|
|
$ |
272,570 |
|
|
|
72 |
% |
Portfolio servicing revenue increased by $272,570, or 72%, for the year ended December 31, 2022
compared to the year ended December 31, 2021. The increase in portfolio servicing revenue is primarily attributable to an increase in non-recurring consulting projects.
Active management revenue
Active
management revenue is generated by buying, selling and trading policies and maintaining policies through to receipt of the claim. Policies are accounted for under both the investment method and fair value method. We have elected on an instrument-by-instrument basis to account for these policies under the investment method, pursuant to ASC 323-30-25-2. LMA engages in direct buying and selling of life settlement policies whereby each potential policy is independently researched to determine if it would be a profitable investment. Policies
purchased under LMA are typically purchased with the intention to sell within twelve months and are measured for under the investment method given that the purchase dates are recent, and policies turn fairly
150
quickly. Policies purchased under LMATT Series 2024, Inc. or LMATT Growth Series 2.2024, Inc. (the LMATT subsidiaries) are intended to be held until the policies mature and are
measured under the fair value method. Upon sale of a life settlement contract, the company will record revenue (gain/loss) for the difference between the agreed-upon purchase price with the buyer and the carrying value of the contract.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years ended December 31, |
|
|
$ Change |
|
|
% Change |
|
|
|
2022 |
|
|
2021 |
|
Active management revenue |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Policies accounted for under the investment method |
|
$ |
37,828,829 |
|
|
$ |
120,000 |
|
|
$ |
37,708,829 |
|
|
|
31,424 |
% |
Policies accounted for under the fair value method |
|
|
5,413,751 |
|
|
|
|
|
|
|
5,413,751 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total active management revenue |
|
$ |
43,242,581 |
|
|
$ |
120,000 |
|
|
$ |
43,122,581 |
|
|
|
35,935 |
% |
Active management revenue increased by $43,122,581, or 35,935%, for the year ended December 31,
2022 compared to the year ended December 31, 2021. The increase in active management revenue was primarily attributable to LMA making a strategic shift and re-organizing the business to include an active
management segment. This shift in business model occurred in 2021. As of December 31, 2022, LMA holds 53 policies, of which 32 are accounted for under the fair value method and 18 are accounted for using the investment method (cost, plus
premiums paid). Policies recorded under the investment method represent those policies purchased by LMA with the intent to sell within the next 12 months. Policies recorded under the investment method resulted in an increase of $37,708,829.
Aggregate face value of policies accounted for using the investment method is $42,330,000 as of December 31, 2022, with a corresponding carrying value of approximately $8,716,111. Additional information regarding policies accounted for under
the investment method is as follows:
|
|
|
|
|
|
|
|
|
|
|
Years ended December 31, |
|
|
|
2022 |
|
|
2021 |
|
Investment method |
|
|
|
|
|
|
|
|
Policies bought |
|
|
145 |
|
|
|
1 |
|
Policies sold |
|
|
127 |
|
|
|
1 |
|
Policies matured |
|
|
2 |
|
|
|
|
|
Average realized gain (loss) on policies sold |
|
|
17 |
% |
|
|
40 |
% |
Number of external counter parties that purchased policies |
|
|
25 |
|
|
|
1 |
|
Life insurance proceeds received |
|
|
2 |
|
|
|
|
|
Policies accounted for under the fair value method, with the intention to hold to maturity, resulted
in an increase in revenue of $5,413,751 driven primarily by an unrealized gain on policies of $5,742,377 for the year ended December 31, 2022 compared to the year ended December 31, 2021. Aggregate face value of policies held at fair value
is $40,092,154 as of December 31, 2022, with a corresponding fair value of $13,809,352. For the policies held at fair value, the unrealized gain on policies of $5,742,377 represents a change in fair value of the aforementioned policies. LMA
realized a gain of $105,000 for the year ended December 31, 2022 for two policies that had matured that were included in the change in fair value of life insurance policies held using the
151
fair value method and made premium payments of $433,626, which were also included in the same line item. Additional information regarding policies accounted for under the fair value method is as
follows:
|
|
|
|
|
|
|
|
|
|
|
Years ended December 31, |
|
|
|
2022 |
|
|
2021 |
|
Fair value method |
|
|
|
|
|
|
|
|
Policies bought |
|
|
32 |
|
|
|
|
|
Policies sold |
|
|
|
|
|
|
|
|
Policies matured |
|
|
2 |
|
|
|
|
|
Average realized gain (loss) on policies sold |
|
|
|
|
|
|
|
|
Number of external counter parties that purchased policies |
|
|
|
|
|
|
|
|
Life insurance proceeds received |
|
|
2 |
|
|
|
|
|
Cost of Revenues (Excluding Depreciation) and Gross Profit
Cost of revenues (excluding depreciation) primarily consists of payroll costs for employees who service policies and consulting expenses for
discretionary commissions directly related to active management trading revenue. Cost of revenues excludes depreciation expense as LMA does not hold any material property and equipment that is directly used to support the servicing or trading of
life settlement policies. The payroll costs related to policy servicing are for recurring and non-recurring projects where the time incurred for servicing policies is measurable and directly correlates to
revenue earned. Similarly, consulting expenses are for discretionary commissions earned directly related to revenue generated as part of the active management revenue stream.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years ended December 31, |
|
|
$ Change |
|
|
% Change |
|
|
|
2022 |
|
|
2021 |
|
|
|
|
|
|
|
Cost of revenue (excluding depreciation) |
|
$ |
6,245,131 |
|
|
$ |
735,893 |
|
|
$ |
5,509,238 |
|
|
|
749 |
% |
Cost of revenues (excluding depreciation) increased by $5,509,238, or 749%, for the year ended
December 31, 2022 compared to the year ended December 31, 2021. The increase in cost of revenues is primarily due to a $5,012,394 increase in consulting expenses which represent primarily discretionary commissions for individuals directly related to
active management trading revenue along with various due diligence and consulting fees. There was also a $708,727 increase in wages related to policy servicing activity as a result of increased headcount and changes to various benefit packages in
2022, offset by a $211,883 decrease in policy serving.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years ended December 31, |
|
|
|
|
|
|
|
|
|
2022 |
|
|
2021 |
|
|
$ Change |
|
|
% Change |
|
Gross profit |
|
$ |
38,468,422 |
|
|
$ |
464,093 |
|
|
$ |
38,004,329 |
|
|
|
8,189 |
% |
Gross profit increased by $38,004,329, or 8,189%, for the year ended December 31, 2022 compared to
the year ended December 31, 2021. The increase in gross profit is primarily due to the expansion of the active service management services which resulted in increased revenues of $43,049,541, or 99%, of the total increase in revenues of $43,122,581,
offset by an increase in cost of revenues of $5,509,238.
Operating Expenses
Sales and Marketing Expenses.
Sales and
marketing expenses primarily consist of advertising and marketing related expenses.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years ended December 31, |
|
|
$ Change |
|
|
% Change |
|
|
|
2022 |
|
|
2021 |
|
Sales and marketing expenses |
|
$ |
2,596,140 |
|
|
$ |
|
|
|
$ |
2,596,140 |
|
|
|
|
|
152
Sales and marketing expenses increased by $2,596,140 for the year ended December 31,
2022 compared to the year ended December 31, 2021. The increase in 2022 is attributable to marketing of the new active management segment. Sales and marketing expense relates to sponsoring a sports organization and are not directly attributable to
revenue generating activity, therefore these expenses do not represent cost of revenue.
General, Administrative and Other.
General, administrative and other primarily consists of compensation and benefits related costs associated with our finance, legal, human
resources, information technology and administrative functions. General, administrative and other costs also consist of third-party professional service fees for external legal, accounting and other consulting services, rent and lease charges,
insurance costs and software expense.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years ended December 31, |
|
|
$ Change |
|
|
% Change |
|
|
|
2022 |
|
|
2021 |
|
|
|
|
|
|
|
General, administrative and other |
|
$ |
1,066,403 |
|
|
$ |
101,406 |
|
|
$ |
964,997 |
|
|
|
952 |
% |
General, administrative and other increased by $964,997, or 952%, for the year ended December 31,
2022 compared to the year ended December 31, 2021. The increase in general, administrative and other is related to various expenses, including but not limited to increases in payroll expense and payroll related expense of $242,628, an increase in
legal expense of $83,644 and an increase in rent expense of $31,561. Additionally, $384,374 in general, administrative and other expenses were recorded in various consolidated entities pertaining to consulting charges, administrator expenses,
accounting, legal and bank fees.
Depreciation.
Depreciation expense consists primarily of depreciation on property and equipment purchased and leasehold improvements made. The property at
LMA currently consists of furniture, fixtures and leasehold improvements for the office and are not directly used to support the servicing or trading of life settlement policies.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years ended December 31, |
|
|
$ Change |
|
|
% Change |
|
|
|
2022 |
|
|
2021 |
|
Depreciation |
|
$ |
4,282 |
|
|
$ |
2,447 |
|
|
$ |
1,835 |
|
|
|
75 |
% |
Depreciation increased by $1,835, or 75%, for the year ended December 31, 2022 compared to the year
ended December 31, 2021. The $1,835 increase in depreciation is primarily due to the acquisition of furniture and fixtures in 2022 and the incremental depreciation expense that accompanies its acquisition.
Unrealized Loss on Investments.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years ended December 31, |
|
|
$ Change |
|
|
% Change |
|
|
|
2022 |
|
|
2021 |
|
Unrealized loss on investments |
|
$ |
1,045,623 |
|
|
$ |
|
|
|
$ |
1,045,623 |
|
|
|
|
% |
Unrealized loss on investments increased by $1,045,623 for the year ended December 31, 2022
compared to the year ended December 31, 2021. During the first and third quarters of 2022, LMA, through three subsidiaries, LMATT Series 2024 Inc., LMATT Growth Series Inc. and LMATT Growth and Income Series Inc., purchased S&P 500 put and
call options through a broker as an economic hedge related to the market-indexed instruments described below. The primary cause of this increase pertains to $971,281, $68,965 and $5,377, respectively, which represents a change in fair value of those
options and is classified as an unrealized loss on investments within the results of operations.
153
Change in Fair Value of Debt.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years ended December 31, |
|
|
$ Change |
|
|
% Change |
|
|
|
2022 |
|
|
2021 |
|
Change in fair value of debt |
|
$ |
90,719 |
|
|
$ |
|
|
|
$ |
90,719 |
|
|
|
|
% |
Change in fair value of debt increased by $90,719 for the year ended December 31, 2022 compared
to the year ended December 31, 2021. While the change from the prior year is due to the entity issuing the below mentioned notes in 2022, the loss from the change in fair value of debt is due to changes in the S&P 500 Index price and
S&P 500 Index volatility. This loss is related to the risk-free valuation scenarios for LMAs debt that are recorded at fair value, which comprises of the notes discussed below.
On March 31, 2022, LMATT Series 2024, Inc., which the Company consolidates for financial reporting, issued $10,166,900 in market-indexed
private placement notes. The notes, titled the Longevity Market Assets Target-Term Series (LMATTSTM ) 2024, Inc. (LMATT Series 2024, Inc.), are market-indexed instruments designed to
provide upside performance exposure of the S&P 500 Index, while limiting downward exposure. Upon maturity of the notes in 2024, the principal, plus the return based upon the S&P 500 Index must be paid. The notes haves a feature to protect
debt holders from market downturns, up to 40%. Any subsequent losses below the 40% threshold will reduce the notes on a one-to-one basis. As of December 31, 2022,
$9,886,900 of the principal amount remained outstanding. The notes are held at fair value, which represents the exit price, or anticipated price to transfer the liability to a third party. As of December 31, 2022, the fair value of the LMATT
Series 2024, Inc. notes was $8,067,291. The notes are secured by the assets of the issuing entities, which includes cash, S&P 500 options and life settlement policies totaling $12,200,797 as of December 31, 2022. The note agreements do not
restrict the trading of life settlement contracts prior to maturity of the note, as total assets of the issuing companies are considered as collateral. There are also no restrictive covenants associated with the notes with which the entities must
comply.
On September 16, 2022, LMATTS Series 2.2024, Inc., a 100% owned subsidiary which the Company consolidates for financial
reporting issued $2,333,391 in market-indexed private placement notes. The notes, titled the Longevity Market Assets Target-Term Growth Series (LMATTSTM) 2.2024, Inc. (LMATT Series 2.2024,
Inc.) are market-indexed instruments designed to provide upside performance exposure of the S&P 500 Index, while limiting downward exposure. Upon maturity of the notes in 2024, the principal, plus the return based upon the S&P 500
Index must be paid. The notes have a feature to provide upside performance participation that is capped at 120% of the performance of the S&P 500. A separate layer of the notes has a feature to protect debt holders from market downturns by up to
20% if the index price experiences a loss during the investment period. After the underlying index has decreased in value by more than 20%, the investments will experience all subsequent losses on a one-to-one basis. As of December 31, 2022, the entire principal amount remained outstanding. The notes are held at fair value, which represents the exit price, or anticipated price to transfer the
liability to a third party. As of December 31, 2022, the fair value of the LMATT Series 2.2024, Inc. notes was $2,354,013. The notes are secured by the assets of the issuing entity, LMATT Series 2.2024, Inc., which includes cash, S&P 500
options and life settlement policies totaling $3,246,756, as of December 31, 2022. The notes agreement does not restrict the trading of life settlement contracts prior to maturity of the notes, as total assets of the issuing company are
considered as collateral. There are also no restrictive covenants associated with the notes with which the entity must comply.
Additionally, on September 16, 2022, LMATT Growth and Income Series 1.2026, Inc., a 100% owned subsidiary which the Company consolidates
for financial reporting issued $400,000 in market-indexed private placement notes. The notes, titled the Longevity Market Assets Target-Term Growth and Income Series 1.2026, Inc (LMATT Growth and Income Series 1.2026, Inc.) are
market-indexed instruments designed to provide upside performance exposure of the S&P 500 Index, while limiting downward exposure. Upon maturity of the notes in 2026, the principal, plus the return based upon the S&P 500 Index must be paid.
The notes have a feature to provide upside performance participation that is capped at 140% of the performance of the S&P 500. A separate layer of the notes has a feature to protect debt holders from market downturns by up to 10% if the index
154
price experiences a loss during the investment period. After the underlying index has decreased in value by more than 10%, the investments will experience all subsequent losses on a one-to-one basis. These notes also include a 4% dividend feature that will be paid annually. As of December 31, 2022, the entire principal amount remained outstanding.
The notes are held at fair value, which represents the exit price, or anticipated price to transfer the liability to a third party. As of December 31, 2022, the fair value of the LMATT Growth and Income Series 1.2026, Inc., notes was $400,000.
The notes are secured by the assets of the issuing entity, LMATT Growth and Income Series 1.2026, Inc., which includes cash, S&P 500 options and life settlement policies totaling $752,236 as of December 31, 2022. The notes agreement does
not restrict the trading of life settlement contracts prior to maturity of the note, as total assets of the issuing company are considered as collateral. There are also no restrictive covenants associated with the notes with which the entity must
comply. See additional fair value considerations within the Fair Value footnote.
Other Operating Expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years ended December 31, |
|
|
$ Change |
|
|
% Change |
|
|
|
2022 |
|
|
2021 |
|
Other operating expense |
|
$ |
|
|
|
$ |
493,849 |
|
|
$ |
(493,849 |
) |
|
|
|
% |
Other operating expense decreased by $493,849 for the year ended December 31, 2022 compared to the
year ended December 31, 2021. This decrease in other operating expense consisted primarily of legal, bank and consulting expenses related to the start-up for LMATT Series 2024 Inc., which occurred in 2021.
Other (Expense)/Income
Other
(expense)/income consists of working capital support that LMA provides to two life settlement providers (the Providers) through a contractual agreement (the Strategic Services and Expenses Support Agreement or
SSES). LMA entered into the SSES with the Providers and simultaneously acquired an option to purchase the outstanding equity ownership of the Providers, upon the achievement by the Providers of certain financial targets. For the years
ended December 31, 2022 and December 31, 2021, the Providers were considered to be VIEs, but were not consolidated in our interim condensed consolidated financial statements as we do not hold a controlling financial interest in the Providers.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years ended December 31, |
|
|
$ Change |
|
|
% Change |
|
|
|
2022 |
|
|
2021 |
|
|
|
|
|
|
|
Other (expense)/income |
|
$ |
(347,013 |
) |
|
$ |
|
|
|
$ |
(347,013 |
) |
|
|
|
% |
Interest (expense) |
|
$ |
(42,798 |
) |
|
$ |
|
|
|
$ |
(42,798 |
) |
|
|
|
% |
Interest income |
|
$ |
1,474 |
|
|
$ |
|
|
|
$ |
1,474 |
|
|
|
|
% |
Other (expense)/ income increased by $347,013, for the year ended December 31, 2022 compared to
the year ended December 31, 2021. The increase in other (expense) is driven by an increase in SSES paid to the Providers described above of $347,013.
Interest (expense) increased by $42,798, for the year ended December 31, 2022 compared to the year ended December 31, 2021. The
increase in interest expense is driven primarily by a $26,587 accrued interest payment relating to LMA Income Series, LP, along with $11,111 and $5,100 in interest expense for LMA and LMATT Growth & Income Series, Inc. for the year ended
December 31, 2022.
Interest income increased by $1,474, for the year ended December 31, 2022 compared to the year ended
December 31, 2021. The decrease in interest income is driven by increases in bank interest.
155
Income Tax Expense
As the Company elected to file as an S-corporation for federal and Florida state income tax purposes,
the Company incurred no federal or Florida state income taxes, except for income taxes recorded related to LMATT Series 2024, Inc. (LMATT), a Delaware C-corporation and wholly owned subsidiary of
LMX Series, LLC (LMX), which LMA consolidates. Accordingly, tax expense is attributable to tax expense for LMATT Series
2024, Inc.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years ended December 31, |
|
|
$ Change |
|
|
% Change |
|
|
|
2022 |
|
|
2021 |
|
Income tax expense |
|
$ |
(889,943 |
) |
|
$ |
|
|
|
$ |
(889,943 |
) |
|
|
|
% |
Income tax expense decreased by $889,943 for the year ended December 31, 2022 compared to the
year ended December 31, 2021. Our effective income tax rate for the year ended December 31, 2022 and year ended December 31, 2021 was 22.22% and 0.0%, respectively. The difference in the effective tax rate for the year ended
December 31, 2021 and year ended December 31, 2021 is related to LMXs taxable income of $3,088,732 resulting in $657,673 of income tax expense, LMATT Growth Series, Inc. taxable income of $562,263 resulting in $142,505 of income tax
expense and LMATT Growth & Income Series, Inc. taxable income of $358,658 resulting in $90,902 of income tax expense.
Results of
OperationsSegment Results
LMA organizes its business into two reportable segments (i) portfolio servicing and
(ii) active management, which generate revenue in different manners. During 2021, we primarily focused on the portfolio servicing business. At the end of June 2021, we underwent a change in our business to focus on active management services in
addition to portfolio servicing.
This segment structure reflects the financial information and reports used by LMAs management,
specifically its chief operating decision maker (CODM), to make decisions regarding LMAs business, including resource allocations and performance assessments as well as the current operating focus in accordance with ASC 280,
Segment Reporting. LMAs CODM is the President and CEO of LMA.
The portfolio servicing segment generates revenues by providing
policy services to customers on a contract basis. The active management segment generates revenues by buying, selling and trading policies and maintaining policies through to death benefit. LMAs reportable segments are not aggregated.
The following tables provides supplemental information of revenue and profitability by operating segment:
Portfolio Servicing
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31, |
|
|
|
2022 |
|
|
2021 |
|
Total revenue |
|
$ |
1,470,973 |
|
|
$ |
1,079,986 |
|
Gross profit |
|
|
300,235 |
|
|
|
406,093 |
|
Total revenue for the portfolio servicing segment increased by $390,987, or 36% for the year ended
December 31, 2022 compared to the year ended December 31, 2021. The increase in Portfolio servicing revenue is primarily attributable to $118,416 in increased related party servicing revenue and $272,570 in Portfolio servicing revenue. Gross profit
from our portfolio servicing segment decreased $105,858, or 26%, for the year ended December 31, 2022 compared to the year ended December 31, 2021. The decrease in gross margin is primarily due to an increase in total cost of revenue of $496,844
partially offset by increases in revenue of $390,987.
156
Active Management
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31, |
|
|
|
2022 |
|
|
2021 |
|
Total revenue |
|
$ |
43,242,581 |
|
|
$ |
120,000 |
|
Gross profit |
|
|
38,168,187 |
|
|
|
58,000 |
|
Total revenue for the active management segment increased by $43,122,581 for the year ended December
31, 2022 compared to the year ended December 31, 2021. Gross profit from our active management segment increased $38,110,187 for the year ended December 31, 2022 compared to the year ended December 31, 2021. The increase in Active management revenue
and gross profit was primarily attributable to LMA making a strategic shift and re-organizing the business to focus on active management services in addition to portfolio servicing at the end of September
2021.
Key Business Metrics and Non-GAAP Financial Measures
The consolidated financial statements of LMA have been prepared in accordance with the rules and regulations of the Securities and Exchange
Commission and are prepared in accordance with U.S. GAAP. We monitor key business metrics and non-GAAP financial measures that assist us in evaluating our business, measuring our performance, identifying
trends and making strategic decisions. We have presented the following non-GAAP measures, their most directly comparable GAAP measure and key business metrics:
Adjusted EBITDA
|
|
|
Non-GAAP Measure |
|
Comparable GAAP Measure |
Adjusted EBITDA |
|
Net Income |
Adjusted EBITDA is net income adjusted for depreciation expense, income tax and other non-cash and non-recurring items that in our judgement significantly impact the period-over-period assessment of performance and operating results that do not directly relate
to business performance within LMAs control. These unusual items may include proceeds from the PPP loan, payments made as part of LMAs expense support commitment, loss on the change in fair value of debt, S&P 500 put and call options
that were entered into as an economic hedge related to the debt (described as the unrealized loss on investments) and other non-recurring items. Management plans to terminate the agreement for the expense
support commitment within the next twelve months. As such, management has deemed this to be non-recurring item. Adjusted EBITDA should not be determined as substitution for net income (loss), cash flows
provided (used in) operating, investing and financing activities, operating income (loss), or other metrics prepared in accordance with U.S. GAAP.
Management believes the use of Adjusted EBITDA assists investors in understanding the ongoing operating performance by presenting comparable
financial results between periods. We believe that by removing the impact of depreciation and amortization and excluding certain non-cash charges, amounts spent on interest and taxes and certain other non-recurring charges that are highly variable from year to year, Adjusted EBITDA provides our investors with performance measures that reflect the impact to operations from trends in changes in revenue, policy
values and operating expenses, providing a perspective not immediately apparent from net income and operating income. The adjustments we make to derive the non-GAAP measure of Adjusted EBITDA exclude items
which may cause short-term fluctuations in net income and operating income and which we do not consider to be the fundamental attributes or primary drivers of our business.
157
The following table presents a reconciliation of Adjusted EBITDA to the most comparable
GAAP financial measure, net income (loss), on a historical basis for the periods indicated below:
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31, |
|
|
|
2022 |
|
|
2021 |
|
Net income |
|
$ |
32,386,975 |
|
|
$ |
(133,609 |
) |
Depreciation expense |
|
|
4,282 |
|
|
|
2,447 |
|
Income tax |
|
|
889,943 |
|
|
|
|
|
Proceeds from PPP loan |
|
|
|
|
|
|
4,831 |
|
Non-recurring legal and consulting fees |
|
|
|
|
|
|
480,574 |
|
Other income (expense) |
|
|
347,013 |
|
|
|
|
|
Interest (expense) |
|
|
42,798 |
|
|
|
|
|
Interest income |
|
|
(1,474 |
) |
|
|
|
|
Change in fair value of debt |
|
|
90,719 |
|
|
|
|
|
Unrealized loss on investments |
|
|
1,045,623 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted EBITDA |
|
|
34,805,879 |
|
|
|
354,243 |
|
|
|
|
|
|
|
|
|
|
Adjusted EBITDA for the year ended December 31, 2022 was $34,805,879 compared to $354,243 for the
year ended December 31, 2021. The increase in adjusted EBITDA is primarily due to the expansion of the active management services which resulted in increased revenues of $43,122,581, offset by an increase in cost of revenues of $38,110,187 for
active management sales.
We monitor the following key business metrics: (i) number of policies serviced, (ii) value of policies
serviced and (iii) total invested dollars. Servicing revenue involves the provision of services to one affiliate by common ownership and third parties which own life insurance policies. The number of policies and the value of policies serviced
represents the volume and dollar value of policies over which the above services are performed. Total invested dollars represent the acquisition cost plus premiums paid by the policy. We use the aforementioned metrics to assess business operations
and provide concrete benchmarks that provide a clear snapshot of growth between the periods under consideration. Please refer to the following Key Business Metrics below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years ended December 31, |
|
|
$ Change |
|
|
% Change |
|
Key business metric |
|
2022 |
|
|
2021 |
|
Number of policies serviced |
|
|
421 |
|
|
|
379 |
|
|
|
42 |
|
|
|
11 |
% |
Value of policies serviced ($) |
|
|
649,842,091 |
|
|
|
600,651,852 |
|
|
|
49,190,239 |
|
|
|
8 |
% |
Total invested dollars ($) |
|
|
163,939,204 |
|
|
|
153,378,077 |
|
|
|
10,561,127 |
|
|
|
7 |
% |
Liquidity and Capital Resources
LMA has financed operations since our inception primarily through customer payments, debt issuances and net proceeds from equity financings in
the form of capital contributions from our limited liability company members. Our principal uses of cash and cash equivalents in recent periods have been funding our operations as LMA must actively manage its working capital and the associated cash
requirements when servicing policies while also effectively utilizing cash and other sources of liquidity to purchase additional policies. As of December 31, 2022 and December 31, 2021, our principal sources of liquidity were cash totaling
$30,052,823 and $102,420, respectively, and LMA had retained earnings of $25,594,141 and $605,048, respectively. During the year ended December 31, 2022, LMA had a net income attributable to LMA of $31,789,093 and during the year ended December 31,
2021, LMA had a net income attributable to LMA of $14,546, respectively. During the year ended December 31, 2022 and 2021, LMA had a net cash provided by (used in) operations of $10,801,252 and ($139,168), respectively.
158
As described above, LMA has entered into an SSES with the Providers. Since inception of
the SSES on January 1, 2021 through December 31, 2021, LMA had incurred $120,000 related to initial funding of operations, and $0 related to expenses. As of December 31, 2022, LMA incurred $347,013 related to expenses. Additionally,
the Providers reimbursed LMA for the initial funding of $120,000 but have not reimbursed other expenses paid by LMA on behalf of the Providers in 2022. For the year ended December 31, 2021, the Providers were considered to be VIEs, but were not
consolidated in our consolidated financial statements due to a lack of the power criterion or the losses/benefits criterion.
Our future
capital requirements will depend on many factors, including our revenue growth rate and the expansion of our active management and portfolio activities. LMA may, in the future, enter into arrangements to acquire or invest in complementary
businesses, products and technologies. LMA may be required to seek additional equity or debt financing.
Cash Flows
The following tables summarizes our cash flows for the periods presented:
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31, |
|
|
|
2022 |
|
|
2021 |
|
Net cash provided by / (used in) operating activities |
|
$ |
10,693,252 |
|
|
$ |
(139,168 |
) |
Net cash provided by / (used in) investing activities |
|
|
(3,704,645 |
) |
|
|
(275,346 |
) |
Net cash provided by / (used in) financing activities |
|
|
22,961,795 |
|
|
|
381,663 |
|
Operating Activities.
During the year ended December 31, 2022, our operating activities generated $10,693,252 of net cash as compared to net cash used from operating
activities of $139,168 during the year ended December 31, 2021. The increase in net cash from operating activities during 2022 compared to 2021 was primarily due to the increased net income, which was primarily attributable to increases in Active
management revenue.
Investing Activities.
During the year ended December 31, 2022, investing activities used $3,704,645 of net cash as compared to $275,346 during the year ended
December 31, 2021. Net cash used in investing activities during the year ended December 31, 2022 was related to purchase of available-for-sale investments, other
investments and the increase in the amounts due from affiliates during the year. Net cash used in investing activities during the year ended December 31, 2021 was related to purchase of
available-for-sale investments and the purchase of property and equipment during the year, along with amounts due from affiliates of $2,904,646.
Financing Activities.
During the year
ended December 31, 2022, financing activities generated $22,961,795 of net cash as compared to net cash generated of $381,663 during the year ended December 31, 2021. Net cash generated in financing activities during the year ended December 31, 2022
was related to the increase in amount for issuance of debt securities of $ 30,028,640, partially offset by amount due to affiliates of $666,845 and distributions to members of $6,400,000. Net cash generated in financing activities during the year
ended December 31, 2021 was related to the increase in the amounts due to members of $781,663, partially offset by distributions to members of $400,000.
159
Contractual Obligations and Commitments
Our significant contractual obligations as of December 31, 2022, include three notes,
LMATTSTM 2024, LMATTSTM 2.2024 and LMATTSTM 1.2026. The $10,166,900 LMATTSTM 2024 notes are a market-indexed instrument designed to provide upside performance exposure of the S&P 500 Index, while limiting downward exposure. Upon maturity of the notes in 2024, the
principal, plus the return based upon the S&P 500 Index must be paid. The notes have a feature to protect debt holders from market downturns, up to 40%. Any subsequent losses below the 40% threshold will reduce the notes. The notes do not pay
interest to the holders. The $2,333,391 LMATTSTM 2.2024 notes are market-indexed instruments designed to provide upside performance exposure of the S&P 500 Index, while limiting downward
exposure. Upon maturity of the notes in 2024, the principal, plus the return based upon the S&P 500 Index must be paid. The notes have a feature to protect debt holders from market downturns, up to 20%. Any subsequent losses below the 20%
threshold will reduce the notes. The notes do not pay interest to the holders. The $400,000 LMATTSTM 1.2026 notes are market-indexed instruments designed to provide upside performance exposure of
the S&P 500 Index, while limiting downward exposure. Upon maturity of the notes in 2026, the principal, plus the return based upon the S&P 500 Index must be paid. The notes have a feature to protect debt holders from market downturns, up to
10%. Any subsequent losses below the 10% threshold will reduce the notes. The notes pay annual interest of 4% on invested capital to the holders.
Additionally, LMA Income Series, GP, LLC, wholly owned and controlled by that LMA Series, LLC, formed a limited partnership, LMA Income
Series, LP, and issued partnership interests to limited partners in a private placement offering. The initial term of the offering is three years with the ability to extend for two additional one-year periods
at the discretion of the general partner, LMA Income Series, GP, LLC. The limited partners will receive an annual dividend of 6.5% paid quarterly and 25% of returns in excess of a 6.5% internal rate of return capped at a 15% net internal rate of
return. The General Partner will receive 75% of returns in excess of a 6.5% internal rate of return to limited partners then 100% in excess of a 15% net internal rate of return. It was determined that LMA Series, LLC is the primary beneficiary of
LMA Income Series, LP and thus has fully consolidated the limited partnership in its consolidated financial statements for the year ended December 31, 2022.
The private placement offerings proceeds will be used to acquire an actively managed large and diversified portfolio of financial assets,
which was not deployed yet as of December 31, 2022. LMA elected to account for the secured borrowing at fair value under the collateralized financing entity guidance within ASC
810-10-30. As of December 31, 2022, the fair value of the secured borrowing was $17,678,349.
Additionally, LMA has operating lease obligations, which are included as liabilities on our balance sheet, for our office space. As of
December 31, 2022, operating lease obligations were $77,395 with $48,127 due in less than one year and $29,268 due within one to three years, which are comprised of the minimum commitments for our office space.
Critical Accounting Policies and Estimates
LMA has prepared our consolidated financial statements in accordance with GAAP. Our preparation of these financial statements requires us to
make estimates, assumptions and judgments that affect the reported amounts of assets, liabilities and related disclosures at the date of the financial statements, as well as revenue and expense recorded during the reporting periods. LMA evaluates
our estimates and judgments on an ongoing basis. LMA bases our estimates on historical experience and/or other relevant assumptions that LMA believes to be reasonable under the circumstances. Actual results may differ materially from
managements estimates.
While our significant accounting policies are described in more detail in Note 2 to our consolidated
financial statements included in this proxy statement, LMA believes the following accounting policies to be critical to the judgments and estimates used in the preparation of our financial statements.
160
Longevity Market Assets Target-Term Series
(LMATTSTM) Notes
On March 31, 2022, LMATT Series 2024, Inc., which LMA
consolidates for financial reporting, issued approximately $10,166,900 in market-indexed private placement notes. The notes, LMATTSTM 2024, are market-indexed instruments designed to provide
upside performance exposure of the S&P 500 Index, while limiting downward exposure. Upon maturity of the notes in 2024, the principal, plus the return based upon the S&P 500 Index must be paid. The notes have a feature to protect debt
holders from market downturns, up to 40%. Any subsequent losses below the 40% threshold will reduce the notes. The notes do not pay interest to the holders.
On September 16, 2022, LMATT Growth Series, Inc., which LMA consolidates for financial reporting, issued approximately $2,333,391 in
market-indexed private placement notes. The notes, LMATTSTM 2.2024, are market-indexed instruments designed to provide upside performance exposure of the S&P 500 Index, while limiting downward
exposure. Upon maturity of the notes in 2024, the principal, plus the return based upon the S&P 500 Index must be paid. The notes have a feature to protect debt holders from market downturns, up to 20%. Any subsequent losses below the 20%
threshold will reduce the notes. The notes do not pay interest to the holders.
On September 16, 2022, LMATT Growth and Income Series,
Inc., which LMA consolidates for financial reporting, issued approximately $400,000 in market-indexed private placement notes. The notes, LMATTSTM 1.2026, are market-indexed instruments designed
to provide upside performance exposure of the S&P 500 Index, while limiting downward exposure. Upon maturity of the notes in 2024, the principal, plus the return based upon the S&P 500 Index must be paid. The notes have a feature to protect
debt holders from market downturns, up to 10%. Any subsequent losses below the 10% threshold will reduce the notes. The notes pay an annual 4% interest rate on invested capital to the holders.
LMA has elected the fair value option in accounting for the instruments. Fair value is determined using Level 3 inputs. The valuation
methodology is based on the Black-Scholes-Merton option-pricing formula and a discounted cash flow analysis. Inputs to the Black-Scholes-Merton model include (i) the S&P 500 Index price, (ii) S&P 500 Index volatility, (iii) a
risk-free rate based on data published by the US Treasury and (iv) a term assumption based on the contractual term of the LMATTTM note. The discounted cash flow analysis includes a discount
rate that is based on the implied discount rate assumption developed by calibrating a valuation model to the purchase price on the initial investment date. The implied discount rate is evaluated for reasonableness by benchmarking it to yields on
actively traded comparable securities.
For the year ended December 31, 2022, LMA has recognized a gain of $268,149 and a loss of
$358,868 for the LMATTSTM 2024 notes and LMATTSTM 2.2024 notes, respectively, on the change in fair value fair value of the debt resulting from
risk-free valuation scenarios, which is included within gain/loss on change in fair value of debt within the interim Condensed Consolidated Statement of Operations.
Longevity Market Assets Income Series, LP
On November 30, 2022, LMA Income Series, GP, LLC, wholly owned and controlled by that LMA Series, LLC, which LMA consolidates, formed a
limited partnership, LMA Income Series, LP, and issued partnership interests to limited partners in a private placement offering. It was determined that LMA Series, LLC is the primary beneficiary of LMA Income Series, LP and thus has fully
consolidated the limited partnership in its consolidated financial statements for the year ended December 31, 2022. The limited partners will receive an annual dividend of 6.5% paid quarterly and 25% of returns in excess of a 6.5% internal rate
of return capped at a 15% net internal rate of return. The general partner will receive 75% of returns in excess of a 6.5% internal rate of return to limited partners then 100% in excess of a 15% net internal rate of return. The general partner
committed $250,000, with the limited partners contributing $17,428,349.
The private placement offerings proceeds were used to acquire an
actively managed large and diversified portfolio of financial assets. LMA, through its consolidated subsidiaries, serves as the portfolio manager for the
161
financial asset portfolio, which includes investment sourcing and monitoring. In this role, LMA has the unilateral ability to acquire and dispose of any of the above investments. LMA elected to
account for the secured borrowing at fair value under the collateralized financing entity guidance within ASC 810-10-30. As of December 31, 2022, the fair value of
the secured borrowing, not including the $250,000 committed from the general partner, was $17,428,349 and there was no gain or loss recognized.
Valuation of Life Insurance Policies
LMA accounts for its holdings of life insurance settlement policies at fair value in accordance with ASC
325-30, Investments in Insurance Contracts. Any resulting changes in estimates are reflected in operations in the period the change becomes apparent.
LMA follows ASC 820, Fair Value Measurements and Disclosures, in estimating the fair value of its life insurance policies, which defines fair
value as an exit price representing the amount that would be received if an asset were sold or that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a
market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the guidance establishes a three-level, fair value hierarchy
that prioritizes the inputs used to measure fair value. Level 1 relates to quoted prices in active markets for identical assets or liabilities. Level 2 relates to observable inputs other than quoted prices included in Level 1.
Level 3 relates to unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. LMAs valuation of life settlements is considered to be Level 3, as
there is currently no active market where LMA is able to observe quoted prices for identical assets. LMAs valuation model incorporates significant inputs that are not observable.
As of December 31, 2022, the aggregate face value of policies held at fair value is approximately $40,092,154, with a corresponding fair
value of approximately $13,809,352. Aggregate face value of policies accounted for using the investment method is $42,330,000 as of December 31, 2022, with a corresponding carrying value of approximately $8,716,111.
Equity Investments in Privately-Held Companies
Equity investments without readily determinable fair values include our investments in privately-held companies in which LMA holds less than a
20% ownership interest and does not have the ability to exercise significant influence. LMA determines fair value using level 3 inputs under the measurement alternative. These investments are recorded at cost minus impairment, if any, plus or minus
changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer.
In
addition, LMA monitors these investments to determine if impairment charges are required based primarily on the financial condition and near-term prospects of these companies. As of December 31, 2022 and December 31, 2021, LMA did not identify
any impairment indictors and determined that the carrying value of $1,300,000 is the fair value for these equity investments in privately held companies, given that there have been no observable price changes.
Available-For-Sale Securities
LMA has investments in securities that are classified as
available-for-sale securities, and which are reflected on the Consolidated Balance Sheets at fair value. These securities solely consist of a convertible promissory note
in a private company that was entered into at arms-length. LMA determines the fair value using unobservable inputs by considering the initial investment value, next round financing and the likelihood of conversion or settlement based on the
contractual terms in the agreement. Unrealized gains and losses on these investments are included as a separate component of accumulated other comprehensive loss, net of tax, on the Consolidated Balance Sheets. LMA classifies its available-for-sale securities as short-term or long-term based on the nature of
162
the investment, its maturity date and its availability for use in current operations. LMA monitors its
available-for-sale securities for possible other-than-temporary impairment when business events or changes in circumstances indicate that the carrying value of the
investment may not be recoverable. As of December 31, 2022, LMA evaluated the fair value of its investment and determined that the fair value approximates the carrying value of $1,000,000, and no unrealized gains and losses were recorded.
Quantitative and Qualitative Disclosures About Market Risk
Not required for smaller reporting companies.
JOBS Act Election
Section 102(b)(1)
of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective
or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended
transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable.
ERES has irrevocably elected to opt out of such extended transition period, which means that when a standard is issued or revised and it has
different application dates for public or private companies, ERES, as an emerging growth company, will adopt the new or revised standard at the time public companies adopt the new or revised standard. As a result, following the consummation of the
Business Combination, LMA will comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies.
163
ABACUS MANAGEMENTS DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion and analysis provide information that management believes
is relevant to an assessment and understanding of Abacus financial condition and results of operations. This discussion should be read in conjunction with Abacus financial statements and related notes thereto that appear elsewhere in
this proxy statement.
In addition to historical financial analysis, this discussion and analysis contains forward-looking
statements based upon current expectations that involve risks, uncertainties and assumptions, as described under the heading Cautionary Note Regarding Forward-Looking Statements. Actual results and timing of selected events may differ
materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth under Risk Factors or elsewhere in this proxy statement. Unless the context otherwise requires, references in
this Abacus Managements Discussion and Analysis of Financial Condition and Results of Operations to we, us, our, and Abacus are intended to mean the business and operations of Abacus
Settlements, LLC.
Overview
Abacus originates life insurance policy settlement contracts as a licensed life settlement provider on behalf of third-party institutional
investors (Financing Entities) interested in investing in the life settlement asset class. Specifically, Abacus originates policies through three primary origination channels (Agents / Financial Advisors,
Direct-to-Consumers and Third Party Intermediaries), screens them for eligibility by verifying that the policy is in force, obtaining consents and disclosures, and
submitting cases for life expectancy estimates. This process is characterized as our origination services, which averages a fee of approximately 2% of face value (Origination Revenue).
Our Business Model
As a life settlement
provider, Abacus serves as a purchaser of outstanding life insurance policies. When serving as a purchaser, Abacus primary purpose in the transaction is to connect buyers and sellers through an origination process. The origination process is
core to Abacus business and drives its economics. Abacus averages approximately 2% of face value in origination fees on policies and has developed three high quality origination channels which include agents and advisors, direct to consumer
and life settlements brokers. Generally, diversification across multiple origination channels lowers average policy acquisition cost and increases estimated returns. Abacus finds sellers through its origination channels using strategic marketing
practices in its core markets, with the purpose of finding policy owners who want to capitalize on their investments prior to death by extracting value from their policies through the sale of such policies to Financing Entities.
Key Factors Affecting Our Performance
Our operations and financial performance are impacted by economic factors affecting the industry, including:
Opportunities in the Life Settlements Industry
Within the life settlements industry, there is significant policy value that lapses on an annual basis. Currently, the life settlements
industry only captures a narrow portion of the potential market leaving significant runway for future growth for industry participants. With the anticipation of growth in total face value of life insurance policies, we believe we are well positioned
to capitalize on the overall market growth as we are licensed in 49 states.
164
Our ability to originate policies is essential to scale our business over time. In order
to support this expected growth, we continue to invest in our technology and marketing infrastructure. In general, we expect our efforts will continue to focus on driving education and awareness of life settlements. In order to meet this growing
demand, we have increased our total headcount by 40% since December 2021.
Macroeconomic Changes
Global macroeconomic factors, including regulatory policies, unemployment, changes in retirement savings, the cost of healthcare, inflation and
tax rate changes impact demand for our origination services. These factors evolve over time and while these changes have not currently made any significant impact on performance, these trends may shift the timing and volume of transactions, or the
number of customers using our origination services.
Impact of COVID-19
The COVID-19 pandemic has had an adverse impact on global commercial activity, particularly on the
global supply chain and workforce availability, and has contributed to significant volatility in the global financial markets including, among other effects, occasional declines in the equity markets, changes in interest rates and reduced liquidity
on a global basis.
The extent to which COVID-19 impacts Abacus business and financial
position will depend on future developments, which are difficult to predict. These future developments may include the severity and scope of the COVID-19 outbreak and the emergence of new variants, which may
unexpectedly change or worsen, and the types and duration of measures imposed by governmental authorities to contain the virus or address its impact. Abacus believes that, as a general matter, these trends and uncertainties are similar to those
faced by other comparable registrants as a result of the pandemic.
165
Components of Results of Operations
Results of Operations
The following
tables set forth our results of operations for each of the periods indicated, and we have presented and expressed the relationship of certain line items as a percentage of revenue for those periods. The period-to-period comparison of financial results is not necessarily indicative of future results.
The following tables set forth our historical results for the periods indicated, and the changes between periods:
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31, |
|
|
|
2022 |
|
|
2021 |
|
Origination revenue |
|
$ |
7,050,007 |
|
|
$ |
4,906,374 |
|
|
|
|
Related-party revenue |
|
|
18,153,456 |
|
|
|
17,685,770 |
|
|
|
|
|
|
|
|
|
|
Total revenue |
|
|
25,203,463 |
|
|
|
22,592,144 |
|
Cost of revenue |
|
|
5,538,470 |
|
|
|
2,678,029 |
|
Related party cost of revenue |
|
|
11,022,535 |
|
|
|
11,527,312 |
|
|
|
|
|
|
|
|
|
|
Gross profit |
|
|
8,642,458 |
|
|
|
8,386,803 |
|
Operating expenses |
|
|
|
|
|
|
|
|
General and administrative expenses |
|
|
8,674,425 |
|
|
|
7,439,549 |
|
Depreciation expense |
|
|
12,165 |
|
|
|
10,139 |
|
|
|
|
|
|
|
|
|
|
Total operating expenses |
|
|
8,686,590 |
|
|
|
7,449,688 |
|
Income from operations |
|
|
(44,132 |
) |
|
|
937,115 |
|
Other income (expense) |
|
|
|
|
|
|
|
|
Interest income (expense) |
|
|
2,199 |
|
|
|
11,500 |
|
Interest Expense |
|
|
(8,817 |
) |
|
|
50,000 |
|
Other income |
|
|
273 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total other income (expense) |
|
|
(6,346 |
) |
|
|
61,500 |
|
Income before income taxes |
|
|
(50,477 |
) |
|
|
998,615 |
|
Provision for income taxes |
|
|
(2,018 |
) |
|
|
(1,200 |
) |
|
|
|
|
|
|
|
|
|
Net income and comprehensive income |
|
$ |
(52,495 |
) |
|
$ |
997,415 |
|
|
|
|
|
|
|
|
|
|
Origination Revenue
Abacus recognizes revenue from origination activities by acting as a provider of life settlements and viatical settlements by representing
investors that are interested in purchasing life settlements on the secondary or tertiary market. Revenue from origination services consists of fees negotiated for each purchase and sale of a policy to an investor, which also include any agent and
broker commissions received and the reimbursement of transaction costs.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31, |
|
|
$ Change |
|
|
% Change |
|
|
|
2022 |
|
|
2021 |
|
Origination revenue |
|
$ |
7,050,007 |
|
|
$ |
4,906,374 |
|
|
|
2,143,633 |
|
|
|
44 |
% |
Revenue increased by $2,143,633 or 44%, for the year ended December 31, 2022 compared to the year
ended December 31, 2021. The increase in revenue is primarily attributable to an increase in agent and broker sales during 2022 of $489,687 and $1,681,175, which is driven by higher face values on the policies originated, partially offset by a
decrease in client direct sales of $63,297. The agent, broker and client direct sales are all in line with normal, recurring business.
166
Related Party Revenue
Abacus has a related party relationship with Nova Trading (US), LLC (Nova Trading), a Delaware limited liability company and Nova
Holding (US) LP, a Delaware limited partnership (Nova Holding and collectively with Nova Trading, the Nova Funds) as the owners of Abacus jointly own 11% of the Nova Funds. Pricing for origination fees is governed by
origination contracts that have been negotiated by both parties and are considered to be arms-length and consistent with origination fees charged to third party customers. For its origination services to the Nova Funds, Abacus earns origination fees
equal to the lesser of (i) 2% of the net death benefit for the policy or (ii) $20,000.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31, |
|
|
$ Change |
|
|
% Change |
|
|
|
2022 |
|
|
2021 |
|
Related Party Revenue |
|
$ |
18,153,456 |
|
|
$ |
17,685,770 |
|
|
|
467,686 |
|
|
|
3 |
% |
For the years ended December 31, 2022 and December 31, 2021, Abacus has originated 333 and 313
policies, respectively, for the Nova Funds with a total value of approximately $87,143,005 and $106,600,000, respectively. Related party revenue increased by $467,686, or 3%, for the year ended December 31, 2022 compared to the year ended December
31, 2021. The increase in related party revenue is primarily attributable to increased agent and direct client sales of $3,627,939, partially offset by decreased broker sales during 2022 of $3,160,223. There was an increase in origination policies
of 16% in 2022, with origination fees increasing 13%.
Cost of Revenue, Related Party Cost of Revenue and Gross Margin
Cost of revenue is primarily comprised of third-party commissions, which includes third-party sales and marketing commission fees, as well as
transaction costs that are reimbursed as part of the origination activity and depreciation and amortization expense. Abacus receives a fee from the purchaser for its part in arranging the life settlement transactions. Out of that fee income, Abacus
pays commissions to the licensed representative of the seller, if one is required. Commission expense is recorded at the same time revenue is recognized and is included within cost of revenue. Depreciation expense consists of depreciation of
property and equipment assets, which are computer equipment. Amortization expense consists primarily of amortization of capitalized costs incurred for the development of internal use software. The costs incurred exclusively consist of fees incurred
from an external consulting firm during the development stage of the project and is amortized on the straight-line basis over an estimated useful life of three years.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31, |
|
|
$ Change |
|
|
% Change |
|
|
|
2022 |
|
|
2021 |
|
Cost of revenue |
|
$ |
5,538,470 |
|
|
$ |
2,678,029 |
|
|
|
2,860,441 |
|
|
|
107 |
% |
Related party cost of revenue |
|
|
11,022,535 |
|
|
|
11,527,312 |
|
|
|
(504,777 |
) |
|
|
-4 |
% |
Gross Profit |
|
|
8,642,458 |
|
|
|
8,386,803 |
|
|
|
255,656 |
|
|
|
3 |
% |
Gross Margin |
|
|
34 |
% |
|
|
37 |
% |
|
|
|
|
|
|
-8 |
% |
Cost of revenue increased by $2,860,441, or 107%, for the year ended December 31, 2022 compared to
the year ended December 31, 2021. The increase in cost of revenue is primarily due to increases in agent commission expenses of $1,570,908 due to increases in agent and broker origination revenue, which is driven by increased origination activity
and an increase in the face value of policies sold to third parties. There was also an increase in life expectancy report fees of $470,883 which is driven off of increases in agent and broker activity during 2022.
Related party cost of revenue decreased by $504,777, or 4%, for the year ended December 31, 2022 compared to the year ended
December 31, 2021. The decrease in related party cost of revenue is primarily attributable to decreases in agent commission expenses of $569,229 as a result of decrease in the total face value of policies sold to the Nova funds, which agent
commission expense is primarily based off of.
Gross profit increased by $255,656, or 3%, for the year ended December 31, 2022 compared to
the year ended December 31, 2021. Gross margin decreased to 34% for the year ended December 31, 2022 compared to
167
37% for the year ended December 31, 2021. The increase in gross profit and decrease in gross margin is primarily due to a decrease in client direct sales of 12%, as no agent commission needs to
be paid for client direct sales, so the margins are much higher than agent and broker origination sales which increased by 16% in 2022.
Operating
Expenses
Operating expenses is comprised of general and administrative expenses as well as depreciation expense.
General and administrative expenses include compensation, payroll, advertising, marketing, insurance, rent, insurance, recruitment, licenses
and other professional fees.
Depreciation expense consists of depreciation of property and equipment assets, which are computer
equipment, and office furniture.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
|
$ Change |
|
|
% Change |
|
|
|
2022 |
|
|
2021 |
|
|
|
|
|
|
|
General and administrative expenses |
|
$ |
8,674,425 |
|
|
$ |
7,439,549 |
|
|
$ |
1,234,876 |
|
|
|
17 |
% |
|
|
|
|
|
Depreciation expense |
|
|
12,165 |
|
|
|
10,139 |
|
|
|
2,026 |
|
|
|
20 |
% |
General and administrative expenses increased by $1,234,876, or 17%, for the year ended December 31,
2022 compared to the year ended December 31, 2021. The increase in general and administrative expenses are primarily due to increases in payroll expenses as a result of higher employee headcounts as there was an increase of 40% during 2022, and
compensation raises. There was an increase in marketing expenses due to increased television ads and radio commercials, as well as increased spending in internet advertising. Salaries and payroll expense, as a percentage of total revenue,
represented 21% and 18% for the years ended December 31, 2022 and 2021, respectively.
Depreciation expense decreased by $2,026, or
20%, for the year ended December 31, 2022 compared to the year ended December 31, 2021. The decrease in the expense is primarily due to a decrease in depreciation for property and equipment, as some assets became fully depreciated during 2022.
Other income (expense)
Other
income (expense) includes interest income, consulting income and other income. Interest income represents the interest earned on Abacus certificates of deposits. Consulting income represents income earned on various origination consulting
services performed. Other income comprises of income from credit card cash rewards.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years ended December 31, |
|
|
$ Change |
|
|
% Change |
|
|
|
2022 |
|
|
2021 |
|
Interest income |
|
$ |
2,199 |
|
|
$ |
11,500 |
|
|
$ |
(9,301 |
) |
|
|
-81 |
% |
Interest expense |
|
|
(8,817 |
) |
|
|
|
|
|
|
(8,817 |
) |
|
|
100 |
% |
Other income |
|
|
273 |
|
|
|
50,000 |
|
|
|
(49,727 |
) |
|
|
-99 |
% |
Interest income decreased by $9,301, or 81%, for the year ended December 31, 2022 compared to the
year ended December 31, 2021. The decrease in interest income is primarily due to an unfavorable change in interest rate terms for Abacus certificate of deposit.
Interest expense increased by $8,817 or 100% for the year ended December 31, 2022 compared to the year ended December 31, 2021. The increase
in interest expense is primarily due to a fee for the certificate of deposit of $1,000 as well as amortized deferred financing fees of $7,817 for the year ended December 31, 2022.
168
Other income decreased by $49,727, or 99%, for the year ended December 31, 2022 compared
to the year ended December 31, 2021. The decrease in other income is primarily due to a decrease in consulting income as the Company serviced a policy during 2021 for $50,000 that did not occur for the year ended December 31, 2022.
Provision for Income Taxes
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years ended December 31, |
|
|
$ Change |
|
|
% Change |
|
|
|
2022 |
|
|
2021 |
|
Provision for income taxes |
|
$ |
(2,018 |
) |
|
$ |
(1,200 |
) |
|
$ |
(818 |
) |
|
|
68 |
% |
Provision for income taxes decreased by $818 or 68%, for the year ended December 31, 2022 compared to
the year ended December 31, 2021. These amounts are primarily LLC annual report filing fees within the various states.
Business Segments
Operating as a centrally led life insurance policy intermediary, Abacus President and Chief Executive Officer is the Chief Operating
Decision Maker (CODM) who allocates resources and assesses financial performance. As a result of this management approach, Abacus is organized as a single operating segment. The CODM reviews performance and allocates resources based on the total
originations, total corresponding revenue generated for the period, gross profit and adjusted EBITDA.
Key Business Metrics and Non-GAAP Financial Measures
Management uses non-GAAP
financial measures, in conjunction with GAAP financial measures, as an integral part of managing our business and to, among other things: (i) monitor and evaluate the performance of our business operations and financial performance;
(ii) facilitate internal comparisons of the historical operating performance of our business operations; (iii) review and assess the operating performance of our management team; (iv) analyze and evaluate financial and strategic
planning decisions regarding future operating investments; and (v) plan for and prepare future annual operating budgets and determine appropriate levels of operating investments.
We monitor the following key business metrics and non-GAAP financial measures that assist us in
evaluating our business, measuring our performance, identifying trends and making strategic decisions. As such, we have presented the following non-GAAP measure, their most directly comparable GAAP measure and
key business metrics:
|
|
|
|
|
|
|
Non-GAAP Measure |
|
Comparable GAAP Measure |
|
|
Adjusted EBITDA |
|
Net Income |
Adjusted EBITDA is net income adjusted for depreciation expense, provision for income taxes, interest
income and non-recurring items that in our judgement significantly impact the period-over-period assessment of performance and operating results. Adjusted EBITDA should not be construed as an indicator of our
operating performance, liquidity, or cash flows provided by or used in operating, investing and financing activities, as there may be significant factors or trends that it fails to address. We caution investors that
non-GAAP financial information departs from traditional accounting conventions. Therefore, its use can make it difficult to compare current results with results from other reporting periods and with the
results of other companies.
Management believes the use of Adjusted EBITDA measures assists investors in understanding the ongoing
operating performance by presenting comparable financial results between periods. We believe that by removing the impact of depreciation and amortization, amounts spent on interest and taxes and certain other
non-recurring income and charges that are highly variable from year to year, Adjusted EBITDA provides our investors with
169
performance measures that reflect the impact to operations from trends in changes in revenue and operating expenses, providing a perspective not immediately apparent from net income and operating
income. The adjustments we make to derive the non-GAAP measure of Adjusted EBITDA exclude items which may cause short-term fluctuations in net income and operating income and which we do not consider to be the
fundamental attributes or primary drivers of our business.
The following table illustrates the reconciliations from net income to adjusted EBITDA for the
year ended December 31, 2022, and 2021:
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31, |
|
|
|
2022 |
|
|
2021 |
|
Net income (loss) and comprehensive income (loss) |
|
$ |
(52,495 |
) |
|
$ |
997,415 |
|
Depreciation expense |
|
|
12,165 |
|
|
|
10,139 |
|
Provision for income taxes |
|
|
2,018 |
|
|
|
1,200 |
|
Interest income |
|
|
(2,199 |
) |
|
|
(11,500 |
) |
Interest expense |
|
|
8,817 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted EBITDA |
|
|
(31,694 |
) |
|
|
997,254 |
|
|
|
|
|
|
|
|
|
|
Adjusted EBITDA for the year ended December 31, 2022 was $(31,694), compared to $997,254 for the year
ended December 31, 2021. This decrease was attributable to higher costs of revenue primarily driven by higher commission expense during 2022 as well as increased general and administrative costs including payroll and marketing for the year ended
December 31, 2022.
We monitor the following key business metrics such as the number of policies originated year-over-year in
measuring our performance. Origination revenues represent fees negotiated for each purchase and sale of a policy to an investor. The number of policy originations represents the volume of policies over which the above origination services are
performed. The number of policy originations directly correlates with origination revenues allowing management to evaluate fees earned upon each transaction. There are no estimates, assumptions, or limitations specific to the number of policy
originations.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31, |
|
|
% Change |
|
|
|
2022 |
|
|
2021 |
|
|
|
|
Number of Policy Originations |
|
|
487 |
|
|
|
445 |
|
|
|
9 |
% |
Liquidity and Capital Resources
We have financed operations since our inception primarily through customer payments and net proceeds from equity financings in the form of
capital contributions from our limited liability company members. Our principal uses of cash and cash equivalents in recent periods have been funding our operations. During the years ended December 31, 2022 and 2021, we had a net income(loss) of
$(52,945) and $997,415, respectively, and net cash provided (used) by operations of $(416,292) and $1,342,763 respectively. We believe our existing cash, cash equivalents, restricted cash, proceeds from equity financings will be sufficient to fund
anticipated cash requirements for the next twelve months.
Our future capital requirements will depend on many factors, including our
revenue growth rate, the expansion of our sales and marketing activities, the timing and extent of spending to support product development efforts. We may, in the future, enter into arrangements to acquire or invest in complementary businesses,
products and technologies. We may be required to seek additional equity or debt financing. The incurrence of additional debt financing would result in debt service obligations, and any future instruments governing such debt could provide for
operating and financing covenants that could restrict our operations.
170
Cash Flows
Cash Flows for the Years Ended December 31, 2022 and 2021
The following table summarizes our cash flows for the years ended December 31, 2022 and 2021:
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31, |
|
|
|
2022 |
|
|
2021 |
|
Net cash provided (used) in operating activities |
|
$ |
(416,206 |
) |
|
$ |
1,342,763 |
|
Net cash provided (used) in investing activities |
|
|
(64,012 |
) |
|
|
(241,528 |
) |
Net cash used in financing activities |
|
|
(660,343 |
) |
|
|
(354,577 |
) |
Operating Activities
During the year ended December 31, 2022, our operating activities used $416,206 of net cash as compared to net cash generated from operating
activities of $1,342,763 during the year ended December 31, 2021. The decrease in net cash from operating activities during 2022 compared to 2021 was primarily due to decreases in contract liabilities. The timing of revenue recognition, customer
billing and cash collection can result in billed accounts receivable, unbilled revenue (contract assets) and deferred revenues (contract liabilities). This decrease in contract liabilities was partially offset by increases in related party
receivables.
Investing Activities
During the year ended December 31, 2022, investing activities used $64,012 of net cash as compared to net cash used in investing activities of
$241,528 during the year ended December 31, 2021. The change in cash used in investing activities was primarily attributable to the amortization of the marketplace development software acquired during December 31, 2021, partially offset by
purchases of property, plant and equipment.
Financing Activities
During the year ended December 31, 2022, financing activities used $660,343 of net cash as compared to $354,577 during the year ended December
31, 2021. The change in cash used in financing activities was primarily attributable to the distributions to members of $659,363 partially offset by an inflow of $980 for amounts due to members and affiliates of $10,877.
Contractual Obligations and Commitments
Our contractual obligations as of December 31, 2022, which are included as liabilities on our balance sheet, include operating lease
obligations of $302,497 with $214,691 due in less than one year and $87,806 due within one to two years, which are comprised of the minimum commitments for our office space.
The Company entered into a one-year letter of credit agreement in August 2022 to support bonding
requirements associated with state insurance licenses and provides the Company the ability to borrow up to $1,012,500 related to state penal bonds. The letter of credit has variable interest based on Wall Street Journal Prime rates, beginning at
6.5%. Interest is only due on the outstanding principal amount. The Company did not draw on the letter of credit during 2022, and as such $0 was outstanding as of December 31, 2022. The Company incurred $23,540 of financing fees associated with
establishing the letter of credit, which have been capitalized in Other current assets and amortized over the stated term.
Critical Accounting
Policies and Estimates
We have prepared our financial statements in accordance with GAAP. Our significant accounting policies are
described in more detail in Note 2 to our financial statements included in this proxy statement. While our preparation of these financial statements requires us to make estimates, assumptions and judgments from time to
171
time that may affect the reported amounts of assets, liabilities and related disclosures, as of the date of these financial statements, we have not identified any estimates made in accordance
with generally accepted accounting principles that involve a significant level of estimation uncertainty which have had or are reasonably likely to have a material impact on the financial condition or results of operations.
Related Party Receivables
Related
party receivables include fees to be reimbursed to Abacus from life expectancy reports, assisted physician services and escrow services incurred on policies that related party financing entities purchase as part of the origination agreement with
Abacus. Related party receivables are stated at their net realizable value. Approximately, three-quarters of the outstanding receivables as of December 31, 2022 were collected in January 2023 and half of these fees as of December 31, 2021
were collected in January 2022. Abacus provides an allowance for doubtful accounts equal to the estimated collection losses that will be incurred in collection of all receivables. The estimated losses are based upon historical collection experience
coupled with a review of the current status of all existing receivables. Account balances are charged off against the allowance for doubtful accounts after all means of collection have been exhausted and the potential for recovery is remote. There
is no allowance for doubtful accounts as of, December 31, 2022 or December 31, 2021.
Intangible Assets
Intangible assets are stated at cost, less accumulated amortization, and consist of capitalized costs incurred for the development of internal
use software. The costs incurred exclusively consist of fees incurred from an external consulting firm during the development stage of the project and are subject to capitalization under ASC 350-40, Internal-Use Software. The software is amortized on the straight-line basis over an estimated useful life of 3 years. Abacus reviews definite-lived intangible assets and other long-lived assets for impairment at
least annually or whenever an event occurs that indicates the carrying amount of an asset may not be recoverable. No impairment was recorded for the years ended December 31, 2022 and 2021.
Revenue Recognition
Abacus
recognizes revenue from origination activities by acting as a provider of life settlements and viatical settlements representing investors that are interested in purchasing life settlements on the secondary or tertiary market. Revenue from
origination services consists of fees negotiated for each purchase and sale of a policy to an investor, which also include any agent and broker commissions received and the reimbursement of transaction costs.
Abacus revenue-generating arrangements are within the scope of Accounting Standards Codification (ASC) 606, Revenue from
Contracts with Customers. Abacus originates life settlements policies with third parties that include settlement brokers, life insurance agents and direct consumers or policyholders. Abacus then provides the administration services needed to
initiate the transfer of the life settlement policies to investors in exchange for an origination fee. Such transactions are entirely performed through an escrow agent. In these arrangements, the customer is the investor, and Abacus has a single
performance obligation to originate a life settlement policy for the investor. The consideration transferred upon each policy is negotiated directly with the investor by Abacus and is dependent upon the policy death benefits held by each life
settlement policy. The revenue is recognized when the performance obligation under the terms of the contracts with customers are satisfied. Abacus recognizes revenue from life settlement transactions when the closing has occurred and any right of
rescission under applicable state law has expired (i.e., the customer obtains control over the policy and has the right to use and obtain the benefits from the policy). While rescission periods may vary by state, most states grant the owner the
right to rescind the contract before the earlier of 30 calendar days after the execution date of the contract or 15 calendar days after life settlement proceeds have been sent to the owner. Purchase and sale of the policies generally occurs
simultaneously, and only the fees received, including any agent and broker commissions and transaction costs reimbursed, are recorded as gross revenue.
172
For agent and broker commissions received and transaction costs reimbursed, Abacus has
determined that they are acting as the principal in the relationship as they maintain control of the services being performed as part of performance obligation prior to facilitating the transfer of the life settlement policy to the investor.
While the origination fees are fixed amounts based on the face value of the policy death benefit, there is variable consideration present due
to the owners rescission right. When variable consideration is present in a contract, Abacus estimates the amount of variable consideration to which it expects to be entitled at contract inception and again at each reporting period until the
amount is known. Abacus applies the variable consideration constraint so that variable consideration is included in the transaction price only to the extent it is probable that a subsequent change in estimate will not result in a significant revenue
reversal. While origination fees are variable due to the rescission periods, given that the rescission periods are relatively short in nature, Abacus has concluded that such fees are fully constrained until the rescission period lapses and thus
records revenue at a fixed amount based on the face value of the policy death benefit after the rescission period is over.
Quantitative and
Qualitative Disclosures About Market Risk
Not required for smaller reporting companies.
JOBS Act Election
Section 102(b)(1)
of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective
or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended
transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. ERES has irrevocably elected to opt out of such extended
transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, ERES, as an emerging growth company, will adopt the new or revised standard at the time public companies
adopt the new or revised standard. As a result, following the consummation of the Business Combination, the Post-Combination Company will comply with new or revised accounting standards on the relevant dates on which adoption of such standards is
required for non-emerging growth companies.
173
MANAGEMENT OF THE
POST-COMBINATION COMPANY FOLLOWING THE BUSINESS COMBINATION
References in this
section to we, our, us and the Companies generally refer to Abacus Settlements, LLC d/b/a Abacus Life, Longevity Market Assets, LLC and their consolidated subsidiaries prior to the Business
Combination and to the Post-Combination Company and its consolidated subsidiaries after giving effect to the Business Combination.
Management and Board of Directors
The following sets forth certain information, as of April 21, 2023, concerning the persons who are expected to serve as executive officers
and members of the board of directors of the Post-Combination Company following the consummation of the Business Combination.
|
|
|
|
|
|
|
Name |
|
Age |
|
|
Title |
Jay Jackson |
|
|
50 |
|
|
Chief Executive Officer and Director Nominee |
Matt Ganovsky |
|
|
58 |
|
|
Co-Founder and Managing Partner |
Kevin Scott Kirby |
|
|
56 |
|
|
Co-Founder and Managing Partner |
Sean McNealy |
|
|
57 |
|
|
Co-Founder, President and Director Nominee |
Bill McCauley |
|
|
50 |
|
|
Chief Financial Officer |
Adam Gusky |
|
|
48 |
|
|
Chief Investment Officer and Director Nominee |
Karla Radka |
|
|
54 |
|
|
Director Nominee |
Cornelius Michiel van Katwijk |
|
|
56 |
|
|
Director Nominee |
Thomas W. Corbett, Jr. |
|
|
73 |
|
|
Director Nominee |
Mary Beth Schulte |
|
|
58 |
|
|
Director Nominee |
Executive Officers
Jay Jackson Chief Executive Officer and Director Nominee
Mr. Jackson is the President and Chief Executive Officer of Abacus. He joined Abacus Settlements, LLC in 2016 as President &
Chief Executive Officer and has also served as Chief Executive Officer of Longevity Market Assets, LLC since June 2019. His strategic business development and creation of innovative new processes and efficiencies has propelled Abacus forward.
Mr. Jackson is an industry thought leader relating to longevity and senior finances; he co-authored the book Pursuing Wealthspan. Mr. Jackson also serves as a current member of the
Orlando Mayors Committee on Livability and Healthy Aging and serves as an Executive Board Member for the Senior Resource Alliance, an agency of the Florida Department of Elder Affairs. Mr. Jackson began his career at Franklin Templeton
Investments, where he served as vice president for more than a decade. Prior to joining Abacus, Mr. Jackson co-founded and managed the Fayerweather Street Life Fund, as well as the Cambridge Life
Management origination platform for FDO Partners, a $3 billion quantitative investment firm founded by Harvard Business School Professor Ken Froot. We believe that Mr. Jackson is qualified to serve on the board of directors of the
Post-Combination Company due to his current role as Chief Executive Officer of Abacus and his 20 years of experience in the financial services and life settlement industry.
Sean McNealy Co-Founder, President and Director Nominee
Mr. McNealy is the Co-Founder and President of Abacus. Mr. McNealy has been a leader in the
life settlements industry for over 16 years with extensive industry experience in marketing and capital markets. Along with the other two Managing Partners, he co-founded Abacus Settlements, LLC in 2004, and
has served as Co-Founder and President of Abacus since that date. Mr. McNealy has written numerous articles about the life settlement industry that have been published in various trade magazines, and has
presented to many large insurance broker consortiums, producer groups and key national accounts. In 1991, he graduated from the
174
University of Central Florida with a Bachelor of Science in Marketing. We believe that Mr. McNealy is qualified to serve on the board of directors of the Post-Combination Company due to his
current role as President of Abacus and experience in the life settlement industry.
Adam Gusky Chief Investment Officer and Director Nominee
Mr. Gusky will be the Chief Investment Officer of the Post-Combination Company. Mr. Gusky has served as the Chief Investment
Officer of East Management Services, LP, an affiliate of East Sponsor, LLC, since the inception of East Management Services in 2010. At East Management Services, Mr. Gusky was responsible for all financial due diligence for acquisitions, and he
was in charge of the reserve-based lending facility. He also developed and implemented the corporate hedging strategy. Mr. Gusky currently serves on the Board of Directors of Rand Capital Corporation, a publicly traded business development
company, where East Asset Management made a control investment. Mr. Gusky received his Bachelor of Arts in History and his MBA from Duke University. We believe that Mr. Gusky is qualified to serve on the board of directors of the
Post-Combination Company due to his role as the Chief Investment Officer of East Management Services and his history as an investor in both public and private companies.
Bill McCauley Chief Financial Officer
Mr. McCauley currently serves as the Chief Financial Officer of Longevity Market Assets, LLC. Following the Business Combination,
Mr. McCauley will serve as the Chief Financial Officer of the Post-Combination Company. From January 2020 through May 2022, Mr. McCauley served as the Chief Financial Officer of Abacus Settlements, LLC, where he managed financial
activities and developed financing models. Prior to joining Abacus, he served as the Chief Financial Officer at IFP Advisors, LLC, a registered investment adviser and broker, where he was responsible for all financial activities of the company and
was involved in both debt and equity financing. Mr. McCauley also served as a Director of Finance at McKinsey & Company from January 2017 until May 2018, where he was responsible for the financial statements of more than 30 start-up businesses. Mr. McCauley received his Bachelor of Science in Accounting from Bentley University and his MBA from Babson College.
Matt Ganovsky Co- Founder and Managing Partner
Mr. Ganovsky has been a leader in the life settlements industry for over 25 years with extensive industry experience. He co-founded Abacus Settlements, LLC, in 2004, and has served as Co-Founder and Managing Partner of Abacus since that date. Mr. Ganovsky manages Abacuss broker
division, with involvement in more than 3,000 transactions. Following the Business Combination, Mr. Ganvosky will serve as the President of the Post-Combination Company. Mr. Ganovsky received his degree in Hospitality and Real Estate from
Valencia College.
Kevin Scott Kirby Co- Founder and Managing Partner
Mr. Kirby co-founded Abacus Settlements, LLC, in 2004, and has served as Co-Founder and Managing Partner of Abacus since that date. Following the Business Combination, Mr. Kirby will serve as the President of the Post-Combination Company. Mr. Kirby has held a Life and Annuity
license in the state of Florida since 2006. He received his Bachelor of Science in Business Administration (BSBA) in Business Management from the University of Central Florida.
Independent Board Members
Karla Radka Director
Nominee
Ms. Radka has been the President and Chief Executive Officer of Senior Resource Alliance, a non-profit agency for the Florida Department of Elder Affairs, since 2019. Ms. Radka previously held leadership roles at
175
Goodwill Industries of Central Florida, where she served as Chief Operating Officer from 2015 through 2019, Florida Family Care, and Community Based Care of Central Florida, a child welfare non-profit. She also founded Public Allies Central Florida, a nationally recognized program, and served as its executive director until 2014. Ms. Radka received her Bachelor of Science and Master of Science in
Counseling from Central Christian University. She also later received a mini-MBA at Rollins College Crummer Graduate School of Business. We believe that Ms. Radka is qualified to serve on the board of
directors of the Post-Combination Company due to her relevant experience as the Chief Executive Officer of Senior Resource Alliance, a non-profit that assists seniors in everyday living and a division of the
Department of the Elder Affairs in Florida.
Thomas W. Corbett, Jr. Director Nominee
Mr. Corbett has been the principal member of Corbett Consulting, LLC since 2015 and, from 2011 to 2015, served as the Governor of
Pennsylvania. He has also served as Pennsylvanias Attorney General and as the US Attorney for the Western District of Pennsylvania. Mr. Corbett received a Bachelor of Arts in political science from Lebanon Valley College and a Juris
Doctor from St. Marys University Law School. He was a member of the board of directors for Composites Consolidation Company LLC from 2015 to 2016 and was a member of the board for Animal Friends of Pittsburgh until 2019. Mr. Corbett has
served as a member of the ERES Board since July 2020. In addition, he currently serves on the board of the Variety Club, The Childrens Charity Pittsburgh. We believe that Mr. Corbett is qualified to serve on the board of directors of the
Post-Combination Company due to his extensive leadership and risk management experience as former Governor of Pennsylvania and former Pennsylvania State Attorney General, as well as his service on other public company boards of directors.
Cornelius Michiel van Katwijk Director Nominee
Cornelius Michiel van Katwijk is the former Chief Financial Officer, Treasurer, Director & Executive Vice President at Transamerica
Life Insurance Co. (Iowa) and the former Treasurer & Senior Vice President at Transamerica Advisors Life Insurance Company of New York where he was employed from September 2012 through September 2021. He also served on the board of
Transamerica Advisors Life Insurance Co. He previously held the position of Group Treasurer at Aegon NV and Chief Financial Officer at AEGON USA LLC (a subsidiary of Aegon NV). Mr. van Katwijk received an MBA from the University of Rochester
and an undergraduate degree from Nyenrode Business Universiteit. We believe that Mr. van Katwijk is qualified to serve on the board of directors of the Post-Combination Company due to former roles as the Chief Financial Officer of Transamerica
and financial leadership positions at Aegon NV and AEGON USA LLC.
Mary Beth Schulte Director Nominee
Ms. Schulte has been a Certified Public Accountant for over 30 years and is currently the Chief Financial Officer of Attivo Partners. In
this role, Ms. Schulte is responsible for providing CFO strategy and accounting services to promote business development to primarily early stage companies. Ms. Schulte formerly served as a Director at Anders CPAs & Advisors until
2022, as well as a Principal at UHY Advisors MO, Inc. from 2015 to 2020. Ms. Schulte also currently serves on the Board of Directors of Richard A. Chaifetz School of Business St. Louis University, Capital Innovators, Cultivation Capital
and Arch Grants. Ms. Schulte received her MBA and Bachelor of Science in Business Administration for Accounting from the Richard A. Chaifetz School of Business St. Louis University. We believe that Ms. Schulte is qualified to serve
on the board of directors of the Post-Combination Company due to her prior experience as a Chief Financial Officer of a public company and a Certified Public Accountant.
176
Corporate Governance
We will structure our corporate governance in a manner ERES and the Companies believe will closely align our interests with those of our
stockholders following the Business Combination. Notable features of this corporate governance include:
|
|
|
we will have independent director representation on our audit, compensation and nominating committees immediately
at the time of the Business Combination, and our independent directors will meet regularly in executive sessions without the presence of our corporate officers or non-independent directors;
|
|
|
|
at least one of our directors will qualify as an audit committee financial expert as defined by the
SEC; and |
|
|
|
we will implement a range of other corporate governance best practices, including implementing a robust director
education program. |
Composition of the Post-Combination Company Board of Directors After the
Business Combination
Our business and affairs are managed under the direction of our board of directors. Our board of directors
will be staggered in three classes, with two (2) directors in Class I (expected to be Adam Gusky and Sean McNealy), three (3) directors in Class II (expected to be Cornelius Michiel van Katwijk, Mary Beth Schulte and Karla Radka) and two
(2) directors in Class III (expected to be Thomas W. Corbett, Jr. and Jay Jackson). See the section entitled Description of Securities of the Post-Combination
CompanyAnti-Takeover ProvisionsClassified Board of Directors.
Board Committees
Our board of directors directs the management of our business and affairs, as provided by Delaware law, and conducts its business
through meetings of the board of directors and standing committees. After the Business Combination, we will have a standing audit committee, nominating committee and compensation committee. In addition, from time to time, special committees may be
established under the direction of the board of directors when necessary to address specific issues.
Audit Committee.
Our audit committee will be responsible for, among other things:
|
|
|
appointing, compensating, retaining, evaluating, terminating and overseeing our independent registered public
accounting firm; |
|
|
|
discussing with our independent registered public accounting firm their independence from management;
|
|
|
|
reviewing, with our independent registered public accounting firm, the scope and results of their audit;
|
|
|
|
approving all audit and permissible non-audit services to be performed by
our independent registered public accounting firm; |
|
|
|
overseeing the financial reporting process and discussing with management and our independent registered public
accounting firm the quarterly and annual financial statements that we file with the SEC; |
|
|
|
overseeing our financial and accounting controls and compliance with legal and regulatory requirements;
|
|
|
|
reviewing our policies on risk assessment and risk management; |
177
|
|
|
reviewing related person transactions; and |
|
|
|
establishing procedures for the confidential anonymous submission of concerns regarding questionable accounting,
internal controls or auditing matters. |
Upon the completion of the Business Combination, our audit committee will
consist of Mary Beth Schulte, Karla Radka and Cornelius Michiel van Katwijk, with Ms. Schulte serving as chair. Rule 10A-3 of the Exchange Act and Nasdaq rules require that our audit committee must be composed
entirely of independent members. Our board of directors has affirmatively determined that Ms. Schulte, Ms. Radka and Mr. van Katwijk each meets the definition of independent director for purposes of serving on the audit committee under
Rule 10A-3 of the Exchange Act and Nasdaq rules. Each member of our audit committee also meets the financial literacy requirements of Nasdaq listing standards. In addition, our board of directors has
determined that Ms. Schulte and Mr. van Katwijk will each qualify as an audit committee financial expert, as such term is defined in Item 407(d)(5) of Regulation S-K. Our board of directors will
adopt a written charter for the audit committee, which will be available on our corporate website at https://abacuslifesettlements.com/ upon the completion of the Business Combination. The information on any of our websites is deemed not to be
incorporated in this proxy statement or to be part of this proxy statement.
Compensation Committee.
Our compensation committee will be responsible for, among other things:
|
|
|
reviewing and approving the corporate goals and objectives, evaluating the performance of and reviewing and
approving, (either alone or, if directed by the board of directors, in conjunction with a majority of the independent members of the board of directors) the compensation of our Chief Executive Officer; |
|
|
|
overseeing an evaluation of the performance of and reviewing and setting or making recommendations to our board
of directors regarding the compensation of our other executive officers; |
|
|
|
reviewing and approving or making recommendations to our board of directors regarding our incentive compensation
and equity-based plans, policies and programs; |
|
|
|
reviewing and approving all employment agreement and severance arrangements for our executive officers;
|
|
|
|
making recommendations to our board of directors regarding the compensation of our directors; and
|
|
|
|
retaining and overseeing any compensation consultants. |
Upon the completion of the Business Combination, our compensation committee will consist of Mary Beth Schulte, Karla Radka and Cornelius
Michiel van Katwijk, with Ms. Schulte serving as chair. Our board of directors has affirmatively determined that Ms. Schulte, Ms. Radka and Mr. van Katwijk each meets the definition of independent director for purposes of serving on the
compensation committee under Nasdaq rules, and are non-employee directors as defined in Rule 16b-3 of the Exchange Act. Our board of directors will adopt a
written charter for the compensation committee, which will be available on our corporate website at https://abacuslifesettlements.com/ upon the completion of the Business Combination. The information on any of our websites is deemed not to be
incorporated in this proxy statement or to be part of this proxy statement.
Nominating Committee.
Our nominating committee will be responsible for, among other things:
|
|
|
identifying individuals qualified to become members of our board of directors, consistent with criteria approved
by our board of directors; |
|
|
|
overseeing succession planning for our Chief Executive Officer and other executive officers;
|
178
|
|
|
periodically reviewing our board of directors leadership structure and recommending any proposed changes to
our board of directors; |
|
|
|
overseeing an annual evaluation of the effectiveness of our board of directors and its committees; and
|
|
|
|
developing and recommending to our board of directors a set of corporate governance guidelines.
|
Upon completion of the Business Combination, our nominating committee will consist of Karla Radka, Mary Beth
Schulte and Thomas W. Corbett, Jr. with Ms. Radka serving as chair. Our board of directors has affirmatively determined that Ms. Radka, Ms. Schulte and Mr. Corbett, Jr. each meets the definition of independent director under Nasdaq
rules. Our board of directors will adopt a written charter for the nominating committee, which will be available on our corporate website at https://abacuslifesettlements.com/ upon the completion of the Business Combination. The information on any
of our websites is deemed not to be incorporated in this proxy statement or to be part of this proxy statement.
Risk Oversight
Our board of directors is responsible for overseeing our risk management process. Our board of directors focuses on our general risk management
strategy, the most significant risks facing us and oversees the implementation of risk mitigation strategies by management. Our audit committee is also responsible for discussing our policies with respect to risk assessment and risk management. Our
board of directors believes its administration of its risk oversight function has not negatively affected our board of directors leadership structure.
Compensation Committee Interlocks and Insider Participation
None of our executive officers serves as a member of the board of directors or compensation committee (or other committee performing equivalent
functions) of any entity that has one or more executive officers serving on our board of directors or compensation committee.
Code of Business Conduct
and Ethics
Prior to the completion of the Business Combination, we will adopt a written code of business conduct and ethics that
applies to our directors, officers and employees, including our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. A copy of the code will be posted on our
corporate website at https://abacuslifesettlements.com/ upon the completion of the Business Combination. In addition, we intend to post on our website all disclosures that are required by law or Nasdaq listing standards concerning any amendments to,
or waivers from, any provision of the code. The information on any of our websites is deemed not to be incorporated in this proxy statement or to be part of this proxy statement.
Compensation of Directors and Officers
Following the closing of the Business Combination, we expect the Post-Combination Companys
executive compensation program to be consistent with the Companies existing compensation policies and philosophies, which are designed to:
|
|
|
attract, retain and motivate senior management leaders who are capable of advancing our mission and strategy and
ultimately, creating and maintaining our long-term equity value. Such leaders must engage in a collaborative approach and possess the ability to execute our business strategy in an industry characterized by
competitiveness and growth; |
|
|
|
reward senior management in a manner aligned with our financial performance; and |
|
|
|
align senior managements interests with our equity owners
long-term interests through equity participation and ownership. |
179
Following the closing of the Business Combination, we expect that decisions with respect to
the compensation of our executive officers, will be made by the compensation committee of our board of directors.
The Post-Combination Companys executive compensation and director compensation programs are further described below under Executive and Director Compensation.
180
EXECUTIVE AND DIRECTOR COMPENSATION
This section discusses the material components of the executive compensation program for Abacus executive officers who are named in the
2022 Summary Compensation Table below. As an emerging growth company, Abacus complies with the executive compensation disclosure rules applicable to smaller reporting companies, as such term is defined in the rules
promulgated under the Securities Act, which require compensation disclosure for Abacus principal executive officer and Abacus two most highly compensated executive officers other than its principal executive officer. In 2022,
Abacus named executive officers and their positions were as follows:
|
|
|
Jay Jackson, Founder, President and Chief Executive Officer; |
|
|
|
Sean McNealy, Founder and President; and |
|
|
|
Matt Ganovsky, Founder and President. |
2022 Summary Compensation Table
The
following table sets forth information concerning the compensation of Abacus named executive officers for the year ended December 31, 2022.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Name |
|
Principal Position |
|
Year |
|
Salary ($) |
|
|
All other compensation ($)(1) |
|
|
Total ($) |
|
Jay Jackson |
|
Chief Executive Officer |
|
2022 |
|
|
210,000 |
|
|
|
28,846 |
|
|
|
238,846 |
|
Sean McNealy |
|
President |
|
2022 |
|
|
210,000 |
|
|
|
|
|
|
|
210,000 |
|
Matt Ganovsky |
|
President |
|
2022 |
|
|
210,000 |
|
|
|
|
|
|
|
210,000 |
|
(1) |
Other compensation reflects medical insurance paid on behalf of the named executive officers.
|
Narrative to the Summary Compensation Table
2022 Annual Base Salary.
Abacus pays the
named executive officers a base salary to compensate them for services rendered to Abacus. The base salary payable to the named executive officers is intended to provide a fixed component of compensation reflecting the executives skill set,
experience, role and responsibilities. For fiscal year 2022, the named executive officers annual base salaries were as follows: Mr. Jackson: ($210,000); Mr. McNealy: ($210,000); and Mr. Ganovsky: ($210,000).
Annual Bonus.
As of
December 31, 2022, Abacus did not pay any annual bonuses to its named executive officers.
Equity Compensation.
As of December 31, 2022, Abacus had no equity compensation plans or outstanding equity awards.
In connection with the Business Combination, ERES will adopt, subject to stockholder approval, the Incentive Plan in order to facilitate the
grant of cash and equity incentives to directors, employees, including named executive officers, and consultants to help attract and retain the services of these individuals. We expect that the Incentive Plan will be effective on the Closing Date,
subject to approval of such plan by ERESs stockholders. For additional information about the Incentive Plan, please refer to Proposal No. 6The Incentive Plan Proposal.
181
Retirement Plans.
Abacus currently maintains a 401(k) retirement savings plan for its employees, including its named executive officers, who satisfy certain
eligibility requirements. Abacuss named executive officers are eligible to participate in the 401(k) plan on the same terms as other full-time employees. The Code allows eligible employees to defer a portion of their compensation, within
prescribed limits, through contributions to the 401(k) plan. Abacus believes that providing a vehicle for tax-deferred retirement savings though its 401(k) plan adds to the overall desirability of its
executive compensation package and further incentivizes its employees, including its named executive officers, in accordance with our compensation policies. Abacus did not make any matching contributions under the 401(k) plan with respect to 2022.
Employee Benefits and Perquisites.
Abacus named executive officers are eligible to participate in Abacus employee benefit plans and programs, including medical and
dental benefits and life insurance, to the same extent as Abacus other full-time employees, subject to the terms and eligibility requirements of those plans. Abacus provides perquisites on a case-by-case basis when it believes it is necessary to attract or retain a named executive officer.
No Tax Gross-Ups.
Abacus has no obligations to make gross-up
payments to cover named executive officers personal income taxes that may pertain to any of the compensation or perquisites paid or provided by Abacus.
Executive Compensation Arrangements.
The
named executive officers were not party to or covered by any employment or severance arrangements for 2021 or 2022. In connection with the Business Combination, Abacus expects to enter into employment agreements with its named executive officers.
These agreements are expected to provide for at-will employment and generally include the named executive officers initial base salary, standard benefit plan eligibility and other terms and conditions of
employment with Abacus. The proposed terms of each of these employment agreements provide for a term of 36 months with 12 month renewals if not terminated at least 90 days before the expiration date. The agreements also are expected to provide for
payments in the event of certain terminations of employment, including a higher severance payment if a termination occurs in connection with a change in control event. The proposed terms of each of these employment agreements are expected to include
a cell-phone reimbursement to the named executive officers.
Under the proposed terms of each of these employment agreements, if the
executive is terminated without cause or resigns for good reason, and timely executes a release of claims against Abacus, he will receive the greater of one year of continued base salary or continued salary for the balance of the then-current
employment term. The employment agreements are expected to also include non-competition and non-solicitation covenants in favor of Abacus for a period of one year after
the executives termination of employment.
Managers.
The managers did not receive any compensation in their role as managers of the Company in 2022.
182
THE BUSINESS COMBINATION
The following is a discussion of the Business Combination and the material terms of the Merger Agreement among ERES, Merger Subs and the
Companies. You are urged to carefully read the Merger Agreement, the Amendment and the Second Amendment, in their entirety, copies of which are attached to this proxy statement as Annex A-1, Annex A-2 and Annex A-3, respectively. This summary does not purport to be complete and may not contain all of the information about the Merger Agreement that is important to you. We encourage you to read the Merger
Agreement carefully and in its entirety. This section is not intended to provide you with any factual information about ERES or the Companies. Such information can be found elsewhere in this proxy statement.
Background of the Business Combination
The terms of the Merger Agreement are the result of negotiations between ERES and the Companies and their respective representatives. The
following is a brief description of the background of these negotiations.
ERES is a blank check company incorporated in Delaware formed
for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. As ERES is an early stage and emerging growth company, it is subject to all
of the risks associated with early stage and emerging growth companies.
The Business Combination with the Companies is the result of
ERESs extensive search for a business combination transaction, during which ERES evaluated a number of potential targets utilizing ERESs relationship network and the investing, operating and transaction experience of ERESs
management team and ERESs board of directors. The terms of the transactions contemplated by the Merger Agreement are the result of arms-length negotiations between the representatives of ERES and
the Companies over the course of approximately six months. The following is a description of the background of these negotiations and the resulting Business Combination.
ERES is a blank check company incorporated on May 22, 2020 as a Delaware corporation and formed for the purpose of effecting a merger,
capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or entities. ERESs efforts to identify a prospective target business initially were focused on identifying
businesses in the energy industry in North America, although ERES reserved the right to pursue an acquisition opportunity in any business or industry.
On July 27, 2020, ERES completed its initial public offering of ERES units, raising total gross proceeds of $300,000,000 pursuant to an
underwriting agreement with Wells Fargo Securities, LLC. On the same date, ERES also completed the sale of Private Placement Warrants to the Sponsor, raising total gross proceeds of $8,000,000. On August 25, 2020, the underwriters exercised
their over-allotment option in full, generating gross proceeds to ERES of $45,000,000. On the same date, simultaneously with the sale of the over-allotment units, ERES completed the sale of additional Private Placement Warrants to the Sponsor,
generating gross proceeds of $900,000.
Prior to completion of the ERES IPO, on June 1, 2020, the Sponsor purchased 8,625,000 Founder
Shares for an aggregate purchase price of $25,000, or approximately $0.003 per share. In July 2020, the Sponsor transferred 10,000 Founder Shares to Thomas W. Corbett, Jr., one of ERESs independent directors, for approximately the same per-share price initially paid by the Sponsor.
Prior to the ERES IPO, neither ERES nor anyone on its
behalf engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with ERES. Following the consummation of the ERES IPO, ERESs directors and officers, at
the direction of the ERES Board, together with certain of ERESs affiliates and their representatives, commenced an active search for prospective businesses or assets to acquire in our initial business combination. Prior to executing the Merger
Agreement, ERESs efforts were limited to organizational activities, completion of the ERES IPO and the evaluation of possible business combinations.
183
In evaluating potential businesses and assets to acquire, ERES generally surveyed the
landscape of potential acquisition opportunities based on its knowledge of, and familiarity with, the M&A marketplace. As part of its regular evaluation of potential acquisition targets, the ERES Board and management periodically discussed the
status of managements discussions with various acquisition targets. These updates generally addressed the potential targets under consideration and the status of the discussions, if any, with the respective acquisition targets. These updates
continued throughout the period of time when ERES was evaluating various acquisition targets.
ERES and its directors, officers and
other representatives considered over 40 potential candidates for business combination opportunities (other than the Companies), engaged in detailed discussions and conducted due diligence with 15 potential targets and their representatives, and
extended 8 offers. Ultimately, no definitive agreement could be reached with the potential targets due to a variety of factors, including valuation, midstream dedications, differing oil and gas reserve assumptions, the general recovery of capital
markets and the improvement in the prices of both crude oil and natural gas.
On April 7, 2022, ERES management was introduced
to the Companies by an executive of a portfolio company of East Asset Management, who had originally met with the Companies on March 29, 2022.
On April 8, 2022, the Companies sent East Asset Management a draft non-disclosure agreement
related to a potential business combination between the parties. ERES provided comments to the draft non-disclosure agreement on April 8, 2022 and the Companies replied on April 10, 2022. Later on
April 10, 2022, ERES provided the final version of the non-disclosure agreement, which was then fully executed by East Asset Management and the Companies. Following execution of the non-disclosure agreement, ERES held an introductory conference call with the Companies, and subsequently began initial due diligence.
On April 22, 2022, Adam Gusky, the Chief Investment Officer of ERES and East Asset Management, and Jay Jackson, the Chief Executive
Officer of the Companies, held an introductory lunch meeting in Winter Haven, Florida to discuss a potential business combination between ERES and the Companies.
Between May 23, 2022 and June 2, 2022, ERES conducted due diligence review of the Companies, including meeting the full Companies
management team at the Companies offices in Orlando, Florida, reviewing the Companies financials and projection model, and discussing certain arrangements with prior providers of capital.
On June 3, 2022, ERES engaged Aviditi as its financial advisor in connection with the proposed business combination. While continuing its
due diligence process, ERES began to prepare a proxy statement to seek an extension of the date by which ERES must complete an initial business combination. On June 6, 2022, ERESs and the Companies respective management teams met at
ERESs offices in Boca Raton, Florida to negotiate a high-level summary letter of intent, subject to a successful extension of ERESs deadline to complete a business combination. On or about June 8, 2022, ERES engaged Latham &
Watkins LLP (Latham) as its legal counsel in connection with the proposed business combination.
On July 14, 2022, ERES
submitted a draft letter of intent with respect to a business combination with the Companies. On July 18, 2022, ERES and the Companies executed the negotiated letter of intent contemplating an acquisition of the Companies by ERES (the
LOI) with a pre-money equity value of the Companies of $618.0 million. The LOI stipulated that, subject to tax diligence and structuring analysis, (i) ERES would remain a publicly traded
company and the equity interests in the Companies would be exchanged for shares in ERES, (ii) there would be a two-year trading lock-up in respect of 85% of the
shares of Class A Common Stock issued to members of the Companies and the Sponsor following the Closing and a one-year trading lock-up with respect to the other 15%
of shares of Class A Common Stock issued to members of the Companies and the Sponsor following the Closing, subject to certain customary exceptions, (iii) the Post-Combination Companys board of directors would consist of four
directors appointed by the Companies, three directors appointed by ERES and a
184
number of additional independent directors designated prior to the Closing by mutual agreement, (iv) the Sponsor and the Company Members would agree to take certain actions in support of a
potential PIPE transaction, (v) the Sponsor would issue the Sponsor PIK Note to ERES, if necessary, (vi) the representations and warranties in the definitive transaction agreement would not survive and (vii) there would also be
customary closing conditions and registration rights.
While negotiating the letter of intent, ERES contacted Deloitte & Touche
LLP (Deloitte) to perform business, accounting and financial, and tax due diligence, including a detailed review of the projected financial model. These diligence efforts included, among other actions, written diligence requests for
documents and the Companies responses to written and verbal questions. On July 11, 2022, Deloitte began preliminary due diligence by sending the Companies an initial data request list. From July 12, 2022, through August 17,
2022, Deloitte requested incremental due diligence information from the Companies and led numerous due diligence calls with both the Companies and ERES (including calls specifically related to projected financials, accounting and tax).
On July 12, 2022, Deloitte led a call with ERES, the Companies and Aviditi to review its initial due diligence request list.
Additionally, on July 13 and July 15, 2022, Deloitte led follow-up calls covering a range of due diligence topics and questions.
On July 20, 2022, Deloitte led a call to share its initial observations and ask incremental questions relating to the financial
projection model and other work performed to date.
On July 19, 2022, Northland was contacted regarding providing a fairness opinion to
determine the fairness, from a financial point of view, to ERES and its unaffiliated Public Stockholders of the consideration paid by ERES to the Company Members pursuant the Merger Agreement, and whether the Companies have an aggregate fair market
value equal to at least 80 percent of the balance of funds in ERESs Trust Account. On July 26, 2022, Northland executed an NDA.
On July 25, 2022, ERESs stockholders voted to approve an extension of the period ERES has to complete an initial business
combination (from July 27, 2022 to January 27, 2023). After giving effect to stockholder redemptions in connection with the extension vote, $97,939,800.60 remained in the Trust Account.
On July 29, 2022, Northland led an introductory call with Jay Jackson, who provided an overview of the Companies.
On August 2, 2022, Deloitte led a tax due diligence call with ERES, the Companies and Aviditi.
On August 3, 2022, Northland led a call to review and discuss the financial projection model with the Companies, ERES and Aviditi.
On August 5, 2022, Deloitte led an accounting due diligence call with ERES, the Companies and Aviditi.
On August 9, 2022, members of ERES management held a telephonic conference with Latham, counsel to ERES, to discuss considerations with
respect to an initial draft of the Merger Agreement prepared by Latham and ERES.
On August 10, 2022, Latham provided an initial
draft of the Merger Agreement to Locke Lord LLP (Locke Lord), counsel to the Companies. In addition to the terms set forth in the LOI, the initial draft of the Merger Agreement contemplated, among other things: (i) the Mergers,
(ii) no survival of the representations, warranties and covenants of the parties beyond the closing date of the Mergers, (iii) listing of the ERES Common Stock and ERES warrants issued to the Company Members on a national securities
exchange following completion of the Merger, (iv) certain covenants regarding claims against the Trust Account, (v) covenants requiring ERES and the
185
Companies to use commercially reasonable efforts in order to obtain regulatory clearance, (vi) the entry into certain ancillary agreements concurrently with the execution of the Merger
Agreement and (vii) representations, warranties and covenants customary for transactions of this type.
Additionally, on
August 9 and August 12, 2022, Northland led follow-up calls to discuss the business and financial projection model with ERES and Aviditi.
On August 15, 2022, Locke Lord provided a revised draft of the Merger Agreement to Latham, which contemplated revisions to the
representations and warranties of both ERES and the Companies. Locke Lord also proposed changes to the interim operating covenants.
On
August 18, 2022, ERES management presented a business overview of the Companies to the ERES Board.
On August 23, 2022, Deloitte
sent its finalized due diligence reports to ERES pursuant to the Statement of Work, dated July 29, 2022.
On August 19, 2022,
Locke Lord provided an initial draft of the Registration Rights Agreement to Latham.
On August 21, 2022, Locke Lord provided a
revised draft of the Merger Agreement to Latham, which contemplated, among other things, revised representations and warranties of ERES.
On August 22, 2022, Latham provided an initial draft of the Sponsor Support Agreement and Company Support Agreement to Locke Lord. Later
that same day, Locke Lord distributed to Latham an initial draft of the Companies disclosure schedules.
On August 23, 2022,
Locke Lord and Latham held a telephonic conference to discuss, negotiate and reach resolution on the outstanding points in the Merger Agreement.
On August 23, 2022, the Abacus Members and the LMA Members unanimously adopted resolutions approving each Companys entry into the
Merger Agreement and authorized and directed each Companys officers to take all necessary actions to consummate the transactions contemplated thereby.
On August 24, 2022, Latham distributed to Locke Lord an initial draft of ERESs disclosure schedules.
On August 29, 2022, the ERES Board held a virtual meeting in which certain officers and representatives of ERES and representatives of
Latham and Northland, were in attendance. At the meeting, the management of ERES provided an overview of the proposed business combination with the Companies (including the rationale for the combined business) and updated the ERES Board regarding
the final negotiations of the terms of the proposed business combination. Representatives of Latham gave a presentation to the ERES Board regarding the directors fiduciary duties under Delaware law and provided a summary of the Merger
Agreement and ancillary agreements. Representatives of Northland provided an overview of the financial analyses summarized under the section entitled The Business CombinationOpinion of Northland, then delivered to the
ERES Board its oral opinion, which was subsequently confirmed by delivery of a written opinion dated August 29, 2022, to the effect that, as of such date and on the basis of and subject to the qualifications, limitations and assumptions set
forth in Northlands written opinion, (i) the consideration to be paid by ERES to the Company Members pursuant to the Merger Agreement, was fair, from a financial point of view, to ERES and its unaffiliated Public Stockholders and
(ii) the Companies have an aggregate fair market value equal to at least 80% of the balance of funds in the Trust Account (excluding deferred underwriting commissions and taxes payable and subject to proportionate adjustments related to
Nasdaqs 80% test). Following the delivery of Northlands oral opinion, the ERES Board, with the assistance of Latham, discussed and reviewed the proposed business combination, the terms and conditions of the Merger Agreement and the key
ancillary agreements (copies of all of which were provided to
186
all of the members of the ERES Board in advance of the meeting), the potential benefits of, and risks relating to, the proposed business combination, the reasons for entering into the Merger
Agreement and the proposed timeline for finalizing the definitive transaction agreements and announcing the proposed business combination. See the section entitled The Business CombinationERES Reasons for Approval of the Business
Combination for additional information related to the factors considered by the ERES Board in approving the Business Combination. At the conclusion of the presentations, the ERES Board unanimously determined, among other things, that the
Business Combination Proposal is in the best interests of ERES and its stockholders and resolved to recommend that its stockholders vote FOR the adoption of the Merger Agreement, and approval of the transactions contemplated
thereby, including the Business Combination.
Later on August 29, 2022, Latham and Locke Lord, together with ERES and the Companies,
finalized the Merger Agreement and the ancillary agreements. ERES, the Companies and the other parties thereto then executed the Merger Agreement, the Sponsor Support Agreement and the Company Support Agreement, as applicable. On the morning of
August 30, 2022, before Nasdaq opened, ERES and the Companies issued a joint press release announcing the execution of the Merger Agreement.
On October 14, 2022, ERES and the Companies executed the Amendment to, among other things, clarify the merger consideration and amend the
regulatory requirements as more further described in the Amendment, a copy of which is attached to this proxy statement as Annex A-2.
On January 20, 2023, ERESs stockholders voted to approve an extension of the period ERES has to complete an initial business combination
(from January 27, 2023 to July 27, 2023). After giving effect to stockholder redemptions in connection with the extension vote, $29,102,648.33 remained in the Trust Account.
On April 20, 2023, ERES and the Companies executed the Second Amendment to, among other things, clarify the stockholder votes required to
approve the Transaction Proposals, require the Companies to deliver or cause to be delivered documentation relating to a tax election at the Closing and extend the Outside Date as more further described in the Second Amendment, a copy of which is
attached to this proxy statement as Annex A-3.
ERES Reasons for Approval of the Business Combination
Recommendation of ERESs Board of Directors and Reasons for the Business Combination
ERESs board of directors, in evaluating the Business Combination, consulted with ERESs management, legal advisors and financial
advisors. In reaching its unanimous resolution (i) approving and declaring the form, terms and provisions of the Merger Agreement, related documents and the transactions contemplated thereby, including the Business Combination, fair to and in the
best interests of ERES and ERESs stockholders, (ii) declaring it advisable for ERES to enter into, and approving the execution and delivery by ERES of, the Merger Agreement and related documents and (iii) recommending that ERESs
stockholders adopt the Merger Agreement, the related documents and approve the transactions contemplated thereby, including the Business Combination, the issuance of shares of Class A Common Stock in connection therewith and the other Proposals,
ERESs board of directors considered a range of factors, including, but not limited to, the factors discussed below. In light of the large number and wide variety of factors considered in connection with its evaluation of the Business
Combination, ERESs board of directors did not consider it practicable to, and did not attempt to, quantify or otherwise assign relative weights to the specific factors that it considered in reaching its determination and supporting its
decision. ERESs board of directors viewed its decision as being based on all of the information available and the factors presented to and considered by it. In addition, individual directors may have given different weight to different
factors.
This explanation of ERESs reasons for the Business Combination and all other information presented in this section is
forward-looking in nature and, therefore, should be read in light of the factors discussed under Forward-Looking Statements.
187
Before reaching its decision, ERESs board of directors reviewed the results of
managements due diligence, which included:
|
|
|
research on industry trends, projected growth and other industry factors; |
|
|
|
meetings and calls with the Companies management team and representatives regarding operations, financial
prospects and potential expansion opportunities, among other customary due diligence matters; |
|
|
|
consultation with ERESs legal and financial advisors; |
|
|
|
review of the Companies material business contracts and certain other legal, intellectual property and
commercial diligence; |
|
|
|
financial, accounting and tax diligence; |
|
|
|
a review of certain projections provided by the Companies; and |
|
|
|
research on comparable companies. |
ERESs board of directors considered a number of factors pertaining to the Business Combination as generally supporting the boards
decision to authorize and approve ERESs entry into the Merger Agreement and the transactions contemplated thereby, including, but not limited to, the following material factors:
|
|
|
Large and Growing Addressable Market. ERESs board of directors considered the large and growing
annual life settlement market opportunity in comparison to current market penetration and trends. In reviewing those factors, ERESs board of directors determined the Companies are well-positioned to capitalize on the growing market;
|
|
|
|
Largely Uncorrelated Alternative Asset Class. ERESs board of directors also considered the unique
nature of life insurance policies relative to other assets, including their cash-collateralization, significant investment-grade counterparts and reduced exposure to market-driven risks; |
|
|
|
Financial Condition. ERESs board of directors also considered factors such as the Companies
historical financial results, outlook, expansion opportunities and financial plan. In considering those factors, ERESs board of directors reviewed the Companies historical growth and its current prospects for growth if the Companies
achieve their business plan, and various historical and current balance sheet items of the Companies. In reviewing those factors, ERESs board of directors determined that the Companies are well-positioned for strong future growth;
|
|
|
|
Strong Leadership Supported by an Experienced Operational and Execution Team. the Companies have a strong
management team with significant operating experience. The senior management of the Companies intends to remain with the Post-Business Combination Company in the capacity of officers and/or directors, providing helpful continuity in advancing
strategic and growth goals; |
|
|
|
Lock-Up. Management of the Companies (among other holders) will be subject to a two-year lockup in respect
of 85% of their Class A Common Stock and a one-year lockup with respect to 15% of their Class A Common Stock, subject to certain customary exceptions, which lockup will provide important stability to the leadership and governance of the
Post-Business Combination Company; |
|
|
|
Opinion of Northland. ERESs board of directors received the oral opinion of Northland (which was
confirmed by Northlands written opinion of August 29, 2022) that the consideration to be paid by ERES to the Company Members pursuant to the Merger Agreement was fair, from a financial point of view, to ERES and its unaffiliated Public
Stockholders; |
|
|
|
Other Alternatives. ERESs board of directors has determined that the proposed Business Combination
represents the best potential business combination for ERES and the most attractive opportunity for ERESs management to accelerate its business plan based upon the process utilized to evaluate and assess other potential acquisition targets.
ERESs board of has also determined that such process has not presented a better alternative; |
188
|
|
|
Stockholder Liquidity. ERESs board of directors considered the fact that in connection with the
Business Combination, ERES stockholders have the option to (i) remain stockholders of the Post-Business Combination Company, (ii) sell their shares of Class A Common Stock on the open market or (iii) redeem their shares of Class A Common Stock for
the per share amount held in the Trust Account; and |
|
|
|
Negotiated Transaction. ERESs board of directors has determined that the financial and other terms
of the Merger Agreement are reasonable and were the product of arms-length negotiations between ERES and the Companies. |
ERESs board of directors also considered various uncertainties and risks and other potentially negative factors concerning the Business
Combination, including, but not limited to, the following:
|
|
|
Macroeconomic Risks. Macroeconomic uncertainty, including the potential impact of the COVID-19 pandemic,
and the effects it could have on the Post-Business Combination Companys revenues; |
|
|
|
Business Plan and Projections May Not Be Achieved. The risk that the Companies may not be able to execute
on the business plan, and realize the financial performance as set forth in the financial projections, in each case as presented to management of ERES; |
|
|
|
Stockholder Vote. The risk that ERESs stockholders may fail to provide the applicable votes
necessary to effect the Business Combination; |
|
|
|
Closing Conditions. The fact that the completion of the Business Combination is conditioned on the
satisfaction of certain closing conditions that are not within ERESs control; |
|
|
|
Litigation. The possibility of (i) litigation challenging the Business Combination or (ii) an adverse
judgment granting permanent injunctive relief that could indefinitely delay consummation of the Business Combination; |
|
|
|
Listing Risks. The challenges associated with preparing the companies, private entities, for the
applicable disclosure and listing requirements to which the Post-Business Combination Company will be subject as a publicly traded company on the Nasdaq; |
|
|
|
Benefits May Not Be Achieved. The risks that the potential benefits of the Business Combination may not be
fully achieved or may not be achieved within the expected timeframe; |
|
|
|
Liquidation of ERES. The risks and costs to ERES if the Business Combination is not completed, including
the risk of diverting management focus and resources from other business combination opportunities, which could result in ERES being unable to effect a business combination by July 27, 2023; |
|
|
|
Redemption Risk. The potential for a significant number of ERES stockholders electing
pursuant to ERESs Existing Charter to redeem their shares prior to the consummation of the Business Combination, which would potentially make the Business Combination more difficult or impossible to complete; |
|
|
|
Growth Initiatives May Not be Achieved. The risk that the Companies growth initiatives may not be
fully achieved or may not be achieved within the expected timeframe; |
|
|
|
ERES Stockholders Receiving a Minority Position in the Post-Business Combination Company. The risks
associated with the minority position in the Post-Business Combination Company that ERES stockholders will hold following consummation of the Business Combination; and |
|
|
|
Fees and Expenses. The fees and expenses associated with completing the Business Combination.
|
In addition to considering the factors described above, ERESs board of directors also considered other factors,
including, without limitation:
|
|
|
Interests of Certain Persons. Some officers and directors of ERES, as well as the Sponsor and its affiliates, may
have interests in the Business Combination (see the section entitled Interests of ERESs Directors and Officers and the Sponsor and its Affiliates in the Business Combination). |
189
|
|
|
Other Risk Factors. Various other risk factors associated with the business of the Companies, as described in the
section entitled Risk Factors appearing elsewhere in this proxy statement. |
ERESs board of
directors concluded that the potential benefits that it expects ERES and its stockholders to achieve as a result of the Business Combination outweigh the potentially negative and other factors associated with the Business Combination. Accordingly,
ERESs board of directors unanimously determined that the Business Combination and the transactions contemplated by the Merger Agreement are advisable and in the best interests of ERES and its stockholders.
Unaudited Prospective Financial Information of the Companies
The Companies do not, as a matter of course, make public projections as to future revenues, earnings, or other results. However, the
Companies management prepared and provided to the Company Members, ERES and ERESs financial advisors certain internal, unaudited prospective financial information in connection with the evaluation of the Business Combination (the
Projections). The Companies management prepared such financial information based on their judgment and assumptions regarding the future financial performance of the Companies.
The unaudited prospective financial information is subjective in many respects. As a result, there can be no assurance that the prospective
results will be realized or that actual results will not be significantly higher or lower than estimated. Since the unaudited prospective financial information covers multiple years, that information by its nature becomes less predictive with each
successive year.
While presented in this proxy statement with numeric specificity, the information set forth in the summary below was
based on numerous variables and assumptions that are inherently uncertain and may be beyond the control of the Companies management, including, among other things, the matters described in the sections entitled Cautionary Statement
Regarding Forward-Looking Statements and Risk Factors. The Companies believe the assumptions in the prospective financial information were reasonable at the time the financial information was prepared, given the information the
Companies had at the time. However, important factors that may affect actual results and cause the results reflected in the prospective financial information not to be achieved include, among other things, risks and uncertainties relating to the
Companies business, industry performance, the regulatory environment, and general business and economic conditions. The prospective financial information also reflects assumptions as to certain business decisions that are subject to change.
The unaudited prospective financial information was not prepared with a view toward public disclosure or with a view toward complying with the guidelines of the SEC, or the guidelines established by the American Institute of Certified Public
Accountants with respect to prospective financial information, but, in the view of the Companies management, was prepared on a reasonable basis, reflects the best currently available estimates and judgments, and presents, to the best of the
Companies managements knowledge and belief, the expected course of action and the expected future financial performance of the Companies. However, this information is not fact and should not be relied upon as being necessarily indicative
of future results, and readers of this proxy statement are cautioned not to place undue reliance on the prospective financial information.
Neither the Companies independent auditors, nor any other independent accountants, have compiled, examined or performed any procedures
with respect to the prospective financial information contained herein, nor have they expressed any opinion or any other form of assurance on such information or its achievability, and assume no responsibility for, and disclaim any association with,
the prospective financial information. The audit reports included in this proxy statement relate to historical financial information. They do not extend to the prospective financial information and should not be read to do so.
EXCEPT AS REQUIRED BY APPLICABLE SECURITIES LAWS, THE COMPANIES DO NOT INTEND TO MAKE PUBLICLY AVAILABLE ANY UPDATE OR OTHER REVISION TO THE
PROSPECTIVE FINANCIAL INFORMATION. THE PROSPECTIVE FINANCIAL INFORMATION DOES
190
NOT TAKE INTO ACCOUNT ANY CIRCUMSTANCES OR EVENTS OCCURRING AFTER THE DATE THAT THE INFORMATION WAS PREPARED. READERS OF THIS PROXY STATEMENT ARE CAUTIONED NOT TO PLACE UNDUE RELIANCE ON THE
UNAUDITED PROSPECTIVE FINANCIAL INFORMATION SET FORTH BELOW. NONE OF THE COMPANIES, ERES NOR ANY OF THEIR RESPECTIVE AFFILIATES, OFFICERS, DIRECTORS, ADVISORS OR OTHER REPRESENTATIVES HAS MADE OR MAKES ANY REPRESENTATION TO ANY COMPANY MEMBER, ERES
STOCKHOLDER OR ANY OTHER PERSON REGARDING ULTIMATE PERFORMANCE COMPARED TO THE INFORMATION CONTAINED IN THE PROSPECTIVE FINANCIAL INFORMATION OR THAT FINANCIAL AND OPERATING RESULTS WILL BE ACHIEVED.
Certain of the measures included in the prospective financial information may be considered non-GAAP financial measures. Non-GAAP financial
measures should not be considered in isolation from, or as a substitute for, financial information presented in compliance with GAAP, and non-GAAP financial measures as used by the Companies may not be comparable to similarly titled amounts used by
other companies. Financial measures provided to a financial advisor in connection with a business combination transaction are excluded from the definition of non-GAAP financial measures and therefore are not subject to SEC rules regarding
disclosures of non-GAAP financial measures, which would otherwise require a reconciliation of a non-GAAP financial measure to a GAAP financial measure. Accordingly, we have not provided a reconciliation of such financial measures.
The following tables sets forth certain summarized prospective financial information regarding the Companies for the years 2022, 2023 and
2024:
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial Projections (in millions) |
|
2022E |
|
|
2023E |
|
|
2024E |
|
Originated Policies |
|
|
501 |
|
|
|
620 |
|
|
|
771 |
|
Revenue |
|
|
62 |
|
|
|
71 |
|
|
|
83 |
|
Earning Before Taxes |
|
|
52 |
|
|
|
54 |
|
|
|
60 |
|
Net Income |
|
|
52 |
|
|
|
42 |
|
|
|
47 |
|
The Companies management team prepared the Projections as of August 25, 2022 based on estimates and
assumptions believed to be reasonable with respect to the expected future financial performance of the Companies on August 25, 2022. The Projections were prepared using several assumptions, including, but not limited to, the following assumptions
that the Companies management believed to be material:
|
|
|
A closing date of the business combination in the first quarter of 2023 and certain anticipated capital
investments based on closing dates in the first quarter of 2023. |
|
|
|
A total of $135 million of capital raised in connection with the transaction, with $35 million coming from
ERESs Trust Account and $100 million from debt financing in the third quarter of 2023, and an incremental $150 million of equity to be raised in the first quarter of 2024. |
|
|
|
At annual policy origination growth of 24% which is partly based on increased incremental spend on marketing and
origination teams. 90% of those policies are projected to be traded or sold directly to others while the remaining 10% are projected to be held for investment. |
|
|
|
Projected growth of expenses at a fixed rate of 3% per annum with the per employee salary expense growth
projected to be 5%. |
|
|
|
An estimated income tax rate of 22% for purposes of calculating the Return on Equity. |
In making the foregoing assumptions, which imply a revenue compound annual growth rate of 15% between 2022 and 2024 for the Projections, the
Companies management relied on a number of factors, including origination growth, new product offerings, industry growth and demand for life insurance policies based on current market conditions.
191
Opinion of Northland
The ERES Board retained Northland to provide a fairness opinion in connection with the Merger. In accordance with the terms and subject to the
conditions set forth in the Merger Agreement, (a) LMA Merger Sub shall merge with and into LMA, with LMA surviving such merger as a direct wholly owned subsidiary of ERES and (b) Abacus Merger Sub shall merge with and into Abacus, with
Abacus surviving such merger as a direct wholly owned subsidiary of ERES. At the Effective Time, (a) each LMA Interest will automatically convert into the right to receive a portion of the Aggregate Merger Consideration and (b) each Abacus
Interest will automatically convert into the right to receive a portion of the Aggregate Merger Consideration.
In selecting Northland,
the ERES Board considered, among other things, Northlands qualifications, expertise and reputation, as well as Northlands knowledge of ERES and the Companies, the businesses of ERES and the Companies and the industries in which ERES and
the Companies operate.
On August 29, 2022, Northland rendered its oral opinion to the ERES Board, which was subsequently confirmed
in a letter dated August 29, 2022, stating that, as of the date of the letter and subject to and based on the assumptions made, procedures followed, matters considered, limitations of the review undertaken and qualifications in such
letter, (a) the consideration to be paid by ERES to the Company Members pursuant to the Merger Agreement is fair, from a financial point of view, to ERES and its unaffiliated Public Stockholders and (b) the Companies have an aggregate
fair market value equal to at least 80 percent of the balance of funds in ERESs Trust Account (excluding deferred underwriting commissions and taxes payable and subject to proportionate adjustment related to Nasdaqs 80 percent
test).
The full text of Northlands written opinion letter, dated August 29, 2022, is attached as Annex H to this
proxy statement. You should read Northlands opinion letter carefully and in its entirety for a discussion of, among other things, the scope of the review undertaken and the assumptions made, procedures followed, matters considered and
qualifications and limitations of the review undertaken by Northland in connection with its opinion. This summary is qualified in its entirety by reference to the full text of the opinion letter. Northlands opinion letter was directed to the
ERES Board, in its capacity as the board of directors of ERES, and addressed only the fairness, from a financial point of view, as of the date of the opinion, to ERES and its unaffiliated Public Stockholders of the consideration paid by ERES to the
Company Members pursuant to the Merger Agreement, and whether the Companies have an aggregate fair market value equal to at least 80 percent of the balance of funds in ERESs Trust Account (excluding deferred underwriting commissions and
taxes payable and subject to proportionate adjustments related to Nasdaqs 80 percent test). The opinion letter does not constitute a recommendation as to how any Public Stockholders should vote with respect to the approval of the Business
Combination or any other matter and does not in any manner indicate the price at which ERESs securities will trade at any time.
In connection with reviewing the Business Combination and rendering its opinion, Northland has informed ERES that, among other things, it has
reviewed:
|
(i) |
the draft of the Merger Agreement, dated August 27, 2022; |
|
(ii) |
certain documents filed by ERES with the SEC, including the registration statement on Form S-1 initially filed July 2, 2020 and amendments thereto, and the related Rule 424(b)(4) final prospectus filed with the SEC on July 24, 2020 and various reports filed with the SEC pursuant to Exchange Act;
|
|
(iii) |
certain publicly available business and financial information relating to ERES and the Companies that Northland
deemed to be relevant; |
|
(iv) |
the Companies historical financial statements for the calendar years ended December 31, 2019,
December 31, 2020 and December 31, 2021; |
|
(v) |
certain non-public financial and business information provided to
Northland by ERES, the Companies and their respective advisors; |
192
|
(vi) |
certain information relating to the historical, current and future operations, financial condition and
prospects of the Companies made available to us by the Companies and ERES, including financial projections for the years ending December 31, 2022, December 31, 2023 and December 31, 2024 prepared by the management of the Companies
relating to the Companies; |
|
(vii) |
certain industry and research reports relevant to the industry in which the Companies operate;
|
|
(viii) |
the reported historical price and trading activity for the securities of ERES, compared to certain financial
stock market information for ERES with certain other publicly traded companies, and reviewed the financial terms of certain recent business combinations, and other studies and analyses it deemed appropriate; and |
|
(ix) |
other documents made available the Companies virtual data room. |
In addition, Northland held discussions with certain members of the respective management teams of ERES and the Companies and certain of their
respective representatives and advisors regarding the business, operations, financial condition and prospects of the Companies, the Business Combination and related matters. Northland also participated in financial and business diligence calls with
executive management of ERES, the Companies and their respective advisors, regarding, among other things, certain financial projections prepared by the Companies, the business and financial results and outlook of the Companies and the Business
Combination structure and background. Northland also compared the financial and operating performance of the Companies with that of companies with publicly traded equity securities that it deemed to be relevant. Northland also conducted such other
analyses, examinations and inquiries and considered such other financial, economic and market criteria as it deemed necessary and appropriate in arriving at its opinion.
With the consent of the ERES Board, Northland assumed and relied upon the accuracy and completeness of all of the financial and other
information furnished to, discussed with or otherwise made available to Northland or that was publicly available. Northland was not engaged to, and did not independently attempt to, verify any of such information. In addition, ERESs and the
Companies respective management teams advised Northland, and Northland has assumed, with the permission of the ERES Board, that the financial projections provided to Northland were reasonably prepared in good faith on bases reflecting the best
available information, estimates and judgments of ERESs and the Companies respective management teams as to the future financial results and condition of the Companies. Northland also relied upon information provided by the
Companies management as to the reasonableness of the financial projections (and the assumptions and bases therefor) provided to Northland. Northland was not engaged to assess the reasonableness or achievability of the projections or the
assumptions on which they were based. Northland expressed no view as to such projections or assumptions and did not undertake any obligation to update its analysis or opinion in the event of any material changes to such projections or estimates.
Northland did not conduct a physical inspection, valuation or appraisal of any of the assets or properties of the Companies, and Northland was not furnished with any such valuation or appraisal.
Northland was not asked to, nor did Northland, offer any opinion as to the material terms of the Merger Agreement or the form of the Business
Combination. Northland was not requested to opine as to, and its opinion did not address, the basic business decision to proceed with or effect the Business Combination. In rendering its opinion, Northland assumed, with the consent of the ERES
Board, that the final executed form of the Merger Agreement would not differ in any material respect from the drafts that Northland examined, and that the conditions to the Business Combination set forth in the Merger Agreement will be satisfied or
waived and that Business Combination will be consummated in a manner consistent with that contemplated by the Merger Agreement. Northland also assumed that all regulatory approvals and consents necessary for the consummation of the Business
Combination would be obtained without any adverse effect on ERES or the Companies or alter the terms of the Business Combination.
Northlands opinion was based on financial, market, economic and other conditions existing on, and information made available to
Northland as of August 29, 2022 and does not address any matters subsequent to
193
such date. Northlands opinion was limited to the fairness, from a financial point of view, to ERES and its unaffiliated Public Stockholders of the consideration paid by ERES to the
Companies Members pursuant to the Merger Agreement and the fair market value of the Companies, in each case, as of the date of the opinion. Northlands opinion does not address ERESs underlying business decision to effect the Business
Combination or any other terms of the Merger Agreement. Although subsequent developments may affect Northlands opinion, Northland does not have any obligation to update, revise or reaffirm its opinion. Northlands opinion was approved by
the Northland Fairness Opinion Committee.
Summary Financial Analyses
The following is a summary of the material financial analyses performed by Northland in arriving at its opinion. Northlands opinion
letter was only one of many factors considered by the ERES Board in evaluating the Business Combination. Neither Northlands opinion nor its financial analyses were determinative of the terms of the Business Combination or of the views of the
ERES Board or ERESs management with respect to the Business Combination. None of the analyses performed by Northland were necessarily assigned a greater significance by Northland than any other, nor does the order of analyses described
represent relative importance or weight given to those analyses by Northland. The summary text describing each financial analysis does not purport to constitute a complete description of Northlands financial analyses, including the
methodologies and assumptions underlying the analyses, and, if viewed in isolation, could create a misleading or incomplete view of the financial analyses performed by Northland. The summary text set forth below does not represent and should not be
viewed by anyone as constituting or purporting to constitute the conclusions reached by Northland with respect to any of the analyses performed by it in connection with its opinion.
Analysis of Selected Publicly Traded Companies.
As part of its financial analyses, Northland reviewed and compared certain publicly available financial data, ratios and trading multiples for
publicly traded companies within the specialty insurance industry that Northland determined, based on its professional judgment, that their businesses, size, financial information, product mix and operating profiles were reasonably comparable to
those the Companies for purposes of this analysis, including the following six companies (collectively, the Selected Publicly Traded Companies):
|
|
|
Cincinnati Financial Corporation |
|
Kinsale Capital Group, Inc. |
|
|
Markel Corporation |
|
RLI Corp. |
|
|
The Progressive Corporation |
|
W.R. Berkley Corporation |
Financial data of the Selected Publicly Traded Companies were based on publicly available information,
including information from public filings, third party equity research reports and publicly available research analysts estimates and forward-looking metrics (such estimates and metrics based on information available via S&P Capital
IQ). Northland reviewed data, including implied market capitalization, current prevailing equity values (Price), Price/earnings before taxes or EBT and Price/earnings per share or EPS, based on consensus estimates
obtained via S&P Capital IQ for each of the Selected Publicly Traded Companies and the Companies.
Based on its professional judgement
and experience, Northland determined that the operations, size, businesses, product mix and financial information of such companies were similar to that of the Companies for purposes of this analysis. The multiples for each of the
above-mentioned financial metrics for each of the Selected Publicly Traded Companies were calculated using their respective closing prices on August 26, 2022 and were based on the most recent publicly available information and information
available via S&P Capital IQ on that date. Financial data for the Companies used to compare to the Selected Publicly Traded Companies was based on estimates of ERESs management and the Companies projections. Based on its
professional judgement and experience, Northland applied a 20% private company discount to the equity value of the Selected Publicly Traded Companies.
194
The following summarizes the results of these analyses with respect to the financial results
and metrics of the Selected Publicly Traded Companies after applying the discounted multiples as set forth above, including:
|
|
|
Price/calendar year 2022 EBT multiples: The Selected Publicly Traded Companies had Price/calendar year
2022 EBT multiples ranging from a low of 8.9x to a high of 28.4x. The mean Price/calendar year 2022 EBT multiple was 22.0x and the median Price/calendar year 2022 EBT multiple was 25.3x; |
|
|
|
Price/calendar year 2023 EBT multiples: The Selected Publicly Traded Companies had Price/calendar year
2023 EBT multiples ranging from a low of 8.7x to a high of 20.8x. The mean Price/calendar year 2023 EBT multiple was 13.4x and the median Price/calendar year 2023 EBT multiple was 12.5x; |
|
|
|
Price/calendar year 2024 EBT multiples: The Selected Publicly Traded Companies Price/calendar year 2024
EBT multiples ranging from a low of 8.0x to a high of 17.6x. The mean Price/calendar year 2024 EBT multiple was 11.2x and the median Price/calendar year 2024 EBT multiple was 11.1x; |
|
|
|
Price/calendar year 2022 EPS multiples: The Selected Publicly Traded Companies had Price/calendar year
2022 EPS multiples ranging from a low of 12.7x to a high of 30.2x. The mean Price/calendar year 2022 EPS multiple was 18.8x and the median Price/calendar year 2022 EPS multiple was 17.6x; |
|
|
|
Price/calendar year 2023 EPS multiples: The Selected Publicly Traded Companies had Price/calendar year
2023 EPS multiples ranging from a low of 11.0x to a high of 25.6x. The mean Price/calendar year 2023 EPS multiple was 16.8x and the median Price/calendar year 2023 EPS multiple was 15.7x; |
|
|
|
Price/calendar year 2024 EPS multiples: The Selected Publicly Traded Companies Price/EPS calendar 2024 EPS
multiples ranging from a low of 10.2x to a high of 21.7x. The mean Price/EPS calendar 2024 EPS multiple was 16.3x and the median Price/EPS calendar 2024 EPS multiple was 14.1x. |
Northland then applied the low to high calendar years 2022, 2023 and 2024 EBT multiples and EPS multiples described above derived from the
Selected Publicly Traded Companies to the corresponding data of the Companies. This analysis indicated approximate aggregate implied enterprise value reference ranges for the Companies of approximately $382 million to $1,390 million,
$388 million to $1,032 million and $399 million to $974 million based on 2022, 2023 and 2024 EBT estimates of approximately $52 million, $54 million and $60 million, respectively, and implied enterprise value
reference ranges for the Companies of approximately $580 million to $1,484 million, $380 million to $992 million and $399 million to $937 million based on 2022, 2023 and 2024 net income of approximately $52 million,
$42 million and $47 million, respectively.
No company used in the Selected Publicly Traded Companies analysis is
identical to the Companies. Northland made qualitative judgments based on its experience and professional judgment concerning differences between the business, financial and operating characteristics of the Companies. In evaluating the Selected
Publicly Traded Companies, Northland made judgments and assumptions with regard to industry performance, general business, economic, market and financial conditions and other matters which are beyond ERESs and the Companies control, such
as the impact of competition on the Companies and the specialty insurance industry generally, industry growth and the absence of any adverse material change in the Companies financial condition and prospects or those of the Companies or the
specialty insurance or the financial markets in general.
Analysis of Selected Precedent Transactions
As part of its financial analyses, Northland also reviewed and compared certain publicly available financial data for certain transactions
involving companies in industries related to specialty insurance industry that were publicly announced, had sufficient data to allow Northland to complete its analysis and which closed between
195
January 1, 2018 and August 26, 2022 The following transactions were used in the analysis (collectively, the Selected Precedent Transactions):
|
|
|
|
|
Closed |
|
Buyer |
|
Target |
August 2021 |
|
Further Global Capital Management, L.P.; TowerBrook Capital Partners L.P. |
|
Coaction Global, Inc. |
|
|
|
June 2021 |
|
The Progressive Corporation |
|
Protective Insurance Corporation |
|
|
|
February 2020 |
|
HCC Insurance Holdings, Inc. |
|
Privilege Underwriters, Inc. |
|
|
|
May 2019 |
|
The Hartford Financial Services Group, Inc. |
|
The Navigators Group, Inc. |
|
|
|
December 2018 |
|
Bain Capital, HarbourVest Partners, Lexington Partners, LGT Capital Partners |
|
esure Group plc |
|
|
|
July 2018 |
|
Kemper Corporation |
|
Infinity Property and Casualty Corporation |
Based on its professional judgment and experience, Northland reviewed and compared certain publicly
available transaction valuation metrics that Northland determined, based on its professional judgment and consideration paid in such transactions, including implied market capitalization, Price/EBT and Price/EPS. The information and financial data
of the selected precedent transactions were based on the most recent publicly available information and S&P Capital IQ.
The following
summarizes the results of these analyses with respect to comparable transactions:
|
|
|
Price/EBT multiples: The Selected Precedent Transactions had Price/next twelve months EBT multiples
ranging from a low of 9.1x to a high of 23.8x. The mean Price/next twelve months EBT multiple was 13.2x and the median Price/EBT multiple was 10.0x; |
|
|
|
Price/EPS multiples: The Selected Precedent Transactions had Price/next twelve months EPS multiples
ranging from a low of 11.5x to a high of 32.6x. The mean Price/next twelve months EPS multiple was 18.6x and the median Price/EBT multiple was 15.9x. |
Northland then applied the low to high next twelve months EBT multiples described above derived from the Selected Precedent Transactions to
the corresponding data of the Companies. This analysis indicated an approximate implied aggregate enterprise value reference range for the Companies of approximately $342 million to $1,030 million. Northland then applied the applied the
low to high next twelve months EPS multiples described above derived from the Selected Precedent Transactions to the corresponding data of the Companies. This analysis indicated an approximate implied aggregate enterprise value reference range for
the Companies of approximately $457 million to $1,438 million.
No transaction used in the Selected Precedent Transactions
analysis is identical to the Business Combination. In evaluating the Selected Precedent Transactions, Northland made judgments and assumptions with regard to industry performance, general business, economic, market and financial conditions and other
matters which are beyond ERESs and the Companies control, such as the impact of competition on the Companies and the specialty insurance industry generally, industry growth and the absence of any adverse material change in the
Companies financial condition and prospects or those of the Companies or the specialty insurance or the financial markets in general.
196
Miscellaneous
The preparation of a financial opinion is a complex analytical process involving various determinations as to the most appropriate and relevant
methods of financial analysis and the application of those methods to the particular circumstances and, therefore, a financial opinion is not readily susceptible to summary description. In arriving at its opinion, Northland did not draw, in
isolation, conclusions from or with regard to any factor or analysis that it considered. Rather, Northland made its determination as to fairness on the basis of its experience and professional judgment after considering the results of all of the
analyses.
The credit, financial and stock markets have from
time-to-time experienced unusual volatility, and Northland was not asked to and expressed no opinion or view as to any potential effects of such volatility on the
Business Combination and did not address potential developments in any such markets. In addition, Northland was not asked to and expressed no opinion or view as to any potential effects of the
COVID-19 pandemic on the Business Combination, ERES or the Companies.
ERES agreed to
pay Northland a cash fee of $1,000,000, of which $100,000 was due upon delivery of the fairness opinion and the remaining $900,000 is due at the Closing. In addition, ERES has agreed to reimburse certain of Northlands expenses related to its
engagement and to indemnify Northland against certain liabilities that may arise from services provided in connection with rendering its opinion.
Northland, as a customary part of its investment banking business, is continually engaged in performing financial analyses regarding
businesses and their securities in connection with acquisitions, negotiated underwritings, competitive biddings, secondary distributions of listed and unlisted securities, private placements and other transactions for estate, corporate and other
purposes.
Stockholders are urged to review the section entitled Risk FactorsRisks Related to the Business of the
Companies in this proxy statement for a description of the risks relating to the Companies business. Stockholders should also read the section entitled Forward-Looking Statements in
this proxy statement for additional information regarding the risks inherent in forward-looking information.
Interests of ERESs Directors
and Executive Officers and the Sponsor and its Affiliates in the Business Combination
In considering the recommendation of the ERES
Board to vote in favor of approval of the Proposals, stockholders should keep in mind that the Sponsor and its affiliates and ERESs directors and officers have interests in such Proposals that are different from or in addition to (and which
may conflict with) those of ERES stockholders. Stockholders should take these interests into account in deciding whether to approve the Proposals presented at the Special Meeting, including the Business Combination Proposal. These interests include,
among other things:
|
|
|
If the Business Combination with the Companies or another business combination is not consummated within the
Completion Window, ERES will cease all operations except for the purpose of winding up, redeeming 100% of the outstanding Public Shares for cash and, subject to the approval of its remaining stockholders and the ERES Board, dissolving and
liquidating. In such event, the 8,625,000 Founder Shares held by ERESs Initial Stockholders, which were acquired for an aggregate purchase price of $25,000, or approximately $0.003 per share, would be worthless because ERESs Initial
Stockholders are not entitled to participate in any redemption or distribution with respect to such shares. The Founder Shares had an aggregate market value of $[●] based upon the closing price of $[●] per share of ERES Class A
Common Stock on Nasdaq on the ERES Record Date. Certain Founder Shares are subject to time-based vesting provisions as described under Other AgreementsSponsor Support Agreement. |
|
|
|
The Sponsor purchased an aggregate of 8,900,000 Private Placement Warrants from ERES for an aggregate purchase
price of $8,900,000 (or $1.00 per warrant). These purchases took place on a private |
197
|
placement basis simultaneously with the consummation of the ERES IPO and associated exercise of the over-allotment option. A portion of the proceeds ERES received from these purchases was placed
in the Trust Account. Such warrants had an aggregate market value of approximately $[●] based upon the closing price of $[●] per public warrant on the Nasdaq on [●], 2023, the ERES Record Date. The Private Placement Warrants will
become worthless if ERES does not consummate a business combination within the Completion Window. The Sponsor paid an aggregate of $8,925,000 for its purchases of the Founder Shares and the Private Placement Warrants. |
|
|
|
In order to finance transaction costs in connection with a business combination, the Sponsor, members of the ERES
founding team or any of their affiliates may, but are not obligated to, loan ERES funds as may be required. In August 2021, the Sponsor committed to provide ERES up to an aggregate of $1,500,000 in loans for working capital purposes. The Working
Capital Note does not bear interest and is repayable in full upon consummation of a business combination. If ERES does not complete a business combination, the Working Capital Note shall not be repaid and all amounts owed under it will be forgiven.
The Working Capital Note is subject to customary events of default, the occurrence of which automatically trigger the unpaid principal balance of the Working Capital Note and all other sums payable with regard to the Working Capital Note becoming
immediately due and payable. As of December 31, 2022, there was a balance of $1,500,000 under this loan. On January 31, 2023, the Sponsor agreed to loan ERES up to an additional $1,500,000 under the Working Capital Note. |
|
|
|
On July 25, 2022, ERES entered into the Extension Note with the Sponsor. Pursuant to the Extension Note, the
Sponsor has agreed that it will contribute to ERES as a loan (each loan being referred to herein as a Contribution) $0.033 for each Public Share that was not redeemed in connection with the stockholder vote to approve the extension of
the deadline by which ERES must complete its initial business combination, for each month until the earlier of (i) the date of the special meeting held in connection with the stockholder vote to approve the Business Combination and
(ii) the date of liquidation of ERES. The Extension Note does not bear interest and is repayable in full upon the earlier of (i) the date of the consummation of ERESs initial business combination and (ii) the date of ERESs
liquidation. At any time prior to payment in full of the principal balance of the Extension Note, the holder of the Extension Note (or a permitted assignee) will have the option, but not the obligation, to convert up to $1,500,000 of the unpaid
principal balance of the Extension Note into that number of Extension Warrants, each whole warrant exercisable for one share of ERES Class A Common Stock equal to the principal amount of the Extension Note so converted divided by $1.50. The
terms of the Extension Warrants will be identical to the terms of the Private Placement Warrants. The Sponsor will have the sole discretion whether to continue extending for additional months, and if the Sponsor determines not to continue extending
for additional months, its obligation to make additional Contributions will terminate. If this occurs, ERES would wind up ERESs affairs and redeem 100% of the outstanding Public Shares in accordance with the procedures set forth in the
Existing Charter. The maturity date of the Extension Note may be accelerated upon the occurrence of an Event of Default (as defined therein). Any outstanding principal under the Extension Note may be prepaid at any time by ERES, at its election and
without penalty, provided, however, that the Sponsor shall have a right to first convert such principal balance as described in Section 17 of the Extension Note upon notice of such prepayment. If the Business Combination is not completed and
ERES winds up, there will not be sufficient assets to repay the Extension Note and it will be worthless. As of December 31, 2022, there was a balance of $1,924,356 under this loan. |
|
|
|
On January 23, 2023, ERES entered into the Second Extension Note with the Sponsor. Pursuant to the Second
Extension Note, the Sponsor agreed to contribute to ERES as a loan $0.033 for each Public Share that was not redeemed in connection with the stockholder vote to approve the extension of the date by which ERES must complete an initial business
combination, for each month until the earlier of (i) the date of consummation of ERESs initial business combination and (ii) the date of liquidation of ERES. The Second Extension Note does not bear interest and is repayable in full upon the
earlier of (i) the date of the consummation of ERESs initial business combination and (ii) the date of ERESs liquidation. At any time prior to payment in full of the principal balance of the Second Extension Note, the holder of the
Second Extension Note (or a permitted assignee) will have the option, but not the |
198
|
obligation, to convert up to $500,000 of the unpaid principal balance of the Second Extension Note into that number of Second Extension Warrants, each whole warrant exercisable for one share of
ERES Class A Common Stock equal to the principal amount of the Second Extension Note so converted divided by $1.50. The terms of the Second Extension Warrants will be identical to the terms of the Private Placement Warrants. The Sponsor will have
the sole discretion whether to continue extending for additional months, and if the Sponsor determines not to continue extending for additional months, its obligation to make additional Contributions will terminate. If this occurs, ERES would wind
up ERESs affairs and redeem 100% of the outstanding Public Shares in accordance with the procedures set forth in the Existing Charter. The maturity date of the Second Extension Note may be accelerated upon the occurrence of an Event of Default
(as defined therein). Any outstanding principal under the Second Extension Note may be prepaid at any time by ERES, at its election and without penalty, provided, however, that the Sponsor shall have a right to first convert such principal balance
as described in Section 17 of the Second Extension Note upon notice of such prepayment. If the Business Combination is not completed and ERES winds up, there will not be sufficient assets to repay the Second Extension Note and it will be worthless.
As of April 17, 2023, there was a balance of $282,748.65 under this loan. |
|
|
|
ERESs directors and officers, and their affiliates are entitled to reimbursement of out-of-pocket expenses incurred by them in connection with certain activities on ERESs behalf, such as identifying and investigating possible business targets and
business combinations. However, if ERES fails to consummate a business combination within the Completion Window, they will not have any claim against the Trust Account for reimbursement. Accordingly, ERES may not be able to reimburse these expenses
if the Business Combination or another business combination is not consummated within the Completion Window. As of December 31, 2022, $0 was outstanding in out-of-pocket expense reimbursements. Additionally, two affiliates of the Sponsor are each
entitled to $10,000 per month for office space, utilities, administrative and support services provided to ERESs management team, which commenced on July 24, 2020 and will continue through the earlier of consummation of the Business
Combination and ERESs liquidation. For the years ended December 31, 2022 and December 31, 2021, the ERES incurred and paid an aggregate of $240,000 and $240,000 in connection with these agreements, respectively. |
|
|
|
The continued indemnification of current directors and officers and the continuation of directors and
officers liability insurance. |
|
|
|
In the event of the liquidation of the Trust Account, the Sponsor has agreed to indemnify and hold harmless ERES
against any and all losses, liabilities, claims, damages and expenses to which ERES may become subject as a result of any claim by (i) any third party for services rendered or products sold to ERES or (ii) a prospective target business
with which ERES has entered into an acquisition agreement, provided that such indemnification of ERES by the Sponsor shall apply only to the extent necessary to ensure that such claims by a third party for services rendered or products sold to ERES
or a target do not reduce the amount of funds in the Trust Account to below (i) $10.00 per share of ERES Class A Common Stock or (ii) such lesser amount per share of ERES Class A Common Stock held in the Trust Account due to
reductions in the value of the trust assets as of the date of the liquidation of the Trust Account, in each case, net of the amount of interest earned on the property in the Trust Account, which may be withdrawn to pay taxes and expenses related to
the administration of the Trust Account, except as to any claims by a third party (including a target) who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under ERESs indemnity of the
underwriters of the ERES IPO against certain liabilities, including liabilities under the Securities Act. If ERES consummates the Business Combination, on the other hand, ERES will be liable for all such claims. |
|
|
|
Pursuant to the Sponsor Support Agreement, the Sponsor has agreed, subject to certain exceptions, not to transfer
(i) 15% of the shares of the Post-Combination Companys common stock received by the Sponsor in connection with the Closing until the date that is 180 days after the Closing Date and (ii) the
|
199
|
remaining 85% of the shares of the Post-Combination Companys common stock received by the Sponsor in connection with the Closing until the date that is 24 months after the Closing Date.
|
|
|
|
Subject to certain limited exceptions, the Private Placement Warrants will not be transferable until 30 days
following the completion of the Business Combination. |
|
|
|
There will be no finders fees, reimbursements or cash payments made by ERES to the Sponsor or ERESs
officers or directors, or ERESs or any of their affiliates, for services rendered to ERES prior to or in connection with the completion of the Business Combination, other than payment of the amount described above for office space, utilities,
administrative and support services described above and repayments of the loans under the Working Capital Note, the Extension Note and the Second Extension Note as described above. The Sponsor and ERESs officers and directors or any of their
respective affiliates will also be reimbursed for any out-of-pocket expenses incurred in connection with ERESs formation, the ERES IPO and activities on
ERESs behalf such as identifying potential target businesses and performing due diligence on suitable business combinations. There is no cap or ceiling on the reimbursement of
out-of-pocket expenses incurred by such persons in connection with activities on our behalf. |
|
|
|
Our Sponsor, officers and directors would hold the following number of shares of common stock in the Post-Combination Company, on a fully diluted basis, at the closing of the Business Combination: |
|
|
|
|
|
|
|
|
|
Name of Person/Entity |
|
Number of Shares of Common Stock(1) |
|
|
Value of Shares(2) |
|
East Sponsor, LLC |
|
|
17,068,333 |
|
|
$ |
170,683,330 |
|
Terrence M. Pegula |
|
|
17,068,333 |
|
|
$ |
170,683,330 |
|
Gary L. Hagerman, Jr. |
|
|
1,000 |
|
|
$ |
10,000 |
|
John P. Sieminski |
|
|
2,500 |
|
|
$ |
25,000 |
|
James S. Morrow |
|
|
0 |
|
|
$ |
0 |
|
William A. Fustos |
|
|
22,000 |
|
|
$ |
220,000 |
|
Thomas W. Corbett, Jr. |
|
|
10,000 |
|
|
$ |
100,000 |
|
Benjamin Wingard(3) |
|
|
4,000 |
|
|
$ |
40,000 |
|
Jacob Long |
|
|
5,000 |
|
|
$ |
50,000 |
|
Adam Gusky |
|
|
2,452 |
|
|
$ |
24,520 |
|
(1) |
(a) Assumes that (i) Public Stockholders exercise the 17,250,000 public warrants, (ii) the Initial Stockholders
exercise the 7,120,000 Private Placement Warrants, (iii) the 1,780,000 warrants in the warrant pool are exercised, (iv) the Sponsor exercises its option to convert up to $1,500,000 of the unpaid principal balance on the Extension Note to 1,000,000
Extension Warrants and exercises such warrants, (v) the Sponsor exercises its option to convert up to $500,000 of the unpaid principal balance on the Second Extension Note to 333,333 Second Extension Warrants and exercises such warrants and (vi) all
shares underlying the Incentive Plan are issued. |
(b) Includes shares that may be issued but are not presently
outstanding and, as such, differs from the share counts shown or assumed in the sections entitled Summary Unaudited Pro Forma Condensed Combined Financial Information, Unaudited Historical Comparative and Pro Forma Combined Per
Share Data of ERES and the Companies, Unaudited Pro Forma Condensed Combined Financial Information and Comparative Historical and Unaudited Pro Forma Combined Per Share Financial Information, which sections are limited
to shares that are presently issued and outstanding.
(2) |
Assumes a value of $10.00 per share, the deemed value of the Class A Common Stock in the Business Combination.
|
(3) |
Benjamin Wingard was a named executive officer for the purposes of the Annual Report on Form 10-K
for fiscal year ended December 31, 2022, filed by ERES on April 18, 2023. Mr. Wingard resigned from ERES effective January 31, 2023. |
|
|
|
Certain of our officers and directors presently have, and any of them in the future may have additional,
fiduciary or contractual obligations to other entities pursuant to which such officer or director is or will |
200
|
be required to present business combination opportunities to such entity. Accordingly, in the future, if any of our officers or directors becomes aware of a business combination opportunity which
is suitable for an entity to which he or she has then-current fiduciary or contractual obligations, he or she will honor his or her fiduciary or contractual obligations to present such opportunity to such entity. We do not believe, however, that any
fiduciary duties or contractual obligations of our officers would materially undermine our ability to complete our business combination. The Existing Charter provides that we renounce our interest in any corporate opportunity offered to any director
or officer unless such opportunity is expressly offered to such person solely in his or her capacity as a director or officer of our company and such opportunity is one we are legally and contractually permitted to undertake and would otherwise be
reasonable for us to pursue, and to the extent such person is permitted to refer that opportunity to us without violating another legal obligation. This waiver allows our Sponsor and its affiliates to allocate opportunities based on a combination of
the objectives and fundraising needs of the target, as well as the investment objectives of the entity. However, we do not believe that the waiver of the corporate opportunities doctrine otherwise had a material impact on our search for an
acquisition target. |
|
|
|
In the aggregate, the Sponsor paid an aggregate of $8,925,000 for the Founder Shares and the Private Placement
Warrants, and the Sponsor and its affiliates have approximately $95,050,000 at risk that depends upon the completion of a business combination. Specifically, approximately $86,150,000 of such at-risk amount is
the value of the Sponsor and its affiliates Founder Shares (assuming a value of $10.00 per share, the deemed value of the Class A Common Stock in the Business Combination), and approximately $8,900,000 of such at-risk amount is the value of the Sponsors Private Placement Warrants (based on the purchase price of $1.00 per Private Placement Warrant). There are no fees contingent upon a business combination payable to
the Sponsors affiliates upon consummation of the Business Combination. There are no out-of-pocket expenses reimbursable to our directors and officers or
affiliates. There are currently no outstanding loans to us from the Sponsor, other than the Working Capital Note in the principal amount of $1,500,000, the Extension Note in the principal amount of up to $1,924,356 issued on July 25, 2022 and
the Second Extension Note in the principal amount of up to $565,497.31 issued on January 23, 2023, as described above. |
|
|
|
Following the completion of the Business Combination, Adam Gusky and Thomas W. Corbett, Jr. will be members of
the board of directors of the Post-Combination Company. As such, in the future, Mr. Gusky and Mr. Corbett, Jr. will receive any cash fees, stock options or stock awards that the board of directors of the Post-Combination Company determines to
pay to its directors. |
|
|
|
Given the interests described above, our Sponsor and its affiliates may earn a positive rate of return on their
investment, even if the Post-Combination Company common stock trades below the price initially paid for the ERES units in the ERES IPO, and the Public Stockholders may experience a negative rate of return following the completion of the Business
Combination. Thus, our Sponsor and its affiliates may have more of an economic incentive for us to, rather than liquidate if we fail to complete our initial business combination by the Completion Window, enter into an initial business combination on
potentially less favorable terms with a potentially less favorable, riskier, weaker-performing or financially unstable business, or an entity lacking an established record of revenues or earnings, than would be the case if such parties had paid the
full offering price for their Founder Shares. |
|
|
|
Our Sponsor, directors and officers beneficially own Founder Shares and warrants that will be worthless and have
incurred reimbursable expenses that may not be reimbursed or repaid if the Business Combination is not approved. As of the date of this proxy statement, the Sponsor has invested an aggregate of approximately $14,132,105 (consisting of $25,000 for
the Founder Shares, $8,900,000 for the Private Placement Warrants, $3,000,000 for the aggregate principal amount of the Working Capital Note, $1,924,356 for the Extension Note and $282,749 for the Second Extension Note). Assuming a value of $10.00
per share, the deemed value of the Class A Common Stock in the Business Combination, the aggregate market value with respect to the common stock, fully diluted, based on |
201
|
Founder Shares and warrants in ERES held by our Sponsor, directors and officers, would be approximately $170,783,330. Thus, the aggregate market value of our Sponsors Founder Shares and
Private Placement Warrants, together with the aggregate outstanding principal amount of the foregoing loans and the foregoing reimbursable expenses, would be approximately $184,915,435. |
The foregoing interests present a risk that the Sponsor and its affiliates will benefit from the completion of a business combination,
including in a manner that may not be aligned with Public Stockholders. As such, the Sponsor may be incentivized to complete an acquisition of a less favorable target company or on terms less favorable to stockholders rather than liquidate.
Interests of the Companies Directors and Executive Officers in the Business Combination
Certain of the Companies managers and executive officers will serve as directors and officers of the Post-Combination Company following
the consummation of the Business Combination. In the future, they will receive the cash and equity-based compensation from the Post-Combination Company that the board of directors of the Post-Combination Company determines to pay to them as managers
and officers.
Board of Directors and Executive Officers After Completion of the Business Combination
The following sets forth certain information, as of April 21, 2023, concerning the persons who are expected to serve as executive officers
and members of the board of directors of the Post-Combination Company following the consummation of the Business Combination.
|
|
|
|
|
|
|
Name |
|
Age |
|
|
Title |
Jay Jackson |
|
|
50 |
|
|
Chief Executive Officer and Director Nominee |
Matt Ganovsky |
|
|
58 |
|
|
Co-Founder and Managing Partner |
Kevin Scott Kirby |
|
|
56 |
|
|
Co-Founder and Managing Partner |
Sean McNealy |
|
|
57 |
|
|
Co-Founder, President and Director Nominee |
Bill McCauley |
|
|
50 |
|
|
Chief Financial Officer |
Adam Gusky |
|
|
48 |
|
|
Chief Investment Officer and Director Nominee |
Karla Radka |
|
|
54 |
|
|
Director Nominee |
Cornelius Michiel van Katwijk |
|
|
56 |
|
|
Director Nominee |
Thomas W. Corbett, Jr. |
|
|
73 |
|
|
Director Nominee |
Mary Beth Schulte |
|
|
58 |
|
|
Director Nominee |
Accounting Treatment of the Business Combination
The Business Combination will be accounted for as a reverse recapitalization with ERES in accordance with GAAP. Under this method of
accounting, ERES has been treated as the acquired company for financial reporting purposes. This determination was primarily based on the Companies stockholders having a relative majority of the voting power of the Post-Combination
Company, the Companies having the authority to appoint a majority of directors on the Board, and senior management of the Companies comprising the majority of the senior management of the Post-Combination Company. LMA was then determined to be the
acquirer for financial reporting purposes based on the relative size of LMA as compared to Abacus, represented by their revenue, equity, gross profit and net income. Accordingly, for accounting purposes, the financial statements of the
combined entity will represent a continuation of the financial statements of LMA with the LMA Merger being treated as the equivalent of LMA issuing stock for the net assets of ERES, accompanied by a recapitalization. The net assets of ERES will be
stated at historical cost, with no goodwill or other intangible assets recorded.
The Abacus Merger will be accounted for using the
acquisition method of accounting. Under the acquisition method of accounting, the assets and liabilities of Abacus will be recorded at estimated fair value as of the
202
acquisition date. The excess of the purchase price over the estimated fair values of the net assets acquired, if applicable, will be recognized as goodwill. For purposes of the unaudited pro
forma condensed combined balance sheet, the purchase consideration has been allocated to the assets acquired and liabilities assumed of Abacus based upon managements preliminary estimate of their fair values, subject to further revision as
additional information becomes available and additional analyses are performed. Differences may occur between these preliminary estimates and the final accounting, expected to be completed after the Closing, and these differences could have a
material impact on the accompanying unaudited pro forma condensed combined financial information and the Companys future results of operations and financial position.
Regulatory Approvals Required for the Business Combination
HSR Act
Completion of the
Business Combination is subject to approval under the HSR Act. Each of the Companies and ERES have agreed to use their respective commercially reasonable efforts to take all actions necessary, proper or advisable under applicable laws to consummate
the Business Combination as promptly as practicable, including all licenses, permits, clearances, consents, approvals, authorizations, authorizations, qualifications and government orders.
Under the HSR Act, and related rules, the transactions may not be completed until notifications have been filed with and certain information
has been furnished to the Antitrust Division of the Department of Justice (the Antitrust Division) and the Federal Trade Commission (the FTC) and all statutory waiting period requirements have been satisfied. ERES filed a
Notification and Report Form with the Antitrust Division and the FTC on September 26, 2022, and the 30-day waiting period expired at 11:59 p.m., New York City time, on October 26, 2022.
At any time before or after the completion of the Business Combination, the Antitrust Division, the FTC or foreign antitrust authorities could
take action under the U.S. or foreign antitrust laws, including seeking to prevent the Business Combination, to rescind the Business Combination or to clear the Business Combination subject to the divestiture of assets of ERES or the Companies
or subject to other remedies. In addition, U.S. state attorneys general could take action under the antitrust laws as they deem necessary or desirable in the public interest including without limitation seeking to enjoin the completion of the
transactions or permitting completion subject to the divestiture of assets of ERES or the Companies or other remedies. Private parties may also seek to take legal action under the antitrust laws under some circumstances. There can be no assurance
that a challenge to the transactions on antitrust grounds will not be made or, if such challenge is made, that it would not be successful.
There can be no assurances that the regulatory approvals discussed above will be received on a timely basis, or as to the ability of ERES and
the Companies to obtain the approvals on satisfactory terms or the absence of litigation challenging such approvals.
FL OIR and CA DOI
In connection with the Business Combination, the ERES must obtain regulatory approvals from the Florida Office of Insurance Regulation
(FL OIR) and, following the Closing, the California Department of Insurance (CA DOI).
Florida.
ERES must obtain the approval of the Florida Insurance Commissioner of ERESs acquisition of control of Abacus before and as a condition
precedent to the closing of the Business Combination. On September 15, 2022, the ERES filed with the FL OIR ERESs application for its acquisition of control of Abacus. The FL OIRs
203
review of ERESs application involves a review by the FL OIR of, among other things, the controlling persons of ERES to determine whether to approve the change of control. This review
process could take up to six months to complete, and there is no assurance that the Florida Insurance Commissioner will approve the application or when the Florida Insurance Commissioner will make a determination on it.
California.
Abacus is currently licensed
as a life settlement provider by the CA DOI. Following the Closing, Abacus will file a new life settlement provider license application with the CA DOI based on the change of control of Abacus in the Business Combination.
Abacus is permitted to continue transacting its life settlement provider business in California while the CA DOI is reviewing Abacus new
life settlement provider license application. Upon submitting Abacus new life settlement provider license application to the CA DOI, the CA DOI will conduct a review of the application, including a review of the new control persons of Abacus.
This review could take up to six months to complete, and there is no assurance that the CA DOI will approve the application or when the California Insurance Commissioner will make a determination on it. If the CA DOI does not approve Abacus
new life settlement provider license application, Abacus will not be able to continue to act as a life settlement provider in the State of California.
Restrictions on Sales of Shares of ERES Common Stock Received in the Business Combination
Following the completion of the Business Combination, any holders of ERES Common Stock will become holders of Post-Combination Company common
stock. The securities laws restrict the resale of securities that are deemed to be restricted securities. Restricted securities are securities which are acquired in an unregistered, private sale from the issuing company or from an
affiliate of the issuing company. Affiliates are people or entities who control, are controlled by, or are under common control with the issuer. There are no restrictions on resale of securities that are not restricted securities. Securities sold by
ERES to the public in its initial public offering are not restricted securities.
Rule 144 under the Securities Act (Rule 144)
provides a safe harbor for the resale of securities. Rule 144 provides that a person who has beneficially owned restricted Post-Combination Company common stock for at least six months would be entitled to sell their securities provided that
(i) such person is not deemed to have been an affiliate of the Post-Combination Company at the time of, or at any time during the three months preceding, a sale and (ii) the Post-Combination Company satisfies the requirements for former
shell companies described below.
Persons who have beneficially owned restricted shares of Post-Combination Company common stock for at
least six months but who are affiliates of the Post-Combination Company at the time of, or at any time during the three months preceding, a sale, would be subject to additional restrictions, by which such person would be entitled to sell within any
three-month period only a number of securities that does not exceed the greater of:
|
|
|
1% of the total number of the shares of Post-Combination Company common stock then outstanding; or
|
|
|
|
the average weekly reported trading volume of the Post-Combination Companys common stock during the four
calendar weeks preceding the filing of a notice on Rule 144 with respect to the sale. |
Sales by affiliates of the
Post-Combination Company under Rule 144 are also limited by manner of sale provisions and notice requirements and to the availability of current public information about the Post-Combination Company.
Restrictions on the Use of Rule 144 by Shell Companies or Former Shell Companies
Rule 144 is not available for the resale of restricted securities issued by shell companies such as ERES or for the Post-Combination Company
(which was previously a special purpose acquisition company, and therefore
204
a shell company). However, Rule 144 also includes an important exception to this prohibition if the following conditions are met:
|
|
|
the issuer of the securities that was formerly a shell company has ceased to be a shell company (which the
Post-Combination Company will cease to be upon completion of the Business Combination); |
|
|
|
the issuer of the securities is subject to the reporting requirements of Section 13 or 15(d) of the Exchange
Act (which the Post-Combination Company will be following the Business Combination); |
|
|
|
the issuer of the securities has filed all Exchange Act reports and material required to be filed, as applicable,
during the preceding 12 months (or such shorter period that the issuer was required to file such reports and materials), other than Form 8-K reports; and |
|
|
|
at least one year has elapsed from the time that the issuer filed current Form 10 type information with the SEC
reflecting its status as an entity that is not a shell company. |
In addition to potential sales pursuant to Rule 144,
holders of restricted shares may be able to sell pursuant to an effective registration statement, see the section entitled Other AgreementsRegistration Rights Agreement.
Post-Combination Company Warrants
Following the Business Combination, any Public Stockholder who exercises publicly traded warrants will receive shares that are not restricted
securities. With respect to warrants that are restricted securities, if the holder exercises the warrant for cash, a new Rule 144 holding period applies with respect to such shares. Instead, if the warrant is exercised without cash (i.e. cashless
exercise), the holding period of the warrant can be tacked to the received common stock for purposes of Rule 144. In addition, warrants that are restricted securities may be sold pursuant to Rule 144 in the same manner and subject to the same
conditions as set forth.
No Appraisal Rights
Holders of ERES Common Stock are not entitled to appraisal rights in connection with the Business Combination under Delaware law.
205
PUBLIC TRADING MARKETS
The ERES Class A Common Stock is listed on the Nasdaq under the symbol ERES. ERESs public warrants are listed on the
Nasdaq under the symbol ERESW. ERESs units are listed on Nasdaq under the symbol ERESU. Following the Business Combination, the Post-Combination Companys common stock
(including common stock issuable in the Business Combination) is expected to be listed on the Nasdaq under the symbol ABL and the Post-Combination Companys public warrants will be listed on
the Nasdaq under the symbol ABLLW. ERESs units will be delisted and deregistered following the Closing.
206
THE MERGER AGREEMENT
This section describes the material terms of the Merger Agreement. The description in this section and elsewhere in this proxy statement is
qualified in its entirety by reference to the complete text of the Merger Agreement, the Amendment and the Second Amendment, copies of which are attached to this proxy statement as Annex A-1, Annex A-2 and Annex A-3, respectively. This summary does not purport to be complete and may not contain all of the information about the Merger Agreement that is
important to you. You are encouraged to read the Merger Agreement carefully and in its entirety. This section is not intended to provide you with any factual information about ERES or the Companies. Such information can be found elsewhere in this
proxy statement. References in this section to the Parent Parties are to ERES and Merger Subs collectively.
The
Merger Agreement summary below is included in this proxy statement only to provide you with information regarding the terms and conditions of the Merger Agreement and not to provide any other factual information regarding ERES, or their respective
businesses. Accordingly, the representations and warranties and other provisions of the Merger Agreement should not be read alone, but instead should be read only in conjunction with the information provided elsewhere in this proxy statement.
Structure of the Business Combination
On August 30, 2022, ERES entered into the Merger Agreement with the Companies and Merger Subs, pursuant to which, among other things and
subject to the terms and conditions contained in the Merger Agreement, Abacus Merger Sub will merge with and into Abacus, with Abacus surviving the Merger as a wholly owned subsidiary of ERES and LMA Merger Sub will merge with and into LMA, with LMA
surviving the Merger as a wholly owned subsidiary of ERES. In connection with the Closing, ERES will be renamed Abacus Life, Inc.
ERES
has agreed to provide its stockholders with the opportunity to redeem shares of Class A Common Stock upon completion of the transactions contemplated by the Merger Agreement.
Consideration to the Equity Holders in the Business Combination
On October 14, 2022, ERES, LMA Merger Sub, Abacus Merger Sub, LMA and Abacus entered into the Amendment, pursuant to which the Merger
Agreement was amended to, among other things, (i) clarify that the value ascribed to the limited liability company interests of the Companies (the Company Member Value) is an amount equal to (a) $618,000,000 minus
(b) $86,250,000, (ii) amend and restate the definition of Stock Consideration to clarify that the number of shares of ERES Class A Common Stock to be issued to the Company Members in connection with the consummation of the Mergers is
the number of shares of ERES Class A Common Stock equal to (a) the Company Member Value minus the Cash Consideration, if any, divided by (b) $10.00, (iii) clarify the intended tax treatment of the transactions contemplated by the
Merger Agreement and the representations and warranties related thereto and (iv) remove the requirement that Abacus shall have been relicensed as a life settlement provider by the California Department of Insurance as a result of the change of
control of Abacus contemplated by the transactions contemplated by the Merger Agreement prior to closing of the Business Combination. For the avoidance of doubt, the Stock Consideration will equal 53,175,000 shares of ERES Class A Common Stock,
assuming the Cash Consideration equals $0.
As part of the Business Combination, the Company Members will receive aggregate
consideration of approximately $531.8 million, payable in newly issued shares of ERES Class A Common Stock at a price of $10.00 per share and, to the extent the Aggregate Transaction Proceeds exceed $200.0 million, at the election of
the Company Members, up to $20.0 million of the aggregate consideration will be payable in cash to the Company Members.
Vote Required for
Approval of the Business Combination and Required Tax Documentation Provided in Connection with Business Combination
On April 20,
2023, ERES, LMA Merger Sub, Abacus Merger Sub, LMA and Abacus entered into the Second Amendment, pursuant to which the Merger Agreement was amended to, among other things, (i) clarify
207
the ERES stockholder votes required to approve the Transaction Proposals, (ii) require the Companies to deliver or cause to be delivered documentation relating to a tax election at the Closing
and (iii) extend the Outside Date from January 27, 2023 to July 27, 2023.
Material Adverse Effect
Under the Merger Agreement, certain representations and warranties of the Companies, on the one hand, and the Parent Parties, on the other
hand, are qualified in whole or in part by a material adverse effect standard for purposes of determining whether a breach of such representations and warranties has occurred. Pursuant to the Merger Agreement, a Material Adverse Effect
means any event, change, development, effect or occurrence that, individually or in the aggregate with all other events, changes, developments, effects or occurrences, has had or would reasonably be expected to be materially adverse to the business,
assets, liabilities, financial condition or results of operations of the Companies or the Parent Parties, as applicable, taken as a whole, subject in each case to certain customary exceptions.
Closing and Effective Time of the Business Combination
The closing of the Business Combination is expected to take place at 10:00 a.m., prevailing Eastern time, at the offices of Latham &
Watkins LLP or at such other place or time as mutually agreed in writing, no later than (i) three (3) Business Days following the satisfaction or waiver of the conditions described below under the section entitled Conditions
to Closing of the Business Combination, or (ii) on such other date as mutually agreed in writing.
Conditions to Closing of the Business
Combination
Conditions to Each Partys Obligations
The respective obligations of the Parties to consummate the transactions contemplated by the Merger Agreement, including the Business
Combination, are subject to the satisfaction, or written waiver by the Parties, at or prior to the Closing of the following conditions:
|
|
|
there must not be in effect any order prohibiting or preventing the consummation of the Business Combination and
no law adopted, enacted or promulgated that makes consummation of the Business Combination illegal or otherwise prohibited; |
|
|
|
all waiting periods and any extensions thereof applicable to the transactions contemplated by the Merger
Agreement under the HSR Act, and any commitments or agreements (including timing agreements) with any governmental entity not to consummate the Business Combination before a certain date, must have expired or been terminated; |
|
|
|
the offer contemplated by this proxy statement must have been completed in accordance with the terms of the
Merger Agreement and this proxy statement; |
|
|
|
the approval of each of the Proposals set forth in this proxy statement must have been obtained in accordance
with the DGCL, ERESs organizational documents and the rules and regulations of Nasdaq; |
|
|
|
the approval of the Business Combination by the Company Members must have been obtained; |
|
|
|
ERES shall have received the approval of the Florida Office of Insurance Regulation with respect to the change of
control of Abacus contemplated under the Merger Agreement without any agreement with, or condition or requirement imposed by, the Florida Office of Insurance Regulation that (i) has, or would reasonably be expected to have a material adverse
effect on the Companies following the Closing or (ii) involves any significant adverse effect on the economic benefits that either ERES or the Companies, respectively, reasonably expects to obtain from the Business Combination;
|
|
|
|
ERES shall have at least $5,000,001 of net tangible assets immediately after the Mergers are effective; and
|
|
|
|
the ERES Common Stock to be issued in the Business Combination must have been approved by the Nasdaq, subject
only to official notice of issuance thereof. |
208
Conditions to the Obligations of the Companies
The obligations of the Companies to consummate the transactions contemplated by the Merger Agreement are subject to the satisfaction, or
written waiver by the Companies, at or prior to the Closing, the following conditions:
|
|
|
the representations and warranties of the Parent Parties (other than fundamental representations), disregarding
qualifications contained therein relating to materiality, must be true and correct as of the Closing Date as if made at and as of such time (or, if given as of an earlier date, as of such earlier date), except that this condition will be satisfied
unless any and all inaccuracies in such representations and warranties of the Parent Parties, in the aggregate, would or would reasonably be expected to result in a Material Adverse Effect with respect to the Parent Parties, and fundamental
representations must be true an correct in all respects as of the Closing Date (or, if given as of an earlier date, such earlier date); |
|
|
|
each of the Parent Parties must have performed in all material respects its obligations under the Merger
Agreement required to be performed by it at or prior to the Closing; |
|
|
|
the Companies must have received a certificate executed and delivered by an authorized officer of the Parent
Parties confirming that the conditions set forth in the immediately preceding bullet points have been satisfied; |
|
|
|
the proceeds from the Business Combination, consisting of (a) the aggregate cash proceeds available for
release to ERES from the Trust Account in connection with the Business Combination (after, for the avoidance of doubt, giving effect to any redemptions of shares of ERES Common Stock by stockholders of ERES but before release of any other funds)
plus (b) any PIPE Investment Amount (while ERES continues to opportunistically seek to raise a PIPE investment, at this time, it has no committed PIPE Investment Amount) minus (c) the Parent Transaction Expenses; minus (d) the Company
Transaction Expenses; minus (e) the Working Capital Loan Amount; and plus the Sponsor PIK Note Amount, must be equal to or in excess of $1.0 million; and |
|
|
|
the directors and executive officers of ERES must have been removed from their respective positions or tendered
their irrevocable resignations effective as of the Closing. |
Conditions to the Obligations of the Parent Parties
The obligations of the Parent Parties to consummate the transactions contemplated by the Merger Agreement are subject to the satisfaction, or
written waiver by the Parent Parties, at or prior to the Closing of the following conditions:
|
|
|
the representations and warranties of the Companies (other than fundamental representations), disregarding
qualifications contained therein relating to materiality, must be true and correct as of the Closing Date as if made at and as of such time (or, if given as of an earlier date, as of such earlier date), except that this condition will be satisfied
unless any and all inaccuracies in such representations and warranties of the Companies, in the aggregate, would or would reasonably be expected to result in a Material Adverse Effect with respect to the Companies, and fundamental representations
must be true an correct in all respects as of the Closing Date (or, if given as of an earlier date, such earlier date); |
|
|
|
the Companies must have performed in all material respects its obligations under the Merger Agreement required to
be performed by it at or prior to the Closing; |
|
|
|
ERES must have received a certificate executed and delivered by an authorized officer of the Companies confirming
that the conditions set forth in the immediately preceding bullet points have been satisfied; |
|
|
|
the Parent Parties must have received a copy of the written consent of the Company Members, which must remain in
full force and effect; |
|
|
|
the Companies must have converted to Delaware limited liability companies at least five business days prior to
the Closing Date; and |
209
|
|
|
since the date of the Merger Agreement, a Material Adverse Effect with respect to the Companies must not have
occurred. |
Representations and Warranties
Under the Merger Agreement, the Companies made customary representations and warranties relating to: organization; authorization;
capitalization; the Companies subsidiaries; consents and approvals; financial statements; absence of undisclosed liabilities; absence of certain changes; real estate; intellectual property; data privacy and security; litigation; material
contracts; taxes; environmental matters; licenses and permits; employee benefits; labor and employment matters; international trade and anti-corruption matters; certain fees; insurance policies; affiliate
transactions; information supplied; customers and suppliers; compliance with laws; sufficiency of assets; investment company act; no regulatory impediments; and disclaimer of warranties.
Under the Merger Agreement, the Parent Parties made customary representations and warranties relating to: organization; authorization;
capitalization; consents and approvals; financial statements; business activities and absence of undisclosed liabilities; absence of certain changes; litigation; material contracts; taxes; compliance with laws; certain fees; SEC reports, Nasdaq
compliance and the Investment Company Act; information supplied; approvals of boards of directors and stockholders; Trust Account; affiliate transactions; independent investigation; employee benefits; valid issuance of securities; regulatory
impediments; and disclaimer of warranties.
Covenants
Covenants of the Parent Parties
The Parent Parties made certain covenants under the Merger Agreement, including, among other things, the following:
|
|
|
During the period from the date of the Merger Agreement through the earlier of (x) termination of the Merger
Agreement and (y) the Closing, except as contemplated by the Merger Agreement, required by applicable law (including COVID-19 measures), described in the ERES disclosure schedules or consented to by the
Companies, ERES will not: make any change to its organizational documents; issue equity capital; split, combine, redeem or reclassify its capital stock; authorize or pay any dividends or make distributions with respect to its capital stock or other
equity; sell, lease or dispose of any of its material properties or assets; incur or guarantee any indebtedness of another person or issue any debt securities; make certain material tax elections; except as required by law, make any material change
in financial or tax accounting methods; take any action likely to prevent, delay or impede the consummation of the Business Combination; make any amendment or modification to the Trust Agreement (as defined in the Merger Agreement); make or allow to
be made any reduction to the amount in the Trust Account other than as expressly permitted by ERESs organizational documents; directly or indirectly acquire or merge with any other person; make any capital expenditures; enter into any new line
of business; adopt or effect a plan of complete or partial liquidation, dissolution, restructuring, recapitalization or other reorganization; or authorize or commit or agree to take any of the foregoing actions. |
|
|
|
Upon satisfaction or waiver of the conditions described above in the section entitled
Conditions to Closing of the Business Combination and provision of notice thereof to Continental Stock Transfer & Trust Company (the Trustee), (a) in accordance with and pursuant to the Trust Agreement,
at the Closing, ERES (i) will cause the documents, opinions and notices required to be delivered to the Trustee pursuant to the Trust Agreement to be delivered and (ii) will use commercially reasonable efforts to cause the Trustee to
(A) pay as and when due all amounts payable to stockholders of ERES holding shares of the ERES Common Stock sold in the ERES IPO who must have previously validly elected to redeem their shares of ERES Common Stock pursuant to ERESs
organizational documents, |
210
|
and (B) immediately thereafter, pay all remaining amounts then available in the Trust Account in accordance with the Merger Agreement and the Trust Agreement and (b) thereafter, the
Trust Account will terminate, except as otherwise provided therein. |
|
|
|
ERES agreed to cause the surviving company to ensure that all rights to indemnification existing at the time the
Merger Agreement was signed in favor of any director or officer of the Companies or its subsidiaries will surviving for not less than six years from the Effective Time, and ERES and the surviving company will not settle, compromise or consent to the
entry of judgment in any action, proceeding or investigation without the written consent of such indemnified person. |
|
|
|
As promptly as practicable following the execution and delivery of the Merger Agreement and the availability of
the Companies financial statements, ERES agreed to prepare and file with the SEC this proxy statement in connection with the transactions contemplated by the Merger Agreement and provide its stockholders with the opportunity for up to
2,856,047 shares of ERES Common Stock to be redeemed in conjunction with a stockholder vote on the transactions contemplated by the Merger Agreement, with this proxy statement to be sent to the stockholders of ERES relating to the Special Meeting in
definitive form, all in accordance with and as required by ERESs organizational documents, any related agreements with ERES, the Sponsor and its affiliates, applicable law and any applicable rules and regulations of the SEC and Nasdaq. As
promptly as practicable following the execution and delivery of the Merger Agreement, ERES agreed to prepare and file with the SEC the registration statement of which this proxy statement forms a part, pursuant to which the offering of shares of
ERES Common Stock to be issued to the Company Members pursuant to the Mergers will be registered under the Securities Act. |
|
|
|
ERES will, as promptly as practicable, establish a record date and hold a meeting of stockholders for the purpose
of voting on the Proposals. ERES will, through its board of directors, recommend to its stockholders that they vote in favor of the Proposals, and will not change, withdraw, withhold, qualify or modify such recommendation except as required by
applicable law. |
|
|
|
ERES will use its reasonable best efforts to (i) cause the shares of ERES Common Stock to be issued to the
Company Members to be approved for listing on Nasdaq upon issuance and (ii) make all necessary and appropriate filings with Nasdaq and undertake all other steps reasonably required prior to the Closing to effect such listing.
|
|
|
|
ERES will make all necessary filings with respect to the transactions contemplated by the Merger Agreement under
the Securities Act, the Exchange Act and applicable blue sky laws and any rules and regulations thereunder. |
|
|
|
Prior to the Closing, the board of directors of ERES, or an appropriate committee of non-employee directors thereof, will adopt a resolution consistent with the interpretive guidance of the SEC so that the acquisition of ERES Common Stock pursuant to the Merger Agreement by any officer or director
of ERES who is expected to become a covered person of ERES for purposes of Section 16 of the Exchange Act and the rules and regulations thereunder will be an exempt transaction for purposes of Section 16 of the Exchange Act.
|
|
|
|
From the date of the Merger Agreement until the earlier of (x) the Effective Time or (y) the date on
which the Merger Agreement is terminated, other than in connection with the transaction contemplated by the Merger Agreement, ERES agreed that it will not, and will not authorize or (to the extent within its control) permit any of its affiliates,
directors, officers, employees, agents or representatives (including investment bankers, attorneys and accountants), in each case in such directors, officers, employees, agents or representatives capacity in such role
with ERES, to, directly or indirectly, (i) knowingly encourage, initiate, solicit, or facilitate, offer, or make any offers or proposals related to, an alternate business combination, (ii) engage in any discussions or negotiations with
respect to an alternate business combination with, or provide any non-public information or data to, any Person that has made, or informs ERES that it is considering making, an alternate business combination
proposal, |
211
|
or (iii) enter into any agreement (whether or not binding) relating to an alternate business combination. ERES must give notice of any alternate business combination to the Companies as soon
as practicable following its awareness of such proposal. |
|
|
|
From and after the Closing, except as otherwise required by applicable law, each Parent Party will not, and will
cause the Post-Combination Company and its subsidiaries not to, make, cause or permit to be made any tax election or adopt or change any method of accounting, in each case that has retroactive effect to any
pre-Closing period of the Companies or any of their subsidiaries. |
|
|
|
The board of directors of ERES will approve and adopt the Omnibus Incentive Plan (as defined in the Merger
Agreement) effective prior to the Closing. |
|
|
|
During the period from the date of the Merger Agreement through the earlier of (x) termination of the Merger
Agreement and (y) the Closing, ERES agrees to provide the Companies notice of (a) any claim, suit, action, or proceeding brought or threatened against any Parent Party or the Sponsor relating to the Merger Agreement, Ancillary Agreements
(as defined in the Merger Agreement), transactions contemplated by the Business Combination or the Special Meeting within two business days of first becoming aware and (b) any proxy contest relating to the Special Meeting.
|
Covenants of the Companies
The Companies made certain covenants under the Merger Agreement, including, among other things, the following:
|
|
|
During the period from the date of the Merger Agreement through the earlier of (x) termination of the Merger
Agreement and (y) the Closing, except as contemplated by the Merger Agreement, required by applicable law (including COVID-19 measures), described in the Companies disclosure schedules or consented
to by ERES, the Companies will operate its business in the ordinary course and will not (subject to certain customary materiality thresholds): make any change to their organizational documents (other than in accordance with the Merger Agreement);
issue equity capital; split, combine, redeem or reclassify its membership interests; sell, lease, license, permit to lapse, transfer, abandon or otherwise dispose of any of their properties or assets that are material to its business; amend in any
adverse respect or terminate any material lease; incur indebtedness; make certain employee benefit grants or adopt any new employee benefit plans; make certain material tax elections; cancel or forgive indebtedness; except as required by law, make
any material change in financial or tax accounting methods; make certain changes with respect to collective bargaining arrangements; implement certain workforce reduction methods; take affirmative steps to waive or release any noncompetition,
nondisclosure, noninterference, nondisparagement or other restrictive covenant obligation of certain current or former employees and contractors; incur certain liens; pay any dividends or make distributions above a certain amount; make any material
change to any cash management practices; compromise certain lawsuits; incur non-ordinary course capital expenditures; acquire certain other business or properties; enter into any new line of business; adopt a
plan of complete or partial liquidation, dissolution, restructuring, recapitalization or other reorganization; fail to use commercially reasonable efforts to maintain existing insurance policies or comparable replacements; amend or modify certain
licenses; take any action that is reasonably likely to prevent, delay or impede the consummation of the Business Combination; or authorize or commit or agree to take any of the foregoing actions. |
|
|
|
From the date of the Merger Agreement until the earlier of (x) the Effective Time or (y) the date on
which the Merger Agreement is terminated, other than in connection with the transaction contemplated by the Merger Agreement, the Companies agreed that they will not, and will not authorize or (to the extent within their control) permit any Company
subsidiary or any of their or any Company subsidiarys affiliates, directors, officers, employees, agents or representatives (including investment bankers, attorneys and accountants), in each case in such directors, officers,
employees, agents or |
212
|
representatives capacity in such role with the Companies, to, directly or indirectly, (i) knowingly encourage, initiate, solicit, or facilitate, offer, or make any offers or proposals
related to, an acquisition proposal, (ii) engage in any discussions or negotiations with respect to an acquisition proposal with, or provide any non-public information or data to, any person that has
made, or informs the Companies that it is considering making, an acquisition proposal, or (iii) enter into any agreement (whether or not binding) relating to an acquisition proposal. The Companies must give notice of any acquisition proposal to
ERES as soon as practicable, but in any event no later than two business days, following their awareness of such proposal. |
|
|
|
From the date of the Merger Agreement through its termination or consummation, the Companies will grant ERES
access to its employees and facilities. |
|
|
|
The Companies will take all actions necessary to terminate certain related party agreements in a manner such that
the surviving company has no liability or obligation following the Effective Time. |
|
|
|
The Companies will obtain the irrevocable approval and adoption of the Merger Agreement from the holders of a
majority of the Company Interests within one business day from the date of the Merger Agreement. |
|
|
|
The Companies will use best efforts to provide ERES, as promptly as practicable, audited financial statements
(audited to the standards of the U.S. Public Company Accounting Oversight Board), including consolidated balance sheets, statements of operations, statements of cash flows and statements of stockholders equity of the Companies as of and
for the years ended December 31, 2021 and 2020, in each case prepared in accordance with GAAP. |
|
|
|
The Companies will convert from Florida limited liability companies to Delaware limited liability companies at
least five business days prior to the Closing. |
Mutual Covenants
The Parties made certain mutual covenants under the Merger Agreement, including, among other things, the following:
|
|
|
Each of the Parties will cooperate and use their commercially reasonable efforts to take, or cause to be taken,
all action, and to do, or cause to be done, all things necessary, proper or advisable under applicable Laws to consummate the transactions contemplated by the Merger Agreement reasonably promptly after the date thereof, including obtaining all
licenses, permits, consents, approvals, authorizations, qualifications and orders of governmental entities necessary to consummate the transactions contemplated by the Merger Agreement. ERES will pay the applicable filing fees due under the HSR Act.
|
|
|
|
The Parties agreed not to make any public announcement without the other partys consent, except as required
by applicable law. |
|
|
|
At the Closing, ERES, the Companies and the Company Members will enter into a Registration Rights Agreement.
|
Termination
The
Merger Agreement may be terminated and the Business Combination abandoned at any time prior to the Closing, as follows:
|
|
|
in writing, by mutual consent of the Parties; |
|
|
|
by ERES or the Companies if any law or order permanently restraining, enjoining or otherwise prohibiting the
consummation of the Merger has been enacted and has become final and non-appealable, except that a party may not terminate the Merger Agreement for this reason if it has breached in any material respect its
obligations set forth in the Merger Agreement in any manner than has proximately contributed to the enactment, issuance, promulgation or entry into such law or order; |
213
|
|
|
by the Companies (if not in breach such that a closing condition cannot be satisfied) if any representation or
warranty is not true and correct or if ERES has failed to perform any covenant or agreement made by any Parent Party in the Merger Agreement, such that the conditions to the obligations of ERES, as described in the section entitled
Conditions to Closing of the Business Combination above, could not be satisfied as of the Closing, and (i) are or cannot be cured within thirty days after written notice from the Companies of such breach is received by
the Parent Parties or (ii) which breach, untruth or inaccuracy, by its nature, cannot be cured prior to the Outside Date; |
|
|
|
by ERES (if not in breach such that a closing condition cannot be satisfied) if any representation or warranty is
not true and correct or if the Companies have failed to perform any covenant or agreement made by the in the Merger Agreement, such that the conditions to the obligations of the Companies, as described in the section entitled
Conditions to Closing of the Business Combination above, could not be satisfied as of the Closing, and (i) are or cannot be cured within thirty days after written notice from ERES of such breach is received by the
Parent Parties or (ii) which breach, untruth or inaccuracy, by its nature, cannot be cured prior to the Outside Date; |
|
|
|
by written notice by any Party if the Closing has not occurred on or prior to January 27, 2023 so long as
such Party is not then in breach of the Merger Agreement in a manner that contributed to the occurrence of the failure of a condition; |
|
|
|
by the Companies if ERESs board of directors changes its recommendation in favor of the Business
Combination; |
|
|
|
by ERES if the required approvals of the Companies have not been obtained or if the required approvals are
revoked, modified or no longer in full force and effect; or |
|
|
|
by ERES or the Companies if the approval of the Proposals is not obtained at the Special Meeting (including any
adjournments of such meeting). |
Amendments
The Merger Agreement may be amended, modified or supplemented at any time only by written agreement of the Parties.
214
OTHER AGREEMENTS
Sponsor Support Agreement
In connection
with the execution of the Merger Agreement, the Sponsor entered into the Sponsor Support Agreement with ERES and the Companies, pursuant to which the Sponsor agreed to, among other things, (i) vote at the Special Meeting any Class A Common
Stock or Class B Common Stock (collectively, the Sponsor Securities), held of record or thereafter acquired in favor of the Proposals, (ii) be bound by certain other covenants and agreements related to the Merger and
(iii) be bound by certain transfer restrictions with respect to the Sponsor Securities, in each case, on the terms and subject to the conditions set forth in the Sponsor Support Agreement. The Sponsor Support Agreement also provides that the
Sponsor has agreed to waive redemption rights in connection with the consummation of the Business Combination with respect to any Sponsor Securities they may hold.
The Sponsor has also agreed, subject to certain exceptions, not to transfer (i) 15% of the shares of the Post-Combination Companys
common stock received by the Sponsor in connection with the Closing until the date that is 180 days after the Closing and (ii) the remaining 85% of the shares of the Post-Combination Companys common stock received by the Sponsor in
connection with the Closing until the date that is 24 months after the Closing.
The Sponsor, the Companies and ERES have also agreed,
subject to certain exceptions, not to transfer any Private Placement Warrants (or any share of ERES Common Stock issued or issuable upon the exercise of the Private Placement Warrants), until 30 days after the closing date of the Business
Combination.
The Sponsor Support Agreement will terminate on the earlier of (i) the termination of the Merger Agreement in
accordance with its terms or (ii) the date that is 24 months from the Closing Date.
Company Support Agreement
In connection with the execution of the Merger Agreement, ERES, the Companies and the Company Members entered into the Company Support
Agreement. The Company Support Agreement provides, among other things, each Company Member agreed to vote, at any meeting of the applicable Company and in any written action by consent of the members of the applicable Company, all of the Member
Interests (i) in favor of the transactions and the adoption of the Merger Agreement and (ii) against certain measures and any other action that would reasonably be expected to interfere with the Mergers, subject to the terms and conditions
set forth in the Company Support Agreement. Each Company Member also agrees to be bound by certain other covenants and agreements related to the Mergers and be bound by certain transfer restrictions with respect to Member Interests, in each case, on
the terms and subject to the conditions set forth in the Company Support Agreement. The Member Interests owned by the Company Members and subject to the Company Support Agreement represent approximately all of the outstanding limited liability
company interests of the Companies. The execution and delivery of written consents by the Company Members will constitute the required company approvals at the time of such delivery. Additionally, the Company Members have agreed to waive any
appraisal rights (including under Section 262 of the DGCL) with respect to the Merger and any rights to dissent with respect to the Merger.
Registration Rights Agreement
The
Merger Agreement contemplates that, at the Closing, ERES, certain stockholders of ERES and certain Company Members (the Holders) will enter into an Amended and Restated Registration Rights Agreement, pursuant to which ERES will agree to
register for resale, pursuant to Rule 415 under the Securities Act, certain shares of ERES Class A Common Stock and other equity securities of ERES that are held by the parties thereto from time to time. Pursuant to the Registration Rights
Agreement, ERES
215
agreed to file a shelf registration statement registering the resale of the Class A Common Stock (including those held as of the effective time or issuable upon future exercise of the
Private Placement Warrants) and the Private Placement Warrants (the Registrable Securities) under the Registration Rights Agreement within 30 days of the closing of the Business Combination. The Holders may request to sell all or any
portion of their Registrable Securities in an underwritten offering (the Underwritten Shelf Takedown) so long as the total offering price is reasonably expected to exceed $20,000,000. The Sponsor may not demand more than two Underwritten
Shelf Takedowns, the Holders (other than the Sponsor) may not demand more than two Underwritten Shelf Takedowns and the Company shall not be obligated to participate in more than four Underwritten Shelf Takedowns, in the aggregate, in any 12-month period. ERES also agreed to provide customary piggyback registration rights, subject to certain requirements and customary conditions. The Registration Rights Agreement also provides that ERES
will pay certain expenses relating to such registrations and indemnify the stockholders against certain liabilities.
Proposed Charter
Pursuant to the terms of the Merger Agreement, in connection with the consummation of the Business Combination, ERES will amend the Existing
Charter to (a) change the number of authorized shares of ERESs capital stock, par value $0.0001 per share, from 221,000,000 shares, consisting of (i) 200,000,000 shares of the Class A Common Stock and 20,000,000 shares of the
Class B Common Stock and (ii) 1,000,000 shares of preferred stock, to 201,000,000 shares, consisting of (i) 200,000,000 shares of common stock and (ii) 1,000,000 shares of preferred stock, (b) eliminate certain provisions in our Existing
Charter relating to the Class B Common Stock, the initial business combination and other matters relating to ERESs status as a blank-check company that will no longer be applicable to us following
the Closing and (c) approve and adopt any other changes contained in the Proposed Charter, a copy of which is attached as Annex B to this proxy statement. In addition, we will amend our Existing Charter to change the name of the
corporation to Abacus Life, Inc. For more information, see the section entitled Proposal No. 2The Charter Approval Proposal.
216
MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES
The following discussion does not purport to be a complete analysis or discussion of all potential tax effects relevant to the Business
Combination. Stockholders are advised to consult with their own personal tax advisor concerning the specific U.S. federal, state, local and non-U.S. income and other tax consequences of the Business
Combination and related transactions applicable to them.
Material U.S. Federal Income Tax Consequences of the Redemption of Public Shares
The following discussion is a summary of certain material U.S. federal income tax consequences for holders of shares of ERES Class A
Common Stock that elect to have their ERES Class A Common Stock redeemed for cash if the Business Combination is completed. This discussion applies only to holders of ERES Class A Common Stock that hold such common stock as a capital
asset within the meaning of Section 1221 of the Code (generally, property held for investment). This discussion does not address all U.S. federal income tax consequences relevant to a holders particular circumstances, including the
alternative minimum tax and the Medicare contribution tax on net investment income. In addition, it does not address consequences relevant to holders subject to special rules, including, without limitation:
|
|
|
U.S. expatriates and former citizens or long-term residents of the United States; |
|
|
|
U.S. Holders whose functional currency is not the U.S. dollar; |
|
|
|
persons holding ERES Class A Common Stock as part of a hedge, straddle, or other risk reduction strategy or
as part of a conversion transaction or other integrated investment; |
|
|
|
banks, insurance companies and other financial institutions; |
|
|
|
real estate investment trusts or regulated investment companies; |
|
|
|
brokers, dealers, or traders in securities; |
|
|
|
controlled foreign corporations, passive foreign investment companies, and corporations
that accumulate earnings to avoid U.S. federal income tax; |
|
|
|
partnerships or other entities or arrangements treated as partnerships for U.S. federal income tax purposes (and
investors therein); |
|
|
|
tax-exempt organizations or governmental organizations;
|
|
|
|
persons deemed to sell our Class A Common Stock under the constructive sale provisions of the Code;
|
|
|
|
persons owning (actually or constructively) 5% or more of our voting shares; |
|
|
|
persons owning (actually or constructively) any LMA or Abacus securities; |
|
|
|
the Sponsor and persons related to the Sponsor; |
|
|
|
persons holding Founder Shares or forward-purchase securities; |
|
|
|
tax-qualified retirement plans; and |
|
|
|
qualified foreign pension funds as defined in Section 897(l)(2) of the Code and entities all of
the interests of which are held by qualified foreign pension funds. |
If an entity or arrangement treated as a
partnership for U.S. federal income tax purposes holds ERES Class A Common Stock, the U.S. federal income tax treatment of a partner in the partnership will generally depend on the status of the partner, the activities of the partnership and
certain determinations made at the partner level. Accordingly, partnerships holding ERES Class A Common Stock and partners in such partnership should consult their own tax advisors about the consequences of the matters discussed below.
217
This discussion is based on the Code, administrative pronouncements, judicial decisions and
final, temporary and proposed Treasury Regulations as of the date hereof, which are subject to change, possibly on a retroactive basis, and changes to any of which subsequent to the date of this proxy statement may affect the tax consequences
described herein. This discussion does not address any aspect of state, local or non-U.S. taxation, or any U.S. federal taxes other than income taxes (such as gift and estate taxes).
We have not sought, and will not seek, a ruling from the IRS as to any U.S. federal income tax consequences described herein. There can be no
assurance that the IRS or a court will not take a contrary position with the discussion herein. Moreover, there can be no assurance that future legislation, regulations, administrative rulings or court decisions will not adversely affect the
accuracy of the statements in this discussion.
THIS DISCUSSION IS FOR INFORMATIONAL PURPOSES ONLY AND IS NOT TAX ADVICE. HOLDERS
SHOULD CONSULT THEIR TAX ADVISORS WITH RESPECT TO THE APPLICATION OF U.S. FEDERAL INCOME TAX LAWS TO THEIR PARTICULAR SITUATION, AS WELL AS ANY TAX CONSEQUENCES ARISING UNDER THE U.S. FEDERAL ESTATE OR GIFT TAX LAWS OR THE LAWS OF ANY STATE, LOCAL
OR NON-U.S. JURISDICTION OR UNDER ANY APPLICABLE INCOME TAX TREATY.
U.S. Holders
For purposes of this discussion, the term U.S. Holder means a beneficial owner of ERES Class A Common Stock who or that is,
for U.S. federal income tax purposes:
|
|
|
an individual who is a citizen or resident of the United States; |
|
|
|
a corporation (or other entity taxable as a corporation) organized in or under the laws of the United States, any
state thereof or the District of Columbia; |
|
|
|
an estate, the income of which is subject to U.S. federal income tax regardless of its source; or
|
|
|
|
a trust that (i) is subject to the primary supervision of a U.S. court and the control of one or more
United States persons (within the meaning of Section 7701(a)(30) of the Code), or (ii) has a valid election in effect to be treated as a United States person for U.S. federal income tax purposes. |
In the event that a U.S. Holders ERES Class A Common Stock is redeemed pursuant to the redemption provisions described in this
proxy statement above under the section entitled ERESs Special Meeting of StockholdersRedemption Rights the treatment of the redemption for U.S. federal income tax purposes will depend on whether the redemption
qualifies as a sale of such holders ERES Class A Common Stock under Section 302 of the Code. If the redemption qualifies as a sale of ERES Class A Common Stock, the U.S. Holder will be treated as described under
Taxation of Redemption Treated as a Sale of ERES Class A Common Stock below. If the redemption does not qualify as a sale of ERES Class A Common Stock, the U.S. Holder will be treated as receiving a
corporate distribution with the tax consequences described below under Taxation of Redemption Treated as a Distribution. Whether a redemption qualifies for sale treatment will depend largely on the total number of shares of
our stock treated as held by the U.S. Holder relative to all of our shares outstanding both before and after the redemption. The redemption of ERES Class A Common Stock generally will be treated as a sale of ERES Class A Common Stock
(rather than as a corporate distribution) if the redemption (i) is substantially disproportionate with respect to the U.S. Holder, (ii) results in a complete termination of the U.S. Holders interest in us or
(iii) is not essentially equivalent to a dividend with respect to the U.S. Holder. These tests are explained more fully below.
In determining whether any of the foregoing tests are satisfied, a U.S. Holder takes into account not only stock actually owned by the U.S.
Holder, but also shares of our stock that are constructively owned by it. A U.S. Holder may constructively own, in addition to stock owned directly, stock owned by certain related individuals
218
and entities in which the U.S. Holder has an interest or that have an interest in such U.S. Holder, as well as any stock the U.S. Holder has a right to acquire by exercise of an option. In order
to meet the substantially disproportionate test, the percentage of our outstanding voting stock actually and constructively owned by the U.S. Holder immediately following the redemption of its ERES Class A Common Stock must, among other
requirements, be less than 80% of the percentage of our outstanding voting stock actually and constructively owned by the U.S. Holder immediately before the redemption. There will be a complete termination of a U.S. Holders interest if either
(i) all of the shares of our stock actually and constructively owned by the U.S. Holder are redeemed or (ii) all of the shares of our stock actually owned by the U.S. Holder are redeemed and the U.S. Holder is eligible to waive, and
effectively waives in accordance with specific rules, the attribution of stock owned by certain family members and the U.S. Holder does not constructively own any other shares of our stock. The redemption of ERES Class A Common Stock will not
be essentially equivalent to a dividend if the redemption results in a meaningful reduction of the U.S. Holders proportionate interest in us. Whether the redemption will result in a meaningful reduction in a U.S. Holders
proportionate interest in us will depend on the particular facts and circumstances. However, the IRS has indicated in a published ruling that even a small reduction in the proportionate interest of a small minority stockholder in a publicly held
corporation who exercises no control over corporate affairs may constitute such a meaningful reduction. The application of these tests generally also takes into account related transactions that occur contemporaneously with the
redemption, including any contemporaneous purchases of common stock by the relevant holder (or persons whose ownership is attributed to such holder) and issuances of common stock (including pursuant to any PIPE Investment (while ERES continues to
opportunistically seek to raise a PIPE investment, at this time, it has no committed PIPE Investment Amount)). A U.S. Holder should consult with its own tax advisors as to the tax consequences of a redemption.
If none of the foregoing tests is satisfied, then the redemption will be treated as a corporate distribution and the tax effects will be as
described under Taxation of Redemption Treated as a Distribution below. After the application of those rules, any remaining tax basis of the U.S. Holder in the redeemed ERES Class A Common Stock will be added to the
U.S. Holders adjusted tax basis in its remaining stock, or, if it has none, possibly to the U.S. Holders adjusted tax basis in other stock constructively owned by it.
Taxation of Redemption Treated as a Sale of ERES Class A Common Stock.
If the redemption of a U.S. Holders shares of ERES Class A Common Stock is treated as a sale, a U.S. Holder generally will recognize
capital gain or loss in an amount equal to the difference between the amount realized and the U.S. Holders adjusted tax basis in the ERES Class A Common Stock treated as sold. Any such capital gain or loss generally will be long-term
capital gain or loss if the U.S. Holders holding period for the ERES Class A Common Stock so disposed of exceeds one year. It is unclear, however, whether the redemption rights with respect to the ERES Class A Common Stock described
in this proxy statement may suspend the running of the applicable holding period for this purpose. If the running of the holding period for the ERES Class A Common Stock is suspended, then non-corporate
U.S. Holders may not be able to satisfy the one-year holding period requirement for long-term capital gain treatment, in which case any gain on a redemption of the shares would be subject to short-term capital
gain treatment and would be taxed at regular ordinary income tax rates. Long-term capital gains recognized by non-corporate U.S. Holders may be eligible to be taxed at reduced rates. The deductibility of
capital losses is subject to limitations.
Generally, the amount of gain or loss recognized by a U.S. Holder is an amount equal to the
difference between (i) the amount of cash received in the redemption and (ii) the U.S. Holders adjusted tax basis in its ERES Class A Common Stock so redeemed. A U.S. Holders adjusted tax basis in its ERES Class A
Common Stock generally will equal the U.S. Holders acquisition cost. Gain or loss is calculated separately with respect to each block of stock. A block of stock is stock of the same class acquired for the same price on the same day.
219
Taxation of Redemption Treated as a Distribution.
If the redemption of a U.S. Holders shares of ERES Class A Common Stock is treated as a distribution, such distribution generally
will constitute a dividend for U.S. federal income tax purposes to the extent paid from our current or accumulated earnings and profits, as determined under U.S. federal income tax principles.
Distributions in excess of current and accumulated earnings and profits will constitute a return of capital that will be applied against and
reduce (but not below zero) the U.S. Holders adjusted tax basis in its ERES Class A Common Stock. Any remaining excess will be treated as gain realized on the sale or other disposition of ERES Class A Common Stock and will be treated
as described under Taxation of Redemption Treated as a Sale of ERES Class A Common Stock above. Dividends received by a U.S. Holder that is a taxable corporation generally will qualify for the dividends
received deduction if the requisite holding period is satisfied. With certain exceptions (including, but not limited to, dividends treated as investment income for purposes of investment interest deduction limitations), and provided certain holding
period requirements are met, dividends received by a non-corporate U.S. Holder may constitute qualified dividends that will be subject to tax at the maximum tax rate accorded to long-term capital
gains. It is unclear whether the redemption rights with respect to the ERES Class A Common Stock described in this proxy statement may prevent a U.S. Holder from satisfying the applicable holding period requirements with respect to the
dividends received deduction or the preferential tax rate on qualified dividend income, as the case may be. If the holding period requirements are not satisfied, then a corporation may not be able to qualify for the dividends received deduction and
would have taxable income equal to the entire dividend amount, and non-corporate U.S. Holders may be subject to tax on such dividend at regular ordinary income tax rates instead of the preferential rate that
applies to qualified dividend income.
Information Reporting and Backup Withholding.
In general, information reporting requirements may apply to the proceeds of the redemption of the ERES Class A Common Stock, unless the
U.S. Holder is an exempt recipient. Backup withholding may apply to such payments if the U.S. Holder fails to provide a taxpayer identification number or a certification of exempt status or has been notified by the IRS that it is subject to backup
withholding (and such notification has not been withdrawn).
Backup withholding is not an additional tax. Any amounts withheld under the
backup withholding rules will be allowed as a refund or a credit against a U.S. Holders U.S. federal income tax liability provided the required information is timely furnished to the IRS.
Non-U.S. Holders
This section applies to you if you are a Non-U.S. Holder with respect to ERES Class A
Common Stock. For this purpose, a Non-U.S. Holder is a beneficial owner (other than an entity or arrangement classified as a partnership for U.S. federal income tax purposes) of our Class A
Common Stock that is not a U.S. Holder.
The characterization for U.S. federal income tax purposes of the redemption of a Non-U.S. Holders ERES Class A Common Stock pursuant to the redemption provisions described in this proxy statement under the section entitled ERESs Special Meeting of
StockholdersRedemption Rights generally will correspond to the U.S. federal income tax characterization of such a redemption of a U.S. Holders ERES Class A Common Stock, as described under U.S. Holders above,
and the consequences of the redemption to the Non-U.S. Holder will be as described below under Taxation of Redemption Treated as a Sale of ERES Class A Common Stock
and Taxation of Redemption Treated as a Distribution, as applicable. It is possible that because the applicable withholding agent may not be able to determine the proper characterization of a redemption of a Non-U.S. Holders ERES Class A Common Stock, the withholding agent might treat the redemption as a distribution subject to withholding tax, as discussed further below.
220
Taxation of Redemption Treated as a Sale of ERES Class A Common Stock.
If ERESs redemption of a Non-U.S. Holders shares of ERES Class A Common Stock is
treated as a sale, a Non-U.S. Holder generally will not be subject to U.S. federal income or withholding tax in respect of gain recognized in connection with such redemption, unless:
|
|
|
the gain is effectively connected with the conduct of a trade of business by the
Non-U.S. Holder within the United States (and, if required by an applicable income tax treaty, the Non-U.S. Holder maintains a permanent establishment in the United
States to which such gain is attributable); |
|
|
|
the Non-U.S. Holder is an individual who is present in the United States
for 183 days or more in the taxable year of the redemption and certain other conditions are met; or |
|
|
|
ERES is or has been a U.S. real property holding corporation for U.S. federal income tax purposes at
any time during the shorter of the five-year period ending on the date of disposition or the period that the Non-U.S. Holder held ERES Class A Common Stock, and, in the case where ERESs Class A
Common Stock is regularly traded on an established securities market, the Non-U.S. Holder has owned, directly or constructively, more than 5% of ERESs Class A Common Stock at any time within the
shorter of the five-year period preceding the disposition or such Non-U.S. Holders holding period for the ERES Class A Common Stock. There can be no assurance that ERES Class A Common Stock
will be treated as regularly traded on an established securities market for this purpose. |
Unless an applicable treaty
provides otherwise, gain described in the first bullet point above will be subject to tax at generally applicable U.S. federal income tax rates as if the Non-U.S. Holder were a U.S. resident. Any gains
described in the first bullet point above of a Non-U.S. Holder that is a corporation for U.S. federal income tax purposes may also be subject to an additional branch profits tax imposed at a 30%
rate (or lower applicable treaty rate). If the second bullet point above applies to a Non-U.S. Holder, such Non-U.S. Holder will be subject to U.S. tax on such Non-U.S. Holders net capital gain for such year (including any gain realized in connection with the redemption) at a tax rate of 15%.
If the third bullet point above applies to a Non-U.S. Holder, gain recognized by such holder in
connection with a redemption treated as a sale of ERES Class A Common Stock will be subject to tax at generally applicable U.S. federal income tax rates. In addition, we may be required to withhold U.S. federal income tax at a rate of 15% of
the amount realized upon such redemption. We do not believe we currently are or have been at any time since our formation a U.S. real property holding corporation and we do not expect to be a U.S. real property holding corporation immediately after
the business combination is completed. However, such determination is factual in nature, and no assurance can be provided that we will not be treated as a U.S. real property holding corporation in a future period.
Taxation of Redemption Treated as a Distribution.
If the redemption of a Non-U.S. Holders shares of ERES Class A Common Stock is treated as a
distribution, such a distribution, to the extent paid out of our current or accumulated earnings and profits (as determined under U.S. federal income tax principles), generally will constitute a dividend for U.S. federal income tax purposes and,
provided such dividend is not effectively connected with the Non-U.S. Holders conduct of a trade or business within the United States, the gross amount of the dividend will be subject to withholding tax
at a rate of 30%, unless such Non-U.S. Holder is eligible for a reduced rate of withholding tax under an applicable income tax treaty and provides proper certification of its eligibility for such reduced rate
(usually on an IRS Form W-8BEN or W-8BEN-E). Any distribution not constituting a dividend will be treated first as reducing (but
not below zero) the Non-U.S. Holders adjusted tax basis in its shares of ERES Class A Common Stock and, to the extent such distribution exceeds the Non-U.S.
Holders adjusted tax basis, as gain realized from the sale or other disposition of ERES Class A Common Stock, which will be treated as described under Taxation of Redemption Treated as a Sale of ERES
Class A Common Stock above.
The withholding tax generally does not apply to dividends paid to a Non-U.S. Holder who provides an IRS Form W-8ECI, certifying that the dividends are effectively connected with the Non-U.S.
Holders conduct of a
221
trade or business within the United States. Instead, the effectively connected dividends will be subject to regular U.S. federal income tax as if the
Non-U.S. Holder were a U.S. resident, subject to an applicable income tax treaty providing otherwise. A Non-U.S. Holder that is a corporation for U.S. federal income tax
purposes receiving effectively connected dividends may also be subject to an additional branch profits tax imposed at a rate of 30% (or a lower applicable treaty rate).
Because it may not be certain at the time a Non-U.S. Holder is redeemed whether such Non-U.S. Holders redemption will be treated as a sale or a corporate distribution, and because such determination will depend in part on a Non-U.S. Holders
particular circumstances, the applicable withholding agent may not be able to determine whether (or to what extent) a Non-U.S. Holder is treated as receiving a dividend for U.S. federal income tax purposes.
Therefore, the applicable withholding agent may withhold tax at a rate of 30% (or such lower rate as may be specified by an applicable income tax treaty) on the gross amount of any consideration paid to a
Non-U.S. Holder in redemption of such Non-U.S. Holders ERES Class A Common Stock, unless (i) the applicable withholding agent has established special
procedures allowing Non-U.S. Holders to certify that they are exempt from such withholding tax and (ii) such Non-U.S. Holders are able to certify that they meet the
requirements of such exemption (e.g., because such Non-U.S. Holders are not treated as receiving a dividend under the Section 302 tests described above). However, there can be no assurance that any
applicable withholding agent will establish such special certification procedures. If an applicable withholding agent withholds excess amounts from the amount payable to a Non-U.S. Holder, such Non-U.S. Holder generally may obtain a refund of any such excess amounts by timely filing an appropriate claim for refund with the IRS. Non-U.S. Holders should consult their
own tax advisors regarding the application of the foregoing rules in light of their particular facts and circumstances and any applicable procedures or certification requirements.
Information Reporting and Backup Withholding.
Information returns will be filed with the IRS in connection with the proceeds from a redemption of ERES Class A Common Stock. A Non-U.S. Holder may have to comply with certification procedures to establish that it is not a United States person in order to avoid information reporting and backup withholding requirements. The certification
procedures required to claim a reduced rate of withholding under a treaty generally will satisfy the certification requirements necessary to avoid the backup withholding as well.
Backup withholding is not an additional tax. The amount of any backup withholding from a payment to a
Non-U.S. Holder will be allowed as a credit against such holders U.S. federal income tax liability and may entitle such holder to a refund, provided that the required information is timely furnished to
the IRS.
Foreign Account Tax Compliance Act Withholding Taxes
Sections 1471 through 1474 of the Code and the Treasury regulations and administrative guidance promulgated thereunder (commonly referred to as
the Foreign Account Tax Compliance Act or FATCA), impose withholding of 30% on payments of dividends on the ERES Class A Common Stock to foreign financial institutions (which is broadly defined for this
purpose and in general includes investment vehicles) and certain other non-U.S. entities unless various U.S. information reporting and due diligence requirements (generally relating to ownership by U.S.
persons of interests in or accounts with those entities) have been satisfied by, or an exemption applies to, the payee (typically certified by the delivery of a properly completed IRS Form W-8BEN-E). The IRS has issued proposed regulations (on which taxpayers may rely until final regulations are issued) that would generally not apply these withholding requirements to gross proceeds from sales
or other disposition proceeds from the ERES Class A Common Stock. Foreign financial institutions located in jurisdictions that have an intergovernmental agreement with the United States governing FATCA may be subject to different rules. Under
certain circumstances, a Non-U.S. Holder might be eligible for refunds or credits of such withholding taxes, and a Non-U.S. Holder might be required to file a U.S.
federal income tax return to claim such refunds or credits. Holders should consult their tax advisors regarding the effects of FATCA on the redemption of their ERES Class A Common Stock.
222
THE INFORMATION PROVIDED ABOVE IS NOT TAX ADVICE. HOLDERS ARE URGED TO CONSULT THEIR TAX
ADVISORS WITH RESPECT TO THE APPLICATION OF U.S. FEDERAL INCOME TAX LAWS TO THEIR PARTICULAR SITUATION, AS WELL AS ANY TAX CONSEQUENCES ARISING UNDER THE U.S. FEDERAL ESTATE OR GIFT TAX LAWS OR THE LAWS OF ANY STATE, LOCAL OR NON-U.S. JURISDICTION OR UNDER ANY APPLICABLE INCOME TAX TREATY.
223
DESCRIPTION OF SECURITIES OF THE
POST-COMBINATION COMPANY
In connection with the Business Combination, the Post-Combination Company will amend and restate its charter and bylaws. The following is a description of the material terms of, and is qualified in its entirety by, the Proposed Charter and the Amended and Restated
Bylaws, each of which will be in effect upon the consummation of the Business Combination, the forms of which are attached as Annex B and Annex C to this proxy statement, respectively.
The Post-Combination Companys purpose is to engage in any lawful act or activity for which
corporations may now or hereafter be organized under the DGCL. Upon the consummation of the Business Combination, the Post-Combination Companys authorized capital stock will consist of 200,000,000 shares
of common stock, par value $0.0001 per share, and 1,000,000 shares of preferred stock, par value $0.0001 per share. No shares of preferred stock will be issued or outstanding immediately after the Business Combination. Unless the Post-Combination Companys board of directors determines otherwise, the Post-Combination Company will issue all shares of its capital stock in uncertificated form.
Common Stock
Holders of shares of Post-Combination Company common stock will be entitled to one vote for each share held of record on all matters submitted to a vote of stockholders. The holders of Post-Combination Company common stock will not have
cumulative voting rights in the election of directors.
Upon the Post-Combination Companys
liquidation, dissolution or winding up and after payment in full of all debts and other liabilities of the Post-Combination Company and to any future holders of preferred stock having liquidation preferences, if any, the holders of common stock will
be entitled to receive pro rata the Post-Combination Companys remaining assets available for distribution. Holders of Post-Combination Company common stock do not
have preemptive, subscription, redemption or conversion rights. There will be no redemption or sinking fund provisions applicable to the common stock. All shares of Post-Combination Company common stock that
will be outstanding at the time of the completion of the Business Combination will be fully paid and non-assessable. The rights, powers, preferences and privileges of holders of Post-Combination Company common
stock will be subject to those of the holders of any shares of Post-Combination Company preferred stock that the board of directors may authorize and issue in the future.
As of April 21, 2023, ERES had 2,685,047 shares of Class A Common Stock and 8,625,000 shares of Class B Common Stock issued and
outstanding, including one holder of record of Class A Common Stock and two holders of record of Class B Common Stock. After giving effect to the Business Combination, we expect the Post-Combination
Company will have approximately 64,656,047 shares of common stock outstanding, consisting of (i) 53,175,000 shares issued to the Company Members (assuming no Cash Consideration is elected by the Company Members), (ii) 2,856,047 shares held
by ERESs Public Stockholders (assuming no redemptions by such Public Stockholders), (iii) 8,615,000 Class B Common Stock shares held by the Sponsor and (iv) 10,000 Class B Common Stock shares held by Mr. Thomas W.
Corbett, Jr., one of ERESs independent director nominees, who was transferred the shares by the Sponsor in July 2020.
Preferred Stock
Upon the consummation of the Business Combination and pursuant to the Proposed Charter that will become effective at or the
consummation of the Business Combination, the total of the Post-Combination Company authorized shares of preferred stock will be 1,000,000 shares. Upon the consummation of the Business Combination, no
shares of preferred stock will be issued or outstanding.
Under the terms of the Proposed Charter, the
Post-Combination Companys board of directors is authorized to issue shares of preferred stock in one or more series without stockholder approval. The board of directors has the discretion to determine
the rights, designations, powers, preferences, privileges, including voting rights, and qualifications, limitations or restrictions of each series of preferred stock.
224
The purpose of authorizing the Post-Combination
Companys board of directors to issue preferred stock and determine its rights and preferences is to eliminate delays associated with a stockholder vote on specific issuances. The issuance of preferred stock, while providing flexibility in
connection with possible acquisitions, future financings and other corporate purposes, could have the effect of making it more difficult for a third party to acquire, or could discourage a third party from seeking to acquire, a majority of the
outstanding voting stock. Additionally, the issuance of preferred stock may adversely affect the holders of common stock by restricting dividends on the common stock, diluting the voting power of the common stock or subordinating the liquidation
rights of the common stock. As a result of these or other factors, the issuance of preferred stock could have an adverse impact on the market price of the common stock.
Dividends
Declaration and payment of any
dividend will be subject to the discretion of the Post-Combination Companys board of directors. The time and amount of dividends will be dependent upon, among other things, the Post-Combination Companys business prospects, results of operations, financial condition, cash requirements and availability, debt repayment obligations, capital expenditure needs, contractual restrictions,
covenants in the agreements governing current and future indebtedness, industry trends, the provisions of Delaware law affecting the payment of dividends and distributions to stockholders and any other factors or considerations the Post-Combination Companys board of directors may regard as relevant.
The Post-Combination Company currently intends to retain all available funds and any future earnings to fund the development and growth of the business, and therefore does not anticipate declaring or paying any cash
dividends on common stock in the foreseeable future.
Anti-Takeover Provisions
The Proposed Charter and the Amended and Restated Bylaws will contain provisions that may delay, defer or discourage another party from
acquiring control of the Post-Combination Company. We expect that these provisions, which are summarized below, will discourage coercive takeover practices or inadequate takeover bids. These provisions are also designed to encourage persons seeking
to acquire control of the Post-Combination Company to first negotiate with the Post-Combination Companys board of directors, which may result in an improvement of the terms of any such acquisition in
favor of the stockholders. However, they also give the Post-Combination Companys board of directors the power to discourage acquisitions that some stockholders may favor.
Authorized but Unissued Shares
The authorized but unissued shares of Post-Combination Company common stock and preferred stock are
available for future issuance without stockholder approval, subject to any limitations imposed by the listing standards of Nasdaq. These additional shares may be used for a variety of corporate finance transactions, acquisitions and employee benefit
plans. The existence of authorized but unissued and unreserved Post-Combination Company common stock and preferred stock could make more difficult or discourage an attempt to obtain control of the Post-Combination Company by means of a proxy
contest, tender offer, merger or otherwise.
Classified Board of Directors
The Proposed Charter provides that the Post-Combination Companys board of directors will be
divided into three classes of directors, with the classes to be as nearly equal in number as possible, and with each director serving a three-year term. As a result, approximately one-third of the Post-Combination Companys board of directors will be elected each year. The classification of directors will have the effect of making it more difficult
for stockholders to change the composition of the Post-Combination Companys board of directors.
225
Stockholder Action; Special Meetings of Stockholders
The Proposed Charter will provide that stockholders may not take action by written consent, but may only take action at annual or special
meetings of stockholders. As a result, a holder controlling a majority of Post-Combination Company capital stock would not be able to amend the Amended and Restated Bylaws or remove directors without holding a
meeting of stockholders called in accordance with the Proposed Charter and the Amended and Restated Bylaws. Further, the Proposed Charter will provide that only the Chairman of the Post-Combination
Companys board of directors, a majority of the board of directors or the Chief Executive Officer of the Post-Combination Company may call special meetings of stockholders, thus prohibiting a stockholder
from calling a special meeting. These provisions might delay the ability of stockholders to force consideration of a proposal or for stockholders controlling a majority of Post-Combination Company capital
stock to take any action, including the removal of directors.
Advance Notice Requirements for Stockholder Proposals and Director Nominations
In addition, the Amended and Restated Bylaws will establish an advance notice procedure for stockholder proposals to be
brought before an annual meeting or special meeting of stockholders. Generally, in order for any matter to be properly brought before a meeting, the matter must be (a) specified in a notice of meeting given by or at the direction of
the Post-Combination Companys board of directors, (b) otherwise properly brought before the meeting by the board of directors, or (c) otherwise properly brought before the meeting by any
stockholder present in person (x) who was a stockholder of record entitled to vote at such annual meeting on the date on which notice of the meeting was given pursuant to the Amended and Restated Bylaws and on the record date for the
determination of stockholders entitled vote at such meeting and (y) who complies with the notice procedures set forth in the Amended and Restated Bylaws, or properly makes such proposal in accordance with Rule
14a-8 under the Exchange Act and the rules and regulations thereunder and complies with requirements of such rules for inclusion of the proposal in the proxy statement for the annual meeting. Further, for
business to be properly brought before an annual meeting by a stockholder, the stockholder must provide timely notice thereof in proper written form to the secretary and the proposed business must be a proper matter for stockholder action. To be
timely, a stockholders notice must be received by the Secretary of Post-Combination Company at the executive offices of the Post-Combination Company not later than close of business on the 90th day nor earlier than the opening of business on
the 120th day before the one-year anniversary of the preceding years annual meeting; provided, however, that if the date of the annual meeting is more than 30 days before or more than 60 days
after such anniversary date, notice by the stockholder to be timely must be so delivered not earlier than close of business on the 120th day before the annual meeting or, if later, not later than the later of (x) the close of business on the
90th day before the meeting and (y) the close of business on the 10th day following the day on which public announcement of the date of the annual meeting was first made.
Stockholders at an annual meeting or special meeting may only consider proposals or nominations properly brought before such
meeting by the Post-Combination Companys board of directors or stockholders pursuant to the requirements described above. These provisions could have the effect of delaying stockholder actions that are favored by the holders of a majority of
the outstanding voting securities until the next stockholder meeting.
Amendment of Charter or Bylaws
Upon consummation of the Business Combination, the Amended and Restated Bylaws may be amended or repealed by the affirmative vote of (a) a
majority of the Post-Combination Companys board of directors or (b) holders of a majority of the voting power of all of the then-outstanding shares entitled
to vote generally in the election of directors, voting together as a single class; provided, however, that, amendment or repeal of Article VIII of the Amended and Restated Bylaws, regarding indemnification of officers, directors and other persons,
requires at least at least 66.7% of the voting power of all of the then outstanding shares.
226
Limitations on Liability and Indemnification of Officers and Directors
The Proposed Charter and Amended and Restated Bylaws will provide indemnification and advancement of expenses for the Post-Combination Companys directors and officers to the fullest extent permitted by the applicable law, subject to certain limited exceptions. The Post-Combination
Company has entered into, or will enter into, indemnification agreements with each of its directors and officers. In some cases, the provisions of those indemnification agreements may be broader than the specific indemnification provisions contained
under the applicable law. In addition, as permitted by the applicable law, the Proposed Charter will include provisions that eliminate the personal liability of directors for monetary damages resulting from breaches of certain fiduciary duties as a
director. The effect of this provision is to restrict the Post-Combination Companys rights and the rights of the Post-Combination Companys stockholders in
derivative suits to recover monetary damages against a director for breach of fiduciary duties as a director.
These provisions may be
held not to be enforceable for violations of the federal securities laws of the United States.
Transfer Restrictions
Pursuant to the Company Support Agreement and the Sponsor Support Agreement, (a) holders of shares of Class A Common Stock issued as
Aggregate Merger Consideration (the Company Holders) and (b) the Sponsor (together with the Company Holders, the Restricted Holders) will, in each case, be subject to certain restrictions on the transfer of (a) 15% of
the shares of ERES Class A Common Stock issued to the respective Restricted Holder in connection with the Closing until the date that is 180 days after the Closing Date and (b) 85% of the shares of ERES Class A Common Stock issued to
the respective Restricted Holder in connection with the Closing until the date that is 24 months after the Closing Date, in each case, subject to certain transfers permitted by the Company Support Agreement and the Sponsor Support Agreement, as
applicable.
Dissenters Rights of Appraisal and Payment
Under the DGCL, with certain exceptions, the Post-Combination Companys stockholders will have
appraisal rights in connection with a merger or consolidation of the Post-Combination Company. Pursuant to Section 262 of the DGCL, stockholders who properly demand and perfect appraisal rights in
connection with such merger or consolidation will have the right to receive payment of the fair value of their shares as determined by the Delaware Court of Chancery.
Stockholders Derivative Actions
Under the DGCL, any of the Post-Combination Companys stockholders may bring an action in the
companys name to procure a judgment in its favor, also known as a derivative action, provided that the stockholder bringing the action is a holder of the Post-Combination Companys shares at the
time of the transaction to which the action relates.
Forum Selection
The Proposed Charter will provide that unless the Post-Combination Company consents in writing to the selection of an alternative forum, the
Court of Chancery of the State of Delaware will, to the fullest extent permitted by applicable law, be the sole and exclusive forum for: (i) any derivative action brought by a stockholder on behalf of the
Post-Combination Company, (ii) any claim of breach of a fiduciary duty owed by any of the Post-Combination Companys directors, officers or employees,
(iii) any claim against the Post-Combination Company, its directors, officers or employees arising under its charter, bylaws or the DGCL or (iv) any claim against the
Post-Combination Company, directors, officers or employees governed by the internal affairs doctrine. The Proposed Charter designates the federal district courts of the United States of America as the
227
exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act. Notwithstanding the foregoing, the provisions of Article XII of the Proposed
Charter shall not apply to any suits brought to enforce any liability or duty created by the Exchange Act, as amended, or any other claim for which the federal courts of the United States have exclusive jurisdiction.
Transfer Agent and Registrar
The
transfer agent and registrar for the common stock is Continental Stock Transfer & Trust Company.
Trading Symbol and Market
We have applied to list the common stock on Nasdaq under the symbol ABL.
Warrants
Public Stockholders Warrants
Upon the Closing, each warrant will entitle the registered holder to purchase one share of
Post-Combination Company common stock at a price of $11.50 per share, subject to adjustment as discussed below, at any time commencing 30 days after the Closing. However, no warrants will be exercisable for
cash unless the Post-Combination Company has an effective and current registration statement covering the shares of Post-Combination Company common stock issuable upon
exercise of the warrants and a current prospectus relating to such shares of Post-Combination Company common stock. Notwithstanding the foregoing, if the
Post-Combination Company common stock is not listed on a national security exchange at the time of any exercise of a warrant such that the common stock satisfies the definition of covered security,
under Section 18(b)(1) of the Securities Act, the Post-Combination Company may, at its option, require holders of the public warrants who exercise their warrants to do so on a cashless basis in accordance with Section 3(a)(9)
of the Securities Act, and, in such case, the Post-Combination Company will not be required to file or maintain in effect a registration statement, but will be required to use its best efforts to register or qualify the shares under applicable blue
sky laws to the extent an exemption is not available. If that exemption or another exemption is not available, holders will not be able to exercise their warrants on a cashless basis. In the event of such cashless exercise, each holder would pay the
exercise price by surrendering the warrants for that number of shares of Post-Combination Company common stock equal to the quotient obtained by dividing (x) the product of the number of shares of Post-Combination Company common stock underlying the warrants, multiplied by the excess of the fair market value over the exercise price of the warrants and the fair market value (defined subsequently)
by (y) the fair market value. The fair market value means the average reported last sale price of the shares of Post-Combination Company common stock for the 10 trading days ending on the
third trading day prior to the date on which the notice of exercise is sent to the holders of warrants. The warrants will expire on the fifth anniversary of the Closing at 5:00 p.m., New York City time, or earlier upon redemption or liquidation.
After the warrants become exercisable, the Post-Combination Company may call the warrants for
redemption, in whole and not in part, as follows:
|
|
|
at a price of $0.01 per warrant; |
|
|
|
upon not less than 30 days prior written notice of redemption to each warrant holder;
|
|
|
|
if, and only if, the reported last sale price of the shares of
Post-Combination Company common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, reclassifications, recapitalizations and the like), for any 20 trading
days within a 30 trading day period commencing at any time after the warrants become exercisable and ending on the third business day prior to the notice of redemption to warrant holders; and |
|
|
|
if, and only if, there is a current registration statement in effect with respect to the shares of Post-Combination Company common stock underlying such warrants. |
228
Commencing 90 days after the warrants become exercisable, the
Post-Combination Company may redeem the outstanding warrants, in whole and not in part, as follows:
|
|
|
at a price equal to a number of shares of common stock to be determined by reference to the table below, based on
the redemption date and the fair market value of the common stock (as defined above) except as otherwise described below; |
|
|
|
upon not less than 30 days prior written notice of redemption to each warrant holder;
|
|
|
|
if, and only if, the last sale price of our common stock equals or exceeds $10.00 per share (as adjusted for
stock splits, stock dividends, reorganizations, reclassifications, recapitalizations and the like) on the trading day prior to the date on which the Post-Combination Company sends the notice of redemption to the warrant holders; and
|
|
|
|
if, and only if, there is a current registration statement in effect with respect to the shares of Post-Combination Company common stock underlying such warrants. |
ERES Class A Common
Stock has not traded at or above $18.00 per share. In both redemption scenarios, ERES has no obligation to notify holders of the warrants that they have become eligible for redemption. However, in the event that ERES decides to redeem the warrants,
ERES shall fix a redemption date and must send a notice of redemption by first class mail, postage prepaid, to the registered holders of the warrants to be redeemed not less than 30 days prior to that redemption date.
The numbers in the table below represent the redemption prices, or the number of shares of Class A Common Stock that a
warrant holder will receive upon redemption by the Post-Combination Company pursuant to the above redemption feature based on the fair market value of the common stock on the corresponding redemption date and the number of months that the
corresponding redemption date precedes the expiration date of the warrants, each as set forth in the table below.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redemption Date
(period to expiration of warrants) |
|
Fair Market Value of common stock |
|
|
$10.00 |
|
|
$11.00 |
|
|
$12.00 |
|
|
$13.00 |
|
|
$14.00 |
|
|
$15.00 |
|
|
$16.00 |
|
|
$17.00 |
|
|
$18.00 |
|
57 months |
|
|
0.257 |
|
|
|
0.277 |
|
|
|
0.294 |
|
|
|
0.310 |
|
|
|
0.324 |
|
|
|
0.337 |
|
|
|
0.348 |
|
|
|
0.358 |
|
|
|
0.365 |
|
54 months |
|
|
0.252 |
|
|
|
0.272 |
|
|
|
0.291 |
|
|
|
0.307 |
|
|
|
0.322 |
|
|
|
0.335 |
|
|
|
0.347 |
|
|
|
0.357 |
|
|
|
0.365 |
|
51 months |
|
|
0.246 |
|
|
|
0.268 |
|
|
|
0.287 |
|
|
|
0.304 |
|
|
|
0.320 |
|
|
|
0.333 |
|
|
|
0.346 |
|
|
|
0.357 |
|
|
|
0.365 |
|
48 months |
|
|
0.241 |
|
|
|
0.263 |
|
|
|
0.283 |
|
|
|
0.301 |
|
|
|
0.317 |
|
|
|
0.332 |
|
|
|
0.344 |
|
|
|
0.356 |
|
|
|
0.365 |
|
45 months |
|
|
0.235 |
|
|
|
0.258 |
|
|
|
0.279 |
|
|
|
0.298 |
|
|
|
0.315 |
|
|
|
0.330 |
|
|
|
0.343 |
|
|
|
0.356 |
|
|
|
0.365 |
|
42 months |
|
|
0.228 |
|
|
|
0.252 |
|
|
|
0.274 |
|
|
|
0.294 |
|
|
|
0.312 |
|
|
|
0.328 |
|
|
|
0.342 |
|
|
|
0.355 |
|
|
|
0.364 |
|
39 months |
|
|
0.221 |
|
|
|
0.246 |
|
|
|
0.269 |
|
|
|
0.290 |
|
|
|
0.309 |
|
|
|
0.325 |
|
|
|
0.340 |
|
|
|
0.354 |
|
|
|
0.364 |
|
36 months |
|
|
0.213 |
|
|
|
0.239 |
|
|
|
0.263 |
|
|
|
0.285 |
|
|
|
0.305 |
|
|
|
0.323 |
|
|
|
0.339 |
|
|
|
0.353 |
|
|
|
0.364 |
|
33 months |
|
|
0.205 |
|
|
|
0.232 |
|
|
|
0.257 |
|
|
|
0.280 |
|
|
|
0.301 |
|
|
|
0.320 |
|
|
|
0.337 |
|
|
|
0.352 |
|
|
|
0.364 |
|
30 months |
|
|
0.196 |
|
|
|
0.224 |
|
|
|
0.250 |
|
|
|
0.274 |
|
|
|
0.297 |
|
|
|
0.316 |
|
|
|
0.335 |
|
|
|
0.351 |
|
|
|
0.364 |
|
27 months |
|
|
0.185 |
|
|
|
0.214 |
|
|
|
0.242 |
|
|
|
0.268 |
|
|
|
0.291 |
|
|
|
0.313 |
|
|
|
0.332 |
|
|
|
0.350 |
|
|
|
0.364 |
|
24 months |
|
|
0.173 |
|
|
|
0.204 |
|
|
|
0.233 |
|
|
|
0.260 |
|
|
|
0.285 |
|
|
|
0.308 |
|
|
|
0.329 |
|
|
|
0.348 |
|
|
|
0.364 |
|
21 months |
|
|
0.161 |
|
|
|
0.193 |
|
|
|
0.223 |
|
|
|
0.252 |
|
|
|
0.279 |
|
|
|
0.304 |
|
|
|
0.326 |
|
|
|
0.347 |
|
|
|
0.364 |
|
18 months |
|
|
0.146 |
|
|
|
0.179 |
|
|
|
0.211 |
|
|
|
0.242 |
|
|
|
0.271 |
|
|
|
0.298 |
|
|
|
0.322 |
|
|
|
0.345 |
|
|
|
0.363 |
|
15 months |
|
|
0.130 |
|
|
|
0.164 |
|
|
|
0.197 |
|
|
|
0.230 |
|
|
|
0.262 |
|
|
|
0.291 |
|
|
|
0.317 |
|
|
|
0.342 |
|
|
|
0.363 |
|
12 months |
|
|
0.111 |
|
|
|
0.146 |
|
|
|
0.181 |
|
|
|
0.216 |
|
|
|
0.250 |
|
|
|
0.282 |
|
|
|
0.312 |
|
|
|
0.339 |
|
|
|
0.363 |
|
9 months |
|
|
0.090 |
|
|
|
0.125 |
|
|
|
0.162 |
|
|
|
0.199 |
|
|
|
0.237 |
|
|
|
0.272 |
|
|
|
0.305 |
|
|
|
0.336 |
|
|
|
0.362 |
|
6 months |
|
|
0.065 |
|
|
|
0.099 |
|
|
|
0.137 |
|
|
|
0.178 |
|
|
|
0.219 |
|
|
|
0.259 |
|
|
|
0.296 |
|
|
|
0.331 |
|
|
|
0.362 |
|
3 months |
|
|
0.034 |
|
|
|
0.065 |
|
|
|
0.104 |
|
|
|
0.150 |
|
|
|
0.197 |
|
|
|
0.243 |
|
|
|
0.286 |
|
|
|
0.326 |
|
|
|
0.361 |
|
0 months |
|
|
|
|
|
|
|
|
|
|
0.042 |
|
|
|
0.115 |
|
|
|
0.179 |
|
|
|
0.233 |
|
|
|
0.281 |
|
|
|
0.323 |
|
|
|
0.361 |
|
The exact fair market value and redemption date may not be set forth in the table above, in which case, if the
fair market value is between two values in the table or the redemption date is between two redemption dates in
229
the table, the number of shares of common stock to be issued for each warrant redeemed will be determined by a straight-line interpolation between the number of shares set forth for the higher
and lower fair market values and the earlier and later redemption dates, as applicable, based on a 365-day year. As reflected in the table above, the Post-Combination Company can redeem the warrants for no
consideration in the event that the warrants are out of the money (i.e., the trading price of our common stock is below the exercise price of the warrants) and about to expire.
The right to exercise will be forfeited unless the warrants are exercised prior to the redemption date specified in the notice of redemption.
On and after the redemption date, a record holder of a warrant will have no further rights except to receive the redemption price for such holders warrant, as calculated pursuant to the above, upon surrender of such warrant.
The redemption criteria for the Post-Combination Companys warrants have been established at a
price which is intended to provide warrant holders a reasonable premium to the initial exercise price and provide a sufficient differential between the then-prevailing share price and the warrant exercise
price so that if the share price declines as a result of the Post-Combination Companys redemption call, the redemption will not cause the share price to drop below the exercise price of the warrants.
If the Post-Combination Company calls the warrants for redemption as described above, the
Post-Combination Companys management will have the option to require all holders that wish to exercise warrants to do so on a cashless basis. In such event, each holder would pay the exercise
price by surrendering the warrants for that number of shares of Post-Combination Company common stock equal to the quotient obtained by dividing (x) the product of the number of shares of Post-Combination Company common stock underlying the warrants, multiplied by the excess of the fair market value (as defined above) over the exercise price of the warrants and by (y) the fair market value.
The warrants were issued in registered form under a warrant agreement between Continental Stock Transfer & Trust Company, as warrant
agent, and ERES. The warrant agreement provides that the terms of the warrants may be amended without the consent of any holder to cure any ambiguity, or cure, correct or supplement any defective provision of the warrant agreement or to add or
change any other provisions with respect to matters or questions arising under the warrant agreement as the parties to the warrant agreement may deem necessary or desirable and that the parties deem to not adversely affect the interest of the
registered holders of the warrants. The warrant agreement requires the approval, by written consent or vote, of the holders of at least 50% of the then outstanding public warrants in order to make any change that adversely affects the interests of
the registered holders; provided that if an amendment adversely affects the Private Placement Warrants in a different manner than the public warrants or vice versa, then the vote or written consent of the registered holders of 65% of the public
warrants and 65% of the Private Placement Warrants, voting as separate classes, is required.
The exercise price and number of shares of Post-Combination Company common stock issuable on exercise of the warrants may be adjusted in certain circumstances including in the event of a stock split, stock dividend, extraordinary dividend or the Post-Combination Companys recapitalization, reorganization, merger or consolidation. However, except as described below, the warrants will not be adjusted for issuances of shares of Post-Combination Company common stock at a price below their respective exercise prices.
In addition,
if the Post-Combination Company issues additional shares of common stock or equity-linked securities for capital raising purposes in connection with the Closing at a newly issued price of less than $9.20 per share of the Post-Combination
Company common stock (with such issue price or effective issue price to be determined in good faith by the Post-Combination Companys board of directors, and in the case of any such issuance to the Sponsor or its affiliates, without taking into
account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance), the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the newly issued price. The warrants may be
exercised upon surrender of the warrant certificate on or prior to the expiration date at the offices of the warrant agent, with the exercise form on
230
the reverse side of the warrant certificate completed and executed as indicated, accompanied by full payment of the exercise price and any and all applicable taxes due in connection with the
exercise of the warrant, by certified or official bank check payable to the Post-Combination Company, for the number of warrants being exercised. The warrant holders do not have the rights or privileges of holders of shares of Post-Combination Company common stock and any voting rights until they exercise their warrants and receive shares of Post-Combination Company common stock. After the issuance
of shares of Post-Combination Company common stock upon exercise of the warrants, each holder will be entitled to one vote for each share held of record on all matters to be voted on by stockholders.
Warrant holders may elect to be subject to a restriction on the exercise of their warrants such that an electing warrant holder would not be
able to exercise their warrants to the extent that, after giving effect to such exercise, such holder would beneficially own in excess of 9.8% of the shares of Post-Combination Company common stock
outstanding.
No fractional shares will be issued upon exercise of the warrants. If, upon exercise of the warrants, a holder would be
entitled to receive a fractional interest in a share, the number of shares of Post-Combination Company common stock to be issued to the warrant holder will be rounded up to the nearest whole number.
Subject to applicable law, any action, proceeding or claim against us or the Post-Combination Company arising out of or relating in any way to
the warrant agreement, including under the Securities Act, will be brought and enforced in the courts of the State of New York or the United States District Court for the Southern District of New York, and we irrevocably submit to such jurisdiction,
which jurisdiction will be the exclusive forum for any such action, proceeding or claim. This exclusive forum provision shall not apply to suits brought to enforce a duty or liability created by the Exchange Act, any other claim for which the
federal district courts of the United States of America are the sole and exclusive forum.
Private Placement Warrants
The Private Placement Warrants (including the Post-Combination Company common stock issuable upon
exercise of the Private Placement Warrants) will not be transferable, assignable or salable until 30 days after the Closing (except, among other limited exceptions, to the Post-Combination Companys
officers and directors and other persons or entities affiliated with the Sponsor). Except as described below, the Private Placement Warrants have terms and provisions that are identical to those of the public warrants, including as to exercise
price, exercisability and exercise period.
If holders of the Private Placement Warrants elect to exercise them on a cashless basis, they
would pay the exercise price by surrendering their warrants for that number of shares of Post-Combination Company common stock equal to the quotient obtained by dividing (x) the product of the number of
shares of Post-Combination Company common stock underlying the warrants multiplied by the difference between the exercise price of the warrants and the fair market value (defined subsequently) by
(y) the fair market value. The fair market value means the average reported closing price of the Post-Combination Company common stock for the 10 trading days ending on the third trading day
prior to the date on which the notice of warrant exercise is sent to the warrant agent.
Pursuant to the Sponsor Support Agreement, the
Sponsor has agreed to be subject to certain restrictions on transfer of the Private Placement Warrants (including the Post-Combination Company common stock issuable upon exercise of any of these warrants)
until the date that is 30 days after the Closing Date, except that, among other limited exceptions, transfers may be made to ERESs officers and directors and other persons or entities affiliated with the Sponsor.
231
CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS
Certain Relationships and Related Person TransactionsPost-Combination Company
Registration Rights Agreement
Following the closing of the Business Combination, ERES, certain stockholders of ERES and certain Company Members will enter into an Amended
and Restated Registration Rights Agreement, pursuant to which ERES will agree to register for resale, pursuant to Rule 415 under the Securities Act, certain shares of ERES Class A Common Stock and other equity securities of ERES that are held
by the parties thereto from time to time. Pursuant to the Registration Rights Agreement, ERES agreed to file a shelf registration statement registering the resale of the Class A Common Stock (including those held as of the effective time or
issuable upon future exercise of the Private Placement Warrants) and the Private Placement Warrants (the Registrable Securities) under the Registration Rights Agreement within 30 days of the closing of the Business Combination. The
Holders may request to sell all or any portion of their Registrable Securities in an underwritten offering (an Underwritten Shelf Takedown) so long as the total offering price is reasonably expected to exceed $20,000,000. The Sponsor may
not demand more than two Underwritten Shelf Takedowns, the Holders (other than the Sponsor) may not demand more than two Underwritten Shelf Takedowns and the Company shall not be obligated to participate in more than four Underwritten Shelf
Takedowns, in the aggregate, in any 12-month period. ERES also agreed to provide customary piggyback registration rights, subject to certain requirements and customary conditions. The Registration
Rights Agreement also provides that ERES will pay certain expenses relating to such registrations and indemnify the stockholders against certain liabilities.
Procedures with Respect to Review and Approval of Related Person Transactions
The board of directors of ERES and the Companies recognize the fact that transactions with related persons present a heightened risk of
conflicts of interests (or the perception thereof). Effective upon the consummation of the Business Combination, the Post-Combination Companys board of directors expects to adopt a written policy on
transactions with related persons that is in conformity with the requirements for issuers having publicly held common stock that is listed on Nasdaq. Under the policy, the Post-Combination Companys legal
team will be primarily responsible for developing and implementing processes and procedures to obtain information regarding related persons with respect to potential related person transactions and then determining, based on the facts and
circumstances, whether such potential related person transactions do, in fact, constitute related person transactions requiring compliance with the policy. If the legal team determines that a transaction or relationship is a related person
transaction requiring compliance with the policy, the Post-Combination Companys general counsel will be required to present to the audit committee all relevant facts and circumstances relating to the
related person transaction. The audit committee will be required to review the relevant facts and circumstances of each related person transaction, including if the transaction is on terms comparable to those that could be obtained in arms
length dealings with an unrelated third party and the extent of the related persons interest in the transaction, take into account the conflicts of interest and corporate opportunity provisions of the
Post-Combination Companys code of business conduct and ethics (which will also be put in place in connection with the Business Combination), and either approve or disapprove the related person
transaction. If advance audit committee approval of a related person transaction requiring the audit committees approval is not feasible, then the transaction may be preliminarily entered into by management upon prior approval of the
transaction by the chair of the audit committee, subject to ratification of the transaction by the audit committee at the audit committees next regularly scheduled meeting; provided, that if ratification is not forthcoming, management will
make all reasonable efforts to cancel or annul the transaction. If a transaction was not initially recognized as a related person transaction, then, upon such recognition, the transaction will be presented to the audit committee for ratification at
the audit committees next regularly scheduled meeting; provided, that if ratification is not forthcoming, management will make all reasonable efforts to cancel or annul the transaction. The
Post-Combination Companys management will update the audit committee as to any material changes to any approved or ratified related person transaction and will provide a status report at least annually
of all then current
232
related person transactions. No director will be permitted to participate in approval of a related person transaction for which he or she is a related person.
Certain Relationships and Related Person TransactionsThe Companies
As consideration of the Business Combination, the Company Members will receive aggregate consideration of approximately $531.8 million,
payable in newly issued shares of ERES Class A Common Stock at a price of $10.00 per share and, to the extent the Aggregate Transaction Proceeds exceed $200.0 million, at the election of the Company Members, up to $20.0 million of the
aggregate consideration will be payable in cash to the Company Members. The Company Members are party to that certain Registration Rights Agreement which provides the Company Members with the opportunity to require ERES to file a shelf registration
statement registering the resale of the common stock received in connection with the Business Combination.
Certain Relationships and Related Person
TransactionsERES
Founder Shares
On June 1, 2020, the Sponsor purchased 8,625,000 Founder Shares of ERES Class B Common Stock, for an aggregate price of
$25,000. The Founder Shares will automatically convert into Class A Common Stock on a one-for-one basis at the time of ERESs initial business combination
and are subject to certain transfer restrictions. The Founder Shares included up to an aggregate of 1,125,000 shares subject to forfeiture to the extent that the over-allotment option was not exercised in full or in part by the
underwriters so that the Founder Shares would represent 20% of the Companys issued and outstanding shares after the Initial Public Offering. In July 2020, the Sponsor transferred 10,000 Founder Shares to Thomas W. Corbett, Jr.,
one of our independent director nominees. As a result of the underwriters election to fully exercise their over-allotment option on August 25, 2020, 1,125,000 Founder Shares are no longer subject to forfeiture.
The Founder Shares are subject to transfer restrictions pursuant to lock-up provisions in a letter
agreement with the Company entered into by the Initial Stockholders, and officers and directors. Those lock-up provisions provide that such securities are not transferable or salable until the earlier to occur
of: (1) one year after the completion of the initial business combination, or (2) subsequent to the initial business combination if ERES completes a liquidation, merger, stock exchange or other similar transaction that results in all
of the Public Stockholders having the right to exchange their Public Shares for cash, securities or other property. Notwithstanding the foregoing, the Sponsor has the right to transfer its ownership in the Founder Shares at any time, and to any
transferee, to the extent that the Sponsor determines, in good faith, that such transfer is necessary to ensure that it and/or any of its parents, subsidiaries or affiliates are in compliance with the Investment Company Act.
Administrative Support Agreement
ERES
entered into an agreement, commencing on July 24, 2020, pursuant to which ERES will pay two affiliates of the Sponsor a total of up to $10,000 each per month for office space, administrative and support services. Upon completion of the
Business Combination or ERESs liquidation, the agreement will terminate and ERES will cease paying these monthly fees.
Forward Purchase
Agreement
On July 2, 2020, ERES entered into a forward purchase agreement pursuant to which East Asset Management, an affiliate of the
Sponsor, has the option to purchase an aggregate of up to 5,000,000 forward purchase units, consisting of one forward purchase share and one-half of one forward purchase warrant, for $10.00 per unit, or an aggregate maximum amount of $50,000,000, in
a private placement that would close simultaneously with the closing of a business combination. The forward purchase agreement was terminated and is of no further effect as of December 2, 2022 pursuant to the termination agreement, dated December 2,
2022, by and between ERES and the Sponsor.
233
Related Party Loans
In order to finance transaction costs in connection with a business combination, the Sponsor, members of ERESs founding team or any of
their affiliates may, but are not obligated to, loan ERES funds as may be required. In August 2021, the Sponsor committed to provide ERES up to an aggregate of $1,500,000 in loans for working capital purposes. The Working Capital Note does not
bear interest and is repayable in full upon consummation of a business combination. If ERES does not complete a business combination, the Working Capital Note shall not be repaid and all amounts owed under it will be forgiven.
The Working Capital Note is subject to customary events of default, the occurrence of which automatically trigger the unpaid principal balance
of the Working Capital Note and all other sums payable with regard to the Working Capital Note becoming immediately due and payable.
Sponsor Loans
On February 15, 2021, the Sponsor committed to provide ERES up to an aggregate of $500,000 in loans for working capital
purposes. These loans will be non-interest bearing, unsecured and will be repaid upon the consummation of a business combination. If ERES does not consummate a business combination, all amounts loaned to ERES
in connection with these loans will be forgiven except to the extent that the ERES has funds available to it outside of its Trust Account. On June 24, 2020, the Sponsor agreed to loan ERES an aggregate of up to $300,000 to cover expenses
related to the ERES IPO pursuant to a promissory note (the IPO Note). The IPO Note was non-interest bearing and payable on the earlier of August 31, 2020 or the completion of the ERES IPO. The
outstanding balance under the IPO Note of $97,126 was repaid at the closing of the ERES IPO on July 27, 2020. Affiliates of ERES and of the Sponsor advanced the Company an aggregate of $265,763 to cover expenses related to the ERES
IPO. The advances were non-interest bearing and due on demand. The outstanding advances of $265,763 were repaid at the closing of the ERES IPO on July 27, 2020.
On July 25, 2022, ERES convened a special meeting of stockholders at which a proposal to extend the date by which ERES has to complete a
Business Combination from July 27, 2022 to January 27, 2023 was approved. In connection with the approval of the Extension Amendment Proposal, ERES issued the Extension Note in the principal amount of up to $1,924,356 to the Sponsor,
pursuant to which the Sponsor agreed to loan ERES up to $1,924,356. The Extension Note bears no interest and is repayable in full upon the earlier of (a) the date of the consummation of ERESs initial business combination or (b) the
date of the liquidation of ERES. At any time prior to payment in full of the principal balance of the Extension Note, the holder of the Extension Note (or a permitted assignee) will have the option, but not the obligation, to convert up to
$1,500,000 of the unpaid principal balance of the Extension Note into that number of Extension Warrants, each whole warrant exercisable for one share of ERES Class A Common Stock equal to the principal amount of the Extension Note so converted
divided by $1.50.
On January 20, 2023, ERES convened a special meeting of stockholders at which a proposal to extend the date by which
ERES has to complete a Business Combination from January 27, 2023 to July 27, 2023 was approved. In connection with the approval of the Second Extension Amendment Proposal, ERES issued the Second Extension Note in the principal amount of up to
$565,497.31 to the Sponsor, pursuant to which the Sponsor agreed to loan ERES up to $565,497.31. The Second Extension Note bears no interest and is repayable in full upon the earlier of (a) the date of the consummation of ERESs initial
business combination or (b) the date of the liquidation of ERES. At any time prior to payment in full of the principal balance of the Second Extension Note, the holder of the Second Extension Note (or a permitted assignee) will have the option, but
not the obligation, to convert up to $500,000 of the unpaid principal balance of the Second Extension Note into that number of Second Extension Warrants, each whole warrant exercisable for one share of ERES Class A Common Stock equal to the
principal amount of the Second Extension Note so converted divided by $1.50.
The terms of the Extension Warrants and Second Extension
Warrants will be identical to the terms of the Private Placement Warrants. The maturity date of the Extension Note and the Second Extension Note may be
234
accelerated upon the occurrence of an Event of Default (as defined therein). Any outstanding principal under the Extension Note and Second Extension Note may be prepaid at any time by ERES, at
its election and without penalty, provided, however, that the Sponsor shall have a right to first convert such principal balance as described in Section 17 of the Extension Note and Second Extension Note upon notice of such prepayment. If the
Business Combination is not completed and ERES winds up, there will not be sufficient assets to repay the Extension Note or Second Extension Note and they will be worthless.
235
STOCKHOLDER PROPOSALS AND NOMINATIONS
Stockholder Proposals
The Special
Meeting to be held on [●], 2023 shall be in lieu of the 2022 annual meeting. Subject to the completion of the Business Combination, the next annual meeting of stockholders will be held by the
Post-Combination Company in 2023. The Amended and Restated Bylaws establish an advance notice procedure for stockholders who wish to present a proposal before the annual meeting of stockholders in 2023. The
Amended and Restated Bylaws provide that the only business that may be conducted at an annual meeting of stockholders is business that is (i) specified in the notice of such meeting (or any supplement or amendment thereto) given by or at the
direction of the board of directors of the Post-Combination Company, (ii) otherwise properly brought before such meeting by or at the direction of the board of directors the
Post-Combination Company, or (iii) otherwise properly brought before such meeting by a stockholder who (a) (1) is a stockholder of record entitled to vote at such meeting on the date of giving of
notice and on the record date for the determination of stockholders entitled to vote at such annual meeting and (2) provides timely notice in the proper form as set forth in the Amended and Restated Bylaws and (b) properly makes such
proposal in accordance with Rule 14a-8 under the Exchange Act. To be timely for the annual meeting of stockholders of the Post-Combination Company, the written notice under clause (iii) above must be
received by the secretary of the Post-Combination Company at the principal executive offices:
|
|
|
not later than close of business on the 90th day; and |
|
|
|
not earlier than close of business on the 120th day, before the one-year
anniversary of the preceding years annual meeting. |
In the event that the date of the annual meeting is more than
30 days before, or more than 60 days after the one-year anniversary of the preceding years annual meeting, notice of a stockholder proposal must be received (i) no earlier than close of business on
the 120th day before such annual meeting and (ii) no later than the later of close of business the 90th day before such annual meeting or close of business on the 10th day following the day on which public announcement of the date of such
meeting is first made by the Post-Combination Company.
Under Rule
14a-8 of the Exchange Act, a stockholder proposal to be included in the proxy statement and proxy card for the annual general meeting pursuant to Rule 14a-8 must be
received at the principal office of the Post-Combination Company a reasonable time before the Post-Combination Company begins to print and send its proxy materials for
such meeting and must comply with Rule 14a-8.
Stockholder Director Nominees
The Amended and Restated Bylaws permit stockholders to nominate directors for appointment at an annual meeting or at a special meeting (but
only if the appointment of directors is a matter specified in the notice of meeting given by or at the direction of the person calling such special meeting) of stockholders, subject to the provisions of the Proposed Charter. To nominate a director,
the stockholder must provide the information required by the Amended and Restated Bylaws. In addition, the stockholder must give timely notice to the secretary of the Post-Combination Company in accordance
with the Amended and Restated Bylaws, which, in general, require that the notice be received by the secretary within the time periods for stockholder proposals (other than proposals pursuant to Rule 14a-8)
described above under the section entitled Stockholder Proposals.
236
STOCKHOLDER COMMUNICATIONS
Stockholders and interested parties may communicate with the board of directors of ERES, any committee chairperson or the non-management directors as a group by writing to the board or committee chairperson in care of East Resources Acquisition Company, 7777 NW Beacon Square Boulevard, Boca Raton, Florida 33487. Following the Business
Combination, such communications should be sent to Abacus Life, Inc., 2101 Park Center Drive, Suite 170, Orlando, Florida 32835. Each communication will be forwarded, depending on the subject matter, to the board of directors, the appropriate
committee chairperson or all non-management directors.
237
DELIVERY OF DOCUMENTS TO STOCKHOLDERS
Pursuant to the rules of the SEC, ERES and its agents that deliver communications to its stockholders are permitted to deliver to two or more
stockholders sharing the same address a single copy of the Companys proxy statement. Upon written or oral request, the Company will deliver a separate copy of the proxy statement to any stockholder at a shared address who wishes to receive
separate copies of such documents in the future. Stockholders receiving multiple copies of such documents may likewise request that the Company deliver single copies of such documents in the future. Stockholders may notify the Company of their
requests by emailing or writing the Company at the Companys principal executive offices at 7777 NW Beacon Square Boulevard, Boca Raton, Florida 33487, info@eastresources.com, Attn: Katelyn Morris.
OTHER MATTERS
As of the date of this proxy statement, the ERES Board does not know of any matters that will be presented for consideration at the Special
Meeting other than as described in this proxy statement. If any other matters properly come before the Special Meeting, or any adjournment or postponement thereof, and are voted upon, the enclosed proxy will be deemed to confer discretionary
authority on the individuals that it names as proxies to vote the shares represented by the proxy as to any of these matters.
APPRAISAL RIGHTS
Holders of ERES Common Stock, ERES units and ERES warrants are not entitled to appraisal rights in connection
with the Business Combination under Delaware law.
238
WHERE YOU CAN FIND MORE INFORMATION
ERES files annual, quarterly and current reports, proxy statements and other information with the SEC. The SEC maintains an internet web site
that contains reports, proxy and information statements, and other information regarding issuers, including us, that file electronically with the SEC. The public can obtain any documents that we file electronically with the SEC at
http://www.sec.gov.
You may obtain additional copies of this proxy statement, at no cost, and you may ask any questions you may have
about the Proposals by contacting us at the following address or email:
East Resources Acquisition Company
7777 NW Beacon Square Boulevard
Boca Raton, Florida 33487
Attn:
Katelyn Morris
Email: info@eastresources.com
You may also obtain these documents at no cost by requesting them in writing or by telephone from ERESs proxy solicitation agent at the
following address and telephone number:
Morrow Sodali LLC
333 Ludlow Street, 5th Floor, South Tower
Stamford, CT 06902
Tel: (800)
662-5200 (toll-free) or
(203) 658-9400 (banks and brokers can call collect)
Email: ERES.info@investor.morrowsodali.com
In order to receive timely delivery of the documents in advance of the Special Meeting, you must make your request for information no later
than [●] (one week prior to the date of the Special Meeting).
239
INDEX TO FINANCIAL STATEMENTS
|
|
|
|
|
East Resources Acquisition Company |
|
|
|
|
Audited Financial Statements |
|
|
|
|
Report of Independent Registered Public Accounting Firm |
|
|
F-3 |
|
Consolidated Balance Sheets as of December 31, 2022 and
2021 |
|
|
F-4 |
|
Consolidated Statements of Operations for the years ended December
31, 2022 and 2021 |
|
|
F-5 |
|
Consolidated Statements of Stockholders Deficit for the years ended December 31,
2022 and 2021 |
|
|
F-6 |
|
Consolidated Statements of Cash Flows for the years ended December
31, 2022 and 2021 |
|
|
F-7 |
|
Notes to Financial Statements |
|
|
F-8 |
|
|
|
Longevity Market Assets, LLC |
|
|
|
|
Audited Consolidated Financial Statements |
|
|
|
|
Report of Independent Registered Public Accounting Firm |
|
|
F-33 |
|
Consolidated Balance Sheets as of December 31, 2022 and
2021 |
|
|
F-35 |
|
Consolidated Statements of Operations for the years ended December
31, 2022 and 2021 |
|
|
F-36 |
|
Consolidated Statements of Changes in Members Equity for the years ended
December 31, 2022 and 2021 |
|
|
F-37 |
|
Consolidated Statements of Cash Flows for the years ended December
31, 2022 and 2021 |
|
|
F-38 |
|
Notes to Consolidated Financial Statements |
|
|
F-39 |
|
|
|
Abacus Settlements, LLC d/b/a Abacus Life |
|
|
|
|
Audited Financial Statements |
|
|
|
|
Report of Independent Registered Public Accounting Firm |
|
|
F-64 |
|
Balance Sheets as of December 31, 2022 and 2021 |
|
|
F-65 |
|
Statements of Operations for the years ended December
31, 2022 and 2021 |
|
|
F-66 |
|
Statements of Cash Flows for the years ended December
31, 2022 and 2021 |
|
|
F-67 |
|
Statements of Changes in Members Equity for the years ended December 31,
2022 and 2021 |
|
|
F-68 |
|
Notes to Financial Statements |
|
|
F-69 |
|
F-1
EAST RESOURCES ACQUISITION COMPANY
INDEX TO FINANCIAL STATEMENTS
F-2
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Stockholders and Board of Directors of
East
Resources Acquisition Company
Opinion on the Financial Statements
We have audited the accompanying consolidated balance sheets of East Resources Acquisition Company (the Company) as of
December 31, 2022 and 2021, the related consolidated statements of operations, changes in stockholders deficit and cash flows for each of the two years in the period ended December 31, 2022 and the related notes (collectively referred to
as the financial statements). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and the results of its operations and its cash
flows for the each of the two years in the period ended December 31, 2022, in conformity with accounting principles generally accepted in the United States of America.
Explanatory ParagraphGoing Concern
The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As more fully
described in Note 1 to the financial statements, the Company has a significant working capital deficiency, has incurred significant losses and needs to raise additional funds to meet its obligations and sustain its operations. Additionally, if the
Company is unable to complete a Business Combination by the close of business on July 27, 2023, the Company will cease all operations except for the purpose of liquidating. These conditions raise substantial doubt about the Companys
ability to continue as a going concern. Managements plans in regard to these matters are also described in Note 1. The consolidated financial statements do not include any adjustments that might result from the outcome of this
uncertainty.
Basis for Opinion
These financial statements are the responsibility of the Companys management. Our responsibility is to express an opinion on the
Companys financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company
in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain
reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial
reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Companys internal control over financial
reporting. Accordingly, we express no such opinion.
Our audits included performing procedures to assess the risks of material
misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial
statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable
basis for our opinion.
/s/ Marcum LLP
Marcum LLP
We have served as the Companys auditor since 2020.
Houston, TX
April 17, 2023
F-3
EAST RESOURCES ACQUISITION COMPANY
CONSOLIDATED BALANCE SHEETS
|
|
|
|
|
|
|
|
|
|
|
December 31,
2022 |
|
|
December 31,
2021 |
|
ASSETS |
|
|
|
|
|
|
|
|
Current assets |
|
|
|
|
|
|
|
|
Cash |
|
$ |
86,572 |
|
|
$ |
853,130 |
|
Prepaid expenses |
|
|
64,914 |
|
|
|
91,625 |
|
|
|
|
|
|
|
|
|
|
Total Current Assets |
|
|
151,486 |
|
|
|
944,755 |
|
|
|
|
Cash and securities held in Trust Account |
|
|
99,222,704 |
|
|
|
345,048,888 |
|
|
|
|
|
|
|
|
|
|
Total Assets |
|
$ |
99,374,190 |
|
|
$ |
345,993,643 |
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS DEFICIT |
|
|
|
|
|
|
|
|
Current liabilitiesAccrued expenses |
|
$ |
9,227,518 |
|
|
$ |
144,254 |
|
Current liabilitiesNote payable to related party |
|
|
4,924,356 |
|
|
|
1,500,000 |
|
Income taxes payable |
|
|
52,485 |
|
|
|
|
|
Deferred underwriting fee payable |
|
|
|
|
|
|
12,075,000 |
|
Forward purchase agreement liability |
|
|
|
|
|
|
1,600,000 |
|
Warrant liability |
|
|
4,576,250 |
|
|
|
13,911,800 |
|
|
|
|
|
|
|
|
|
|
Total Liabilities |
|
|
18,780,609 |
|
|
|
29,231,054 |
|
|
|
|
|
|
|
|
|
|
Commitments |
|
|
|
|
|
|
|
|
|
|
|
Class A common stock subject to possible redemption, $0.0001 par value; 9,718,972 and
34,500,000 shares at $10.18 and 10.00 per share at December 31, 2022 and December 31, 2021, respectively |
|
|
98,983,437 |
|
|
|
345,000,000 |
|
|
|
|
Stockholders Deficit |
|
|
|
|
|
|
|
|
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and
outstanding |
|
|
|
|
|
|
|
|
Class A common stock, $0.0001 par value; 200,000,000 shares authorized; 0 issued and
outstanding (excluding 34,500,000 shares subject to possible redemption) |
|
|
|
|
|
|
|
|
Class B common stock, $0.0001 par value; 20,000,000 shares authorized; 8,625,000 shares
issued and outstanding |
|
|
863 |
|
|
|
863 |
|
Additional paid-in capital |
|
|
24,137 |
|
|
|
24,137 |
|
Accumulated deficit |
|
|
(18,414,856 |
) |
|
|
(28,262,411 |
) |
|
|
|
|
|
|
|
|
|
Total Stockholders Deficit |
|
|
(18,389,856 |
) |
|
|
(28,237,411 |
) |
|
|
|
|
|
|
|
|
|
TOTAL LIABILITIES AND STOCKHOLDERS DEFICIT |
|
$ |
99,374,190 |
|
|
$ |
345,993,643 |
|
|
|
|
|
|
|
|
|
|
The accompanying notes are
an integral part of the consolidated financial statements.
F-4
EAST RESOURCES ACQUISITION COMPANY
CONSOLIDATED STATEMENTS OF OPERATIONS
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended December 31, 2022 |
|
|
For the Year Ended December 31, 2021 |
|
Formation and operating costs |
|
$ |
11,722,287 |
|
|
$ |
1,382,681 |
|
|
|
|
|
|
|
|
|
|
Loss from operations |
|
|
(11,722,287 |
) |
|
|
(1,382,681 |
) |
Other income (expense): |
|
|
|
|
|
|
|
|
Change in fair value of warrant liability |
|
|
9,335,550 |
|
|
|
15,899,200 |
|
Change in fair value of forward purchase agreement liability |
|
|
600,000 |
|
|
|
1,300,000 |
|
Gain on deferred underwriting fees waiver |
|
|
513,188 |
|
|
|
|
|
Interest earnedbank |
|
|
10,031 |
|
|
|
62 |
|
Interest earned on marketable securities held in Trust Account |
|
|
672,439 |
|
|
|
22,784 |
|
|
|
|
|
|
|
|
|
|
Other income (expense), net |
|
|
11,131,208 |
|
|
|
17,222,046 |
|
|
|
|
|
|
|
|
|
|
Income before provision for income taxes |
|
|
(591,079 |
) |
|
|
15,839,365 |
|
|
|
|
|
|
|
|
|
|
Income tax expense |
|
|
52,485 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Income (Loss) |
|
$ |
(643,564 |
) |
|
$ |
15,839,365 |
|
|
|
|
|
|
|
|
|
|
Basic and diluted weighted average shares outstanding, Class A common stock subject to
possible redemption |
|
|
23,637,084 |
|
|
|
34,500,000 |
|
|
|
|
|
|
|
|
|
|
Basic and diluted net loss per share, Class A common stock subject to possible
redemption |
|
$ |
(0.02 |
) |
|
$ |
0.37 |
|
|
|
|
|
|
|
|
|
|
Basic and diluted weighted average shares outstanding,
Non-redeemable common stock |
|
|
8,625,000 |
|
|
|
8,625,000 |
|
|
|
|
|
|
|
|
|
|
Basic and diluted net income per share, Non-redeemable
common stock |
|
$ |
(0.02 |
) |
|
$ |
0.37 |
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of the consolidated financial statements.
F-5
EAST RESOURCES ACQUISITION COMPANY
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS DEFICIT
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the year ended December 31, 2022 |
|
|
|
Class A Common Stock |
|
|
Class B Common Stock |
|
|
Additional Paid-in Capital |
|
|
Accumulated Deficit |
|
|
Total Stockholders Deficit |
|
|
|
Shares |
|
|
Amount |
|
|
Shares |
|
|
Amount |
|
BalanceJanuary 1, 2022 |
|
|
|
|
|
$ |
|
|
|
|
8,625,000 |
|
|
$ |
863 |
|
|
$ |
24,137 |
|
|
$ |
(28,262,411 |
) |
|
$ |
(28,237,411 |
) |
Net income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(643,564 |
) |
|
|
(643,564 |
) |
Deferred underwriting fees waiver |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11,561,812 |
|
|
|
11,561,812 |
|
Termination of forward purchase agreement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,000,000 |
|
|
|
1,000,000 |
|
Remeasurement of Class A common stock to redemption value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2,070,693 |
) |
|
|
(2,070,693 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BalanceDecember 31, 2022 |
|
|
|
|
|
$ |
|
|
|
|
8,625,000 |
|
|
$ |
863 |
|
|
$ |
24,137 |
|
|
$ |
(18,414,856 |
) |
|
$ |
(18,389,856 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the year ended December 31, 2021 |
|
|
|
Class A Common Stock |
|
|
Class B Common Stock |
|
|
Additional Paid-in Capital |
|
|
Accumulated Deficit |
|
|
Total Stockholders Equity (Deficit) |
|
|
|
Shares |
|
|
Amount |
|
|
Shares |
|
|
Amount |
|
BalanceJanuary 1, 2021 |
|
|
|
|
|
$ |
|
|
|
|
8,625,000 |
|
|
$ |
863 |
|
|
$ |
24,137 |
|
|
$ |
(44,101,776 |
) |
|
$ |
(44,076,776 |
) |
Net income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15,839,365 |
|
|
|
15,839,365 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BalanceDecember 31, 2021 |
|
|
|
|
|
$ |
|
|
|
|
8,625,000 |
|
|
$ |
863 |
|
|
$ |
24,137 |
|
|
$ |
(28,262,411 |
) |
|
$ |
(28,237,411 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of the consolidated financial statements.
F-6
EAST RESOURCES ACQUISITION COMPANY
CONSOLIDATED STATEMENTS OF CASH FLOWS
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended December 31, 2022 |
|
|
For the Year Ended December 31, 2021 |
|
Cash Flows from Operating Activities: |
|
|
|
|
|
|
|
|
Net income (loss) |
|
$ |
(643,564 |
) |
|
$ |
15,839,365 |
|
Adjustments to reconcile net income (loss) to net cash used in operating activities: |
|
|
|
|
|
|
|
|
Amortization of prepaid insurance |
|
|
425,144 |
|
|
|
236,417 |
|
Change in fair value of warrant liability |
|
|
(9,335,550 |
) |
|
|
(15,899,200 |
) |
Change in fair value of forward purchase agreement liability |
|
|
(600,000 |
) |
|
|
(1,300,000 |
) |
Gain on deferred underwriting fees waiver |
|
|
(513,188 |
) |
|
|
|
|
Interest earned on marketable securities held in Trust Account |
|
|
(672,439 |
) |
|
|
(22,784 |
) |
Changes in operating assets and liabilities: |
|
|
|
|
|
|
|
|
Prepaid insurance |
|
|
(398,433 |
) |
|
|
(93,292 |
) |
Income taxes payable |
|
|
52,485 |
|
|
|
|
|
Accrued expenses |
|
|
9,083,264 |
|
|
|
2,939 |
|
|
|
|
|
|
|
|
|
|
Net cash used in operating activities |
|
|
(2,602,281 |
) |
|
|
(1,236,555 |
) |
|
|
|
|
|
|
|
|
|
Cash Flows from Investing Activities: |
|
|
|
|
|
|
|
|
Trust Account withdrawal for redemption of Class A shares |
|
|
248,087,256 |
|
|
|
|
|
Payment into Trust Account |
|
|
(1,924,356 |
) |
|
|
|
|
Trust Account withdrawal for payment of taxes |
|
|
335,723 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by investing activities |
|
|
246,498,623 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash Flows from Financing Activities: |
|
|
|
|
|
|
|
|
Redemption of Class A Common Stock |
|
|
(248,087,256 |
) |
|
|
|
|
Proceeds from note payableRelated Party |
|
|
3,424,356 |
|
|
|
1,500,000 |
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) financing activities |
|
|
(244,662,900 |
) |
|
|
1,500,000 |
|
|
|
|
|
|
|
|
|
|
Net Change in Cash |
|
|
(766,558 |
) |
|
|
263,445 |
|
CashBeginning |
|
|
853,130 |
|
|
|
589,685 |
|
|
|
|
|
|
|
|
|
|
CashEnding |
|
$ |
86,572 |
|
|
$ |
853,130 |
|
|
|
|
|
|
|
|
|
|
Non-cash investing and financing
activities: |
|
|
|
|
|
|
|
|
Remeasurement of Class A common stock subject to possible redemption to redemption
value |
|
$ |
2,070,693 |
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
Termination of forward purchase agreement |
|
$ |
1,000,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred underwriting fee payable |
|
$ |
(12,075,000 |
) |
|
$ |
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of the consolidated financial statements.
F-7
EAST RESOURCES ACQUISITION COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2022
NOTE 1.
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
East Resources Acquisition Company (the Company) is a newly organized
blank check company incorporated in Delaware on May 22, 2020 for the purpose of effecting a merger, capital stock exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the
Business Combination). While the Company may pursue an acquisition opportunity in any business, industry, sector or geographical location, it intends to focus its search for a target business in the energy industry in North America. The
Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies.
As of December 31, 2022, the Company had not commenced any operations. All activity for the year ended December 31, 2022 relates to
the Companys formation, its initial public offering (Initial Public Offering), which is described below, and, subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not
generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generated non-operating income in the form of interest income from the proceeds
derived from the Initial Public Offering until June 2022, when the investments in the trust account (the Trust Account) holding the proceeds were liquidated to thereafter be held in cash.
The registration statement for the Companys Initial Public Offering was declared effective on July 22, 2020. On July 27, 2020,
the Company consummated the Initial Public Offering of 30,000,000 units (the Units and, with respect to the shares of Class A common stock included in the Units sold, the Public Shares), at $10.00 per Unit, generating
gross proceeds of $300,000,000, which is described in Note 3.
Simultaneously with the closing of the Initial Public Offering, the Company
consummated the sale of 8,000,000 warrants (the Private Placement Warrants) at a price of $1.00 per Private Placement Warrant in a private placement to East Sponsor, LLC (the Sponsor), generating gross proceeds of $8,000,000,
which is described in Note 4.
On August 25, 2020, the underwriters exercised their over-allotment option in full, resulting in an
additional 4,500,000 Units issued for total gross proceeds of $45,000,000. In connection with the underwriters exercise of their over-allotment option in full, the Company also consummated the sale of an additional 900,000 Private Placement
Warrants at $1.00 per Private Placement Warrant, generating total proceeds of $900,000. A total of $45,000,000 was deposited into the Trust Account, bringing the aggregate proceeds held in the Trust Account to $345,000,000.
Transaction costs amounted to $19,840,171, consisting of $6,900,000 of underwriting fees, $12,075,000 of deferred underwriting fees and
$865,171 of other offering costs.
Following the closing of the Initial Public Offering on July 27, 2020 and the exercise of the
over-allotment option on August 25, 2020, an amount of $345,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account
(the Trust Account) located in the United States and invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the Investment Company
Act), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund meeting certain conditions of Rule 2a-7 of the Investment Company Act, as
determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the funds in the Trust Account to the Companys stockholders, as described below. The investments in the Trust
Account were liquidated in June 2022 to thereafter be held in cash.
F-8
EAST RESOURCES ACQUISITION COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2022
The Companys management has broad discretion with respect to the specific
application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward completing a Business Combination. The Company
must complete its initial Business Combination with one or more target businesses that together have a fair market value equal to at least 80% of the net assets held in the Trust Account (excluding the amount of any deferred underwriting commissions
held in the Trust Account) at the time of the agreement to enter into a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the issued and outstanding
voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company. There is no assurance that the Company will
be able to successfully effect a Business Combination.
The Company will provide its stockholders with the opportunity to redeem all or a
portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the
Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company. The stockholders will be entitled to redeem their shares for a pro rata portion of the amount held in the Trust Account
(initially $10.00 per share), calculated as of two business days prior to the completion of a Business Combination, including any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its
tax obligations. There will be no redemption rights upon the completion of a Business Combination with respect to the Companys warrants.
In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon
consummation of such Business Combination and a majority of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required under applicable law or stock exchange listing requirements and the Company does not
decide to hold a stockholder vote for business or other reasons, the Company will, pursuant to its Certificate of Incorporation (the Certificate of Incorporation), conduct the redemptions pursuant to the tender offer rules of the
Securities and Exchange Commission (SEC), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination. If the Company
seeks stockholder approval in connection with a Business Combination, the holders of the Founder Shares have agreed to vote their Founder Shares (as defined in Note 5) and any Public Shares purchased in or after the Initial Public Offering in favor
of approving a Business Combination and to waive their redemption rights with respect to any such shares in connection with a stockholder vote to approve a Business Combination. However, in no event will the Company redeem its Public Shares in an
amount that would cause its net tangible assets to be less than $5,000,001. In such case, the Company would not proceed with the redemption of its Public Shares and the related Business Combination, and instead may search for an alternate Business
Combination. Additionally, each public stockholder may elect to redeem its Public Shares, without voting, and if they do vote, irrespective of whether they vote for or against a proposed Business Combination.
Notwithstanding the foregoing, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions
pursuant to the tender offer rules, the Companys Certificate of Incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a
group (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the Exchange Act)), will be restricted from redeeming its shares with respect to more than an aggregate of 20% of the Public Shares
without the Companys prior written consent.
F-9
EAST RESOURCES ACQUISITION COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2022
The Sponsor has agreed (a) to waive its redemption rights with respect to any
Founder Shares and Public Shares held by it in connection with the completion of a Business Combination and (b) not to propose an amendment to the Certificate of Incorporation (i) to modify the substance or timing of the Companys
obligation to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or (ii) with respect to any other provision relating to stockholders rights or pre-initial Business Combination activity, unless the Company provides the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment and (iii) to waive its
rights to liquidating distributions from the Trust Account with respect to the Founder Shares if the Company fails to complete a Business Combination. The Company will have until July 27, 2023 (or such earlier time that the Company elects not
to deposit additional funds into the Trust Account, as described below) to complete a Business Combination (the Combination Period). If the Company is unable to complete a Business Combination within the Combination Period, the Company
will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than 10 business days thereafter, redeem 100% of the outstanding Public Shares, at a
per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned (less up to $100,000 of interest to pay dissolution expenses), divided by the
number of then outstanding Public Shares, which redemption will completely extinguish public stockholders rights as stockholders (including the right to receive further liquidation distributions, if any), and (iii) as promptly as
reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Companys board of directors, dissolve and liquidate, subject in each case to its obligations under Delaware law to provide for claims
of creditors and the requirements of other applicable law.
The Sponsor has agreed to waive its liquidation rights with respect to the
Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor acquires Public Shares in or after the Proposed Initial Public Offering, such Public Shares will be entitled to liquidating
distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 5) held in the Trust
Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the
Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00).
The Sponsor has agreed that it will be liable to the Company, if and to the extent any claims by a third party for services rendered or
products sold to the Company, or by a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (1) $10.00 per Public Share or (2) such
lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of trust assets, in each case net of the amount of interest which may be withdrawn to pay taxes. This
liability will not apply with respect to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account nor will it apply to any claims under the Companys indemnity of the underwriters of the
Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the Securities Act). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third
party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by
endeavoring to have all vendors, service providers (other than the Companys independent public accountants), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any
right, title, interest or claim of any kind in or to monies held in the Trust Account.
F-10
EAST RESOURCES ACQUISITION COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2022
On July 25, 2022, the Company convened a special meeting of stockholders at which a
proposal to extend the date by which the Company has to complete a Business Combination from July 27, 2022 to January 27, 2023 (the First Extension Amendment Proposal) was approved. In connection with the special meeting, the
Company provided the stockholders the opportunity to redeem all or a portion of their Class A common stock, and stockholders holding 24,781,028 shares of Class A common stock exercised their right to redeem such shares for a pro rata
portion of the funds in the Trust Account. Consequently, approximately $248,087,256 (approximately $10.01 per share) was removed from the Trust Account to pay such redeeming holders. Additionally, in connection with the approval of the First
Extension Amendment Proposal, the Company issued a promissory note (the First Extension Note) in the principal amount of up to $1,924,356 to the Sponsor, pursuant to which the Sponsor agreed to loan the Company up to $1,924,356. The
First Extension Note bears no interest and is repayable in full upon the earlier of (a) the date of consummation of the Companys Business Combination or (b) the date of liquidation of the Company. In order to further extend the
period the Company has to complete a Business Combination beyond the 27th of a given month, an additional $320,726 was to be deposited into the Trust Account commencing on July 27, 2022 and
on the 27th of each subsequent month, or portion thereof, for each additional month that the Company requires to complete a Business Combination from July 27, 2022 until January 27, 2023. As of December 31, 2022, $1,924,356 has been
deposited into Trust Account by our Sponsor.
On August 30, 2022, the Company, LMA Merger Sub, LLC, a Delaware limited liability
company and a wholly owned subsidiary of the Company (LMA Merger Sub), Abacus Merger Sub, LLC, a Delaware limited liability company and a wholly owned subsidiary of the Company (Abacus Merger Sub), Longevity Market Assets,
LLC, a Florida limited liability company (LMA) and Abacus Settlements, LLC, a Florida limited liability company (Abacus) entered into an Agreement and Plan of Merger, as amended on October 14, 2022 (as it may be further
amended, supplemented or otherwise modified from time to time in accordance with its terms, the Merger Agreement), pursuant to which, subject to the satisfaction or waiver of certain conditions precedent in the Merger Agreement,
(i) LMA Merger Sub will merge with and into LMA, with LMA surviving such merger as a direct wholly owned subsidiary of the Company (the LMA Merger) and (ii) Abacus Merger Sub will merge with and into Abacus, with Abacus
surviving such merger as a direct wholly owned subsidiary of the Company (the Abacus Merger and, together with the LMA Merger and the other transactions contemplated by the Merger Agreement, the Proposed Business
Combination). The Proposed Business Combination is expected to be consummated in the first half of 2023, subject to the fulfillment of certain conditions. Subject to the terms of the Merger Agreement, the aggregate merger consideration with
respect to the holders of issued and outstanding limited liability company interests in LMA and Abacus will consist of approximately $531.8 million, payable in a number of newly issued shares of Class A common stock at a deemed value of
$10.00 per share, with a portion of the aggregate merger consideration payable in cash upon the satisfaction of certain conditions. For additional information regarding the Merger Agreement, see the Companys Current Reports on Form 8-K filed on August 30, 2022 and October 14, 2022, and the Companys preliminary proxy statement (as amended, the Proxy Statement), initially filed with the Securities and Exchange
Commission (the SEC) on October 14, 2022.
On January 20, 2023, the Company convened a special meeting of
stockholders at which a proposal to extend the date by which the Company has to complete a Business Combination from January 27, 2023 to July 27, 2023 (the Second Extension Amendment Proposal) was approved. In connection with
the special meeting, stockholders were provided an opportunity to redeem all or a portion of their Class A common stock, and stockholders holding 6,862,925 shares of Class A common stock exercised their right to redeem such shares for a
pro rata portion of the funds in the Trust Account. Consequently, approximately $70,070,464 (approximately $10.21 per share) was removed from the Trust Account to pay such redeeming holders. Additionally, in connection with the approval of the
Second Extension Amendment Proposal, the Company issued a promissory note (the Second Extension Note) in the principal amount of up to $565,497 to the
F-11
EAST RESOURCES ACQUISITION COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2022
Sponsor, pursuant to which the Sponsor agreed to loan us up to $565,497. The Second Extension Note bears no interest and is repayable in full upon the earlier of (a) the date of consummation
of Companys Business Combination or (b) the date of liquidation of the Company. In order to further extend the period the Company has to complete a Business Combination beyond the 27th of a given month until July 27, 2023, the
Sponsor will deposit an additional $94,250 into the Trust Account commencing on January 27, 2023 and on the 27th of each subsequent month until July 27, 2023. As of April 17, 2023, $282,750 has been deposited into Trust Account by the
Sponsor for the second extension.
Risks and Uncertainties
Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is
reasonably possible that the virus could have a negative effect on the Companys financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial
statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Going Concern
Considerations
As of December 31, 2022, the Company had $86,572 in cash and a working capital deficiency of $14,052,873.
Until the consummation of a Business Combination, the Company will be using the funds not held in the Trust Account for identifying and
evaluating prospective acquisition candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to acquire, and structuring, negotiating and consummating the Business
Combination. The Company may need to raise additional capital through loans or additional investments from its Sponsor, stockholders, officers, directors, or third parties. The Companys officers, directors and Sponsor may, but are not
obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Companys working capital needs. Accordingly, the Company may not be able to obtain additional
financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a
potential transaction, and reducing overhead expenses. In addition, the Company may have to liquidate if the Business Combination is not completed by July 27, 2023.
The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all or that it
will complete a Business Combination prior to the expiration of the Combination Period. The Company is in the process of preparing and finalizing the Proxy Statement with the SEC for the purpose of soliciting stockholder approval of the Proposed
Business Combination at a special meeting of the Companys stockholders as promptly as possible. If the Proposed Business Combination is approved at a special meeting for such purpose, the Company would consummate the Proposed Business
Combination shortly thereafter. These conditions raise substantial doubt about the Companys ability to continue as a going concern through one year from the issuance of these financial statements. These financial statements do not include any
adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.
NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The
accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) for financial information
F-12
EAST RESOURCES ACQUISITION COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2022
and in accordance with the instructions to Form 10-K and Article 8 of Regulation S-X promulgated under the
Securities Act. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting.
Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying condensed financial statements
include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.
Emerging Growth Company
The
Company is an emerging growth company, as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the JOBS Act), and it may take advantage of certain exemptions from
various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation
requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on
executive compensation and stockholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1)
of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective
or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and
comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected to irrevocably opt out of such extended transition period,
which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, will adopt the new or revised standard at the time public companies adopt the new or revised standard. This
may make comparison of the Companys financial statements with another emerging growth company that has not opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards
used.
Use of Estimates
The
preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the
financial statements and the reported amounts of revenues and expenses during the reporting periods.
Making estimates requires management
to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating
its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents
The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. In June 2022, the Company liquidated all investments held in the Trust Account to thereafter be held in the form of
cash in the Trust Account.
F-13
EAST RESOURCES ACQUISITION COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2022
Marketable Securities Held in Trust Account
Prior to the liquidation of investments in the Trust Account, the Companys portfolio of investments was comprised of U.S. government
securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily
determinable fair value, or a combination thereof. When the Companys investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities and are recognized at fair value. When
the Companys investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Gains and losses resulting from the change in fair value of these securities are included in gain on
investments held in the Trust Account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.
At December 31, 2022, substantially all of the assets held in the Trust Account were held in cash, as further explained in Note 1 above.
At December 31, 2021, substantially all of the assets held in the Trust Account were held in money market funds, which primarily invest in U.S. Treasury Bills.
Class A Common Stock Subject to Possible Redemption
The Company accounts for its shares of Class A common stock subject to possible redemption in accordance with the guidance in Accounting
Standards Codification (ASC) Topic 480 Distinguishing Liabilities from Equity. Shares of Class A common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value.
Conditionally redeemable common stock (including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Companys
control) is classified as temporary equity. At all other times, common stock is classified as stockholders equity. The Companys Class A common stock features certain redemption rights that are considered to be outside of the
Companys control and subject to occurrence of uncertain future events. Accordingly, Class A common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders equity section
of the Companys balance sheet.
At December 31, 2022 and December 31, 2021, the Class A common stock reflected in the
condensed balance sheets is reconciled in the following table:
|
|
|
|
|
Gross Proceeds |
|
$ |
345,000,000 |
|
Less: |
|
|
|
|
Proceeds allocated to Public Warrants |
|
|
(14,662,500 |
) |
Proceeds allocated to FPA liability |
|
|
(1,000,000 |
) |
Class A common stock issuance costs |
|
|
(18,978,817 |
) |
Plus: |
|
|
|
|
Remeasurement of carrying value to redemption value |
|
|
34,641,317 |
|
|
|
|
|
|
Class A common stock subject to possible redemption at December 31, 2021 |
|
$ |
345,000,000 |
|
|
|
|
|
|
Redemption of Class A common stock |
|
|
(248,087,256 |
) |
Remeasurement of carrying value to redemption value |
|
|
146,337 |
|
Contribution to trust account for extension |
|
|
1,924,356 |
|
|
|
|
|
|
Class A common stock subject to possible redemption at December 31, 2022 |
|
$ |
98,983,437 |
|
|
|
|
|
|
F-14
EAST RESOURCES ACQUISITION COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2022
Derivative Financial Instruments
The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded
derivatives in accordance with ASC Topic 815, Derivatives and Hedging. The Companys derivative instruments are recorded at fair value and re-valued at each reporting date, with changes in the
fair value reported in the Statement of Operations. Derivative assets and liabilities are classified on the balance sheet as current or non-current based on whether or not
net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. The Company has determined the warrants and the forward contract for additional warrants are
derivatives. As the financial instruments meet the definition of a derivative the warrants and the forward contract for additional warrants are measured at fair value at issuance and at each reporting date in accordance with ASC 820, Fair Value
Measurement, with changes in fair value recognized in the Statement of Operations in the period of change.
Income Taxes
The Company follows the asset and liability method of accounting for income taxes under ASC 740, Income Taxes. Deferred tax assets
and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and
liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax
rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.
ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax
positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties
related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2022 and 2021. The Company is currently not aware of any issues under
review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.
Inflation Reduction Act of 2022
On August 16, 2022, the Inflation Reduction Act of 2022 (the IR Act) was signed into federal law. The IR Act provides for,
among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1,
2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the
repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In
addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the Treasury) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise
tax. Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to
the excise tax in connection with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and
F-15
EAST RESOURCES ACQUISITION COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2022
repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any PIPE or
other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other
guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction
in the cash available on hand to complete a Business Combination and inhibit the Companys ability to complete a Business Combination.
Net
Income (Loss) per Common Share
The Company complies with accounting and disclosure of FASB ASC Topic 260, Earnings Per
Share. Net income per share is computed by dividing net income by the weighted-average number of shares of common stock outstanding during the period, excluding common stock shares subject to forfeiture. The Company has not considered the
effect of the warrants sold in the Initial Public Offering and private placement to purchase an aggregate of 26,150,000 shares in the calculation of diluted loss per share, since the inclusion of such warrants would be anti-dilutive.
The Companys statements of operations include a presentation of income per share for common shares subject to possible redemption in a
manner similar to the two-class method of income per share. Net income per common share, basic and diluted, for Common stock subject to possible redemption is calculated by dividing the proportionate share of
income on earnings, net of applicable franchise and income taxes, by the weighted average number of Common stock subject to possible redemption outstanding over the period. Net loss is allocated evenly on a pro rata basis between Class A and
Class B based on weighted average number of shares of common stock outstanding over the period.
Consistent with ASC Topic 480-10-S99-3A, accretion associated with the redeemable shares of Class A common stock is excluded from earnings per share as the
redemption value approximates its fair value. The calculation of diluted income per common share does not consider the effect of the warrants issued since the exercise of the warrants are contingent upon the occurrence of future events. However, the
diluted earnings per share calculation includes the shares subject to forfeiture from the first day of the interim period in which the contingency on such shares was resolved.
The following table reflects the calculation of basic and diluted net income (loss) per common share (in dollars, except per share amounts):
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended December 31, 2022 |
|
|
For the Year Ended December 31, 2021 |
|
Net earnings (loss) |
|
$ |
(643,564 |
) |
|
$ |
15,839,365 |
|
|
|
|
|
|
|
|
|
|
Net earnings attributable to shareholders |
|
$ |
(643,564 |
) |
|
$ |
1,956,991 |
|
Redeemable Class A Common Stock |
|
|
|
|
|
|
|
|
Numerator: Earnings (loss) allocable to Redeemable Class A Common Stock |
|
$ |
(471,513 |
) |
|
$ |
12,671,492 |
|
Denominator: Weighted Average Share Outstanding, Redeemable Class A Common Stock |
|
|
23,637,084 |
|
|
|
34,500,000 |
|
Basic and diluted net earnings per share, Redeemable Class A |
|
$ |
(0.02 |
) |
|
$ |
0.37 |
|
|
|
|
|
|
|
|
|
|
F-16
EAST RESOURCES ACQUISITION COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2022
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended December 31, 2022 |
|
|
For the Year Ended December 31, 2021 |
|
Non-Redeemable Class A and Class B Common
Stock |
|
|
|
|
|
|
|
|
Numerator: Earnings (loss) allocable to Non-Redeemable
Class A and Class B Common Stock |
|
$ |
(172,051 |
) |
|
$ |
3,167,873 |
|
Denominator: Weighted Average Non- Redeemable Class A
and Class B Common Stock |
|
|
8,625,000 |
|
|
|
8,625,000 |
|
Basic and diluted net loss per share, Non-Redeemable
Class A and Class B |
|
$ |
(0.02 |
) |
|
$ |
0.37 |
|
|
|
|
|
|
|
|
|
|
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial
institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.
Fair Value of Financial Instruments
The fair value of the Companys assets and liabilities, which qualify as financial instruments under ASC Topic 820, Fair Value
Measurement, approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.
Fair
Value Measurements
The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and
reported at fair value at least annually.
The fair value of the Companys financial assets and liabilities reflects
managements estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement
date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal
assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and
liabilities:
|
|
|
Level 1: |
|
Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide
pricing information on an ongoing basis. |
|
|
Level 2: |
|
Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are
not active. |
|
|
Level 3: |
|
Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. |
F-17
EAST RESOURCES ACQUISITION COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2022
In some circumstances, the inputs used to measure fair value might be categorized within
different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
Reclassification
Certain prior
period amounts have been reclassified to conform to current presentation.
Recent Accounting Standards
In August 2020, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2020-06, DebtDebt with Conversion and Other Options (Subtopic 470-20) and Derivatives and HedgingContracts in Entitys Own Equity (Subtopic 815-40) (ASU 2020-06) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models
that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entitys own equity. The
new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entitys own equity. ASU 2020-06 amends the diluted earnings per
share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2022 for public
business entities that meet the definition of a Securities SEC filer, excluding entities eligible to be smaller reporting companies as defined by the SEC and should be applied on a full or modified retrospective basis, with early adoption permitted
beginning on January 1, 2021. The Company has adopted the standard on January 1, 2022 and has assessed that it had no impact on the accounting of the Company.
Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a
material effect on the Companys financial statements.
NOTE 3. PUBLIC OFFERING
Pursuant to the Initial Public Offering, the Company sold 34,500,000 Units, which includes the full exercise by the underwriters of their
over-allotment option on August 25, 2020, in the amount of 4,500,000 Units, at a purchase price of $10.00 per Unit. Each Unit consists of one share of Class A common stock and one-half of one
redeemable warrant (Public Warrant). Each whole Public Warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 8).
NOTE 4. PRIVATE PLACEMENT
Simultaneously
with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 8,900,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant, for an aggregate purchase price of $8,900,000. Each Private Placement
Warrant is exercisable for one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 8). The proceeds from the sale of the Private Placement Warrants were added to the net proceeds from the Initial Public
Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of
the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless.
F-18
EAST RESOURCES ACQUISITION COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2022
NOTE 5. RELATED PARTY TRANSACTIONS
Founder Shares
On June 1,
2020, the Sponsor purchased 8,625,000 shares (the Founder Shares) of the Companys Class B common stock, par value $0.0001 per share (the Class B common stock), for an aggregate price of $25,000. The Founder
Shares will automatically convert into Class A common stock on a one-for-one basis at the time of the Companys initial Business Combination and are subject to
certain transfer restrictions. The Founder Shares included up to an aggregate of 1,125,000 shares subject to forfeiture to the extent that the over-allotment option was not exercised in full or in part by the underwriters so that the Founder Shares
would represent 20% of the Companys issued and outstanding shares after the Initial Public Offering. In July 2020, Sponsor transferred 10,000 founder shares to Thomas W. Corbett, Jr., one of our independent director nominees. As a result of
the underwriters election to fully exercise their over-allotment option on August 25, 2020, 1,125,000 Founder Shares are no longer subject to forfeiture.
The Companys Founder Shares are subject to transfer restrictions pursuant to lock-up provisions
in a letter agreement with the Company entered into by the initial stockholders, and officers and directors. Those lock-up provisions provide that such securities are not transferable or salable until the
earlier to occur of: (1) one year after the completion of the initial Business Combination, or (2) subsequent to the initial Business Combination if the Company completes a liquidation, merger, stock exchange or other similar transaction
that results in all of the public stockholders having the right to exchange their Public Shares for cash, securities or other property. Notwithstanding the foregoing, the Sponsor has the right to transfer its ownership in the Founder Shares at any
time, and to any transferee, to the extent that the Sponsor determines, in good faith, that such transfer is necessary to ensure that it and/or any of its parents, subsidiaries or affiliates are in compliance with the Investment Company Act of 1940.
Further, and notwithstanding the foregoing, if subsequent to the initial Business Combination the reported last sale price of the common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations,
recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after our initial Business Combination, all of the Founder Shares will be released from the
lock-up. Any permitted transferees will be subject to the same restrictions and other agreements of the initial stockholders with respect to any Founder Shares.
As noted above, prior to the closing of the IPO, our Sponsor transferred 10,000 Founder Shares to our independent directors in recognition of
and as compensation for their future services to the Company. The transfer of Founder Shares to these directors is within the scope of FASB ASC Topic 718, Compensation-Stock Compensation (ASC 718). Under ASC 718, stock-based
compensation associated with equity-classified awards is measured at fair value upon the grant date. The fair value of the 10,000 shares granted to our independent directors was $61,173 or $6.12 per share. Compensation expense related to the Founder
Shares is recognized only when the performance condition (i.e. the remediation of the lock-up provision) is probable of achievement under the applicable accounting literature. Stock-based compensation would be
recognized at the date the lock-up provisions have been remediated, or are probable to be remediated, in an amount equal to the number of Founder Shares times the grant date fair value per share (unless
subsequently modified) less the amount initially received for the transfer of the Founder Shares. As of December 31, 2021, the Company has not yet entered into any definitive agreements in connection with any Business Combination and as such,
the lock-up provisions have not been remediated and are not probable to be remediated. Any such agreements may be subject to certain conditions to closing, such as, for example, approval by the Companys
shareholders. As a result, the Company determined that, taking into account that there is a possibility that a Business Combination might not happen, no stock-based compensation expense should be recognized until the Business Combination occurs.
F-19
EAST RESOURCES ACQUISITION COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2022
Administrative Support Agreement
The Company entered into an agreement, commencing on July 24, 2020 through the earlier of the Companys consummation of a Business
Combination and its liquidation, to pay two affiliates of the Sponsor $10,000 each, per month, for office space and administrative support services. For the years ended December 31, 2022 and 2021, the Company incurred and paid $240,000.
Related Party Loans
In order to
finance transaction costs in connection with a Business Combination, the Sponsor, members of the Companys founding team or any of their affiliates may, but are not obligated to, loan the Company funds as may be required (Working Capital
Loans or Note). In August 2021, the Sponsor committed to provide the Company up to an aggregate of $1,500,000 in loans for working capital purposes. The Note does not bear interest and is repayable in full upon consummation of a
Business Combination. If the Company does not complete a Business Combination, the Note shall not be repaid and all amounts owed under it will be forgiven. As of December 31, 2022 and December 31, 2021, there was a balance of $1,500,000
under this loan. Subsequent to the reporting period, on January 31, 2023, the Sponsor agreed to loan us up to an additional $1,500,000 under this loan. Upon the consummation of a Business Combination, the holder of the Note (or a permitted
assignee) shall have the option, but not the obligation, to convert all or a portion of the unpaid principal balance of the Note into that number of Working Capital Warrants equal to the principal amount of the Note so converted divided by $1.50.
The conversion option should be bifurcated and accounted for as a derivative in accordance with ASC 815. However, the exercise price of the underlying warrants was greater than the warrant fair value as of December 31, 2022, and when the
Note was drawn on. The Company believes that the likelihood of the Sponsors exercise of the option to convert the Note to warrants is de minimis. As a result, the Company recorded zero liability related to the conversion option.
The terms of the Working Capital Warrants will be identical to the terms of the warrants issued by the Company to the Sponsor in a private
placement that took place simultaneously with the Companys Initial Public Offering. The Note is subject to customary events of default, the occurrence of which automatically trigger the unpaid principal balance of the Note and all other sums
payable with regard to the Note becoming immediately due and payable. As of December 31, 2022 and 2021, there was a balance of $1,500,000 under this loan.
Sponsor Loans
On
February 15, 2021, the Sponsor committed to provide the Company up to an aggregate of $500,000 in loans for working capital purposes. These loans will be non-interest bearing, unsecured and will be repaid
upon the consummation of a Business Combination. If the Company does not consummate a Business Combination, all amounts loaned to the Company in connection with these loans will be forgiven except to the extent that the Company has funds available
to it outside of its Trust Account. As of December 31, 2022 and 2021, the outstanding balance of the loan is $0. On June 24, 2020, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover expenses related to the
Initial Public Offering pursuant to a promissory note (the Note). The Note was non-interest bearing and payable on the earlier of August 31, 2020 or the completion of the Initial Public
Offering. The outstanding balance under the Note of $97,126 was repaid at the closing of the Initial Public Offering on July 27, 2020. Affiliates of the Company and of the Sponsor advanced the Company an aggregate of $265,763 to cover expenses
related to the Initial Public Offering. The advances were non-interest bearing and due on demand.
The outstanding advances of $265,763 were repaid at the closing of the Initial Public Offering on July 27, 2020.
F-20
EAST RESOURCES ACQUISITION COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2022
On July 25, 2022, in connection with the approval of the First Extension Amendment
Proposal, the Company issued the Extension Note in the principal amount of up to $1,924,356 to the Sponsor, pursuant to which the Sponsor agreed to loan the Company up to $1,924,356. The First Extension Note bears no interest and is repayable in
full upon the earlier of (a) the date of the consummation of the Companys Business Combination, or (b) the date of the liquidation of the Company. The maturity date of the First Extension Note may be accelerated upon the occurrence
of an Event of Default (as defined therein). Any outstanding principal under the First Extension Note may be prepaid at any time by the Company, at its election and without penalty, provided, however, that the Sponsor shall have a right to first
convert such principal balance as described in Section 17 of the First Extension Note upon notice of such prepayment. If a Business Combination is not completed and the Company winds up, there will not be sufficient assets to repay the First
Extension Note and it will be worthless. As of December 31, 2022, $1,924,356 had been deposited into Trust Account by the Sponsor to extend the period the Company has to complete a Business Combination from July 27, 2022 to
January 27, 2023.
Upon the consummation of a Business Combination, the holder of the Note (or a permitted assignee) shall have the
option, but not the obligation, to convert up to $1,500,000 or a portion of the unpaid principal balance of the Note into that number of Working Capital Warrants equal to the principal amount of the Note so converted divided by $1.50. The conversion
option should be bifurcated and accounted for as a derivative in accordance with ASC 815. However, the exercise price of the underlying warrants was greater than the warrant fair value as of December 31, 2022, and when the Note was drawn on. The
Company believes that the likelihood of the Sponsors exercise of the option to convert the Note to warrants is de minimis. As a result, the Company recorded zero liability related to the conversion option.
On September 29, 2022, the Sponsor agreed to loan the Company an aggregate of $1,500,000 to cover expenses related to the Business
Combination and other operating activities until the consummation of the initial business combination, this is a separate $1,500,000 than the convertible note discussed above. This note bears no interest and is repayable in full upon the earlier of
(a) the date of the consummation of the Companys initial business combination, or (b) if the initial business combination does not occur this note will not be repaid.
NOTE 6. COMMITMENTS
Registration Rights
Pursuant to a registration rights agreement entered into on July 23, 2020, the holders of the Founder Shares, Private
Placement Warrants and warrants that may be issued upon conversion of the Working Capital Loans (and any shares of Class A common stock issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion
of Working Capital Loans and upon conversion of the Founder Shares) are entitled to registration rights. The holders of these securities will be entitled to make up to three demands, excluding short form demands, that the Company register such
securities. In addition, the holders have certain piggy-back registration rights with respect to registration statements filed subsequent to the completion of a Business Combination. However, the registration rights agreement provides
that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lockup period. The Company will bear the expenses incurred in connection with the filing of any such
registration statements.
Underwriting Agreement
The underwriters were paid a cash underwriting discount of $6,900,000 in the aggregate. In addition, the underwriters were entitled to a
deferred fee of $0.35 per Unit, or $12,075,000. The deferred fee was to become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the
underwriting agreement.
F-21
EAST RESOURCES ACQUISITION COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2022
On November 25, 2022, the Company received a letter providing notice from Wells
Fargo Securities, LLC. (Wells Fargo), waiving any entitlement to their portion of the $12,075,000 deferred underwriting fee that accrued from Wells Fargos participation as the underwriters of the Initial Public Offering and their
right of first refusal to act as co-placement agents in connection with any equity or debt financing transaction (including any investment banking and financial advisory services) related to the Business
Combination. Such waiver reduces the estimated expenses of the Business Combination by $12,075,000. A portion of deferred underwriting discount previously recorded in the additional paid-in capital is recorded
as a recovery in the additional paid-in capital and a portion previously expensed is recorded as a recovery in the statement of operations in year ended December 31, 2022.
Forward Purchase Agreement
On
July 2, 2020, the Company entered into a forward purchase agreement pursuant to which East Asset Management, LLC (East Asset Management), an affiliate of the Sponsor, agreed to purchase an aggregate of up to 5,000,000 units (the
forward purchase units), consisting of one share of Class A common stock (the forward purchase shares) and one-half of one warrant to purchase one share of Class A common
stock (the forward purchase warrants), for $10.00 per unit, or an aggregate maximum amount of $50,000,000, in a private placement that will close simultaneously with the closing of a Business Combination. East Asset Management was to
purchase a number of forward purchase units that would result in gross proceeds to the Company necessary to enable the Company to consummate a Business Combination and pay related fees and expenses, after first applying amounts available to the
Company from the Trust Account (after paying the deferred underwriting discount and giving effect to any redemptions of Public Shares) and any other financing source obtained by the Company for such purpose at or prior to the consummation of a
Business Combination, plus any additional amounts mutually agreed by the Company and East Asset Management to be retained by the post-business combination company for working capital or other purposes. East Asset Managements obligation to
purchase forward purchase units was, among other things, conditioned on the Business Combination (including the target assets or business, and the terms of the Business Combination) being reasonably acceptable to East Asset Management and on a
requirement that such initial Business Combination is approved by a unanimous vote of the Companys board of directors. In determining whether a target is reasonably acceptable to East Asset Management, the Company expected that East Asset
Management would consider many of the same criteria as the Company will consider but would also consider whether the investment is an appropriate investment for East Asset Management. The Forward Purchase Agreement is treated as a level 3 financial
instrument under ASC 820. This agreement was terminated on December 2, 2022. Please refer to Note 10 for additional information.
Trust
Extension
On July 25, 2022, the Company convened a special meeting of stockholders at which the First Extension Amendment
Proposal was approved, extending the date by which the Company has to complete a Business Combination from July 27, 2022 to January 27, 2023. In connection with the special meeting, the Company provided the stockholders the opportunity to
redeem all or a portion of their Class A common stock, and stockholders holding 24,781,028 shares of Class A common stock exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account. Consequently,
approximately $248,087,256 (approximately $10.01 per share) was removed from the Trust Account to pay such redeeming holders. Additionally, in connection with the approval of the First Extension Amendment Proposal, the Company issued the First
Extension Note in the principal amount of up to $1,924,356 to the Sponsor, pursuant to which the Sponsor agreed to loan the Company up to $1,924,356. The First Extension Note bears no interest and is repayable in full upon the earlier of
(a) the date of the consummation of the Companys Business Combination or (b) the date of the liquidation of the Company. In order to further extend the period the Company has to complete a Business
F-22
EAST RESOURCES ACQUISITION COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2022
Combination beyond July 27, 2022, an additional $320,726 was deposited into the Trust Account commencing on July 27, 2022 and on the 27th of each subsequent month, or portion thereof,
for each additional month that the Company requires to complete a Business Combination from July 27, 2022 until January 27, 2023.
In conjunction with the Business Combination, certain legal and advisory fees have been incurred and will become due at closing of the
Business Combination. The Company has accrued approximately $3.1 million in such legal fees and $4.8 million in advisory fees, these amounts are reflected in the consolidated financial statements as of December 31, 2022
Business Combination
On
August 30, 2022, the Company, LMA Merger Sub, Abacus Merger Sub, LMA and Abacus, entered into (the Merger Agreement), pursuant to which, subject to the satisfaction or waiver of certain conditions precedent in the Merger Agreement, (i) LMA
Merger Sub will merge with and into LMA, with LMA surviving such merger as a direct wholly owned subsidiary of the Company and (ii) Abacus Merger Sub will merge with and into Abacus, with Abacus surviving such merger as a direct wholly owned
subsidiary of the Company. The Proposed Business Combination is expected to be consummated in the first half of 2023, subject to the fulfillment of certain conditions. Subject to the terms of the Merger Agreement, the aggregate merger consideration
with respect to the holders of issued and outstanding limited liability company interests in LMA and Abacus will consist of approximately $531.8 million, payable in a number of newly issued Company Class A common stock at a deemed value of
$10.00 per share, with a portion of the aggregate merger consideration payable in cash upon the satisfaction of certain conditions.
NOTE 7.
STOCKHOLDERS EQUITY
Preferred StockThe Company is authorized to issue 1,000,000 shares of preferred stock
with a par value of $0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Companys board of directors. As of December 31, 2022 and December 31,
2021, there were no shares of preferred stock issued or outstanding.
Class A Common
StockThe Company is authorized to issue 200,000,000 shares of Class A common stock with a par value of $0.0001 per share. At December 31, 2022 and December 31, 2021, there was 0 shares of
Class A common stock issued and outstanding, excluding the 9,718,972 and 34,500,000 shares of Class A common stock subject to possible redemption at December 31, 2022 and December 31, 2021, respectively. In connection with the
special meeting convened on July 25, 2022 related to the First Extension Amendment Proposal, stockholders totaling 24,781,028 shares of Class A common stock exercised their right to redeem such shares for a pro rata portion of the funds
held in the Trust Account.
Class B Common StockThe Company is authorized to issue
20,000,000 shares of Class B common stock with a par value of $0.0001 per share. As of December 31, 2022 and December 31, 2021, there was 8,625,000 shares of Class B common stock issued and outstanding.
Common stockholders of record are entitled to one vote for each share held on all matters to be voted on by stockholders. Holders of the
Class A common stock and holders of the Class B common stock will vote together as a single class on all matters submitted to a vote of the Companys stockholders, except as required by law.
The Class B common stock are identical to the shares of Class A common stock included in the Units sold in the Initial Public
Offering, and holders of Class B common stock have the same stockholder rights as public
F-23
EAST RESOURCES ACQUISITION COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2022
stockholders, except that (i) the Class B common stock are subject to certain transfer restrictions, as described in more detail below, (ii) the Sponsor, officers and directors
have entered into a letter agreement with the Company, pursuant to which they have agreed (A) to waive their redemption rights with respect to any Class B common stock and any Public Shares held by them in connection with the completion of
a Business Combination and (B) to waive their rights to liquidating distributions from the Trust Account with respect to any Class B common stock held by them if the Company fails to complete a Business Combination within the Combination
Period, although they will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares they hold if the Company fails to complete a Business Combination within the Combination Period, (iii) the Class B
common stock will automatically convert into shares of Class A common stock at the time of a Business Combination, on a one-for-one basis, subject to adjustment
pursuant to certain anti-dilution rights and (iv) are subject to registration rights. If the Company submits a Business Combination to the public stockholders for a vote, the Sponsor has agreed to vote any Class B common stock held by it
and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination.
With certain limited
exceptions, the shares of Class B common stock are not transferable, assignable or salable (except to the Companys officers and directors and other persons or entities affiliated with the Sponsor, each of whom will be subject to the same
transfer restrictions) until the earlier of (A) one year after the completion of a Business Combination or (B) subsequent to a Business Combination, (x) if the last sale price of the Class A common stock equals or exceeds $12.00
per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business
Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of the stockholders having the right to exchange their shares of common
stock for cash, securities or other property.
NOTE 8. WARRANT LIABILITY
Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants.
The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination and (b) 12 months from the closing of the Proposed Offering. The Public Warrants will expire five years from the completion of a
Business Combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation.
The Company will not be obligated to
deliver any shares of Class A common stock pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act with respect to the shares of
Class A common stock underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration, or a valid exemption from registration is available. No
warrant will be exercisable and the Company will not be obligated to issue a share of Class A common stock upon exercise of a warrant unless the share of Class A common stock issuable upon such warrant exercise has been registered,
qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants.
The
Company has agreed that as soon as practicable, but in no event later than 20 business days after the closing of a Business Combination, it will use its commercially reasonable efforts to file with the SEC a registration statement for the
registration, under the Securities Act, of the shares of Class A common stock issuable upon exercise of the warrants. The Company will use its commercially reasonable efforts to cause the same to become effective and to maintain the
effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration or redemption of the warrants in accordance with the provisions of the warrant agreement. If a registration statement covering the issuance
of the shares of Class A common
F-24
EAST RESOURCES ACQUISITION COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2022
stock issuable upon exercise of the warrants is not effective by the 60th business day after the closing of a Business Combination, warrant holders may, until such time as there is an effective
registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a cashless basis in accordance with Section 3(a)(9) of the Securities Act or
another exemption. In addition, if the shares of Class A common stock are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a covered security under
Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of the Public Warrants who exercise their warrants to do so on a cashless basis in accordance with Section 3(a)(9) of the Securities Act
and, in the event the Company elects to do so, the Company will not be required to file or maintain in effect a registration statement, but it will use its best efforts to register or qualify the shares under applicable blue sky laws to the extent
an exemption is not available.
Redemption of Warrants for CashOnce the warrants become exercisable, the Company may redeem
the outstanding Public Warrants for cash:
|
|
|
in whole and not in part; |
|
|
|
at a price of $0.01 per warrant; |
|
|
|
upon not less than 30 days prior written notice of redemption to each warrant holder; and
|
|
|
|
if, and only if, the last sale price of the Class A common stock equals or exceeds $18.00 per share (as
adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which
the Company sends the notice of redemption to the warrant holders. |
If and when the warrants become redeemable by the
Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws. However, the Company will not redeem the warrants unless an effective
registration statement under the Securities Act covering the shares of Class A common stock issuable upon exercise of the warrants is effective and a current prospectus relating to those shares of Class A common stock is available
throughout the 30-day redemption period, except if the warrants may be exercised on a cashless basis and such cashless exercise is exempt from registration under the Securities Act.
Redemption of Warrants for Shares of Class A Common StockOnce the warrants become exercisable, the
Company may redeem the outstanding warrants for shares of Class A common stock:
|
|
|
in whole and not in part; |
|
|
|
at a price equal to a number of shares of Class A common stock to be determined by reference to the agreed
table set forth in the warrant agreement based on the redemption date and the fair market value of the Class A common stock; |
|
|
|
upon not less than 30 days prior written notice of redemption to each warrant holder; and
|
|
|
|
if, and only if, the last sale price of the Class A common stock equals or exceeds $10.00 per share (as
adjusted per share splits, share dividends, reorganizations, recapitalizations and the like) on the trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. |
The exercise price and number of shares of Class A common stock issuable upon exercise of the warrants may be adjusted in certain
circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, except as described below, the warrants will not be adjusted
F-25
EAST RESOURCES ACQUISITION COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2022
for issuance of Class A common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to
complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any
distribution from the Companys assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.
In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising
purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by
the Companys board of directors, and in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the
Newly Issued Price), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the completion of a
Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Companys shares of Class A common stock during the 20 trading day period starting on the trading day prior to the day on which the
Company completes a Business Combination (such price, the Market Value) is below $9.20 per share, the exercise price of the Public Warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and
the Newly Issued Price, and the $10.00 and $18.00 per share redemption trigger prices described above adjacent to Redemption of Warrants For Cash and Redemption of Warrants For Shares of Class A Common Stock will be
adjusted (to the nearest cent) to be equal to 100% and 180% of the higher of the Market Value and the Newly Issued Price, respectively.
The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that
(x) the Private Placement Warrants and the shares of Class A common stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business
Combination, subject to certain limited exceptions, (y) the Private Placement Warrants will be exercisable on a cashless basis and be non-redeemable so long as they are held by the initial purchasers or
their permitted transferees and (z) the Private Placement Warrants and the shares of Class A common stock issuable upon exercise of the Private Placement Warrants will be entitled to registration rights. If the Private Placement Warrants
are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.
NOTE 9. INCOME TAX
The Companys
net deferred tax assets are as follows:
|
|
|
|
|
|
|
|
|
Description |
|
December 31, 2022 |
|
|
December 31, 2021 |
|
Deferred tax assets |
|
|
|
|
|
|
|
|
Net operating loss carryforward |
|
$ |
|
|
|
$ |
57,440 |
|
Startup and organizational expenses |
|
|
753,230 |
|
|
|
322,752 |
|
|
|
|
|
|
|
|
|
|
Total deferred tax assets |
|
|
753,230 |
|
|
|
380,192 |
|
Valuation Allowance |
|
|
(753,230 |
) |
|
|
(380,192 |
) |
|
|
|
|
|
|
|
|
|
Deferred tax assets, net of allowance |
|
$ |
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
F-26
EAST RESOURCES ACQUISITION COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2022
The income tax provision consists of the following:
|
|
|
|
|
|
|
|
|
Description |
|
December 31, 2022 |
|
|
December 31, 2021 |
|
Federal |
|
|
|
|
|
|
|
|
Current |
|
|
41,592 |
|
|
|
|
|
Deferred |
|
|
(243,908 |
) |
|
|
(380,192 |
) |
State and Local |
|
|
|
|
|
|
|
|
Current |
|
|
10,893 |
|
|
|
|
|
Deferred |
|
|
(129,130 |
) |
|
|
|
|
Change in valuation allowance |
|
|
373,038 |
|
|
|
380,192 |
|
|
|
|
|
|
|
|
|
|
Income tax provision |
|
$ |
52,485 |
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
As of December 31, 2022 and December 31, 2021, the Company had $0, and $273,522 of U.S.
federal net operating loss carryovers, which do not expire, available to offset future taxable income, respectively.
In assessing the
realization of the deferred tax assets, management considers whether it is more likely than not that some portion of all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the
generation of future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable
income and tax planning strategies in making this assessment. After consideration of all of the information available, management believes that significant uncertainty exists with respect to future realization of the deferred tax assets and has
therefore established a full valuation allowance. For the years ended December 31, 2022 and 2021, the change in the valuation allowance was $373,038 and $380,192, respectively.
A reconciliation of the federal income tax rate to the Companys effective tax rate is as follows:
|
|
|
|
|
|
|
|
|
Description |
|
December 31, 2022 |
|
|
December 31, 2021 |
|
Statutory federal income tax rate |
|
|
21.0 |
% |
|
|
21.0 |
% |
State taxes, net of federal tax benefit |
|
|
20.39 |
% |
|
|
|
% |
Merger costs |
|
|
(358.38 |
)% |
|
|
|
% |
Change in fair value of warrants |
|
|
331.68 |
% |
|
|
(21.1 |
)% |
Change in fair value of forward purchase agreement liability |
|
|
21.32 |
% |
|
|
(1.7 |
)% |
Deferred underwriting fees |
|
|
18.23 |
% |
|
|
|
% |
Valuation allowance |
|
|
(63.11 |
)% |
|
|
1.8 |
% |
|
|
|
|
|
|
|
|
|
Income tax provision |
|
|
(8.87 |
)% |
|
|
(0.0 |
)% |
|
|
|
|
|
|
|
|
|
The Company files income tax returns in the U.S. federal jurisdiction and is subject to examination
by the various taxing authorities. The Companys tax returns since inception remain open to examination by the taxing authorities. The Company considers Florida to be a significant state tax jurisdiction.
F-27
EAST RESOURCES ACQUISITION COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2022
NOTE 10. FAIR VALUE MEASUREMENTS
The following table presents information about the Companys assets and liabilities that are measured at fair value on a recurring basis
at December 31, 2022 and December 31, 2021, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Description |
|
Level |
|
|
December 31, 2022 |
|
|
Level |
|
|
December 31, 2021 |
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Marketable securities held in Trust Account |
|
|
1 |
|
|
|
99,222,704 |
|
|
|
1 |
|
|
|
345,048,888 |
|
|
|
|
|
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant LiabilityPublic Warrants |
|
|
1 |
|
|
|
3,018,750 |
|
|
|
1 |
|
|
|
9,177,000 |
|
Warrant LiabilityPrivate Placement Warrants |
|
|
2 |
|
|
|
1,557,500 |
|
|
|
2 |
|
|
|
4,734,800 |
|
Forward Purchase Agreement Liability |
|
|
3 |
|
|
|
|
|
|
|
3 |
|
|
|
1,600,000 |
|
The Public Warrants and Private Placement Warrants (collectively, the Warrants) and
forward purchase agreement were accounted for as liabilities in accordance with ASC 815-40 and are presented separately in the condensed balance sheets. The warrant liabilities and forward purchase agreement
liability are measured at fair value at inception and on a recurring basis, with changes in fair value presented separately in the condensed statements of operations.
The following table presents the roll forward for the Level 3 Derivative liabilities as of December 31, 2022 and 2021:
|
|
|
|
|
Level 3 Derivative liabilities as of December 31, 2021 |
|
$ |
1,600,000 |
|
Change in fair value of forward purchase agreement |
|
|
(600,000 |
) |
Cancelation of forward purchase agreement |
|
|
(1,000,000 |
) |
|
|
|
|
|
Level 3 Derivative liabilities as of December 31, 2022 |
|
$ |
|
|
|
|
|
|
|
Level 3 Derivative liabilities as of December 31, 2020 |
|
$ |
13,046,000 |
|
Change in fair value of Private Placement Warrants |
|
|
(5,411,200 |
) |
Change in fair value of forward purchase agreement |
|
|
(1,300,000 |
) |
Transfer from Level 3 to Level 2 derivative Private Placement Warrants |
|
|
(4,734,800 |
) |
|
|
|
|
|
Level 3 Derivative liabilities as of December 31, 2021 |
|
$ |
1,600,000 |
|
|
|
|
|
|
The subsequent measurements of the Public Warrants after the detachment of the Public Warrants from
the Units on September 14, 2020 were classified as Level 1 due to the use of an observable market quote in an active market. For periods subsequent to the detachment of the Public Warrants from the Units, the close price of the Public
Warrant price will be used as the fair value as of each relevant date. The Private Placement Warrants are considered to be a Level 2 fair value measurement and are valued the same as Public Warrant even though they are not traded on the market.
The Private Placement Warrants were considered a Level 3 fair value measurement prior to Quarterly period ended September 30, 2021 using a binomial lattice model. The binomial lattice models primary unobservable input utilized in
determining the fair value of the Warrants is the expected volatility of the common stock. The expected volatility as of the Initial Public Offering date was derived from observable public warrant pricing on comparable blank-check
companies without an identified target.
F-28
EAST RESOURCES ACQUISITION COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2022
The following table presents the changes in the fair value of warrant liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Private Placement |
|
|
Public |
|
|
Warrant Liabilities |
|
Investment liabilities as of December 31, 2021 |
|
$ |
4,734,800 |
|
|
$ |
9,177,000 |
|
|
$ |
13,911,800 |
|
Change in valuation inputs or other assumptions |
|
|
(3,177,300 |
) |
|
|
(6,158,250 |
) |
|
|
(9,335,550 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment liabilities as of December 31, 2022 |
|
$ |
1,557,500 |
|
|
$ |
3,018,750 |
|
|
$ |
4,576,250 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative liabilities as of December 31, 2020 |
|
$ |
10,146,000 |
|
|
$ |
19,665,000 |
|
|
$ |
29,811,000 |
|
Change in valuation inputs or other assumptions |
|
|
(5,411,200 |
) |
|
|
(10,488,000 |
) |
|
|
(15,899,200 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value as of December 31, 2021 |
|
$ |
4,734,800 |
|
|
$ |
9,177,000 |
|
|
$ |
13,911,800 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The forward purchase agreement was valued using the publicly traded price of the Companys
Units, based upon the fact that the Forward Purchase Units are equivalent to the Companys publicly traded Units, and the publicly traded price of the Units considered (i) the markets expectation of an initial Business Combination
and (ii) the Companys redemption of the common stock within the Units at $10.00 per shares if an initial Business Combination does not occur. The forward purchase agreement was terminated on December 2, 2022.
The following table presents the quantitative information regarding Level 3 fair value measurements of the forward purchase agreement:
|
|
|
|
|
|
|
December 31, 2021 |
|
Unit price |
|
$ |
10.31 |
|
Term to initial business combination (in years) |
|
|
0.5 |
|
Risk-free rate |
|
|
0.19 |
% |
Dividend yield |
|
|
0.0 |
% |
The following table presents the changes in the fair value of the forward purchase agreement
liability:
|
|
|
|
|
Fair value as of December 31, 2021 |
|
$ |
1,600,000 |
|
Change in fair value |
|
|
(600,000 |
) |
Cancelation of forward purchase agreement |
|
|
(1,000,000 |
) |
|
|
|
|
|
Fair value as of December 31, 2022 |
|
$ |
|
|
|
|
|
|
|
Fair value as of December 31, 2020 |
|
|
2,900,000 |
|
Change in fair value |
|
|
(1,300,000 |
) |
|
|
|
|
|
Fair value as of December 31, 2021 |
|
$ |
1,600,000 |
|
|
|
|
|
|
F-29
EAST RESOURCES ACQUISITION COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2022
NOTE 11. SUBSEQUENT EVENTS
The Company evaluates subsequent events and transactions that occurred after the balance sheet date up to the date that the financial
statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.
On January 20, 2023, the Company convened a special meeting of stockholders at which the Second Extension Amendment Proposal to extend
the date by which the Company has to complete a Business Combination from January 27, 2023 to July 27, 2023 was approved. In connection with the special meeting, stockholders were provided an opportunity to redeem all or a portion of their
Class A common stock, and stockholders holding 6,862,925 shares of Class A common stock exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account. Consequently, approximately $70,070,464
(approximately $10.21 per share) was removed from the Trust Account to pay such redeeming holders. Additionally, in connection with the approval of the Second Extension Amendment Proposal, the Company issued the Second Extension Note in the
principal amount of up to $565,497 to the Sponsor, pursuant to which the Sponsor agreed to loan us up to $565,497. The Second Extension Note bears no interest and is repayable in full upon the earlier of (a) the date of consummation of
Companys Business Combination or (b) the date of liquidation of the Company. In order to further extend the period the Company has to complete a Business Combination beyond the 27th of a given month until July 27, 2023, the Sponsor
will deposit an additional $94,250 into the Trust Account commencing on January 27, 2023 and on the 27th of each subsequent month until July 27, 2023. As of April 17, 2023, $282,750 has been deposited into Trust Account by the
Sponsor.
F-30
Longevity Market
Assets, LLC
Consolidated Financial Statements as of and
for the Years Ended December 31, 2022 and
2021, and
Report of Independent Registered
Public Accounting Firm
F-31
LONGEVITY MARKET ASSETS, LLC
TABLE OF CONTENTS
F-32
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM
Members
Longevity Market
Assets, LLC
Opinion on the financial statements
We
have audited the accompanying consolidated balance sheets of Longevity Market Assets, LLC (a Florida limited liability company) and subsidiaries (the Company) as of December 31, 2022 and 2021, the related consolidated statements of
operations and comprehensive income (loss), changes in members equity, and cash flows for each of the two years in the period ended December 31, 2022, and the related notes (collectively referred to as the financial
statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and the results of its operations and its cash flows for each
of the two years in the period ended December 31, 2022, in conformity with accounting principles generally accepted in the United States of America.
Basis for opinion
These financial statements are the
responsibility of the Companys management. Our responsibility is to express an opinion on the Companys financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight
Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the
PCAOB.
We conducted our audits in accordance with the standards of the PCAOB and in accordance with auditing standards generally accepted in the United
States of America. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to
have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an
opinion on the effectiveness of the Companys internal control over financial reporting. Accordingly, we express no such opinion.
Our audits
included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis,
evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the
financial statements. We believe that our audits provide a reasonable basis for our opinion.
F-33
|
|
|
We have served as the Companys auditor since |
|
2022. Philadelphia, Pennsylvania |
March 24, 2023 |
F-34
LONGEVITY MARKET ASSETS, LLC
CONSOLIDATED BALANCE SHEETS
AS OF DECEMBER 31, 2022 AND 2021
|
|
|
|
|
|
|
|
|
|
|
2022 |
|
|
2021 |
|
ASSETS |
|
|
|
|
|
|
|
|
CURRENT ASSETS: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
30,052,823 |
|
|
$ |
102,420 |
|
Accounts receivable |
|
|
10,448 |
|
|
|
|
|
Related party receivable |
|
|
198,364 |
|
|
|
67,491 |
|
Due from affiliates |
|
|
2,904,646 |
|
|
|
|
|
Prepaid expenses and other current assets |
|
|
116,646 |
|
|
|
24,905 |
|
|
|
|
|
|
|
|
|
|
Total current assets |
|
|
33,282,927 |
|
|
|
194,816 |
|
PROPERTY AND EQUIPMENTNet |
|
|
18,617 |
|
|
|
22,899 |
|
OTHER ASSETS |
|
|
|
|
|
|
|
|
Operating
right-of-use asset |
|
|
77,011 |
|
|
|
122,503 |
|
Life settlement policies, at cost |
|
|
8,716,111 |
|
|
|
|
|
Life settlement policies, at fair value |
|
|
13,809,352 |
|
|
|
|
|
Available for sale securities, at fair value |
|
|
1,000,000 |
|
|
|
250,000 |
|
Other investments |
|
|
1,300,000 |
|
|
|
1,250,000 |
|
Other non-current assets, at fair value |
|
|
890,829 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL ASSETS |
|
$ |
59,094,847 |
|
|
$ |
1,840,218 |
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND MEMBERS EQUITY |
|
|
|
|
|
|
|
|
CURRENT LIABILITIES: |
|
|
|
|
|
|
|
|
Accounts payable |
|
$ |
40,014 |
|
|
$ |
|
|
Due to affiliates |
|
|
263,785 |
|
|
|
930,630 |
|
Operating lease liabilities- current portion |
|
|
48,127 |
|
|
|
45,107 |
|
Accrued transaction costs |
|
|
908,256 |
|
|
|
|
|
Other current liabilities |
|
|
42,227 |
|
|
|
20,192 |
|
|
|
|
|
|
|
|
|
|
Total current liabilities |
|
|
1,302,409 |
|
|
|
995,929 |
|
|
|
|
|
|
|
|
|
|
Long-term debt, at fair value |
|
|
28,249,653 |
|
|
|
|
|
Operating lease liabilities- noncurrent portion |
|
|
29,268 |
|
|
|
77,396 |
|
|
|
|
|
|
|
|
|
|
Deferred tax liability |
|
|
1,363,820 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL LIABILITIES |
|
|
30,945,150 |
|
|
|
1,073,325 |
|
|
|
|
|
|
|
|
|
|
COMMITMENTS AND CONTINGENCIES (Note 9) |
|
|
|
|
|
|
|
|
MEMBERS EQUITY: |
|
|
|
|
|
|
|
|
Common units, $10.00 par value; 5,000 common units issued and outstanding at December 31,
2022 and 2021 |
|
|
50,000 |
|
|
|
50,000 |
|
Additional paid-in capital |
|
|
660,000 |
|
|
|
660,000 |
|
Retained earnings |
|
|
25,487,323 |
|
|
|
205,048 |
|
Accumulated other comprehensive income |
|
|
1,052,836 |
|
|
|
|
|
Non-controlling interest |
|
|
899,538 |
|
|
|
(148,155 |
) |
|
|
|
|
|
|
|
|
|
Total members equity |
|
|
28,149,697 |
|
|
|
766,893 |
|
|
|
|
|
|
|
|
|
|
TOTAL LIABILITIES AND EQUITY |
|
$ |
59,094,847 |
|
|
$ |
1,840,218 |
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these consolidated financial statements.
F-35
LONGEVITY MARKET ASSETS, LLC
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021
|
|
|
|
|
|
|
|
|
|
|
2022 |
|
|
2021 |
|
REVENUES: |
|
|
|
|
|
|
|
|
Portfolio servicing revenue |
|
|
|
|
|
|
|
|
Related party servicing revenue |
|
$ |
818,300 |
|
|
$ |
699,884 |
|
Portfolio Servicing revenue |
|
|
652,672 |
|
|
|
380,102 |
|
|
|
|
|
|
|
|
|
|
Total portfolio servicing revenue |
|
|
1,470,973 |
|
|
|
1,079,986 |
|
Active management revenue |
|
|
|
|
|
|
|
|
Investment Income from life insurance policies held using investment method |
|
|
37,828,829 |
|
|
|
120,000 |
|
Change in fair value of life insurance policies (policies held using fair value method) |
|
|
5,413,751 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total active management revenue |
|
|
43,242,581 |
|
|
|
120,000 |
|
|
|
|
Total revenues |
|
|
44,713,553 |
|
|
|
1,199,986 |
|
|
|
|
COST OF REVENUES (Excluding depreciation stated below) |
|
|
6,245,131 |
|
|
|
735,893 |
|
|
|
|
|
|
|
|
|
|
Gross profit |
|
|
38,468,422 |
|
|
|
464,093 |
|
|
|
|
OPERATING EXPENSES: |
|
|
|
|
|
|
|
|
Sales and marketing |
|
|
2,596,140 |
|
|
|
|
|
General, administrative and other |
|
|
1,066,403 |
|
|
|
101,406 |
|
Change in fair value of debt |
|
|
90,719 |
|
|
|
|
|
Unrealized loss on investments |
|
|
1,045,623 |
|
|
|
|
|
Other operating expenses |
|
|
|
|
|
|
493,849 |
|
Depreciation |
|
|
4,282 |
|
|
|
2,447 |
|
|
|
|
|
|
|
|
|
|
Total operating expenses |
|
|
4,803,168 |
|
|
|
597,702 |
|
|
|
|
|
|
|
|
|
|
Operating income (loss) |
|
|
33,665,255 |
|
|
|
(133,609 |
) |
|
|
|
|
|
|
|
|
|
OTHER (EXPENSE) INCOME |
|
|
|
|
|
|
|
|
Interest (expense), net |
|
|
(41,324 |
) |
|
|
|
|
Other (expense) |
|
|
(347,013 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total other (expense) income |
|
|
(388,337 |
) |
|
|
|
|
Net income (loss) before tax |
|
|
33,276,917 |
|
|
|
(133,609 |
) |
|
|
|
|
|
|
|
|
|
Income tax expense |
|
|
889,943 |
|
|
|
|
|
|
|
|
NET INCOME (LOSS) |
|
|
32,386,975 |
|
|
|
(133,609 |
) |
|
|
|
LESS: NET INCOME (LOSS) ATTRIBUTABLE TO NONCONTROLLING INTEREST |
|
|
704,699 |
|
|
|
(148,155 |
) |
|
|
|
|
|
|
|
|
|
NET INCOME ATTRIBUTABLE TO LONGEVITY MARKET ASSETS, LLC |
|
$ |
31,682,275 |
|
|
$ |
14,546 |
|
|
|
|
|
|
|
|
|
|
EARNINGS PER UNIT: |
|
|
|
|
|
|
|
|
Basic earnings per unit |
|
$ |
6,477.39 |
|
|
$ |
2.91 |
|
Diluted earnings per unit |
|
$ |
6,477.39 |
|
|
$ |
2.91 |
|
Weighted average shares outstandingbasic |
|
|
5,000 |
|
|
|
5,000 |
|
Weighted average shares outstandingdiluted |
|
|
5,000 |
|
|
|
5,000 |
|
|
|
|
NET INCOME |
|
|
32,386,975 |
|
|
|
|
|
Other comprehensive income, net of tax: |
|
|
|
|
|
|
|
|
Change in fair value of debt |
|
|
1,395,829 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income before non-controlling
interests |
|
|
33,782,804 |
|
|
|
|
|
Less: Net income attributable to non-controlling
interests |
|
|
704,699 |
|
|
|
|
|
Less: Comprehensive income attributable to non-controlling
interests |
|
|
342,994 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income attributable to Longevity Market Assets, LLC |
|
$ |
32,735,111 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these consolidated financial statements.
F-36
LONGEVITY MARKET ASSETS, LLC
CONSOLIDATED STATEMENTS OF CHANGES IN MEMBERS EQUITY
FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Units |
|
|
Additional
Paid-In
Capital |
|
|
Retained
Earnings |
|
|
Non-
Controlling
Interests |
|
|
Accumulated
Other Comprehensive
Income |
|
|
Total
Members
Equity |
|
|
|
Units |
|
|
Amount |
|
BALANCE AS OF DECEMBER 31, 2021 |
|
|
1,000 |
|
|
$ |
50,000 |
|
|
$ |
660,000 |
|
|
$ |
590,502 |
|
|
$ |
|
|
|
|
|
|
|
$ |
1,300,502 |
|
Distributions |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(400,000 |
) |
|
|
|
|
|
|
|
|
|
$ |
(400,000 |
) |
Net income (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14,546 |
|
|
|
(148,155 |
) |
|
|
|
|
|
$ |
(133,609 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BALANCE AS OF DECEMBER 31, 2021 |
|
|
1,000 |
|
|
|
50,000 |
|
|
|
660,000 |
|
|
|
205,048 |
|
|
|
(148,155 |
) |
|
|
|
|
|
|
766,893 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distributions |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(6,400,000 |
) |
|
|
|
|
|
|
|
|
|
$ |
(6,400,000 |
) |
Other Comprehensive Income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
342,994 |
|
|
|
1,052,836 |
|
|
$ |
1,395,829 |
|
Net income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31,682,275 |
|
|
|
704,699 |
|
|
|
|
|
|
$ |
32,386,975 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BALANCE AS OF DECEMBER 31, 2022 |
|
|
5,000 |
|
|
$ |
50,000 |
|
|
$ |
660,000 |
|
|
$ |
25,487,323 |
|
|
$ |
899,538 |
|
|
$ |
1,052,836 |
|
|
$ |
28,149,697 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-37
LONGEVITY MARKET ASSETS, LLC
CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021
|
|
|
|
|
|
|
|
|
|
|
2022 |
|
|
2021 |
|
CASH FLOWS FROM OPERATING ACTIVITIES: |
|
|
|
|
|
|
|
|
Net income (loss) |
|
$ |
32,386,975 |
|
|
$ |
(133,609 |
) |
Adjustments to reconcile net income (loss) to net cash provided by operating activities: |
|
|
|
|
|
|
|
|
Depreciation |
|
|
4,282 |
|
|
|
2,447 |
|
Unrealized loss on investments |
|
|
1,045,623 |
|
|
|
|
|
Unrealized (gain) on policies |
|
|
(5,742,377 |
) |
|
|
|
|
Change in fair value of debt |
|
|
90,719 |
|
|
|
|
|
Income tax expense |
|
|
889,943 |
|
|
|
|
|
Non-cash lease expense |
|
|
383 |
|
|
|
|
|
Changes in operating assets and liabilities: |
|
|
|
|
|
|
|
|
Accounts receivable |
|
|
(10,448 |
) |
|
|
|
|
Related party receivable |
|
|
(130,873 |
) |
|
|
(11,047 |
) |
Other receivable |
|
|
|
|
|
|
18,315 |
|
Prepaid expenses |
|
|
(91,741 |
) |
|
|
(23,738 |
) |
Other noncurrent assets |
|
|
(1,936,452 |
) |
|
|
|
|
Accounts payable |
|
|
40,014 |
|
|
|
|
|
Accrued transaction costs |
|
|
908,256 |
|
|
|
|
|
Other current liabilities |
|
|
22,035 |
|
|
|
8,463 |
|
Life Settlement Policies purchased, at fair value |
|
|
(8,066,975 |
) |
|
|
|
|
Life Settlement Policies purchased, at cost |
|
|
(8,716,111 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by/(used in) operating activities |
|
|
10,693,254 |
|
|
|
(139,169 |
) |
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM INVESTING ACTIVITIES: |
|
|
|
|
|
|
|
|
Purchase of property and equipment |
|
|
|
|
|
|
(25,346 |
) |
Purchase of available for sale securities |
|
|
(750,000 |
) |
|
|
(250,000 |
) |
Purchase of other investments, at cost |
|
|
(50,000 |
) |
|
|
|
|
Due from affiliates |
|
|
(2,904,646 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash (used in) investing activities |
|
|
(3,704,646 |
) |
|
|
(275,346 |
) |
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM FINANCING ACTIVITIES: |
|
|
|
|
|
|
|
|
Issuance of long term debt, at fair value |
|
|
30,028,640 |
|
|
|
|
|
Due to affiliates |
|
|
(666,845 |
) |
|
|
781,663 |
|
Member capital distribution |
|
|
(6,400,000 |
) |
|
|
(400,000 |
) |
|
|
|
|
|
|
|
|
|
Net cash provided by/(used in) financing activities |
|
|
22,961,795 |
|
|
|
381,663 |
|
|
|
|
|
|
|
|
|
|
NET INCREASE (DECREASE) IN CASH |
|
|
29,950,403 |
|
|
|
(32,852 |
) |
CASH AT THE BEGINNING OF THE YEAR |
|
|
102,420 |
|
|
|
135,272 |
|
|
|
|
|
|
|
|
|
|
CASH AT THE END OF THE YEAR |
|
$ |
30,052,823 |
|
|
$ |
102,420 |
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these consolidated financial statements.
F-38
LONGEVITY MARKET ASSETS, LLC
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021
1. |
DESCRIPTION OF BUSINESS |
Longevity Market Assets, LLC (together with its subsidiaries, the Company or LMA) was formed in February 2017 as
Abacus Life Services, LLC in the state of Florida and subsequently changed its name in February 2022. The Company is a provider of services pertaining to life insurance settlements and offers policy servicing to owners and purchasers of life
settlement assets, as well as consulting, valuation, and actuarial services. The Company offers value to the owners of life settlements by monitoring and maintaining the policy, and performing all administrative work involved to keep the policy in
force and at the premium level most advantageous to the owner.
The Company is also engaged in buying and selling of life settlement
policies in which it uses its own capital, and purchases life settlement contracts with the intent to either hold to maturity to receive the associated death claim payout, or to sell to another purchaser of life settlement contracts for a gain on
the sale. The Company is headquartered in Orlando, Florida.
On August 30, 2022, the Company entered into an Agreement and Plan of
Merger (the Merger Agreement) with East Resources Acquisition Company (ERES), which was subsequently amended on October 14, 2022 and April 20, 2023. As part of the Merger Agreement, the total transaction value is
$618,000,000, where the holders of the Companys common units together with the holders of Abacus Settlements, LLC (Abacus), a commonly owned affiliate, will receive aggregate consideration of approximately $531,800,000, payable in
a number of newly issued shares of ERES Class A common stock, par value $0.0001 per share (ERES Class A common stock), with a value ascribed to each share of ERES Class A common stock of $10.00 and, to the extent the
aggregate transaction proceeds exceed $200.0 million, at the election of the Companys and Abacuss members, up to $20.0 million will be payable in cash to the Companys and Abacuss members. The transaction is expected
to close in Q2 2023, subject to shareholder approval and customary closing conditions. The Company has accrued $908,226 of legal, advisory and audit fees related to the pending merger transaction, which have been included in Accrued Transaction
Costs on the Consolidated Balance Sheets.
2. |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES |
Basis of PresentationThe accompanying consolidated financial statements of the Company have been prepared in accordance with the
rules and regulations of the Securities and Exchange Commission (SEC) and are prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP). These statements include the
financial statements of Longevity Market Assets, LLC and its wholly owned and controlled subsidiaries and subsidiaries in which the Company holds a controlling financial interest or is the primary beneficiary. Intercompany transactions and
accounts have been eliminated in consolidation.
Consolidation of Variable Interest EntitiesFor entities in which the Company
has variable interests, the Company first evaluates whether the entity meets the definition of a variable interest entity (VIE) or a voting interest entity (VOE). If the entity is a VIE, the Company focuses on identifying
whether it has the power to direct the activities that most significantly impact the VIEs economic performance and whether it has the obligation to absorb losses or the right to receive benefits from the VIE. If the Company is the primary
beneficiary of a VIE, the assets, liabilities, and results of operations of the variable interest entity will be included in the Companys consolidated financial statements. The proportionate share not owned by the Company is recognized as
Noncontrolling interest and Net income (loss) attributable to noncontrolling interest on the Consolidated Balance Sheets and Consolidated Statements of Operations and Comprehensive (Loss) Income, respectively. If the entity is a VOE, the Company
evaluates whether it has the power to control the VOE through a majority voting interest or through other arrangements.
F-39
Accounting Standards Codification (ASC) Topic 810, Consolidations,
requires the Company to separately disclose on its Consolidated Balance Sheets the assets of consolidated VIEs and liabilities of consolidated VIEs as to which there is no recourse against the Company. As of December 31, 2022, total assets and
liabilities of consolidated VIEs is $30,073,972 and $27,116,762, respectively. As of December 31, 2021, total assets and liabilities of consolidated VIEs is $400 and $0, respectively.
On October 4, 2021, the Company entered into an Operating Agreement with LMX Series, LLC (LMX) and three other
unaffiliated investors to obtain a 70% ownership interest in LMX, which was newly formed in August 2021. LMX had no operating activity prior to the Operating Agreement being signed. LMX has a wholly owned subsidiary, LMATT
Series 2024, Inc., a Delaware C-Corporation. While the Company and three other investors each contributed $100 to LMX, the Company directs the most significant activities by managing the investment
offerings, and sponsoring and creating structured investment grade insurance liabilities, and thus was provided a 70% ownership interest. LMX is a VIE and the Company is the primary beneficiary of LMX. The Company has included the results of LMX and
its subsidiaries in its consolidated financial statements for the year ended December 31, 2022.
On March 3, 2022, the Company
formed Longevity Market Advisors, LLC (Longevity Market Advisors), which the Company has an 80% ownership interest in. The Longevity Market Advisors legal entity was established primarily for the purpose of acquiring the assets of a
broker/dealer, Regional Investment Services, Inc. (RIS), an Ohio corporation. Longevity Market Advisors is a VIE and the Company is the primary beneficiary of Longevity Market Advisors. The purchase price in exchange for RIS was $60,000.
The Company evaluated whether this represented a business combination or an asset acquisition under ASC 805. While the purchase of RIS represents a business, it was further determined that as RIS was purchased for the primary reason of being
registered by the Financial Industry Regulatory Authority (FINRA). As there are no tangible or intangible assets of value from RIS that would meet the capitalization criteria that have standalone value, the Company has expensed the
purchase in general and administrative costs. Upon closing of the transaction, Longevity Market Advisors will comprise 100% of the ownership structure of RIS, and RIS will be a wholly owned subsidiary. The Company has included the results of
Longevity Market Advisors and its subsidiaries in its consolidated financial statements for the year ended December 31, 2022.
On
November 30, 2022, LMA Series, LLC, a wholly owned subsidiary of the Company, signed an Operating Agreement to be the sole member of a newly created general partnership, LMA Income Series, GP, LLC. Subsequent to that, LMA Income Series, GP, LLC
formed a limited partnership, LMA Income Series, LP and issued partnership interests to limited partners in a private placement offering. It was determined that LMA Series, LLC is the primary beneficiary of LMA Income Series, LP and thus has fully
consolidated the limited partnership in its consolidated financial statements for the year ended December 31, 2022.
Non-Consolidated Variable Interest EntitiesOn January 1, 2021, the Company entered into an option agreement with two commonly owned full-service origination, servicing and investment providers
(the Providers) in which the Company agreed to fund certain capital needs with an option to purchase the outstanding equity ownership of the Providers.
The Company accounted for its investment in the call options as an equity security, pursuant to ASC 321. In arriving at this accounting
conclusion, the Company first considered whether the call option met the definition of a derivative pursuant to ASC 815 and concluded that it did not as the instrument does not provide for net settlement and accordingly is not a derivative. The
Company also concluded that the call option does not provide the Company with a controlling financial interest in the legal entity pursuant to ASC 810. The call option includes material contingencies prior to exercisability that the Company does not
anticipate will be resolved; additionally, the call option is in a legal entity for which the share price has no readily determinable fair value. The Companys basis in the call option, pursuant to ASC 321, is zero and accordingly the call
option is not reflected in the statement of financial position.
F-40
The Company provided $347,013 of funding for the year ended December 31, 2022 which
is included in Other (Expense) Income on the Consolidated Statements of Operations and Comprehensive Income (Loss) and $120,000 of funding for the year ended December 31, 2021 which was repaid in full by the Providers during that same year. See
Note 9, Commitments and Contingencies.
For the years ended December 31, 2022 and 2021, the Providers were considered to
be VIEs, but were not consolidated in the Companys consolidated financial statements due to a lack of the power criterion or the losses/benefits criterion. For the year ended December 31, 2022, the unaudited financial information for the
unconsolidated VIEs are as follows: held assets of $126,040 and liabilities of $0 and held assets of $861,924 and liabilities of $358,586, respectively. As of December 31, 2021, unaudited financial information for the non-consolidated VIEs were as follows: held assets of $122,279 and liabilities of $0 and held assets of $474,288 and liabilities of $2,218, respectively.
Noncontrolling InterestNoncontrolling interest represents the share of consolidated entities owned by third parties. At the date
of formation or upon acquisition, the Company recognizes noncontrolling interest on the Consolidated Balance Sheets at an amount equal to the noncontrolling interests proportionate share of the relative fair value of any assets and liabilities
acquired. Noncontrolling interest is subsequently adjusted for the noncontrolling shareholders additional contributions, distributions, and the shareholders share of the net earnings or losses of each respective consolidated entity.
Net income of a consolidated entity is allocated to noncontrolling interests based on the noncontrolling shareholders ownership interest
during the period. The net income or loss that is not attributable to the Company is reflected in Net income (loss) attributable to noncontrolling interests in the Consolidated Statement of Operations and Comprehensive Income (Loss).
Use of Estimates The preparation of U.S. GAAP financial statements requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and changes therein, and disclosure of contingent assets and liabilities at the date of financial statements and the reports amounts of revenue and expenses during the reporting periods.
The Companys estimates, judgments and assumptions are continually evaluated based on available information and experience. Because of the use of estimates inherent in the financial reporting process, actual results could differ from the
estimates. Estimates are used when accounting for revenue recognition and related costs, the selection of useful lives of property and equipment, valuation of other receivables, valuation of other investments, valuation of life settlement policies,
valuation of available for sale securities, impairment testing, income taxes and legal reserves.
Life Insurance Settlement
PoliciesThe Company accounts for its holdings of life insurance settlement policies in accordance with ASC 325-30, Investments in Insurance Contracts. The Company accounts for life
settlement policies purchased that it intends to hold to maturity at fair value and life settlement policies that it intends to trade in the near term at cost plus premiums paid.
The Company follows ASC 820, Fair Value Measurements and Disclosures, in estimating the fair value of its life insurance policies
held at fair value. ASC 820 defines fair value as an exit price representing the amount that would be received if an asset were sold or that would be paid to transfer a liability in an orderly transaction between market participants at the
measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the guidance
establishes a three-level, fair value hierarchy that prioritizes the inputs used to measure fair value. Level 1 relates to quoted prices in active markets for identical assets or liabilities. Level 2 relates to observable inputs other than
quoted prices included in Level 1. Level 3 relates to unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The Companys valuation of life
settlements is considered to be Level 3, as there is currently no active market where it is able to observe quoted prices for identical assets. The Companys valuation model incorporates significant inputs that are not observable. See
Note 10, Fair Value Measurements. For policies held at fair value, changes in fair value are reflected in operations in the period the change is calculated.
F-41
For policies held under the investment method, the Company tests the impairment if it
becomes aware of information indicating that the carrying value plus undiscounted future premiums of a policy may not be recoverable. This information is gathered initially through extensive underwriting procedures at purchase of the settlement
contract, as well as through periodic underwriting review that includes medical reports and life expectancy evaluations. The policies held by the Company using the investment method are expected to be owned for a shorter-term and are actively
marketed to potential buyers. The market feedback received through these interactions provides the Company with information related to a potential impairment. If a policy is determined to be impaired, the Company will adjust the carrying value to
the fair value determined through the impairment analysis.
The Company accounts for cash proceeds from sale and maturity of life insurance
settlement policies, as well as cash outflows for premium payments, as operating activities within the Consolidated Statements of Cash Flows.
Going ConcernManagement evaluates at each annual and interim period whether there are conditions or events, considered in the
aggregate, that raise substantial doubt about Companys ability to continue as a going concern within one year after the date that the consolidated financial statements are issued. Managements evaluation is based on relevant conditions
and events that are known and reasonably knowable at the date that the consolidated financial statements are issued. Management has concluded that there are no conditions or events, considered in the aggregate, that raise substantial doubt about
Companys ability to continue as a going concern within one year after the date these consolidated financial statements were issued.
Cash and Cash EquivalentsCash and cash equivalents include short-term and all
highly-liquid debt instruments purchased with an original maturity of three months or less.
Fair Value MeasurementsThe following fair value hierarchy is used in selecting inputs for those assets and liabilities measured at
fair value that distinguishes between assumptions based on market data (observable inputs) and the Companys assumptions (unobservable inputs). The Company evaluates these inputs and recognizes transfers between levels, if any, at the end of
each reporting period. The hierarchy consists of three levels:
Level 1Valuation based
on quoted market prices in active markets for identical assets or liabilities.
Level 2Valuation based on inputs other than Level 1 inputs that are observable for
the assets or liabilities either directly or indirectly.
Level 3Valuation based on
prices or valuation techniques that require inputs that are both significant to the fair value measurement and supported by little or no observable market activity.
The Companys financial instruments consist of cash, cash equivalents, accounts receivables, due to affiliates, equity investments in
privately held companies, S&P options, life settlement policies, available for sale securities, market-indexed debt and secured borrowings. Cash, cash equivalents, accounts receivables, and due to affiliates are stated at their carrying value,
which approximates fair value due to the short time to the expected receipt or payment date.
Equity investments in privately held
companies without readily determinable fair values are recognized at fair value on a nonrecurring basis when observable price changes from orderly transactions for identical or similar investments become available. Available-for-sale securities are measured at fair value using inputs that are not readily determinable. Unrealized holding gains and losses are excluded from earnings and reported in other comprehensive
income until realized.
S&P options are recognized at fair value using quoted market prices in active markets, with changes in fair
value included in net income. Market-indexed debt is measured on a quarterly basis, with qualifying changes in fair value recognized in net income, except for the portion of the total change in the fair value of the liability that results from a
change in the instrument-specific credit risk, which is separately included in
F-42
other comprehensive income in accordance with ASC 825-10-45-5. The
measurement approach for life settlement policies is included above within the Life Settlement Policies disclosure.
Related party
receivablesRelated party receivable are amounts owed to the Company by related party customers for services delivered. Management regularly reviews customer accounts for collectability and will record an allowance for these accounts when
deemed necessary. Management determines the allowance for credit losses based on a review of outstanding receivables, historical collection experience, current economic conditions, and reasonable and supportable forecasts. Related party receivables
are charged off against the allowance for credit losses when deemed uncollectible (after all means of collection have been exhausted and the potential for recovery is deemed remote). Recoveries of related party receivables previously written off are
recorded when received. Due to the nature of operations, related party receivables are due primarily from parties which the Company serves. As a result, management deems all amounts due to be collectable. If the financial condition of the
Companys customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required. The Company did not record material allowance for credit losses as of December 31, 2022 and
December 31, 2021, respectively.
Other InvestmentsEquity investments without readily determinable fair values include
the Companys investments in privately-held companies in which the Company holds less than a 20% ownership interest and does not have the ability to exercise significant influence. The Company measures these investments at cost, and these
investments are adjusted through net earnings when they are deemed to be impaired or when there is an adjustment from observable price changes (referred to as the measurement alternative). These investments are included in other
investments on the financial statements, at cost on the Consolidated Balance Sheets. In addition, the Company monitors these investments to determine if impairment charges are required based primarily on the financial condition and near-term
prospects of these companies.
Available-For-Sale
SecuritiesThe Company has investments in securities that are classified as available-for-sale securities, and which are reflected on the Consolidated Balance
Sheets at fair value. These securities solely consist of a convertible promissory note in a private company that was entered into at arms-length. The Company determines the fair value using unobservable inputs by considering the initial investment
value, next round financing, and the likelihood of conversion or settlement based on the contractual terms in the agreement. If any unrealized gains and losses on these investments are incurred, these would be included as a separate component of
accumulated other comprehensive loss, net of tax, on the Consolidated Balance Sheets. The Company classifies its available-for-sale securities as short-term or long-term
based on the nature of the investment, its maturity date and its availability for use in current operations. The Company monitors the fair value of the securities fall below amortized cost basis. Credit losses identified are reflected in the
allowance for credit losses and any credit losses reversed are recognized in earnings. As of December 31, 2022 and 2021, the fair value of the securities were determined to materially approximate amortized cost basis, thus no unrealized gains
or losses were recorded, and the Company did not record any allowance for credit losses. The Company writes off uncollectible accrued interest receivable balances in a timely manner. The Company did not have material accrued interest on its available-for-sale securities as of December 31, 2022 and December 31, 2021.
Other Noncurrent Assets, at fair value The other noncurrent assets balance consists of S&P 500 put and call options
that were purchased through a broker as an economic hedge related to the market-indexed instruments that are included in Long-Term Debt. The Company records these options at fair value and recognizes changes in fair value as part of net income.
ConcentrationsFinancial instruments that potentially subject the Company to concentrations of credit risk consist principally of
cash and cash equivalents, accounts receivable and available-for-sale securities. The Company maintains its cash in bank deposit accounts with high-quality financial
institutions which, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts. The Company believes it is not exposed to any significant credit risk on its cash and cash equivalents. For accounts
receivable, the Company is exposed to credit risk in the event of nonpayment by customers to the extent of the amounts recorded on the accompanying Consolidated Balance Sheets. The Company extends
F-43
different levels of credit to its customers and maintains allowance for doubtful accounts based upon the expected collectability of accounts receivable. The Companys procedures for
determining this allowance includes evaluating individual customer receivables, considering a customers financial condition, monitoring credit history and current economic conditions, and using historical experience applied to an aging of
accounts.
Two related party customers accounted for 75% and 16% of the total accounts receivable as of December 31, 2022 and two
related party customers accounted for 51% and 49% as of December 31, 2021. The largest receivables balances are from related parties where exposed credit risk is low. As such, there is no allowance for doubtful accounts as of December 31,
2022 and December 31, 2021.
One customer accounted for 51% of active management revenue, while 22% of revenue related to two policies
that matured that were accounted for under the investment method for the year ended December 31, 2022. Two related party customers each accounted for 28% of the portfolio servicing revenue for the year ended December 31, 2022. Three
customers accounted for 29%, 29% and 20% of the total revenues for the year ended December 31, 2021, respectively.
Property and
Equipment, NetProperty and equipment are stated at cost less accumulated depreciation and are depreciated on a straight-line basis over the following estimated useful lives:
|
|
|
|
|
Estimated Useful Life |
Furniture and fixtures |
|
5 years |
Leasehold improvements |
|
Shorter of remaining lease term or estimated useful life |
Expenditures for maintenance and repairs that do not extend the useful lives of property and equipment
are expensed as incurred. Upon retirement or sale of assets, the cost and related accumulated depreciation are written off and any resulting gain or loss is reflected in the accompanying Consolidated Statements of Operations and Comprehensive Income
(Loss).
Property and equipment are tested for recoverability whenever events or changes in circumstance indicate that their carrying
amounts may not be recoverable. An impairment loss is recognized if the carrying amount of property and equipment is not recoverable and exceeds its fair value. Recoverability is determined based on the undiscounted cash flows expected to result
from the use and eventual disposition of the asset or asset group. There were no impairments recognized during the years ended December 31, 2022 and 2021, respectively. Property and equipment to be disposed of are reported at the lower of
carrying amount or fair value less cost to sell.
Revenue RecognitionThe Company generally derives its revenue from life
settlement servicing and consulting activities (Portfolio Servicing Revenue) and life settlement trading activities (Active Management Revenue).
Portfolio Servicing RevenuePortfolio servicing is comprised of servicing activities and consulting activities. The
Company enters into service agreements with the owners of life settlement contracts and is responsible for maintaining the policy, manages processing of claims in the event of death of the insured and ensuring timely payment of optimized premiums
computed to derive maximum return on maturity of the policy. The company neither assumes the ownership of the contracts nor undertakes the responsibility to make the premium payments, which remains with the owner of the policy. These service
arrangements have contractual terms typically ranging from one-month to ten years and include fixed charges within its contracts as part of the total transaction price which are recognized on gross basis. To
the extent that variable consideration is not constrained, the Company includes an estimate of the variable amount, as appropriate, within the total transaction price and updates its assumptions over the duration of the contract. Variable
consideration has not been material. The duties performed by the company under these arrangements are considered as a single performance obligation that is satisfied on a monthly basis as the customer simultaneously receives and consumes the benefit
provided by the Company as the Company performs the service. As such, revenue is recognized for services provided for the corresponding month.
F-44
Under consulting engagements, the Company provides services typically for the owners of
life settlement contracts who are often customers of the servicing business line, or customers of Abacus. These consulting engagements are comprised of valuation, actuarial services, and overall policy assessments related to life settlement
contracts and are short-term in nature. The performance obligations are typically identified as separate services with a specific deliverable or a group of deliverables to be provided in tandem, as agreed to in the engagement letter or contract.
Each service provided under a contract is considered as a performance obligation and revenue is recognized at a point in time when the deliverable or group of deliverables is transferred to the customer.
Active Management RevenueThe Company also engages in buying and selling life settlement policies whereby each
potential policy is independently researched to determine if it would be a profitable investment. Some of the policies are purchased with the intent to hold to maturity, while others are held for trading to be sold for a gain. The Company elects to
account for each investment in life settlement contracts using either the investment method or the fair value method. Once the accounting method is elected for each policy, it cannot be changed. Under the investment method, investments in contracts
are based on the initial investment at the purchase price plus all initial direct costs. Continuing costs (e.g., policy premiums, statutory interest and direct external costs, if any) to keep the policy in force are capitalized. Under the fair value
method, the company will record the initial investment of the transaction price and remeasures the investment at fair value at each subsequent reporting period. Changes in fair value are reported on earnings when they occur. Upon sale of a life
settlement contract, the company will record revenue (gain/loss) for the difference between the agreed-upon purchase price with the buyer, and the carrying value of the contract.
Other Consideration Payment terms and conditions vary by contract type, although terms generally require payment
within 30 days of the invoice date. In certain arrangements, the Company receives payment from a customer either before or after the performance obligation has been satisfied; however, the Companys contracts do not contain a significant
financing component.
Cost to Obtain and Fulfill Contracts Costs to obtain contracts solely relate to
commissions for brokers agents and employees who are directly involved in buying and selling policies as part of the active management revenue stream. The Company has elected to apply the ASC 606, Revenue from Contracts with Customers,
practical expedient which allows us to expense these costs as incurred if the amortization period related to the resulting asset would be one year or less. The Company has no significant instances of contracts that would be amortized for
a period greater than a year, and therefore has no contract costs capitalized for these arrangements.
Segments Operating
segments are defined as components of an entity for which separate financial information is available and that is regularly reviewed by the chief operating decision maker (CODM) in deciding how to allocate resources to an individual
segment and in assessing performance. The Companys CODM is the President and Chief Executive Officer (CEO). The Company has determined that it operates in two operating segments and two reportable segments, portfolio servicing and
active management as the CODM reviews financial information presented for purposes of making operating decisions, allocating resources, and evaluating financial performance.
Income Taxes The Company is taxed as an S-corporation for U.S. federal income tax purposes
as provided in Section 1362(a) of the Internal Revenue Code with the exception of three consolidated entities that are Delaware C-corporations. These VIEs and subsidiaries include LMATT
Series 2024, Inc., the wholly owned subsidiary of LMX Series, LLC., which is consolidated into LMA as a VIE, as well as LMATT Growth Series 2.2024, Inc., a wholly owned subsidiary of LMATT Growth Series, Inc., and LMATT Growth and Income
Series 1.2026, Inc., a wholly owned subsidiary of LMATT Growth and Income Series, Inc., which are all included in the consolidated financial statements. As such, the Companys income or loss and credits are passed through to the members and
reported on their individual federal income tax return. The three C-corporations file federal returns and in the state of Florida, where the businesses operates.
For LMATT Series 2024, Inc., taxes on earnings are based on pretax financial accounting income (losses).
F-45
The Company records uncertain tax positions in accordance with ASC 740, Income
Taxes, on the basis of a two-step process whereby: (i) management determines whether it is more likely than not that the tax positions will be sustained based on the technical merits of the position,
and (ii) for those tax positions that meet the more likely than not recognition threshold, management recognizes the largest amount of tax benefit that is greater than 50% likely to be realized upon ultimate settlement with the related tax
authority. There are currently no uncertain tax positions.
The Company recognizes interest and penalties as a component of income tax
expense. The Company is subject to routine audits by taxing jurisdictions; however, there are currently no audits for any tax periods in progress.
Leases The Company accounts for its leases in accordance with ASC 842, Leases. A contract is or contains a lease if there
is identified property, plant and equipment that is either explicitly or implicitly specified in the contract and the lessee has the right to control the use of the property, plant and equipment throughout the contract term, which is based on an
evaluation of whether the lessee has the right to direct the use of the property, plant and equipment.
The Company has one lease for
office space in Orlando, Florida that is accounted for as an operating lease and goes through July 31, 2024. The Company is responsible for utilities, maintenance, taxes and insurance, which are variable payments based on a reimbursement to the
lessor of the lessors costs incurred. The Company excludes variable lease payments from the measurement of lease liabilities and right-of-use (ROU)
assets recognized on the Companys Consolidated Balance Sheets. Variable lease payments are recognized as a lease expense on the Companys Consolidated Statements of Operations and Comprehensive Income in the period incurred. The Company
has elected the practical expedient to account for lease components and non-lease components together as a single lease component for its real estate lease noted above.
The Company has elected the short-term lease exemption, which permits the Company to not recognize a lease liability and ROU asset for leases
with an original term of one year or less. Currently the Company does not have any short-term leases. The Companys current lease includes a renewal option. The Company has determined that the renewal option is not reasonably certain of
exercise based on an evaluation of contract, market and asset-based factors, and therefore does not include periods covered by renewal options in its lease term. The Companys leases generally do not include purchase options, residual value
guarantees, or material restrictive covenants.
The Company determines its lease liability and ROU by calculating the present value of
future lease payments. The present value of future lease payments is discounted using the Companys incremental borrowing rate. As the Companys leases generally do not have a readily determinable implicit rate, the Company uses its
incremental borrowing rate based on market yields and comparable credit ratings, adjusted for lease term, to determine the present value of fixed lease payments based on information available at the lease commencement date.
The Company does not have any finance leases, nor is the Company a lessor (or sublessor).
See Note 16 for additional disclosures related to leases.
Earnings Per UnitThe Company has only one class of equity for net income (loss)per unit. Basic net income per unit is calculated
by dividing net income by the weighted average number of units outstanding during the applicable period. If the number of units outstanding increases as a result of a stock dividend or stock split or decreases as a result of a reverse stock split,
the computations of basic net income per unit are adjusted retroactively for all periods presented to reflect that change in capital structure. If such changes occur after the close of the reporting period but before issuance of the financial
statements, the per-unit computations for that period and any prior-period financial statements presented are based on the new number of units.
F-46
3. |
LIFE INSURANCE SETTLEMENT POLICIES |
As of December 31, 2022, the Company holds 53 life settlement policies, of which 35 are accounted for under the fair value method and 18
are accounted for using the investment method (cost, plus premiums paid). Aggregate face value of policies held at fair value is approximately $40,092,154 as of December 31, 2022, with a corresponding fair value of approximately $13,809,352.
Aggregate face value of policies accounted for using the investment method is $42,330,000 as of December 31, 2022, with a corresponding carrying value of approximately $8,716,111.
As of December 31, 2021, the Company did not own life settlement policies. As such, information herein has been presented only for the
Consolidated Balance Sheets, dated as of December 31, 2022.
As of December 31, 2022, the Company did not have any contractual
restrictions on its ability to sell policies, including those held as collateral for the issuance of long-term debt. See Note 11, Long-Term Debt.
Life expectancy reflects the probable number of years remaining in the life of a class of persons determined statistically, affected by such
factors as heredity, physical condition, nutrition, and occupation. It is not an estimate or an indication of the actual expected maturity date or indication of the timing of expected cash flows from death benefits. The following tables summarize
the Companys life insurance policies grouped by remaining life expectancy as of December 31, 2022:
Policies Carried at Fair
Value
|
|
|
|
|
|
|
|
|
|
|
|
|
Remaining Life Expectancy (Years) |
|
Number of Life Insurance Policies |
|
|
Face Value |
|
|
Fair Value |
|
0-1 |
|
|
|
|
|
$ |
|
|
|
$ |
|
|
1-2 |
|
|
1 |
|
|
|
200,000 |
|
|
|
160,000 |
|
2-3 |
|
|
11 |
|
|
|
3,085,549 |
|
|
|
2,274,406 |
|
3-4 |
|
|
1 |
|
|
|
2,200,000 |
|
|
|
1,406,451 |
|
4-5 |
|
|
1 |
|
|
|
1,000,000 |
|
|
|
526,416 |
|
Thereafter |
|
|
21 |
|
|
|
33,606,605 |
|
|
|
9,442,079 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
35 |
|
|
$ |
40,092,154 |
|
|
$ |
13,809,352 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Policies accounted for using the investment method
|
|
|
|
|
|
|
|
|
|
|
|
|
Remaining Life Expectancy (Years) |
|
Number of
Life Insurance Policies |
|
|
Face Value |
|
|
Carrying Value |
|
0-1 |
|
|
1 |
|
|
$ |
3,000,000 |
|
|
$ |
1,220,000 |
|
1-2 |
|
|
1 |
|
|
|
500,000 |
|
|
|
327,683 |
|
2-3 |
|
|
2 |
|
|
|
2,000,000 |
|
|
|
1,039,088 |
|
3-4 |
|
|
1 |
|
|
|
500,000 |
|
|
|
260,000 |
|
4-5 |
|
|
2 |
|
|
|
3,850,000 |
|
|
|
845,000 |
|
Thereafter |
|
|
11 |
|
|
|
32,480,000 |
|
|
|
5,024,340 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18 |
|
|
$ |
42,330,000 |
|
|
$ |
8,716,111 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-47
Estimated premiums to be paid by the Company for its portfolio accounted for using the
investment method during each of the five succeeding calendar years and thereafter as of December 31, 2022, are as follows:
|
|
|
|
|
2023 |
|
$ |
799,201 |
|
2024 |
|
|
896,961 |
|
2025 |
|
|
895,559 |
|
2026 |
|
|
981,749 |
|
2027 |
|
|
1,096,323 |
|
Thereafter |
|
|
4,197,118 |
|
|
|
|
|
|
Total |
|
$ |
8,866,912 |
|
|
|
|
|
|
The Company is required to pay premiums to keep its portion of life insurance policies in force. The
estimated total future premium payments could increase or decrease significantly to the extent that actual mortalities of insureds differ from the estimated life expectancies.
For policies accounted for under the investment method, the Company has not been made aware of information causing a material change to
assumptions relating to the timing of realization of life insurance settlement proceeds. The Company has also not been made aware of information indicating impairment to the carrying value of policies.
4. |
PROPERTY AND EQUIPMENT, NET |
Property and equipment, net comprised of the following:
|
|
|
|
|
|
|
|
|
|
|
As of |
|
|
As of |
|
|
|
December 31, 2022 |
|
|
December 31, 2021 |
|
Furniture and fixtures |
|
$ |
19,444 |
|
|
$ |
19,444 |
|
Leasehold improvements |
|
|
5,902 |
|
|
|
5,902 |
|
|
|
|
|
|
|
|
|
|
Property and equipmentgross |
|
|
25,346 |
|
|
|
25,346 |
|
|
|
|
Less: accumulated depreciation |
|
|
(6,729 |
) |
|
|
(2,447 |
) |
|
|
|
|
|
|
|
|
|
Property and equipmentnet |
|
$ |
18,617 |
|
|
$ |
22,899 |
|
|
|
|
|
|
|
|
|
|
Depreciation expense for the years ended December 31, 2022 and 2021 was $4,282 and $2,447,
respectively.
5. |
AVAILABLE-FOR-SALE
SECURITIES, AT FAIR VALUE |
Convertible Promissory NotesThe Company holds convertible promissory notes in
a separate unrelated insurance technology company. In November 2021, the Company purchased a $250,000 note and then purchased an additional note in January 2022 for $250,000 as part of the Tranche 5 offering (Tranche 5 Promissory Note).
The Tranche 5 Promissory Note pays six percent (6%) interest per annum. The Tranche 5 Promissory Note matures November 12, 2023 (2023 Maturity Date) and will be paid in full as to outstanding principal and accrued interest on the
2023 Maturity Date unless the Tranche 5 Promissory Note converts prior to the 2023 Maturity Date. Conversion into preferred shares occurs if the technology company engages in an additional equity financing event that yields gross cash proceeds in
excess of $1,000,000 (Next Equity Financing).
In October 2022, the Company purchased an additional convertible promissory note
in the same unrelated insurance technology company for $500,000 as part of the Tranche 6 offering (Tranche 6 Promissory Note and collectively with the Tranche 5 Promissory Note, the Convertible Promissory
Notes). The Tranche 6 Promissory Note pays eight percent (8%) interest per annum and matures September 30, 2024 (2024 Maturity Date) and will be paid in full as to outstanding principal and accrued interest on the 2024
F-48
Maturity Date unless the Tranche 6 Promissory Note converts prior to the 2024 Maturity Date. Conversion into preferred shares occurs if the technology company engages in an additional equity
financing event that yields gross cash proceeds in excess of $5,000,000 (Next Round Securities).
The Company applies the available-for-sale method of accounting for its investment in the Convertible Promissory Notes which are debt investments. The Convertible Promissory Notes do not qualify for
either the held-to-maturity method due to the Convertible Promissory Notes conversion rights or the trading-securities method because the Company holds the
Convertible Promissory Notes as a long-term investment. The Convertible Promissory Notes are measured at fair value at each reporting-period end. Unrealized gains and losses are reported in other comprehensive income until realized. As of
December 31, 2022, the Company evaluated the fair value of its investment and determined that the fair value approximates the carrying value of $1,000,000 and there was no unrealized gain or loss recorded.
6. |
OTHER INVESTMENTS AND OTHER NONCURRENT ASSETS |
Other Investments:
Convertible Preferred Stock OwnershipThe Company owns convertible preferred stock in two entities, further described below:
On July 22, 2020, the Company purchased 224,551 units of an unrelated insurance technology companys Series Seed Preferred
units for $750,000 (Seed Units). Upon conversion, the Seed Units held by the Company would represent 8.1% control in the technology company. During December 2022, the Company purchased an incremental 14,970 of Series Seed Preferred units
for $50,000 and had a total of $800,000 investment as of December 31, 2022.
On December 21, 2020, the Company purchased
207,476 shares of a separate unrelated insurance technology companys Series B-1 preferred stock for $500,000 (Preferred Shares). The Preferred Shares are convertible into voting common
stock of the technology company at the option of the Company. Upon conversion, the Preferred Shares would represent less than 1% control in the technology company.
The Company applies the measurement alternative for its investments in the Seed Units and Preferred Shares because these investments are of an
equity nature, and the Company does not have the ability to exercise significant influence over operating and financial policies of entities even in the event of conversion of the Seed Units or Preferred Shares. Under the measurement alternative,
the Company records the investment based on original cost less impairments, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the investee. The Companys
share of income or loss of such companies is not included in the Companys Consolidated Statements of Operations and Comprehensive Income (Loss). The Company tests its investments for impairment whenever circumstances indicate that the carrying
value of the investment may not be recoverable. No impairment of investments occurred for the years ended December 31, 2022 and 2021.
Other Noncurrent Assets- at fair value:
S&P OptionsThe Company owns S&P 500 put and call options that were purchased through a broker as an economic hedge
related to the market-indexed debt instruments included in the long-term debt note. The value is based on shares owned and quoted market prices in active markets. Changes in fair value are recorded in the Unrealized Loss on Investments line item on
the income statement.
7. |
CONSOLIDATION OF VARIABLE INTEREST ENTITIES |
The Company consolidates VIEs for which it is the primary beneficiary or VOEs for which it controls through a majority voting interest or other
arrangement. See Note 2 for more information on how the Company evaluates an entity for consolidation.
F-49
The Company evaluated any entity in which it had a variable interest upon formation to
determine whether the entity should be consolidated. The Company also evaluated the consolidation conclusion during each reconsideration event, such as changes in the governing documents or additional equity contributions to the entity. During the
year ended December 31, 2022, the Company consolidated LMX, Longevity Market Advisors and LMA Income Series, LP, which had total assets and liabilities of $30,073,972 and $27,116,762, respectively. For the year ended December 31, 2021, the
Company consolidated LMX, which had total assets and liabilities of $400 and $0, respectively. The Company did not deconsolidate any entities during the years ended December 31, 2022 or December 31, 2021.
For the year ended December 31, 2022, the Company held total assets of $987,964 and liabilities of $358,586, in unconsolidated VIEs. As of
December 31, 2021, the Company held total assets of $596,567 and liabilities of $2,218 in unconsolidated VIEs.
Segment InformationThe Company organizes its business into two reportable segments (1) Portfolio Servicing and
(2) Active Management, which generate revenue in different manners.
This segment structure reflects the financial information and
reports used by the Companys management, specifically its CODM, to make decisions regarding the Companys business, including resource allocations and performance assessments as well as the current operating focus in compliance with
ASC 280, Segment Reporting. The Companys CODM is the President and CEO of the Company.
The Portfolio
Servicing segment generates revenues by providing policy services to customers on a contract basis.
The Active Management segment
generates revenues by buying, selling and trading policies and maintaining policies through to death benefit. The Companys reportable segments are not aggregated.
The Companys method for measuring profitability on a reportable segment basis is gross profit. The CODM does not review asset information
related to investments nor expenditures incurred for long-lived assets given the Companys investments are recognized on a cost basis and the Companys long-lived assets are immaterial to the consolidated financial statements.
F-50
Information related to the Companys reporting segments for the years ended
December 31, 2022 and December 31, 2021 is as follows:
|
|
|
|
|
|
|
|
|
|
|
As of December 31, 2022 |
|
|
As of December 31, 2021 |
|
Portfolio Servicing |
|
$ |
1,470,973 |
|
|
$ |
1,079,986 |
|
|
|
|
Active Management |
|
|
43,242,581 |
|
|
|
120,000 |
|
|
|
|
|
|
|
|
|
|
Total Revenue |
|
$ |
44,713,553 |
|
|
$ |
1,199,986 |
|
|
|
|
|
|
|
|
|
|
Portfolio Servicing |
|
$ |
300,235 |
|
|
$ |
406,093 |
|
|
|
|
Active Management |
|
|
38,168,187 |
|
|
|
58,000 |
|
|
|
|
|
|
|
|
|
|
Gross profit |
|
$ |
38,468,422 |
|
|
$ |
464,093 |
|
|
|
|
|
|
|
|
|
|
Sales and Marketing |
|
$ |
(2,596,140 |
) |
|
$ |
|
|
General, administrative and other |
|
|
(1,066,403 |
) |
|
|
(101,406 |
) |
Other operating expenses |
|
|
|
|
|
|
(493,849 |
) |
Depreciation |
|
|
(4,282 |
) |
|
|
(2,447 |
) |
Other expense |
|
|
(347,013 |
) |
|
|
|
|
Interest (expense) |
|
|
(42,798 |
) |
|
|
|
|
Interest income |
|
|
1,474 |
|
|
|
|
|
Change on fair value of debt |
|
|
(90,719 |
) |
|
|
|
|
Unrealized gain(loss) on investments |
|
|
(1,045,623 |
) |
|
|
|
|
Income tax expense |
|
|
(889,943 |
) |
|
|
|
|
Net loss attributable to non-controlling interest |
|
|
(704,699 |
) |
|
|
148,155 |
|
|
|
|
|
|
|
|
|
|
Net income attributable to Longevity Market Assets, LLC |
|
$ |
31,682,275 |
|
|
$ |
14,546 |
|
|
|
|
|
|
|
|
|
|
9. |
COMMITMENTS AND CONTINGENCIES |
Legal ProceedingsOccasionally, the Company may be subject to various proceedings, lawsuits, disputes, or claims. The
Company investigates these claims as they arise and accrues a liability when losses are probable and reasonably estimated. Although claims are inherently unpredictable, the Company is currently not aware of any matters that, if determined adversely
to the Company, would individually or taken together, have a material adverse effect on the Companys business, financial position, results of operations, or cash flows.
Commitment The Company has entered into a Strategic Services and Expenses Support Agreement (Expense Support
Agreement) with two commonly owned full-service origination, servicing, and investment providers (the Providers) in exchange for an option to purchase the outstanding equity ownership of the Providers. Pursuant to the Expense
Support Agreement, LMA provides financial support and advice for the expenses of the Providers incurred in connection with their life settlement transactions businesses and the Providers are required to hire a life settlement transactions operations
employee of an affiliate of LMA. No later than December 1 of each calendar year, LMA provides a budget for the Providers, in which LMA commits to extend financial support for all operating expenses up to the budgeted amount. Operating
Expenses for purposes of the Expense Support Agreement means all annual operating expenses of the Providers incurred in the ordinary course of business, excluding the premiums paid for the Providers insurance coverages that are allocable to
the insurance coverage provided to Institutional Life Holdings, LLC, which owns all the outstanding membership interests of the Providers if unrelated to the Providers settlement businesses.
Since inception of the Expense Support Agreement on January 1, 2021 through December 31, 2021, LMA had incurred $120,000 related to
initial funding of operations, which were subsequently reimbursed and $0
F-51
related to expenses. For the year ended December 31, 2022, LMA incurred $347,013 of expenses related to the Expense Support Agreement, which is included in the Other Expense line of the
Consolidated Statements of Operations and Comprehensive Income (Loss) and have not been reimbursed by the Providers.
10. |
FAIR VALUE MEASUREMENTS |
The Company determines fair value based on assumptions that market participants would use in pricing an asset or a liability in the principal
or most advantageous market. When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following
levels:
|
|
|
Level 1 inputs: Unadjusted quoted prices in active markets for identical assets or liabilities accessible to
the reporting entity at the measurement date. |
|
|
|
Level 2 inputs: Other than quoted prices in Level 1 inputs that are observable for the asset or
liability, either directly or indirectly, for substantially the full term of the asset or liability. |
|
|
|
Level 3 inputs: Unobservable inputs for the asset or liability used to measure fair value to the extent that
observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at the measurement date. |
Recurring Fair Value MeasurementsThe assets and liabilities measured at estimated fair value on a recurring basis and their
corresponding placement in the fair value hierarchy are presented in the tables below.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31, 2022 |
|
Fair Value Hierarchy |
|
|
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
|
|
Total |
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Life settlement policies |
|
$ |
|
|
|
$ |
|
|
|
$ |
13,809,352 |
|
|
$ |
13,809,352 |
|
Available-for-sale
securities, at fair value |
|
|
|
|
|
|
|
|
|
|
1,000,000 |
|
|
|
1,000,000 |
|
Other Investments |
|
|
|
|
|
|
|
|
|
|
1,300,000 |
|
|
|
1,300,000 |
|
S&P 500 options |
|
|
890,829 |
|
|
|
|
|
|
|
|
|
|
|
890,829 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tot assets held at fair value |
|
$ |
890,829 |
|
|
$ |
|
|
|
$ |
16,109,352 |
|
|
$ |
17,000,181 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-term debt |
|
$ |
|
|
|
$ |
|
|
|
$ |
28,249,653 |
|
|
$ |
28,249,653 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Value Hierarchy |
|
As of December 31, 2021 |
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
|
|
Total |
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Life settlement policies |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Available-for-sale
securities, at fair value |
|
|
|
|
|
|
|
|
|
|
250,000 |
|
|
|
250,000 |
|
Other investments |
|
|
|
|
|
|
|
|
|
|
1,250,000 |
|
|
|
1,250,000 |
|
Other non-current assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tot assets held at fair value |
|
$ |
|
|
|
$ |
|
|
|
$ |
1,500,000 |
|
|
$ |
1,500,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-term debt |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Life Settlement PoliciesThe Company separately accounts for each owned life
settlement policy using either the fair value method, or the investment method (cost, plus premiums paid). The valuation method is chosen upon contract acquisition and is irrevocable.
F-52
For policies carried at fair value, the Company utilizes valuation services of
third-party actuarial firm, who value the contracts using Level 3 unobservable inputs, including actuarial assumptions, such as life expectancies and cash flow discount rates. The valuation model is based on a discounted cash flow analysis and
is sensitive to changes in the discount rate used. The Company utilizes a discount rate of 12% for policy valuation, which is based on economic and company-specific factors.
For life settlement policies carried using the investment method, the Company measures these at the cost of the policy plus premiums paid. The
policies accounted for using the investment method totaled $8,716,111 at December 31, 2022 and $0 at December 31, 2021.
Discount Rate SensitivityChanges in the 12% discount rate on the death benefit and premiums used to estimate the policies issued
under LMATT Series 2024, Inc (LMATT Policies) fair value has been analyzed. If the discount rate increased or decreased by 2 percentage points and the other assumptions used to estimate fair value remained the same, the
change in estimated fair value as of December 31, 2022, would be as follows:
|
|
|
|
|
|
|
|
|
As of December 31, 2022 |
|
|
|
|
Change in |
|
Rate Adjustment |
|
Fair Value |
|
|
Fair Value |
|
+2% |
|
$ |
12,376,891 |
|
|
$ |
(1,432,461 |
) |
No change |
|
|
13,809,352 |
|
|
|
|
|
-2% |
|
|
15,571,704 |
|
|
|
1,762,352 |
|
Credit Exposure to Insurance CompaniesThe following table provides information about the
life insurance issuer concentrations that exceed 10% of total death benefit or 10% of total fair value of the Companys life insurance policies as of December 31, 2022:
|
|
|
|
|
|
|
|
|
|
|
|
|
Carrier |
|
Face Value |
|
|
Fair Value |
|
|
Rating |
|
American General Life Insurance Company |
|
|
17 |
% |
|
|
15 |
% |
|
|
A |
|
John Hancock Life Insurance Company |
|
|
31 |
|
|
|
30 |
|
|
|
A+ |
|
ReliaStar Life Insurance Company |
|
|
5 |
|
|
|
10 |
|
|
|
NR |
|
Principal Life |
|
|
10 |
|
|
|
10 |
|
|
|
A+ |
|
Securian Life Insurance Company |
|
|
12 |
|
|
|
4 |
|
|
|
A+ |
|
The following table provides a roll forward of the fair value of life insurance as of
December 31, 2022:
|
|
|
|
|
Fair value at December 31, 2021 |
|
$ |
|
|
|
|
|
|
|
Policies purchased |
|
|
8,161,975 |
|
|
|
|
|
|
Realized gain on matured/sold policies |
|
|
105,000 |
|
Premius Paid |
|
|
(433,626 |
) |
Unrealized gain on held policies |
|
|
5,742,377 |
|
|
|
|
|
|
Change in estimated fair value |
|
|
5,413,751 |
|
Matured/sold policies |
|
|
(200,000 |
) |
Premiums paid |
|
|
433,626 |
|
|
|
|
|
|
Fair value at December 31, 2022 |
|
$ |
13,809,352 |
|
|
|
|
|
|
Long-Term DebtSee Note 11, Long-Term Debt for background
information on the market-indexed debt. The Company has elected the fair value option in accounting for the instruments. Fair value is determined using Level 3 inputs. The valuation methodology is based on the Black-Scholes-Merton
option-pricing formula and a discounted cash flow analysis. Inputs to the Black-Scholes-Merton model include (i) the S&P 500 Index price, (ii) S&P 500 Index volatility, (iii) a risk-free rate based on data published by the US
Treasury, and (iv) a term assumption based on the contractual term of the LMATT Notes. The discounted cash flow analysis includes a discount rate that is based on the implied discount rate developed
F-53
by calibrating a valuation model to the purchase price on the initial investment date. The implied discount rate is evaluated for reasonableness by benchmarking it to yields on actively traded
comparable securities.
The total change in fair value of the debt resulted in a gain of $1,778,987. This comprises of a gain of
$1,052,836, net of tax, which is included within accumulated other comprehensive income and $342,994, net of tax, which is included in equity of noncontrolling interests resulting from risk-adjusted valuation scenarios and a recognized a loss of
$90,719 on the change in fair value of the debt resulting from risk-free valuation scenarios, which is included within Change in fair value of debt within the Consolidated Statements of Operations and Comprehensive Income (Loss) for the year
ended December 31, 2022.
The following table provides a roll forward of the fair value of the issued as of December 31, 2022:
|
|
|
|
|
Fair value at December 31, 2021 |
|
$ |
|
|
|
|
|
|
|
Debt issued to third parties |
|
$ |
30,028,640 |
|
|
|
|
|
|
Unrealized loss on change in fair value (risk-free) |
|
|
90,719 |
|
Unrealized (gain) on change in fair value (credit-adjusted) |
|
|
(1,869,706 |
) |
|
|
|
|
|
Change in estimated fair value |
|
|
(1,778,987 |
) |
|
|
|
|
|
Fair value at December 31, 2022 |
|
$ |
28,249,653 |
|
|
|
|
|
|
Other Noncurrent Assets: S&P 500 Options In February 2022, LMATT
Series 2024, Inc., which the Company consolidates for financial reporting, purchased and sold S&P 500 call and put options through a broker. The Company purchased and sold additional S&P 500 call options through a broker in
September 2022 through their 100% owned and fully consolidated subsidiaries, LMATT Growth Series 2.2024, Inc. and LMATT Growth & Income Series 1.2026, Inc. The options are exchange traded, and fair value is determined using Level 1
inputs of quoted market prices as of the Consolidated Balance Sheets date. Changes in fair value are classified as Unrealized gain/loss on investments within the Consolidated Statements of Operations and Comprehensive Income (Loss).
Financial Instruments Measured at Fair Value on a Nonrecurring BasisThe following financial assets, composed of equity securities
without readily determinable fair values, are adjusted to fair value when observable price changes are identified, or an impairment charge is recognized. Such fair value measurements are based predominantly on Level 3 inputs.
Available-for-Sale InvestmentThe Convertible
Promissory Notes are classified as an available-for-sale securities. Available-for-sale
investments are subsequently measured at fair value. Unrealized holding gains and losses are excluded from earnings and reported in other comprehensive income until realized. The Company determines fair value of its available-for-sale investments using unobservable inputs by considering the initial investment value, next round financing, and the likelihood of conversion or settlement based on the contractual terms in the
agreement. The Company initially purchased a $250,000 convertible promissory note from the issuer in 2021 and then on January 7, 2022, the Company purchased an additional $250,000 convertible promissory note from the same issuer and then an
additional $500,000 in October 2022. As of December 31, 2022 and 2021, the Company evaluated the fair value of its Convertible Promissory Notes and determined that the fair value approximates the carrying value of $1,000,000 and $250,000,
respectively.
Other InvestmentsThe Company determines fair value using Level 3 inputs under the measurement alternative.
These investments are recorded at cost, minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. Impairment is assessed
qualitatively. As of December 31, 2022 and 2021, the Company did not identify any impairment indictors and determined that the carrying value of $1,300,000 and $1,250,000, respectively, is the fair value for these equity investments in
privately held companies, given that there have been no observable price changes.
F-54
Long-Term Debt LMATT 1.2026 IssuanceThe Company has issued $400,000
in market-indexed notes, which include participation in S&P 500 index returns and offer downside market protection. See additional information in the Long-Term Debt footnote. The company evaluates the fair value of the note using Level 3
unobservable inputs. As of December 31, 2022, the Company evaluated the fair value of the note and determined that the fair value approximates the carrying value of $400,000.
Financial Instruments Where Carrying Value Approximates Fair ValueThe carrying value of cash, cash equivalents, accounts
receivables, and due to affiliates approximates fair value due to the short-term nature of their maturities.
Long-term debt comprises of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2022 |
|
|
December 31, 2021 |
|
|
|
Cost |
|
|
Fair value |
|
|
Cost |
|
|
Fair value |
|
Market-indexed notes: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LMATT Series 2024, Inc. |
|
$ |
9,866,900 |
|
|
$ |
8,067,291 |
|
|
$ |
|
|
|
$ |
|
|
LMATT Series 2.2024, Inc. |
|
|
2,333,391 |
|
|
|
2,354,013 |
|
|
|
|
|
|
|
|
|
LMATT Growth & Income Series 1.2026, Inc |
|
|
400,000 |
|
|
|
400,000 |
|
|
|
|
|
|
|
|
|
Secured borrowing: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LMATT Income Series, LP |
|
|
17,428,349 |
|
|
|
17,428,349 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total long-term debt |
|
$ |
30,028,640 |
|
|
$ |
28,249,653 |
|
|
$ |
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LMATT Series 2024, Inc. Market-Indexed Notes:
On March 31, 2022, LMATT Series 2024, Inc., which the Company consolidates for financial reporting, issued $10,166,900 in
market-indexed private placement notes. The notes, titled the Longevity Market Assets Target-Term Series (LMATTS) 2024, are market-indexed instruments designed to provide upside performance exposure of the S&P 500 Index, while limiting downward
exposure. Upon maturity of the notes in 2024, the principal, plus the return based upon the S&P 500 Index must be paid. The notes have a feature to protect debt holders from market downturns, up to 40%. Any subsequent losses below the 40%
threshold will reduce the notes on a one-to-one basis. As of December 31, 2022, $9,886,900 of the principal amount remained outstanding.
The notes are held at fair value, which represents the exit price, or anticipated price to transfer the liability to a third party. As of
December 31, 2022, the fair value of the LMATT Series 2024, Inc. notes was $8,067,291.
The notes are secured by the assets of the
issuing entities, which includes cash, S&P 500 options, and life settlement policies totaling $12,200,797 as of December 31, 2022. The notes agreements do not restrict the trading of life settlement contracts prior to maturity of the notes,
as total assets of the issuing companies are considered as collateral. There are also no restrictive covenants associated with the notes with which the entities must comply.
LMATT Series 2.2024, Inc. Market-Indexed Notes:
On September 16, 2022, LMATTS Series 2.2024, Inc., a 100% owned subsidiary which the Company consolidates for financial reporting issued
$2,333,391 in market-indexed private placement notes. The notes, titled the Longevity Market Assets Target-Term Growth Series 2.2024, Inc. (LMATTSTM Series 2.2024, Inc.) are market-indexed instruments designed to provide upside
performance exposure of the S&P 500 Index, while limiting downward exposure. Upon maturity of the notes in 2024, the principal, plus the return based upon the S&P 500 Index must be paid. The notes have a feature to provide upside performance
F-55
participation that is capped at 120% of the performance of the S&P 500. A separate layer of the notes have a feature to protect debt holders from market downturns by up to 20% if the index
price experiences a loss during the investment period. After the underlying index has decreased in value by more than 20%, the investments will experience all subsequent losses on a
one-to-one basis. As of December 31, 2022, the entire principal amount remained outstanding.
The notes are held at fair value, which represents the exit price, or anticipated price to transfer the liability to a third party. As of
December 31, 2022, the fair value of the LMATT Series 2.2024, Inc. notes was $2,354,013.
The notes are secured by the assets of the
issuing entity, LMATT Series 2.2024, Inc., which include cash, S&P 500 options, and life settlement policies totaling $3,246,756 as of December 31, 2022. The notes agreement does not restrict the trading of life settlement contracts prior
to maturity of the notes, as total assets of the issuing company are considered as collateral. There are also no restrictive covenants associated with the notes with which the entity must comply.
LMATT Growth and Income Series 1.2026, Inc. Market-Indexed Notes:
Additionally, on September 16, 2022, LMATT Growth and Income Series 1.2026, Inc., a 100% owned subsidiary which the Company consolidates
for financial reporting issued $400,000 in market-indexed private placement notes. The notes, titled the Longevity Market Assets Target-Term Growth and Income Series 1.2026, Inc (LMATTSTM Growth and Income Series 1.2026, Inc.) are
market-indexed instrument designed to provide upside performance exposure of the S&P 500 Index, while limiting downward exposure. Upon maturity of the notes in 2026, the principal, plus the return based upon the S&P 500 Index must be paid.
The notes have a feature to provide upside performance participation that is capped at 140% of the performance of the S&P 500. A separate layer of the notes have a feature to protect debt holders from market downturns by up to 10% if the index
price experiences a loss during the investment period. After the underlying index has decreased in value by more than 10%, the investment will experience all subsequent losses on a
one-to-one basis. These notes also include a 4% dividend feature that will be paid annually. As of December 31, 2022, the entire principal amount remained
outstanding.
The notes are held at fair value, which represents the exit price, or anticipated price to transfer the liability to a third
party. As of December 31, 2022, the fair value of the LMATT Growth and Income Series 1.2026, Inc. notes was $400,000.
The notes are
secured by the assets of the issuing entity, LMATT Growth and Income Series 1.2026, Inc., which include cash, S&P 500 options, and life settlement policies totaling $752,236 as of December 31, 2022. The notes agreement does not restrict the
trading of life settlement contracts prior to maturity of the notes, as total assets of the issuing company are considered as collateral. There are also no restrictive covenants associated with the notes with which the entity must comply.
See additional fair value considerations within the Fair Value footnote.
LMA Income Series, LP and LMA Income Series, GP, LLC Secured Borrowing
LMA Income Series, GP, LLC, wholly owned and controlled by that LMA Series, LLC, formed a limited partnership, LMA Income Series, LP and issued
partnership interests to limited partners in a private placement offering. The initial term of the offering is three years with the ability to extend for two additional one-year periods at the discretion of
the general partner, LMA Income Series, GP, LLC. The limited partners will receive an annual dividend of 6.5% paid quarterly and 25% of returns in excess of a 6.5% internal rate of return capped at a 15% net internal rate of return. The General
Partner will receive 75% of returns in excess of a 6.5% internal rate of return to limited partners then 100% in excess of a 15% net internal rate of return.
F-56
It was determined that LMA Series, LLC is the primary beneficiary of LMA Income Series,
LP and thus has fully consolidated the limited partnership in its consolidated financial statements for the year ended December 31, 2022.
The private placement offerings proceeds will be used to acquire an actively managed large and diversified portfolio of financial assets. LMA,
through its consolidated subsidiaries, serves as the portfolio manager for the financial asset portfolio, which includes investment sourcing and monitoring. In this role, LMA has the unilateral ability to acquire and dispose of any of the above
investments. As the partnership does not represent a business in accordance with ASC 810 and is a consolidated subsidiary that only holds financial assets, this represents a transfer subject to ASC 860-10. As
the financial assets are not transferred outside the consolidated group, the proceeds from the offering shall be classified as a liability unless it meets the definition of a participating interest and the derecognition criteria in ASC 860 are met.
The transferred interest did not meet the definition of a participating interest as LMA possesses the unilateral ability to direct the sale of the financial assets (ASC 860-10-50-6A(d)). In accordance with ASC 860-30-25-2, as the transfer of the
financial assets did not meet the definition of a participating interest, LMA shall recognize the proceeds received from the offering as a secured borrowing.
LMA elected to account for the secured borrowing at fair value under the collateralized financing entity guidance within ASC 810-10-30. As of December 31, 2022, the fair value of the secured borrowing was $17,428,349.
The Company is authorized to issue up to 5,000 units of par value common units. Holders of the Companys common units are entitled to
one vote for each share. At December 31, 2022 and 2021, there were 5,000 units issued and outstanding. Holders of the common units were entitled to receive, in the event of a liquidation, dissolution or winding up, ratably the assets
available for distribution to the stockholders after payment of all liabilities.
13. |
EMPLOYEE BENEFIT PLAN |
The Company has a defined contribution plan in the U.S. intended to qualify under Section 401 (k) of the Internal Revenue Code (the
401(k) Plan). The 401(k) Plan covers substantially all employees who meet minimum age and service requirements and allows participants to defer up to 100% of their annual compensation on a
pre-tax basis. For the years ended December 31, 2022 and 2021, the Company elected to match 50% of employee contributions up to a maximum of 4% of eligible employee compensation. For the years ended
December 31, 2022 and 2021, the Company recognized expenses related to the 401(k) Plan amounting to $22,559 and $8,368, respectively.
As the Company elected to file as an S-corporation for federal and state income tax purposes, the
Company incurred no federal or state income taxes, except for income taxes recorded related to some of their consolidated variable interest entities and subsidiaries which are taxable C corporations. These VIEs and subsidiaries include LMATT Series
2024, Inc., the wholly owned subsidiary of LMX Series, LLC, which is consolidated into LMA as a VIE, as well as LMATT Growth Series 2.2024, Inc., a wholly owned subsidiary of LMATT Growth Series, Inc., and LMATT Growth and Income Series 1.2026,
Inc., a wholly owned subsidiary of LMATT Growth and Income Series, Inc., all of which are 100% owned subsidiaries and fully consolidated. Accordingly, tax expense (benefit) is attributable to amounts for LMATT Series 2024, Inc, LMATT Growth Series,
Inc. and LMATT Growth and Income Series, Inc.
F-57
The components of provision for income taxes are as follows:
|
|
|
|
|
|
|
|
|
|
|
December 31, 2022 |
|
|
December 31, 2021 |
|
Current provision: |
|
|
|
|
|
|
|
|
Federal |
|
$ |
|
|
|
$ |
|
|
State |
|
|
|
|
|
|
|
|
Foreign |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current tax |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred provision (benefit): |
|
|
|
|
|
|
|
|
Federal |
|
|
737,376 |
|
|
|
|
|
State |
|
|
152,567 |
|
|
|
|
|
Foreign |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total deferred tax |
|
|
889,943 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income taxes |
|
$ |
889,943 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the years ended December 31, 2022 and 2021, the income tax expense differs from the
provision that would result from applying federal and state statutory tax rates to income before income taxes due to the Companys S-corporation election recognized for federal and state purposes.
For LMATT Series 2024, Inc., LMATT Growth Series, Inc. and LMATT Growth and Income Series, Inc., the Company recognized $889,943 of
provision related to income taxes for the year ended December 31, 2022. For the year ended December 31, 2021, the Company recognized no provision related to income taxes for LMATT Series 2024, Inc. because the Company incurred operating
losses and maintained a full valuation allowance against its net deferred tax assets.
The effective income tax rate differs from the
federal statutory income tax rate applied to the profit loss before provision for income taxes due to the following:
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2022 |
|
|
Year Ended December 31, 2021 |
|
Income tax benefit computed at federal statutory rate |
|
$ |
6,988,153 |
|
|
$ |
(28,058 |
) |
Effect of pass through entities |
|
$ |
(6,147,068 |
) |
|
$ |
(75,650 |
) |
State taxes, net of federal benefit |
|
|
174,024 |
|
|
|
(21,458 |
) |
Valuation allowance |
|
|
(125,166 |
) |
|
|
125,166 |
|
|
|
|
|
|
|
|
|
|
Income tax benefit at effective tax rate |
|
$ |
889,943 |
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
F-58
The effects of temporary differences that give rise to significant portions of the
deferred tax assets are as follows:
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2022 |
|
|
Year Ended December 31, 2021 |
|
Deferred tax assets: |
|
|
|
|
|
|
|
|
Net operating loss carryforwards |
|
$ |
167,554 |
|
|
$ |
125,166 |
|
Basis Difference in Life Insurance Contracts |
|
$ |
109,903 |
|
|
|
|
|
Other |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross deferred tax assets |
|
|
277,457 |
|
|
|
125,166 |
|
|
|
|
Less: valuation allowance |
|
|
|
|
|
|
(125,166 |
) |
|
|
|
|
|
|
|
|
|
Total deferred tax assets |
|
|
277,457 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred tax liabilities: |
|
|
|
|
|
|
|
|
Unrealized Gain |
|
|
(1,641,277 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Other |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross deferred tax liabilities |
|
|
(1,641,277 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred tax liabilitiesnet of allowance |
|
$ |
(1,363,820 |
) |
|
$ |
|
|
|
|
|
|
|
|
|
|
|
The components of the Companys net deferred tax assets are subject to realizability analysis in
accordance with ASC 740. The establishment of a valuation allowance is based on consideration of all available evidence, both positive and negative, concerning the expectation of future realization, including, among other items: historical operating
results; forecasts of future operations; the duration of statutory carryforward periods; experience with tax attributes expiring unused; and future reversals of existing taxable temporary differences and tax planning alternatives. In making such
judgments, greater weight is given to evidence that can be objectively verified. Based on this analysis, the Company determined that sufficient positive evidence existed as of December 31, 2022 to support releasing the valuation allowance
recorded against net operating loss tax attributes at December 31, 2021.
The Company has $661,092 of Federal Net Operating Losses and
$661,092 State Net Operating Losses that can be carried forward indefinitely. The Federal Net Operating Losses may be used to offset 80% of taxable income in a given year.
The Company did not have any unrecognized tax benefits relating to uncertain tax positions at December 31, 2022 and 2021 and did not
recognize any interest or penalties related to uncertain tax position at December 31, 2022 and 2021. The Company does not anticipate that changes in its unrecognized tax benefits will have a material impact on the Consolidated Statements of
Operations and Comprehensive Income during 2023.
15. |
RELATED PARTY TRANSACTIONS |
As of December 31, 2022 and 2021, $263,785 and $930,630 of due to affiliates, respectively, were payable to the companies in which
Companys members own interest. As of December 31, 2022 and 2021, $2,904,646 and $0 of due from affiliates, respectively, were receivable from the companies in which the Companys members own interest or are currently in negotiations
with. The majority of the due from affiliate amount represents transaction costs incurred by the Company related to the planned business combination in which ERES has committed to reimburse the Company upon consummation of the merger.
The Company has a related party relationship with Nova Trading (US), LLC (Nova Trading), a Delaware limited liability company, and
Nova Holding (US) LP, a Delaware limited partnership (Nova Holding and collectively with Nova Trading, Nova Funds), as the owners of the Company jointly own 11% of the
F-59
Nova Funds. The Company also earns service revenue related to policy and administrative services on behalf of Nova Funds. The annual servicing fee is equal to 50 basis points (0.50%) times the
invested amount in policies held by Nova Funds. The servicing fee is billed monthly. The Company earned $818,300 and $699,884, respectively, in service revenue related to Nova Funds for the years ended December 31, 2022 and December 31,
2021.
The Company also uses Abacus to originate life settlement policies that it accounts for under the investment method. For the year
ended December 31, 2022, the Company incurred $2,268,150 in origination expenses for life settlement policies that are included as part of active management revenue, given that revenue is presented on a net basis.
At December 31, 2022 and 2021, there were $196,289 and $67,491, respectively, in expense reimbursements owed from the Nova funds, which
are included as related party receivables in the accompanying balance sheets.
In April 2021, the Company entered into an agreement to lease office space in Orlando, Florida from a related party. The lease is classified as
an operating lease and goes through July 31, 2024. The Company does not have any other leasing activities.
The Companys ROU
assets and lease liabilities for its operating leases consisted of the following amounts as of December 31, 2022 and 2021:
|
|
|
|
|
|
|
|
|
|
|
Year Ended |
|
|
Year Ended |
|
|
|
December 31, 2022 |
|
|
December 31, 2021 |
|
Assets: |
|
|
|
|
|
|
|
|
Operating lease
right-of-use assets |
|
$ |
77,011 |
|
|
$ |
122,503 |
|
Liabilities: |
|
|
|
|
|
|
|
|
Operating lease liability, current |
|
|
48,127 |
|
|
|
45,107 |
|
Operating lease liability, non-current |
|
|
29,268 |
|
|
|
77,396 |
|
Total lease liability |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
77,395 |
|
|
|
122,503 |
|
The Company recognizes lease expense for its operating leases within general, administrative, and
other expenses on the Companys Consolidated Statements of Operations and Comprehensive Income (Loss). The Companys lease expense for the periods presented consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
Year Ended |
|
|
Year Ended |
|
|
|
December 31, 2022 |
|
|
December 31, 2021 |
|
Operating lease cost |
|
$ |
48,784 |
|
|
$ |
19,868 |
|
Variable lease cost |
|
|
3,664 |
|
|
|
1,019 |
|
|
|
|
|
|
|
|
|
|
|
|
|
52,449 |
|
|
|
20,887 |
|
The following table shows supplemental cash flow information related to lease activities for the
periods presented:
|
|
|
|
|
|
|
|
|
Cash paid for amounts included in the measurement of the lease liability |
|
|
|
|
|
|
|
|
Operating cash flows from operating leases |
|
$ |
48,399 |
|
|
$ |
19,868 |
|
|
|
|
ROU assets obtained in exchange for new lease liabilities |
|
|
|
|
|
$ |
139,025 |
|
F-60
The table below shows a weighted-average analysis for lease terms and discount rates for
all operating leases for the periods presented:
|
|
|
|
|
|
|
|
|
|
|
Year Ended |
|
|
Year Ended |
|
|
|
December 31, 2022 |
|
|
December 31, 2021 |
|
Weighted-average remaining lease term (in years) |
|
|
1.58 |
|
|
|
2.58 |
|
Weighted-average discount rate |
|
|
3.36 |
% |
|
|
3.36 |
% |
Future minimum noncancelable lease payments under the Companys operating leases on an
undiscounted basis reconciled to the respective lease liability at December 31, 2022 are as follows:
|
|
|
|
|
|
|
Operating leases |
|
2023 |
|
$ |
49,855 |
|
2024 |
|
|
29,514 |
|
2025 |
|
|
|
|
2026 |
|
|
|
|
2027 |
|
|
|
|
Thereafter |
|
|
|
|
|
|
|
|
|
Total operating lease payments (undiscounted) |
|
|
79,369 |
|
Less: Imputed interest |
|
|
(1,974 |
) |
|
|
|
|
|
Lease liability as of December 31, 2022 |
|
$ |
77,395 |
|
|
|
|
|
|
The Company evaluated subsequent events and transactions from the balance sheet date through March 24, 2023, the date at which
the financial statements were issued.
* * * * * *
F-61
Abacus Settlements, LLC d/b/a Abacus Life
Financial Statements as of and for the Years Ended December 31, 2022, and 2021, and
Report of Independent Registered Public Accounting Firm
F-62
ABACUS SETTLEMENTS, LLC D/B/A ABACUS LIFE
TABLE OF CONTENTS
F-63
|
|
|
GRANT THORNTON LLP |
|
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM |
|
|
Two Commerce Square 2001 Market St., Suite 700 Philadelphia, PA 19103-7065
D +1 215 561 4200
F +1 215 561 1066 |
|
Members Abacus Settlements, LLC
d/b/a Abacus Life Opinion on the financial statements
We have audited the accompanying balance sheets of Abacus Settlements, LLC d/b/a Abacus
Life (a Florida limited liability company) (the Company) as of December 31, 2022 and 2021, the related statements of operations and comprehensive (loss) income, changes in members equity, and cash flows for each of the two
years in the period ended December 31, 2022, and the related notes (collectively referred to as the financial statements). In our opinion, the financial statements present fairly, in all material respects, the financial position of
the Company as of December 31, 2022 and 2021, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2022, in conformity with accounting principles generally accepted in the United
States of America. Basis for opinion
These financial statements are the responsibility of the Companys management. Our
responsibility is to express an opinion on the Companys financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are
required to be independent with respect to the Company in accordance with U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB and in accordance
with auditing standards generally accepted in the United States of America. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether
due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over
financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Companys internal control over financial reporting. Accordingly, we express no such opinion.
Our audits included performing procedures to assess the risks of material misstatement
of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our
audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our
opinion.
We have served as the Companys auditor since
2022. Philadelphia, Pennsylvania
February 17, 2023 |
|
|
GT.COM |
|
Grant Thornton LLP is the U.S. member firm of Grant Thornton International Ltd (GTIL). GTIL and each of its member firms are separate legal entities and are not a worldwide
partnership. |
F-64
ABACUS SETTLEMENTS, LLC D/B/A ABACUS LIFE
BALANCE SHEETS
AS OF DECEMBER 31, 2022 AND 2021
|
|
|
|
|
|
|
|
|
|
|
2022 |
|
|
2021 |
|
ASSETS |
|
|
|
|
|
|
|
|
CURRENT ASSETS: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
1,458,740 |
|
|
$ |
2,599,302 |
|
Related party receivables |
|
|
402,749 |
|
|
|
590,371 |
|
Other receivables |
|
|
122,455 |
|
|
|
40,000 |
|
Prepaid expenses |
|
|
216,150 |
|
|
|
305,516 |
|
Other current assets |
|
|
15,633 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current assets |
|
|
2,215,727 |
|
|
|
3,535,189 |
|
|
|
|
|
|
|
|
|
|
PROPERTY AND EQUIPMENTNet |
|
|
72,218 |
|
|
|
33,303 |
|
INTANGIBLE ASSETSNet |
|
|
148,933 |
|
|
|
214,071 |
|
OTHER ASSETS: |
|
|
|
|
Operating
right-of-use asset |
|
|
300,866 |
|
|
|
367,508 |
|
Due from members and affiliates |
|
|
1,448 |
|
|
|
16,536 |
|
State security deposits |
|
|
206,873 |
|
|
|
206,640 |
|
Certificate of deposit |
|
|
262,500 |
|
|
|
918,750 |
|
Other non-current assets |
|
|
7,246 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total other assets |
|
|
778,933 |
|
|
|
1,509,434 |
|
|
|
|
|
|
|
|
|
|
TOTAL ASSETS |
|
$ |
3,215,812 |
|
|
$ |
5,291,997 |
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND MEMBERS EQUITY |
|
|
|
|
CURRENT LIABILITIES: |
|
|
|
|
Accounts Payable |
|
$ |
36,750 |
|
|
$ |
|
|
Accrued payroll and other expenses |
|
|
541,866 |
|
|
|
510,846 |
|
Operating lease liabilities- current portion |
|
|
214,691 |
|
|
|
135,321 |
|
Contract liabilitydeposits on pending settlements |
|
|
322,150 |
|
|
|
1,678,791 |
|
Due to members |
|
|
1,411 |
|
|
|
11,857 |
|
|
|
|
|
|
|
|
|
|
Total current liabilities |
|
|
1,116,869 |
|
|
|
2,336,815 |
|
|
|
|
|
|
|
|
|
|
Operating lease liabilities- noncurrent portion |
|
|
87,806 |
|
|
|
232,187 |
|
|
|
|
|
|
|
|
|
|
Total liabilities |
|
$ |
1,204,675 |
|
|
$ |
2,569,002 |
|
|
|
|
|
|
|
|
|
|
COMMITMENTS AND CONTINGENCIES (NOTE 7) |
|
|
|
|
MEMBERS EQUITY: |
|
|
|
|
|
|
|
|
Common units; $10 par value; 400 common units issued and outstanding at December 31, 2022 and
2021 |
|
|
4,000 |
|
|
|
4,000 |
|
Additional paid-in capital |
|
|
80,000 |
|
|
|
80,000 |
|
Retained earnings |
|
|
1,927,137 |
|
|
|
2,638,995 |
|
|
|
|
|
|
|
|
|
|
Total members equity |
|
|
2,011,137 |
|
|
|
2,722,995 |
|
|
|
|
|
|
|
|
|
|
TOTAL LIABILITIES AND MEMBERS EQUITY |
|
$ |
3,215,812 |
|
|
$ |
5,291,997 |
|
|
|
|
|
|
|
|
|
|
See accompanying notes to financial statements.
F-65
ABACUS SETTLEMENTS, LLC D/B/A ABACUS LIFE
STATEMENTS OF OPERATIONS AND COMPREHENSIVE (LOSS) INCOME
FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021
|
|
|
|
|
|
|
|
|
|
|
2022 |
|
|
2021 |
|
ORIGINATION REVENUE |
|
$ |
7,050,007 |
|
|
$ |
4,906,374 |
|
RELATED PARTY REVENUE |
|
|
18,153,456 |
|
|
|
17,685,770 |
|
|
|
|
|
|
|
|
|
|
Total revenue |
|
|
25,203,463 |
|
|
|
22,592,144 |
|
COST OF REVENUE |
|
|
5,538,470 |
|
|
|
2,678,029 |
|
RELATED PARTY COST OF REVENUE |
|
|
11,022,535 |
|
|
|
11,527,312 |
|
|
|
|
|
|
|
|
|
|
Total cost of revenue |
|
|
16,561,005 |
|
|
|
14,205,341 |
|
GROSS PROFIT |
|
|
8,642,458 |
|
|
|
8,386,803 |
|
OPERATING EXPENSES: |
|
|
|
|
|
|
|
|
General and administrative expenses |
|
|
8,674,425 |
|
|
|
7,439,549 |
|
Depreciation expense |
|
|
12,165 |
|
|
|
10,139 |
|
|
|
|
|
|
|
|
|
|
Total operating expenses |
|
|
8,686,590 |
|
|
|
7,449,688 |
|
(LOSS) INCOME FROM OPERATIONS |
|
|
(44,132 |
) |
|
|
937,115 |
|
OTHER (EXPENSE) INCOME: |
|
|
|
|
|
|
|
|
Interest income |
|
|
2,199 |
|
|
|
11,500 |
|
Interest (expense) |
|
|
(8,817 |
) |
|
|
0 |
|
Consulting income |
|
|
273 |
|
|
|
50,000 |
|
|
|
|
|
|
|
|
|
|
Total other (expense)/ income |
|
|
(6,345 |
) |
|
|
61,500 |
|
|
|
|
|
|
|
|
|
|
(LOSS) INCOME BEFORE INCOME TAXES |
|
|
(50,477 |
) |
|
|
998,615 |
|
INCOME TAX EXPENSE |
|
|
2,018 |
|
|
|
1,200 |
|
|
|
|
|
|
|
|
|
|
Net (loss) income and comprehensive (loss) income |
|
$ |
(52,495 |
) |
|
$ |
997,415 |
|
|
|
|
|
|
|
|
|
|
WEIGHTED-AVERAGE UNITS USED IN COMPUTING
NET INCOME (LOSS) PER UNIT: |
|
|
|
|
|
|
|
|
Basic |
|
|
400 |
|
|
|
400 |
|
Diluted |
|
|
400 |
|
|
|
400 |
|
NET INCOME (LOSS) PER UNIT: |
|
|
|
|
|
|
|
|
Basic earnings per unit |
|
$ |
(131.24 |
) |
|
$ |
2,493.54 |
|
Diluted earnings per unit |
|
$ |
(131.24 |
) |
|
$ |
2,493.54 |
|
See accompanying
notes to financial statements.
F-66
ABACUS SETTLEMENTS, LLC D/B/A ABACUS LIFE
STATEMENTS OF CASH FLOWS
FOR THE YEARS ENDED
DECEMBER 31, 2022 AND 2021
|
|
|
|
|
|
|
|
|
|
|
2022 |
|
|
2021 |
|
CASH FLOWS FROM OPERATING ACTIVITIES: |
|
|
|
|
|
|
|
|
Net (loss) income |
|
$ |
(52,495 |
) |
|
$ |
997,415 |
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
|
|
|
|
|
Depreciation expense |
|
|
25,184 |
|
|
|
18,651 |
|
Amortization expense |
|
|
80,138 |
|
|
|
12,593 |
|
Amortization of deferred financing fees |
|
|
7,817 |
|
|
|
|
|
Non-cash lease expense |
|
|
1,631 |
|
|
|
|
|
Changes in operating assets and liabilities: |
|
|
|
|
|
|
|
|
Related party receivables |
|
|
187,622 |
|
|
|
(456,240 |
) |
Other receivables |
|
|
(82,455 |
) |
|
|
(40,000 |
) |
Prepaid expenses |
|
|
89,366 |
|
|
|
(58,316 |
) |
Other non-current assets |
|
|
(7,246 |
) |
|
|
|
|
Accounts payable |
|
|
36,750 |
|
|
|
|
|
Accrued payroll and other expenses |
|
|
31,020 |
|
|
|
(4,349 |
) |
Contract liabilitydeposits on pending settlements |
|
|
(1,356,641 |
) |
|
|
610,541 |
|
State security deposit |
|
|
(233 |
) |
|
|
(32 |
) |
Certificate of deposit |
|
|
656,250 |
|
|
|
262,500 |
|
|
|
|
|
|
|
|
|
|
Net cash (used in)/ from operating activities |
|
|
(383,291 |
) |
|
|
1,342,763 |
|
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM INVESTING ACTIVITIES: |
|
|
|
|
|
|
|
|
Purchase of property and equipment |
|
|
(64,099 |
) |
|
|
|
|
Purchase of intangible asset |
|
|
(15,000 |
) |
|
|
(226,664 |
) |
Change in due from members and affiliates |
|
|
15,088 |
|
|
|
(14,864 |
) |
|
|
|
|
|
|
|
|
|
Net cash (used in) investing activities |
|
|
(64,011 |
) |
|
|
(241,528 |
) |
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM FINANCING ACTIVITIES: |
|
|
|
|
|
|
|
|
Financing fees |
|
|
(23,450 |
) |
|
|
|
|
Change in due to members |
|
|
(10,446 |
) |
|
|
3,639 |
|
Distributions to members |
|
|
(659,363 |
) |
|
|
(358,216 |
) |
|
|
|
|
|
|
|
|
|
Net cash (used in) financing activities |
|
|
(693,259 |
) |
|
|
(354,577 |
) |
|
|
|
|
|
|
|
|
|
NET (DECREASE)/ INCREASE IN CASH AND CASH EQUIVALENTS |
|
|
(1,140,562 |
) |
|
|
746,658 |
|
CASH AND CASH EQUIVALENTSBeginning of year |
|
|
2,599,302 |
|
|
|
1,852,644 |
|
|
|
|
|
|
|
|
|
|
CASH AND CASH EQUIVALENTSEnd of year |
|
$ |
1,458,740 |
|
|
$ |
2,599,302 |
|
|
|
|
|
|
|
|
|
|
See accompanying notes to financial statements.
F-67
ABACUS SETTLEMENTS, LLC D/B/A ABACUS LIFE
STATEMENTS OF CHANGES IN MEMBERS EQUITY
FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional
Paid-in Capital |
|
|
Retained
Earnings |
|
|
Total
Members Equity |
|
|
|
Common units |
|
|
|
Units |
|
|
Amount |
|
BALANCEJanuary 1, 2021 |
|
|
400 |
|
|
$ |
4,000 |
|
|
$ |
80,000 |
|
|
|
1,999,796 |
|
|
|
2,083,796 |
|
Net income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
997,415 |
|
|
|
997,415 |
|
Distributions |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(358,216 |
) |
|
|
(358,216 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BALANCEDecember 31, 2021 |
|
|
400 |
|
|
|
4,000 |
|
|
|
80,000 |
|
|
|
2,638,995 |
|
|
|
2,722,995 |
|
Net (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(52,495 |
) |
|
|
(52,495 |
) |
Distributions |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(659,363 |
) |
|
|
(659,363 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BALANCEDecember 31, 2022 |
|
|
400 |
|
|
$ |
4,000 |
|
|
$ |
80,000 |
|
|
$ |
1,927,137 |
|
|
$ |
2,011,137 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See accompanying notes to financial statements.
F-68
ABACUS SETTLEMENTS, LLC D/B/A ABACUS LIFE
NOTES TO FINANCIAL STATEMENTS
1. |
DESCRIPTION OF THE BUSINESS |
Abacus Settlements, LLC d/b/a Abacus Life (the Company) was formed in 2004 in the state of New York. In 2016, the Company obtained
its licensure in Florida and re-domesticated to that state.
The Company acts as a purchaser of
outstanding life insurance policies on behalf of investors (financing entities) by locating policies and screening them for eligibility for a life settlement, including verifying that the policy is in force, obtaining consents and
disclosures, and submitting cases for life expectancy estimates, also known as origination services. When the sale of a policy is completed, this is deemed settled and the policy is then referred to as either a life
settlements, in which the insureds life expectancy is greater than two years or viatical settlements, in which the insureds life expectancy is less than two years.
The Company is not an insurance company, and therefore does not underwrite insurable risks for its own account.
On August 30, 2022, the Company entered into an Agreement and Plan of Merger (the Merger Agreement) with East Resources
Acquisition Company (ERES), which was subsequently amended on October 14, 2022 and April 20, 2023. As part of the Merger Agreement, the total transaction value is $618,000,000, where the holders of the Companys common
units together with the holders of Longevity Markets Assets, LLC (LMA), a commonly owned affiliate, will receive aggregate consideration of approximately $531,800,000, payable in a number of newly issued shares of ERES Class A
common stock, par value $0.0001 per share (ERES Class A common stock), with a value ascribed to each share of ERES Class A common stock of $10.00 and, to the extent the aggregate transaction proceeds exceed $200.0 million,
at the election of the Companys and LMAs members, up to $20.0 million of the aggregate consideration will be payable in cash to the Companys and LMAs members. The transaction is expected to close in Q2 2023, subject to
shareholder approval and customary closing conditions.
2. |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES |
Basis of PresentationThe accompanying financial statements are presented in accordance with the rules and regulations of the
Securities and Exchange Commission (SEC) and are prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP).
Use of EstimatesThe preparation of U.S. GAAP financial statements requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and changes therein, and disclosure of contingent assets and liabilities at the date of financial statements and the reports amounts of revenue and expenses during the reporting periods.
Companys estimates, judgments and assumptions are continually evaluated based on available information and experience. Because of the use of estimates inherent in the financial reporting process, actual results could differ from the estimates.
Estimates are used when accounting for revenue recognition and related costs, the selection of useful lives of property and equipment, impairment testing, valuation of other receivables, income taxes and legal reserves.
Going ConcernManagement evaluates at each annual and interim period whether there are conditions or events, considered in the
aggregate, that raise substantial doubt about Companys ability to continue as a going concern within one year after the date that the financial statements are issued. Managements evaluation is based on relevant conditions and events that
are known and reasonably knowable at the date that the financial statements are issued. Management has concluded that there are no conditions or events, considered in the aggregate, that raise substantial doubt about Companys ability to
continue as a going concern within one year after the date these financial statements were issued.
Cash and Cash
EquivalentsCash and cash equivalents include short-term and all highly-liquid debt instruments purchased with an original maturity of three months or less.
F-69
Related party receivablesRelated party receivables include fees to be
reimbursed to the Company from life expectancy reports, assisted physician services and escrow services incurred on policies that related party financing entities purchase as part of the origination agreement with the Company. Related party
receivables are stated at their net realizable value. Approximately, three-quarters of the outstanding receivables as of December 31, 2022 were collected in January 2023 and half of these fees as of December 31, 2021 were collected in
January 2022. The Company recognizes allowances for credit losses equal to the estimated collection losses that will be incurred in collection of all receivables. Management determines the allowance for credit losses based on a review of outstanding
receivables, historical collection experience, current economic conditions, and reasonable and supportable forecasts. Account balances are charged off against the allowance for credit losses when deemed uncollectible (after all means of collection
have been exhausted and the potential for recovery is deemed remote). The Company does not have any material allowance for credit losses as of December 31, 2022 or December 31, 2021. Refer to Note 12Related Party Transactions for
additional information.
Other receivablesOther receivables include origination fees for policies in which the recission
period has ended, but the funds have not been received yet from financing entities. These fees were collected in the subsequent month.
The
Company provides an allowance for credit losses equal to the estimated collection losses that will be incurred in collection of all receivables. Management determines the allowance for credit losses based on a review of outstanding receivables,
historical collection experience, current economic conditions, and reasonable and supportable forecasts. Account balances are charged off against the allowance for credit losses after all means of collection have been exhausted and the potential for
recovery is deemed remote. The Company does not have any material allowance for credit losses as of December 31, 2022 or December 31, 2021.
If the financial condition of the Companys customers were to deteriorate, resulting in an impairment of their ability to make payments,
additional allowances may be required. The Company did not record material allowance for credit losses as of December 31, 2022 and December 31, 2021, respectively.
ConcentrationsAll of the Companys revenues are derived from life settlement transactions in which the Company represents
financing entities that purchased existing life insurance policies. One financing entity, a company in which the Companys members own interests, represented 60% and 76% of the Companys revenues in 2022 and 2021, respectively. The
Company works with licensed life settlement brokers and agents who represent the sellers. No single broker or agent represented the sellers for over 10% of the Companys life settlement commission expense in 2022 and 2021.
The Company maintains cash deposits with a major bank which from time to time may exceed federally insured limits. The Company periodically
assesses the financial condition of the institution and believes that the risk of loss is minimal. For accounts receivable, the Company is exposed to credit risk in the event of nonpayment by customers to the extent of the amounts recorded on the
accompanying Balance Sheet. The Company extends different levels of credit to its customers and maintains allowance for credit loss accounts based upon the expected collectability of accounts receivable. The Companys procedures for determining
this allowance includes evaluating individual customer receivables, considering a customers financial condition, monitoring credit history and current economic conditions, using historical experience applied to an aging of accounts, and
reasonable and supportable forecasts.
Property and EquipmentNetProperty and equipment, net is stated at cost less
accumulated depreciation. Depreciation expense is recognized over the useful lives of the assets using the straight-line method. The estimated useful life of each asset category is as follows:
|
|
|
|
|
|
|
Years |
|
Computer equipment |
|
|
5 |
|
Office furniture |
|
|
5 |
|
F-70
Expenditures for repairs and maintenance are charged to expense in the period incurred.
When items of property and equipment are sold or retired, the related costs and accumulated depreciation are removed from the accounts. The difference between the net book value of the assets and proceeds from disposal is recognized as a gain or
loss on disposal, which is included in other income), in the statements of operations and comprehensive (loss) income.
Property and
equipment are tested for recoverability whenever events or changes in circumstance indicate that their carrying amounts may not be recoverable. An impairment loss is recognized if the carrying amount of property and equipment is not recoverable and
exceeds its fair value. Recoverability is determined based on the undiscounted cash flows expected to result from the use and eventual disposition of the asset or asset group. There were no impairments recognized during the years ended
December 31, 2022 and 2021, respectively. Property and equipment to be disposed of are reported at the lower of carrying amount or fair value less cost to sell.
Intangible AssetsNetIntangible assets are stated at cost, less accumulated amortization, and consist of capitalized costs
incurred for the development of internal use software. The costs incurred exclusively consist of fees incurred from an external consulting firm during the development stage of the project and are subject to capitalization under Accounting Standards
Codification (ASC) 350-40, Internal-Use Software. The software is amortized on the straight-line basis over an estimated useful life of 3 years.
Company reviews definite-lived intangible assets and other long-lived assets for impairment whenever an event occurs that indicates the carrying amount of an asset may not be recoverable. No impairment was recorded for the years ended
December 31, 2022 and 2021.
State security deposit and Certificate of DepositAs a requirement of the licensing process,
the Company is required to maintain a security deposit with a depository bank for the New Jersey Department of Banking and Insurance. The Company maintains a money market account in TD Wealth (NJ) to comply with these requirements. Additionally, a
deposit was made with the Florida Department of Financial Services to meet a similar requirement in the state of Florida. Further, Bank of America required the Company to purchase a certificate of deposit as collateral for an irrevocable letter of
credit, which supports the bonds that are required by certain states for licensing. As these deposits cannot be withdrawn due to regulatory requirements, they are not short term in nature and are classified as noncurrent assets on the balance
sheets.
Fair Value MeasurementsThe following fair value hierarchy is used in selecting inputs for those assets and
liabilities measured at fair value that distinguishes between assumptions based on market data (observable inputs) and the Companys assumptions (unobservable inputs). The Company evaluates these inputs and recognizes transfers between levels,
if any, at the end of each reporting period. The hierarchy consists of three levels:
Level 1Valuation based on quoted
market prices in active markets for identical assets or liabilities;
Level 2Valuation based on inputs other than
Level 1 inputs that are observable for the assets or liabilities either directly or indirectly;
Level 3Valuation
based on prices or valuation techniques that require inputs that are both significant to the fair value measurement and supported by little or no observable market activity.
The carrying values of the Companys financial assets and liabilities, including cash and cash equivalents, premiums, commissions and fees
receivable, premiums payable and accrued expenses and other current liabilities, approximate their fair values because of the short period of time to maturity and liquidity of those instruments.
Revenue RecognitionThe Company recognizes revenue from origination activities by acting as a provider of life settlements and
viatical settlements representing investors that are interested in purchasing life settlements on the secondary or tertiary market. Revenue from origination services consists of fees negotiated for each purchase and sale of a policy to an investor,
which also include any agent and broker
F-71
commissions received and the reimbursement of transaction costs. For revenue disaggregation based upon the source of the policy, see disclosure in Note 8Revenue.
The Companys revenue-generating arrangements are within the scope of ASC 606, Revenue from Contracts with Customers. The Company
originates life settlements policies with third parties that include settlement brokers, life insurance agents, and direct consumers or policyholders. The Company then provides the administration services needed to initiate the transfer of the life
settlement policies to investors in exchange for an origination fee. Such transactions are entirely performed through an escrow agent. In these arrangements, the customer is the investor, and the Company has a single performance obligation to
originate a life settlement policy for the investor. The consideration transferred upon each policy is negotiated directly with the investor by the Company and is dependent upon the policy death benefits held by each life settlement policy. The
revenue is recognized when the performance obligation under the terms of the contracts with customers are satisfied. The Company recognizes revenue from life settlement transactions when the closing has occurred and any right of rescission under
applicable state law has expired (i.e., the customer obtains control over the policy and has the right to use and obtain the benefits from the policy). While rescission periods may vary by state, most states grant the owner the right to rescind the
contract before the earlier of 30 calendar days after the execution date of the contract or 15 calendar days after life settlement proceeds have been sent to the owner. Purchase and sale of the policies generally occurs simultaneously, and only the
fees received, including any agent and broker commissions and transaction costs reimbursed, are recorded as gross revenue.
For agent and
broker commissions received and transaction costs reimbursed, the Company has determined that it is acting as the principal in the relationship as it maintains control of the services being performed as part of performance obligation prior to
facilitating the transfer of the life settlement policy to the investor.
While the origination fees are fixed amounts based on the face
value of the policy death benefit, there is variable consideration present due to the owners recission right. When variable consideration is present in a contract, the Company estimates the amount of variable consideration to which it expects to be
entitled at contract inception and again at each reporting period until the amount is known. The entity applies the variable consideration constraint so that variable consideration is included in the transaction price only to the extent it is
probable that a subsequent change in estimate will not result in a significant revenue reversal. While origination fees are variable due to the recission periods, given that the recission periods are relatively short in nature, the Company has
concluded that such fees are fully constrained until the rescission period lapses and thus records revenue at a fixed amount based on the face value of the policy death benefit after the recission period is over.
Cost to Obtain or Fulfill ContractsCosts to obtain or fulfill contracts include commissions for brokers or agents under specific
agreements that would not be incurred without a contract being signed and executed. The Company has elected to apply the ASC 606 practical expedient which allows us to expense these costs as incurred if the amortization period related to
the resulting asset would be one year or less. The Company has no instances of contracts that would be amortized for a period greater than a year, and therefore has no contract costs capitalized for these arrangements.
Contract BalancesThe timing of revenue recognition, customer billing and cash collection can result in billed accounts receivable,
unbilled receivables (contract assets), and deferred revenues (contract liabilities). Contract liabilities consist of deposits on pending settlements, where origination fees and commissions were received from policies that had closed in December,
but the right of rescission period had not expired as of December 31.
CommissionsThe Company receives a fee from the
purchaser for their part in arranging the life settlement transactions. Out of that fee income, the Company pays commissions to the licensed representative of the seller, if one is required. Commission expense is recorded at the same time revenue is
recognized and is included in the accompanying statements of operations and comprehensive (loss) income as cost of sales.
F-72
SegmentOperating segments are defined as components of an entity for which
separate financial information is available and that is regularly reviewed by the chief operating decision maker (CODM) in deciding how to allocate resources to an individual segment and in assessing performance. The Companys CODM
is its President and Chief Executive Officer. The Company has determined that it operates in one operating segment and one reportable segment, as the CODM reviews financial information presented for purposes of making operating decisions, allocating
resources, and evaluating financial performance.
Income TaxesThe Company is taxed as an
S-corporation for U.S. federal income tax purposes as provided in Section 1362(a) of the Internal Revenue Code. As such, the Companys income or loss and credits are passed through to the members and
reported on their individual Federal income tax return. The Company is required to file tax returns in most of the states in which it does business. Not all of the states recognize S-corporations as pass-through entities, and the Company is taxed at the corporate level. Accordingly, the Company pays income taxes to those states that do not treat S corporations as
pass-through entities for tax purposes. The income tax expense or benefit is based on taxable income allocated to the states that do not recognize S-corporations as pass-through entities.
The Company records uncertain tax positions in accordance with ASC 740, Income
Taxes, on the basis of a two-step process whereby: (i) management determines whether it is more likely than not that the tax positions will be sustained based on the technical merits of the position,
and (ii) for those tax positions that meet the more likely than not recognition threshold, management recognizes the largest amount of tax benefit that is greater than 50 percent likely to be realized upon ultimate settlement with the
related tax authority.
The Company recognizes interest and penalties as a component of income tax expense. The Company is subject to
routine audits by taxing jurisdictions; however, there are currently no audits for any tax periods in progress.
AdvertisingAll advertising expenditures incurred by the Company are charged to expense in the period to which they relate and are
included in general and administrative expenses on the accompanying statements of operations and comprehensive (loss) income. Advertising expense totaled $1,414,828 and $1,803,000 for the years ended December 31, 2022 and 2021, respectively.
LeasesThe Company accounts for its leases in accordance with ASC 842, Leases. A contract is or contains a lease if
there is identified property, plant and equipment that is either explicitly or implicitly specified in the contract and the lessee has the right to control the use of the property, plant and equipment throughout the contract term, which is based on
an evaluation of whether the lessee has the right to direct the use of the property, plant and equipment.
In April 2022, the Company
entered into an agreement to lease additional office space in Orlando, Florida from a vendor. The lease commenced on May 1, 2022 and goes through October 30, 2023.
Historically, the Companys lease portfolio consisted of a single lease of office space in Orlando, Florida, which is accounted for as an
operating lease. In April 2021, the lease was modified to expand the office space leased by the Company and also extend the term of the lease through July 31, 2024. The Company is responsible for utilities, maintenance, taxes and insurance,
which are variable payments based on a reimbursement to the lessor of the lessors costs incurred. The Company excludes variable lease payments from the measurement of lease liabilities and right-of-use (ROU) assets recognized on the Companys balance sheets. Variable lease payments are recognized as a lease expense on the Companys statements of operations and
comprehensive (loss) income in the period incurred. The Company has elected the practical expedient to account for lease components and non-lease components together as a single lease component for its real
estate leases noted above.
The Company has elected the short-term lease exemption, which permits the Company to not recognize a lease
liability and ROU asset for leases with an original term of one year or less. Currently, the Company does not have any short-term leases. The Companys current lease includes a renewal option. The Company has determined that the renewal option
is not reasonably certain of exercise based on an evaluation of
F-73
contract, market and asset-based factors, and therefore does not include periods covered by renewal options in its lease term. The Companys leases generally do not include purchase options,
residual value guarantees, or material restrictive covenants.
The Company determines its lease liability and ROU by calculating the
present value of future lease payments. The present value of future lease payments is discounted using the Companys incremental borrowing rate. As the Companys leases generally do not have a readily determinable implicit rate, the
Company uses its incremental borrowing rate based on market yields and comparable credit ratings, adjusted for lease term, to determine the present value of fixed lease payments based on information available at the lease commencement date.
The Company does not have any finance leases, nor is the Company a lessor (or sublessor).
See Note 14 for additional disclosures related to leases.
Earnings Per UnitThe Company has only one class of equity. Basic net (loss) income per unit is calculated by dividing net (loss)
income by the weighted average number of units outstanding during the applicable period. If the number of units outstanding increases as a result of a unit dividend or unit split or decreases as a result of a reverse unit split, the computations of
basic net (loss) income per unit are adjusted retroactively for all periods presented to reflect that change in capital structure. If such changes occur after the close of the reporting period but before issuance of the financial statements, the per-units computations for that period and any prior-period financial statements presented are based on the new number of units.
Operating as a centrally-led life insurance policy intermediary, the Companys President and Chief
Executive Officer is the CODM who allocates resources and assesses financial performance based on financial information presented for the Company as a whole. As a result of this management approach, the Company is organized as a single operating
segment.
4. |
PROPERTY AND EQUIPMENTNET |
Property and equipment, net consists of the following:
|
|
|
|
|
|
|
|
|
|
|
2022 |
|
|
2021 |
|
Computer equipment |
|
$ |
91,993 |
|
|
$ |
45,172 |
|
Office furniture |
|
|
68,778 |
|
|
|
54,069 |
|
Leasehold improvement |
|
|
2,569 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total property and equipment |
|
|
163,340 |
|
|
|
99,241 |
|
Less: accumulated depreciation |
|
|
(91,122 |
) |
|
|
(65,938 |
) |
|
|
|
|
|
|
|
|
|
Property and equipmentnet |
|
$ |
72,218 |
|
|
$ |
33,303 |
|
|
|
|
|
|
|
|
|
|
Depreciation expense recorded for property and equipment was $25,184 and $18,651, of which $13,019
and $8,512 has been included in cost of sales, for the years ended December 31, 2022 and 2021, respectively.
Intangible assetsnet, consist of the following:
|
|
|
|
|
|
|
|
|
|
|
2022 |
|
|
2021 |
|
Software |
|
$ |
241,664 |
|
|
$ |
226,664 |
|
Less: accumulated amortization |
|
|
92,731 |
|
|
|
12,593 |
|
|
|
|
|
|
|
|
|
|
Intangible assetsnet |
|
$ |
148,933 |
|
|
$ |
214,071 |
|
|
|
|
|
|
|
|
|
|
F-74
Amortization expense for the year ended December 31, 2022 and 2021 amounted to
$80,138 and $12,593, respectively, and has been included in cost of sales.
6. |
ACCRUED PAYROLL AND OTHER EXPENSES |
The Companys accrued payroll and other expenses were as follows:
|
|
|
|
|
|
|
|
|
|
|
2022 |
|
|
2021 |
|
Accrued payroll |
|
$ |
224,168 |
|
|
$ |
188,529 |
|
Accrued credit card fees |
|
|
235,680 |
|
|
|
172,189 |
|
Other expenses |
|
|
82,018 |
|
|
|
150,128 |
|
|
|
|
|
|
|
|
|
|
Total accrued payroll and other expenses |
|
$ |
541,866 |
|
|
$ |
510,846 |
|
|
|
|
|
|
|
|
|
|
7. |
COMMITMENTS AND CONTINGENCIES |
Legal ProceedingsThe Company is a defendant in a lawsuit brought by a third party. The third party seeks to rescind a viatical
settlement contract regarding a $4 million life insurance policy as the third party contends that the subject transaction documents were inconsistent with Delaware law and therefore the rescission provisions of the transaction documents were
not enforceable. The trial is expected to begin in April 2023. The Company believes it has acted properly and in accordance with applicable state law and regulations. Legal counsel feels that a favorable outcome is likely for the Company; therefore,
no liability has been accrued on the accompanying balance sheets. Although the Company believes there is no merit to this case, there is a five (5) million-dollar errors and omissions insurance policy in place with a $50,000 deductible per
occurrence, which would limit any exposure to the Company.
Letter of creditThe Company entered into a one-year letter of credit agreement in August 2022 to support bonding requirements associated with state insurance licenses and provide the Company the ability to borrow up to $1,012,500 related to state penal
bonds. The letter of credit has variable interest based on Wall Street Journal Prime rates, beginning at 6.5%. Interest is only due on the outstanding principal amount. The Company did not draw on the letter of credit during 2022, as such $0 was
outstanding as of December 31, 2022. The Company incurred $23,450 of financing fees associated with establishing the letter of credit, which have been capitalized in other current assets and amortized over the stated term.
Remaining performance obligationThe Company is recognizing revenue at a point in time when the closing has occurred and any right
of rescission under applicable state law has expired. As of December 31, 2022 and 2021, there are $322,150 and $1,678,791 in revenues allocated to performance obligations to be satisfied, of which all are expected to be recognized as revenue in
the following year when the right of rescission has expired.
Disaggregated RevenueThe following table presents a
disaggregation of the Companys revenue by major sources for the years ended December 31, 2022 and 2021:
|
|
|
|
|
|
|
|
|
|
|
2022 |
|
|
2021 |
|
Agent |
|
$ |
12,156,552 |
|
|
$ |
7,668,256 |
|
Broker |
|
|
9,938,808 |
|
|
|
11,378,713 |
|
Client direct |
|
|
3,108,103 |
|
|
|
3,545,175 |
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
25,203,463 |
|
|
$ |
22,592,144 |
|
|
|
|
|
|
|
|
|
|
F-75
Contract BalancesThe balances of contract liabilities arising from
contracts with customers for the years ended December 31, 2022 and 2021 were as follows:
|
|
|
|
|
|
|
|
|
|
|
2022 |
|
|
2021 |
|
Contract liabilitiesbeginning of year |
|
$ |
1,678,791 |
|
|
$ |
1,068,250 |
|
Additions to Contract Liabilities |
|
|
322,150 |
|
|
|
1,678,791 |
|
Recognition of revenue deferred in the prior year |
|
|
(1,678,791 |
) |
|
|
(1,068,250 |
) |
|
|
|
|
|
|
|
|
|
Contract liabilitiesend of year |
|
$ |
322,150 |
|
|
$ |
1,678,791 |
|
|
|
|
|
|
|
|
|
|
Since the Company elected to file as an S-corporation for Federal and State income tax purposes, the
Company incurred no Federal or State income taxes. Accordingly, tax expense is attributable to minimum state tax payments that are due regardless of their S-corporation status and income position.
The components of expense for income taxes for the years ended December 31, 2022 and 2021 are as follows:
|
|
|
|
|
|
|
|
|
|
|
2022 |
|
|
2021 |
|
State income taxes: |
|
|
|
|
|
|
|
|
Current |
|
$ |
2,018 |
|
|
$ |
1,200 |
|
Deferred |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expense for income taxes |
|
$ |
2,018 |
|
|
$ |
1,200 |
|
|
|
|
|
|
|
|
|
|
This expense solely relates to state minimum tax for state taxes that have been paid and settled
during the respective years shown above.
For the years ended December 31, 2022 and 2021, the income tax expense differs from the
provision that would result from applying state statutory tax rates to the income before income taxes due to the Companys S-corporation election. A reconciliation of the statutory federal income tax rate
to the Companys effective tax rate is as follows:
|
|
|
|
|
|
|
|
|
Tax at federal statutory rate |
|
|
21.00 |
% |
|
|
21.00 |
% |
State taxes, net of federal benefit |
|
|
(4.00 |
) |
|
|
0.12 |
|
U.S. income attributable to pass-through entity |
|
|
(21.00 |
) |
|
|
(21.00 |
) |
|
|
|
|
|
|
|
|
|
Effective income tax rate |
|
|
(4.00 |
)% |
|
|
0.12 |
% |
|
|
|
|
|
|
|
|
|
The Company did not have any unrecognized tax benefits relating to uncertain tax positions at
December 31, 2022 and 2021 and did not recognize any interest or penalties related to uncertain tax position at December 31, 2022 and 2021.
Given the companys S-Corporation status, temporary book and tax differences do not create a
deferred tax asset or liability on the balance sheets. Accordingly, an assessment of realizability of any deferred tax asset balances is not relevant.
On March 27, 2020, the CARES Act was enacted. The CARES Act includes provisions, among others, addressing the carryback of net operating
losses for specific periods, refunds of alternative minimum tax credits, temporary modifications to the limitations placed on the tax deductibility of net interest expenses, and technical amendments for qualified improvement property. Additionally,
the CARES Act provides for various payroll incentives, including PPP loans, refundable employee retention tax credits, and the deferral of the employer-paid portion of social security payroll taxes.
F-76
The Company had a 401(k) Safe Harbor and Discretionary Profit-Sharing Plan (the Plan) with a service provider until May 30, 2021, at
which time the Company switched to Paychexs Retirement Services 401(k) Profit Sharing Plan. All eligible employees are able to participate in voluntary salary reduction contributions to the Profit-Sharing Plan. All employees who have
completed one year of service with the Company are eligible to receive employer matching contributions. The Company may match contributions to the Profit-Sharing Plan, up to 4% of compensation. For the years ended December 31, 2022 and 2021,
the Company made a discretionar
y contribution of $0 and $100,000 to the Profit Sharing Plan, respectively.
The Company is authorized to issue up to 400 units of par value common units. Holders of the Companys common units are entitled to one
vote for each share. At December 31, 2022 and 2021, there were 400 shares of common units issued and outstanding. Holders of the common units were entitled to receive, in the event of a liquidation, dissolution or winding up, ratably the assets
available for distribution to the unit holders after payment of all liabilities.
12. |
RELATED PARTY TRANSACTIONS |
Due from members and affiliates includes $1,448 and $16,536 of short-term advances to affiliates with no stated terms at December 31, 2022
and 2021, respectively. Due to members and affiliates includes $1,411 and $11,857 of distributions owed to members at December 31, 2022 and 2021, respectively.
The Company has a related party relationship with Nova Trading (US), LLC (Nova Trading), a Delaware limited liability company and
Nova Holding (US) LP, a Delaware limited partnership (Nova Holding and collectively with Nova Trading, the Nova Funds) as the owners of the Company jointly own 11% of the Nova Funds. For the years ended December 31, 2022
and December 31, 2021, the Company has originated 333 and 313 policies, respectively, for the Nova Funds with a total value of $87,143,005 and $106,633,792. For its origination services to the Nova Funds, the Company earns origination fees
equal to the lesser of (i) 2% of the net death benefit for the policy or (ii) $20,000 in addition to agent and broker commissions and reimbursements for transaction expenses, where the Company has determined that it is acting as the
principal. For the years ended December 31, 2022 and December 31, 2021, revenue earned and contracts originated are as follows:
|
|
|
|
|
|
|
|
|
|
|
December 31, |
|
|
December 31, |
|
|
|
2022 |
|
|
2021 |
|
Origination fee revenue |
|
$ |
6,586,922 |
|
|
$ |
6,158,458 |
|
Commissions and transaction reimbursement revenue |
|
$ |
8,656,885 |
|
|
$ |
11,093,512 |
|
|
|
|
|
|
|
|
|
|
Total revenue |
|
$ |
15,243,806 |
|
|
$ |
17,251,970 |
|
|
|
|
|
|
|
|
|
|
Cost |
|
|
87,143,005 |
|
|
|
106,633,792 |
|
Face value |
|
|
481,648,010 |
|
|
|
459,217,638 |
|
Total policies |
|
|
333 |
|
|
|
313 |
|
Average Age |
|
|
75 |
|
|
|
78 |
|
The Company also has two other affiliated investors that it provides origination services for. Total
revenue earned related to the other affiliated investors was $2,909,650 and $433,800, respectively of which $2,268,150 and $0 related to Longevity Market Assets, LLC (LMA), for the years ended December 31, 2022 and December 31,
2021, respectively. Total cost of sales were $2,365,650 and $433,800 for the other affiliated investors for the years ended December 31, 2022 and December 31, 2021, respectively.
In addition, at December 31, 2022 and 2021, there were $175,194 and $590,371, respectively, in expense reimbursements due from the Nova
funds, which are included as related party receivables in the accompanying balance sheets.
F-77
13. |
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION. |
For the years ended December 31, 2022 and December 31, 2021, respectively, supplemental cash flow information and supplemental
disclosure of non-cash investing and financing activity consists of the following:
|
|
|
|
|
|
|
|
|
|
|
2022 |
|
|
2021 |
|
Supplemental cash flow information: |
|
|
|
|
|
|
|
|
Cash paid for income taxes |
|
$ |
0 |
|
|
$ |
1,200 |
|
Supplemental disclosure of non-cash investing and
financing activity: |
|
|
|
|
|
|
|
|
Distributions owed to the members |
|
|
1,411 |
|
|
|
11,857 |
|
The Companys ROU assets and lease liabilities for its operating leases consisted of the following amounts as of December 31, 2022
and 2021:
|
|
|
|
|
|
|
|
|
|
|
As of December 31, |
|
|
|
2022 |
|
|
2021 |
|
Assets |
|
|
|
|
|
|
|
|
Operating lease
right-of-use asset |
|
$ |
300,866 |
|
|
$ |
367,508 |
|
Liabilities |
|
|
|
|
|
|
|
|
Operating lease liability, current |
|
|
214,691 |
|
|
|
135,321 |
|
Operating lease liability, noncurrent |
|
|
87,806 |
|
|
|
232,187 |
|
|
|
|
|
|
|
|
|
|
Total operating lease liabilities |
|
$ |
302,497 |
|
|
$ |
367,508 |
|
The Company recognizes lease expense for its operating leases within general and administrative
expenses on the Companys statements of operations and comprehensive (loss) income. The Companys lease expense for the periods presented consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
|
|
2022 |
|
|
2021 |
|
Operating lease cost |
|
$ |
190,183 |
|
|
$ |
126,178 |
|
Variable lease cost |
|
|
9,403 |
|
|
|
10,756 |
|
|
|
|
|
|
|
|
|
|
Total lease cost |
|
$ |
199,586 |
|
|
$ |
136,935 |
|
|
|
|
|
|
|
|
|
|
The following table shows supplemental cash flow information related to lease activities for the
periods presented:
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
|
|
2022 |
|
|
2021 |
|
Cash paid for amounts included in the measurement of the lease liability |
|
|
|
|
|
|
|
|
Operating cash flows from operating leases |
|
|
201,478 |
|
|
|
126,178 |
|
ROU assets obtained in exchange for new lease liabilities |
|
|
123,541 |
|
|
|
417,076 |
|
The table below shows a weighted-average analysis for lease term and discount rate for all operating
leases as of December 31, 2022 and 2021:
|
|
|
|
|
|
|
|
|
|
|
As of December 31, |
|
|
|
2022 |
|
|
2021 |
|
Weighted-average remaining lease term (in years) |
|
|
1.41 |
|
|
|
2.58 |
|
Weighted-average discount rate |
|
|
3.71 |
% |
|
|
3.36 |
% |
F-78
Future minimum noncancelable lease payments under the Companys operating leases on
an undiscounted basis reconciled to the respective lease liability at December 31, 2022 are as follows:
|
|
|
|
|
|
|
Operating Leases |
|
2023 |
|
|
221,182 |
|
2024 |
|
|
88,543 |
|
2025 |
|
|
|
|
2026 |
|
|
|
|
2027 |
|
|
|
|
Thereafter |
|
|
|
|
|
|
|
|
|
Total operating lease payments (undiscounted) |
|
$ |
309,726 |
|
Less: Imputed interest |
|
|
(7,229 |
) |
|
|
|
|
|
Lease liability as of December 31, 2022 |
|
$ |
302,497 |
|
|
|
|
|
|
The Company has evaluated its subsequent events through February 17, 2023, the date that the financial statements were available to be
issued.
* * * * * *
F-79
ANNEX A-1
AGREEMENT AND PLAN OF MERGER
by and among
EAST RESOURCES ACQUISITION COMPANY,
LMA MERGER SUB, LLC,
ABACUS MERGER SUB, LLC,
LONGEVITY MARKET ASSETS, LLC,
and
ABACUS
SETTLEMENTS, LLC
Dated as of August 30, 2022
LIST OF EXHIBITS
|
|
|
Exhibit A |
|
Definitions |
Exhibit B |
|
Form of Sponsor Support Agreement |
Exhibit C |
|
Form of Company Support Agreement |
Exhibit D |
|
Form of Second Amended and Restated Certificate of Incorporation of Parent |
Exhibit E |
|
Form of Amended and Restated Bylaws of Parent |
Exhibit F |
|
Form of Amended and Restated Registration Rights Agreement |
A-1-iv
AGREEMENT AND PLAN OF MERGER
This AGREEMENT AND PLAN OF MERGER, dated August 30, 2022 (this Agreement), is made and entered into
by and among East Resources Acquisition Company, a Delaware corporation (Parent), LMA Merger Sub, LLC, a Delaware limited liability company and wholly owned subsidiary of Parent (LMA Merger Sub), Abacus Merger
Sub, LLC, a Delaware limited liability company and wholly owned subsidiary of Parent (Abacus Merger Sub and, together with LMA Merger Sub and Parent, the Parent Parties), Longevity Market Assets, LLC, a Florida
limited liability company (LMA), and Abacus Settlements, LLC, a Florida limited liability company (Abacus and, together with LMA, the Companies). Parent, LMA Merger Sub, Abacus Merger Sub, LMA
and Abacus are sometimes individually referred to in this Agreement as a Party and collectively as the Parties. Capitalized terms used in this Agreement shall have the meanings ascribed to them in
Exhibit A attached hereto.
RECITALS
WHEREAS, each of LMA Merger Sub and Abacus Merger Sub is a newly formed entity for the purposes of the transactions contemplated hereby;
WHEREAS, the LMA Members collectively own all of the issued and outstanding limited liability company interests in LMA (the LMA
Interests);
WHEREAS, the Abacus Members collectively own all of the issued and outstanding limited liability company interests
in Abacus (the Abacus Interests);
WHEREAS, upon the terms and subject to the conditions of this Agreement, the Parties
intend to enter into a business combination transaction pursuant to which, in accordance with the General Corporation Law of the State of Delaware (the DGCL) and the Delaware Limited Liability Company Act
(DLLCA), (i) LMA Merger Sub shall merge with and into LMA, with LMA surviving such merger (the LMA Merger) as a direct wholly owned subsidiary of Parent (the LMA Surviving Company) and
(ii) Abacus Merger Sub shall merge with and into Abacus, with Abacus surviving such merger (the Abacus Merger and, together with the LMA Merger, the Mergers) as a direct wholly owned subsidiary of Parent
(the Abacus Surviving Company and, together with the LMA Surviving Company, the Surviving Companies), whereby all LMA Interests and Abacus Interests will be exchanged for the Aggregate Merger Consideration as
further described herein;
WHEREAS, the board of directors of Parent has (a) determined that it is in the best interests of Parent
and its stockholders for Parent to enter into this Agreement and the Ancillary Agreements, (b) unanimously approved the execution and delivery of this Agreement and the Ancillary Agreements, Parents performance of its obligations
hereunder and thereunder and the consummation of the transactions contemplated hereby and thereby, including the Mergers, and (c) recommended adoption and approval of this Agreement and the Ancillary Agreements and the transactions contemplated
hereby and thereby by the stockholders of Parent;
WHEREAS, Parent, as the sole member of each of LMA Merger Sub and Abacus Merger Sub,
has approved and adopted this Agreement and the Ancillary Agreements, the Mergers and the transactions contemplated by this Agreement and the Ancillary Agreements pursuant to action taken by unanimous written consent in accordance with the
requirements of the DLLCA and the Organizational Documents of each of LMA Merger Sub and Abacus Merger Sub;
WHEREAS, the board of
managers of LMA has approved and adopted this Agreement and the Ancillary Agreements, the Mergers and the transactions contemplated by this Agreement and the Ancillary Agreements pursuant to action taken by unanimous written consent in accordance
with the requirements of the Florida Revised Limited Liability Company Act (the FRLLCA) and the Organizational Documents of LMA;
A-1-1
WHEREAS, the board of managers of Abacus has approved and adopted this Agreement and the
Ancillary Agreements, the Mergers and the transactions contemplated by this Agreement and the Ancillary Agreements pursuant to action taken by unanimous written consent in accordance with the requirements of the FRLLCA and the Organizational
Documents of Abacus;
WHEREAS, concurrently with the execution of this Agreement and in accordance with the terms hereof, in connection
with the transactions contemplated hereby, ERES Sponsor has entered into a Sponsor Support Agreement, dated as of the date hereof (the Sponsor Support Agreement), with each of the Companies and Parent, in the form set forth on
Exhibit B hereto;
WHEREAS, concurrently with the execution of this Agreement and in accordance with the terms hereof, in
connection with the transactions contemplated hereby, the Company Members have entered into a Company Support Agreement, dated as of the date hereof (the Company Support Agreement), with each of the Companies and Parent, in the
form set forth on Exhibit C hereto;
WHEREAS, following the date hereof and prior to Closing, Parent and the Companies may enter
into subscription agreements (as amended or modified from time to time, collectively, the Subscription Agreements) with certain investors (collectively, the Subscribers), pursuant to which, among other things,
each Subscriber is expected to agree to subscribe for and purchase on the Closing Date immediately prior to the Mergers, and Parent or each Company, as the case may be, is expected to agree to issue and sell to each such Subscriber on the Closing
Date immediately prior to the Mergers, the number of shares of Parent Common Stock or such other security as set forth in the applicable Subscription Agreement in exchange for the purchase price set forth therein, in each case, on the terms and
subject to the conditions set forth in the applicable Subscription Agreement;
WHEREAS, as a condition to the consummation of the
transactions contemplated hereby and in accordance with the terms hereof, Parent shall provide an opportunity to its stockholders to have their Parent Common Stock redeemed for the consideration, and on the terms and subject to the conditions and
limitations, set forth in this Agreement and Parents Organizational Documents in conjunction with obtaining approval from the stockholders of Parent for the transactions contemplated hereby (collectively with the other transactions,
authorization and approvals set forth in the Proxy Statement, the Offer);
WHEREAS, immediately prior to the
consummation of the transactions contemplated hereby, Parent shall, subject to obtaining the Parent Stockholder Approval, adopt the second amended and restated certificate of incorporation (the A&R Charter) in the form set
forth on Exhibit D hereto;
WHEREAS, immediately prior to the consummation of the transactions contemplated hereby, Parent shall
adopt the amended and restated bylaws (the A&R Bylaws) in the form set forth on Exhibit E hereto;
WHEREAS,
for U.S. federal income Tax purposes, it is intended that each of the Mergers qualify as a reorganization within the meaning of Section 368(a) of the Code to which each of Parent, LMA, Abacus, LMA Merger Sub and Abacus Merger Sub
are parties pursuant to Section 368(b) of the Code and that this Agreement constitutes a plan of reorganization for purposes of Sections 354, 361 and 368 of the Code and the Treasury Regulations promulgated thereunder; and
WHEREAS, the Parties desire to make certain representations, warranties, covenants and other agreements in connection with the foregoing and
also prescribe certain conditions to the Mergers as specified herein.
A-1-2
NOW, THEREFORE, in consideration of the foregoing and the respective representations,
warranties, covenants, agreements and conditions set forth in this Agreement, and intending to be legally bound hereby, each Party hereby agrees:
ARTICLE I
THE MERGERS
Section 1.1 The Mergers.
(a) Upon the terms and subject to the conditions set forth in this
Agreement and in accordance with the DLLCA, at the Effective Time, LMA Merger Sub shall merge with and into LMA. Following the LMA Merger, the separate limited liability company existence of LMA Merger Sub will cease and LMA will continue as the LMA
Surviving Company and as a wholly owned Subsidiary of Parent; provided that notwithstanding the LMA Merger, LMA will not be included within the meaning of the term Parent Parties for purposes of this Agreement. The LMA Merger will be consummated in
accordance with this Agreement and the DLLCA and evidenced by a certificate of merger between LMA Merger Sub and LMA (the LMA Certificate of Merger). The LMA Merger will be effective at such time as the Parties duly file the LMA
Certificate of Merger with the Secretary of State of the State of Delaware or at such other date or time as Parent and the Companies agree in writing and specify in the LMA Certificate of Merger (the LMA Effective Time).
(b) Upon the terms and subject to the conditions set forth in this Agreement and in accordance with the DLLCA, at the Effective
Time, Abacus Merger Sub shall merge with and into Abacus. Following the Abacus Merger, the separate limited liability company existence of Abacus Merger Sub will cease and Abacus will continue as the Abacus Surviving Company and as a wholly owned
Subsidiary of Parent; provided that notwithstanding the Abacus Merger, Abacus will not be included within the meaning of the term Parent Parties for purposes of this Agreement. The Abacus Merger will be consummated in accordance with this Agreement
and the DLLCA and evidenced by a certificate of merger between Abacus Merger Sub and Abacus (the Abacus Certificate of Merger, together with the LMA Certificate of Merger, the Certificates of Merger). The Abacus
Merger will be effective at such time as the Parties duly file the Abacus Certificate of Merger with the Secretary of State of the State of Delaware or at such other date or time as Parent and Abacus agree in writing and specify in the Abacus
Certificate of Merger (the Abacus Effective Time and, together with the LMA Effective Time, the Effective Time).
Section 1.2 Effects of the Mergers.
(a) The LMA Merger will have the effect set forth in this Agreement and the relevant provisions of the DLLCA. Without limiting
the generality of the foregoing, and subject hereto, at the LMA Effective Time, all property, rights, privileges, immunities, powers and franchises of LMA Merger Sub will vest in the LMA Surviving Company, and all claims, obligations, restrictions,
disabilities, liabilities, debts and duties of LMA Merger Sub will become the claims, obligations, restrictions, disabilities, liabilities, debts and duties of the LMA Surviving Company.
(b) The Abacus Merger will have the effect set forth in this Agreement and the relevant provisions of the DLLCA. Without
limiting the generality of the foregoing, and subject hereto, at the Abacus Effective Time, all property, rights, privileges, immunities, powers and franchises of Abacus Merger Sub will vest in the Abacus Surviving Company, and all claims,
obligations, restrictions, disabilities, liabilities, debts and duties of Abacus Merger Sub will become the claims, obligations, restrictions, disabilities, liabilities, debts and duties of the Abacus Surviving Company.
Section 1.3 Governing Documents. At the Effective Time, the Organizational Documents of each of the
Surviving Companies shall be amended and restated in forms mutually agreed by Parent and each Company prior to the Closing Date.
A-1-3
Section 1.4 Directors and Officers. At the Effective
Time, the directors and officers set forth in Section 1.4 of the Company Disclosure Schedules will become the directors and officers of each Surviving Company and Parent and will remain the directors and officers of each
Surviving Company and Parent after the Mergers, until their respective successors are duly elected or appointed and qualified, or their earlier death, resignation or removal.
ARTICLE II
EFFECT OF THE MERGERS; CONVERSION OF SECURITIES
Section 2.1 Allocation Schedule; Conversion of Securities.
(a) Allocation Schedule. At least five (5) Business Days prior to the Closing, the Companies shall deliver to
Parent and the Exchange Agent an allocation schedule (the Allocation Schedule) setting forth, as of the date thereof:
(i) (A) the LMA Interests held by each LMA Member and (B) the Abacus Interests held by each Abacus Member;
(ii) the portion of the Stock Consideration (specifying the number of shares of Parent Common Stock) allocated to each Company
Member based on this Article II (including, for the avoidance of doubt, the number of shares of Parent Common Stock that would be allocated to each LMA Member and Abacus Member, as applicable, assuming the Available Cash Amount is zero);
(iii) subject to Section 2.2(b), the pro rata portion of any Cash Consideration to be allocated to
each Company Member making a Cash Election, if any;
(iv) reasonably detailed calculations with respect to the components
and subcomponents of the foregoing clauses (i) through (iv) (including any exchange (or similar) ratio on which such calculations are based); and
(v) a certificate, duly executed by the chief executive officer (or equivalent) of each Company, that the information and
calculations delivered are, and will be as of immediately prior to the Effective Time, (A) true and correct in all respects and (B) in accordance with the applicable provisions of this Agreement, the Organizational Documents of each
Company and applicable Laws.
The Companies will review any comments to the Allocation Schedule provided by Parent and consider in good
faith and incorporate all reasonable comments proposed by Parent and acceptable to the Companies at least two (2) Business Days prior to the Effective Time. Notwithstanding anything herein to the contrary, the Parent Parties and the Exchange
Agent will be entitled to rely upon the Allocation Schedule for purposes of allocating the respective portions of the Aggregate Merger Consideration to the Company Members under this Agreement or under the Exchange Agent Agreement, as applicable,
and upon delivery, payment and issuance of the Aggregate Merger Consideration on the Closing Date to the Exchange Agent, the Parent Parties shall be deemed to have satisfied all obligations with respect to the payment of the Aggregate Merger
Consideration under this Agreement, and none of them shall have (A) any further obligations to either Company, the Company Members or any other Person with respect to the payment of any consideration under this Agreement, or (B) any
liability with respect to the allocation of the consideration under this Agreement, and each Company and each Company Member hereby irrevocably waives and releases the Parent Parties (and, on and after the Closing, the Surviving Companies) from any
and all claims arising out of or resulting from or related to such Allocation Schedule and the allocation of the Aggregate Merger Consideration among the Company Members as set forth in the Allocation Schedule.
(b) LMA Interests. At the Effective Time, by virtue of the LMA Merger and without any action on the part of any LMA
Member, each LMA Interest that is issued and outstanding as of immediately prior to the LMA Effective Time shall be canceled and converted into the right to receive a portion of the Aggregate Merger Consideration in accordance with the Allocation
Schedule.
A-1-4
(c) Abacus Interests. At the Effective Time, by virtue of the Abacus
Merger and without any action on the part of any Abacus Member, each Abacus Interest that is issued and outstanding as of immediately prior to the Abacus Effective Time shall be canceled and converted into the right to receive a portion of the
Aggregate Merger Consideration in accordance with the Allocation Schedule.
Section 2.2 Payment of the
Aggregate Merger Consideration.
(a) At or prior to the Effective Time, Parent shall deposit, or shall cause to be
deposited, with the Exchange Agent, in trust for the benefit of the Company Members, (i) evidence of book-entry shares representing a number of whole shares of Parent Common Stock equal to the Stock Consideration deliverable to the Company
Members and (ii) the Cash Consideration owed by Parent to the Company Members, if any, pursuant to this Article II. Any such shares of Parent Common Stock deposited with the Exchange Agent shall hereinafter be referred to as
the Exchange Agent Fund. The Exchange Agent Fund shall be subject to the terms of this Agreement and the Exchange Agent Agreement. Subject to Section 2.4, at the Closing, Parent shall cause to be
issued or paid from the Exchange Agent Fund to each Company Member immediately prior to the Effective Time, evidence of book-entry shares representing the Stock Consideration in respect of such LMA Interests or Abacus Interests, as the case may be,
held by such Company Member and the applicable portion of the Cash Consideration, if any, pursuant to the Allocation Schedule.
(b) Cash Election. In the event that, immediately prior to the Closing, the Available Cash Amount is greater than $0,
each Company Member shall be entitled to receive a portion of the consideration to be paid in exchange for such Company Members Abacus Interests or LMA Interests, as the case may be, in cash in lieu of receipt of Parent Common Stock (a
Cash Election) in accordance with such Company Members pro rata portion of the Cash Consideration, if any, as set forth on the Allocation Schedule. A Company Member shall make a Cash Election by notifying the Companies of
such Cash Election prior to the Companies delivery of the Allocation Schedule in accordance with Section 2.1(a). The determination of the Companies, as set forth on the Allocation Schedule, shall be final, conclusive
and binding in the event of ambiguity or uncertainty as to whether or not a Cash Election has been properly made, deemed to be made, or revoked. The Companies may make any rules as are consistent with this Agreement for the implementation of Cash
Elections as shall be necessary or desirable to effect such elections in accordance with the terms of this Agreement.
Section 2.3 Exchange Procedures for Company Members.
(a) Payment Procedures.
Prior to the Closing, each Company shall mail or otherwise deliver, or shall cause the Exchange Agent to mail or otherwise deliver, to each LMA Member and Abacus Member entitled to receive its allocated portion of the Aggregate Merger Consideration,
a letter of transmittal containing instructions for surrender of the LMA Interests and Abacus Interests reasonably acceptable to Parent and each Company or as may be reasonably required by the Exchange Agent (the Company Letter of
Transmittal). Subject to the satisfaction of the conditions in Article VI, in the event that at least three (3) Business Days prior to the Closing Date an LMA Member or Abacus Member entitled to receive its allocated portion of
the Aggregate Merger Consideration does not deliver to the Exchange Agent a duly executed and completed Company Letter of Transmittal, then such failure shall not alter, limit or delay the Closing; provided that such LMA Member or Abacus Member
shall not be entitled to receive its allocated portion of the Aggregate Merger Consideration until such Person delivers a duly executed and completed Company Letter of Transmittal to the Exchange Agent. Upon delivery of such duly executed Company
Letter of Transmittal to the Exchange Agent, such LMA Member or Abacus Member shall be entitled to receive, subject to the terms and conditions of this Agreement and the Allocation Schedule, the allocated portion of the Aggregate Merger
Consideration in respect of his, her or its interests referenced in such Company Letter of Transmittal. Until surrendered as contemplated by this Section 2.3, each LMA Interest or Abacus Interest, as the case may be, shall
be deemed at all times after the Effective Time to represent only the right to receive upon such surrender the Aggregate Merger Consideration to which such Person is entitled pursuant to this Article II and as allocated pursuant to the
Allocation Schedule.
A-1-5
(b) No Further Rights. All Aggregate Merger Consideration paid or
issued by Parent upon the surrender of LMA Interests or Abacus Interests in accordance with the terms of this Article II and pursuant to the Allocation Schedule shall be deemed to have been exchanged and paid in full satisfaction of all
rights pertaining to the securities represented by such LMA Interests or Abacus Interests, and there shall be no further registration of transfers on the transfer books of the Surviving Companies of membership interests of either Company that were
issued and outstanding immediately prior to the Effective Time. From and after the Effective Time, the LMA Members and Abacus Members shall cease to have any rights as members of LMA and Abacus, respectively, except as provided in this Agreement or
by applicable Laws.
(c) Changes in Parent Stock. If at any time between the date of this Agreement and the
Effective Time, the outstanding shares of Parent Common Stock or Parent Class B Stock shall have been increased, decreased, changed into or exchanged for a different number of kind of shares or securities as a result of a subdivision,
reorganization, recapitalization, reclassification, stock dividend, stock split, reverse stock split, combination or other similar change in capitalization, in each case other than in connection with the Mergers, then the definition of Parent Share
Value shall be equitably adjusted to reflect such change; provided, that nothing in this Section 2.3(c) shall be construed to permit Parent to take any action with respect to its securities that is prohibited by the terms
of this Agreement.
(d) Fractional Shares. Notwithstanding anything to the contrary contained herein, no evidence of
book-entry shares representing fractional shares of Parent Common Stock shall be issued pursuant to this Agreement. In lieu of any fractional share of Parent Common Stock to which the each LMA Member or Abacus Member would otherwise be entitled, the
Exchange Agent shall round up or down to the nearest whole share of Parent Common Stock, with a fraction of 0.5 rounded up. No cash settlements shall be made with respect to fractional shares eliminated by rounding.
(e) Dividends. No dividends or other distributions declared with
respect to Parent Common Stock, the record date for which is at or after the Effective Time, shall be paid to any LMA Member or Abacus Member that has not delivered a properly completed, duly executed Company Letter of Transmittal. After the
delivery of such materials, the LMA Member or Abacus Member, as the case may be, shall be entitled to receive any such dividends or other distributions, without any interest thereon, which had become payable with respect to Parent Common Stock
issuable to such LMA Member or Abacus Member.
Section 2.4 Withholding Rights. The Parties, each
Surviving Company and the Exchange Agent shall be entitled to deduct and withhold from the consideration otherwise payable pursuant to this Agreement such Taxes as it is required to deduct and withhold with respect to such payment under the Code or
any other applicable Laws (as reasonably determined by each of the Parties, the Surviving Companies and the Exchange Agent); provided, however, except (a) with respect to payments in the nature of compensation to be made to employees or former
employees or (b) any withholding resulting from the failure of the Companies to provide a FIRPTA Certificate pursuant to Section 5.7(c), that prior to any such withholding, the Parent Stockholders or the LMA Members or
Abacus Members, as applicable, shall be provided reasonable notice of such intent to withhold. To the extent any that amounts are so deducted and withheld by the Parties, the Surviving Companies or the Exchange Agent, as the case may be, such
deducted and withheld amounts shall be (i) timely remitted to the appropriate Governmental Entity and (ii) will be treated for all purposes of this Agreement as having been paid to the Person in respect of which such deduction and
withholding was made. The Parties shall cooperate in good faith to eliminate or reduce any such deduction or withholding (including through the request and provision of any statements, forms or other documents to reduce or eliminate any such
deduction or withholding).
ARTICLE III
REPRESENTATIONS AND WARRANTIES OF THE COMPANIES
Except as set forth in the applicable disclosure schedules delivered by each Company to the Parent Parties concurrently with
the execution of this Agreement (the Company Disclosure Schedules), and
A-1-6
subject to the terms, conditions and limitations set forth in this Agreement, each Company hereby jointly and severally represents and warrants to the Parent Parties, as of the date of this
Agreement and the Closing Date, as follows:
Section 3.1 Organization. Each Group Company
(a) is a corporation or limited liability company duly incorporated or organized, validly existing and in good standing under the Laws of its respective jurisdiction of incorporation or organization, and (b) has all requisite power and
authority to own, lease and operate its properties and to carry on in all respects its businesses as now being conducted. Each Group Company is duly qualified, licensed or registered as a foreign entity to transact business, and is in good standing,
under the Laws of each jurisdiction where the character of its properties or assets owned, leased or operated by it, or the location of the properties or assets owned, leased or operated by it, requires such qualification, licensing or registration,
except where the failure of such qualification, licensing or registration would not reasonably be expected to be material to the Group Companies, taken as a whole. The Organizational Documents of each Group Company, as amended to the date of this
Agreement and as previously made available by or on behalf of each Group Company to Parent, are true, correct and complete. Each Group Company is in compliance with the provisions of its Organizational Documents.
Section 3.2 Authorization. Each Company has the requisite limited liability company power and authority
to execute and deliver this Agreement and the Ancillary Agreements to which it is a party and to perform its obligations hereunder and thereunder, and to consummate the transactions contemplated hereby and thereby, subject to the irrevocable
approval and adoption of this Agreement by (i) the holders of a majority of the issued and outstanding LMA Interests (the LMA Member Approval) and (ii) the holders of a majority of the issued and outstanding Abacus
Interests (the Abacus Member Approval and, together with the LMA Member Approval, the Requisite Company Approvals). The Requisite Company Approvals are the only votes or approvals of holders of any class,
series or type of equity securities of the Companies necessary to adopt this Agreement and any Ancillary Agreement or to approve the transactions contemplated hereby and thereby. The execution and delivery of this Agreement and the Ancillary
Agreements and the consummation of the transactions contemplated hereby and thereby have been duly authorized by each Company and their boards of managers. Assuming the due authorization, execution and delivery by each other party to this Agreement
and the Ancillary Agreements to which each Company is a party, this Agreement and each Ancillary Agreement constitute, or will constitute, as applicable, the legal, valid and binding obligation of each Company, enforceable against each Company in
accordance with its terms, subject to applicable bankruptcy, insolvency and other similar Laws affecting the enforceability of creditors rights generally, general equitable principles and the discretion of courts in granting equitable
remedies.
Section 3.3 Capitalization.
(a) Section 3.3(a) of the Company Disclosure Schedules sets forth (i) the respective ownership of the issued and
outstanding LMA Interests and Abacus Interests and (ii) the beneficial and record owners of the LMA Interests and the Abacus Interests. All of the issued and outstanding LMA Interests and Abacus Interests are duly authorized, validly issued,
fully paid and nonassessable. None of the issued and outstanding LMA Interests or Abacus Interests were issued in violation of any preemptive rights, Laws or Orders, and the LMA Interests and the Abacus Interests are owned, beneficially and of
record, by the LMA Members and the Abacus Members, respectively, free and clear of all Liens. Neither of the Companies has at any time issued or granted, and there are no outstanding or authorized, compensatory equity or equity-linked interests with
respect to the common units or preferred units, common stock, preferred stock or other capital stock of, or other equity or voting interests in, the Companies, including without limitation, any options, appreciation rights, restricted stock or stock
unit awards, profits interests, restricted units, phantom equity or similar awards or rights. There are no Contracts to which either Company is a party that require either Company to repurchase, redeem or otherwise acquire any LMA Interests or
Abacus Interests or securities convertible into or exchangeable for LMA Interests or Abacus Interests or to make any investment in any other Person.
(b) All of the issued and outstanding ownership interests of each Company Subsidiary are duly authorized, validly issued, fully
paid, nonassessable, free of preemptive rights, restrictions on transfer (other
A-1-7
than restrictions under applicable federal, state and other securities Laws), and are owned by each Company, whether directly or indirectly, free and clear of all Liens. There are no options,
warrants, convertible securities, stock appreciation, phantom stock, stock-based performance unit, profit participation, restricted stock, restricted stock unit, other equity-based compensation award or similar rights with respect to any Company
Subsidiary and no rights, exchangeable securities, securities, phantom rights, appreciation rights, performance units, commitments or other agreements relating to the ownership interests of any Company Subsidiary or obligating
either Company or any Company Subsidiary to issue, deliver or sell, or cause to be issued, delivered or sold, any ownership interests of, or any other interest in, any Company Subsidiary, including any securities convertible or exercisable into
ownership interests of any Company Subsidiary. There are no Contracts to which any Company Subsidiary is a party which require such Company Subsidiary to repurchase, redeem or otherwise acquire any ownership interests or securities convertible into
or exchangeable for such ownership interests or to make any investment in any other Person.
(c) Except as set forth on
Section 3.3(c) of the Company Disclosure Schedules, there are no voting trusts, stockholder agreements, proxies or other agreements in effect with respect to the voting or transfer of any LMA Interests or Abacus Interests.
No Company Subsidiary owns any LMA Interests or Abacus Interests. There are no voting trusts, stockholder agreements, proxies or other agreements in effect with respect to any ownership interests of any Company Subsidiary.
Section 3.4 Company Subsidiaries. Section 3.4 of the Company
Disclosure Schedules sets forth a true and complete list of (a) the Company Subsidiaries, listing for each Company Subsidiary its name, type of entity, the jurisdiction of its incorporation, formation or organization, as applicable, and
(b) its authorized equity interests, the number and type of its issued and outstanding equity interests and the current ownership of such equity interests. Except for the Company Subsidiaries, the Companies do not own, directly or indirectly,
any ownership, equity, profits or voting interests in any Person or have any Contracts to purchase any such interests.
Section 3.5 Consents and Approvals; No Violations. Except as set forth on Section 3.5, of the Company Disclosure Schedules, and subject to the receipt of the Requisite Company Approvals, the filing of the
Certificates of Merger, and the satisfaction of the applicable requirements of the HSR Act, and assuming the truth and accuracy of the Parent Parties representations and warranties contained in Section 4.4 and the
representations and warranties of the Parent Parties contained in any Ancillary Agreement, neither the execution and delivery of this Agreement or any Ancillary Agreement nor the consummation of the Transactions will (a) conflict with or result
in any breach of any provision of the Organizational Documents of any Group Company, (b) require any filing with, or the obtaining of any consent or approval of, any Governmental Entity, (c) result in a violation of or a default (or give
rise to any right of termination, cancellation, or acceleration) under, any of the terms, conditions or provisions of any Company Material Contract or Lease, (d) result in the creation of any Lien upon any of the properties or assets of any
Group Company (other than Permitted Liens), or (e) violate in any Law, Order, or Lien applicable to any Group Company, except for violations or defaults which would not reasonably be expected to be material to the Group Companies, taken as a
whole.
Section 3.6 Financial Statements.
(a) The Companies have made available to Parent true, correct and complete copies of (i) the audited balance sheets of
each Company as of December 31, 2021 and December 31, 2020, and, in each case, the related audited statements of operations and changes in members equity and cash flows of each of the Companies for the fiscal year then ended,
together with all related notes and schedules thereto, accompanied by the reports thereon of each of the Companies independent auditors (collectively referred to as the Financial Statements), and (ii) the unaudited
balance sheets of each of the Companies as of June 30, 2022 (the Interim Balance Sheet) and the related unaudited statements of operations and changes in members equity and cash flows of the applicable Company for
the six-month period then ended (together with the Interim Balance Sheet, the Interim Financial Statements). Each of the Financial Statements and the Interim Financial Statements
(a) has been prepared in accordance with GAAP applied on a consistent
A-1-8
basis throughout the periods indicated (except as may be indicated in the notes thereto), (b) fairly presents the financial position, results of operations and cash flows of the applicable
Company as at the respective dates thereof and for the respective periods indicated therein, except as otherwise noted therein and subject, in the case of the Interim Financial Statements, to normal and recurring
year-end adjustments that are not material in amount or kind and the absence of notes and (c) was prepared from, and is in accordance with, the books and records of the applicable Company.
(b) The books of account and other financial records of each of the Companies have been kept accurately in the Ordinary Course,
the transactions entered therein represent bona fide transactions, and the revenues, expenses, assets and liabilities of each of the Companies have been properly recorded therein in accordance with GAAP. Each of the Companies has established and
maintains a system of internal accounting controls over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) sufficient
to provide reasonable assurances: (i) that transactions, receipts and expenditures of each of the Companies are being executed and made only in accordance with required authorizations of management of each of the Companies, (ii) that
transactions are recorded in all material respects as necessary to permit preparation of financial statements in conformity with GAAP and to maintain accountability for assets, (iii) regarding prevention or timely detection of unauthorized
acquisition, use or disposition of the assets of each of the Companies, (iv) that the amount recorded for assets on the books and records of each of the Companies is compared with the existing assets at reasonable intervals and appropriate
action is taken with respect to any difference and (v) that accounts, notes and other receivables and inventory are recorded accurately.
(c) The amount of Cash and Cash Equivalents and the Indebtedness of each of the Companies, in each case, as of June 30,
2022, are reasonably and accurately set forth on Section 3.6(c) of the Company Disclosure Schedules, and since such date, neither of the Companies has (i) declared, set aside or paid any dividend or made any other
distribution or (ii) made any payment of the type that would be required to be disclosed on Section 3.22 of the Company Disclosure Schedules if it had been made on the Closing Date.
Section 3.7 No Undisclosed Liabilities. Except as set forth in the Interim Balance Sheet, the Group
Companies do not have any liabilities or obligations of the type required to be disclosed in the Interim Balance Sheet in accordance with GAAP (including as a result of COVID-19 and COVID-19 Measures), whether accrued, absolute, contingent or otherwise and/or arising out of any transactions entered into at or prior to the date hereof, or any action or inaction at or prior to the date hereof, or
any state of facts existing at or prior to the date hereof or otherwise, except for liabilities or obligations (a) incurred or accrued since the Balance Sheet Date in the Ordinary Course (none of which relate to noncompliance with any
applicable Law or License, breach of Contract, breach of warranty, tort, infringement, misappropriation, dilution or Action), (b) that arise under any Company Material Contract, none of which arose out of a breach of Contract or violation of
Law, (c) incurred since the Balance Sheet Date pursuant to or in connection with this Agreement or the transactions contemplated hereby, (d) disclosed in this Agreement (or the Company Disclosure Schedules) or (e) that are accurately
accrued or reserved against on the face of the Interim Balance Sheet, the Interim Financial Statements, or the Financial Statements or detailed in the notes thereto.
Section 3.8 Absence of Certain Changes. Except as set forth on Section 3.8 of the Company
Disclosure Schedules, since the Balance Sheet Date:
(a) the Group Companies have conducted their business in the Ordinary
Course;
(b) no Group Company has sold, assigned, transferred, leased, abandoned or otherwise disposed of any of its
properties or assets that is material to such Group Company (including any Intellectual Property);
(c) there has been no
Material Adverse Effect on the Group Companies taken as a whole;
(d) there has been no casualty, loss, damage or
destruction of any property that is material to the Group Companies, taken as a whole, and that is not covered by insurance;
A-1-9
(e) no Group Company has established, adopted, amended, materially modified
or terminated any Company Benefit Plans except as required by applicable Law or in the Ordinary Course with respect to annual renewals of group welfare benefits;
(f) there has been no change in the accounting methods or practices of any Group Company or any change in depreciation or
amortization policies or rates theretofore adopted by the Group Companies; and
(g) no Group Company has taken any action
or omitted to take an action, which, if taken or omitted to be taken after the date of this Agreement, would require the consent of Parent in accordance with Section 5.1.
Section 3.9 Real Estate.
(a) No Group Company owns any real property.
(b) Section 3.9(b) of the Company Disclosure Schedules lists each real property leased, subleased, licensed or otherwise
used or occupied by any Group Company (each, a Leased Real Property and collectively, the Leased Real Properties), and sets forth the name of the landlord, the name of the entity holding such leasehold
interest and the street address of each Leased Real Property.
(c) True, correct and complete copies of all leases,
subleases, licenses, amendments, extensions, guaranties and other material agreements related thereto with respect to the Leased Real Properties (individually, a Lease and collectively, the Leases)
have been made available to Parent, and none of such Leases has been modified following the date of this Agreement, except to the extent that such modifications have been disclosed by the copies thereof made available to the Parent Parties.
Section 3.9(b) of the Company Disclosure Schedules sets forth a true and complete list of all Leases, including the date and name of the parties to each Lease, and in the case of any oral Lease, a written summary of the
material terms of such Lease.
(d) The Leased Real Properties identified in Section 3.9(b) of the
Company Disclosure Schedules constitute all of the real property leased, occupied, or otherwise utilized or intended to be utilized in connection with the business of the Group Companies.
(e) The Group Companies hold a good and valid leasehold estate in the Leased Real Properties subject to the terms of their
respective Leases, free and clear of all Liens, except for Permitted Liens.
(f) Except as set forth on
Section 3.9(f) of the Company Disclosure Schedules, with respect to each of the Leased Real Property: (i) the Lease for such Leased Real Property is legal, valid, binding, enforceable and in full force and effect,
subject to proper authorization and execution of such lease by the other party thereto and subject to bankruptcy, insolvency, reorganization, moratorium or similar Laws of general applicability relating to or affecting creditors rights and to
general principles of equity, (ii) no Group Company nor to the Knowledge of the Companies, any other party to the Lease is in breach or default under such Lease and no event has occurred or circumstance exists which, with the delivery of
notice, the passage of time or both, would constitute such a breach or default, or permit the termination, modification or acceleration of rent under such Lease, (iii) no security deposit or portion thereof deposited with respect to such Lease
has been applied in respect of a breach or default thereunder which has not been replenished to the extent required under such Lease, (iv) no Group Company owes any brokerage commissions or finders fees with respect to such Lease,
(v) no Group Company has subleased, licensed or otherwise granted any Person the right to use or occupy the Leased Real Property (or any portion thereof), (vi) no Group Company has collaterally assigned or granted any other security
interest in such Leased Real Property or any interest therein and (vii) no Group Companys possession and quiet enjoyment of the Leased Real Property under such Lease has been disturbed, and there are no disputes with respect to such
Lease.
Section 3.10 Intellectual Property.
(a) Section 3.10(a) of the Company Disclosure Schedules contains a complete list (i) of all Company Registered
Intellectual Property owned by the Group Companies and (ii) of the Company Products. The
A-1-10
Group Companies uses of its social media accounts (Accounts) have complied in all material respects with all applicable Laws as well as all material terms and conditions
or terms of use applicable to the Accounts (the Social Media Terms). There are no legal actions, audits, or investigations, whether settled, pending, or to the Knowledge of the Companies, threatened, alleging any (A) breach
or other violation of any Social Media Terms by any Group Company; (B) violation under the Digital Millennium Copyright Act, 1998 or (C) defamation, violation of rights of any Person, or any other violation by any Group Company in
connection with its use of social media.
(b) The Group Companies possess all source code and other documentation and
materials reasonably necessary to use and operate any Software included in the Company Owned Intellectual Property and have not disclosed, delivered, licensed or otherwise made available, and the Group Companies do not have a duty or obligation
(whether present, contingent or otherwise) to disclose, deliver, license or otherwise make available, any source code for any Software included in the Company Owned Intellectual Property to any Person, other than employees or contractors in the
Ordinary Course who are in each case subject to Confidentiality Agreements.
(c) Except as set forth on
Section 3.10(c) of the Company Disclosure Schedules, (i) a Group Company exclusively owns and possesses all right, title and interest in, or has the right pursuant to a valid and enforceable, subject to applicable
bankruptcy, insolvency and other similar Laws affecting the enforceability of creditors rights generally, general equitable principles and the discretion of courts in granting equitable remedies, written license to use, all Intellectual
Property and Company Product Data used in or necessary for the conduct of the business of the Group Companies as it is currently conducted (collectively, the Company Intellectual Property), free and clear of all Liens (other than
Permitted Liens), (ii) the Company Owned Intellectual Property is, valid, subsisting and, to the Knowledge of the Companies, enforceable, and there are no judgments finding any such Company Registered Intellectual Property to be invalid or
unenforceable, and (iii) there are no proceedings pending or, to the Knowledge of the Companies, threatened, that challenge the validity, use, ownership, registrability, or enforceability of the Company Registered Intellectual Property.
(d) Except as set forth in Section 3.10(d) of the Company Disclosure Schedules, (i) to the
Knowledge of the Company neither the use of the Company Intellectual Property used by the Group Companies in the conduct of their business, nor the conduct of their business (including the licensing of Company Products) infringes, misappropriates or
otherwise violates, nor has in the last six (6) years infringed, misappropriated or otherwise violated, the rights of any third party in any Intellectual Property; and (ii) no Group Company has received any written notices, threats or
requests for indemnification alleging any of the same.
(e) (i) There are no claims, proceedings, actions, suits,
complaints, demands or similar actions currently pending or, to the Knowledge of the Companies, threatened, or that have been brought since the Look-Back Date, by any Group Company against any Person alleging infringement, misappropriation, or
violation of any Company Owned Intellectual Property; and (ii) to the Knowledge of the Companies, no Person is currently infringing, misappropriating, or otherwise violating, nor has infringed, misappropriated or otherwise violated any of the
Company Owned Intellectual Property.
(f) No Group Company uses and has not used any Open Source Software or any
modification or derivative thereof (i) in a manner that would grant or purport to grant to any Person any rights to or immunities under any of the Company Owned Intellectual Property, or (ii) under any license requiring a Group Company to
disclose or distribute the source code to any of the Software included in the Company Owned Intellectual Property, to license or provide the source code to any of the Software included in the Company Owned Intellectual Property for the purpose of
making derivative works, or to make available for redistribution to any Person the source code to any of the Software included in the Company Owned Intellectual Property at no or minimal charge.
(g) Each Group Company has taken commercially reasonable measures to maintain and protect all Company Owned Intellectual
Property, including the secrecy, confidentiality and value of its trade secrets and other confidential information. Without limiting the generality of the foregoing, no Group Company has
A-1-11
disclosed any material confidential Company Owned Intellectual Property (including any source code to any Company Products) to any Person other than pursuant to a commercially reasonable written
agreement pursuant to which such Person agrees to protect the confidentiality of such trade secrets and other confidential information (Confidentiality Agreement) and, to the Knowledge of the Companies, no Person has breached any
such agreement.
(h) All Persons that have been involved in the conception, development, reduction to practice or other
creation of any Company Owned Intellectual Property (including Company Products) have done so pursuant to a commercially reasonable agreement that protects the confidential information of each Group Company and assigns to each applicable Group
Company exclusive ownership of all of such Intellectual Property and, to the Knowledge of the Companies, no Person has breached any such agreement.
(i) No Group Company is under any obligation, whether written or otherwise, to develop any Intellectual Property (including any
elements of any Company Products) for any third party (including any customer or end user).
(j) To the Knowledge of the
Companies, there are, and since the Look-Back Date have been, no manifest defects, technical concerns or problems (collectively, Technical Deficiencies) in any of the Company Products currently offered by any Group Company which
have not been repaired and that would prevent the same from performing in accordance with their specifications of functionality descriptions in any material respect, and there is no Malicious Code in any of the Company Products or Company Systems.
No Group Company has received any material written complaints from customers related to any Malicious Code or Technical Deficiencies in any Company Products.
(k) The Group Companies own, lease, license, or otherwise have the legal right to use its Company Systems, and such Company
Systems are sufficient for the needs of the Group Companies business as it is currently conducted. The Group Companies have put commercially reasonable safeguards in place designed to protect the confidentiality, integrity, and security of the
Company Systems and the data stored therein or transmitted thereby including by implementing industry standard procedures preventing unauthorized access and the introduction of any virus, worm, Trojan horse or similar disabling code or program
(Malicious Code), and the taking and storing on-site and off-site of back-up copies of critical data. The
Group Companies have implemented and maintain commercially reasonable security, disaster avoidance and recovery and business continuity plans, procedures and facilities, including by implementing systems and procedures that provide monitoring and
alerting of any problems, issues or vulnerabilities in the Company Systems. In the last twelve (12) months, there has not been any material failure with respect to any of the Company Systems that has not been remedied or replaced in all
material respects.
(l) The consummation of the transactions contemplated by this Agreement will not result in the loss or
impairment of, or payment of, any additional material amounts with respect to, nor require the consent of any other Person in respect of, each Group Companys right to own, use, or hold for use any of the Company Intellectual Property or
Company Systems in a manner substantially similar to the manner in which the Company Intellectual Property and Company Systems were owned, used, or held for use by such Group Company prior to the Closing Date. The Group Companies have all rights in
and to the Company Product Data necessary for the operation of their business, including where applicable the rights to publish, reproduce, distribute, license, sell and create derivative works of the Company Product Data.
Section 3.11 Data Privacy and Security.
(a) Each Group Company and the conduct of its business and, to the Knowledge of the Companies, all Data Partners, in the last
five (5) years have been in compliance with all Data Security Requirements in all material respects. The Transactions will not result in any liabilities to the Companies in violation of any Data Security Requirements. To the extent that any
Personal Data comprises Personal Information as defined under the CCPA, all Personal Data is an asset that will be transferred as part of these Transactions, as contemplated by section 1798.140(t)(2)(D) of the CCPA.
A-1-12
(b) Since the Look-Back Date, the Group Companies have, and have taken
reasonable steps to require all Data Partners to have, implemented and at all times maintained administrative, organizational, physical and technical safeguards to: (i) protect and maintain the confidentiality, integrity and security of
Personal Data against any unlawful, accidental or unauthorized control, use, access, disclosure, interruption, modification, destruction, compromise or corruption (a Security Incident); and (ii) identify and address internal and
external risks to the privacy and security of Personal Data in their possession or control.
(c) Since the Look-Back date,
neither the Group Companies, nor, to the Knowledge of the Companies, any Data Partners, have: (i) experienced any Security Incidents that required notification to any Person, or (ii) received any notice, request, claim, complaint,
correspondence or other communication from any Governmental Entity or other Person relating to any Security Incident or violation of any Data Security Requirements.
Section 3.12 Litigation.
(a) Except as set forth on Section 3.12 of the Company Disclosure Schedules, in the last five
(5) years, (i) there have not been, and there are no Actions or Orders (including those brought or threatened by or before any Governmental Entity) pending or to the Knowledge of the Companies threatened against or otherwise relating to any
Group Company or any of their respective properties or assets at Law or in equity or to the Knowledge of the Companies any of the members, managers, directors, officers or employees of the Group Companies with regard to their actions as such,
including Actions or Orders that challenge or seek to enjoin, alter or materially delay the transactions contemplated by this Agreement or any Ancillary Agreement and (ii) there is no pending or, to the Knowledge of the Companies, threatened
audit, examination or investigation by any Governmental Entity against any Group Company or any of their respective properties or assets or to the Knowledge of the Companies any of the members, managers, directors, officers or employees of the Group
Companies with regard to their actions as such, but excluding, in each case of clauses (i) and (ii), Actions or Orders that would not reasonably be expected to be material to the Group Companies, taken as a whole.
(b) No Group Company has filed in the last five (5) years, or intends to file, any material Action against any other
Person.
Section 3.13 Company Material Contracts.
(a) Section 3.13(a) of the Company Disclosure Schedules sets forth a true, correct and complete list
of the following Contracts to which any Group Company, as of the date of this Agreement, is a party (Company Material Contracts):
(i) any stockholder, partnership, investors rights, voting, right of first refusal and
co-sale, or registration rights agreement, or other Contract with a holder of equity interests of any Group Company relating to their ownership of such equity interests;
(ii) any non-competition Contract or other Contract that purports to limit (A) the
ability of any Group Company from operating or doing business in any location, market or line of business, (B) the Persons to whom any Group Company may sell products or deliver services, or (C) the Persons that the Companies may hire or
solicit for hire;
(iii) any employment or consulting Contract with any current or former employee (to the extent of any
ongoing liability) or individual service provider of any Group Company that (A) provides annual base compensation in excess of $100,000 or (B) is not terminable at-will and without any liability to
any Group Company (other than standard employee confidentiality or non-disclosure agreements) or that cannot be terminated without the payment of severance or similar separation payments (except to the extent
required by applicable Law);
(iv) change in control, transaction bonus, retention bonus, stay and pay or similar
agreements with any current or former (to the extent of any ongoing liability) employee or individual service provider of any Group Company;
A-1-13
(v) any Contract under which it is a licensee of or is otherwise granted by
a third party any rights to use any Intellectual Property (other than (x) non- exclusive licenses for Open Source Software or (y) non-exclusive end user licenses of commercially-available Software
used solely for the Companys internal use with replacement total cost of less than $100,000);
(vi) any Contract
under which it is a licensor or otherwise grants to a third party any rights to use any Intellectual Property, other than Intellectual Property licensed to customers on a non-exclusive basis in the Ordinary
Course;
(vii) any Contract for the development of Intellectual Property by a third party for the benefit of a Group
Company;
(viii) (A) any Contract containing an agreement by a Group Company to provide any Person with access to the
source code for any Software included in the Company Owned Intellectual Property or (B) any Contract between a Group Company, on the one hand, and an escrow agent, on the other hand, to provide for the source code for any Software included in
the Company Owned Intellectual Property to be put in escrow;
(ix) any collective bargaining agreement or other Contract
with any labor union, works council, or other labor organization;
(x) any Contract providing for indemnification by any
Group Company of any Person other than in the Ordinary Course of Business;
(xi) any note, debenture, other evidence of
Indebtedness, guarantee, loan, credit or financing agreement or instrument or other Contract for money borrowed by any Group Company, including any agreement or commitment for future loans, credit or financing, in each case, in excess of $250,000;
(xii) any Contract under which any Group Company is lessee of or holds or operates any tangible property, including real
property, owned by any other Person, except for any lease or agreement under which the aggregate annual rental payments do not exceed $100,000;
(xiii) any Contract involving the formation of a (A) joint venture, (B) partnership or (C) limited liability
company (except, in the cause of clauses (B) and (C), any Company Subsidiary);
(xiv) any Contracts listed on
Section 3.22 of the Company Disclosure Schedules;
(xv) any Contract with any Material Customer
or Material Supplier;
(xvi) any Contract or group of related Contracts (other than
non-continuing purchase orders) reasonably expected to result in future payments to or by any Group Company in excess of $250,000 per annum, except for Contracts that are terminable on less than 30 days
notice without penalty;
(xvii) any Contract that grants to any Person, other than a Group Company, (A) a most favored
pricing provision or (B) any exclusive rights, rights of first refusal, rights of first negotiation or similar rights;
(xviii) any Contract entered into in the last five (5) years, for the settlement of any Action for which any Group Company
has any ongoing liability or obligation;
(xix)any Contract requiring or providing for any capital expenditure by any Group
Company after June 30, 2022 in excess of $250,000;
(xx) any material interest rate, currency or other hedging
Contract;
(xxi) any Contract for (A) the divestiture of any business, properties or assets of any Group Company or
(B) the acquisition by any Group Company of any operating business, properties or assets, whether by merger, purchase, sale of equity or assets or otherwise, in each case, which contains continuing obligations or liabilities with respect to a
Group Company;
A-1-14
(xxii) any distributor, reseller, sales representative, marketing or
advertising Contract (other than non-continuing purchase orders);
(xxiii) any
Contract containing any provision pursuant to which any Group Company will be obligated to make a payment to any Person at the Closing as a direct result of the consummation of the transactions contemplated by this Agreement or any Ancillary
Agreement;
(xxiv) any Contract between any Group Company, on the one hand, and any member, manager, officer, director or
Affiliate (other than a wholly owned Subsidiary of the either of the Companies) of either of the Companies or any Company Subsidiary or any of their respective associates or immediate family members (as such terms are
defined in Rule 12b-2 and Rule 16a-1 of the Exchange Act), on the other hand, including any Contract pursuant to which any Group Company has an obligation to indemnify
such member, manager, officer, director, Affiliate, associate or immediate family member;
(xxv)any other Contract (other
than non-continuing purchase orders) not of the types described above in this Section 3.13 that involves consideration paid or received by any Group Company in excess of $250,000 in
any twelve (12) month period; or
(xxvi) any outstanding written commitment to enter into any Contract of the type
described in subsections (i) through (xxv) of this Section 3.13(a).
(b) The Company
Material Contracts (except those that are canceled, rescinded or terminated after the date hereof in accordance with their terms) are in full force and effect in accordance with their respective terms with respect to the applicable Group Company,
and, to the Knowledge of the Companies, the other party thereto, subject to bankruptcy, insolvency, reorganization, moratorium and similar Laws of general applicability relating to or affecting creditors rights and to general principles of
equity. There does not exist under any Company Material Contract any event of default or event or condition that constitutes a violation, breach or event of default thereunder on the part of any Group Company, in each case, that is material to the
Group Companies, taken as a whole. None of the Group Companies has given notice of its intent to terminate, materially modify, materially amend or otherwise materially alter the terms and conditions of any Company Material Contract or has received
any such written notice from any other party thereto, in each case other than in connection with the scheduled end or termination or other non-breach related expiration of such Contract.
Section 3.14 Tax Returns; Taxes. Except as otherwise disclosed on
Section 3.14 of the Company Disclosure Schedules:
(a) all income and other material Tax Returns
of the Group Companies required to have been filed with any Governmental Entity in accordance with any applicable Law have been duly and timely filed (taking into account extensions of time for filing) and are correct and complete in all material
respects;
(b) all income and other material Taxes due and owing by any of the Group Companies have been paid in full,
except for Taxes being contested in good faith and for which adequate reserves have been established in accordance with GAAP;
(c) there are not currently any extensions of time in effect with respect to the dates on which any Tax Returns of the Group
Companies were or are due to be filed;
(d) no claims for additional unpaid Taxes have been asserted in writing since the
Look-Back Date, and no proposals or deficiencies for any Taxes of the Group Companies are currently being asserted, proposed or, to the Knowledge of the Companies, threatened, and no audit or investigation of any Tax Return of the Group Companies is
currently underway, pending or, to the Knowledge of the Companies, threatened;
(e) the Group Companies have withheld and
paid all material Taxes required to have been withheld and paid in connection with amounts paid to any employee, independent contractor, creditor, stockholder or other third party;
A-1-15
(f) there are no outstanding waivers or agreements by or on behalf of the
Group Companies for the extension of time for the assessment of any Taxes or any deficiency thereof and none of the Companies or the Company Subsidiaries has waived any statute of limitations in respect of Taxes;
(g) there are no Liens for Taxes against any asset of the Group Companies (other than Permitted Liens);
(h) the Companies are not a party to any Tax indemnification or Tax receivable, allocation, sharing or similar agreement under
which the Group Companies will have any liability for Taxes after the Closing (excluding (x) customary commercial agreements the primary subject of which is not Taxes and (y) any agreements that are solely among Group Companies);
(i) no Group Company has been a member of an affiliated group filing a consolidated U.S. federal income Tax Return (other than
a group the common parent of which was a Group Company); or has any material liability for the Taxes of any Person (other than a Person that is a member of a group of which a Group Company is the common parent) under Treasury Regulations Section 1.1502-6 (or any corresponding or any similar provision of state, local or foreign income Tax Law), as a transferee or successor, or by contract (excluding customary commercial agreements the primary
subject of which is not Taxes);
(j) no Group Company is or has been a party to any listed transaction, as
defined in Treasury Regulations Section 1.6011-4(b)(2);
(k) no written claim
has ever been made by an Governmental Entity in a jurisdiction where the Group Companies do not file Tax Returns that any Group Company may be subject to taxation by that jurisdiction and which claim has not been resolved;
(l) none of the Group Companies have been a United States real property holding corporation within the meaning of
Section 897(c)(2) of the Code during the applicable period specified in Section 897(c)(1)(A)(ii) of the Code;
(m) no Group Company will be required to include any material item of income in, or exclude any material deduction from,
taxable income for any taxable period (or portion thereof) ending after the Closing Date as a result of any: (i) adjustments under Section 481 of the Code (or any corresponding or similar provision of state, local or foreign income Tax
Law); (ii) change in method of accounting, or use of an improper method of accounting, for a taxable period ending on or prior to the Closing Date; (iii) closing agreement as described in Section 7121 of the Code (or any
corresponding or similar provision of state, local or foreign income Tax Law) executed on or prior to the Closing Date; (iv) intercompany transactions as described in Treasury Regulations
Section 1.1502-13 (or any corresponding or similar provision of state, local or foreign income Tax Law) or excess loss account described in Treasury Regulations
Section 1.1502-19 (or any corresponding or similar provision of state, local or foreign income Tax Law), in each case, entered into or created on or prior to the Closing Date; (v) installment sale or
open transaction disposition made on or prior to the Closing Date; or (vi) prepaid amount received on or prior to the Closing Date, other than amounts reflected on the Financial Statements and amounts accrued in the Ordinary Course since then;
(n) since the Look-Back Date, no Group Company has distributed stock of another Person, or has had its stock distributed
by another Person, in a transaction that purported or intended to be governed in whole or in part by Section 355 of the Code;
(o) none of the Group Companies have had a permanent establishment (within the meaning of an applicable Tax treaty or
convention between the United States and such foreign country), or otherwise been subject to taxation in any country other than the country of such Group Companys formation;
(p) the unpaid Taxes of the Group Companies did not, as of June 30, 2022, exceed the reserve for Tax liability (excluding
any reserve for deferred Taxes established to reflect timing differences between book and Tax income) set forth on the face of the Interim Balance Sheet (rather than in any notes thereto). Since the Look-Back Date, the Group Companies have not
incurred any liability for Taxes outside the ordinary course of business or otherwise inconsistent with past custom and practice.
A-1-16
(q) the Companies each (i) have been a validly electing S
corporation (an S corporation) within the meaning of Section 1361(a) of the Code (and under any analogous state or local Tax Law) at all times since formation; (ii) are treated as an association taxable as a
corporation for United States federal income Tax purposes pursuant to Treasury Regulations Section 301.7701-3(c)(1)(v)(C); and (iii) will be an S corporation immediately prior to the Effective Time;
(r) at all times since formation, the Companies each (i) have no potential liability for any Tax under
Section 1374 of the Code (or any corresponding or similar provision of state, local or foreign income Tax Law) as a result of the Mergers and (ii) have not, in the last five (5) years, acquired assets from another corporation in a
transaction in which its Tax basis for the acquired assets were determined, in whole or in part, by reference to the Tax basis of the acquired assets (or any other property) in the hands of the transferor;
(s) the U.S. federal tax classification of each Subsidiary is listed on Section 3.14(s) of the Company
Disclosure Schedules; and
(t) no Group Company has taken, or agreed to take, any action, or to the Knowledge of the
Companies is aware of any fact or circumstance, that could reasonably be expected to prevent the Mergers, taken together, from qualifying as a reorganization within the meaning of Section 368(a) of the Code.
Section 3.15 Environmental Matters.
(a) Each Group Company is and since the Look-Back Date been in compliance in all material respects with all applicable
Environmental Laws, which compliance has included obtaining and complying in all material respects with all material Environmental Permits required for the occupation of its facilities and the operation of its business.
(b) No Group Company has (i) treated, stored, disposed of, arranged for or permitted the disposal of, transported,
handled, manufactured, distributed, exposed any Person to, or released any Hazardous Substance, or (ii) owned or operated any facility or property which is or has been contaminated by any Hazardous Substance by any Group Company, in each case
so as to give rise to material liability of the Group Companies pursuant to any Environmental Laws.
(c) None of the Group
Companies has assumed, undertaken, provided an indemnity with respect to, or otherwise become subject to, any material obligation or material liability of any other Person relating to any Hazardous Substance and/or arising under Environmental Laws.
(d) Since the Look-Back Date, no Group Company has received notice from any Governmental Entity or any Person that such
Group Company is subject to any material pending Action, Order or actual or alleged liability (i) based upon any Environmental Law, including arising out of any act or omission of any Group Company or any of their respective employees, agents
or Representatives, or (ii) relating to any Release of Hazardous Substance, including claims arising out of the ownership, use, control or operation by any Group Company of any facility, site, area or property from which there was a Release of
any Hazardous Substance.
Section 3.16 Licenses and Permits.
(a) The Group Companies own, hold or possess all Licenses, permits, approvals, authorizations, consents and registrations that
are necessary to entitle them to own or lease, operate and use their assets or properties and to carry on and conduct the business of the Group Companies as currently conducted. Section 3.16 of the Company Disclosure
Schedules sets forth a true, complete and correct list of all such Licenses that are required or material to the operation of the Group Companies business, including any and all certificates of authority to transact insurance. The Group
Companies are in compliance with all of the terms and requirements of each License listed in Section 3.16 of the Company Disclosure Schedules. Since the Look-Back Date, the Group Companies have not at any time received any
written notice from any Governmental Entity regarding any actual or proposed revocation, suspension or termination of, or
A-1-17
modification (other than any expansion of authority) to, any License, in each case other than any such item that has been cured or otherwise resolved to the satisfaction of such Governmental
Entity or that is no longer being pursued by such Governmental Entity following a response by the Group Companies. All Licenses are valid and in full force and effect as of the date hereof, and all fees and charges due and owing with respect to such
Licenses as of the date hereof have been paid in full.
(b) Since the Look-Back Date, the Group Companies have not at any
time received any written or oral communication from any Governmental Entity regarding any actual or alleged material violation of, or material failure on the part of the Group Companies to comply with, any Law relating to their Licenses or conduct
of the Group Companies business (or that the Group Companies or, to the Knowledge of the Companies, a Producer as it relates to the Group Companies is under investigation by any Governmental Entity for any alleged violation of or noncompliance
with any Laws relating to their respective Licenses or conduct of their respective businesses).
(c) Section 3.16 of
the Company Disclosure Schedules sets forth a true, correct and complete list of all of the Group Companies material customer referral agreements in place prior to the date hereof. To the Knowledge of the Companies, all such Producers hold all
necessary Licenses for the businesses contemplated in such referral agreements.
Section 3.17 Company
Benefit Plans.
(a) Section 3.17(a) of the Company Disclosure Schedules contains a true, correct and complete
list of each material Company Benefit Plan. With respect to each Company Benefit Plan, the Companies have provided Parent true, correct and complete copies of the following documents, to the extent applicable: (i) the current plan document and
any related trust documents, and amendments thereto; (ii) the three most recent annual returns (Forms 5500 and schedules thereto) and the most recent actuarial report, if any; (iii) the most recent IRS determination, opinion or advisory
letter; (iv) the most recent summary plan description and any material modifications thereto; (v) any related insurance contracts or funding arrangements; and (vi) all material non-routine
correspondence with any Governmental Entity relating to a Company Benefit Plan dated since the Look-Back Date. No Group Company has any plan or commitment to adopt or enter into any additional Company Benefit Plan or to amend or terminate any
existing Company Benefit Plan. No Group Company has sponsored, maintained, contributed to, or has been required to sponsor, maintain, participate in or contribute to, any employee benefit plan, program, or other arrangement providing compensation or
benefits to any employee, officer, director or independent contractor (current or former) of the Group Companies (or any dependent thereof) which is subject to the Laws of any jurisdiction outside of the United States.
(b) Except as set forth on Section 3.17(b) of the Company Disclosure Schedules:
|
(i) |
No Company Benefit Plan is, and no Group Company (including any ERISA Affiliate thereof) contributes to, or is
required to contribute to or has any liability with respect to a multiemployer plan (as defined in Sections 3(37) or 4001(a)(3) of ERISA), a multiple employer plan described in Section 413(c) of the Code, or a
multiple employer welfare arrangement (as defined in Section 3(40) of ERISA), and no Group Company has any current or contingent obligation or liability in connection with any such multiemployer plan
or multiple employer plan, including by reason of at any time being considered a single employer under Section 414 of the Code with any other Person; |
|
(ii) |
No Company Benefit Plan is, and no Group Company (including any ERISA Affiliate thereof) contributes to, is
required to contribute to or has any actual or contingent liability or obligations under or with respect to a plan that is or was subject to Section 302 or Title IV of ERISA or Section 412 of the Code; |
|
(iii) |
Each Company Benefit Plan and related trust has been established, funded, maintained, operated and administered
in all material respects in accordance with its terms and in compliance with all |
A-1-18
|
applicable Laws (including ERISA and the Code), and all contributions, premiums, reimbursements, distributions or payments required to be made with respect to any Company Benefit Plan for all
periods ending prior to or as of the date hereof have been timely made, or, to the extent not yet due, have been made, paid, or properly accrued to the extent required under GAAP; |
|
(iv) |
No liability, claim, Action, audit, investigation or litigation is pending or, to the Knowledge of the
Companies, threatened with respect to any Company Benefit Plan (other than routine claims for benefits payable in the Ordinary Course and appeals of denial of such claims); |
|
(v) |
Each Company Benefit Plan that is intended to be qualified within the meaning of
Section 401(a) of the Code has received a favorable determination letter from the U.S. Internal Revenue Service (the IRS), or may rely upon a favorable opinion letter from the IRS for a master or prototype plan,
and, to the Knowledge of the Companies, no event has occurred and no condition exists which would reasonably be expected to adversely affect the qualification of such Company Benefit Plan; |
|
(vi) |
No Group Company has incurred nor have any events occurred that would reasonably be expected to result in the
imposition of any penalty or Tax under Sections 4980D, 4980H, 6721 or 6722 of the Code with respect to any Company Benefit Plan or any failure by the Companies to comply with all applicable requirements under the Patient Protection and Affordable
Care Act, and no Company Benefit Plan provides for post-employment or post-termination medical, health, or life insurance or any other welfare-type benefits to any current or former employee, officer or director of any Group Company, except as
required by COBRA for which the covered person pays the cost of coverage as required under COBRA or as otherwise mandated by applicable Law; |
|
(vii) |
No Group Company has filed an application under the IRS Employee Plans Compliance Resolution System or the
Department of Labors Voluntary Fiduciary Correction Program with respect to any Company Benefit Plan since the Look-Back Date with respect to which current or contingent liability to a Group Company remains. |
(c) Neither the execution and delivery of this Agreement nor the consummation of the transactions contemplated hereby (either
alone or in conjunction with any other event) could result in the payment of any excess parachute payment within the meaning of Section 280G of the Code.
(d) Except as set forth on Section 3.17(d) of the Company Disclosure Schedules, neither the execution
and delivery of this Agreement nor the consummation of the transactions contemplated hereby (either alone or in conjunction with any other event), other than any arrangement or agreement entered into with Parent in connection with this Agreement,
will, directly or indirectly, (A) result in any payment (whether in cash, property or the vesting of property), benefit or other right becoming due to any employee, officer, director or independent contractor (current or former) of the Group
Companies, (B) increase any compensation or benefits otherwise payable under any Company Benefit Plan or otherwise, (C) result in the acceleration of the time of payment, funding or vesting of any such compensation, benefits, or other
rights under any such Company Benefit Plan or otherwise, or (D) result in an obligation to fund or otherwise set aside assets to secure to any extent any of the obligations under any Company Benefit Plan.
(e) No Group Company has an obligation to gross-up or reimburse any individual for any
Tax or related interest or penalties incurred by such individual, including under Sections 409A or 4999 of the Code or otherwise.
(f) Each Company Benefit Plan that constitutes in any part a nonqualified deferred compensation plan subject to
Section 409A of the Code has been operated and maintained in all material respects in operational and documentary compliance with Section 409A of the Code and applicable IRS guidance thereunder.
A-1-19
(g) To the Knowledge of the Companies, there has not been any
prohibited transaction (as such term is defined in Section 406 of ERISA or Section 4975 of the Code, other than a transaction that is exempt under a statutory or administrative exemption) with respect to any Company Benefit
Plan.
(h) Neither of the Companies nor, to the Knowledge of the Companies, any other fiduciary (as defined in
Section 3(21) of ERISA) has any material liability for breach of fiduciary duty or any other failure to act or comply in connection with the administration or investment of the assets of any Company Benefit Plan.
Section 3.18 Labor Relationships.
(a) None of the Group Companies employees are represented by a union, works council, or other labor organization or
employee representative body, nor are any of the Group Companies party to or bound by any collective bargaining agreement, works council agreement or other Contract or bargaining relationship with any union, works council, or other labor
organization or employee representative body. To the Knowledge of the Companies, there are no, and since the Look-Back Date have been no, pending or threatened union organizing or decertification activities relating to employees of any of the Group
Companies.
(b) There are no, and since the Look-Back Date, there have not been any pending, or to the Knowledge of the
Companies, threatened, walk outs, strikes, handbilling, picketing, lockouts, work stoppages, unfair labor practice charges, material grievances, labor arbitrations, or other material labor disputes against or affecting any Group Company.
(c) Each Group Company is, and since the Look-Back Date has been, in compliance in all material respects with all applicable
Laws related to labor, employment, and employment practices including those related to terms and conditions of employment, wages, hours, worker classification (including the classification of independent contractors and exempt and non-exempt employees), health and safety, immigration (including the completion of Forms I-9 for all employees and the proper confirmation of employee visas), employment
harassment, discrimination or retaliation, whistleblowing, disability rights or benefits, equal opportunity, plant closures and layoffs (including the WARN Act), employee trainings and notices, workers compensation, labor relations, employee
leave issues, COVID-19, affirmative action, unemployment insurance, and collective bargaining.
(d) Except as would not result in material liability for the Group Companies, since the Look-Back Date (i) the Group
Companies have paid all wages, salaries, wage premiums, commissions, bonuses, fees or other compensation which has or have come due and payable to its current and former employees and independent contractors under applicable Law, Contract or policy,
and (ii) each individual who has provided services to the Group Companies since the Look-Back Date and who is or was classified and treated as an independent contractor is and has been properly classified and treated as such for all applicable
purposes.
(e) To the Knowledge of the Companies, no Person is in any respect in violation of any material term of any
employment agreement, nondisclosure agreement, common law nondisclosure obligation, fiduciary duty, noncompetition agreement, restrictive covenant or other obligation: (i) to the Group Companies or (ii) with respect to any Person who is a
current employee or independent contractor of the Group Companies, to any third party with respect to such Persons right to be employed or engaged by the Group Companies or to the knowledge or use of trade secrets or proprietary information.
(f) To the Knowledge of the Companies, no executive, officer or key employee of the Group Companies intends to terminate
his or her employment prior to or within the twelve (12) month period following the Closing.
(g) Except as would not
result in material liability for the Group Companies, no Group Company is party to a settlement agreement with a current or former director, officer, employee or independent contractor of such Group Company that involves allegations relating to
sexual harassment, sexual misconduct, discrimination or retaliation by either (i) a director or an officer of the Group Company or
A-1-20
(ii) an employee of the Group Company at the level of Vice President or above. To the Knowledge of the Companies, since the Look-Back Date, no allegations of sexual harassment, sexual
misconduct, discrimination or retaliation have been made against (i) a director or an officer of any Group Company or (ii) an employee of a Group Company at the level of Vice President or above.
(h) None of the Group Companies have engaged in any mass layoff or plant closing (in each case, as
defined in the WARN Act) since the Look-Back Date that would violate or in any way implicate the WARN Act. The Group Companies are, and since the Look-Back Date, the Companies have been, in compliance in all material respects with the WARN Act. The
Group Companies, taken as a whole, employ or otherwise engage the Persons sufficient to operate the business of the Group Companies as currently conducted.
Section 3.19 International Trade & Anti-Corruption Matters.
(a) None of the Group Companies, nor any of their respective officers, directors, or employees, nor to the Knowledge of the
Companies, any agent or other third party representative acting on behalf of the Group Companies: (x) is currently, or has since the Look-Back Date: (i) a Sanctioned Person, (ii) organized, resident or located in a Sanctioned Country,
(iii) engaging in any dealings or transactions with any Sanctioned Person or in any Sanctioned Country, to the extent such activities violate applicable Sanctions Laws or Ex-Im Laws, or
(iv) otherwise in violation, in any material respect, of applicable Sanctions Laws, Ex-Im Laws, or the anti-boycott Laws administered by the U.S. Department of Commerce and the U.S. Department of
Treasurys Internal Revenue Service (collectively, Trade Control Laws); or (y) has at any time (i) made or accepted any unlawful payment or given, offered, promised, or authorized or agreed to give, any money
or thing of value, directly or indirectly, to any Government Official or other Person in violation of any applicable Anti-Corruption Laws, or (ii) otherwise violated applicable Anti-Corruption Laws. The Group Companies have maintained complete
and accurate books and records, including records of payments to any agents, consultants, representatives, third parties and Government Officials.
(b) Since the Look-Back Date, none of the Group Companies have, in connection with or relating to the business of the Group
Companies, received from any Governmental Entity or any other Person any notice, inquiry, or internal or external allegation, made any voluntary or involuntary disclosure to a Governmental Entity, or conducted any internal investigation or audit
concerning any actual or potential violation or wrongdoing related to Trade Control Laws or Anti-Corruption Laws.
(c) None
of the Group Companies has imported merchandise into the United States that has been or is covered by an anti-dumping duty order or countervailing duty order or is subject to or otherwise covered by any pending anti-dumping or countervailing duty
investigation by agencies of the United States government.
Section 3.20 Certain Fees. No Parent
Party or Group Company shall be obligated to pay or bear any brokerage, finders or other fee or commission to any broker, finder or investment banker in connection with the transactions contemplated by this Agreement based upon arrangements
made by or on behalf of any of the Group Companies or any of their respective Affiliates.
Section 3.21
Insurance Policies. Section 3.21 of the Company Disclosure Schedules contains a true, correct and complete list of all insurance policies carried by the Group Companies. All insurance policies carried by or for the
benefit of the Group Companies provide coverage reasonably sufficient for a business of the size and type operated by the Group Companies. All such insurance policies are in full force and effect, all premiums with respect thereto covering all
periods up to the Closing on the Closing Date will have been paid, shall otherwise be maintained by the applicable Group Company in full force and effect as they apply to any matter, action or event relating to the Group Companies occurring through
the Closing Date, and no notice of cancellation, termination, reduction in coverage or disallowance of any claim has been received by any Group Company with respect to any such policy. There are no pending claims by any Group Company against any
insurance carrier under any such insurance policy for which coverage has been denied or disputed by the applicable insurance carrier (other than a customary reservation of rights notice). The Company has made available to Parent true, correct and
complete copies of all such policies.
A-1-21
Section 3.22 Affiliate Transactions. Except for
employment relationships and compensation, benefits, travel advances and employee loans in the Ordinary Course as disclosed on Section 3.22(i) of the Company Disclosure Schedules, there are, and since the Look-Back Date
there have been, no transactions or Contracts between any Group Company, on the one hand, and any (i) member, manager, director, officer, employee or Affiliate of any of the foregoing persons on the other (except any transactions or Contracts
that are not material to the applicable Group Company), (ii) holder of any ownership interests of any Group Company or (iii) member of any of the respective immediate families of any of the foregoing. Section 3.22(ii)
of the Company Disclosure Schedules sets forth all Contracts between either of the Companies or any of the Company Subsidiaries, on the one hand, and any member, manager, director, officer, or employee of either of the Companies or any Person
directly or indirectly owning 5% or more of the LMA Interests or Abacus Interests or any of their respective Affiliates, on the other hand. Except as set forth on Section 3.22(iii) of the Company Disclosure Schedules, none
of the Group Companies or their respective Affiliates, members, managers, directors, officers or employees possesses, directly or indirectly, any material financial interest in, or is a director, officer or employee of, any Person which is a
Material Customer, Material Supplier or material competitor of any Group Company.
Section 3.23
Information Supplied. None of the information supplied or to be supplied by the Companies for inclusion or incorporation by reference in the Proxy Statement will, at the date the Proxy Statement is first mailed or at the time of the Parent
Common Stockholders Meeting, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they are
made, not misleading (subject to the qualifications and limitations set forth in the materials provided by the Companies or that are included in the Proxy Statement). Notwithstanding the foregoing, the Companies make no representation, warranty or
covenant with respect to (a) statements made or incorporated by reference therein based on information supplied by the Parent Parties for inclusion or incorporation by reference in the Proxy Statement or any Parent Reports, or (b) any
projections or forecasts included in the Proxy Statement.
Section 3.24 Customers, and Suppliers.
Section 3.24 of the Company Disclosure Schedules sets forth a list of the Group Companies (a) top fifteen (15) customers, based on amounts paid for goods or services for the fiscal year ending December 31,
2021, and for the trailing six (6) month period ending June 30, 2022, showing the approximate total sales by the Group Companies to each such material customer (each such customer, a Material Customer) and (b) (i)
the top fifteen (15) suppliers and vendors of goods and services to the Group Companies based on amounts paid for goods or services for the fiscal year ending December 31, 2021, and for the trailing six (6) month period ending
June 30, 2022, and the approximate total purchases by the Group Companies from each such material supplier, during each such period and (ii) any sole source supplier of any good or services of the Group Companies, other than any sole
source supplier providing goods or services for which the Group Companies can readily obtain a replacement supplier without a material increase in the cost of supply (each such supplier listed in the foregoing (i)-(ii), a Material
Supplier). No such Material Customer or Material Supplier listed on Section 3.24 of the Company Disclosure Schedules has (1) terminated or threatened to terminate its relationship with any of the Group
Companies, (2) as of the date hereof, materially reduced its business with any of the Group Companies or adversely modified its relationship with any of the Group Companies, (3) as of the date hereof, notified any of the Group Companies of
its intention to take any such action and, to the Knowledge of the Companies, no such Material Customer or Material Supplier is contemplating such action, or (4) to the Knowledge of the Companies, has become insolvent or is subject to
bankruptcy proceedings.
Section 3.25 Compliance with Laws. Each Group Company is, and has been
since the Look-Back Date, in compliance in all material respects with all Laws, Orders and, during the period of their application, COVID-19 Measures, which are, in each case, applicable to their respective
businesses, operations, assets and properties. The Company has not received any notice of, or been charged with, any material violation of any such Laws, Orders or COVID-19 Measures.
A-1-22
Section 3.26 Sufficiency of Assets. The Group
Companies have good and marketable title to, or, in the case of leased properties and assets, valid leasehold interests in, all of the material items of tangible personal property used or held for use in the business of the Group Companies, free and
clear of any and all Liens (other than Permitted Liens). The tangible assets owned or leased by the Group Companies constitute all of the tangible assets reasonably necessary for the continued conduct of the business of the Group Companies after the
Closing in the Ordinary Course.
Section 3.27 Investment Company Act. Each Group Company is not,
and immediately following the Closing will not be, an investment company or a Person directly or indirectly controlled by or acting on behalf of an investment company, in each case within the meaning of the
Investment Company Act.
Section 3.28 No Regulatory Impediments. There are no facts or
circumstances related to the identity, financial condition, jurisdiction of domicile or regulatory status of any Group Company or any of their respective Affiliates that, to the Knowledge of the Companies, would reasonably be expected to materially
impair or delay the ability to obtain the consents, approvals, authorizations and waivers that are the subject of Section 6.1(f) or to execute or perform its or the Group Companies obligations under this Agreement or
the Ancillary Agreements, including the consummation of the Transactions. As of the date of this Agreement, neither of the Companies nor any of their Affiliates has received written notification or, to the Knowledge of the Companies, oral notice or
communication from any Governmental Entity that such Governmental Entity would oppose the Transactions or refuse to grant or issue its consent or approval, if required, with respect to the Transactions.
Section 3.29 No Additional Representations or Warranties. Except as expressly provided in this
Article III (as modified by the Company Disclosure Schedules) or the Ancillary Agreements to which it is a party, neither of the Companies, nor any of their respective directors, managers, officers, employees, equityholders, partners, members
or representatives has made, or is making, any representation or warranty whatsoever (whether express or implied) to the Parent Parties and no such party shall be liable in respect of the accuracy or completeness of any information provided to the
Parent Parties.
ARTICLE IV
REPRESENTATIONS AND WARRANTIES OF THE PARENT PARTIES
Except as set forth in (i) the disclosure schedules delivered by Parent to the Companies concurrently with the execution
of this Agreement (the Parent Disclosure Schedules) or (ii) any Parent Reports (excluding any disclosures in any risk factors section that do not constitute statements of fact, disclosures in any
forward-looking statements disclaimers and other disclosures that are generally cautionary, predictive or forward-looking in nature), and subject to the terms, conditions and limitations set forth in this Agreement, the Parent Parties hereby jointly
and severally represent and warrant to the Companies, as of the date of this Agreement and the Closing Date, as follows, in each case, excluding any action taken or declined to be taken by an officer of either LMA Merger Sub or Abacus Merger Sub:
Section 4.1 Organization. Each of the Parent Parties is a corporation or limited liability company
duly incorporated or organized, validly existing and in good standing under the Laws of the State of Delaware. Each of the Parent Parties has all requisite corporate or limited liability company power and authority, as applicable, to own, lease and
operate its properties and to carry on in all material respects its business as now being conducted, except where the failure to have such power or authority would not prevent or materially delay the consummation of the transactions contemplated by
this Agreement or the Ancillary Agreements to which such Parent Party is a party. Each of the Parent Parties is duly qualified, licensed or registered as a foreign entity to transact business, and is in good standing, under the Laws of each
jurisdiction where the character of its properties or assets owned, leased or operated by it, its activities, or the location of the properties or assets owned, leased or operated by it requires such qualification, licensing or registration, except
where the failure of such qualification, licensing or registration would not reasonably be expected to have a Material Adverse Effect. Except for LMA Merger Sub and Abacus Merger Sub,
A-1-23
Parent has no Subsidiaries. Except as set forth in the preceding sentence, none of Parent, LMA Merger Sub or Abacus Merger Sub owns, directly or indirectly, any interest or investments (whether
equity or debt) in any Person, whether incorporated or unincorporated. Except as provided hereby, no Parent Party is party to any Contract that obligates any Parent Party to invest money in, loan money to or make any capital contribution to any
other Person.
Section 4.2 Authorization. Each of the Parent Parties has the requisite corporate or
limited liability company power and authority, as applicable, to execute and deliver this Agreement and the Ancillary Agreements to which it is a party, to perform its obligations hereunder and thereunder and to consummate the transactions
contemplated hereby and thereby, subject in the case of the consummation of the Mergers, to the receipt of the requisite approval of the Transaction Proposals by the Parent Stockholders. The affirmative vote of the holders of a majority of the
shares of Parent Common Stock and Parent Class B Stock, voting together as a single class, that are voted at the Parent Common Stockholders Meeting, is the only vote of the holders of Parents capital stock required to approve the
Transaction Proposals, assuming a quorum is present (the Parent Stockholder Approval). Parent Stockholder Approval of the Transaction Proposals are the only votes of any class or series of Parents capital stock necessary to
adopt this Agreement and any Ancillary Agreement and to approve the transactions contemplated hereby and thereby. The execution and delivery of this Agreement and the Ancillary Agreements and the consummation of the transactions contemplated hereby
and thereby have been duly authorized by all necessary corporate and limited liability company action. This Agreement has been, and the Ancillary Agreements to which any of the Parent Parties are or will be a party as of the Closing Date shall be,
duly authorized, executed and delivered by each of the Parent Parties, as applicable, and, assuming the due authorization, execution and delivery by each other party hereto and thereto, constitutes the legal, valid and binding obligations of each of
the Parent Parties, as applicable, enforceable against each of the Parent Parties, as applicable, in accordance with their respective terms, subject to applicable bankruptcy, insolvency and other similar Laws affecting the enforceability of
creditors rights generally, general equitable principles and the discretion of courts in granting equitable remedies.
Section 4.3 Capitalization.
(a) Parent is the sole record and beneficial owner of all of the ownership
interests of each of LMA Merger Sub and Abacus Merger Sub, free and clear of all Liens. All of the issued and outstanding ownership interests of the Parent Parties have been duly authorized and validly issued, and are fully paid and non-assessable. No Person other than Parent has any rights with respect to the ownership interests of each of LMA Merger Sub and Abacus Merger Sub, and no such rights arise by virtue of or in connection with the
transactions contemplated by this Agreement.
(b) The authorized capital stock of Parent consists only of 221,000,000
shares of capital stock, consisting of (i) 200,000,000 shares of Parent Common Stock, (ii) 20,000,000 shares of Parent Class B Stock and (iii) 1,000,000 shares of preferred stock. As of the date hereof, the issued and outstanding
capital stock of Parent consists of 18,343,972 shares of capital stock, consisting of (A) 9,718,972 shares of Parent Common Stock, (B) 8,625,000 shares of Parent Class B Stock and (C) no shares of preferred stock. In addition, as
of the date hereof, (1) 17,250,000 shares of Parent Common Stock are issuable upon the exercise of the Parent public warrants, (2) 8,900,000 shares of Parent Common Stock are issuable upon the exercise of the Parent private warrants and (3) up
to 2,500,000 shares of Parent Common Stock are issuable pursuant to the Forward Purchase Agreement. All of the shares of Parent Common Stock issuable pursuant to this Agreement at the Effective Time will be, when so issued, (x) duly authorized,
validly issued, fully paid and nonassessable and free of preemptive rights, (y) issued pursuant to an effective registration statement filed under the Securities Act, or an appropriate exemption therefrom, and in accordance therewith, and
(z) registered under the Exchange Act. Except pursuant to this Agreement or the other documents contemplated hereby, and other than in connection with the Forward Purchase Agreement, any Subscription Agreements that may be entered into in
connection with the Transactions, the Parent public warrants, the Parent private warrants and any Working Capital Warrants issued upon conversion of the
A-1-24
Working Capital Loans, (a) there are no stock appreciation, phantom stock, stock-based performance unit, profit participation, restricted stock, restricted stock unit, other equity based
compensation award or similar rights with respect to Parent and no options, warrants, rights, convertible or exchangeable securities, phantom rights, appreciation rights, performance units, commitments or other agreements relating to the
Parent Common Stock, Parent Class B Stock or Parent preferred stock, or obligating Parent to issue, deliver or sell, or cause to be issued, delivered or sold any shares of Parent Common Stock, Parent Class B Stock, Parent preferred stock
or any other interest in Parent, including any security convertible or exercisable into Parent Common Stock, Parent Class B Stock or Parent preferred stock and (b) there are no Contracts to which Parent is a party which require Parent to
repurchase, redeem or otherwise acquire any shares of Parent Common Stock, Parent Class B Stock, Parent preferred stock or any other interest in Parent. Each share of Parent Common Stock that has been sold has been sold pursuant to an effective
registration statement filed under the Securities Act, or an appropriate exemption therefrom, and in accordance therewith. All shares of Parent Common Stock are registered under the Exchange Act. None of the issued and outstanding shares of Parent
Common Stock, Parent Class B Stock, Parent public warrants, or Parent private warrants were issued in violation of any preemptive rights, Laws or Orders. Except as set forth on Section 4.3(b) of the Parent Disclosure
Schedules, there are no voting trusts, stockholder agreements, proxies or other agreements in effect with respect to the voting or transfer of any shares of Parent Common Stock or any other interests in Parent.
(c) Each holder of any of the shares of Parent Class B Stock initially issued to ERES Sponsor in connection with
Parents initial public offering (i) is obligated to vote all such shares of Parent Class B Stock in favor of approving the transactions contemplated hereby, and (ii) is not entitled to redeem any of such shares of Parent
Class B Stock pursuant to the Organizational Documents of Parent in the Offer.
Section 4.4
Consents and Approvals; No Violations. Subject to the receipt of the Parent Stockholder Approval of the Transaction Proposals, the filing of the Certificates of Merger, the filing of any Parent Report, the filing of the Proxy Statement and
the applicable requirements of the HSR Act, and assuming the truth and accuracy of each Companys representations and warranties contained in Section 3.5 and the representations and warranties of each Company contained
in any Ancillary Agreement, neither the execution and delivery of this Agreement or any Ancillary Agreement nor the consummation of the Transactions will (A) conflict with or result in any material breach of any provision of the Organizational
Documents of any Parent Party, (B) require any filing with, or the obtaining of any material consent or approval of, any Governmental Entity, (C) result in a material violation of or material default (or give rise to any right of
termination, cancellation or acceleration) under, any of the terms, conditions or provisions of any note, mortgage, other evidence of indebtedness, guarantee, license, agreement, lease or other contract, instrument or obligation to which any Parent
Party is a party or by which any Parent Party or any of their respective assets may be bound, (D) result in the creation of any Lien upon any of the properties or assets of any Parent Party (other than Permitted Liens) or (E) violate in
any material respect any Law or Order applicable to any Parent Party, except for violations or defaults which would not reasonably be expected to be material to the Parent Parties, taken as a whole.
Section 4.5 Financial Statements.
(a) The financial statements and notes contained or incorporated by reference in the Parent Reports fairly present, in all
material respects, (a) the financial condition of Parent as at the respective dates of, and for the periods referred to in, such financial statements, in accordance with GAAP applied on a consistent basis throughout the periods indicated
(except as may be indicated in the notes thereto or, in the case of the unaudited financial statements, as permitted by Regulation S-X of the SEC), and (b) the consolidated financial position, results of
operations, income and cash flows of Parent as at the respective dates of, and for the periods referred to in, such financial statements (subject, in the case of the unaudited financial statements, to normal
year-end adjustments that are not material in amount or kind and the absence of footnotes), except as otherwise noted therein. Parent has no material off-balance sheet
arrangements that are not disclosed in the Parent Reports.
A-1-25
(b) Except as not required in reliance on exemptions from various reporting
requirements by virtue of Parents status as an emerging growth company within the meaning of the Securities Act, as modified by the JOBS Act, since December 31, 2020, (i) Parent has established and maintained a system of
internal controls over financial reporting (as defined in Rule 13a-15 and Rule 15d-15 under the Exchange Act) sufficient to provide reasonable assurance regarding the
reliability of Parents financial reporting and the preparation of Parents financial statements for external purposes in accordance with GAAP and (ii) Parent has established and maintained disclosure controls and procedures (as
defined in Rule 13a-15 and Rule 15d-15 under the Exchange Act) designed to ensure that material information relating to Parent is made known to Parents principal
executive officer and principal financial officer by others within Parent, particularly during the periods in which the periodic reports required under the Exchange Act are being prepared.
Section 4.6 Business Activities; No Undisclosed Liabilities.
(a) Since their respective dates of incorporation, none of Parent, LMA Merger Sub or Abacus Merger Sub has conducted any
business activities other than activities: (i) related to Parents initial public offering, (ii) directed towards the accomplishment of a Business Combination and (iii) related to the execution of this Agreement and the other
Ancillary Agreements to which it is a party, the performance of its obligations hereunder and thereunder and matters ancillary thereto. Other than under this Agreement or the Ancillary Agreements or pursuant to the performance of its obligations
thereunder, none of Parent, LMA Merger Sub or Abacus Merger Sub has any liabilities.
(b) Except as set forth in the
balance sheet of Parent included in Parents Annual Report on Form 10-K for the fiscal year ended December 31, 2021 for the 12-months ended December 31,
2021, no Parent Party has any liabilities or obligations of the type required to be disclosed in a consolidated balance sheet of the Parent Parties in accordance with GAAP, except for liabilities and obligations (a) incurred since
December 31, 2021 in the Ordinary Course, (b) incurred since December 31, 2021 pursuant to or in connection with this Agreement or the transactions contemplated hereby, (c) disclosed in any Parent filings with the SEC,
(d) disclosed in this Agreement (or the Parent Disclosure Schedules) or (e) which would not reasonably be expected to be material to such Parent Party.
Section 4.7 Absence of Certain Changes. Except set forth in any Parent Reports filed prior to the date
of this Agreement, and except as contemplated by this Agreement, since Parents incorporation:
(a) Parent has
conducted its business in all material respects in the Ordinary Course;
(b) there has been no Material Adverse Effect on
any Parent Party; and
(c) Parent has not taken any action or omitted to take an action, which, if taken or omitted to be
taken after the date of this Agreement, would require the consent of each Company in accordance with Section 5.2.
Section 4.8 Litigation.
(a) Except as set forth on Section 4.8 of the Parent Disclosure Schedules, there are no material
Actions or Orders (including those brought or threatened by or before any Governmental Entity) pending or, to the knowledge of Parent, threatened against or otherwise relating to any Parent Party or any of their respective properties at Law or in
equity, including Actions or Orders that challenge or seek to enjoin, alter or materially delay the transactions contemplated by this Agreement or any Ancillary Agreement, but excluding, in each case, Actions or Orders that would not reasonably be
expected to be material to the Parent Parties, taken as a whole.
(b) Parent has not filed any material suit, litigation,
arbitration, claim or action against any other Person since its formation.
A-1-26
Section 4.9 Parent Material Contracts.
(a) Section 4.9(a) of the Parent Disclosure Schedules sets forth a true, correct and complete list of the Parent
Material Contracts.
(b) The Parent Material Contracts (except those that are canceled, rescinded or terminated after the
date hereof in accordance with their terms) are in full force and effect in all material respects in accordance with their respective terms with respect to Parent and, to the knowledge of Parent, the other party thereto, assuming the due
authorization, execution and delivery by such other party thereto, subject to bankruptcy, insolvency, reorganization, moratorium and similar Laws of general applicability relating to or affecting creditors rights and to general principles of
equity. To the knowledge of Parent, there does not exist under any Parent Material Contract any event of material default or event or condition that constitutes a material violation, breach or event of default thereunder on the part of Parent, in
each case that would reasonably be expected to have a Material Adverse Effect.
Section 4.10 Tax
Returns; Taxes. Except as otherwise disclosed on Section 4.10 of the Parent Disclosure Schedules:
(a) all income and other material Tax Returns of Parent required to have been filed with any Governmental Entity in accordance
with any applicable Law have been duly and timely filed (taking into account extensions of time for filing) and are correct and complete in all material respects;
(b) all income and other material Taxes due and owing by Parent have been paid in full, except for Taxes being contested in
good faith and for which adequate reserves have been established in accordance with GAAP;
(c) there are not currently any
extensions of time in effect with respect to the dates on which any Tax Return of Parent were or are due to be filed;
(d)
no claims for additional unpaid Taxes have been asserted in writing since the Look-Back Date and no proposals or deficiencies for any Taxes of Parent are currently being asserted, proposed or, to the knowledge of Parent, threatened, and no audit or
investigation of any Tax Return of Parent is currently underway, pending or, to the knowledge of Parent, threatened;
(e)
Parent has withheld and paid all material Taxes required to have been withheld and paid in connection with amounts paid to any employee, independent contractor, creditor, stockholder or other third party;
(f) there are no outstanding waivers or agreements by or on behalf of Parent for the extension of time for the assessment of
any Taxes or any deficiency thereof and Parent has not waived any statute of limitations in respect of Taxes;
(g) there
are no Liens for Taxes against any asset of Parent (other than Permitted Liens);
(h) Parent is not a party to any Tax
indemnification or Tax receivable, allocation, sharing or similar agreement under which Parent will have any liability for Taxes after the Closing (excluding customary commercial agreements the primary subject of which is not Taxes);
(i) Parent has not been a member of an affiliated group filing a consolidated U.S. federal income Tax Return (other than a
group the common parent of which was Parent) and does not have any material liability for the Taxes of any Person (other than any subsidiary of any group the common parent of which was Parent) under Treasury Regulations Section 1.1502-6 (or any corresponding or similar provision of state, local or foreign income Tax Law), as a transferee or successor, or by contract (excluding customary commercial agreements the primary
subject of which is not Taxes);
(j) Parent is not and has not been a party to any listed transaction, as
defined in Treasury Regulations Section 1.6011-4(b)(2);
A-1-27
(k) no written claim has ever been made by an Governmental Entity in a
jurisdiction where Parent does not file Tax Returns that Parent may be subject to taxation by that jurisdiction and which claim has not been resolved;
(l) Parent is, and has been at all times since formation, treated as a corporation for United States federal income Tax
purposes;
(m) Parent will not be required to include any material item of income in, or exclude any material deduction
from, taxable income for any taxable period (or portion thereof) ending after the Closing Date as a result of any: (i) adjustments under Section 481 of the Code (or any corresponding or similar provision of state, local or foreign income
Tax Law); (ii) change in method of accounting, or use of an improper method of accounting, for a taxable period ending on or prior to the Closing Date; (iii) closing agreement as described in Section 7121 of the Code (or any
corresponding or similar provision of state, local or foreign income Tax Law) executed on or prior to the Closing Date; (iv) intercompany transactions as described in Treasury Regulations
Section 1.1502-13 (or any corresponding or similar provision of state, local or foreign income Tax Law) or excess loss account described in Treasury Regulations
Section 1.1502-19 (or any corresponding or similar provision of state, local or foreign income Tax Law), in each case, entered into or created on or prior to the Closing Date; (v) installment sale or
open transaction disposition made on or prior to the Closing Date; or (vi) prepaid amount received on or prior to the Closing Date, other than amounts reflected on the financial statements of Parent and amounts accrued in the Ordinary Course
since then;
(n) Since the Look-Back Date, Parent has not distributed stock of another Person, or has had its stock
distributed by another Person, in a transaction that purported or intended to be governed in whole or in part by Section 355 of the Code;
(o) Parent has not had a permanent establishment (within the meaning of an applicable Tax treaty or convention between the
United States and such foreign country), or otherwise been subject to taxation in any country other than the country of its formation; and
(p) Parent has not taken, or agreed to take, any action, or has knowledge of any fact or circumstance, that could reasonably be
expected to prevent the Mergers, taken together, from qualifying as a reorganization within the meaning of Section 368(a) of the Code.
Section 4.11 Compliance with Laws. Each Parent Party is in compliance in all material respects with all
Laws which are applicable to their respective businesses, operations, assets and properties, except for noncompliance which would not reasonably be expected to have a Material Adverse Effect. No Parent Party has received any written notice of, or
been charged with, a material violation of any such Laws.
Section 4.12 Certain Fees. Except as set
forth on Section 4.12 of the Parent Disclosure Schedules, none of the Group Companies or the LMA Members or the Abacus Members shall be directly or indirectly obligated to pay or bear (e.g., by virtue of any
payment by or obligation of any of the Parent Parties or any of their respective Affiliates at or at any time after the Closing) any brokerage, finders or other fee or commission to any broker, finder or investment banker in connection with
the transactions contemplated by this Agreement based upon arrangements made by or on behalf of any of the Parent Parties or any of their respective Affiliates.
Section 4.13 SEC Filings; NASDAQ; Investment Company Act.
(a) Parent has filed with or furnished, as applicable, all forms, statements, certifications, reports and documents required to
be filed or furnished by it with the SEC pursuant to the Exchange Act or the Securities Act since July 23, 2020.
(b)
As of its filing date (and as of the date of any amendment), each Parent Report complied in all material respects with the applicable requirements of the Securities Act, the Exchange Act and the Sarbanes-Oxley Act, as the case may be.
A-1-28
(c) As of their respective filing dates (or, if amended or superseded by a
filing prior to the date hereof or the Closing Date, then on the date of such filing), except as may have been revised, corrected or superseded by any subsequent filing prior to the date hereof, the Parent Reports were prepared in all material
respects in accordance with the requirements of the Securities Act, the Exchange Act and the Sarbanes-Oxley Act, as the case may be, and none of the Parent Reports contained any untrue statement of a material fact or omitted to state a material fact
required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading.
(d) Except as may have been corrected by any subsequent filing prior to the date hereof, each Parent Report that is a
registration statement, as amended or supplemented, if applicable, filed pursuant to the Securities Act, as of the date such registration statement or amendment became effective, did not contain any untrue statement of a material fact or omit to
state any material fact required to be stated therein or necessary to make the statements therein not misleading.
(e) The
issued and outstanding shares of Parent Common Stock are registered pursuant to Section 12(b) of the Exchange Act and are listed for trading on NASDAQ under the symbol ERES. The Parent public warrants are registered pursuant to
Section 12(b) of the Exchange Act and are listed for trading on NASDAQ under the symbol ERESW. The Parent units are registered pursuant to Section 12(b) of the Exchange Act and are listed for trading on NASDAQ under the symbol
ERESU. Since July 23, 2020, Parent has complied in all material respects with the applicable listing and corporate governance rules and regulations of NASDAQ, and there are no actions, suits or proceedings pending or, to the
knowledge of Parent, threatened, and Parent has not received any notice from NASDAQ or the SEC regarding the revocation of such listing or otherwise regarding the delisting of the Parent Common Stock.
(f) Parent maintains disclosure controls and procedures (as defined by Rule 13a-15(e)
under the Exchange Act). Such disclosure controls and procedures are reasonably designed to ensure that all material information required to be disclosed by Parent in the reports and documents that it files under the Exchange Act is recorded,
processed, summarized and reported on a timely basis to the individuals responsible for the preparation of Parents filings with the SEC and other public disclosure documents and to make the certifications required pursuant to Sections 302
and 906 of the Sarbanes-Oxley Act. Parent maintains effective internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act).
(g) Parent is in compliance in all material respects with the provisions of Sarbanes-Oxley Act and the provisions of the
Exchange Act and the Securities Act relating thereto, which under the terms of such provisions and applicable SEC guidance (including the dates by which such compliance is required) have become applicable to Parent.
(h) Parent is not, and immediately following the Closing will not be, an investment company or a Person directly or
indirectly controlled by or acting on behalf of an investment company, in each case within the meaning of the Investment Company Act. Parent constitutes an emerging growth company within the meaning of the JOBS
Act and will remain an emerging growth company immediately following the Closing.
Section 4.14 Information Supplied. None of the information supplied or to be supplied by any Parent
Party for inclusion or incorporation by reference in the Proxy Statement will, at the date the Proxy Statement is first mailed or at the time of the Parent Common Stockholders Meeting, contain any untrue statement of a material fact or omit to state
any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they are made, not misleading (subject to the qualifications and limitations set forth in the materials
provided by Parent or that are included in the Proxy Statement). Notwithstanding the foregoing, no Parent Party makes any representation, warranty or covenant with respect to (a) statements made or incorporated by reference therein based on
information supplied by, or on behalf of, the Group Companies for inclusion or incorporation by reference in the Proxy Statement, or (b) any projections or forecasts included in the Proxy Statement.
A-1-29
Section 4.15 Board Approval; Stockholder Vote. The
board of directors or similar governing body of each Parent Party, as applicable (including any required committee or subgroup of the board of directors or similar governing body of such Parent Party, as applicable) has, as of the date of this
Agreement, unanimously (a) approved and declared the advisability of this Agreement and the Ancillary Agreements and the consummation of the transactions contemplated hereby and thereby, and (b) determined that the consummation of the
transactions contemplated hereby and thereby are in the best interests of such Parent Party and the stockholders or members of such Parent Party, as applicable. Other than the approval of the Transaction Proposals by the Parent Stockholders, no
other corporate or limited liability company proceedings on the part of any Parent Party are necessary to approve the consummation of the transactions contemplated hereby.
Section 4.16 Trust Account.
(a) As of the date hereof, Parent has $97,939,800.60 (the Trust Amount) in the account established by
Parent for the benefit of its Public Stockholders (the Trust Account), with such funds held in cash in trust by Continental Stock Transfer & Trust Company (the Trustee) pursuant to the
Investment Management Trust Agreement, dated as of July 21, 2020, by and between Parent and the Trustee (the Trust Agreement). Other than pursuant to the Trust Agreement, the obligations of Parent under this Agreement
are not subject to any conditions, consents, approvals, notices or other requirements regarding Parents, its Affiliates or any other Persons ability to obtain financing for the consummation of the transactions contemplated hereby.
(b) The Trust Agreement has been duly approved by the Parents Board of Directors, complies with applicable Law, and
has not been amended or modified, is valid and in full force and effect and is enforceable in accordance with its terms, subject to applicable bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and other similar Laws affecting
the enforceability of creditors rights generally and subject, as to enforceability, to general equitable principles and the discretion of courts in granting equitable remedies. There are no separate Contracts, side letters or other
understandings (whether written or unwritten, express or implied) (i) between Parent and the Trustee that would cause the description of the Trust Agreement in the Parent Reports to be inaccurate in any material respect, or (ii) to
Parents knowledge, that would entitle any Person (other than stockholders of Parent holding Parent Common Stock sold in Parents initial public offering who shall have elected to redeem their shares of Parent Common Stock pursuant to
Parents Organizational Documents and otherwise with respect to deferred underwriting commissions) to any portion of the proceeds in the Trust Account. Prior to the Closing, none of the funds held in the Trust Account may be released except
(A) to pay income and franchise Taxes from any interest income earned in the Trust Account, (B) to pay working capital related costs and (C) to redeem Parent Common Stock in accordance with the provisions of Parents
Organizational Documents. There are no Actions pending or, to Parents knowledge, threatened with respect to the Trust Account.
Section 4.17 Affiliate Transactions. Except as described in the Parent Reports, there are no material transactions, agreements, arrangements or understandings between any Parent Party, on the one hand, and any director, officer,
employee, stockholder, warrant holder or Affiliate of such Parent Party.
Section 4.18 Independent
Investigation; No Reliance. The Parent Parties have conducted their own independent investigation, verification, review and analysis of the business, operations, assets, liabilities, results of operations, financial condition, technology and
prospects of the Group Companies, which investigation, review and analysis was conducted by the Parent Parties and their respective Affiliates and, to the extent the Parent Parties deemed appropriate, by the Representatives of the Parent Parties.
Each Parent Party acknowledges that it and its Representatives have been provided access to the personnel, properties, premises and records of the Group Companies for such purpose. In entering into this Agreement, each Parent Party acknowledges that
it has relied solely upon the aforementioned investigation, review and analysis and not on any factual representations or opinions of the Companies or any of the Companies
A-1-30
Representatives (except the specific representations and warranties of the Companies expressly set forth in Article III of this Agreement or in any certificate delivered
by either of the Companies pursuant to this Agreement), and each Parent Party acknowledges and agrees, to the fullest extent permitted by Law, that: (a) neither the Companies nor any of their managers, directors, officers, equityholders,
members, employees, Affiliates, controlling Persons, agents, advisors or Representatives makes or has made any oral or written representation or warranty, either express or implied, as to the accuracy or completeness of (i) any of the
information set forth the due diligence materials, or (ii) the pro-forma financial information, projections or other forward-looking statements of the Group Companies, in each case in expectation or
furtherance of the transactions contemplated by this Agreement; and (b) neither the Group Companies nor any of their managers, directors, officers, employees, equityholders, members, Affiliates, controlling Persons, agents, advisors,
Representatives or any other Person shall have any liability or responsibility whatsoever to any of the Parent Parties or their respective directors, officers, managers, members, employees, Affiliates, controlling Persons, agents or Representatives
on any basis (including in contract or tort, under federal or state securities Laws or otherwise) based upon any information provided or made available, or statements made (including set forth in management summaries relating to the Companies
provided to the Parent Parties, in materials furnished in the Companies data site (virtual or otherwise), in presentations by either of the Companies management or otherwise), to any of the Parent Parties or their respective directors,
officers, managers, members, employees, Affiliates, controlling Persons, advisors, agents or Representatives (or any omissions therefrom), unless, in each case, to the extent any such information is also subject to disclosure under this Agreement or
the Company Disclosure Schedules.
Section 4.19 Employees and Employee Benefits. No Parent Party or
any subsidiary has ever employed any employees and the Parent Parties have no unsatisfied material liability with respect to any employee. The Parent Parties do not currently maintain or have any direct liability under any employee benefit plan.
Section 4.20 Valid Issuance. The shares of Parent Common Stock issuable as Stock Consideration,
when issued, sold and delivered in accordance with the terms of this Agreement, will be duly authorized and validly issued, fully paid and nonassessable and will be issued free and clear of any Liens (other than such Liens as created by
Parents Organizational Documents or applicable securities Laws) and any preemptive rights.
Section 4.21 No Regulatory Impediments. There are no facts or circumstances related to the identity,
financial condition, jurisdiction of domicile or regulatory status of any Parent Party or any of their respective Affiliates that, to the knowledge of Parent, would reasonably be expected to materially impair or delay the ability to obtain the
consents, approvals, authorizations and waivers that are the subject of Section 6.1(f) or to execute or perform its or the other Parent Parties obligations under this Agreement or the Ancillary Agreements, including
the consummation of the Transactions. As of the date of this Agreement, neither Parent nor any of its Affiliates has received written notification or, to the knowledge of Parent, oral notice or communication from any Governmental Entity that such
Governmental Entity would oppose the Transactions or refuse to grant or issue its consent or approval, if required, with respect to the Transactions.
Section 4.22 No Additional Representations or Warranties. Except as expressly provided in this
Article IV (as modified by the Parent Disclosure Schedules), none of the Parent Parties, nor any of their respective directors, managers, officers, employees, equityholders, partners, members or representatives has made, or is making, any
representation or warranty whatsoever (whether express or implied) to the Companies or their Affiliates and no such party shall be liable in respect of the accuracy or completeness of any information provided or made available to the Companies or
their Affiliates. Without limiting the foregoing, the Companies acknowledge that their advisors have made their own investigation of the Parent Parties.
A-1-31
ARTICLE V
COVENANTS
Section 5.1 Interim Operations of the Companies. Each of the Companies agrees that, during the period from the date of this Agreement to the earlier of (x) termination of this Agreement in accordance with
Section 8.1, and (y) Closing, except as (i) otherwise contemplated by this Agreement or any Ancillary Agreement, (ii) required by applicable Laws (including COVID-19
Measures), (iii) described in Section 5.1 of the Company Disclosure Schedules or (iv) consented to by Parent (which consent shall not be unreasonably withheld, conditioned or delayed by Parent):
(a) each of the Companies shall, and shall cause its Subsidiaries to, conduct its business in the Ordinary Course in all
material respects and, to the extent consistent with the foregoing, use its commercially reasonable efforts to (i) preserve intact its present business organization, (ii) keep available the services of its officers and key employees and
(iii) maintain existing relationships with its Material Customers, Material Suppliers and other material business relationships with it; and
(b) each of the Companies shall not, and shall cause each of its Subsidiaries not to, effect any of the following:
(i) make any change in or amendment to its Organizational Documents (other than in accordance with this Agreement, including
the Redomestication);
(ii) make any change in or amendment to any of its compliance programs or procedures;
(iii) issue or sell, or authorize to issue or sell, any membership interests, shares of its capital stock or any other
ownership interests, as applicable, or issue or sell, or authorize to issue or sell, any securities convertible into or exchangeable for, or options, warrants or rights to purchase or subscribe for, or enter into any Contract with respect to the
issuance or sale of, any shares of its membership interests, capital stock or any other ownership interests, as applicable;
(iv) split, combine, redeem or reclassify, or purchase or otherwise acquire, any membership interests, shares of its capital
stock or any other ownership interests, as applicable;
(v) sell, lease, license, permit to lapse, transfer, abandon or
otherwise dispose of any of its properties or assets (including any Company Owned Intellectual Property) that are material to its business, other than (A) pursuant to Company Material Contracts to which any of the Group Companies are a party
that are in effect as of the date of this Agreement, (B) non-exclusive licenses of Company Owned Intellectual Property granted in the Ordinary Course, or (C) sales or other dispositions for fair
consideration in the Ordinary Course;
(vi) amend in any adverse respect or terminate any Company Material Contract or
Lease;
(vii) (A) incur any Indebtedness in excess of $500,000, other than short-term Indebtedness or letters of
credit incurred in the Ordinary Course or borrowings under existing credit facilities, or (B) make any loans or advances to any other Person;
(viii) except as required under the terms of any Company Benefit Plan set forth on Section 3.17(a) of
the Company Disclosure Schedules, in each case, in effect as of the date hereof (A) pay, announce, promise or grant, whether orally or in writing, to any employee, officer, director or independent contractor of the Group Companies, any increase
in compensation or benefits, except Ordinary Course annual or merit salary increases, (B) adopt or establish any new compensation or benefit plans or arrangements, or amend or terminate, or agree to amend or terminate, any existing Company
Benefit Plans (other than amendments to group welfare plans made in the Ordinary Course in conjunction with annual renewals of group welfare benefits), (C) accelerate the time of payment, vesting or funding of any compensation or benefits under any
Company Benefit Plan (including any plan or arrangement that would be a Company Benefit Plan if it was in effect on the date hereof), (D) terminate (other than for cause), furlough or temporarily lay off the employment or service of any employee or
independent contractor whose total annual base compensation
A-1-32
exceeds $250,000, or (E) hire any or engage employee or independent contractor whose total annual base compensation exceeds $250,000;
(ix) (a) make, change or rescind any material Tax election, (b) settle or compromise any claim, notice, audit report or
assessment in respect of any material Taxes, (c) file any amended material Tax Return or claim for a material Tax refund, (d) surrender any right to claim a refund of material Taxes, (e) enter into any Tax allocation agreement, Tax
sharing agreement, Tax indemnity agreement, or closing agreement related to any Tax (excluding any agreement entered into the Ordinary Course and not primarily related to Taxes), (f) fail to pay any income or other material Tax that becomes due and
owing, other than Taxes being contested in good faith through appropriate proceedings, and for which adequate reserves have been established in accordance with GAAP, (g) request any Tax ruling from a competent authority or, (h) except in
the Ordinary Course, consent to any extension or waiver of the statute of limitations period applicable to any material Tax claim or assessment;
(x) cancel or forgive any Indebtedness in excess of $50,000 owed to the Group Companies;
(xi) except as may be required by applicable Law or GAAP, make any material change in the financial or Tax accounting methods,
principles or practices of the Group Companies (or change an annual accounting period);
(xii) unless required by
applicable Laws, (i) modify, extend, terminate, negotiate, or enter into any collective bargaining agreement, works council agreement or any other Contract with any labor union, works council, or other labor organization, or (ii) recognize
or certify any labor union, labor organization, works council, or other labor organization, or group of employees, as the bargaining representative for any employees of the Group Companies;
(xiii) implement or announce any mass layoffs, plant closings, reductions in force, or other actions
that would reasonably be expected to trigger notice the federal Worker Adjustment and Retraining Notification Act of 1988 or any similar Law (collectively, the WARN Act);
(xiv) waive or release any noncompetition, nonsolicitation, nondisclosure, noninterference, nondisparagement, or other
restrictive covenant obligation of any current or former employee or independent contractor with base annual compensation in excess of $200,000;
(xv) grant or otherwise create or consent to the creation of any Lien (other than a Permitted Lien) on any of its material
assets or Leased Real Properties;
(xvi) declare, set aside or pay any dividend or make any other distribution to
equityholders of the Companies; provided, that each of LMA and Abacus may make equity distributions in the amount in excess of their respective cash balances so long as such balances are not less than $1,000,000;
(xvii) make any material change to any of the cash management practices of the Group Companies, including materially deviating
from or materially altering any of its practices, policies or procedures in paying accounts payable or collecting accounts receivable;
(xviii) waive, release, assign, settle or compromise any material rights, claims, suits, actions, audits, reviews, hearings,
proceedings, investigations or litigation (whether civil, criminal, administrative or investigative) against either Company or any Company Subsidiary other than waivers, releases, assignments, settlements or compromises that do not exceed $250,000
individually or $500,000 in the aggregate;
(xix) make or incur any capital expenditures, except for capital expenditures
(A) in the Ordinary Course or (B) in an amount not to exceed $1,000,000 individually or $2,500,000 in the aggregate;
(xx) buy, purchase or otherwise acquire (by merger, consolidation, acquisition of stock or assets or otherwise), directly or
indirectly, any assets, securities, properties, interests or businesses, other than (A) inventory and supplies in the Ordinary Course or (B) other assets in an amount not to exceed $100,000 individually or $250,000 in the aggregate;
A-1-33
(xxi) enter into any new line of business;
(xxii) adopt or effect a plan of complete or partial liquidation, dissolution, restructuring, recapitalization or other
reorganization, other than the Mergers and the transactions contemplated hereunder;
(xxiii) fail to use commercially
reasonable efforts to maintain existing insurance policies or comparable replacement policies consistent with levels maintained by the Group Companies on the date of this Agreement;
(xxiv) amend or modify any material term of, or terminate (excluding any expiration in accordance with its terms), any License
set forth on Section 3.16 of the Company Disclosure Schedules;
(xxv) take any action (other than
actions explicitly permitted by this Agreement) that is reasonably likely to prevent, delay or impede the consummation of the Mergers or the other transactions contemplated by this Agreement; or
(xxvi) authorize any of, or commit or agree to take any of, the foregoing actions in respect of which it is restricted by the
provisions of this Section 5.1.
(c) In the event that either of the Companies is required to
change or amend its written compliance programs or procedures required under applicable law, such Company shall provide a copy of the updated compliance programs or procedures to the Parent Parties within five (5) Business Days of such revision
or amendment.
Section 5.2 Interim Operations of the Parent Parties. Each Parent Party
agrees that, during the period from the date of this Agreement to the earlier of (x) termination of this Agreement in accordance with Section 8.1, and (y) Closing, except as (i) otherwise contemplated by this
Agreement or any Ancillary Agreement, (ii) required by applicable Law (including COVID-19 Measures), (iii) described in Section 5.2 of the Parent Disclosure Schedules or
(iv) consented to by the Companies (which consent shall not be unreasonably withheld, conditioned or delayed by the Companies), that such Parent Party shall not take any of the following actions:
(a) make any change in or amendment to its Organizational Documents (other than in accordance with this Agreement);
(b) other than (i) seeking and negotiating Subscription Agreements or (ii) as set forth on
Section 5.2(b) of the Parent Disclosure Schedules (the Permitted Financing), issue or sell, or authorize to issue or sell, any membership interests, shares of its capital stock or any other ownership
interests, as applicable, or issue or sell, or authorize to issue or sell, any securities convertible into or exchangeable for, or options, warrants or rights to purchase or subscribe for, or enter into any Contract with respect to the issuance or
sale of, any shares of its membership interests, capital stock or any other ownership interests, as applicable;
(c) split,
combine, redeem or reclassify, or purchase or otherwise acquire, any membership interests, shares of its capital stock or any other ownership interests, as applicable (other than in accordance with the Offer or the Mergers at the Closing);
(d) authorize or pay any dividends or make any distribution with respect to its outstanding shares of capital stock or other
equity interests (whether in cash, assets, stock or other securities of such Parent Party) or otherwise make any payments to any stockholder of such Parent Party in their capacity as such (other than in accordance with the Offer at the Closing);
(e) sell, lease or otherwise dispose of any of its properties or assets that are material to its business;
(f) incur any Indebtedness (other than borrowings and draw-downs under Working Capital Loans in effect as of the date hereof)
or guarantee any Indebtedness of another Person, issue or sell any debt securities or warrants or other rights to acquire any debt securities of either Company or any of the Company Subsidiaries or guaranty any debt securities of another Person;
A-1-34
(g) (i) make, change or rescind any material Tax election, (ii) settle
or compromise any claim, notice, audit report or assessment in respect of any material Taxes, (iii) file any amended material Tax Return or claim for a material Tax refund, (iv) surrender any right to claim a refund of material Taxes,
(v) enter into any Tax allocation agreement, Tax sharing agreement, Tax indemnity agreement, or closing agreement related to any Tax (excluding any agreement entered into in the Ordinary Course and not primarily related to Taxes), (vi) fail to
pay any income or other material Tax that becomes due and owing, other than Taxes being contested in good faith through appropriate proceedings, and for which adequate reserves have been established in accordance with GAAP, (vii) request any
Tax ruling from a competent authority or, (viii) except in the Ordinary Course, consent to any extension or waiver of the statute of limitations period applicable to any material Tax claim or assessment;
(h) except as may be required by Law or GAAP, make any material change in the financial or Tax accounting methods, principles
or practices of such Parent Party (or change an annual accounting period);
(i) take any action (other than actions
explicitly permitted by this Agreement) that is reasonably likely to prevent, materially delay or impede the consummation of the Mergers or the other transactions contemplated by this Agreement;
(j) make any amendment or modification to the Trust Agreement;
(k) make or allow to be made any reduction in the Trust Amount, other than as expressly permitted by its Organizational
Documents;
(l) directly or indirectly acquire, whether by merger or consolidating with, or acquiring all or substantially
all of the assets of, any other Person;
(m) make any capital expenditures;
(n) enter into any new line of business;
(o) adopt or effect a plan of complete or partial liquidation, dissolution, restructuring, recapitalization or other
reorganization, other than the Mergers and the transactions contemplated hereunder; or
(p) authorize any of, or commit or
agree to take any of, the foregoing actions in respect of which it is restricted by the provisions of this Section 5.2.
Section 5.3 Trust Account. Upon satisfaction or waiver of the conditions set forth in Article VI
and provision of notice thereof to the Trustee (which notice Parent shall provide to the Trustee in accordance with the terms of the Trust Agreement), (a) in accordance with and pursuant to the Trust Agreement, at the Closing, Parent
(i) shall cause the documents, opinions and notices required to be delivered to the Trustee pursuant to the Trust Agreement to be so delivered, and (ii) shall use commercially reasonable efforts to cause the Trustee to (A) pay as and
when due all amounts payable to stockholders of Parent holding shares of the Parent Common Stock sold in Parents initial public offering who shall have previously validly elected to redeem their shares of Parent Common Stock pursuant to
Parents Organizational Documents, and (B) immediately thereafter, pay all remaining amounts then available in the Trust Account in accordance with this Agreement and the Trust Agreement, and (b) thereafter, the Trust Account shall
terminate, except as otherwise provided therein.
Section 5.4 Commercially Reasonable Efforts;
Consents.
(a) Each of the Parties shall, and shall cause their Affiliates to, cooperate, and use their respective
commercially reasonable efforts to take, or cause to be taken, all action, and to do, or cause to be done, all things necessary, proper or advisable under applicable Laws to consummate the Transactions as promptly as practicable after the date
hereof, including (i) obtaining all licenses, permits, clearances, consents, approvals, authorizations, qualifications and orders of Governmental Entities necessary to consummate the Transactions and (ii) seeking, negotiating and entering
into Subscription Agreements. Parent shall pay 100% of the applicable filing fees due under the HSR Act in connection with the Mergers. In addition to the
A-1-35
foregoing, the Companies agree to provide such assurances as to financial capability, resources and creditworthiness as may be reasonably requested by any third party whose consent or approval is
sought in connection with the Transactions; provided, however that any costs incurred in connection with such consents shall be Company Transaction Expenses.
(b) Without limiting the generality of the foregoing, each Party will, and will cause its Affiliates to, promptly after
execution of this Agreement (but in no event later than ten (10) Business Days after the date hereof) make all filings as are required under the HSR Act for the Transactions and such filings shall request early termination of any applicable
waiting period under the HSR Act; provided, that in the event that the U.S. Federal Trade Commission or Antitrust Division of the U.S. Department of Justice is not accepting such filings under the HSR Act because of a government shutdown, such
deadline shall be extended, if applicable, to the next Business Day following the date on which filings under the HSR Act are again accepted. Each Party will use its commercially reasonable efforts to (i) promptly furnish to the other such
necessary information and reasonable assistance as the other may request in connection with its preparation of any filing under the HSR Act for the Transactions and (ii) take (and cause its Affiliates to take) other actions necessary to cause
the expiration or termination of the applicable waiting periods under the HSR Act for the Transactions as soon as practicable. Each Party will promptly provide the other with copies of all written communications (and summaries of the substance of
all oral communications) between each of them, any of their Affiliates or any of its or their Representatives, on the one hand, and any Governmental Entity, on the other hand, with respect to this Agreement or the Transactions. Without limiting the
generality of the foregoing, and subject to applicable Law, each of the Group Companies and Parent Parties will, and will cause their Affiliates to: (A) promptly notify the other Parties of any written communication made to or received by them,
as the case may be, from any Governmental Entity regarding the Transactions; (B) permit each other to review in advance any proposed written communication to any such Governmental Entity regarding the Transactions and incorporate reasonable
comments thereto; (C) not agree to participate in any substantive meeting or discussion with any such Governmental Entity in respect of any filing, investigation or inquiry concerning this Agreement or the Transactions unless, to the extent
reasonably practicable, it consults with the other Party in advance and, to the extent permitted by such Governmental Entity, gives the other Party the opportunity to attend; (D) not agree to extend any waiting period under the HSR Act or enter
into any agreement with any Governmental Entity not to consummate the Transactions, except with the prior written consent of the other Parties (such consent not to be unreasonably withheld, conditioned or delayed); and (E) furnish each other
with copies of all correspondence, filings (except for filings made under the HSR Act) and written communications between such Party and their Affiliates and their respective agents, on one hand, and any such Governmental Entity, on the other hand,
in each case, with respect to this Agreement and the Transactions. Notwithstanding anything to the contrary contained in this Agreement, nothing in this Section 5.4 or otherwise in this Agreement shall require any Party or any of its
Affiliates to offer, propose, negotiate, agree to, consent to or effect (A) the sale, divestiture, transfer, license or other disposal of, or hold separate with respect to, any entities, assets, businesses or interests of any Party or its
Affiliates, (B) the creation, termination, amendment or assignment of commercial relationships, agreements, licenses or contractual rights or obligations, (C) conduct of business restrictions, including restrictions on any Partys or
its Affiliates ability to manage, operate or own any entities, assets, businesses or interests, (D) any other change or restructuring of any entities, assets, businesses or interests, or of any Party or its Affiliates or (E) any
other remedy, condition, undertaking or commitment of any kind. No Party shall, or shall permit its Affiliates to, take any of the actions described in the foregoing sentence without each other Partys prior written consent. No Party or any of
its Affiliates shall be required to contest, resist, defend against or appeal any Action, whether judicial or administrative, challenging or seeking to prevent, prohibit, delay or declare unlawful this Agreement or any of the Transactions.
(c) No Party shall take any action that would reasonably be expected to materially adversely affect or materially delay the
clearance, consent, approval or authorization of any Governmental Entity of the Transactions.
A-1-36
Section 5.5 Public Announcements. None of the Parties
shall, and each Party shall cause its Affiliates not to, make or issue any public announcement or press release to the general public with respect to this Agreement or the transactions contemplated by this Agreement without the prior written consent
of the other Parties, which consent shall not be unreasonably withheld, conditioned or delayed; provided, that no such consent or prior notice shall be required in connection with any public announcement or press release the content of which is
consistent with that of any prior or contemporaneous public announcement or press release by any Party in compliance with this Section 5.5. Nothing in this Section 5.5 shall limit any Party from
making any announcements, statements or acknowledgments that such Party is required by applicable Law or the requirements of any national securities exchange to make, issue or release; provided, that, to the extent practicable, the Party making such
announcement, statement or acknowledgment shall provide such announcement, statement or acknowledgment to the other Parties prior to release and consider in good faith any comments from such other Parties.
Section 5.6 Access to Information; Confidentiality.
(a) From the date hereof until the earlier of the termination of this Agreement in accordance with its terms and Closing, upon
reasonable advance notice, each of the Companies shall, and shall cause each of its Subsidiaries to, provide to Parent Parties and their representatives during normal business hours reasonable access to all employee, facilities, books and records of
the Group Companies reasonably requested by Parent; provided that (a) such access shall be at the risk of Parent Parties and their representatives, (b) such access shall occur in such a manner as each Company reasonably determines to be
appropriate to protect the confidentiality of the transactions contemplated by this Agreement and (c) nothing herein shall require the Companies to provide access to, or to disclose any information to, the Parent Parties or any of their
representatives if such access or disclosure, in the good faith reasonable belief of each Company, (i) would cause significant competitive harm to any Group Company if the transactions contemplated by this Agreement are not consummated,
(ii) would waive any legal privilege or (iii) would be in violation of applicable laws or regulations of any Governmental Entity (including the HSR Act and any other applicable Laws). For the avoidance of doubt, neither Company shall be
obligated under this Section 5.6(a) to permit the Parent Parties or any of their representatives to conduct any invasive, intrusive or subsurface sampling or testing of any media at either Companys properties or
facilities. All of such information provided to the Parent Parties shall be treated as confidential information pursuant to the terms of the Transaction Confidentiality Agreement, the provisions and restrictions of which are by this reference hereby
incorporated herein.
(b) From the date hereof until the earlier of the termination of this Agreement in accordance with
its terms and Closing, upon reasonable advance notice, Parent shall provide to the Companies and their representatives during normal business hours reasonable access to all employee, facilities, books and records of Parent reasonably requested by
the Companies; provided that (a) such access shall be at the risk of the Companies and their representatives, (b) such access shall occur in such a manner as Parent reasonably determines to be appropriate to protect the
confidentiality of the transactions contemplated by this Agreement and (c) nothing herein shall require Parent to provide access to, or to disclose any information to, the Companies or any of their representatives if such access or disclosure,
in the good faith reasonable belief of Parent, (i) would cause significant competitive harm to Parent if the transactions contemplated by this Agreement are not consummated, (ii) would waive any legal privilege or (iii) would be in
violation of applicable laws or regulations of any Governmental Entity (including the HSR Act and any other applicable Laws). For the avoidance of doubt, Parent shall not be obligated under this Section 5.6(b) to permit the
Companies or any of their representatives to conduct any invasive, intrusive or subsurface sampling or testing of any media at Parents properties or facilities. All of such information provided to the Companies shall be treated as confidential
information pursuant to the terms of the Transaction Confidentiality Agreement, the provisions and restrictions of which are by this reference hereby incorporated herein.
A-1-37
Section 5.7 Tax Matters.
(a) Certain Taxes. All transfer, documentary, sales, use, value added, excise, stock transfer, stamp, recording,
registration and any similar Taxes and fees (including any penalties and interest) incurred in connection with the Mergers (Transfer Taxes) shall be borne by the Surviving Companies. For the avoidance of doubt Transfer Taxes shall
not include any federal, state, local or foreign Taxes measured by or based upon income or gains. The Parties shall cooperate in filing all necessary Tax Returns and other documentation with respect to all such Transfer Taxes.
(b) Tax Returns, Audits and Cooperation. Parent and the Companies shall cooperate fully, as and to the extent reasonably
requested by the other Party, in connection with the filing of Tax Returns of the Group Companies and any audit, litigation or other proceeding with respect to Taxes of the Group Companies. Such cooperation shall include the retention and (upon the
other Partys reasonable request) the provision of records and information which are reasonably relevant to any such audit and making employees available on a mutually convenient basis to provide additional information and explanation of any
material provided hereunder.
(c) FIRPTA Certificate. At or prior to the Closing, each Company shall deliver or
cause to be delivered to Parent (i) a certificate of each Company certifying that each Company is not, and has not been, a United States real property holding corporation, within the meaning of Section 897 of the Code, during
the applicable period specified in Section 897(c)(1)(A)(ii) of the Code and (ii) a form of notice to the IRS prepared in accordance with the requirements of Treasury Regulation Section 1.897-2(h)(2) (together, the FIRPTA
Certificate).
(d) Tax Treatment. Each of the Parties intends that each Merger shall qualify as a
reorganization within the meaning of Section 368(a) of the Code, and that this Agreement be, and hereby is, adopted as a plan of reorganization for the purposes of Sections 354, 361 and 368 of the Code and Treasury
Regulations Section 1.368-2(g). The Parties agree to report for all Tax purposes in a manner consistent with, and not otherwise take any U.S. federal income Tax position inconsistent with, this Section 5.7(d) unless
otherwise required by a change in applicable Law, or as required pursuant to a determination within the meaning of Section 1313 of the Code. Except as required by applicable Law, the Parties shall not take any action, or fail to
take any action, that could reasonably be expected to prevent the Mergers from qualifying as a reorganization within the meaning of Section 368(a) of the Code.
(e) Tax Opinions. Each of Parent and the Companies shall cooperate and use their respective commercially
reasonable efforts to obtain at their sole expense any Tax opinions required by the SEC to be filed with the SEC in connection with the Proxy Statement, including by delivering customary representation letters to applicable counsel.
Section 5.8 Directors and Officers Indemnification.
(a) Parent agrees to cause each Surviving Company to ensure, and each Surviving Company immediately following the Closing
agrees to ensure, that all rights to indemnification now existing in favor of any individual who, at or prior to the Effective Time, was a director, officer or manager of any Group Company (collectively, with such individuals heirs, executors
or administrators, the Indemnified Persons) solely to the extent as provided in the respective governing documents and indemnification agreements to which the Group Company is a party or bound, shall survive the Mergers and
shall continue in full force and effect for a period of not less than six (6) years from the Effective Time and indemnification agreements and the provisions with respect to indemnification and limitations on liability set forth in such
governing documents shall not be amended, repealed or otherwise modified in any manner that would adversely affect the rights of the Indemnified Persons thereunder; provided, that in the event any claim or claims are asserted or made within such six
(6) year period, all rights to indemnification in respect of any such claim or claims shall continue until final disposition of any and all such claims. Neither Parent nor the Surviving Companies shall settle, compromise or consent to the entry
of judgment in any action, proceeding or investigation or threatened action, proceeding or investigation without the written consent of such Indemnified Person.
A-1-38
(b) Within thirty (30) days of the Closing Date, the Surviving
Companies shall pay any additional premium necessary to obtain six (6) years of runoff tail coverage on Parents current policy of directors and officers liability insurance, which shall be effective for a period
from the Closing through and including the date six (6) years after the Closing Date with respect to claims arising from facts or events that occurred on or before the Closing. The amount paid by the Surviving Companies under this
Section 5.8(b) is referred to as the Tail Premium.
(c) From and after the
Effective Time, the Parent Parties agree to cause the Surviving Companies, and each Surviving Company immediately following the Closing agrees, to indemnify, defend and hold harmless, as set forth as of the date hereof in the Organizational
Documents of each Company and to the fullest extent permitted under applicable Law, all Indemnified Persons with respect to all acts and omissions arising out of such individuals services as officers or directors of any Group Company occurring
prior to the Effective Time, including the execution of, and the transactions contemplated by, this Agreement. Without limitation of the foregoing, in the event any such Indemnified Person is or becomes involved, in any capacity, in any action,
proceeding or investigation in connection with any matter, including the transactions contemplated by this Agreement, occurring prior to, on or after the Effective Time, each Surviving Company, from and after the Effective Time, shall pay, as
incurred, such Indemnified Persons legal and other expenses (including the cost of any investigation and preparation) incurred in connection therewith. The Surviving Companies shall pay, within thirty (30) days after any request for
advancement, all expenses, including attorneys fees, which may be incurred by any Indemnified Person in enforcing this Section 5.8 or any action involving an Indemnified Person resulting from the transactions
contemplated by this Agreement subject to an undertaking by such Indemnified Person to return such advancement if such Indemnified Person is ultimately determined to not be entitled to indemnification hereunder.
(d) Notwithstanding any other provisions hereof, the obligations of the Parent Parties and the Surviving Companies contained in
this Section 5.8 shall be binding upon the successors and assigns of the Parent Parties and the Surviving Companies. In the event any of the Parent Parties or the Surviving Companies, or any of their respective successors
or assigns, (i) consolidates with or merges into any other Person, or (ii) transfers all or substantially all of its properties or assets to any Person, then, and in each case, proper provision shall be made, as a condition to entering
into any such transaction, so that the successors and assigns of any Parent Party or the Surviving Companies, as the case may be, are required to honor the indemnification and other obligations set forth in this
Section 5.8.
(e) The obligations of the Parent Parties and the Surviving Companies under this
Section 5.8 shall survive the Closing and shall not be terminated or modified in such a manner as to affect adversely any Indemnified Person to whom this Section 5.8 applies without the written
consent of such affected Indemnified Person (it being expressly agreed that the Indemnified Persons to whom this Section 5.8 applies shall be third party beneficiaries of this Section 5.8, each of
whom may enforce the provisions of this Section 5.8).
(f) Nothing in this Agreement is intended
to, shall be construed to or shall release, waive or impair any rights to directors and officers insurance claims under any policy that is or has been in existence with respect to the Group Companies or any of their respective directors
or officers, it being understood and agreed that the indemnification provided for in this Section 5.8 is not prior to or in substitution for any such claims under such policies.
Section 5.9 Proxy Statement.
(a) As promptly as practicable following the execution and delivery of this Agreement and the availability of the PCAOB
Financial Statements, Parent shall, in accordance with this Section 5.9, prepare and file with the SEC a proxy statement (as amended or supplemented from time to time, the Proxy Statement) for the purpose
of soliciting proxies from the Parent Stockholders for the Transaction Proposals. Each of Parent and the Companies shall use its reasonable best efforts to cause the Proxy Statement to comply with the rules and regulations promulgated by the SEC.
Parent shall pay all of the fees in connection with the preparation, filing and mailing of the Proxy Statement. Each of Parent and the
A-1-39
Companies shall furnish all information concerning it as may reasonably be requested by the other Party in connection with such actions and the preparation of the Proxy Statement.
(b) Without limitation, in the Proxy Statement, Parent shall (i) solicit proxies from holders of Parent Common Stock and
Parent Class B Stock to vote at the Parent Common Stockholders Meeting in favor of (A) the adoption of this Agreement and the approval of the transactions contemplated hereby pursuant to Section 251 of the DGCL, (B) the issuance
of Parent Common Stock issuable pursuant to this Agreement at the Effective Time, (C) the adoption of an Omnibus Incentive Plan to be negotiated between the Parties prior to Closing (the Omnibus Incentive Plan), (D) approval
of the A&R Charter and each change to the A&R Charter that is required to be separately approved, and (E) any other proposals the Parties deem necessary or desirable to consummate the transactions contemplated hereby (collectively, the
Transaction Proposals), and (ii) file with the SEC financial and other information about the transactions contemplated hereby in accordance with the Exchange Act. The Proxy Statement will comply as to form and substance with
the applicable requirements of the Exchange Act and the rules and regulations thereunder. Each Company shall furnish all information concerning it and its Affiliates to Parent, and provide such other assistance, as may be reasonably requested in
connection with the preparation, filing and distribution of the Proxy Statement, and the Proxy Statement shall include all information reasonably requested by the Companies to be included therein. Without limiting the generality of the foregoing,
the Companies shall reasonably cooperate with Parent in connection with Parents preparation for inclusion in the Proxy Statement of pro forma financial statements that comply with the requirements of Regulation
S-X under the rules and regulations of the SEC (as interpreted by the staff of the SEC) to the extent such pro forma financial statements are required by the Proxy Statement. Each of the Companies and Parent
shall promptly notify the other upon the receipt of any comments from the SEC or any request from the SEC for amendments or supplements to the Proxy Statement and shall provide the other with copies of all correspondence between it and its
Representatives, on the one hand, and the SEC, on the other hand. Each of the Companies and Parent shall use its reasonable best efforts to respond as promptly as reasonably practicable to any comments from the SEC with respect to the Proxy
Statement.
(c) Prior to filing with the SEC, Parent will make available to the Companies drafts of the Proxy Statement,
and any material amendment or supplement to the Proxy Statement and will provide the Companies with a reasonable opportunity to comment on such drafts, shall consider such comments in good faith and shall accept all reasonable additions, deletions
or changes suggested by the Companies in connection therewith. Parent shall provide written notice (email permitted) to the Companies upon filing any such documents with the SEC (including response to any comments from the SEC with respect thereto).
Parent will advise the Companies promptly after receipt of notice thereof, of (i) the time when the Proxy Statement has been filed, (ii) receipt of oral or written notification of the completion of the review of the Proxy Statement by the
SEC, (iii) the filing of any supplement or amendment to the Proxy Statement, (iv) any request by the SEC for amendment of the Proxy Statement, (v) any comments from the SEC relating to the Proxy Statement and responses thereto, or
(vi) requests by the SEC for additional information. Parent shall promptly respond to any SEC comments on the Proxy Statement and shall use its reasonable best efforts to have the Proxy Statement cleared by the SEC under the Exchange Act as
soon after filing as practicable; provided, that prior to responding to any material requests or comments from the SEC, Parent will make available to the Companies drafts of any such response and provide the Companies with a reasonable
opportunity to comment on such drafts.
(d) If at any time prior to the Parent Common Stockholder Meeting there shall be
discovered any information that should be set forth in an amendment or supplement to the Proxy Statement so that the Proxy Statement would not include any misstatement of a material fact or omit to state any material fact necessary to make the
statements therein, in light of the circumstances under which they were made, not misleading, Parent shall, at its sole expense, promptly transmit to its stockholders an amendment or supplement to the Proxy Statement containing such information. If,
at any time prior to the Effective Time, either Company discovers any information, event or circumstance relating to the Group Companies or any of their respective Affiliates, officers, directors or employees that should be set forth in an amendment
or a
A-1-40
supplement to the Proxy Statement so that the Proxy Statement would not include any misstatement of a material fact or omit to state any material fact necessary to make the statements therein, in
light of the circumstances under which they were made, not misleading, then such Company shall promptly inform Parent of such information, event or circumstance.
(e) Parent shall timely make all necessary filings with respect to the transactions contemplated hereby under the Securities
Act, the Exchange Act and applicable blue sky laws and any rules and regulations thereunder.
(f) Each Company
shall use its commercially reasonable efforts to promptly provide Parent with all information concerning the Group Companies reasonably requested by Parent for inclusion in the Proxy Statement and any amendment or supplement to the Proxy Statement
(if any). Each Company shall cause the officers and employees of the Group Companies to be reasonably available to Parent and its counsel in connection with the drafting of the Proxy Statement and responding in a timely manner to comments on the
Proxy Statement from the SEC.
(g) Parent shall not terminate or withdraw the Offer other than in connection with the valid
termination of this Agreement in accordance with Article VIII. Parent shall extend the Offer for any period required by any rule, regulation, interpretation or position of the SEC, NASDAQ or the respective staff thereof that is applicable to
the Offer. Nothing in this Section 5.9(g) shall (i) impose any obligation on Parent to extend the Offer beyond the Outside Date, or (ii) be deemed to impair, limit or otherwise restrict in any manner the right of
Parent to terminate this Agreement in accordance with Article VIII.
(h) Parent shall use its reasonable best
efforts to (i) cause the shares of Parent Common Stock to be issued to the Company Members as provided in Article II to be approved for listing on NASDAQ upon issuance, and (ii) make all necessary and appropriate filings with NASDAQ
and undertake all other steps reasonably required prior to the Closing Date to effect such listing.
Section 5.10 Parent Common Stockholder Meeting.
(a) Parent shall, as promptly as practicable, establish a record date (which date shall be mutually agreed with the Companies)
and, as soon as practicable following the Proxy Statement being cleared by the SEC, duly call, give notice of, convene and hold a meeting of Parents stockholders (the Parent Common Stockholders Meeting); provided
that Parent may postpone or adjourn the Parent Common Stockholders Meeting on one or more occasions (i) to solicit additional proxies for the purpose of obtaining the Parent Stockholder Approval, (ii) for the absence of a quorum and
(iii) to allow reasonable additional time for the filing or mailing of any supplemental or amended disclosure that Parent has determined in good faith after consultation with outside legal counsel is required under applicable Law and for such
supplemental or amended disclosure to be disseminated and reviewed by Parent Stockholders prior to the Parent Common Stockholders Meeting; provided, that, without the consent of each Company, the Parent Common Stockholders Meeting (x) may not
be adjourned to a date that is more than 15 days after the date for which the Parent Common Stockholders Meeting was originally scheduled (excluding any adjournments required by applicable Law) and (y) shall not be held later than three
(3) Business Days prior to the Outside Date.
(b) Parent shall, through its board of directors, recommend to its
stockholders that they vote in favor of the Transaction Proposals (the Parent Board Recommendation) and Parent shall include the Parent Board Recommendation in the Proxy Statement. Except as required by applicable Law (including
Delaware law relating to fiduciary duties, upon the receipt of advice of outside counsel), the board of directors of Parent shall not (and no committee or subgroup thereof shall) change, withdraw, withhold, qualify or modify, or publicly propose to
change, withdraw, withhold, qualify or modify, the Parent Board Recommendation (a Change in Recommendation). Parent shall promptly, but in any event no later than within one (1) Business Day, notify the Companies in writing
of any final determination to make a Change in Recommendation.
Section 5.11 Requisite Company
Approvals. Upon the terms set forth in this Agreement and the Ancillary Agreements, each Company shall obtain promptly after the execution of this Agreement, and in any event
A-1-41
no later than the Requisite Company Approvals Deadline, the Requisite Company Approvals. The Requisite Company Approvals shall be irrevocable with respect to all LMA Interests and Abacus
Interests owned beneficially or of record by each of the LMA Members and Abacus Members, respectively, or as to which such LMA Members or Abacus Members, as the case may be, have, directly or indirectly, the right to vote or direct the voting
thereof.
Section 5.12 Section 16 of the Exchange Act. Prior to the Closing, the board of directors
of Parent, or an appropriate committee of non-employee directors thereof, shall adopt a resolution consistent with the interpretive guidance of the SEC so that the acquisition of Parent Common Stock pursuant
to this Agreement by any officer or director of the Group Companies who is expected to become a covered person of Parent for purposes of Section 16 of the Exchange Act and the rules and regulations thereunder
(Section 16) shall be an exempt transaction for purposes of Section
16.
Section 5.13 Nonsolicitation.
(a) From the date of this Agreement until the earlier of (i) the Effective Time or (ii) the date on which this
Agreement is terminated in accordance with Article VIII, other than in connection with the transactions contemplated hereby, each Parent Party agrees that it will not, and will not authorize or (to the extent within its control) permit any of
its Subsidiaries or any of its or its Subsidiaries directors, officers, employees, agents or representatives (including investment bankers, attorneys and accountants), in each case in such directors, officers, employees,
agents or representatives capacity in such role with the applicable Parent Party, to, directly or indirectly, (i) knowingly encourage, initiate, solicit or facilitate, offer or make any offers or proposals related to a Business
Combination, (ii) enter into, engage in or continue any discussions or negotiations with respect to any Business Combination with, or provide any non-public information, data or access to employees to,
any Person that has made, or that is considering making, a proposal with respect to a Business Combination, or (iii) enter into any agreement (whether or not binding) relating to a Business Combination. Each Parent Party shall promptly notify
the Companies of any submissions, proposals or offers made with respect to a Business Combination as soon as practicable, but in any event no later than two (2) Business Days, following such Parent Partys awareness thereof.
(b) From the date of this Agreement until the earlier of (i) the Effective Time or (ii) the date on which this
Agreement is terminated in accordance with Article 8, each Company agrees that it will not, and will not authorize or (to the extent within its control) permit any of its Affiliates, directors, officers, employees, agents or representatives
(including investment bankers, attorneys and accountants) to, directly or indirectly, (A) knowingly encourage, initiate, solicit, or facilitate any inquiries regarding or the making of offers or proposals that constitute an Acquisition Proposal
(except as otherwise required by Law), (B) engage in any discussions or negotiations with respect to an Acquisition Proposal with, or provide any non-public information or data to, any Person that has made, or
informs the Companies that it is considering making, an Acquisition Proposal, or (C) enter into any agreement (whether or not binding) relating to an Acquisition Proposal. The Company shall give notice of any Acquisition Proposal to Parent as
soon as practicable, but in any event no later than two (2) Business Days, following its awareness thereof. For purposes of this Agreement, Acquisition Proposal means any contract, proposal, offer or indication of interest in
any form, written or oral, relating to any transaction or series of related transactions (other than transactions with the Parent Parties) involving any acquisition, merger, amalgamation, share exchange, recapitalization, consolidation, liquidation
or dissolution involving acquisition of all or any material portion of either Company or either of their businesses or assets or any material portion of either Companys capital stock or other ownership interests.
Section 5.14 Termination of Agreements. Each Company shall take all actions necessary to terminate each
agreement between each Company, on the one hand, and any officer or director of either Company or any entity controlled by any such officer or director, on the other hand, at or prior to the Effective Time, in a manner such that no Group Company has
any liability or obligation following the Effective Time pursuant to such agreements.
A-1-42
Section 5.15 Elections and Other Matters. From and
after the Closing Date, each Parent Party shall not, and shall cause the Group Companies not to, make, cause or permit to be made any Tax election or adopt or change any method of accounting, in each case that has retroactive effect to any Pre-Closing Tax Period of the Company or any Company Subsidiary.
Section 5.16 PCAOB Financial Statements. Each Company agrees to use commercially reasonable efforts to
provide Parent, as promptly as practicable, audited financial statements (audited to the standards of the U.S. Public Company Accounting Oversight Board), including consolidated balance sheets, statements of operations, statements of cash flows, and
statements of stockholders equity of each Company as of and for the years ended December 31, 2021 and 2020, in each case, prepared in accordance with GAAP (and not materially different than GAAP) (the PCAOB Financial
Statements).
Section 5.17 Omnibus Incentive Plan. Prior to the Closing Date, Parent
shall adopt, and submit for stockholder approval at the Parent Common Stockholders Meeting the Omnibus Incentive Plan.
Section 5.18 A&R Registration Rights Agreement. At the Closing, Parent, each Company and each of the Company Members shall enter into an amended and restated registration rights agreement substantially in the form attached hereto
as Exhibit F (the A&R Registration Rights Agreement).
Section 5.19 Governing Documents. In connection with the consummation of the Transactions, Parent shall
adopt the A&R Bylaws and the A&R Charter.
Section 5.20 Conversion to Delaware LLC. At
least five (5) Business Days prior to the Closing Date, each Company shall convert from a Florida limited liability company to a Delaware limited liability company (the Redomestication) in a transaction that is intended to be
treated as a reorganization under Section 368(a)(1)(F) of the Code. Each Company shall provide Parent reasonable time to review all documents necessary to effectuate the Redomestication, and all such documents used in the Redomestication shall
be in a form reasonably acceptable to Parent.
Section 5.21 Warrant Pool. At the Closing,
(a) ERES Sponsor shall forfeit one million and seven-hundred and eighty thousand (1,780,000) Parent private warrants and (b) Parent shall issue an equal number of new warrants, with terms substantially similar to the forfeited Parent
private warrants that are exercisable for Parent Common Stock, to an entity designated by the Companies in writing to be allocated among the Company Members and existing and future employees of the Companies.
Section 5.22 Certain Notices from Parent to Companies. Parent agrees that, during the period from the date of this Agreement to
the earlier of (x) termination of this Agreement in accordance with Article VIII, and (y) Closing, Parent shall provide to the Companies notice of (a) each claim, suit, action or proceeding brought or threatened against any of the
Parent Parties or ERES Sponsor related to this Agreement, any of the Ancillary Agreements, any of the transactions contemplated by this Agreement, the Offer or the Parent Common Stockholders Meeting within two (2) Business Days of first
becoming aware thereof and shall provide a true and complete copy of any related complaint as soon as reasonably available and (b) any proxy contest related to the Parent Common Stockholders Meeting.
ARTICLE VI
CONDITIONS TO OBLIGATIONS OF THE PARTIES
Section 6.1 Conditions to Each Partys Obligations. The respective obligation of
each Party to consummate the transactions contemplated by this Agreement is subject to the satisfaction (or written waiver by such Party) at or prior to the Closing of the following conditions:
(a) No Injunction. There will be no effective Order of any nature prohibiting or preventing the consummation of the
Transactions and no Law shall have been adopted, enacted or promulgated that makes consummation of the Transactions illegal or otherwise prohibited;
A-1-43
(b) HSR Act. All waiting periods (and any extensions thereof)
applicable to the Transactions under the HSR Act, and any commitments or agreements (including timing agreements) with any Governmental Entity not to consummate the Transactions before a certain date, shall have expired or been terminated;
(c) Completion of Offer. The Offer shall have been completed in accordance with the terms hereof and the Proxy
Statement;
(d) Requisite Company Approvals. The Requisite Company Approvals shall have been obtained;
(e) Parent Stockholder Approval. The Parent Stockholder Approval shall have been obtained;
(f) Regulatory Approvals. (i) The Parent shall have received the approval of the Florida Office of Insurance
Regulation with respect to the change of control of Abacus contemplated by the transactions under this Agreement without any Burdensome Condition and (ii) Abacus shall have been relicensed as a life settlement provider by the California
Department of Insurance as a result of the change of control of Abacus contemplated by the transactions under this Agreement, or the California Department of Insurance shall have otherwise approved the change of control of Abacus contemplated by the
transactions under this Agreement, in either case without any Burdensome Condition.
(g) Net Tangible Assets. After
giving effect to the Transactions, Parent shall have at least $5,000,001 of net tangible assets (as determined in accordance with Rule 3a51-1(g)(1) of the Exchange Act) immediately after the Effective Time;
and
(h) NASDAQ. The Parent Common Stock to be issued in the Mergers shall have been approved for listing on NASDAQ,
subject only to official notice of issuance thereof.
Section 6.2 Conditions to Obligations of the
Companies. The obligations of the Companies to consummate the transactions contemplated by this Agreement are further subject to the satisfaction (or written waiver by the Companies) at or prior to the Closing of the following conditions:
(a) Representations and Warranties. (i) The representations and warranties of the Parent Parties contained in
Article IV (other than the Parent Fundamental Representations) shall be true and correct as of the Closing Date as if made at and as of such date (except for representations and warranties that speak as of a specific date
prior to the Closing Date, in which case such representations and warranties need only be true and correct as of such earlier date); provided, that this condition shall be deemed satisfied unless any and all inaccuracies in such representations and
warranties, in the aggregate, would result in a Material Adverse Effect (ignoring for the purposes of this Section 6.2(a)(i) any qualifications by materiality contained in such representations or
warranties) and (ii) the Parent Fundamental Representations shall be true and correct in all material respects as of the Closing Date as if made at and as of such date (except for representations and warranties that speak as of a specific date
prior to the Closing Date, in which case such Parent Fundamental Representations need only be true and correct in all material respects as of such earlier date);
(b) Performance of Obligations. Each of the Parent Parties shall have performed in all material respects its obligations
under this Agreement required to be performed by it at or prior to the Closing pursuant to the terms hereof;
(c) Parent
Parties Officers Certificate. An authorized officer of the Parent Parties shall have executed and delivered to the Companies a certificate (the Parent Closing Certificate) as to compliance with the
conditions set forth in Section 6.2(a) and Section 6.2(b) hereof;
(d)
Transaction Proceeds. The Aggregate Transaction Proceeds, plus the Sponsor PIK Note Amount, if any, shall be equal to or greater than $1,000,000, and evidence thereof shall have been delivered to the Companies; and
(e) D&O Resignations. The directors and executive officers of Parent listed in
Section 6.2(e) of the Parent Disclosure Schedules shall have been removed from their respective positions or tendered their irrevocable resignations, in each case effective as of the Effective Time.
A-1-44
Section 6.3 Conditions to Obligations of the
Parent Parties. The obligations of the Parent Parties to consummate the transactions contemplated by this Agreement are further subject to the satisfaction (or written waiver by the Parent Parties) at or prior to the Closing of the following
conditions:
(a) Representations and Warranties. (i) The representations and warranties of the Companies
contained in Article III (other than the Companies Fundamental Representations) shall be true and correct as of the date of this Agreement and as of Closing Date as if made at and as of such date (except for representations and warranties
that speak as of a specific date prior to the Closing Date, in which case such representations and warranties need only be true and correct as of such earlier date); provided, that this condition shall be deemed satisfied unless any and all
inaccuracies in such representations and warranties, in the aggregate, would result in a Material Adverse Effect (ignoring for the purposes of this Section 6.3(a) any qualifications by Material Adverse Effect
or materiality contained in such representations or warranties) and (ii) the Companies Fundamental Representations shall be true and correct in all material respects as of the Closing Date as if made at and as of such date
(except for representations and warranties that speak as of a specific date prior to the Closing Date, in which case such Companies Fundamental Representations need only be true and correct in all material respects as of such earlier date);
(b) Performance of Obligations. Each of the Companies shall have performed in all material respects its obligations
under this Agreement required to be performed by it at or prior to the Closing pursuant to the terms hereof;
(c)
Company Closing Certificate. An authorized officer of each Company shall have executed and delivered to the Parent Parties a certificate (the Company Closing Certificate) as to each of the Companies compliance
with the conditions set forth in Section 6.3(a) and Section 6.3(b);
(d) Member Approvals. The Parent Parties shall have received a copy of the LMA Member Approval and Abacus Member
Approval, each of which shall remain in full force and effect;
(e) Redomestication. The Redomestication shall have
occurred; and
(f) No Material Adverse Effect. Since the date of this Agreement, there shall not have occurred a
Material Adverse Effect.
Section 6.4 Frustration of Closing Conditions. Neither the Companies nor
the Parent Parties may rely on the failure of any condition set forth in Section 6.1, Section 6.2 or Section 6.3, as the case may be, if such failure was caused by such
Partys failure to comply with any provision of this Agreement.
ARTICLE VII
CLOSING
Section 7.1 Closing. Subject to the terms and conditions of this Agreement, the closing of the transactions contemplated by this Agreement (the Closing) shall occur as promptly as possible, and in any event no
later than three (3) Business Days following the satisfaction or waiver of the conditions to the obligations of the Parties set forth in Article VI (other than those conditions that by their nature are to be fulfilled at Closing, but
subject to the satisfaction or waiver of such conditions) or on such other date as the Parties may agree in writing. The date of the Closing shall be referred to herein as the Closing Date. The Closing shall occur at the
offices of Latham & Watkins LLP located at 811 Main Street, Suite 3700, Houston, TX 77002, at 9:00 a.m. (Central Time) or at such other place or at such other time as the Parties may agree in writing.
Section 7.2 Deliveries by the Companies. At the Closing, the Companies will deliver or cause to be
delivered to Parent (unless delivered previously) the following:
(a) the Certificates of Merger, executed by LMA and
Abacus, as applicable;
(b) the Company Closing Certificate;
A-1-45
(c) the A&R Registration Rights Agreement executed by each Company and
each of the Company Members; and
(d) any other document required to be delivered by the Companies at Closing pursuant to
this Agreement.
Section 7.3 Deliveries by Parent. At the Closing, Parent will deliver or cause to
be delivered to the Companies the following:
(a) the Parent Closing Certificate;
(b) the A&R Registration Rights Agreement executed by Parent; and
(c) any other document required to be delivered by the Parent Parties at Closing pursuant to this Agreement.
ARTICLE VIII
TERMINATION
Section 8.1 Termination. This Agreement may be terminated at any time at or prior to the Closing:
(a) in
writing, by mutual consent of Parent and each of the Companies;
(b) by Parent or the Companies if any Law or Order
permanently restraining, enjoining or otherwise prohibiting consummation of the Mergers shall have been enacted, issued, promulgated, enforced or entered and shall have become final and non-appealable;
provided, that the right to terminate this Agreement pursuant to this Section 8.1(b) shall not be available to any Party that has breached in any material respect its obligations set forth in this Agreement in any manner
that shall have proximately contributed to the enactment, issuance, promulgation, enforcement or entry of such Law or Order; provided, further, that the Governmental Entity issuing such Order has jurisdiction over the parties hereto with respect to
the transactions contemplated hereby;
(c) by the Companies, if any of the representations or warranties set forth in
Article IV shall not be true and correct or if Parent has failed to perform any covenant or agreement on the part of Parent set forth in this Agreement (including an obligation to consummate the Closing) such that the condition to Closing set
forth in either Section 6.2(a) or Section 6.2(b) could not be satisfied and the breach or breaches causing such representations or warranties not to be true and correct, or the failures to perform
any covenant or agreement, as applicable, is (or are) not cured or cannot be cured within the earlier of (i) thirty (30) days after written notice thereof is delivered to Parent by each Company and (ii) the Outside Date; provided, however,
both Companies are not then in breach of this Agreement so as to prevent the condition to Closing set forth in Section 6.3(a) or Section 6.3(b) from being satisfied;
(d) by Parent, if any of the representations or warranties set forth in Article III shall not be true and
correct or if the Companies have failed to perform any covenant or agreement on the part of the Companies set forth in this Agreement (including an obligation to consummate the Closing) such that the condition to Closing set forth in
either Section 6.3(a) or Section 6.3(b) could not be satisfied and the breach or breaches causing such representations or warranties not to be true and correct, or the failures to perform any covenant or agreement,
as applicable, is (or are) not cured or cannot be cured within the earlier of (i) thirty (30) days after written notice thereof is delivered to the Companies by Parent, and (ii) the Outside Date; provided, however, that Parent is
not then in breach of this Agreement so as to prevent the condition to Closing set forth in either Section 6.2(a) or Section 6.2(b) from being satisfied;
(e) by written notice by any Party if the Closing has not occurred on or prior to January 27, 2023
(the Outside Date); provided, that if the conditions to Closing set forth in Section 6.1(a), Section 6.1(b) or Section 6.1(f), with respect to the
HSR Act or any regulatory approval, have not been satisfied or waived on or prior to the Outside Date but all other conditions to Closing set forth in Article VI have been satisfied or
A-1-46
waived (except for those conditions that by their nature are to be satisfied at the Closing), the Outside Date shall automatically be extended to April 27, 2023 and, such date, as so
extended, shall be the Outside Date for all purposes under this Agreement; provided, further, that the right to terminate this Agreement pursuant to this Section 8.1(e) shall not be available to any Party that
has breached in any material respect its obligations set forth in this Agreement in any manner that shall have proximately contributed to the occurrence of the failure of a condition to the consummation of the Mergers;
(f) by the Companies if there has been a Change in Recommendation; and
(g) by Parent if the Requisite Company Approvals are not obtained by the Requisite Company Approvals Deadline or such Requisite
Company Approvals are revoked, modified or no longer in full force and effect; and
(h) by Parent or the Companies if the
approval of the Transaction Proposals is not obtained at the Parent Common Stockholders Meeting (including any adjournments thereof).
Section 8.2 Procedure and Effect of Termination. In the event of the termination of this Agreement pursuant to Section 8.1 by the Parent Parties, on the one hand, or the Companies, on the other hand, written
notice thereof shall forthwith be given to the other Parties specifying the provision hereof pursuant to which such termination is made, and this Agreement shall be terminated and become void and have no effect, and there shall be no liability
hereunder on the part of any of the Parent Parties or the Companies, except that this Section 8.2, Section 5.5 (Public Announcements), Section 9.2 (Fees and Expenses),
Section 9.3 (Notices), Section 9.4 (Severability), Section 9.8 (Consent to Jurisdiction, Etc.), Section 9.10 (Governing Law),
Section 9.16 (No Recourse) and Section 9.19 (Trust Account Waiver) shall survive any termination of this Agreement. Nothing in this Section 8.2 shall (a) relieve or
release any Party to this Agreement of any liability or damages (which the Parties acknowledge and agree shall not be limited to reimbursement of expenses or
out-of-pocket cost) arising out of such Partys Fraud, intentional misrepresentation, or willful or intentional breach of any provision of this Agreement or
(b) impair the right of any Party hereto to compel specific performance by the other Party or Parties, as the case may be, of such Partys obligations under this Agreement.
ARTICLE IX
MISCELLANEOUS
Section 9.1 Release. Effective as of the Effective Time, each Parent Party and each of the Surviving Companies on behalf of itself and its past, present or future successors, assigns, employees, agents, equityholders, partners,
Affiliates and representatives (including their past, present or future officers and directors) (the Releasors) hereby irrevocably and unconditionally releases, acquits and forever discharges (except with respect to those
obligations arising under or in connection with this Agreement or the Ancillary Agreements) the LMA Members, Abacus Members, ERES Sponsor, the Parent Stockholders, their respective predecessors, successors, parents, subsidiaries and other
Affiliates, and all of their respective current and former officers, directors, members, managers, shareholders, employees, agents and representatives (the Released Parties) of and from any and all actions, suits, claims, causes
of action, damages, accounts, liabilities and obligations (including attorneys fees) held by any Releasor, whether known or unknown, matured or unmatured, suspected or unsuspected, liquidated or unliquidated, absolute or contingent, direct or
derivative, to the extent arising out of or relating to such Released Partys ownership of securities of the Companies or the Parent Parties, except for any of the foregoing (i) set forth in, pursuant to, or arising out of this Agreement
or the transactions contemplated hereby or (ii) in the case of Fraud. The Releasors irrevocably covenant to refrain, to cause their respective Affiliates to refrain, from, directly or indirectly, asserting any claim, or commencing, instituting
or causing to be commenced any action, of any kind against any Released Party, based upon any matter released hereby.
A-1-47
Section 9.2 Fees and Expenses. Except as otherwise
set forth in this Agreement, each party hereto shall be responsible for and pay its own expenses incurred in connection with this Agreement and the Transactions, including all fees of its legal counsel, financial advisers and accountants; provided
that if the Closing shall occur, the Surviving Companies shall pay or cause to be paid the Parent Transaction Expenses and Company Transaction Expenses.
Section 9.3 Notices. All notices and other communications hereunder shall be in writing and shall be
deemed to have been duly given (a) when delivered in person or, by facsimile or by e-mail, (b) on the next Business Day when sent by overnight courier or (c) on the second succeeding Business
Day when sent by registered or certified mail (postage prepaid, return receipt requested) to the respective Parties at the following addresses (or at such other address for a Party as shall be specified by like notice):
If to the Parent Parties, to:
c/o East Resources Acquisition Company
7777 NW Beacon Square Boulevard
Boca Raton, Florida 33487
Attention: John P. Sieminski
E-mail: jsieminski@emslp.com
with a required concurrent copy (which shall not constitute notice to the
Parent Parties) to:
Latham & Watkins LLP
811 Main Street, Suite 3700
Houston, Texas 77002
Attention: Ryan J. Maierson
E-mail: ryan.maierson@lw.com
If to the Companies (prior to the Closing) to:
Longevity Market Assets, LLC
2101 Park Center Drive, Suite 170
Orlando, Florida 32835
Attention: Jay Jackson
Email:
jay@abacuslife.com
Abacus Settlements, LLC
2101 Park Center Drive, Suite 220
Orlando, Florida 32835
Attention: Jay Jackson
Email:
jay@abacuslife.com
with a required concurrent copy (which shall not constitute notice to the Group Companies) to:
Locke Lord LLP
Terminus 200,
Suite 1200
3333 Piedmont Road, NE
Atlanta, Georgia 30305
Attention: Brian T. Casey
E-mail: bcasey@lockelord.com
All such notices, requests, demands, waivers and communications shall be
deemed received upon (i) actual receipt thereof by the addressee, or (ii)
actual delivery thereof to the appropriate address.
Section 9.4 Severability. If any term or other
provision of this Agreement is invalid, illegal or incapable of being enforced by any rule of Law or public policy, all other terms, conditions and provisions of this Agreement shall nevertheless remain in full force and effect so long as the
economic or legal substance of
A-1-48
the transactions contemplated by this Agreement is not affected in any manner materially adverse to any Party. Upon such determination that any term or other provision is invalid, illegal or
incapable of being enforced, the Parties shall negotiate in good faith to modify this Agreement so as to effect the original intent of the Parties as closely as possible in a mutually acceptable manner in order that the transactions contemplated by
this Agreement be consummated as originally contemplated to the fullest extent possible.
Section 9.5
Binding Effect; Assignment. This Agreement and all of the provisions hereof shall be binding upon and shall inure to the benefit of the Parties and their respective successors and permitted assigns. Neither this Agreement nor any of the
rights, interests or obligations hereunder shall be assigned in whole or in part, directly or indirectly, including by operation of law, by any Party without the prior written consent of the other Parties, and any attempted or purported assignment
or delegation in violation of this Section 9.5 shall be null and void.
Section 9.6 No Third Party Beneficiaries. Except as otherwise provided in
Section 5.8, Section 9.1 and Section 9.16, this Agreement is exclusively for the benefit of the Companies, and their respective successors and permitted assigns, with
respect to the obligations of the Parent Parties under this Agreement, and for the benefit of the Parent Parties, and their respective successors and permitted assigns, with respect to the obligations of the Companies under this Agreement, and this
Agreement shall not be deemed to confer upon or give to any other third party, including any Parent Stockholder, holders of Parent private warrants and holders of Parent public warrants any remedy, claim, liability, reimbursement,
cause of action or other right, including the right to rely upon the representations and warranties set forth in this Agreement. The representations and warranties in this Agreement are the product of negotiations among the Parties. Any inaccuracies
in such representations and warranties are subject to waiver by the Parties in accordance with Section 9.13. In some instances, the representations and warranties in this Agreement may represent an allocation among the
Parties of risks associated with particular matters regardless of the knowledge of any of the Parties. Consequently, Persons other than the Parties may not rely upon the representations and warranties in this Agreement as characterizations of actual
facts or circumstances as of the date of this Agreement or as of any other date.
Section 9.7 Section
Headings. The Article and Section headings contained in this Agreement are exclusively for the purpose of reference, are not part of the agreement of the Parties and shall not in any way affect the meaning or interpretation of this Agreement.
Section 9.8 Consent to Jurisdiction, Etc. Each Party, and any Person asserting rights as a third
party beneficiary hereunder, irrevocably agrees that any Legal Dispute shall be brought exclusively in the courts of the State of Delaware; provided that if subject matter jurisdiction over such Legal Dispute is vested exclusively in the United
States federal courts, such Legal Dispute shall be heard in the United States District Court for the District of Delaware. Each Party, and any Person asserting rights as a third party beneficiary hereunder, hereby irrevocably and unconditionally
submits to the jurisdiction of such courts (and of the appropriate appellate courts therefrom) in any such suit, action or proceeding and irrevocably waives, to the fullest extent permitted by Laws, any objection that it may now or hereafter have to
the laying of the venue of any such suit, action or proceeding in any such court or that any such Legal Dispute that is brought in any such court has been brought in an inconvenient forum. During the period a Legal Dispute that is filed in
accordance with this Section 9.8 is pending before a court, all actions, suits or proceedings with respect to such Legal Dispute or any other Legal Dispute, including any counterclaim, cross-claim or interpleader, shall be
subject to the exclusive jurisdiction of such court. Each Party, and any Person asserting rights as a third party beneficiary hereunder, may bring such Legal Dispute only if it hereby waives, and shall not assert as a defense in any Legal Dispute,
that (a) such Party is not personally subject to the jurisdiction of the above named courts for any reason, (b) such action, suit or proceeding may not be brought or is not maintainable in such court, (c) such Partys property is
exempt or immune from execution, (d) such Legal Dispute is brought in an inconvenient forum or (e) the venue of such action, suit or proceeding is improper. A final judgment in any action, suit or proceeding described in this
Section 9.8
A-1-49
following the expiration of any period permitted for appeal and subject to any stay during appeal shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any
other manner provided by applicable Laws. EACH OF THE PARTIES, AND ANY PERSON ASSERTING RIGHTS AS A THIRD PARTY BENEFICIARY HEREUNDER, MAY BRING A LEGAL DISPUTE ONLY IF IT IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT TO TRIAL BY JURY ON ANY
CLAIMS OR COUNTERCLAIMS ASSERTED IN ANY LEGAL DISPUTE RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY AND FOR ANY COUNTERCLAIM RELATING THERETO. IF THE SUBJECT MATTER OF ANY SUCH LEGAL DISPUTE IS ONE IN WHICH THE WAIVER OF JURY
TRIAL IS PROHIBITED, NO PARTY, NOR ANY PERSON ASSERTING RIGHTS AS A THIRD PARTY BENEFICIARY, SHALL ASSERT IN SUCH LEGAL DISPUTE A NONCOMPULSORY COUNTERCLAIM ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.
FURTHERMORE, NO PARTY, NOR ANY PERSON ASSERTING RIGHTS AS A THIRD PARTY BENEFICIARY, SHALL SEEK TO CONSOLIDATE ANY SUCH LEGAL DISPUTE WITH A SEPARATE ACTION OR OTHER LEGAL PROCEEDING IN WHICH A JURY TRIAL CANNOT BE WAIVED.
Section 9.9 Entire Agreement. This Agreement (including the Company Disclosure Schedules and
Exhibits attached hereto) and the Ancillary Agreements constitute the entire agreement among the Parties with respect to the subject matter of this Agreement and supersede all other prior agreements and understandings, both written and oral,
between the Parties with respect to the subject matter of this Agreement. Each Party acknowledges and agrees that, in entering into this Agreement, such Party has not relied on any representations, warranties, promises or assurances, written or
oral, that are not reflected in this Agreement (including the Company Disclosure Schedules and Exhibits attached hereto) or the Ancillary Agreements.
Section 9.10 Governing Law. This Agreement shall be governed by and construed in solely accordance
with the laws of the State of Delaware (regardless of the laws that might otherwise govern under applicable principles of conflicts of laws thereof) as to all matters, including matters of validity, construction, effect, performance and
remedies.
Section 9.11 Specific Performance. The Parties acknowledge that the rights of each
Party to consummate the transactions contemplated hereby are unique and recognize and affirm that in the event of a breach of this Agreement by any Party, money damages may be inadequate and the non-breaching
Party may have no adequate remedy at law. Accordingly, the Parties agree that such non-breaching Party shall have the right, in addition to any other rights and remedies existing in their favor at law or in
equity, to enforce its rights and the other Partys obligations hereunder not only by an action or actions for damages but also by an action or actions for specific performance, injunctive and/or other equitable relief (without posting of bond
or other security), including any order, injunction or decree sought by such non-breaching Party to cause the other Party to perform its respective agreements and covenants contained in this Agreement. Each
Party further agrees that the only permitted objection that it may raise in response to any action for equitable relief is that it contests the existence of a breach or threatened breach of this Agreement, and that no Party shall allege, and each
Party hereby irrevocably waives the defense, that there is an adequate remedy at law.
Section 9.12
Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed to be an original, but all of which taken together shall constitute one and the same agreement. Signatures to this Agreement transmitted by electronic
mail in .pdf form, or by any other electronic means designed to preserve the original graphic and pictorial appearance of a document (including DocuSign or other such services), will be deemed to have the same effect as physical delivery of the
paper document bearing the original signatures. No Party shall be bound until such time as all of the Parties have executed counterparts of this Agreement.
A-1-50
Section 9.13 Amendment; Modification; Waiver.
This Agreement may be amended, modified or supplemented at any time only by written agreement of the Parties. The conditions to each of the Parties respective obligations to consummate the Transactions are for the sole benefit of such Party
and may be waived by such Party in whole or in part to the extent permitted by applicable Law; provided, however, that any such waiver shall only be effective if made in writing and executed by the Party against whom the waiver is to be effective.
No failure or delay by any Party in exercising any right, power or privilege hereunder or under applicable Law shall operate as a waiver of such rights and, except as otherwise expressly provided herein, no single or partial exercise thereof shall
preclude any other or further exercise thereof or the exercise of any other right, power or privilege. The rights and remedies herein provided shall be cumulative and not exclusive of any rights or remedies provided by Law.
Section 9.14 Time of Essence. With regard to all dates and time periods set forth in this Agreement,
time is of the essence.
Section 9.15 Schedules. Disclosure of any fact or item in any Schedule
hereto referenced by a particular Section in this Agreement shall be deemed to have been disclosed with respect to every other Section in this Agreement in respect of which the applicability of such disclosure is reasonably apparent on its face. The
specification of any dollar amount in the representations or warranties contained in this Agreement or the inclusion of any specific item in any Schedules is not intended to imply that such amounts, or higher or lower amounts or the items so
included or other items, are or are not material, and no Party shall use the fact of the setting of such amounts or the inclusion of any such item in any dispute or controversy as to whether any obligation, items or matter not described herein or
included in a Schedule is or is not material for purposes of this Agreement or otherwise.
Section 9.16
No Recourse. Except to the extent otherwise set forth in the Ancillary Agreements, all claims, obligations, liabilities, or causes of action (whether in contract or in tort, in law or in equity, or granted by statute) that may be based upon,
in respect of, arise under, out or by reason of, be connected with, or relate in any manner to this Agreement, or the negotiation, execution, or performance of this Agreement (including any representation or warranty made in, in connection with, or
as an inducement to, this Agreement), may be made only against (and such representations and warranties are those solely of) the Parties, and then only with respect to the specific obligations set forth herein with respect to such Party. No Person
who is not a Party, including any current, former or future director, officer, employee, incorporator, member, partner, manager, stockholder, equityholder, Affiliate, agent, attorney, representative or assignee of, and any financial advisor or
lender to, any Party, or any current, former or future director, officer, employee, incorporator, member, partner, manager, stockholder, Affiliate, agent, attorney, representative or assignee of, and any financial advisor or lender to, any of the
foregoing (collectively, the Nonparty Affiliates), shall have any liability (whether in contract or in tort, in law or in equity, or granted by statute) for any claims, causes of action, obligations, or liabilities arising
under, out of, in connection with, or related in any manner to this Agreement or based on, in respect of, or by reason of this Agreement or its negotiation, execution, performance or breach (other than as set forth in the Ancillary Agreements), and,
to the maximum extent permitted by Laws (other than as set forth in the Ancillary Agreements), each Party hereby waives and releases all such liabilities, claims, causes of action and obligations against any such Nonparty Affiliates. Without
limiting the foregoing, to the maximum extent permitted by Laws (other than as set forth in the Ancillary Agreements), (a) each Party hereby waives and releases any and all rights, claims, demands or causes of action that may otherwise be
available in contract or in tort, at law or in equity, or granted by statute, to avoid or disregard the entity form of a Party or otherwise impose liability of a Party on any Nonparty Affiliate, whether granted by statute or based on theories of
equity, agency, control, instrumentality, alter ego, domination, sham, single business enterprise, piercing the veil, unfairness, undercapitalization, or otherwise, and (b) each Party disclaims any reliance upon any Nonparty Affiliates with
respect to the performance of this Agreement or any representation or warranty made in, in connection with, or as an inducement to, this Agreement.
A-1-51
Section 9.17 Construction.
(a) Unless the context of this Agreement otherwise clearly requires, (i) references to the plural include the singular,
and references to the singular include the plural, (ii) references to one gender include the other gender, (iii) the words include, includes and including do not limit the preceding terms or words and
shall be deemed to be followed by the words without limitation, (iv) the terms hereof, herein, hereunder, hereto and similar terms in this Agreement refer to this Agreement as a
whole and not to any particular provision of this Agreement, (v) the terms day and days mean and refer to calendar day(s), (vi) any statement in this Agreement to the effect that any information, document, or other
material has been made available by any of the Group Companies shall mean that a true, correct, and complete copy of such information, document, or other material was included in and available at the LMA Drive online data
site at least four (4) Business Days prior to the date hereof and was not removed after being included in such online data site, and (vii) the terms year and years mean and refer to calendar year(s).
(b) Unless otherwise set forth in this Agreement and for disclosure purposes only if made available to Parent, references in
this Agreement to (i) any document, instrument or agreement (including this Agreement) (A) includes and incorporates all exhibits, schedules and other attachments thereto, (B) includes all documents, instruments or agreements issued
or executed in replacement thereof and (C) means such document, instrument or agreement, or replacement or predecessor thereto, as amended, modified or supplemented from time to time in accordance with its terms and in effect at any given time,
and (ii) a particular Law means such Law, as amended, modified, supplemented or succeeded from time to time and in effect on the date hereof. All Article, Section, Exhibit and Schedule references herein are to Articles, Sections, Exhibits and
Schedules of this Agreement, unless otherwise specified.
(c) This Agreement shall not be construed as if prepared by one
of the Parties, but rather according to its fair meaning as a whole, as if all Parties had prepared it.
Section 9.18 Non-Survival.
|
(a) |
Except for the representations in Section 3.28 and
Section 4.21, none of the representations, warranties or pre-Closing covenants in this Agreement (or in any Ancillary Agreement or other document, certificate or instrument delivered
pursuant to or in connection with this Agreement) shall survive the Closing. The Parties acknowledge and agree that, in the event that the Closing occurs, no Party may bring a claim, suit, action or proceeding against Parent, the LMA Members, the
Abacus Members or any of their respective Affiliates, claiming, based upon or arising out of a breach of any their respective representations, warranties or any covenants the performance of which is substantially in the period prior to Closing.
|
|
(b) |
This Article IX and the covenants and agreements contained in or made pursuant to this Agreement (or in
any document, certificate or instrument delivered pursuant to or in connection with this Agreement) that by their terms apply in whole or in part after the Closing shall survive the Closing in accordance with their terms. |
Section 9.19 Trust Account Waiver. Notwithstanding anything else in this Agreement, the Group
Companies acknowledge that they have read the prospectus dated July 23, 2020 (the Prospectus) and understand that Parent has established the Trust Account for the benefit of Parents Public Stockholders and that Parent
may disburse monies from the Trust Account only (a) to Parent in limited amounts from time to time in order to permit Parent to pay its operating expenses, (b) if Parent completes the transactions which constitute a Business Combination,
then to those Persons and in such amounts as described in the Prospectus, and (c) if Parent fails to complete a Business Combination within the allotted time period and liquidates, subject to the terms of the Trust Agreement, to Parent in
limited amounts to permit Parent to pay the costs and expenses of its liquidation and dissolution, and then to Parents Public Stockholders. All liabilities and obligations of Parent due and owing or incurred at or prior to the Closing shall be
paid as and when due, including all amounts payable (x) to Parents Public Stockholders in the event they elect to have
A-1-52
their shares redeemed in accordance with Parents Organizational Documents and/or the liquidation of Parent, (y) to Parent after, or concurrently with, the consummation of a Business
Combination, and (z) to Parent in limited amounts for its operating expenses and tax obligations incurred in the Ordinary Course. The Group Companies further acknowledge that, if the transactions contemplated by this Agreement (or, upon
termination of this Agreement, another Business Combination) are not consummated by January 27, 2023, Parent will be obligated to return to its stockholders the amounts being held in the Trust Account, unless such date is otherwise extended.
Upon the Closing, Parent shall cause the Trust Account to be disbursed to Parent and as otherwise contemplated by this Agreement. Accordingly, the Group Companies, for each of themselves and their respective subsidiaries, affiliated entities,
directors, officers, employees, equityholders, representatives, advisors and all other associates and Affiliates, hereby waive all rights, title, interest or claim of any kind to collect from the Trust Account any monies that may be owed to them by
Parent for any reason whatsoever, including for a breach of this Agreement by Parent or any negotiations, agreements or understandings with Parent (whether in the past, present or future), and will not seek recourse against the Trust Account at any
time for any reason whatsoever, in each case except as expressly contemplated by this Agreement. This paragraph will survive the termination of this Agreement for any reason.
[Signature pages follow.]
A-1-53
IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed as of the date
first above written.
|
|
|
|
|
PARENT: |
|
EAST RESOURCES ACQUISITION COMPANY |
|
|
By: |
|
/s/ Gary L. Hagerman, Jr. |
|
|
Name: Gary L. Hagerman, Jr. |
|
|
Title: Chief Financial Officer and Treasurer |
Signature Page to
Agreement and Plan of Merger
A-1-54
|
|
|
|
|
LMA MERGER SUB: |
|
LMA MERGER SUB, LLC |
|
|
By: |
|
East Resources Acquisition Company,
its sole member |
|
|
By: |
|
/s/ Gary L. Hagerman, Jr. |
|
|
Name: Gary L. Hagerman, Jr. |
|
|
Title: Chief Financial Officer and Treasurer |
Signature Page to
Agreement and Plan of Merger
A-1-55
|
|
|
|
|
ABACUS MERGER SUB: |
|
ABACUS MERGER SUB, LLC |
|
|
By: |
|
East Resources Acquisition Company,
its sole member |
|
|
By: |
|
/s/ Gary L. Hagerman, Jr. |
|
|
Name: Gary L. Hagerman, Jr. |
|
|
Title: Chief Financial Officer and Treasurer |
Signature Page to
Agreement and Plan of Merger
A-1-56
|
|
|
|
|
LMA: |
|
LONGEVITY MARKET ASSETS, LLC |
|
|
By: |
|
/s/ Jay Jackson |
|
|
Name: Jay Jackson |
|
|
Title: Chief Executive Officer |
Signature Page to
Agreement and Plan of Merger
A-1-57
|
|
|
|
|
ABACUS: |
|
ABACUS SETTLEMENTS, LLC |
|
|
By: |
|
/s/ Jay Jackson |
|
|
Name: Jay Jackson |
|
|
Title: Chief Executive Officer |
Signature Page to
Agreement and Plan of Merger
A-1-58
EXHIBIT A
DEFINITIONS
For
purposes of this Agreement, each of the following terms (including the singular and plural thereof, as applicable) shall have the meaning set forth below:
Abacus Interest means the limited liability company interests in Abacus.
Abacus Members means the holders of Abacus Interests as set forth in
Section 3.3(a) the Company Disclosure Schedules.
Actions means actions,
mediations, suits, litigations, arbitrations, claims, charges, grievances, complaints, proceedings, audits, inquiries, investigations or reviews.
Affiliate of any specified Person means any other Person directly or indirectly controlling or controlled
by, or under common control with, such specified Person. For the avoidance of doubt, securitization vehicles created by or on behalf of the Companies or their Subsidiaries shall not be their Affiliates.
Aggregate Merger Consideration means the Cash Consideration and the Stock Consideration, collectively.
Aggregate Transaction Proceeds means an amount equal to: (a) the aggregate cash proceeds available for
release to Parent from the Trust Account in connection with the Transactions; plus (b) the PIPE Investment Amount; minus (c) the aggregate amount of cash proceeds required to satisfy the redemption of any shares of Parent
Common Stock by stockholders of Parent; minus (d) the Parent Transaction Expenses; minus (e) the Company Transaction Expenses; minus (e) the Working Capital Loan Amount.
Ancillary Agreements means, collectively, the Transaction Confidentiality Agreement, the Company Support
Agreement, the Sponsor Support Agreement and the A&R Registration Rights Agreement.
Anti-Corruption
Laws means all U.S. and non-U.S. Laws relating to the prevention of corruption and bribery, including, without limitation, the U.S. Foreign Corrupt Practices Act of 1977, as amended, and the UK
Bribery Act of 2010.
Available Cash Amount means an amount equal to the Aggregate Transaction Proceeds
minus $200,000,000.
Balance Sheet Date means the date of the Interim Balance Sheet.
Burdensome Condition means, in connection with any approval of the Florida Office of Insurance Regulation,
the California Insurance Department, or any agreement with, or condition or requirement imposed by the Florida Office of Insurance Regulation or the California Department of Insurance that (a) has, or would reasonably be expected to have, a
Material Adverse Effect on the Companies following the Closing or (b) involves any significant adverse effect on the economic benefits that either (i) Parent or (ii) the Companies, respectively, reasonably expects to obtain from the
Transactions.
Business Combination has the meaning given to such term in the Organizational Documents
of Parent.
Business Day means any day except Saturday, Sunday or any days on which banks are generally
not open for business in New York, New York.
CARES Act means the Coronavirus Aid, Relief, and Economic
Security Act (Pub. L. 116-136) and any administrative or other guidance published with respect thereto by any Governmental Entity.
Cash and Cash Equivalents means the cash, cash equivalents, checks received but not cleared and deposits in
transit of the Group Companies as of the Closing, measured in accordance with GAAP and absent any effects of the transactions contemplated hereby. For the avoidance of doubt, Cash and Cash Equivalents shall not include restricted cash, any cash
overdrafts, issued but uncleared checks or other negative balances.
A-1
Cash Consideration means an amount of cash equal to the
Available Cash Amount, if any, and payable to Company Members in accordance with Article II; provided that, the Cash Consideration shall not exceed $20,000,000, in the aggregate.
COBRA means Part 6 of Subtitle B of Title I of ERISA, Section 4980B of the Code, and any similar state
Law.
Code means the United States Internal Revenue Code of 1986, as amended, or any successor Law.
Company Benefit Plan means (i) each employee benefit plan as defined in Section 3(3)
of the Employee Retirement Income Security Act of 1974, as amended, (ERISA) and (ii) any other plan, policy, program or agreement (including any employment, bonus, incentive or deferred compensation, equity or equity-based
compensation, severance, retention, supplemental retirement, change in control or similar plan, policy, program or agreement) providing compensation or other benefits to any current or former director, officer, individual consultant, worker or
employee, which are maintained, sponsored or contributed to by a Group Company, or to which a Group Company is a party or has or may have any liability, and in each case whether or not (1) subject to the Laws of the United States, (2) in
writing or (3) funded, but excluding in each case any statutory plan, program or arrangement that is required under applicable law and maintained by any Governmental Entity.
Company Fundamental Representations means the representations and warranties set forth in
Section 3.1 (Organization), Section 3.2 (Authorization), Section 3.3 (Capitalization), Section 3.4 (Company Subsidiaries), and
Section 3.8(c) (Absence of Certain Changes).
Company Members means the LMA
Members and the Abacus Members, collectively.
Company Owned Intellectual Property means all Company
Intellectual Property that is owned or purported to be owned by any Group Company, including all Company Products.
Company Product Data means all data and information, whether in electronic or any other form or medium, that
is accessed, collected, used, processed, stored, shared, distributed, transferred, disclosed, destroyed, or disposed of by any of the Company Products.
Company Products means each product and service (whether for internal or external use) that is or has been
developed, marketed, licensed, sold, performed, produced, serviced, distributed, or otherwise made available by any Group Company, including any product or service currently under development by any Group Company.
Company Registered Intellectual Property means all registrations, issuances, and applications for Company
Owned Intellectual Property, including any of the foregoing set forth on Section 3.10(a) of the Company Disclosure Schedules.
Company Subsidiary means any Subsidiary of either Company.
Company Systems means all Software, computer hardware (whether general or special purpose), electronic data
processing systems, information systems, record keeping systems, communications systems, telecommunication systems, networks, interfaces, platforms, servers, peripherals, and computer systems, in each case that is owned, solely used by, or under the
control of the Group Companies in the conduct of their business.
Company Transaction Expenses means the
legal, accounting, financial advisory, and other advisory, transaction or consulting fees and expenses incurred and paid by each Company, the Company Members (but, with respect to the Company Members, only to the extent a Group Company is obligated
to pay such fees or expenses) in connection with the transactions contemplated by this Agreement, without limitation, (a) any fees and expenses payable under the terms of any management agreement or related to the termination of any Contract
with an Affiliate, and (b) the Tail Premium.
A-2
Contract means any written or oral contract, lease,
license, indenture, instrument, undertaking or other legally enforceable agreement (other than standard click through licenses or agreements).
COVID-19 means SARS-CoV-2 or
COVID-19, and any evolutions or mutations thereof or related or associated epidemics, pandemic or disease outbreaks.
COVID-19 Measures means any quarantine, shelter in
place, stay at home, workforce reduction, social distancing, shut down, closure, sequester or any other Law, Order, directive, guidelines or recommendations by any Governmental Entity in connection with or in response to COVID-19, including, but not limited to, the CARES Act and FFCRA.
Data
Partners means, collectively, all vendors, processors or other third parties Processing Personal Data for or on behalf of the Group Companies and/or with whom the Group Companies otherwise share Personal Information.
Data Security Requirements means, collectively, all of the following to the extent relating to Processing
Personal Data by a Group Company: (i) applicable Laws (including the California Consumer Privacy Act (CCPA) and General Data Protection Regulation (GDPR) (EU) 2016/679), (ii) binding and enforceable guidelines and industry standard applicable
to the industry in which any Group Companys business operates (including as applicable the Payment Card Industry Data Security Standard (PCI-DSS)), (iii) the Group Companies own internal and
external data security rules, policies, and procedures, and (iv) contractual obligations relating to the Processing of Personal Data by which the Companies are bound.
Environmental Laws means all federal, state and local Laws relating to public or worker health and safety
(to the extent relating to exposure to Hazardous Substances), protection of the environment (including surface or ground water, drinking water supply, soil, surface or subsurface strata or medium, or ambient air), pollution, or Hazardous Substances
(including exposure to or Release of Hazardous Substances).
Environmental Permits means all Licenses
applicable to any Group Company issued pursuant to Environmental Laws.
Equity Value means $618,000,000.
ERES Sponsor means East Sponsor, LLC, a Delaware limited liability company .
ERISA Affiliate means any Person that together with the Companies or a Company Subsidiary, is or was, at a
relevant time, treated as a single employer under Section 414(b), (c) or (m) of the Code.
Ex-Im Laws means (i) all U.S. Laws relating to export, reexport, transfer, and import controls, including, without limitation, the Export Administration Regulations, the customs and import Laws
administered by U.S. Customs and Border Protection, and (ii) all non-U.S. Laws relating to export, reexport, transfer, and import controls, including the EU Dual Use Regulation, except to the extent
inconsistent with U.S. law.
Exchange Act means the United States Securities Exchange Act of 1934, as
amended, and the rules and regulations promulgated thereunder.
Exchange Agent means Continental Stock
Transfer & Trust Company.
Exchange Agent Agreement means the paying and exchange agent
agreement to be entered into at or prior to Closing by Parent and the Exchange Agent.
FFCRA means the
Families First Corona Response Act (Public Law 116-127) and any administrative or other guidance published with respect thereto by any Governmental Entity.
Forward Purchase Agreement means that certain Forward Purchase Agreement, dated as of July 2, 2020, by
and between Parent and East Asset Management, LLC, a Delaware limited liability company and an Affiliate of Parent, as amended, restated, modified or supplemented from time to time.
A-3
Fraud means actual, knowing and intentional common law
fraud under the laws of the State of Delaware with respect to the making of the representations and warranties contained in Article III or Article IV.
GAAP means generally accepted accounting principles in the United States.
Government Official shall mean any officer or employee of a Governmental Entity or any department, agency or
instrumentality thereof, including state-owned entities, or of a public organization or any Person acting in an official capacity for or on behalf of any such government, department, agency, or instrumentality or on behalf of any such public
organization.
Governmental Entity means any multinational, national, federal, state or local
government, any political subdivision thereof or any governmental authority or agency, including any court, administrative or regulatory agency, department, instrumentality, tribunal, arbitrator, legislative body, authority, body or commission, or
any arbitral body (public or private), in the United States or in a foreign jurisdiction.
Group
Companies means, collectively, each Company and each Company Subsidiary.
Hazardous Substance
means any chemical, material or substance listed, classified, defined or regulated as a toxic or hazardous substance, waste, pollutant, contaminant, or words of similar meaning or regulatory effect, or with respect to which the use, handling or
disposal by the Group Companies is governed by or subject to applicable Law.
HSR Act means the
Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended.
Indebtedness means, without
duplication, with respect to any Person, all obligations (including all obligations in respect of principal, accrued interest, penalties, breakage costs, fees and premiums) of such Person (a) for borrowed money, (b) evidenced by notes,
bonds, debentures, hedging or swap arrangements or similar contracts or instruments, (c) for the deferred purchase price of assets, property, goods or services (other than trade payables, or accruals incurred in the Ordinary Course) and with
respect to any conditional sale, title retention, consignment or similar arrangements, (d) under capital leases, (e) by which such Person assured a creditor against loss, including letters of credit and bankers acceptances, in each
case to the extent drawn upon or currently payable and not contingent, (f) for earn-out or contingent payments related to acquisitions or investments, (g) for outstanding severance obligations and
any accrued, but unpaid, annual bonus obligations, plus the employers share of payroll, social security, Medicare and unemployment Taxes and other similar assessments associated therewith (computed as though all such amounts were
payable on the Closing Date), (h) for unfunded pension or retirement agreements, programs, policies, or other arrangements, (i) in respect of dividends declared or distributions payable, and (j) in the nature of guarantees of the
obligations described in clauses (a) through (i) above of any other Person, in each case excluding intercompany indebtedness.
Intellectual Property means all intellectual property and other proprietary rights throughout the world,
including all of the following: (a) trademarks, service marks, trade names, trade dress, corporate names, logos, Internet domain names, Internet websites and URLs, social media identifiers and other indicia of origin (together with the goodwill
associated therewith); (b) patents, patent applications and inventions and all improvements thereto (whether or not patentable or reduced to practice); (c) copyrights and all works of authorship (whether or not copyrightable);
(d) registrations and applications for any of the foregoing; (e) trade secrets, know-how, processes, methods, techniques, inventions, formulae, technologies, algorithms, layouts, designs, protocols,
specifications, data compilations and databases, and proprietary rights in confidential information; (f) Software; (g) rights of privacy and publicity, including the right to use the name, likeness, image, signature and biographical
information of any natural Person; and (h) moral rights.
Investment Company Act means the
Investment Company Act of 1940, as amended, and the rules and regulations of the SEC promulgated thereunder.
JOBS
Act means the Jumpstart Our Business Startups Act of 2012.
A-4
Knowledge of the Companies means the actual knowledge of
Jay Jackson, Sean McNealy, Scott Kirby and Matt Ganovsky, after reasonable inquiry.
Law means any laws,
common laws, statutes, rules, acts, codes, regulations, ordinances, determinations, executive orders or Orders of, or issued by, Governmental Entities in the United States or in a foreign jurisdiction.
Legal Dispute means any action, suit or proceeding between or among the Parties arising in connection with
any disagreement, dispute, controversy or claim arising out of or relating to this Agreement or any related document.
Licenses means all licenses, approvals, authorizations, consents, notices, waivers, declarations, permits
(including operation permits), registrations and certificates issued by any Governmental Entity.
Liens
means mortgages, liens, pledges, security interests, charges, claims, restrictions, licenses, deeds of trust, defects in title, contingent rights or other burdens, options or encumbrances.
LMA Interest means the limited liability company interests in LMA.
LMA Members means the holders of LMA Interests as set forth in Section 3.3(a) of
the Company Disclosure Schedules.
Look-Back Date means January 1, 2020.
Material Adverse Effect means, with respect to any specified Party, any event, change, development, effect
or occurrence that, individually or in the aggregate with all other events, changes, developments, effects or occurrences, has had or would reasonably be expected to have a materially adverse effect on the business, assets, liabilities, financial
condition or results of operations of such Party and its Subsidiaries, taken as a whole; provided, that the term Material Adverse Effect shall not include any event, change, development, effect or occurrence to the extent
caused by or attributable to (a) changes or proposed changes in laws, regulations or binding decisions of any Governmental Entity, (b) changes or proposed changes in GAAP, (c) actions or omissions of such Party taken with the prior
written consent of all the other Parties hereto pursuant to this Agreement, (d) actions or omissions of such Party required by this Agreement or the Ancillary Agreements, (e) general economic conditions, including changes in the credit,
debt, financial, capital markets (including changes in interest or exchange rates, prices of any security or market index or any disruption of such markets), in each case, in the United States or anywhere else in the world, (f) events or
conditions generally affecting the industries in which such Party operates, (g) global, national or regional political conditions, including national or international hostilities, acts of terror or acts of war, sabotage or terrorism or military
actions or any escalation or worsening of any hostilities, acts of war, sabotage or terrorism or military actions, (h) any epidemic, pandemic or disease outbreak (including COVID-19) or any COVID-19 Measures or any change in COVID-19 Measures or interpretations thereof following the date of this Agreement, (i) acts of God, earthquakes, hurricanes, tornados
or other natural disasters, (j) the announcement or pendency of this Agreement or the transactions contemplated hereby or the identity of the Parties in connection with the transactions contemplated hereby, (k) the failure by such Party to
take any commercially reasonable action that is prohibited by this Agreement unless the other Parties hereto have consented in writing and in advance to the taking thereof, or (l) any failure to meet any projections, forecasts, guidance,
estimates, milestones, budgets or financial or operating predictions of revenue, earnings, cash flow or cash position; provided, that the matters described in clauses (e) through (g) shall be included in the term Material
Adverse Effect to the extent any such matter has a disproportionate, materially adverse effect on the business, assets, financial condition or results of operations of such Party and its Subsidiaries, taken as a whole, relative to other
participants in the same business as such Party (in which case only the incremental disproportionate effect may be taken into account in determining whether there has been or would be a Material Adverse Effect, to the extent such change is not
otherwise excluded from being taken into account by clauses (a) through (l) above).
A-5
Open Source Software means any Software that is licensed
pursuant to: (a) a license that is approved by the Open Source Initiative and listed at http://www.opensource.org/licenses, which licenses include all versions of the GNU General Public License (GPL), the GNU Lesser General Public License
(LGPL), the GNU Affero GPL, the MIT license, the Eclipse Public License, the Common Public License, the CDDL, the Mozilla Public License (MPL), the Artistic License, the Netscape Public License, the Sun Community Source License (SCSL), and the Sun
Industry Standards License (SISL); and (b) any license to Software that is considered free or open source software by the Open Source Foundation or the Free Software Foundation; or (c) any Reciprocal License, in
each case whether or not source code is available or used in such license.
Order means any award,
order, judgment, decision, determination, writ, injunction, ruling or decree entered, issued, made or rendered by any Governmental Entity of competent jurisdiction in the United States or in a foreign jurisdiction.
Ordinary Course means, with respect to any Party, the ordinary course of business consistent with the past
practices of such Party.
Organizational Documents means (a) the certificate of incorporation,
(b) bylaws, (c) any charter or similar document adopted or filed in connection with the creation, formation or organization of a Person, (d) any limited liability company, partnership or shareholder agreement, and (e) any
amendment to any of the foregoing.
Parent Class B Stock means the Class B
common stock, par value $0.0001 per share, of Parent.
Parent Common Stock means the Class A common
stock, par value $0.0001 per share, of Parent.
Parent Fundamental Representations means the
representations and warranties set forth in Section 4.1 (Organization), Section 4.2 (Authorization), Section 4.3 (Capitalization), and
Section 4.7(b) (Absence of Certain Changes).
Parent Legal Expenses means the
fees, costs and expenses of legal counsel incurred by the Parent Parties in connection with the transactions contemplated hereby.
Parent Material Contract means a material contract, as such term is defined in Regulation S-K of the SEC, to which Parent is party.
Parent Private Warrants
means the redeemable warrants of Parent, each exercisable in accordance with its terms to purchase one (1) share of Parent Common Stock at an exercise price of eleven dollars and fifty cents ($11.50) per share, subject to adjustment, that were
sold in a private placement concurrently with the closing of Parents initial public offering.
Parent Public
Warrants means the redeemable warrants of Parent, each exercisable in accordance with its terms to purchase one (1) share of Parent Common Stock at an exercise price of eleven dollars and fifty cents ($11.50) per share, subject to
adjustment, that were sold as part of the Parent units in Parents initial public offering.
Parent
Reports means each form, statement, registration statement, prospectus, report, schedule, proxy statement and other document (including exhibits and schedules thereto and the other information incorporated therein) filed with or furnished
to the SEC on a voluntary basis or otherwise since July 23, 2020 by Parent pursuant to the Securities Act or the Exchange Act, including any amendments thereto.
Parent Share Value means $10.00.
Parent Stockholders means the holders of Parent Common Stock or Parent Class B Stock.
Parent Transaction Expenses means the fees, costs and expenses incurred by the Parent Parties in connection
with the transactions contemplated hereby, including the deferred underwriting commission paid to the underwriters of Parents initial public offering and the fees, costs and expenses of its financial advisors and accountants and the Parent
Legal Expenses.
A-6
Permitted Liens means (a) Liens for Taxes not yet
due and payable or that are being contested in good faith and for which adequate reserves have been established in accordance with GAAP, (b) statutory Liens of landlords with respect to Leased Real Property, (c) Liens of carriers,
warehousemen, mechanics, materialmen and repairmen incurred in the Ordinary Course and for amounts which are not yet due and payable, (d) in the case of Leased Real Property, zoning, building and other land use Laws regulating the use or
occupancy of such Leased Real Property or the activities conducted thereon which are imposed by any Governmental Entity having jurisdiction over such Leased Real Property which are not violated by the current use or occupancy of such Leased Real
Property or the operation of the business conducted thereon, (e) in the case of Leased Real Property, restrictions, variances, covenants, rights of way, encumbrances, easements and other similar matters of record, none of which, individually or
in the aggregate, interfere or would interfere in any material respect with the present use of or occupancy of the affected parcel by the applicable Group Company or the operation of the business conducted thereon, (f) Liens securing the
Indebtedness of any Group Company to be released on or prior to Closing and (g) in the case of Intellectual Property, non-exclusive licenses that are granted in the Ordinary Course.
Person means any individual, partnership, joint venture, corporation, trust, limited liability company,
unincorporated organization or other entity or any Governmental Entity.
Personal Data means all data
relating to one or more individual(s) that is personally identifying (i.e., data that identifies, describes, is reasonably capable of being associated with, or could reasonably be linked, directly or indirectly, with a particular
individual (whether in electronic or any other form or medium)) or that is otherwise protected by the Data Security Requirements.
PIPE Investment Amount means the proceeds, if any, received by the Companies or Parent pursuant to the
Subscription Agreements entered into after the date hereof, pursuant to which, among other things, each Subscriber agrees to subscribe for and purchase on the Closing Date immediately prior to the Mergers, and Parent or the Companies, as the case
may be, agrees to issue and sell to each such Subscriber on the Closing Date immediately prior to the Mergers, the number of shares of Parent Common Stock or such other security set forth in the applicable Subscription Agreement in exchange for the
purchase price set forth therein, in each case, on the terms and subject to the conditions set forth in the applicable Subscription Agreement.
Pre-Closing Tax Period means all taxable periods ending on or before
the Closing Date and the portion of any Straddle Period through the end of the Closing Date.
Process or
Processing means any operation or set of operations performed on Personal Data (whether electronically or in any other form or medium), including the collection, use, access, storage, recording, distribution, transfer, import,
export, privacy protection (including security measures), disposal or disclosure of Personal Data.
Producer means any producer, distributor, broker, agent, general agent, managing general agent, master
broker agency, broker general agency, financial specialist or other Person responsible for soliciting, selling, marketing or producing insurance policies.
Reciprocal License means a license of an item of Software that requires or that conditions any rights
granted in such license upon: (i) the disclosure, distribution or licensing of any other Software (other than such item of Software as provided by a third party in its unmodified form); (ii) a requirement that any disclosure, distribution or
licensing of any other Software (other than such item of Software in its unmodified form) be at no charge; (iii) a requirement that any other licensee of the Software be permitted to access the source code of, modify, make derivative works of,
or reverse-engineer any such other Software; (iv) a requirement that such other Software be redistributable by other licensees; or (v) the grant of any patent rights (other than patent rights in such item of Software), including non-assertion or patent license obligations (other than patent obligations relating to the use of such item of Software).
Release means any spilling, leaking, pumping, pouring, emitting, emptying, discharging, injecting,
escaping, dumping or disposing into the environment.
A-7
Representatives of any Person shall mean such
Persons directors, managers, officers, employees, agents, attorneys, consultants, advisors or other representatives.
Requisite Company Approvals Deadline means 5:00 p.m. Eastern Time on the first Business Day after the date
of this Agreement.
Sanctioned Country means any country or region that is or has since the Look-Back
Date been the subject or target of a comprehensive embargo under Sanctions Laws (as of the date of this Agreement, Cuba, Iran, North Korea, Sudan, Syria and the Crimea region of Ukraine).
Sanctioned Person means any individual or entity that is the target of sanctions or restrictions under
Sanctions Laws or Ex-Im Laws, including: (i) any individual or entity listed on any applicable U.S. or non-U.S. sanctions-or export-related restricted party list, including, the U.S. Department of the Treasurys Office of Foreign Asset
Controls (OFAC) Specially Designated Nationals and Blocked Persons List and the EU Consolidated List; (ii) any entity that is, where relevant under applicable Sanctions or Ex-Im Laws, 50 percent (50%) or greater owned (in
the aggregate), directly or indirectly, or otherwise controlled by a Person or Persons described in clause (i); or (iii) any person resident, operating, or organized in a Sanctioned Country.
Sanctions Laws means all Laws relating to economic or trade sanctions administered or enforced by the United
States (including by OFAC or the U.S. Department of State), the United Nations Security Council, and the European Union.
SEC means the United States Securities and Exchange Commission.
Securities Act means the United States Securities Act of 1933, as amended, and the rules and regulations
promulgated thereunder.
Software means all computer software (in object code or source code format),
data and databases, and related documentation.
Sponsor PIK Note Amount has the meaning set forth in the
Sponsor Support Agreement.1
Stock Consideration
means the number of shares of Parent Common Stock equal to (a) Equity Value divided by (b) the Parent Share Value.
Straddle Period means any taxable period that includes (but does not end on) the Closing Date.
Subsidiary or Subsidiaries means with respect to any Person, any corporation, limited
liability company, partnership, association, or business entity, whether incorporated or unincorporated, of which (a) if a corporation, a majority of the total voting power of shares of stock entitled (without regard to the occurrence of any
contingency) to vote in the election of directors, managers, or trustees thereof is at the time owned or controlled, directly or indirectly, by that Person or one or more Subsidiaries of that Person or a combination thereof, (b) if a partnership
(whether general or limited), a general partner interest is at the time owned or controlled, directly or indirectly, by that Person or one or more Subsidiaries of that Person or a combination thereof or (c) if a limited liability company,
partnership, association, or other business entity (other than a corporation), a majority of partnership or other similar ownership interest thereof is at the time owned or controlled, directly or indirectly, by that Person or one or more
Subsidiaries of that Person or a combination thereof. For purposes hereof, a Person or Persons shall be deemed to have a majority ownership interest in a limited liability company, partnership, association, or other business entity (other than a
corporation) if such Person or Persons shall be allocated a majority of limited liability company, partnership, association, or other business entity gains or losses.
1 |
Note to Draft: To equal the minimum cash threshold minus the Aggregate Transaction Proceeds, subject to
a cap equal to the aggregate Parent Transaction Expenses, Company Transaction Expenses and the Working Capital Loan Amount. A form of the Sponsor PIK Note will be attached to the Sponsor Support Agreement. |
A-8
Tax Return means any report, return, declaration, claim
for refund or information return or statement or other information required or permitted to be supplied to a Governmental Entity in connection with Taxes together with any attachments and all amendments thereto.
Taxes means (i) all federal, state, local or non-U.S. taxes,
including income, franchise, capital stock, real property, personal property, tangible, withholding, employment, payroll, social security, social contribution, unemployment compensation, disability, stamp, transfer, registration, escheat, sales,
use, excise, gross receipts, value-added, estimated, alternative or add-on minimum, customs and all other taxes, assessments, duties, levies, and other governmental charges of any kind in the nature of a tax,
whether disputed or not, and any charges, additions, interest or penalties imposed by any Governmental Entity with respect thereto, (ii) any liability for or in respect of the payment of any amount of a type described in clause (i) of this
definition as a result of being a member of an affiliated, combined, consolidated, unitary or other group for Tax purposes, and (iii) any liability for or in respect of the payment of any amount described in clauses (i) or (ii) of this
definition as a transferee or successor, or by contract (excluding customary commercial agreements the primary subject of which is not Taxes).
Transaction Confidentiality Agreement means that certain Confidentiality Agreement, dated August 8,
2022, by and among LMA, Abacus and East Asset Management, LLC, a Delaware limited liability company and an Affiliate of Parent.
Transactions means the transactions contemplated by this Agreement and the Ancillary Agreements to occur at
or immediately prior to the Closing, including the Mergers.
Treasury Regulations means the Income Tax
Regulations promulgated under the Code.
Working Capital Loan Amount means the aggregate amount of cash
proceeds required to repay in full the Working Capital Loans as of the Effective Time.
Working Capital
Loans means the outstanding loans made to Parent by ERES Sponsor as of the Effective Time as set forth on Section A of the Parent Disclosure Schedules, portions of which loaned amounts may be converted, at the option of the lender,
into warrants identical to the Parent Private Warrants at a price of one dollar and fifty cents ($1.50) per warrant upon consummation of a Business Combination (such warrants, the Working Capital Warrants).
Additionally, each of the following terms is defined in the Section set forth opposite such term:
|
|
|
Term |
|
Section |
Agreement |
|
Preamble |
Abacus |
|
Preamble |
Abacus Certificate of Merger |
|
1.1(b) |
Abacus Effective Time |
|
1.1(b) |
Abacus Interests |
|
Recitals |
Abacus Member Approval |
|
3.2 |
Abacus Merger |
|
Recitals |
Abacus Merger Sub |
|
Preamble |
Abacus Surviving Company |
|
Recitals |
Accounts |
|
3.10(a) |
Acquisition Proposal |
|
5.13(b) |
Agreement |
|
Preamble |
Allocation Schedule |
|
2.1(a) |
A&R Bylaws |
|
Recitals |
A&R Charter |
|
Recitals |
A&R Registration Rights Agreement |
|
5.18 |
Cash Consideration |
|
2.2(b) |
Cash Election |
|
2.2(b) |
A-9
|
|
|
Term |
|
Section |
Certificates of Merger |
|
1.1(b) |
Change in Recommendation |
|
5.10 |
Closing |
|
7.1 |
Closing Date |
|
7.1 |
Companies |
|
Preamble |
Company Closing Certificate |
|
6.3(c) |
Company Disclosure Schedules |
|
Article III |
Company Intellectual Property |
|
3.10(c) |
Company Letter of Transmittal |
|
2.3(a) |
Company Material Contracts |
|
3.13 |
Company Support Agreement |
|
Recitals |
Confidentiality Agreement |
|
3.10(g) |
DGCL |
|
Recitals |
DLLCA |
|
Recitals |
East Asset Management |
|
Recitals |
Effective Time |
|
1.1(b) |
ERISA |
|
Exhibit A |
Exchange Agent Fund |
|
2.2(a) |
Financial Statements |
|
3.6 |
FIRPTA Certificate |
|
5.7(c) |
Forward Purchase Amount |
|
Recitals |
Forward Purchase Securities |
|
Recitals |
FRLLCA |
|
Recitals |
Indemnified Persons |
|
5.8(a) |
Interim Balance Sheet |
|
3.6 |
Interim Financial Statements |
|
3.6 |
IRS |
|
3.17(b)(iv) |
Lease |
|
3.9(c) |
Leases |
|
3.9(c) |
Leased Real Property |
|
3.9(b) |
LMA |
|
Preamble |
LMA Certificate of Merger |
|
1.1(a) |
LMA Interests |
|
Recitals |
LMA Effective Time |
|
1.1(a) |
LMA Member Approval |
|
3.2 |
LMA Merger |
|
Recitals |
LMA Merger Sub |
|
Preamble |
LMA Surviving Company |
|
Recitals |
Malicious Code |
|
3.10(k) |
Material Customer |
|
3.24 |
Material Supplier |
|
3.24 |
Mergers |
|
Recitals |
Merger Sub |
|
Preamble |
Nonparty Affiliates |
|
9.16 |
OFAC |
|
Exhibit A |
Offer |
|
Recitals |
Offering Shares |
|
5.9(a) |
Omnibus Incentive Plan |
|
5.9(a) |
Outside Date |
|
8.1(e) |
Parent |
|
Preamble |
Parent Board Recommendation |
|
5.10 |
Parent Closing Certificate |
|
6.2(c) |
Parent Common Stockholders Meeting |
|
5.10 |
A-10
|
|
|
Term |
|
Section |
Parent Disclosure Schedules |
|
Article IV |
Parent Fundamental Representations |
|
6.2(a) |
Parent Parties |
|
Preamble |
Parent Stockholder Approval |
|
4.2 |
Parties |
|
Preamble |
Party |
|
Preamble |
PCAOB Financial Statements |
|
5.17 |
Permitted Financing |
|
5.2(b) |
PIPE Investors |
|
Recitals |
PIPE Investment |
|
Recitals |
Prospectus |
|
9.19 |
Proxy Statement |
|
5.9(a) |
Redomestication |
|
5.20 |
Released Parties |
|
9.1 |
Releasors |
|
9.1 |
Requisite Company Approvals |
|
3.2 |
S corporation |
|
3.14(q) |
Section 16 |
|
5.12 |
Security Incident |
|
3.11(b) |
Social Media Terms |
|
3.10(a) |
Sponsor Support Agreement |
|
Recitals |
Subscribers |
|
Recitals |
Subscription Agreements |
|
Recitals |
Surviving Companies |
|
Recitals |
Tail Premium |
|
5.8(b) |
Technical Deficiencies |
|
3.10(j) |
Trade Control Laws |
|
3.19(a) |
Transaction Proposals |
|
5.9(a) |
Transfer Taxes |
|
5.7 |
Trust Account |
|
4.16(a) |
Trust Agreement |
|
4.16(a) |
Trust Amount |
|
4.16(a) |
Trustee |
|
4.16(a) |
WARN Act |
|
5.1(b)(xiii) |
Working Capital Warrants |
|
Exhibit A |
A-11
ANNEX A-2
Execution Version
FIRST AMENDMENT TO
AGREEMENT AND PLAN OF MERGER
This First Amendment (First Amendment) to the Merger Agreement (as defined below) is entered into as of October 14,
2022, by and among East Resources Acquisition Company, a Delaware corporation (Parent), LMA Merger Sub, LLC, a Delaware limited liability company and wholly owned subsidiary of Parent (LMA Merger Sub), Abacus
Merger Sub, LLC, a Delaware limited liability company and wholly owned subsidiary of Parent (Abacus Merger Sub), Longevity Market Assets, LLC, a Florida limited liability company (LMA), and Abacus Settlements,
LLC, a Florida limited liability company (Abacus). Parent, LMA Merger Sub, Abacus Merger Sub, LMA and Abacus are sometimes referred to in this First Amendment collectively as the Parties. Capitalized terms used
but not defined herein shall have the meanings assigned to such terms in the Merger Agreement.
RECITALS
WHEREAS, the Parties entered into that certain Agreement and Plan of Merger, dated as of August 30, 2022 (as may be amended, modified or
supplemented from time to time, the Merger Agreement); and
WHEREAS, the Parties desire to amend the Merger Agreement
in accordance with Section 9.13 thereof as more fully set forth herein in order to, among other things, clarify the terms of the consideration to be issued or paid to the Company Members in connection with the consummation of the Mergers.
NOW THEREFORE, in consideration of the mutual agreements contained herein and for good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, and intending to be legally bound hereby, the Parties hereby agree as follows:
1. Amendment to Merger Agreement.
|
(a) |
Recital of the Merger Agreement is hereby amended by amending and restating the tax treatment recital as
follows: |
WHEREAS, for U.S. federal income Tax purposes, it is intended that each of the Mergers qualify as a
reorganization within the meaning of Section 368(a) of the Code to which each of Parent, LMA, Abacus, LMA Merger Sub and Abacus Merger Sub are parties pursuant to Section 368(b) of the Code (the Intended Tax
Treatment) and that this Agreement constitutes a plan of reorganization for purposes of Sections 354, 361 and 368 of the Code and the Treasury Regulations promulgated thereunder
|
(b) |
Exhibit A of the Merger Agreement is hereby amended by deleting the definition of Equity Value.
|
|
(c) |
Exhibit A of the Merger Agreement is hereby amended by amending and restating the definitions of
Burdensome Condition and Stock Consideration as follows: |
Burdensome
Condition means, in connection with any approval of the Florida Office of Insurance Regulation, any agreement with, or condition or requirement imposed by the Florida Office of Insurance Regulation that (a) has, or would reasonably be
expected to have, a Material Adverse Effect on the Companies following the Closing or (b) involves any significant adverse effect on the economic benefits that either (i) Parent or (ii) the Companies, respectively, reasonably expects
to obtain from the Transactions.
A-2-1
Stock Consideration means the number of shares of Parent Common Stock
equal to (a) the Company Member Value minus the Cash Consideration, if any, divided by (b) the Parent Share Value. For the avoidance of doubt, the Stock Consideration shall equal 53,175,000 shares of Parent Common Stock,
assuming the Cash Consideration equals $0.
|
(d) |
Exhibit A of the Merger Agreement is hereby amended by adding the following definitions: |
Company Member Value means an amount equal to (a) the Transaction Value minus (b) the Founder Share
Implied Value.
Founder Share Implied Value means an amount equal to (a) 8,625,000 multiplied by (b) the
Parent Share Value.
Transaction Value means $618,000,000.
Intended Tax Treatment
Recitals.
|
(e) |
Section 6.1(f) of the Merger Agreement is hereby amended and restated as follows: |
Regulatory Approvals. Parent shall have received the approval of the Florida Office of Insurance Regulation with respect to the
change of control of Abacus contemplated by the transactions under this Agreement without any Burdensome Condition.
|
(f) |
Article II of the Merger Agreement is hereby amended by adding a new Section 2.5 as follows:
|
Section 2.5 Stock Consideration in Excess of Pro Rata Portion.
In the event that the portion of the Stock Consideration allocated to a Company Member as set forth in the Allocation Schedule is greater than such Company Members pro rata portion of the Aggregate Merger Consideration, the number of shares of
Parent Common Stock issuable to such Company Member in excess of such Company Members pro rata portion of the Aggregate Merger Consideration shall be deemed issued to such Company Member at Closing, subject to and contingent upon the
imposition of transfer restrictions and forfeiture conditions with respect to such excess shares of Parent Common Stock to be set forth in a written agreement between Parent and such Company Member in form and substance reasonably satisfactory to
Parent; provided, however, that in no event shall such excess shares of Parent Common Stock, which are subject to transfer restrictions and forfeiture conditions, exceed an amount of Parent Common Stock that would preclude the Parties from
treating the Mergers in a manner consistent with the Intended Tax Treatment. For the avoidance of doubt, the shares of Parent Common Stock issued to a Company Member as Stock Consideration in respect of such Company Members pro rata portion of
the Aggregate Merger Consideration shall not be subject to additional transfer restrictions and forfeiture conditions pursuant to the preceding sentence.
|
(g) |
Section 3.15(t) of the Merger Agreement is hereby amended and restated as follows: |
no Group Company has taken, or agreed to take, any action, or to the Knowledge of the Companies is aware of any fact or circumstance,
that could reasonably be expected to prevent or impede the Intended Tax Treatment.
|
(h) |
Section 4.10(p) of the Merger Agreement is hereby amended and restated as follows: |
Parent has not taken, or agreed to take, any action, or has knowledge of any fact or circumstance, that could reasonably be expected to
prevent or impede the Intended Tax Treatment.
A-2-2
|
(i) |
Section 5.7(d) of the Merger Agreement is hereby amended and restated as follows: |
Section 5.7(d) Tax Treatment.
(i) Each
of the Parties intends that each Merger shall qualify as a reorganization within the meaning of Section 368(a) of the Code, and that this Agreement be, and hereby is, adopted as a plan of reorganization for the purposes
of Sections 354, 361 and 368 of the Code and Treasury Regulations Section 1.368-2(g). The Parties agree to report for all Tax purposes in a manner consistent with, and not otherwise take any U.S. federal income Tax position inconsistent with,
this Section 5.7(d) unless otherwise required by a change in applicable Law, or as required pursuant to a determination within the meaning of Section 1313 of the Code. Except as required by applicable Law, the Parties shall not
take any action, or fail to take any action, that could reasonably be expected to prevent or impede the Intended Tax Treatment.
(ii)
Each of the Parties shall cooperate, including by making structural changes that may reasonably be necessary or warranted and that are not reasonably expected to impede or materially delay consummation of the Mergers, with each other and shall use
their commercially reasonable efforts to obtain the Intended Tax Treatment.
2. Confirmation. Except as
otherwise expressly provided herein, the provisions of the Merger Agreement shall remain in full force and effect in accordance with their respective terms following the execution of this First Amendment.
3. Governing Law; Jurisdiction; Waiver of Jury Trial. Sections 9.2 through 9.14, Section 9.16 and
Section 9.17 of the Merger Agreement are incorporated by reference herein and shall apply hereto mutatis mutandis.
4. Headings. The descriptive headings contained in this First Amendment are included for convenience of
reference only and shall not affect in any way the meaning or interpretation of this First Amendment.
5. Counterparts. This First Amendment may be executed in two or more counterparts, each of which shall be deemed
to be an original, but all of which taken together shall constitute one and the same agreement. Delivery of an executed counterpart of a signature page to this First Amendment by electronic means, including DocuSign,
e-mail, or scanned pages, shall be effective as delivery of a manually executed counterpart to this First Amendment.
[Signature Pages Follow]
A-2-3
IN WITNESS WHEREOF, each of the Parties has caused this First Amendment to be duly executed
on its behalf as of the date first above written.
|
|
|
EAST RESOURCES ACQUISITION
COMPANY |
|
|
By: |
|
/s/ Gary L. Hagerman, Jr. |
Name: |
|
Gary L. Hagerman, Jr. |
Title: |
|
Chief Financial Officer and Treasurer |
|
|
|
LMA MERGER SUB, LLC |
|
|
By: |
|
East Resources Acquisition Company, its sole
member |
|
|
By: |
|
/s/ Gary L. Hagerman, Jr. |
Name: |
|
Gary L. Hagerman, Jr. |
Title: |
|
Chief Financial Officer and Treasurer |
|
|
|
ABACUS MERGER SUB, LLC |
|
|
By: |
|
East Resources Acquisition Company, its sole
member |
|
|
By: |
|
/s/ Gary L. Hagerman, Jr. |
Name: |
|
Gary L. Hagerman, Jr. |
Title: |
|
Chief Financial Officer and Treasurer |
Signature Page to
First Amendment to Agreement and Plan of Merger
|
|
|
LONGEVITY MARKET ASSETS, LLC |
|
|
By: |
|
/s/ Jay Jackson |
Name: |
|
Jay Jackson |
Title: |
|
CEO |
|
|
|
ABACUS SETTLEMENTS, LLC |
|
|
By: |
|
/s/ Jay Jackson |
Name: |
|
Jay Jackson |
Title: |
|
CEO |
Signature Page to
First Amendment to Agreement and Plan of Merger
ANNEX A-3
SECOND AMENDMENT TO
AGREEMENT AND PLAN OF MERGER
This Second Amendment (Second Amendment) to the Merger Agreement (as defined below) is entered into as of April 20,
2023, by and among East Resources Acquisition Company, a Delaware corporation (Parent), LMA Merger Sub, LLC, a Delaware limited liability company and wholly owned subsidiary of Parent (LMA Merger Sub), Abacus
Merger Sub, LLC, a Delaware limited liability company and wholly owned subsidiary of Parent (Abacus Merger Sub), Longevity Market Assets, LLC, a Florida limited liability company (LMA), and Abacus Settlements,
LLC, a Florida limited liability company (Abacus). Parent, LMA Merger Sub, Abacus Merger Sub, LMA and Abacus are sometimes referred to in this Second Amendment collectively as the Parties. Capitalized terms used
but not defined herein shall have the meanings assigned to such terms in the Merger Agreement.
RECITALS
WHEREAS, the Parties entered into that certain Agreement and Plan of Merger, dated as of August 30, 2022, as amended on October 14,
2022 (as may be further amended, modified or supplemented from time to time, the Merger Agreement); and
WHEREAS, the
Parties desire to amend the Merger Agreement in accordance with Section 9.13 thereof as more fully set forth herein in order to, among other things, clarify the stockholder votes required to approve the Transaction
Proposals, require the Companies to deliver or cause to be delivered documentation relating to a tax election at the Closing and extend the Outside Date.
NOW THEREFORE, in consideration of the mutual agreements contained herein and for good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, and intending to be legally bound hereby, the Parties hereby agree as follows:
1. Amendment to Merger
Agreement.
|
(a) |
Section 4.2 of the Merger Agreement is hereby amended and restated as follows:
|
Section 4.2 Authorization. Each of the Parent Parties has the requisite corporate or
limited liability company power and authority, as applicable, to execute and deliver this Agreement and the Ancillary Agreements to which it is a party, to perform its obligations hereunder and thereunder and to consummate the transactions
contemplated hereby and thereby, subject in the case of the consummation of the Mergers, to the receipt of the requisite approval of the Transaction Proposals by the Parent Stockholders. The affirmative votes of the holders of a majority of the
shares of Parent Common Stock and Parent Class B Stock, voting (a) together as a single class, in the case of the Business Combination Proposal, the NASDAQ Proposal and the Incentive Plan Proposal, that are voted at the Parent Common
Stockholders Meeting, and (b) together as a single class, and as separate classes, in the case of the Charter Amendment Proposal, that are outstanding and entitled to vote on the Charter Amendment Proposal, are the only votes of the holders of
Parents capital stock required to approve the Transaction Proposals, assuming a quorum is present (the Parent Stockholder Approval). Parent Stockholder Approval of the Transaction Proposals are the only votes of any class or
series of Parents capital stock necessary to adopt this Agreement and any Ancillary Agreement and to approve the transactions contemplated hereby and thereby. The execution and delivery of this Agreement and the Ancillary Agreements and the
consummation of the transactions contemplated hereby and thereby have been duly authorized by all necessary corporate and limited liability company action. This Agreement has been, and the Ancillary Agreements to which any of the Parent Parties are
or will be a party as of the Closing Date shall be, duly authorized, executed and delivered by each of the Parent Parties, as
applicable, and, assuming the due authorization, execution and delivery by each other party hereto and thereto, constitutes the legal, valid and binding obligations of each of the Parent Parties,
as applicable, enforceable against each of the Parent Parties, as applicable, in accordance with their respective terms, subject to applicable bankruptcy, insolvency and other similar Laws affecting the enforceability of creditors rights
generally, general equitable principles and the discretion of courts in granting equitable remedies.
|
(b) |
Section 5.9(b) of the Merger Agreement is hereby amended and restated as follows:
|
(b) Without limitation, in the Proxy Statement, Parent shall (i) solicit proxies from holders
of Parent Common Stock and Parent Class B Stock to vote at the Parent Common Stockholders Meeting in favor of (A) the adoption of this Agreement and the approval of the transactions contemplated hereby pursuant to Section 251 of the
DGCL (the Business Combination Proposal), (B) the issuance of Parent Common Stock issuable pursuant to this Agreement at the Effective Time (the NASDAQ Proposal), (C) the adoption of an Omnibus Incentive Plan to
be negotiated between the Parties prior to Closing (the Omnibus Incentive Plan and such proposal, the Incentive Plan Proposal), (D) approval of the A&R Charter and each change to the A&R Charter that is
required to be separately approved (the Charter Amendment Proposal), and (E) any other proposals the Parties deem necessary or desirable to consummate the transactions contemplated hereby (collectively, the
Transaction Proposals), and (ii) file with the SEC financial and other information about the transactions contemplated hereby in accordance with the Exchange Act. The Proxy Statement will comply as to form and substance with
the applicable requirements of the Exchange Act and the rules and regulations thereunder. Each Company shall furnish all information concerning it and its Affiliates to Parent, and provide such other assistance, as may be reasonably requested in
connection with the preparation, filing and distribution of the Proxy Statement, and the Proxy Statement shall include all information reasonably requested by the Companies to be included therein. Without limiting the generality of the foregoing,
the Companies shall reasonably cooperate with Parent in connection with Parents preparation for inclusion in the Proxy Statement of pro forma financial statements that comply with the requirements of Regulation
S-X under the rules and regulations of the SEC (as interpreted by the staff of the SEC) to the extent such pro forma financial statements are required by the Proxy Statement. Each of the Companies and Parent
shall promptly notify the other upon the receipt of any comments from the SEC or any request from the SEC for amendments or supplements to the Proxy Statement and shall provide the other with copies of all correspondence between it and its
Representatives, on the one hand, and the SEC, on the other hand. Each of the Companies and Parent shall use its reasonable best efforts to respond as promptly as reasonably practicable to any comments from the SEC with respect to the Proxy
Statement.
|
(c) |
Section 7.2 of the Merger Agreement is hereby amended and restated as follows:
|
Section 7.2 Deliveries by the Companies. At the Closing, the Companies will deliver or
cause to be delivered to Parent (unless delivered previously) the following:
(a) the Certificates of Merger, executed by
LMA and Abacus, as applicable;
(b) the Company Closing Certificate;
(c) the A&R Registration Rights Agreement executed by each Company and each of the Company Members;
(d) a duly executed and file-stamped copy of IRS Form 8832, indicating an election to be treated as an entity disregarded
separate from Parent pursuant to Treasury Regulations Section 301.7701-3(c) with an effective date of the next business day after the effective date of the Merger, by LMA and Abacus, as applicable; and
(e) any other document required to be delivered by the Companies at Closing pursuant to this Agreement.
A-3-2
|
(d) |
Section 8.1(e) of the Merger Agreement is hereby amended and restated as follows:
|
(e) by written notice by any Party if the Closing has not occurred on or prior to July 27,
2023 (the Outside Date).
2. Confirmation. Except as otherwise expressly provided herein, the provisions of
the Merger Agreement shall remain in full force and effect in accordance with their respective terms following the execution of this Second Amendment.
3. Governing Law; Jurisdiction; Waiver of Jury Trial. Sections 9.2 through 9.14, Section 9.16
and Section 9.17 of the Merger Agreement are incorporated by reference herein and shall apply hereto mutatis mutandis.
4. Headings. The descriptive headings contained in this Second Amendment are included for convenience of reference only and shall not
affect in any way the meaning or interpretation of this Second Amendment.
5. Counterparts. This Second Amendment may be executed
in two or more counterparts, each of which shall be deemed to be an original, but all of which taken together shall constitute one and the same agreement. Delivery of an executed counterpart of a signature page to this Second Amendment by electronic
means, including DocuSign, e-mail, or scanned pages, shall be effective as delivery of a manually executed counterpart to this Second Amendment.
[Signature Pages Follow]
A-3-3
IN WITNESS WHEREOF, each of the Parties has caused this Second Amendment to be duly
executed on its behalf as of the date first above written.
|
|
|
EAST RESOURCES ACQUISITION COMPANY |
|
|
By: |
|
/s/ Gary L. Hagerman, Jr. |
Name: |
|
Gary L. Hagerman, Jr. |
Title: |
|
Chief Financial Officer and Treasurer |
|
LMA MERGER SUB, LLC |
|
|
By: |
|
East Resources Acquisition Company, |
|
|
its sole member |
|
|
By: |
|
/s/ Gary L. Hagerman, Jr. |
Name: |
|
Gary L. Hagerman, Jr. |
Title: |
|
Chief Financial Officer and Treasurer |
|
ABACUS MERGER SUB, LLC |
|
|
By: |
|
East Resources Acquisition Company, |
|
|
its sole member |
|
|
By: |
|
/s/ Gary L. Hagerman, Jr. |
Name: |
|
Gary L. Hagerman, Jr. |
Title: |
|
Chief Financial Officer and Treasurer |
Signature Page to Second Amendment to Agreement and Plan of Merger
|
|
|
LONGEVITY MARKET ASSETS, LLC |
|
|
By: |
|
/s/ Jay Jackson |
Name: |
|
Jay Jackson |
Title: |
|
CEO |
|
ABACUS SETTLEMENTS, LLC |
|
|
By: |
|
/s/ Jay Jackson |
Name: |
|
Jay Jackson |
Title: |
|
CEO |
Signature Page to Second Amendment to Agreement and Plan of Merger
ANNEX B
FORM OF A&R CHARTER
SECOND AMENDED AND RESTATED
CERTIFICATE OF INCORPORATION
OF
EAST RESOURCES
ACQUISITION COMPANY
[ ], 20[ ]
East Resources Acquisition Company, a corporation organized and existing under the laws of the State of Delaware (the
Corporation), DOES HEREBY CERTIFY AS FOLLOWS:
1. The name of the Corporation is East Resources Acquisition
Company. The original certificate of incorporation of the Corporation was filed with the Secretary of State of the State of Delaware on May 22, 2020 which was subsequently amended and restated as of July 23, 2020 (the
Amended and Restated Certificate).
2. This Second Amended and Restated Certificate of Incorporation (this
Second Amended and Restated Certificate), which both restates and amends the provisions of the Amended and Restated Certificate, was duly adopted in accordance with Sections 228, 242 and 245 of the General
Corporation Law of the State of Delaware, as amended from time to time (the DGCL).
3. This Second Amended and
Restated Certificate of Incorporation shall become effective on the date of filing with the Secretary of State of Delaware.
4. The text
of the Amended and Restated Certificate is hereby restated and amended in its entirety to read as follows:
ARTICLE I
NAME
The name of the
corporation is Abacus Life, Inc. (the Corporation).
ARTICLE II
PURPOSE
The purpose of
the Corporation is to engage in any lawful act or activity for which corporations may be organized under the DGCL. In addition to the powers and privileges conferred upon the Corporation by law and those incidental thereto, the Corporation shall
possess and may exercise all the powers and privileges that are necessary or convenient to the conduct, promotion or attainment of the business or purposes of the Corporation.
ARTICLE III
REGISTERED
AGENT
The address of the Corporations registered office in the State of Delaware is 850 New Burton Road, Ste. 201, in the City
of Dover, County of Kent, State of Delaware, 19904, and the name of the Corporations registered agent at such address is Cogency Global Inc.
B-1
ARTICLE IV
CAPITALIZATION
Section 4.1 Authorized Capital Stock. The total number of shares of all classes of capital stock, each with a par value of $0.0001
per share, which the Corporation is authorized to issue is 201,000,000 shares, consisting of (a) 200,000,000 shares of common stock (the Common Stock) and (b) 1,000,000 shares of preferred stock, par value $0.0001
per share (the Preferred Stock).
Section 4.2 Preferred Stock. The Board of Directors of the
Corporation (the Board) is hereby expressly authorized to provide out of the unissued shares of the Preferred Stock for one or more series of Preferred Stock and to establish from time to time the number of shares to be
included in each such series and to fix the voting rights, if any, designations, powers, preferences and relative, participating, optional, special and other rights, if any, of each such series and any qualifications, limitations and restrictions
thereof, as shall be stated in the resolution or resolutions adopted by the Board providing for the issuance of such series and included in a certificate of designation (a Preferred Stock Designation) filed pursuant to the
DGCL, and the Board is hereby expressly vested with the authority to the full extent provided by law, now or hereafter, to adopt any such resolution or resolutions.
Section 4.3 Common Stock.
(a) Voting.
(i) Except
as otherwise required by law or this Second Amended and Restated Certificate (including any Preferred Stock Designation), the holders of the shares of Common Stock shall exclusively possess all voting power with respect to the Corporation.
(ii) Except as otherwise required by law or this Second Amended and Restated Certificate (including any Preferred Stock Designation), the
holders of shares of Common Stock shall be entitled to one vote for each such share on each matter properly submitted to the stockholders of the Corporation on which the holders of the Common Stock are entitled to vote.
(iii) Except as otherwise required by law or this Second Amended and Restated Certificate (including any Preferred Stock Designation), at any
annual or special meeting of the stockholders of the Corporation, holders of Common Stock shall have the exclusive right to vote for the election of directors and on all other matters properly submitted to a vote of the stockholders. Notwithstanding
the foregoing, except as otherwise required by law or this Second Amended and Restated Certificate (including any Preferred Stock Designation), holders of shares of any series of Common Stock shall not be entitled to vote on any amendment to this
Second Amended and Restated Certificate (including any amendment to any Preferred Stock Designation) that relates solely to the terms of one or more outstanding series of Preferred Stock or other series of Common Stock if the holders of such
affected series of Preferred Stock or Common Stock, as applicable, are entitled, either separately or together with the holders of one or more other such series, to vote thereon pursuant to this Second Amended and Restated Certificate (including any
Preferred Stock Designation) or the DGCL.
(b) Dividends. Subject to applicable law, the rights, if any, of the holders of any
outstanding series of the Preferred Stock, the holders of shares of Common Stock shall be entitled to receive such dividends and other distributions (payable in cash, property or capital stock of the Corporation) when, as and if declared thereon by
the Board from time to time out of any assets or funds of the Corporation legally available therefor and shall share equally on a per share basis in such dividends and distributions.
(c) Liquidation, Dissolution or Winding Up of the Corporation. Subject to applicable law, the rights, if any, of the holders of any
outstanding series of the Preferred Stock, in the event of any voluntary or involuntary liquidation, dissolution or winding up of the Corporation, after payment or provision for payment of the debts
B-2
and other liabilities of the Corporation, the holders of shares of Common Stock shall be entitled to receive all the remaining assets of the Corporation available for distribution to its
stockholders, ratably in proportion to the number of shares of Common Stock held by them.
Section 4.4 Rights and Options. The
Corporation has the authority to create and issue rights, warrants and options entitling the holders thereof to acquire from the Corporation any shares of its capital stock of any class or classes, with such rights, warrants and options to be
evidenced by or in instrument(s) approved by the Board. The Board is empowered to set the exercise price, duration, times for exercise and other terms and conditions of such rights, warrants or options; provided, however, that the
consideration to be received for any shares of capital stock issuable upon exercise thereof may not be less than the par value thereof.
ARTICLE V
BOARD OF
DIRECTORS
Section 5.1 Board Powers. The business and affairs of the Corporation shall be managed by, or under the
direction of, the Board. In addition to the powers and authority expressly conferred upon the Board by statute, this Second Amended and Restated Certificate or the Bylaws of the Corporation (Bylaws), the Board is hereby
empowered to exercise all such powers and do all such acts and things as may be exercised or done by the Corporation, subject, nevertheless, to the provisions of the DGCL, this Second Amended and Restated Certificate, and any Bylaws adopted by the
stockholders of the Corporation; provided, however, that no Bylaws hereafter adopted by the stockholders of the Corporation shall invalidate any prior act of the Board that would have been valid if such Bylaws had not been adopted.
Section 5.2 Number, Election and Term.
(a) The number of directors of the Corporation, other than those who may be elected by the holders of one or more series of the Preferred
Stock voting separately by class or series, shall be fixed from time to time exclusively by the Board pursuant to a resolution adopted by a majority of the Board.
(b) Subject to Section 5.5, the Board shall be divided into three classes, as nearly equal in number as possible and
designated Class I, Class II and Class III. The Board is authorized to assign members of the Board already in office to Class I, Class II or Class III. The term of the initial Class I Directors shall expire at the
first annual meeting of the stockholders of the Corporation following the effectiveness of this Second Amended and Restated Certificate; the term of the initial Class II Directors shall expire at the second annual meeting of the stockholders of
the Corporation following the effectiveness of this Second Amended and Restated Certificate; and the term of the initial Class III Directors shall expire at the third annual meeting of the stockholders of the Corporation following the
effectiveness of this Second Amended and Restated Certificate. At each succeeding annual meeting of the stockholders of the Corporation, beginning with the first annual meeting of the stockholders of the Corporation following the effectiveness of
this Second Amended and Restated Certificate, each of the successors elected to replace the class of directors whose term expires at that annual meeting shall be elected for a three-year term or until the election and qualification of their
respective successors in office, subject to their earlier death, resignation or removal. Subject to Section 5.5, if the number of directors that constitute the Board is changed, any increase or decrease shall be apportioned
by the Board among the classes so as to maintain the number of directors in each class as nearly equal as possible, but in no case shall a decrease in the number of directors constituting the Board shorten the term of any incumbent director. Subject
to the rights of the holders of one or more series of Preferred Stock, voting separately by class or series, to elect directors pursuant to the terms of one or more series of Preferred Stock, directors shall be elected by a plurality of the votes
cast by the stockholders present in person or represented by proxy at the meeting and entitled to vote thereon. The Board is hereby expressly authorized, by resolution or resolutions thereof, to assign members of the Board already in office to the
aforesaid classes at the time this Second Amended and Restated Certificate (and therefore such classification) becomes effective in accordance with the DGCL.
B-3
(c) Subject to Section 5.5, a director shall hold office until the
annual meeting for the year in which his or her term expires and until his or her successor has been elected and qualified, subject, however, to such directors earlier death, resignation, retirement, disqualification or removal.
(d) Unless and except to the extent that the Bylaws shall so require, the election of directors need not be by written ballot. There is no
cumulative voting with respect to the election of directors.
Section 5.3 Newly Created Directorships and Vacancies. Subject
to Section 5.5, newly created directorships resulting from an increase in the number of directors and any vacancies on the Board resulting from death, resignation, retirement, disqualification, removal or other cause may be
filled solely and exclusively by a majority vote of the remaining directors then in office, even if less than a quorum, or by a sole remaining director (and not by stockholders), and any director so chosen shall hold office for the remainder of the
full term of the class of directors to which the new directorship was added or in which the vacancy occurred and until his or her successor has been elected and qualified, subject, however, to such directors earlier death, resignation,
retirement, disqualification or removal.
Section 5.4 Removal. Subject to Section 5.5 and except as
otherwise required by this Second Amended and Restated Certificate, any or all of the directors may be removed from office at any time, but only for cause and only by the affirmative vote of holders of a majority of the voting power of all then
outstanding shares of capital stock of the Corporation entitled to vote generally in the election of directors, voting together as a single class.
Section 5.5 Preferred StockDirectors. Notwithstanding any other provision of this Article V, and
except as otherwise required by law, whenever the holders of one or more series of the Preferred Stock shall have the right, voting separately by class or series, to elect one or more directors, the term of office, the filling of vacancies, the
removal from office and other features of such directorships shall be governed by the terms of such series of the Preferred Stock as set forth in this Second Amended and Restated Certificate (including any Preferred Stock Designation) and such
directors shall not be included in any of the classes created pursuant to this Article V unless expressly provided by such terms.
ARTICLE VI
BYLAWS
In furtherance and not in limitation of the powers conferred upon it by law, the Board shall have the power and is expressly
authorized to adopt, amend, alter or repeal the Bylaws by the affirmative vote of a majority of the total number of directors present at a regular or special meeting of the Board at which there is a quorum or by unanimous written consent. The Bylaws
also may be adopted, amended, altered or repealed by the stockholders; provided, however, that in addition to any vote of the holders of any class or series of capital stock of the Corporation required by law or by this Second Amended
and Restated Certificate (including any Preferred Stock Designation), the affirmative vote of the holders of at least a majority of the voting power of all then outstanding shares of capital stock of the Corporation entitled to vote generally in the
election of directors, voting together as a single class, shall be required for the stockholders of the Corporation to adopt, amend, alter or repeal the Bylaws; and provided further, however, that no Bylaws hereafter adopted by the
stockholders of the Corporation shall invalidate any prior act of the Board that would have been valid if such Bylaws had not been adopted.
ARTICLE VII
SPECIAL
MEETINGS OF STOCKHOLDERS; ACTION BY WRITTEN CONSENT
Section 7.1 Special Meetings. Subject to the rights, if any, of the
holders of any outstanding series of the Preferred Stock, and to the requirements of applicable law, special meetings of stockholders of the Corporation may be called only by the Chairman of the Board, Chief Executive Officer of the Corporation, or
the Board
B-4
pursuant to a resolution adopted by a majority of the Board, and the ability of the stockholders of the Corporation to call a special meeting is hereby specifically denied. Except as provided in
the foregoing sentence, special meetings of stockholders of the Corporation may not be called by another person or persons.
Section 7.2 Advance Notice. Advance notice of stockholder nominations for the election of directors and of business to be brought
by stockholders before any meeting of the stockholders of the Corporation shall be given in the manner provided in the Bylaws.
Section 7.3 Action by Written Consent. Except as may be otherwise provided for or fixed pursuant to this Second Amended and
Restated Certificate (including any Preferred Stock Designation) relating to the rights of the holders of any outstanding series of Preferred Stock, any action required or permitted to be taken by the stockholders of the Corporation must be effected
by a duly called annual or special meeting of such stockholders and may not be effected by written consent of the stockholders.
ARTICLE
VIII
LIMITED LIABILITY; INDEMNIFICATION
Section 8.1 Limitation of Director Liability. A director or officer of the Corporation shall not be personally liable to the
Corporation or its stockholders for monetary damages for breach of fiduciary duty as a director or officer, except to the extent such exemption from liability or limitation thereof is not permitted under the DGCL as the same exists or may hereafter
be amended unless a director or officer violated his or her duty of loyalty to the Corporation or its stockholders, acted in bad faith, knowingly or intentionally violated the law, authorized unlawful payments of dividends, unlawful stock purchases
or unlawful redemptions, or derived improper personal benefit from his or her actions as a director. Any amendment, modification or repeal of the foregoing sentence shall not adversely affect any right or protection of a director or officer of the
Corporation hereunder in respect of any act or omission occurring prior to the time of such amendment, modification or repeal.
Section 8.2 Indemnification and Advancement of Expenses.
(a) To the fullest extent permitted by applicable law, as the same exists or may hereafter be amended, the Corporation shall indemnify and
hold harmless each person who is or was made a party or is threatened to be made a party to or is otherwise involved in any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (a
proceeding) by reason of the fact that he or she is or was a director or officer of the Corporation or, while a director or officer of the Corporation, is or was serving at the request of the Corporation as a director,
officer, employee or agent of another corporation or of a partnership, joint venture, trust, other enterprise or nonprofit entity, including service with respect to an employee benefit plan (an indemnitee), whether the
basis of such proceeding is alleged action in an official capacity as a director, officer, employee or agent, or in any other capacity while serving as a director, officer, employee or agent, against all liability and loss suffered and expenses
(including, without limitation, attorneys fees, judgments, fines, ERISA excise taxes and penalties and amounts paid in settlement) reasonably incurred by such indemnitee in connection with such proceeding. The Corporation shall to the fullest
extent not prohibited by applicable law pay the expenses (including attorneys fees) incurred by an indemnitee in defending or otherwise participating in any proceeding in advance of its final disposition; provided, however, that,
to the extent required by applicable law, such payment of expenses in advance of the final disposition of the proceeding shall be made only upon receipt of an undertaking, by or on behalf of the indemnitee, to repay all amounts so advanced if it
shall ultimately be determined that the indemnitee is not entitled to be indemnified under this Section 8.2 or otherwise. The rights to indemnification and advancement of expenses conferred by this
Section 8.2 shall be contract rights and such rights shall continue as to an indemnitee who has ceased to be a director, officer, employee or agent and shall inure to the benefit of his or her heirs, executors and
administrators. Notwithstanding the foregoing provisions of this Section 8.2(a), except for proceedings to enforce rights to indemnification and advancement of expenses, the Corporation shall indemnify and advance expenses
to an
B-5
indemnitee in connection with a proceeding (or part thereof) initiated by such indemnitee only if such proceeding (or part thereof) was authorized by the Board.
(b) The rights to indemnification and advancement of expenses conferred on any indemnitee by this Section 8.2 shall
not be exclusive of any other rights that any indemnitee may have or hereafter acquire under law, this Second Amended and Restated Certificate, the Bylaws, an agreement, vote of stockholders or disinterested directors, or otherwise.
(c) Any repeal or amendment of this Section 8.2 by the stockholders of the Corporation or by changes in law, or the
adoption of any other provision of this Second Amended and Restated Certificate inconsistent with this Section 8.2, shall, unless otherwise required by law, be prospective only (except to the extent such amendment or change
in law permits the Corporation to provide broader indemnification rights on a retroactive basis than permitted prior thereto), and shall not in any way diminish or adversely affect any right or protection existing at the time of such repeal or
amendment or adoption of such inconsistent provision in respect of any proceeding (regardless of when such proceeding is first threatened, commenced or completed) arising out of, or related to, any act or omission occurring prior to such repeal or
amendment or adoption of such inconsistent provision.
(d) This Section 8.2 shall not limit the right of the
Corporation, to the extent and in the manner authorized or permitted by law, to indemnify and to advance expenses to persons other than indemnitees.
ARTICLE IX
[RESERVED]
ARTICLE X
CORPORATE OPPORTUNITY
To
the extent allowed by law, the doctrine of corporate opportunity, or any other analogous doctrine, shall not apply with respect to the Corporation or any of its officers or directors, and the Corporation renounces any expectancy that any of the
directors or officers of the Corporation will offer any such corporate opportunity of which he or she may become aware to the Corporation, except, the doctrine of corporate opportunity shall apply with respect to any of the directors or officers of
the Corporation only with respect to a corporate opportunity that was offered to such person solely in his or her capacity as a director or officer of the Corporation and such opportunity is one the Corporation is legally and contractually permitted
to undertake and would otherwise be reasonable for the Corporation to pursue, and to the extent the director or officer is permitted to refer that opportunity to the Corporation without violating any legal obligation.
ARTICLE XI
AMENDMENTS
The Corporation reserves the right at any time and from time to time to amend, alter, change or repeal any provision contained in
this Second Amended and Restated Certificate (including any Preferred Stock Designation), and other provisions authorized by the laws of the State of Delaware at the time in force that may be added or inserted, in the manner now or hereafter
prescribed by this Second Amended and Restated Certificate and the DGCL; and, except as set forth in Article VIII, all rights, preferences and privileges of whatever nature herein conferred upon stockholders, directors or
any other persons by and pursuant to this Second Amended and Restated Certificate in its present form or as hereafter amended are granted subject to the right reserved in this Article XI.
B-6
ARTICLE XII
EXCLUSIVE FORUM FOR CERTAIN LAWSUITS
Section 12.1 Forum. Unless the Corporation consents in writing to the selection of an alternative forum, the Court of
Chancery of the State of Delaware (the Court of Chancery) shall to the fullest extent permitted by law be the sole and exclusive forum for any stockholder (including a beneficial owner) to bring (i) any derivative
action or proceeding brought on behalf of the Corporation, (ii) any action asserting a claim of breach of a fiduciary duty owed by any director, officer or other employee of the Corporation to the Corporation or the Corporations
stockholders, (iii) any action asserting a claim against the Corporation, its directors, officers or employees arising pursuant to any provision of the DGCL or this Second Amended and Restated Certificate or the Bylaws, or (iv) any action
asserting a claim against the Corporation, its directors, officers or employees governed by the internal affairs doctrine, except for, as to each of (i) through (iv) above, any claim as to which the Court of Chancery determines that there
is an indispensable party not subject to the jurisdiction of the Court of Chancery (and the indispensable party does not consent to the personal jurisdiction of the Court of Chancery within ten days following such determination), which is vested in
the exclusive jurisdiction of a court or forum other than the Court of Chancery, or for which the Court of Chancery does not have subject matter jurisdiction; and subject to the preceding provisions of this Section 12.1, the federal district
courts of the United States of America shall be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act of 1933, as amended.
Section 12.2 Consent to Jurisdiction. If any action the subject matter of which is within the scope of
Section 12.1 immediately above is filed in a court other than a court located within the State of Delaware (a Foreign Action) in the name of any stockholder, such stockholder shall be deemed to
have consented to (i) the personal jurisdiction of the state and federal courts located within the State of Delaware in connection with any action brought in any such court to enforce Section 12.1 immediately above (an
FSC Enforcement Action) and (ii) having service of process made upon such stockholder in any such FSC Enforcement Action by service upon such stockholders counsel in the Foreign Action as agent for such
stockholder.
Any person or entity purchasing or otherwise acquiring any interest in any security of the Corporation shall be deemed to
have notice of and consented to this Article XII. Notwithstanding the foregoing, the provisions of this Article XII shall not apply to suits brought to enforce any liability or duty created by the Exchange Act or any other claim for
which the federal courts of the United States have exclusive jurisdiction.
ARTICLE XIII
SEVERABILITY
If any
provision or provisions (or any part thereof) of this Second Amended and Restated Certificate shall be held to be invalid, illegal or unenforceable as applied to any person or entity or circumstance for any reason whatsoever, then, to the fullest
extent permitted by law, (i) the validity, legality and enforceability of such provisions in any other circumstance and of the remaining provisions of this Second Amended and Restated Certificate (including, without limitation, each portion of
any paragraph of this Second Amended and Restated Certificate containing any such provision held to be invalid, illegal or unenforceable that is not itself held to be invalid, illegal or unenforceable) and the application of such provision to other
persons or entities and circumstances shall not in any way be affected or impaired thereby, and (ii) the provisions of this Second Amended and Restated (including, without limitation, each portion of any paragraph of this Second Amended and
Restated Certificate containing any such provision held to be invalid, illegal or unenforceable) shall be construed so as to permit the Corporation to protect its directors, officers, employees and agents from personal liability in respect of their
faith service or for the benefit of the Corporation to the fullest extent permitted by law.
[Signature page follows]
B-7
IN WITNESS WHEREOF, East Resources Acquisition Company has caused this Second Amended and
Restated Certificate to be duly executed and acknowledged in its name and on its behalf by an authorized officer as of the date first set forth above.
|
|
|
EAST RESOURCES ACQUISITION COMPANY |
|
|
By: |
|
|
Name: |
|
|
Title: |
|
|
[Signature Page to Second
Amended and Restated Certificate of Incorporation]
B-8
ANNEX C
FORM OF A&R BYLAWS
AMENDED AND RESTATED
BYLAWS
OF
ABACUS LIFE, INC.
(THE
CORPORATION)
ARTICLE I
OFFICES
Section 1.1. Registered Office. The registered office of the Corporation within the State of Delaware shall
be located at either (a) the principal place of business of the Corporation in the State of Delaware or (b) the office of the corporation or individual acting as the Corporations registered agent in Delaware.
Section 1.2. Additional Offices. The Corporation may, in addition to its registered office in the State of
Delaware, have such other offices and places of business, both within and outside the State of Delaware, as the Board of Directors of the Corporation (the Board) may from time to time determine or as the business and
affairs of the Corporation may require.
ARTICLE II
STOCKHOLDERS MEETINGS
Section 2.1. Annual Meetings. The annual meeting of stockholders shall be held at such place, either within
or without the State of Delaware, and time and on such date as shall be determined by the Board and stated in the notice of the meeting, provided that the Board may in its sole discretion determine that the meeting shall not be held at any
place, but may instead be held solely by means of remote communication pursuant to Section 9.5(a). At each annual meeting, the stockholders entitled to vote on such matters shall elect those directors of the
Corporation to fill any term of a directorship that expires on the date of such annual meeting and may transact any other business as may properly be brought before the meeting.
Section 2.2. Special Meetings. Subject to the rights of the holders of any outstanding series of the
preferred stock of the Corporation (Preferred Stock), and to the requirements of applicable law, special meetings of stockholders, for any purpose or purposes, may be called only by the Chairman of the Board, the Chief
Executive Officer or the Board pursuant to a resolution adopted by a majority of the Board, and may not be called by any other person. Special meetings of stockholders shall be held at such place, either within or without the State of Delaware, and
at such time and on such date as shall be determined by the Board and stated in the Corporations notice of the meeting, provided that the Board may in its sole discretion determine that the meeting shall not be held at any place, but
may instead be held solely by means of remote communication pursuant to Section 9.5(a).
Section 2.3. Notices. Written notice of each stockholders meeting stating the place, if any, date, and time
of the meeting, and the means of remote communication, if any, by which stockholders and proxy holders may be deemed to be present in person and vote at such meeting and the record date for determining the stockholders entitled to vote at the
meeting, if such date is different from the record date for determining stockholders entitled to notice of the meeting, shall be given in the manner permitted by Section 9.3 to each stockholder entitled to vote
thereat as of the record date for determining the stockholders entitled to notice of the meeting, by the Corporation not less than 10 nor more than 60 days before the date of the meeting unless otherwise required by
C-1
the General Corporation Law of the State of Delaware (the DGCL). If said notice is for a stockholders meeting other than an annual meeting, it shall in addition state
the purpose or purposes for which the meeting is called, and the business transacted at such meeting shall be limited to the matters so stated in the Corporations notice of meeting (or any supplement thereto). Any meeting of stockholders as to
which notice has been given may be postponed, and any meeting of stockholders as to which notice has been given may be cancelled, by the Board upon public announcement (as defined in Section 2.7(c)) given before the
date previously scheduled for such meeting.
Section 2.4. Quorum. Except as otherwise provided by
applicable law, the Corporations Certificate of Incorporation, as the same may be amended or restated from time to time (the Certificate of Incorporation) or these Bylaws, the presence, in person or by proxy, at a
stockholders meeting of the holders of shares of outstanding capital stock of the Corporation representing a majority of the voting power of all outstanding shares of capital stock of the Corporation entitled to vote at such meeting shall constitute
a quorum for the transaction of business at such meeting, except that when specified business is to be voted on by a class or series of stock voting as a class, the holders of shares representing a majority of the voting power of the outstanding
shares of such class or series shall constitute a quorum of such class or series for the transaction of such business. If a quorum shall not be present or represented by proxy at any meeting of the stockholders of the Corporation, the chairman of
the meeting may adjourn the meeting from time to time in the manner provided in Section 2.6 until a quorum shall attend. The stockholders present at a duly convened meeting may continue to transact business until
adjournment, notwithstanding the withdrawal of enough stockholders to leave less than a quorum. Shares of its own stock belonging to the Corporation or to another corporation, if a majority of the voting power of the shares entitled to vote in the
election of directors of such other corporation is held, directly or indirectly, by the Corporation, shall neither be entitled to vote nor be counted for quorum purposes; provided, however, that the foregoing shall not limit the right
of the Corporation or any such other corporation to vote shares held by it in a fiduciary capacity.
Section 2.5. Voting of
Shares.
(a) Voting Lists. The Secretary of the Corporation (the Secretary) shall prepare, or shall
cause the officer or agent who has charge of the stock ledger of the Corporation to prepare and make, at least 10 days before every meeting of stockholders, a complete list of the stockholders of record entitled to vote at such meeting;
provided, however, that if the record date for determining the stockholders entitled to vote is less than 10 days before the meeting date, the list shall reflect the stockholders entitled to vote as of the tenth day before the meeting
date, arranged in alphabetical order and showing the address and the number and class of shares registered in the name of each stockholder. Nothing contained in this Section 2.5(a) shall require the Corporation to include
electronic mail addresses or other electronic contact information on such list. Such list shall be open to the examination of any stockholder, for any purpose germane to the meeting, during ordinary business hours for a period of at least
10 days prior to the meeting: (i) on a reasonably accessible electronic network, provided that the information required to gain access to such list is provided with the notice of the meeting, or (ii) during ordinary business
hours, at the principal place of business of the Corporation. In the event that the Corporation determines to make the list available on an electronic network, the Corporation may take reasonable steps to ensure that such information is available
only to stockholders of the Corporation. If the meeting is to be held at a place, then the list shall be produced and kept at the time and place of the meeting during the whole time thereof, and may be inspected by any stockholder who is present. If
a meeting of stockholders is to be held solely by means of remote communication as permitted by Section 9.5(a), the list shall be open to the examination of any stockholder during the whole time of the meeting on a
reasonably accessible electronic network, and the information required to access such list shall be provided with the notice of meeting. The stock ledger shall be the only evidence as to who are the stockholders entitled to examine the list required
by this Section 2.5(a) or to vote in person or by proxy at any meeting of stockholders.
(b) Manner of
Voting. At any stockholders meeting, every stockholder entitled to vote may vote in person or by proxy. If authorized by the Board, the voting by stockholders or proxy holders at any meeting conducted by
C-2
remote communication may be effected by a ballot submitted by electronic transmission (as defined in Section 9.3), provided that any such electronic
transmission must either set forth or be submitted with information from which the Corporation can determine that the electronic transmission was authorized by the stockholder or proxy holder. The Board, in its discretion, or the chairman of the
meeting of stockholders, in such persons discretion, may require that any votes cast at such meeting shall be cast by written ballot.
(c) Proxies. Each stockholder entitled to vote at a meeting of stockholders or to express consent or dissent to corporate action in
writing without a meeting may authorize another person or persons to act for such stockholder by proxy, but no such proxy shall be voted or acted upon after three years from its date, unless the proxy provides for a longer period. Proxies need not
be filed with the Secretary until the meeting is called to order, but shall be filed with the Secretary before being voted. Without limiting the manner in which a stockholder may authorize another person or persons to act for such stockholder as
proxy, either of the following shall constitute a valid means by which a stockholder may grant such authority. No stockholder shall have cumulative voting rights.
(i) A stockholder may execute a writing authorizing another person or persons to act for such stockholder as proxy. Execution may be
accomplished by the stockholder or such stockholders authorized officer, director, employee or agent signing such writing or causing such persons signature to be affixed to such writing by any reasonable means, including, but not limited
to, by facsimile signature.
(ii) A stockholder may authorize another person or persons to act for such stockholder as proxy by
transmitting or authorizing the transmission of an electronic transmission to the person who will be the holder of the proxy or to a proxy solicitation firm, proxy support service organization or like agent duly authorized by the person who will be
the holder of the proxy to receive such transmission, provided that any such electronic transmission must either set forth or be submitted with information from which it can be determined that the electronic transmission was authorized by the
stockholder. Any copy, facsimile telecommunication or other reliable reproduction of the writing or transmission authorizing another person or persons to act as proxy for a stockholder may be substituted or used in lieu of the original writing or
transmission for any and all purposes for which the original writing or transmission could be used; provided that such copy, facsimile telecommunication or other reproduction shall be a complete reproduction of the entire original writing or
transmission.
(d) Required Vote. Subject to the rights of the holders of one or more series of Preferred Stock, voting separately
by class or series, to elect directors pursuant to the terms of one or more series of Preferred Stock, at all meetings of stockholders at which a quorum is present, the election of directors shall be determined by a plurality of the votes cast by
the stockholders present in person or represented by proxy at the meeting and entitled to vote thereon. All other matters presented to the stockholders at a meeting at which a quorum is present shall be determined by the vote of a majority of the
votes cast by the stockholders present in person or represented by proxy at the meeting and entitled to vote thereon, unless the matter is one upon which, by applicable law, the Certificate of Incorporation, these Bylaws or applicable stock exchange
rules, a different vote is required, in which case such provision shall govern and control the decision of such matter.
(e) Inspectors
of Election. The Board may, and shall if required by law, in advance of any meeting of stockholders, designate one or more persons as inspectors of election, who may be employees of the Corporation or otherwise serve the Corporation in other
capacities, to act at such meeting of stockholders or any adjournment thereof and to make a written report thereof. The Board may appoint one or more persons as alternate inspectors to replace any inspector who fails to act. If no inspectors of
election or alternates are appointed by the Board, the chairman of the meeting shall appoint one or more inspectors to act at the meeting. Each inspector, before discharging his or her duties, shall take and sign an oath faithfully to execute the
duties of inspector with strict impartiality and according to the best of his or her ability. The inspectors shall ascertain and report the number of outstanding shares and the voting power of each; determine the number of shares present in person
or represented by proxy at the meeting and the validity of proxies and ballots; count all votes and ballots and report the results; determine and retain for a reasonable period a record of the disposition of any challenges made to any determination
by the inspectors; and certify their determination of the number of shares represented at the
C-3
meeting and their count of all votes and ballots. No person who is a candidate for an office at an election may serve as an inspector at such election. Each report of an inspector shall be in
writing and signed by the inspector or by a majority of them if there is more than one inspector acting at such meeting. If there is more than one inspector, the report of a majority shall be the report of the inspectors.
Section 2.6. Adjournments. Any meeting of stockholders, annual or special, may be adjourned by the chairman
of the meeting, from time to time, whether or not there is a quorum, to reconvene at the same or some other place. Notice need not be given of any such adjourned meeting if the date, time, and place, if any, thereof, and the means of remote
communication, if any, by which stockholders and proxy holders may be deemed to be present in person and vote at such adjourned meeting are announced at the meeting at which the adjournment is taken. At the adjourned meeting the stockholders, or the
holders of any class or series of stock entitled to vote separately as a class, as the case may be, may transact any business that might have been transacted at the original meeting. If the adjournment is for more than 30 days, notice of the
adjourned meeting shall be given to each stockholder of record entitled to vote at the meeting. If after the adjournment a new record date for stockholders entitled to vote is fixed for the adjourned meeting, the Board shall fix a new record date
for notice of such adjourned meeting in accordance with Section 9.2, and shall give notice of the adjourned meeting to each stockholder of record entitled to vote at such adjourned meeting as of the record date fixed for
notice of such adjourned meeting.
Section 2.7. Advance Notice for Business.
(a) Annual Meetings of Stockholders. No business may be transacted at an annual meeting of stockholders, other than business that is
either (i) specified in the Corporations notice of meeting (or any supplement thereto) given by or at the direction of the Board, (ii) otherwise properly brought before the annual meeting by or at the direction of the Board or
(iii) otherwise properly brought before the annual meeting by any stockholder of the Corporation (x) who is a stockholder of record entitled to vote at such annual meeting on the date of the giving of the notice provided for in this
Section 2.7(a) and on the record date for the determination of stockholders entitled to vote at such annual meeting and (y) who complies with the notice procedures set forth in this
Section 2.7(a). Notwithstanding anything in this Section 2.7(a) to the contrary, only persons nominated for election as a director to fill any term of a directorship that expires on the date of the
annual meeting pursuant to Section 3.2 will be considered for election at such meeting.
(i) In addition to any
other applicable requirements, for business (other than nominations) to be properly brought before an annual meeting by a stockholder, such stockholder must have given timely notice thereof in proper written form to the Secretary and such business
must otherwise be a proper matter for stockholder action. Subject to Section 2.7(a)(iii), a stockholders notice to the Secretary with respect to such business, to be timely, must be received by the Secretary at the
principal executive offices of the Corporation not later than the close of business on the 90th day nor earlier than the opening of business on the 120th day before the anniversary date of the immediately preceding annual meeting of stockholders;
provided, however, that in the event that the annual meeting is more than 30 days before or more than 60 days after such anniversary date, notice by the stockholder to be timely must be so delivered not earlier than the close of
business on the 120th day before the meeting and not later than the later of (x) the close of business on the 90th day before the meeting or (y) the close of business on the 10th day following the day on which public announcement of the
date of the annual meeting is first made by the Corporation. The public announcement of an adjournment or postponement of an annual meeting shall not commence a new time period (or extend any time period) for the giving of a stockholders
notice as described in this Section 2.7(a).
(ii) To be in proper written form, a stockholders notice to
the Secretary with respect to any business (other than nominations) must set forth as to each such matter such stockholder proposes to bring before the annual meeting (A) a brief description of the business desired to be brought before the
annual meeting, the text of the proposal or business (including the text of any resolutions proposed for consideration and in the event such business includes a proposal to amend these Bylaws, the language of the proposed amendment) and the reasons
C-4
for conducting such business at the annual meeting, (B) the name and record address of such stockholder and the name and address of the beneficial owner, if any, on whose behalf the proposal
is made, (C) the class or series and number of shares of capital stock of the Corporation that are owned beneficially and of record by such stockholder and by the beneficial owner, if any, on whose behalf the proposal is made, (D) a
description of all arrangements or understandings between such stockholder and the beneficial owner, if any, on whose behalf the proposal is made and any other person or persons (including their names) in connection with the proposal of such
business by such stockholder, (E) any material interest of such stockholder and the beneficial owner, if any, on whose behalf the proposal is made in such business and (F) a representation that such stockholder (or a qualified
representative of such stockholder) intends to appear in person or by proxy at the annual meeting to bring such business before the meeting.
(iii) The foregoing notice requirements of this Section 2.7(a) shall be deemed satisfied by a stockholder
as to any proposal (other than nominations) if the stockholder has notified the Corporation of such stockholders intention to present such proposal at an annual meeting in compliance with Rule 14a-8
(or any successor thereof) of the Securities Exchange Act of 1934, as amended (the Exchange Act), and such stockholder has complied with the requirements of such rule for inclusion of such proposal in a proxy statement
prepared by the Corporation to solicit proxies for such annual meeting. No business shall be conducted at the annual meeting of stockholders except business brought before the annual meeting in accordance with the procedures set forth in this
Section 2.7(a), provided, however, that once business has been properly brought before the annual meeting in accordance with such procedures, nothing in this Section 2.7(a) shall be
deemed to preclude discussion by any stockholder of any such business. If the Board or the chairman of the annual meeting determines that any stockholder proposal was not made in accordance with the provisions of this
Section 2.7(a) or that the information provided in a stockholders notice does not satisfy the information requirements of this Section 2.7(a), such proposal shall not be presented for action
at the annual meeting. Notwithstanding the foregoing provisions of this Section 2.7(a), if the stockholder (or a qualified representative of the stockholder) does not appear at the annual meeting of stockholders of the
Corporation to present the proposed business, such proposed business shall not be transacted, notwithstanding that proxies in respect of such matter may have been received by the Corporation.
(iv) In addition to the provisions of this Section 2.7(a), a stockholder shall also comply with all applicable
requirements of the Exchange Act and the rules and regulations thereunder with respect to the matters set forth herein. Nothing in this Section 2.7(a) shall be deemed to affect any rights of stockholders to request
inclusion of proposals in the Corporations proxy statement pursuant to Rule 14a-8 under the Exchange Act.
(b) Special Meetings of Stockholders. Only such business shall be conducted at a special meeting of stockholders as shall have been
brought before the meeting pursuant to the Corporations notice of meeting. Nominations of persons for election to the Board may be made at a special meeting of stockholders at which directors are to be elected pursuant to the
Corporations notice of meeting only pursuant to Section 3.2.
(c) Public Announcement. For
purposes of these Bylaws, public announcement shall mean disclosure in a press release reported by the Dow Jones News Service, Associated Press or comparable national news service or in a document publicly filed by the
Corporation with the Securities and Exchange Commission pursuant to Sections 13, 14 or 15(d) of the Exchange Act (or any successor thereto).
Section 2.8. Conduct of Meetings. The chairman of each annual and special meeting of stockholders shall be
the Chairman of the Board or, in the absence (or inability or refusal to act) of the Chairman of the Board, the Chief Executive Officer (if he or she shall be a director) or, in the absence (or inability or refusal to act) of the Chief Executive
Officer or if the Chief Executive Officer is not a director, the President (if he or she shall be a director) or, in the absence (or inability or refusal to act) of the President or if the President is not a director, such other person as shall be
appointed by the Board. The date and time of the opening and the closing of the polls for each matter upon which the stockholders will vote at a meeting shall be announced at the meeting by the chairman of the meeting. The Board may adopt such rules
and regulations for the conduct of the meeting of
C-5
stockholders as it shall deem appropriate. Except to the extent inconsistent with these Bylaws or such rules and regulations as adopted by the Board, the chairman of any meeting of stockholders
shall have the right and authority to convene and to adjourn the meeting, to prescribe such rules, regulations and procedures and to do all such acts as, in the judgment of such chairman, are appropriate for the proper conduct of the meeting. Such
rules, regulations or procedures, whether adopted by the Board or prescribed by the chairman of the meeting, may include, without limitation, the following: (a) the establishment of an agenda or order of business for the meeting; (b) rules
and procedures for maintaining order at the meeting and the safety of those present; (c) limitations on attendance at or participation in the meeting to stockholders of record of the Corporation, their duly authorized and constituted proxies or
such other persons as the chairman of the meeting shall determine; (d) restrictions on entry to the meeting after the time fixed for the commencement thereof; and (e) limitations on the time allotted to questions or comments by
participants. Unless and to the extent determined by the Board or the chairman of the meeting, meetings of stockholders shall not be required to be held in accordance with the rules of parliamentary procedure. The secretary of each annual and
special meeting of stockholders shall be the Secretary or, in the absence (or inability or refusal to act) of the Secretary, an Assistant Secretary so appointed to act by the chairman of the meeting. In the absence (or inability or refusal to act)
of the Secretary and all Assistant Secretaries, the chairman of the meeting may appoint any person to act as secretary of the meeting.
Section 2.9. Consents in Lieu of Meeting. Unless otherwise provided by the Certificate of
Incorporation, until the Corporation consummates an initial public offering, any action required to be taken at any annual or special meeting of stockholders, or any action which may be taken at any annual or special meeting of such
stockholders, may be taken without a meeting, without prior notice and without a vote, if a consent in writing, setting forth the action so taken, shall be signed by the holders of outstanding stock entitled to vote thereon having not less than the
minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares entitled to vote thereon were present and voted, and shall be delivered to the Corporation by delivery to its registered office in the
State of Delaware, its principal place of business, or an officer or agent of the Corporation having custody of the book in which proceedings of meetings of stockholders are recorded. Delivery made to the Corporations registered office shall
be by hand or by certified or registered mail, return receipt requested.
Every written consent shall bear the date of signature of each
stockholder who signs the consent, and no written consent shall be effective to take the corporate action referred to therein unless, within 60 days of the earliest dated consent delivered in the manner required by this section and the DGCL to
the Corporation, written consents signed by a sufficient number of holders entitled to vote to take action are delivered to the Corporation by delivery to its registered office in Delaware, its principal place of business or an officer or agent of
the Corporation having custody of the book in which proceedings of meetings of stockholders are recorded. Delivery made to the Corporations registered office shall be by hand or by certified or registered mail, return receipt requested.
ARTICLE III
DIRECTORS
Section 3.1. Powers; Number. The business and affairs of the Corporation shall be managed by or
under the direction of the Board, which may exercise all such powers of the Corporation and do all such lawful acts and things as are not by statute or by the Certificate of Incorporation or by these Bylaws required to be exercised or done by the
stockholders. Directors need not be stockholders or residents of the State of Delaware. Subject to the Certificate of Incorporation, the number of directors shall be fixed exclusively by resolution of the Board.
Section 3.2. Advance Notice for Nomination of Directors.
(a) Only persons who are nominated in accordance with the following procedures shall be eligible for election as directors of the Corporation,
except as may be otherwise provided by the terms of one or more series
C-6
of Preferred Stock with respect to the rights of holders of one or more series of Preferred Stock to elect directors. Nominations of persons for election to the Board at any annual meeting of
stockholders, or at any special meeting of stockholders called for the purpose of electing directors as set forth in the Corporations notice of such special meeting, may be made (i) by or at the direction of the Board or (ii) by any
stockholder of the Corporation (x) who is a stockholder of record entitled to vote in the election of directors on the date of the giving of the notice provided for in this Section 3.2 and on the record date for the
determination of stockholders entitled to vote at such meeting and (y) who complies with the notice procedures set forth in this Section 3.2.
(b) In addition to any other applicable requirements, for a nomination to be made by a stockholder, such stockholder must have given timely
notice thereof in proper written form to the Secretary. To be timely, a stockholders notice to the Secretary must be received by the Secretary at the principal executive offices of the Corporation (i) in the case of an annual meeting, not
later than the close of business on the 90th day nor earlier than the close of business on the 120th day before the anniversary date of the immediately preceding annual meeting of stockholders; provided, however, that in the event that
the annual meeting is more than 30 days before or more than 60 days after such anniversary date, notice by the stockholder to be timely must be so received no earlier than the close of business on the 120th day before the meeting and not later
than the later of (x) the close of business on the 90th day before the meeting or (y) the close of business on the 10th day following the day on which public announcement of the date of the annual meeting was first made by the Corporation;
and (ii) in the case of a special meeting of stockholders called for the purpose of electing directors, not later than the close of business on the 10th day following the day on which public announcement of the date of the special meeting is
first made by the Corporation. In no event shall the public announcement of an adjournment or postponement of an annual meeting or special meeting commence a new time period (or extend any time period) for the giving of a stockholders notice
as described in this Section 3.2.
(c) Notwithstanding anything in paragraph (b) to the contrary, in
the event that the number of directors to be elected to the Board at an annual meeting is greater than the number of directors whose terms expire on the date of the annual meeting and there is no public announcement by the Corporation naming all of
the nominees for the additional directors to be elected or specifying the size of the increased Board before the close of business on the 90th day prior to the anniversary date of the immediately preceding annual meeting of stockholders, a
stockholders notice required by this Section 3.2 shall also be considered timely, but only with respect to nominees for the additional directorships created by such increase that are to be filled by election at such
annual meeting, if it shall be received by the Secretary at the principal executive offices of the Corporation not later than the close of business on the 10th day following the date on which such public announcement was first made by the
Corporation.
(d) To be in proper written form, a stockholders notice to the Secretary must set forth (i) as to each person whom
the stockholder proposes to nominate for election as a director (A) the name, age, business address and residence address of the person, (B) the principal occupation or employment of the person, (C) the class or series and number of
shares of capital stock of the Corporation that are owned beneficially or of record by the person and (D) any other information relating to the person that would be required to be disclosed in a proxy statement or other filings required to be
made in connection with solicitations of proxies for election of directors pursuant to Section 14 of the Exchange Act and the rules and regulations promulgated thereunder; and (ii) as to the stockholder giving the notice (A) the name
and record address of such stockholder as they appear on the Corporations books and the name and address of the beneficial owner, if any, on whose behalf the nomination is made, (B) the class or series and number of shares of capital
stock of the Corporation that are owned beneficially and of record by such stockholder and the beneficial owner, if any, on whose behalf the nomination is made, (C) a description of all arrangements or understandings relating to the nomination
to be made by such stockholder among such stockholder, the beneficial owner, if any, on whose behalf the nomination is made, each proposed nominee and any other person or persons (including their names), (D) a representation that such stockholder
(or a qualified representative of such stockholder) intends to appear in person or by proxy at the meeting to nominate the persons named in its notice and (E) any other information relating to such stockholder and the beneficial owner, if any,
on whose behalf the nomination is made that would be required to be disclosed
C-7
in a proxy statement or other filings required to be made in connection with solicitations of proxies for election of directors pursuant to Section 14 of the Exchange Act and the rules and
regulations promulgated thereunder. Such notice must be accompanied by a written consent of each proposed nominee to being named as a nominee and to serve as a director if elected.
(e) If the Board or the chairman of the meeting of stockholders determines that any nomination was not made in accordance with the provisions
of this Section 3.2, or that the information provided in a stockholders notice does not satisfy the information requirements of this Section 3.2, then such nomination shall not be considered
at the meeting in question. Notwithstanding the foregoing provisions of this Section 3.2, if the stockholder (or a qualified representative of the stockholder) does not appear at the meeting of stockholders of the
Corporation to present the nomination, such nomination shall be disregarded, notwithstanding that proxies in respect of such nomination may have been received by the Corporation.
(f) In addition to the provisions of this Section 3.2, a stockholder shall also comply with all of the applicable
requirements of the Exchange Act and the rules and regulations thereunder with respect to the matters set forth herein. Nothing in this Section 3.2 shall be deemed to affect any rights of the holders of Preferred Stock to
elect directors pursuant to the Certificate of Incorporation.
Section 3.3. Compensation. Unless
otherwise restricted by the Certificate of Incorporation or these Bylaws, the Board shall have the authority to fix the compensation of directors, including for service on a committee of the Board, and may be paid either a fixed sum for attendance
at each meeting of the Board or other compensation as director. The directors may be reimbursed their expenses, if any, of attendance at each meeting of the Board. No such payment shall preclude any director from serving the Corporation in any other
capacity and receiving compensation therefor. Members of committees of the Board may be allowed like compensation and reimbursement of expenses for service on the committee.
ARTICLE IV
BOARD
MEETINGS
Section 4.1. Annual Meetings. The Board shall meet as soon as practicable after the
adjournment of each annual stockholders meeting at the place of the annual stockholders meeting unless the Board shall fix another time and place and give notice thereof in the manner required herein for special meetings of the Board. No notice to
the directors shall be necessary to legally convene this meeting, except as provided in this Section 4.1.
Section 4.2. Regular Meetings. Regularly scheduled, periodic meetings of the Board may be held without notice
at such times, dates and places (within or without the State of Delaware) as shall from time to time be determined by the Board.
Section 4.3. Special Meetings. Special meetings of the Board (a) may be called by the Chairman of the
Board or President and (b) shall be called by the Chairman of the Board, President or Secretary on the written request of at least a majority of directors then in office, or the sole director, as the case may be, and shall be held at such time,
date and place (within or without the State of Delaware) as may be determined by the person calling the meeting or, if called upon the request of directors or the sole director, as specified in such written request. Notice of each special meeting of
the Board shall be given, as provided in Section 9.3, to each director (i) at least 24 hours before the meeting if such notice is oral notice given personally or by telephone or written notice given by hand delivery or
by means of a form of electronic transmission and delivery; (ii) at least two days before the meeting if such notice is sent by a nationally recognized overnight delivery service; and (iii) at least five days before the meeting if such
notice is sent through the United States mail. If the Secretary shall fail or refuse to give such notice, then the notice may be given by the officer who called the meeting or the directors who requested the meeting. Any and all business that may be
transacted at a regular meeting of the Board may be transacted at a special meeting. Except as may be otherwise expressly provided by applicable law, the Certificate
C-8
of Incorporation, or these Bylaws, neither the business to be transacted at, nor the purpose of, any special meeting need be specified in the notice or waiver of notice of such meeting. A special
meeting may be held at any time without notice if all the directors are present or if those not present waive notice of the meeting in accordance with Section 9.4.
Section 4.4. Quorum; Required Vote. A majority of the Board shall constitute a quorum for the transaction of
business at any meeting of the Board, and the act of a majority of the directors present at any meeting at which there is a quorum shall be the act of the Board, except as may be otherwise specifically provided by applicable law, the Certificate of
Incorporation or these Bylaws. If a quorum shall not be present at any meeting, a majority of the directors present may adjourn the meeting from time to time, without notice other than announcement at the meeting, until a quorum is present.
Section 4.5. Consent In Lieu of Meeting. Unless otherwise restricted by the Certificate of Incorporation or
these Bylaws, any action required or permitted to be taken at any meeting of the Board or any committee thereof may be taken without a meeting if all members of the Board or committee, as the case may be, consent thereto in writing or by electronic
transmission, and the writing or writings or electronic transmission or transmissions (or paper reproductions thereof) are filed with the minutes of proceedings of the Board or committee. Such filing shall be in paper form if the minutes are
maintained in paper form and shall be in electronic form if the minutes are maintained in electronic form.
Section 4.6. Organization. The chairman of each meeting of the Board shall be the Chairman of the Board or,
in the absence (or inability or refusal to act) of the Chairman of the Board, the Chief Executive Officer (if he or she shall be a director) or, in the absence (or inability or refusal to act) of the Chief Executive Officer or if the Chief Executive
Officer is not a director, the President (if he or she shall be a director) or in the absence (or inability or refusal to act) of the President or if the President is not a director, a chairman elected from the directors present. The Secretary shall
act as secretary of all meetings of the Board. In the absence (or inability or refusal to act) of the Secretary, an Assistant Secretary shall perform the duties of the Secretary at such meeting. In the absence (or inability or refusal to act) of the
Secretary and all Assistant Secretaries, the chairman of the meeting may appoint any person to act as secretary of the meeting.
ARTICLE
V
COMMITTEES OF DIRECTORS
Section 5.1. Establishment. The Board may, by resolution of the Board, designate one or more committees, each
committee to consist of one or more of the directors of the Corporation. Each committee shall keep regular minutes of its meetings and report the same to the Board when required by the resolution designating such committee. The Board shall have the
power at any time to fill vacancies in, to change the membership of, or to dissolve any such committee.
Section 5.2. Available Powers. Any committee established pursuant to Section 5.1
hereof, to the extent permitted by applicable law and by resolution of the Board, shall have and may exercise all of the powers and authority of the Board in the management of the business and affairs of the Corporation, and may authorize the seal
of the Corporation to be affixed to all papers that may require it.
Section 5.3. Alternate Members. The
Board may designate one or more directors as alternate members of any committee, who may replace any absent or disqualified member at any meeting of such committee. In the absence or disqualification of a member of the committee, the member or
members thereof present at any meeting and not disqualified from voting, whether or not he, she or they constitute a quorum, may unanimously appoint another member of the Board to act at the meeting in place of any such absent or disqualified
member.
Section 5.4. Procedures. Unless the Board otherwise provides, the time, date, place, if any, and
notice of meetings of a committee shall be determined by such committee. At meetings of a committee, a majority of the
C-9
number of members of the committee (but not including any alternate member, unless such alternate member has replaced any absent or disqualified member at the time of, or in connection with, such
meeting) shall constitute a quorum for the transaction of business. The act of a majority of the members present at any meeting at which a quorum is present shall be the act of the committee, except as otherwise specifically provided by applicable
law, the Certificate of Incorporation, these Bylaws or the Board. If a quorum is not present at a meeting of a committee, the members present may adjourn the meeting from time to time, without notice other than an announcement at the meeting, until
a quorum is present. Unless the Board otherwise provides and except as provided in these Bylaws, each committee designated by the Board may make, alter, amend and repeal rules for the conduct of its business. In the absence of such rules each
committee shall conduct its business in the same manner as the Board is authorized to conduct its business pursuant to Article III and Article IV of these Bylaws.
ARTICLE VI
OFFICERS
Section 6.1. Officers. The officers of the Corporation elected by the Board shall be one Chief
Executive Officer, a Chief Financial Officer, a Secretary and such other officers (including without limitation, a Chairman of the Board, Chief Operating Officer, Presidents, Vice Presidents, Partners, Managing Directors and Senior Managing
Directors) as the Board from time to time may determine. Officers elected by the Board shall each have such powers and duties as generally pertain to their respective offices, subject to the specific provisions of this
Article VI. Such officers shall also have such powers and duties as from time to time may be conferred by the Board. The Chief Executive Officer or President may also appoint such other officers (including without
limitation one or more Vice Presidents and Controllers) as may be necessary or desirable for the conduct of the business of the Corporation. Such other officers shall have such powers and duties and shall hold their offices for such terms as may be
provided in these Bylaws or as may be prescribed by the Board or, if such officer has been appointed by the Chief Executive Officer or President, as may be prescribed by the appointing officer.
(a) Chairman of the Board. The Chairman of the Board shall preside when present at all meetings of the stockholders and the Board. The
Chairman of the Board shall have general supervision and control of the acquisition activities of the Corporation subject to the ultimate authority of the Board, and shall be responsible for the execution of the policies of the Board with respect to
such matters. In the absence (or inability or refusal to act) of the Chairman of the Board, the Chief Executive Officer (if he or she shall be a director) shall preside when present at all meetings of the stockholders and the Board. The powers and
duties of the Chairman of the Board shall not include supervision or control of the preparation of the financial statements of the Corporation (other than through participation as a member of the Board). The position of Chairman of the Board and
Chief Executive Officer may be held by the same person and may be held by more than one person.
(b) Chief Executive Officer. The
Chief Executive Officer shall be the chief executive officer of the Corporation, shall have general supervision of the affairs of the Corporation and general control of all of its business subject to the ultimate authority of the Board, and shall be
responsible for the execution of the policies of the Board with respect to such matters, except to the extent any such powers and duties have been prescribed to the Chairman of the Board pursuant to Section 6.1(a) above. In
the absence (or inability or refusal to act) of the Chairman of the Board, the Chief Executive Officer (if he or she shall be a director) shall preside when present at all meetings of the stockholders and the Board. The position of Chief Executive
Officer and President may be held by the same person and may be held by more than one person.
(c) President and Chief Operating
Officer. The President and Chief Operating Officer shall make recommendations to the Chief Executive Officer on all operational matters that would normally be reserved for the final executive responsibility of the Chief Executive Officer. In the
absence (or inability or refusal to act) of the Chairman of the Board and Chief Executive Officer, the President and Chief Operating Officer (if he or she shall be a director) shall preside when present at all meetings of the stockholders and the
Board. The President and Chief Operating Officer shall also perform such duties and have such powers as shall be designated by the
C-10
Board. The position of President, Chief Operating Officer and Chief Executive Officer may be held by the same person.
(d) Vice Presidents. In the absence (or inability or refusal to act) of the President, the Vice President (or in the event there be
more than one Vice President, the Vice Presidents in the order designated by the Board) shall perform the duties and have the powers of the President. Any one or more of the Vice Presidents may be given an additional designation of rank or function.
(e) Secretary.
(i)
The Secretary shall attend all meetings of the stockholders, the Board and (as required) committees of the Board and shall record the proceedings of such meetings in books to be kept for that purpose. The Secretary shall give, or cause to be given,
notice of all meetings of the stockholders and special meetings of the Board and shall perform such other duties as may be prescribed by the Board, the Chairman of the Board, Chief Executive Officer or President. The Secretary shall have custody of
the corporate seal of the Corporation and the Secretary, or any Assistant Secretary, shall have authority to affix the same to any instrument requiring it, and when so affixed, it may be attested by his or her signature or by the signature of such
Assistant Secretary. The Board may give general authority to any other officer to affix the seal of the Corporation and to attest the affixing thereof by his or her signature.
(ii) The Secretary shall keep, or cause to be kept, at the principal executive office of the Corporation or at the office of the
Corporations transfer agent or registrar, if one has been appointed, a stock ledger, or duplicate stock ledger, showing the names of the stockholders and their addresses, the number and classes of shares held by each and, with respect to
certificated shares, the number and date of certificates issued for the same and the number and date of certificates cancelled.
(f)
Chief Financial Officer. The Chief Financial Officer shall perform all duties commonly incident to that office (including, without limitation, the care and custody of the funds and securities of the Corporation, which from time to time may
come into the Chief Financial Officers hands and the deposit of the funds of the Corporation in such banks or trust companies as the Board, Chief Executive Officer or the President may authorize).
Section 6.2. Term of Office; Removal; Vacancies. The elected officers of the Corporation shall be appointed
by the Board and shall hold office until their successors are duly elected and qualified by the Board or until their earlier death, resignation, retirement, disqualification, or removal from office. Any officer may be removed, with or without cause,
at any time by the Board. Any officer appointed by the Chief Executive Officer or President may also be removed, with or without cause, by the Chief Executive Officer or President, as the case may be, unless the Board otherwise provides. Any vacancy
occurring in any elected office of the Corporation may be filled by the Board. Any vacancy occurring in any office appointed by the Chief Executive Officer or President may be filled by the Chief Executive Officer, or President, as the case may be,
unless the Board then determines that such office shall thereupon be elected by the Board, in which case the Board shall elect such officer.
Section 6.3. Other Officers. The Board may delegate the power to appoint such other officers and agents, and
may also remove such officers and agents or delegate the power to remove same, as it shall from time to time deem necessary or desirable.
Section 6.4. Multiple Officeholders; Stockholder and Director Officers. Any number of offices may be held by
the same person unless the Certificate of Incorporation or these Bylaws otherwise provide. Officers need not be stockholders or residents of the State of Delaware.
C-11
ARTICLE VII
SHARES
Section 7.1. Certificated and Uncertificated Shares. The shares of the Corporation may be certificated or
uncertificated, subject to the sole discretion of the Board and the requirements of the DGCL.
Section 7.2.
Multiple Classes of Stock. If the Corporation shall be authorized to issue more than one class of stock or more than one series of any class, the Corporation shall (a) cause the powers, designations, preferences and relative,
participating, optional or other special rights of each class of stock or series thereof and the qualifications, limitations or restrictions of such preferences and/or rights to be set forth in full or summarized on the face or back of any
certificate that the Corporation issues to represent shares of such class or series of stock or (b) in the case of uncertificated shares, within a reasonable time after the issuance or transfer of such shares, send to the registered owner
thereof a written notice containing the information required to be set forth on certificates as specified in clause (a) above; provided, however, that, except as otherwise provided by applicable law, in lieu of the foregoing
requirements, there may be set forth on the face or back of such certificate or, in the case of uncertificated shares, on such written notice a statement that the Corporation will furnish without charge to each stockholder who so requests the
powers, designations, preferences and relative, participating, optional or other special rights of each class of stock or series thereof and the qualifications, limitations or restrictions of such preferences or rights.
Section 7.3. Signatures. Each certificate representing capital stock of the Corporation shall be signed by or
in the name of the Corporation by (a) the Chairman of the Board, the Chief Executive Officer, the President or a Vice President and (b) the Treasurer, an Assistant Treasurer, the Secretary or an Assistant Secretary of the Corporation. Any
or all the signatures on the certificate may be a facsimile. In case any officer, transfer agent or registrar who has signed or whose facsimile signature has been placed upon a certificate shall have ceased to be such officer, transfer agent or
registrar before such certificate is issued, such certificate may be issued by the Corporation with the same effect as if such person were such officer, transfer agent or registrar on the date of issue.
Section 7.4. Consideration and Payment for Shares.
(a) Subject to applicable law and the Certificate of Incorporation, shares of stock may be issued for such consideration, having in the case
of shares with par value a value not less than the par value thereof, and to such persons, as determined from time to time by the Board. The consideration may consist of any tangible or intangible property or any benefit to the Corporation including
cash, promissory notes, services performed, contracts for services to be performed or other securities, or any combination thereof.
(b)
Subject to applicable law and the Certificate of Incorporation, shares may not be issued until the full amount of the consideration has been paid, unless upon the face or back of each certificate issued to represent any partly paid shares of capital
stock or upon the books and records of the Corporation in the case of partly paid uncertificated shares, there shall have been set forth the total amount of the consideration to be paid therefor and the amount paid thereon up to and including the
time said certificate representing certificated shares or said uncertificated shares are issued.
Section 7.5. Lost, Destroyed or
Wrongfully Taken Certificates.
(a) If an owner of a certificate representing shares claims that such certificate has been lost,
destroyed or wrongfully taken, the Corporation shall issue a new certificate representing such shares or such shares in uncertificated form if the owner: (i) requests such a new certificate before the Corporation has notice that the certificate
representing such shares has been acquired by a protected purchaser; (ii) if requested by the Corporation, delivers to the Corporation a bond sufficient to indemnify the Corporation against any claim that
C-12
may be made against the Corporation on account of the alleged loss, wrongful taking or destruction of such certificate or the issuance of such new certificate or uncertificated shares; and
(iii) satisfies other reasonable requirements imposed by the Corporation.
(b) If a certificate representing shares has been lost,
apparently destroyed or wrongfully taken, and the owner fails to notify the Corporation of that fact within a reasonable time after the owner has notice of such loss, apparent destruction or wrongful taking and the Corporation registers a transfer
of such shares before receiving notification, the owner shall be precluded from asserting against the Corporation any claim for registering such transfer or a claim to a new certificate representing such shares or such shares in uncertificated form.
Section 7.6. Transfer of Stock.
(a) If a certificate representing shares of the Corporation is presented to the Corporation with an endorsement requesting the registration of
transfer of such shares or an instruction is presented to the Corporation requesting the registration of transfer of uncertificated shares, the Corporation shall register the transfer as requested if:
(i) in the case of certificated shares, the certificate representing such shares has been surrendered;
(ii) (A) with respect to certificated shares, the endorsement is made by the person specified by the certificate as entitled to such shares;
(B) with respect to uncertificated shares, an instruction is made by the registered owner of such uncertificated shares; or (C) with respect to certificated shares or uncertificated shares, the endorsement or instruction is made by any
other appropriate person or by an agent who has actual authority to act on behalf of the appropriate person;
(iii) the Corporation has
received a guarantee of signature of the person signing such endorsement or instruction or such other reasonable assurance that the endorsement or instruction is genuine and authorized as the Corporation may request;
(iv) the transfer does not violate any restriction on transfer imposed by the Corporation that is enforceable in accordance
with Section 7.8(a); and
(v) such other conditions for such transfer as shall be provided for under
applicable law have been satisfied.
(b) Whenever any transfer of shares shall be made for collateral security and not absolutely, the
Corporation shall so record such fact in the entry of transfer if, when the certificate for such shares is presented to the Corporation for transfer or, if such shares are uncertificated, when the instruction for registration of transfer thereof is
presented to the Corporation, both the transferor and transferee request the Corporation to do so.
Section 7.7.
Registered Stockholders. Before due presentment for registration of transfer of a certificate representing shares of the Corporation or of an instruction requesting registration of transfer of uncertificated shares, the Corporation may treat
the registered owner as the person exclusively entitled to inspect for any proper purpose the stock ledger and the other books and records of the Corporation, vote such shares, receive dividends or notifications with respect to such shares and
otherwise exercise all the rights and powers of the owner of such shares, except that a person who is the beneficial owner of such shares (if held in a voting trust or by a nominee on behalf of such person) may, upon providing documentary evidence
of beneficial ownership of such shares and satisfying such other conditions as are provided under applicable law, may also so inspect the books and records of the Corporation.
Section 7.8. Effect of the Corporations Restriction on Transfer
(a) A written restriction on the transfer or registration of transfer of shares of the Corporation or on the amount of shares of the
Corporation that may be owned by any person or group of persons, if permitted by the
C-13
DGCL and noted conspicuously on the certificate representing such shares or, in the case of uncertificated shares, contained in a notice, offering circular or prospectus sent by the Corporation
to the registered owner of such shares within a reasonable time prior to or after the issuance or transfer of such shares, may be enforced against the holder of such shares or any successor or transferee of the holder including an executor,
administrator, trustee, guardian or other fiduciary entrusted with like responsibility for the person or estate of the holder.
(b) A
restriction imposed by the Corporation on the transfer or the registration of shares of the Corporation or on the amount of shares of the Corporation that may be owned by any person or group of persons, even if otherwise lawful, is ineffective
against a person without actual knowledge of such restriction unless: (i) the shares are certificated and such restriction is noted conspicuously on the certificate; or (ii) the shares are uncertificated and such restriction was contained
in a notice, offering circular or prospectus sent by the Corporation to the registered owner of such shares within a reasonable time prior to or after the issuance or transfer of such shares.
Section 7.9. Regulations. The Board shall have power and authority to make such additional rules and
regulations, subject to any applicable requirement of law, as the Board may deem necessary and appropriate with respect to the issue, transfer or registration of transfer of shares of stock or certificates representing shares. The Board may appoint
one or more transfer agents or registrars and may require for the validity thereof that certificates representing shares bear the signature of any transfer agent or registrar so appointed.
ARTICLE VIII
INDEMNIFICATION
Section 8.1. Right to Indemnification. To the fullest extent permitted by applicable law, as the same exists
or may hereafter be amended, the Corporation shall indemnify and hold harmless each person who was or is made a party or is threatened to be made a party to or is otherwise involved in any threatened, pending or completed action, suit or proceeding,
whether civil, criminal, administrative or investigative (hereinafter a proceeding), by reason of the fact that he or she is or was a director or officer of the Corporation or, while a director or officer of the
Corporation, is or was serving at the request of the Corporation as a director, officer, employee or agent of another corporation or of a partnership, joint venture, trust, other enterprise or nonprofit entity, including service with respect to an
employee benefit plan (hereinafter an Indemnitee), whether the basis of such proceeding is alleged action in an official capacity as a director, officer, employee or agent, or in any other capacity while serving as a
director, officer, employee or agent, against all liability and loss suffered and expenses (including, without limitation, attorneys fees, judgments, fines, ERISA excise taxes and penalties and amounts paid in settlement) reasonably incurred
by such Indemnitee in connection with such proceeding; provided, however, that, except as provided in Section 8.3 with respect to proceedings to enforce rights to indemnification, the Corporation
shall indemnify an Indemnitee in connection with a proceeding (or part thereof) initiated by such Indemnitee only if such proceeding (or part thereof) was authorized by the Board.
Section 8.2. Right to Advancement of Expenses. In addition to the right to indemnification conferred
in Section 8.1, an Indemnitee shall also have the right to be paid by the Corporation to the fullest extent not prohibited by applicable law the expenses (including, without limitation, attorneys fees) incurred
in defending or otherwise participating in any such proceeding in advance of its final disposition (hereinafter an advancement of expenses); provided, however, that, if the DGCL requires, an advancement of
expenses incurred by an Indemnitee in his or her capacity as a director or officer of the Corporation (and not in any other capacity in which service was or is rendered by such Indemnitee, including, without limitation, service to an employee
benefit plan) shall be made only upon the Corporations receipt of an undertaking (hereinafter an undertaking), by or on behalf of such Indemnitee, to repay all amounts so advanced if it shall ultimately be determined
that such Indemnitee is not entitled to be indemnified under this Article VIII or otherwise.
Section 8.3. Right of Indemnitee to Bring Suit. If a claim under Section 8.1
or Section 8.2 is not paid in full by the Corporation within 60 days after a written claim therefor has been received by the Corporation, except
C-14
in the case of a claim for an advancement of expenses, in which case the applicable period shall be 20 days, the Indemnitee may at any time thereafter bring suit against the Corporation to
recover the unpaid amount of the claim. If successful in whole or in part in any such suit, or in a suit brought by the Corporation to recover an advancement of expenses pursuant to the terms of an undertaking, the Indemnitee shall also be entitled
to be paid the expense of prosecuting or defending such suit. In (a) any suit brought by the Indemnitee to enforce a right to indemnification hereunder (but not in a suit brought by an Indemnitee to enforce a right to an advancement of
expenses) it shall be a defense that, and (b) in any suit brought by the Corporation to recover an advancement of expenses pursuant to the terms of an undertaking, the Corporation shall be entitled to recover such expenses upon a final judicial
decision from which there is no further right to appeal (hereinafter a final adjudication) that, the Indemnitee has not met any applicable standard for indemnification set forth in the DGCL. Neither the failure of the
Corporation (including its directors who are not parties to such action, a committee of such directors, independent legal counsel, or its stockholders) to have made a determination prior to the commencement of such suit that indemnification of the
Indemnitee is proper in the circumstances because the Indemnitee has met the applicable standard of conduct set forth in the DGCL, nor an actual determination by the Corporation (including a determination by its directors who are not parties to such
action, a committee of such directors, independent legal counsel, or its stockholders) that the Indemnitee has not met such applicable standard of conduct, shall create a presumption that the Indemnitee has not met the applicable standard of conduct
or, in the case of such a suit brought by the Indemnitee, shall be a defense to such suit. In any suit brought by the Indemnitee to enforce a right to indemnification or to an advancement of expenses hereunder, or by the Corporation to recover an
advancement of expenses pursuant to the terms of an undertaking, the burden of proving that the Indemnitee is not entitled to be indemnified, or to such advancement of expenses, under this Article VIII or otherwise shall be
on the Corporation.
Section 8.4. Non-Exclusivity of Rights. The
rights provided to any Indemnitee pursuant to this Article VIII shall not be exclusive of any other right, which such Indemnitee may have or hereafter acquire under applicable law, the Certificate of Incorporation, these
Bylaws, an agreement, a vote of stockholders or disinterested directors, or otherwise.
Section 8.5.
Insurance. The Corporation may maintain insurance, at its expense, to protect itself and/or any director, officer, employee or agent of the Corporation or another corporation, partnership, joint venture, trust or other enterprise against any
expense, liability or loss, whether or not the Corporation would have the power to indemnify such person against such expense, liability or loss under the DGCL.
Section 8.6. Indemnification of Other Persons. This Article VIII shall not limit
the right of the Corporation to the extent and in the manner authorized or permitted by law to indemnify and to advance expenses to persons other than Indemnitees. Without limiting the foregoing, the Corporation may, to the extent authorized from
time to time by the Board, grant rights to indemnification and to the advancement of expenses to any employee or agent of the Corporation and to any other person who is or was serving at the request of the Corporation as a director, officer,
employee or agent of another corporation or of a partnership, joint venture, trust or other enterprise, including service with respect to an employee benefit plan, to the fullest extent of the provisions of this
Article VIII with respect to the indemnification and advancement of expenses of Indemnitees under this Article VIII.
Section 8.7. Amendments. Any repeal or amendment of this Article VIII by
the Board or the stockholders of the Corporation or by changes in applicable law, or the adoption of any other provision of these Bylaws inconsistent with this Article VIII, will, to the extent permitted by applicable
law, be prospective only (except to the extent such amendment or change in applicable law permits the Corporation to provide broader indemnification rights to Indemnitees on a retroactive basis than permitted prior thereto), and will not in any way
diminish or adversely affect any right or protection existing hereunder in respect of any act or omission occurring prior to such repeal or amendment or adoption of such inconsistent provision; provided, however, that amendments or
repeals of this Article VIII shall require the affirmative vote of the stockholders holding at least 66.7% of the voting power of all outstanding shares of capital stock of the Corporation.
C-15
Section 8.8. Certain Definitions. For purposes of
this Article VIII, (a) references to other enterprise shall include any employee benefit plan; (b) references to fines shall include any excise taxes
assessed on a person with respect to an employee benefit plan; (c) references to serving at the request of the Corporation shall include any service that imposes duties on, or involves services by, a person with
respect to any employee benefit plan, its participants, or beneficiaries; and (d) a person who acted in good faith and in a manner such person reasonably believed to be in the interest of the participants and beneficiaries of an employee
benefit plan shall be deemed to have acted in a manner not opposed to the best interest of the Corporation for purposes of Section 145 of the DGCL.
Section 8.9. Contract Rights. The rights provided to Indemnitees pursuant to this
Article VIII shall be contract rights and such rights shall continue as to an Indemnitee who has ceased to be a director, officer, agent or employee and shall inure to the benefit of the Indemnitees heirs, executors
and administrators.
Section 8.10. Severability. If any provision or provisions of this
Article VIII shall be held to be invalid, illegal or unenforceable for any reason whatsoever: (a) the validity, legality and enforceability of the remaining provisions of this Article VIII
shall not in any way be affected or impaired thereby; and (b) to the fullest extent possible, the provisions of this Article VIII (including, without limitation, each such portion of this Article VIII containing
any such provision held to be invalid, illegal or unenforceable) shall be construed so as to give effect to the intent manifested by the provision held invalid, illegal or unenforceable.
ARTICLE IX
MISCELLANEOUS
Section 9.1. Place of Meetings. If the place of any meeting of stockholders, the Board or committee of the
Board for which notice is required under these Bylaws is not designated in the notice of such meeting, such meeting shall be held at the principal business office of the Corporation; provided, however, if the Board has, in its sole
discretion, determined that a meeting shall not be held at any place, but instead shall be held by means of remote communication pursuant to Section 9.5 hereof, then such meeting shall not be held at any place.
Section 9.2. Fixing Record Dates.
(a) In order that the Corporation may determine the stockholders entitled to notice of any meeting of stockholders or any adjournment thereof,
the Board may fix a record date, which shall not precede the date upon which the resolution fixing the record date is adopted by the Board, and which record date shall not be more than 60 nor less than 10 days before the date of such meeting.
If the Board so fixes a date, such date shall also be the record date for determining the stockholders entitled to vote at such meeting unless the Board determines, at the time it fixes such record date, that a later date on or before the date of
the meeting shall be the date for making such determination. If no record date is fixed by the Board, the record date for determining stockholders entitled to notice of and to vote at a meeting of stockholders shall be at the close of business on
the business day next preceding the day on which notice is given, or, if notice is waived, at the close of business on the business day next preceding the day on which the meeting is held. A determination of stockholders of record entitled to notice
of or to vote at a meeting of stockholders shall apply to any adjournment of the meeting; provided, however, that the Board may fix a new record date for the adjourned meeting, and in such case shall also fix as the record date for
stockholders entitled to notice of such adjourned meeting the same or an earlier date as that fixed for determination of stockholders entitled to vote in accordance with the foregoing provisions of this Section 9.2(a) at
the adjourned meeting.
(b) In order that the Corporation may determine the stockholders entitled to receive payment of any dividend or
other distribution or allotment of any rights or the stockholders entitled to exercise any rights in respect of any change, conversion or exchange of stock, or for the purpose of any other lawful action, the Board may fix a record date, which record
date shall not precede the date upon which the resolution fixing the record
C-16
date is adopted, and which record date shall be not more than 60 days prior to such action. If no record date is fixed, the record date for determining stockholders for any such purpose
shall be at the close of business on the day on which the Board adopts the resolution relating thereto.
Section 9.3.
Means of Giving Notice.
(a) Notice to Directors. Whenever under applicable law, the Certificate of Incorporation or
these Bylaws notice is required to be given to any director, such notice shall be given either (i) in writing and sent by mail, or by a nationally recognized delivery service, (ii) by means of facsimile telecommunication or other form of
electronic transmission, or (iii) by oral notice given personally or by telephone. A notice to a director will be deemed given as follows: (i) if given by hand delivery, orally, or by telephone, when actually received by the director,
(ii) if sent through the United States mail, when deposited in the United States mail, with postage and fees thereon prepaid, addressed to the director at the directors address appearing on the records of the Corporation, (iii) if
sent for next day delivery by a nationally recognized overnight delivery service, when deposited with such service, with fees thereon prepaid, addressed to the director at the directors address appearing on the records of the Corporation,
(iv) if sent by facsimile telecommunication, when sent to the facsimile transmission number for such director appearing on the records of the Corporation, (v) if sent by electronic mail, when sent to the electronic mail address for such
director appearing on the records of the Corporation, or (vi) if sent by any other form of electronic transmission, when sent to the address, location or number (as applicable) for such director appearing on the records of the Corporation.
(b) Notice to Stockholders. Whenever, under applicable law, the Certificate of Incorporation or these Bylaws notice is required to be
given to any stockholder, such notice may be given (i) in writing and sent either by hand delivery, through the United States mail, or by a nationally recognized overnight delivery service for next day delivery, or (ii) by means of a form
of electronic transmission consented to by the stockholder, to the extent permitted by, and subject to the conditions set forth in Section 232 of the DGCL. A notice to a stockholder shall be deemed given as follows: (i) if given by hand
delivery, when actually received by the stockholder, (ii) if sent through the United States mail, when deposited in the United States mail, with postage and fees thereon prepaid, addressed to the stockholder at the stockholders address
appearing on the stock ledger of the Corporation, (iii) if sent for next day delivery by a nationally recognized overnight delivery service, when deposited with such service, with fees thereon prepaid, addressed to the stockholder at the
stockholders address appearing on the stock ledger of the Corporation, and (iv) if given by a form of electronic transmission consented to by the stockholder to whom the notice is given and otherwise meeting the requirements set forth
above, (A) if by facsimile transmission, when directed to a number at which the stockholder has consented to receive notice, (B) if by electronic mail, when directed to an electronic mail address at which the stockholder has consented to
receive notice, (C) if by a posting on an electronic network together with separate notice to the stockholder of such specified posting, upon the later of (1) such posting and (2) the giving of such separate notice, and (D) if by
any other form of electronic transmission, when directed to the stockholder. A stockholder may revoke such stockholders consent to receiving notice by means of electronic communication by giving written notice of such revocation to the
Corporation. Any such consent shall be deemed revoked if (1) the Corporation is unable to deliver by electronic transmission two consecutive notices given by the Corporation in accordance with such consent and (2) such inability becomes
known to the Secretary or an Assistant Secretary or to the Corporations transfer agent, or other person responsible for the giving of notice; provided, however, the inadvertent failure to treat such inability as a revocation
shall not invalidate any meeting or other action.
(c) Electronic Transmission. Electronic transmission
means any form of communication, not directly involving the physical transmission of paper, that creates a record that may be retained, retrieved and reviewed by a recipient thereof, and that may be directly reproduced in paper form by such a
recipient through an automated process, including but not limited to transmission by telex, facsimile telecommunication, electronic mail, telegram and cablegram.
(d) Notice to Stockholders Sharing Same Address. Without limiting the manner by which notice otherwise may be given effectively by the
Corporation to stockholders, any notice to stockholders given by the Corporation
C-17
under any provision of the DGCL, the Certificate of Incorporation or these Bylaws shall be effective if given by a single written notice to stockholders who share an address if consented to by
the stockholders at that address to whom such notice is given. A stockholder may revoke such stockholders consent by delivering written notice of such revocation to the Corporation. Any stockholder who fails to object in writing to the
Corporation within 60 days of having been given written notice by the Corporation of its intention to send such a single written notice shall be deemed to have consented to receiving such single written notice.
(e) Exceptions to Notice Requirements. Whenever notice is required to be given, under the DGCL, the Certificate of Incorporation or
these Bylaws, to any person with whom communication is unlawful, the giving of such notice to such person shall not be required and there shall be no duty to apply to any governmental authority or agency for a license or permit to give such notice
to such person. Any action or meeting that shall be taken or held without notice to any such person with whom communication is unlawful shall have the same force and effect as if such notice had been duly given. In the event that the action taken by
the Corporation is such as to require the filing of a certificate with the Secretary of State of Delaware, the certificate shall state, if such is the fact and if notice is required, that notice was given to all persons entitled to receive notice
except such persons with whom communication is unlawful.
Whenever notice is required to be given by the Corporation, under any provision of the DGCL, the
Certificate of Incorporation or these Bylaws, to any stockholder to whom (1) notice of two consecutive annual meetings of stockholders and all notices of stockholder meetings or of the taking of action by written consent of stockholders without
a meeting to such stockholder during the period between such two consecutive annual meetings, or (2) all, and at least two payments (if sent by first-class mail) of dividends or interest on securities during a 12-month period, have been mailed
addressed to such stockholder at such stockholders address as shown on the records of the Corporation and have been returned undeliverable, the giving of such notice to such stockholder shall not be required. Any action or meeting that shall
be taken or held without notice to such stockholder shall have the same force and effect as if such notice had been duly given. If any such stockholder shall deliver to the Corporation a written notice setting forth such stockholders then
current address, the requirement that notice be given to such stockholder shall be reinstated. In the event that the action taken by the Corporation is such as to require the filing of a certificate with the Secretary of State of Delaware, the
certificate need not state that notice was not given to persons to whom notice was not required to be given pursuant to Section 230(b) of the DGCL. The exception in subsection (1) of the first sentence of this paragraph to the requirement that
notice be given shall not be applicable to any notice returned as undeliverable if the notice was given by electronic transmission.
Section 9.4. Waiver of Notice. Whenever any notice is required to be given under applicable law, the Certificate
of Incorporation, or these Bylaws, a written waiver of such notice, signed by the person or persons entitled to said notice, or a waiver by electronic transmission by the person entitled to said notice, whether before or after the time stated
therein, shall be deemed equivalent to such required notice. All such waivers shall be kept with the books of the Corporation. Attendance at a meeting shall constitute a waiver of notice of such meeting, except where a person attends for the express
purpose of objecting to the transaction of any business on the ground that the meeting was not lawfully called or convened.
Section
9.5. Meeting Attendance via Remote Communication Equipment.
(a) Stockholder Meetings. If authorized by
the Board in its sole discretion, and subject to such guidelines and procedures as the Board may adopt, stockholders entitled to vote at such meeting and proxy holders not physically present at a meeting of stockholders may, by means of remote
communication:
(i) participate in a meeting of stockholders; and
(ii) be deemed present in person and vote at a meeting of stockholders, whether such meeting is to be held at a designated place or solely by
means of remote communication, provided that (A) the Corporation shall implement reasonable measures to verify that each person deemed present and permitted to vote at the meeting by means of remote communication is a stockholder or
proxy holder, (B) the Corporation shall implement
C-18
reasonable measures to provide such stockholders and proxy holders a reasonable opportunity to participate in the meeting and, if entitled to vote, to vote on matters submitted to the applicable
stockholders, including an opportunity to read or hear the proceedings of the meeting substantially concurrently with such proceedings, and (C) if any stockholder or proxy holder votes or takes other action at the meeting by means of remote
communication, a record of such votes or other action shall be maintained by the Corporation.
(b) Board Meetings. Unless otherwise
restricted by applicable law, the Certificate of Incorporation or these Bylaws, members of the Board or any committee thereof may participate in a meeting of the Board or any committee thereof by means of conference telephone or other communications
equipment by means of which all persons participating in the meeting can hear each other. Such participation in a meeting shall constitute presence in person at the meeting, except where a person participates in the meeting for the express purpose
of objecting to the transaction of any business on the ground that the meeting was not lawfully called or convened.
Section
9.6. Dividends. The Board may from time to time declare, and the Corporation may pay, dividends (payable in cash, property or shares of the Corporations capital stock) on the Corporations outstanding shares of capital
stock, subject to applicable law and the Certificate of Incorporation.
Section 9.7. Reserves. The Board may set
apart out of the funds of the Corporation available for dividends a reserve or reserves for any proper purpose and may abolish any such reserve.
Section 9.8. Contracts and Negotiable Instruments. Except as otherwise provided by applicable law, the Certificate
of Incorporation or these Bylaws, any contract, bond, deed, lease, mortgage or other instrument may be executed and delivered in the name and on behalf of the Corporation by such officer or officers or other employee or employees of the Corporation
as the Board may from time to time authorize. Such authority may be general or confined to specific instances as the Board may determine. The Chairman of the Board, the Chief Executive Officer, the President, the Chief Financial Officer, the
Treasurer or any Vice President may execute and deliver any contract, bond, deed, lease, mortgage or other instrument in the name and on behalf of the Corporation. Subject to any restrictions imposed by the Board, the Chairman of the Board, the
Chief Executive Officer, President, the Chief Financial Officer, the Treasurer or any Vice President may delegate powers to execute and deliver any contract, bond, deed, lease, mortgage or other instrument in the name and on behalf of the
Corporation to other officers or employees of the Corporation under such persons supervision and authority, it being understood, however, that any such delegation of power shall not relieve such officer of responsibility with respect to the
exercise of such delegated power.
Section 9.9. Fiscal Year. The fiscal year of the Corporation shall be fixed by the
Board.
Section 9.10. Seal. The Board may adopt a corporate seal, which shall be in such form as the Board
determines. The seal may be used by causing it or a facsimile thereof to be impressed, affixed or otherwise reproduced.
Section
9.11. Books and Records. The books and records of the Corporation may be kept within or outside the State of Delaware at such place or places as may from time to time be designated by the Board.
Section 9.12. Resignation. Any director, committee member or officer may resign by giving notice thereof in writing or by
electronic transmission to the Chairman of the Board, the Chief Executive Officer, the President or the Secretary. The resignation shall take effect at the time it is delivered unless the resignation specifies a later effective date or an effective
date determined upon the happening of an event or events. Unless otherwise specified therein, the acceptance of such resignation shall not be necessary to make it effective.
Section 9.13. Surety Bonds. Such officers, employees and agents of the Corporation (if any) as the Chairman of the Board,
the Chief Executive Officer, the President or the Board may direct, from time to time,
C-19
shall be bonded for the faithful performance of their duties and for the restoration to the Corporation, in case of their death, resignation, retirement, disqualification or removal from office,
of all books, papers, vouchers, money and other property of whatever kind in their possession or under their control belonging to the Corporation, in such amounts and by such surety companies as the Chairman of the Board, the Chief Executive
Officer, President or the Board may determine. The premiums on such bonds shall be paid by the Corporation and the bonds so furnished shall be in the custody of the Secretary.
Section 9.14. Securities of Other Corporations. Powers of attorney, proxies, waivers of notice of meeting,
consents in writing and other instruments relating to securities owned by the Corporation may be executed in the name of and on behalf of the Corporation by the Chairman of the Board, the Chief Executive Officer, the President, any Vice President or
any officers authorized by the Board. Any such officer, may, in the name of and on behalf of the Corporation, take all such action as any such officer may deem advisable to vote in person or by proxy at any meeting of security holders of any
corporation in which the Corporation may own securities, or to consent in writing, in the name of the Corporation as such holder, to any action by such corporation, and at any such meeting or with respect to any such consent shall possess and may
exercise any and all rights and power incident to the ownership of such securities and which, as the owner thereof, the Corporation might have exercised and possessed. The Board may from time to time confer like powers upon any other person or
persons.
Section 9.15. Amendments. The Board shall have the power to adopt, amend, alter or repeal the Bylaws. The
affirmative vote of a majority of the Board shall be required to adopt, amend, alter or repeal the Bylaws. The Bylaws also may be adopted, amended, altered or repealed by the stockholders; provided, however, that in addition to any
vote of the holders of any class or series of capital stock of the Corporation required by applicable law or the Certificate of Incorporation, the affirmative vote of the holders of at least a majority of the voting power (except as otherwise
provided in Section 8.7) of all outstanding shares of capital stock of the Corporation entitled to vote generally in the election of directors, voting together as a single class, shall be required for the stockholders to adopt, amend, alter
or repeal the Bylaws.
C-20
ANNEX D
SPONSOR SUPPORT AGREEMENT
August 30, 2022
East Resources Acquisition
Company
7777 NW Beacon Square Boulevard
Boca Raton, Florida
33487
Abacus Settlements, LLC
2101 Park Center Drive,
Suite 2200
Orlando, Florida 32835
and
Longevity Market Assets, LLC
2101 Park Center Drive, Suite 2200
Orlando, Florida 32835
Ladies and Gentlemen:
Reference is made to that certain Agreement and Plan of Merger, dated as of the date hereof (as it may be amended, restated or otherwise
modified from time to time in accordance with its terms, the Merger Agreement), by and among East Resources Acquisition Company, a Delaware corporation (Parent), LMA Merger Sub, LLC, a Delaware limited liability
company (LMA Merger Sub), Abacus Merger Sub, LLC, a Delaware limited liability company (Abacus Merger Sub and, together with LMA Merger Sub and Parent, the Parent Parties), Longevity Market
Assets, LLC, a Florida limited liability company (LMA), and Abacus Settlements, LLC, a Florida limited liability company (Abacus and, together with LMA, the Companies). This sponsor support
agreement (this Sponsor Support Agreement) is being entered into and delivered by the Companies, Parent and East Sponsor, LLC, a Delaware limited liability company (ERES Sponsor), in connection with the
transactions contemplated by the Merger Agreement. Capitalized terms used, but not defined, herein shall have the meanings ascribed to such terms in the Merger Agreement.
In consideration of the foregoing and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged,
Sponsor, Parent and the Companies hereby agree that:
1. Waiver of Anti-dilution Protection. ERES Sponsor hereby, automatically and
without any further action by ERES Sponsor or Parent, irrevocably (a) waives any adjustment to the conversion ratio set forth in Parents Organizational Documents and any rights to other anti-dilution protections pursuant to Parents
Organizational Documents or otherwise, and (b) agrees not to assert or perfect any rights to adjustment or other anti-dilution protections, in each case, with respect to the rate that all of the shares of Parents Class B Common
Stock, par value $0.0001 per share (Parent Class B Common Stock), held by ERES Sponsor convert into shares of Parents Class A Common Stock, par value $0.0001 per share (Parent
Class A Common Stock and, together with the Parent Class B Common Stock, the Parent Common Stock), in connection with the consummation of the transactions contemplated by the Merger Agreement.
2. New Shares. If, between the date of this Sponsor Support Agreement and the Closing, (a) any shares of Parent Common Stock,
Parent Private Warrants, Parent Public Warrants or other equity interests of Parent are issued to ERES Sponsor or the outstanding shares of Parent Common Stock or, if applicable, Parent Private Warrants or Parent Public Warrants owned by ERES
Sponsor shall have been changed into a different number of shares or a different class, by reason of any dividend, subdivision, reclassification, recapitalization, split,
D-1
combination or exchange, or any similar event, (b) ERES Sponsor purchases or otherwise acquires beneficial ownership of any shares of Parent Common Stock, Parent Private Warrants, Parent
Public Warrants or other equity interests of Parent or (c) ERES Sponsor acquires the right to vote or share in the voting of any shares of Parent Common Stock, Parent Private Warrants, Parent Public Warrants or other equity interests of Parent
(such Parent Common Stock, Parent Public Warrants, Parent Private Warrants or other equity interests of Parent issued or acquired by ERES Sponsor pursuant to the foregoing clauses (a), (b) or (c), collectively New Securities),
then such New Securities issued to or acquired or purchased by ERES Sponsor shall be subject to the terms of this Sponsor Support Agreement to the same extent as if they constituted Sponsor Securities (as defined below) as of the date hereof, and
the number of shares of Parent Common Stock to be terminated, forfeited, surrendered, subject to vesting and cancelled pursuant to this Sponsor Support Agreement will be equitably adjusted to reflect such change; provided, however, that
nothing in this Section 2 shall be construed to permit Parent to take any action with respect to its securities that is prohibited by the terms and conditions of the Merger Agreement.
3. No Transfer. During the period commencing on the date hereof and ending on the earlier of (a) the Effective Time, (b) the
termination of the Merger Agreement in accordance with its terms and (c) the liquidation of Parent, ERES Sponsor shall not, directly or indirectly, (i) sell, offer to sell, contract or agree to sell, hypothecate, pledge, grant a security
interest in or lien on, grant any option to purchase or otherwise dispose of or agree to dispose of, file (or participate in the filing of) a registration statement with the SEC or establish or increase a put equivalent position or liquidate or
decrease a call equivalent position within the meaning of Section 16 of the Exchange Act, with respect to any shares of Parent Common Stock, Parent Private Warrants, Parent Public Warrants or other equity interests of Parent owned by ERES
Sponsor, (ii) enter into any swap or other arrangement that Transfers to another, in whole or in part, any of the economic consequences of ownership of any shares of Parent Common Stock, Parent Private Warrants, Parent Public Warrants or other
equity interests of Parent owned by ERES Sponsor or (iii) take any action in furtherance of or announce any intention to, in each case, effect any transaction specified in clause (i) or (ii). ERES Sponsor agrees not to, directly or
indirectly, deposit any of the Sponsor Securities in a voting trust, enter into a voting trust or subject any of the Sponsor Securities to any arrangement with respect to the voting of such Sponsor Securities other than this Sponsor Support
Agreement. Any Transfer or attempted Transfer of Sponsor Securities in violation of this Section 3 shall be, to the fullest extent permitted by applicable Law, null and void ab initio. For purposes of this Sponsor Support
Agreement, Transfer shall mean the (i) sale of, offer to sell, contract or agreement to sell, hypothecate, pledge, grant a security interest in or lien on, grant of any option to purchase or otherwise dispose of or agreement
to dispose of, directly or indirectly, or establishment or increase of a put equivalent position or liquidation with respect to or decrease of a call equivalent position within the meaning of Section 16 of the Exchange Act with respect to, any
limited liability company interest or security, (ii) entry into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any limited liability company interest or security,
whether any such transaction is to be settled by delivery of such securities, in cash or otherwise, or (iii) public announcement of any intention to effect any transaction specified in clause (i) or (ii).
4. No Solicitation. During the period commencing on the date hereof and ending on the earlier of (a) the Effective Time,
(b) the termination of the Merger Agreement in accordance with its terms and (c) the liquidation of Parent, ERES Sponsor shall not, and ERES Sponsor shall not authorize or (to the extent within its control) permit any of its directors,
officers, employees, agents or representatives to, directly or indirectly, (i) knowingly encourage, initiate, solicit or facilitate, offer or make any offers or proposals related to a Business Combination, (ii) enter into, engage in or
continue any discussions or negotiations with respect to any Business Combination with, or provide any non-public information, data or access to employees to, any Person that has made, or that is considering
making, a proposal with respect to a Business Combination, or (iii) enter into any agreement (whether or not binding) relating to a Business Combination, in each case, other than to or with the Companies and their respective Representatives.
From and after the date hereof, ERES Sponsor shall, and shall instruct its officers and directors to, and ERES Sponsor shall instruct and cause its Representatives, its Subsidiaries and their respective Representatives to, immediately cease and
terminate all discussions and negotiations with any Persons that may be ongoing with respect to an Acquisition Proposal (other than the Company, its Subsidiaries and their
D-2
respective Representatives). ERES Sponsor shall promptly notify the Company of any submissions, proposals or offers made with respect to a Business Combination as soon as practicable following
ERES Sponsors awareness thereof.
5. Sponsor PIK Note. ERES Sponsor agrees that, in the event that immediately prior to the
Closing, the Aggregate Transaction Proceeds are less than $1,000,000 (the Minimum Cash Amount), it shall make an unsecured loan to Parent (in substantially the form attached hereto as Exhibit A, the Sponsor PIK
Note) in an amount (the Sponsor PIK Note Amount) equal to the lesser of (a) the difference between the Minimum Cash Amount and the Aggregate Transaction Proceeds and (b) the sum of the Parent Transaction
Expenses, the Company Transaction Expenses and the Working Capital Loan Amount; provided, however, that the Sponsor PIK Note Amount shall not exceed an amount equal to the sum of (x) the Parent Transaction Expenses, (y) the Company
Transaction Expenses and (z) the Working Capital Loan Amount, unless otherwise agreed by ERES Sponsor in its sole discretion.
6.
Representations and Warranties. ERES Sponsor hereby represents and warrants to the Companies as follows:
(a) ERES
Sponsor owns free and clear of all Liens (other than transfer restrictions under applicable securities Laws) (i) 8,615,000 shares of Parent Class B Common Stock and (ii) 8,900,000 Private Placement Warrants (the Sponsor
Securities). ERES Sponsor has, and will have at all times during the term of this Sponsor Support Agreement, the sole voting power with respect to the Sponsor Securities. The Sponsor Securities are the only equity securities in Parent
owned of record or beneficially by Sponsor on the date of this Sponsor Support Agreement, and none of the Sponsor Securities are subject to any proxy, voting trust or other agreement or arrangement with respect to the voting of the Sponsor
Securities, except as provided hereunder and pursuant to that certain Letter Agreement, dated as of July 23, 2020, by and among Parent, ERES Sponsor and Parents directors and officers. ERES Sponsor does not hold or own any rights to
acquire (directly or indirectly) any equity interests of Parent or any equity securities convertible into, or which can be exchanged for, equity securities of Parent.
(b) ERES Sponsor has been duly formed and is validly existing as a limited liability company and in good standing under the
Laws of its jurisdiction of formation, and has the requisite power and authority to own, lease or operate all of its properties and assets and to conduct its business as it is now being conducted. ERES Sponsor has all requisite power and authority
to execute and deliver this Sponsor Support Agreement and to consummate the transactions contemplated hereby and to perform all of its obligations hereunder. The execution and delivery of this Sponsor Support Agreement have been, and the
consummation of the transactions contemplated hereby has been, duly authorized by all requisite action by ERES Sponsor. This Sponsor Support Agreement has been duly and validly executed and delivered by Sponsor and, assuming this Sponsor Support
Agreement has been duly authorized, executed and delivered by the other parties hereto, this Sponsor Support Agreement constitutes, and upon its execution will constitute, a legal, valid and binding obligation of ERES Sponsor enforceable against it
by the Companies in accordance with its terms, subject to applicable bankruptcy, insolvency and other similar Laws affecting the enforceability of creditors rights generally, general equitable principles and the discretion of courts in
granting equitable remedies.
(c) There are no Actions pending against ERES Sponsor or any of its directors, managers or
officers, or to the knowledge of ERES Sponsor threatened against ERES Sponsor or any of its directors, managers or officers, by or before (or, in the case of threatened Actions, that would be before) any arbitrator or any Governmental Entity, that
would reasonably be expected to challenge or seek to enjoin, alter or materially delay the performance by ERES Sponsor of its obligations under this Sponsor Support Agreement.
(a) The execution and delivery of this Sponsor Support Agreement by ERES Sponsor does not, and the performance by ERES Sponsor
of its obligations hereunder will not, (i) conflict with or result in a violation of ERES Sponsors Organization Documents or (ii) require any consent or approval that has not been given or other action that has not been taken by any
Person (including under any Contract binding upon ERES Sponsor or the Sponsor Securities), in each case, to the extent such consent, approval or other action would
D-3
reasonably be expected to prevent, enjoin or materially delay the performance by ERES Sponsor of its obligations under this Sponsor Support Agreement.
(b) Except as expressly described on Section 4.12 of the Parent Disclosure Schedules, no broker, finder, investment banker
or other Person is entitled to any brokerage fee, finders fee or other commission in connection with the transactions contemplated by the Merger Agreement based upon arrangements made by ERES Sponsor, for which Parent or any of its Affiliates
may become liable.
(c) ERES Sponsor has had the opportunity to read the Merger Agreement and this Sponsor Support
Agreement and has had the opportunity to consult with its tax and legal advisors.
(d) ERES Sponsor has not entered into,
and shall not enter into, any agreement that would restrict, limit or interfere with the performance of ERES Sponsors obligations hereunder.
(e) ERES Sponsor understands and acknowledges that, as a material inducement to Parent and each of the Companies entering into
the Merger Agreement, Parent and each of the Companies is entering into the Merger Agreement in reliance upon ERES Sponsors execution and delivery of this Sponsor Support Agreement.
7. Sponsor Agreements. Unless the Merger Agreement is terminated in accordance with its terms, ERES Sponsor hereby unconditionally and
irrevocably agrees to:
(a) at the Parent Common Stockholders Meeting (including any adjournment thereof or any other
stockholder or warrantholder meeting of Parent at which any of the Transaction Proposals are to be voted on), to be present in person or by proxy and vote, or cause to be voted at such meeting, all Sponsor Securities entitled to vote thereon in
favor of the Transaction Proposals;
(b) at the Parent Common Stockholders Meeting (including any adjournment thereof or
any other stockholder or warrantholder meeting of Parent at which any of the Transaction Proposals are to be voted on), to be present in person or by proxy and vote, or cause to be voted at such meeting, all Sponsor Securities entitled to vote
thereon unconditionally against (i) any Business Combination other than with the Company, its stockholders and their respective affiliates and representatives; (ii) any merger, consolidation, combination, sale of substantial assets,
reorganization, recapitalization, dissolution, liquidation or winding up of Parent; (iii) any change in the business, management or board of directors of Parent (the Board); and (iv) any other action, proposal or
agreement that would be reasonably expected to (1) impede, frustrate, nullify, interfere with, delay, postpone or adversely affect the Transaction Proposals or any of the other transactions contemplated by the Merger Agreement, in each case,
other than the proposal to adjourn the Parent Common Stockholders Meeting, if necessary, to permit further solicitation of proxies because there are not sufficient votes to approve and adopt the other Transaction Proposals, (2) result in a
breach of any covenant, representation or warranty or other obligation or agreement of Parent or ERES Sponsor under the Merger Agreement, (3) result in a breach of any covenant, representation or warranty or other obligation or agreement of
ERES Sponsor contained in this Sponsor Support Agreement, (4) result in any of the conditions set forth in Article VI of the Merger Agreement not being fulfilled or (5) change in any manner the dividend policy or capitalization of,
including the voting rights of any class of capital stock of, Parent;
(c) at any applicable annual or special meeting of
Parent or action taken by written consent in lieu thereof prior to the Closing, vote or consent to, or cause to be voted or consented to, at such meeting (or written consent in lieu thereof), all Sponsor Securities entitled to vote thereon for such
actions as are necessary to cause the election of members of the board of directors (or similar governing body) of the Company consistent with Section 1.4 of the Merger Agreement; and
(d) not redeem any shares of Parent Common Stock owned by it in connection with the Parent Common Stockholders Meeting.
8. Lock-Up; Transfer Restrictions.
D-4
(a) ERES Sponsor agrees that it shall not Transfer (i) any Phase I Lock-up Shares until the date that is 180 days after the Closing Date and (ii) any Phase II Lock-up Shares until the date that is 24 months after the Closing Date. For
purposes of this Sponsor Support Agreement, (x) Phase I Lock-up Shares means 15% of the Parent Common Stock received by ERES Sponsor in connection with the Closing and (y) Phase II Lock-up Shares means 85% of the shares of Parent Common Stock received by ERES Sponsor in connection with the Closing.
(b) ERES Sponsor agrees that it shall not effectuate any Transfer of Private Placement Warrants or Parent Common Stock
underlying such Private Placement Warrants until thirty (30) days after the Closing Date.
(c) Notwithstanding the
provisions set forth in paragraphs 8(a) and (b), Transfers of Phase I Lock-up Shares or Phase II Lock-up Shares are permitted (i) to Parents officers or
directors, any affiliate or family member of any of Parents officers or directors, any members or partners of ERES Sponsor or their affiliates, any affiliates of ERES Sponsor, or any employees of such affiliates; (ii) in the case of an
individual, by gift to a member of one of the individuals immediate family or to a trust, the beneficiary of which is a member of the individuals immediate family, an affiliate of such person or to a charitable organization;
(iii) in the case of an individual, by virtue of laws of descent and distribution upon death of the individual; (iv) in the case of an individual, pursuant to a qualified domestic relations order; (v) by virtue of the laws of Delaware
or ERES Sponsors organizational documents upon liquidation or dissolution of ERES Sponsor; or (vi) in the event of Parents completion of a liquidation, merger, share exchange or other similar transaction which results in all of
Parents stockholders having the right to exchange their Parent Common Stock for cash, securities or other property subsequent to the Closing; provided, however, that in the case of clauses (i) through (v), these permitted
transferees must enter into a written agreement with Parent agreeing to be bound by the transfer restrictions imposed on ERES Sponsor under this Sponsor Support Agreement.
9. Further Assurances. ERES Sponsor hereby irrevocably and unconditionally agrees not to commence or participate in, and to take all
actions necessary to opt out of any class action with respect to, any action or claim, derivative or otherwise, against the Companies, Parent or any of their respective Affiliates, successors and assigns relating to the negotiation, execution or
delivery of this Sponsor Support Agreement, the Merger Agreement or the consummation of the transactions contemplated hereby and thereby.
10. No Inconsistent Agreement. ERES Sponsor hereby represents and covenants that ERES Sponsor has not entered into, and shall not enter
into, any agreement that would restrict, limit or interfere with the performance of ERES Sponsors obligations hereunder.
11.
Termination. This Sponsor Support Agreement shall terminate, and have no further force and effect, upon the earlier of (a) the termination of the Merger Agreement in accordance with its terms or (b) the date that is 24 months from
the Closing Date. No such termination shall relieve ERES Sponsor, Parent or the Company from any liability resulting from a breach of this Sponsor Support Agreement occurring prior to such termination.
12. Miscellaneous. Sections 9.2 through 9.14, Section 9.16 and Section 9.17 of the Merger Agreement are incorporated by
reference herein and shall apply hereto mutatis mutandis.
[Signature Pages Follow.]
D-5
Please indicate your agreement to the terms of this Sponsor Support Agreement by signing
where indicated below.
|
|
|
EAST SPONSOR, LLC |
|
|
By: |
|
East Asset Management, LLC, |
|
|
the Managing Member of East Sponsor, LLC |
|
|
By: |
|
/s/ Gary L. Hagerman, Jr. |
Name: |
|
Gary L. Hagerman, Jr. |
Title: |
|
Chief Financial Officer and Treasurer |
Signature Page to
Sponsor Support Agreement
D-6
|
|
|
Accepted and Agreed: |
|
EAST RESOURCES ACQUISITION COMPANY |
|
|
By: |
|
/s/ Gary L. Hagerman, Jr. |
Name: |
|
Gary L. Hagerman, Jr. |
Title: |
|
Chief Financial Officer and Treasurer |
Signature Page to
Sponsor Support Agreement
D-7
|
|
|
Accepted and Agreed: |
|
LONGEVITY MARKET ASSETS, LLC |
|
|
By: |
|
/s/ Jay Jackson |
Name: |
|
Jay Jackson |
Title: |
|
Chief Executive Officer |
|
|
|
ABACUS SETTLEMENTS, LLC |
|
|
By: |
|
/s/ Jay Jackson |
Name: |
|
Jay Jackson |
Title: |
|
Chief Executive Officer |
Signature Page to
Sponsor Support Agreement
D-8
EXHIBIT A
Form of Sponsor PIK Note
THIS UNSECURED
SENIOR PROMISSORY NOTE (NOTE) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE SECURITIES ACT), OR ANY STATE SECURITIES LAWS. THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND
MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO MAKER THAT SUCH REGISTRATION IS NOT
REQUIRED.
UNSECURED SENIOR PROMISSORY NOTE
|
|
|
Original Principal Amount: $[ ] |
|
Dated as of [ ] |
|
|
Boca Raton, Florida |
Abacus Life, Inc. (f/k/a East Resources Acquisition Company), a Delaware corporation
(Maker), promises to pay to the order of East Sponsor, LLC, a Delaware limited liability company, or its registered, permitted assigns or successors in interest (Payee), the amount set out above as the Original
Principal Amount, as such amount may be (i) increased pursuant to the payment in kind of any interest under this Note as provided in Section 2 and any other additional amounts due from Maker to Payee hereunder and
added to such amount pursuant to the terms hereof or (ii) reduced pursuant to any repayment effected in accordance with the terms hereof (the balance of such amount from time to time being the Outstanding Principal Balance),
and any other amounts owed by Maker to Payee hereunder on the Maturity Date (as defined below) in lawful money of the United States of America, on the terms and conditions described below. All payments on this Note shall be made by check or wire
transfer of immediately available funds or as otherwise determined by Maker to such account as Payee may from time to time designate by written notice in accordance with the provisions of this Note.
1. Principal. If this Note has not yet been redeemed or otherwise repaid, the entire Outstanding Principal Balance of this Note
shall be due and payable by Maker on [●] (the Maturity Date).2 The Outstanding Principal Balance may be prepaid by Maker in full or in part, at any time, without premium
or penalty, at the election of Maker. Under no circumstances shall any individual, including but not limited to any officer, director, employee or stockholder of Maker, be obligated personally for any obligations or liabilities of Maker hereunder.
2. Payment of Interest.
(a) During the term of this Note, interest shall accrue daily on the Outstanding Principal Balance at a rate equal to 12.0% per annum
compounding semi-annually. The accrual of interest on Outstanding Principal Balance as of any date will be calculated based on the Outstanding Principal Balance as of the close of business on the immediately preceding Interest Payment Due Date (or,
if no preceding Interest Payment Due Date, on the date hereof).
(b) Accrued and unpaid interest due under this Note shall be payable in
arrears on March 31, June 30, September 30 and December 31 of each year, commencing on []3 (each, an Interest Payment Due Date), and shall be paid, at
the sole option of Maker, (i) by check or wire transfer of immediately available funds in an amount equal to such accrued and unpaid interest, or (ii) by adding all such accrued and unpaid interest to the Outstanding Principal Balance
under this Note on such Interest Payment Due Date (such payment, a PIK
2 |
To be the date that is five years following the closing of the business combination. |
3 |
To be the last day of the first full quarter following the closing of the business combination.
|
Exhibit A
D-9
Interest Payment), which addition of accrued and unpaid interest will be effective as of 9:00 a.m., Eastern Time, on such Interest Payment Due Date. Interest shall accrue and shall
be computed daily on the basis of a 365-day year.
(c) On each Interest Payment Due Date for which
a PIK Interest Payment is elected by Maker, Maker shall make a record on its books and in the register of the increase in the Outstanding Principal Balance of this Note due to the completion of a PIK Interest Payment, which addition of such accrued
and unpaid interest will be effective as of 9:00 a.m., Eastern Time, on such Interest Payment Due Date, each Note shall represent the increased Outstanding Principal Balance and no separate Note will be issued with respect to such accrued and unpaid
interest.
3. Security. This Note is a general unsecured obligation of Maker.
4. Application of Payments. All payments shall be applied first to payment in full of any costs incurred in the collection of
any sum due under this Note, including (without limitation) reasonable attorneys fees, then to the payment in full of any late charges and finally to the reduction of the Outstanding Principal Balance.
5. Change of Control Event.
(a) Change of Control Event Notice. Maker shall deliver to Payee a written notice of a Change of Control Event (the Change of
Control Notice) as promptly as practicable, and, in any event, no later than the earlier of (i) three (3) business days following the execution of a definitive agreement relating to a Change of Control Event or (ii) twenty
(20) business days prior to the anticipated Change of Control Effective Time. The date of the anticipated Change of Control Effective Time will be determined in good faith Maker.
(b) Change of Control Election. Following the receipt of a Change of Control Notice, Payee may, at its option, make a COC Redemption
Election with respect to this Note no later than the close of business on the day that is fifteen (15) business days prior to the anticipated Change of Control Effective Time (the COC Deadline).
(c) Redemption upon Change of Control Event. Subject to, and immediately upon, the Change of Control Effective Time, if Payee has
delivered a COC Redemption Election by the COC Deadline, Maker shall redeem this Note (in full but not in part) for an amount in cash equal to the Outstanding Principal Balance, plus any accrued and unpaid interest thereon, as of the Change of
Control Effective Time.
(d) Definitions. For purposes of this Note, the following terms shall have the respective meanings set
forth below:
(1) Change of Control Effective Time means the point in time at which a Change of Control
Event closes or is otherwise consummated.
(2) Change of Control Event means (i) the
closing of the sale, lease, transfer or other disposition by Maker or any material subsidiary of all or substantially all of the assets of Maker and its subsidiaries, taken as a whole, in one transaction or a series of related transactions, or the
sale or disposition (whether by merger, consolidation or otherwise) of one or more subsidiaries if substantially all of the assets of Maker and its subsidiaries, taken as a whole, are held by such subsidiary or subsidiaries, except where such sale,
lease, transfer or other disposition is to a wholly-owned subsidiary, (ii) the consummation of the merger or consolidation of Maker or a subsidiary, and Maker issues shares of its capital stock pursuant to such merger or consolidation, with or
into another entity (except a merger or consolidation in which the holders of capital stock of Maker immediately prior to such merger or consolidation continue to own beneficially at least a majority of the voting power of the capital stock of Maker
and/or the surviving or acquiring entity, whether on a combined basis or individually), (iii) the closing of the transfer (whether by merger, consolidation or otherwise), in one
D-10
transaction or a series of related transactions, to a person or group of affiliated persons (other than an underwriter of Makers securities), of Makers securities if, after such
closing, such person or group of affiliated persons would hold more than forty nine percent (49%) of the outstanding voting stock of Maker (or the surviving or acquiring entity), or (iv) a liquidation, dissolution or winding up of Maker.
(3) COC Redemption Election means an election by Payee to have Maker redeem this Note pursuant to
Section 5(c).
6. Ranking and Priority. This Note will be indebtedness of Maker, ranking
(i) equally in right of payment with any other present and future senior unsecured indebtedness of Maker and (ii) ranking senior in right of payment to any present and future subordinated indebtedness of Maker and to any present or future
equity securities or other interests of Maker.
7. Events of Default. The following shall constitute an event of default
(Event of Default):
(a) Failure to Make Required Payments. Failure by Maker to pay the Outstanding Principal
Balance due pursuant to this Note within five (5) business days of the Maturity Date.
(b) Voluntary Bankruptcy, Etc. The
commencement by Maker of a voluntary case under any applicable bankruptcy, insolvency, reorganization, rehabilitation or other similar law, or the consent by it to the appointment of or taking possession by a receiver, liquidator, assignee, trustee,
custodian, sequestrator (or other similar official) of Maker or for any substantial part of its property, or the making by it of any assignment for the benefit of creditors, or the failure of Maker generally to pay its debts as such debts become
due, or the taking of corporate action by Maker in substantial furtherance of any of the foregoing.
(c) Involuntary Bankruptcy,
Etc. The entry of a decree or order for relief by a court having jurisdiction in the premises in respect of Maker in an involuntary case under any applicable bankruptcy, insolvency or other similar law, or appointing a receiver, liquidator,
assignee, custodian, trustee, sequestrator (or similar official) of Maker or for any substantial part of its property, or ordering the winding-up or liquidation of its affairs, and the continuance of any such
decree or order unstayed and in effect for a period of 60 consecutive days.
(d) Default under other Indebtedness. The failure by
Maker to perform or comply with any term, covenant, condition or agreement contained in any agreement(s) or instrument(s) governing any indebtedness for borrowed money in an aggregate principal amount in excess of $[1,000,000], whether such
indebtedness now exists or is created after the date hereof, (i) that, after giving effect to any applicable grace period, causes, or permits the holder or holders of such indebtedness or a trustee or other representative on its or their behalf
(with or without the giving of notice, the lapse of time or both) to cause, the entire amount of such indebtedness to become due prior to its stated maturity (or in the case of any such indebtedness constituting a guarantee by Maker in respect of
indebtedness to become payable in full) or become subject to a mandatory offer purchase by the obligor or (ii) constitutes a failure to pay the principal or interest (regardless of amount) of any such indebtedness when due and payable.
8. Remedies.
(a)
Upon the occurrence of an Event of Default specified in Section 7(a) hereof, Payee may, by written notice to Maker, declare this Note to be due immediately and payable, whereupon the Outstanding Principal Balance of this
Note, and all other amounts payable by Maker to Payee hereunder, shall become immediately due and payable without presentment, demand, protest or other notice of any kind, all of which are hereby expressly waived, anything contained herein or in the
documents evidencing the same to the contrary notwithstanding.
(b) Upon the occurrence of an Event of Default specified in
Section 7(b), Section 7(c) or Section 7(d) the Outstanding Principal Balance of this Note, and all other amounts payable by Maker to Payee hereunder, shall automatically
and immediately become due and payable, in all cases without any action on the part of Payee.
D-11
9. Enforcement Costs. In case any Outstanding Principal Balance of this Note
is not paid when due, Maker shall be liable for all reasonable costs of enforcement and collection of this Note incurred by Payee and any permitted transferee, including but not limited to reasonable attorneys fees and expenses.
10. Waivers. Maker and all endorsers and guarantors of, and sureties for, this Note waive presentment for payment, demand,
notice of dishonor, protest, and notice of protest with regard to the Note, all errors, defects and imperfections in any proceedings instituted by Payee under the terms of this Note, and all benefits that might accrue to Maker by virtue of any
present or future laws exempting any property, real or personal, or any part of the proceeds arising from any sale of any such property, from attachment, levy or sale under execution, or providing for any stay of execution, exemption from civil
process, or extension of time for payment; and Maker agrees that any real estate that may be levied upon pursuant to a judgment obtained by virtue hereof, or any writ of execution issued hereon, may be sold upon any such writ in whole or in part in
any order desired by Payee.
11. Unconditional Liability. Maker hereby waives all notices in connection with the delivery,
acceptance, performance, default, or enforcement of the payment of this Note, and agrees that its liability shall be unconditional, without regard to the liability of any other party, and shall not be affected in any manner by any indulgence,
extension of time, renewal, waiver or modification granted or consented to by Payee, and consents to any and all extensions of time, renewals, waivers, or modifications that may be granted by Payee with respect to the payment or other provisions of
this Note, and agrees that additional makers, endorsers, guarantors, or sureties may become parties hereto without notice to Maker or affecting Makers liability hereunder. Any failure of Payee to exercise any right hereunder shall not be
construed as a waiver of the right to exercise the same or any other right at any time and from time to time thereafter. Payee may accept late payments, or partial payments, even though marked payment in full or containing words of
similar import or other conditions, without waiving any of its rights.
12. Notices. All notices, statements or other
documents which are required or contemplated by this Note shall be made in writing and delivered: (i) personally or sent by first class registered or certified mail, overnight courier service or facsimile or electronic transmission to the
address designated in writing, (ii) by facsimile to the number most recently provided to such party or such other address or fax number as may be designated in writing by such party or (iii) by electronic mail, to the electronic mail
address most recently provided to such party or such other electronic mail address as may be designated in writing by such party. Any notice or other communication so transmitted shall be deemed to have been given on the day of delivery, if
delivered personally, on the business day following receipt of written confirmation, if sent by facsimile or electronic transmission, one (1) business day after delivery to an overnight courier service or five (5) days after mailing if
sent by mail. As of the date of this Note, the following addresses are designated for notices: Maker, 2101 Park Center Drive, Suite 220, Orlando, Florida 32835, Attn: Jay Jackson, email: jay@abacuslife.com; Payee, 7777 NW Beacon Square Boulevard,
Boca Raton, Florida 33487, Attn: Gary L. Hagerman, Jr., email: ghagerman@emslp.com.
13. Construction; Governing Law; Venue; Waiver Of
Jury Trial; Etc. THIS NOTE SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK, WITHOUT REGARD TO CONFLICT OF LAW PROVISIONS THEREOF. MAKER HEREBY IRREVOCABLY AND UNCONDITIONALLY SUBMITS, FOR ITSELF AND ITS PROPERTY,
TO THE NONEXCLUSIVE JURISDICTION OF THE SUPREME COURT OF THE STATE OF NEW YORK SITTING IN NEW YORK COUNTY AND OF THE UNITED STATES DISTRICT COURT OF THE SOUTHERN DISTRICT OF NEW YORK, AND ANY APPELLATE COURT FROM ANY THEREOF, IN ANY ACTION OR
PROCEEDING ARISING OUT OF OR RELATING TO THIS NOTE, OR FOR RECOGNITION OR ENFORCEMENT OF ANY JUDGMENT, AND EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY AND UNCONDITIONALLY AGREES THAT ALL CLAIMS IN RESPECT OF ANY SUCH ACTION OR PROCEEDING MAY BE
HEARD AND DETERMINED IN SUCH NEW YORK STATE OR, TO THE EXTENT PERMITTED BY LAW, IN SUCH FEDERAL COURT. EACH OF THE PARTIES HERETO AGREES THAT A FINAL JUDGMENT IN ANY SUCH ACTION OR PROCEEDING SHALL BE CONCLUSIVE AND MAY BE
D-12
ENFORCED IN OTHER JURISDICTIONS BY SUIT ON THE JUDGMENT OR IN ANY OTHER MANNER PROVIDED BY LAW. NOTHING IN THIS NOTE SHALL AFFECT ANY RIGHT THAT PAYEE OR ANY PERMITTED TRANSFEREE MAY OTHERWISE
HAVE TO BRING ANY ACTION OR PROCEEDING RELATING TO THIS NOTE AGAINST MAKER OR ITS PROPERTIES IN THE COURTS OF ANY OTHER JURISDICTION. MAKER WAIVES PERSONAL SERVICE OF ANY AND ALL PROCESS UPON IT AND CONSENTS THAT ALL SUCH SERVICE OF PROCESS BE MADE
BY REGISTERED MAIL DIRECTED TO MAKER AT ITS ADDRESS SET FORTH IN SECTION 11 OR TO ANY OTHER ADDRESS AS MAY APPEAR IN PAYEES OR SUCH PERMITTED TRANSFEREES RECORDS AS THE ADDRESS OF MAKER. IN ANY ACTION, SUIT OR PROCEEDING IN
RESPECT OF OR ARISING OUT OF THIS NOTE, PAYEE AND MAKER WAIVE TRIAL BY JURY, AND EACH OF MAKER AND PAYEE WAIVES (I) THE RIGHT TO INTERPOSE ANY SET-OFF OR COUNTERCLAIM OF ANY NATURE OR DESCRIPTION,
(II) ANY OBJECTION BASED ON FORUM NON CONVENIENS OR VENUE, AND (III) ANY CLAIM FOR CONSEQUENTIAL, PUNITIVE OR SPECIAL DAMAGES.
14. Severability. Any provision contained in this Note which is prohibited or unenforceable in any jurisdiction shall, as to
such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render
unenforceable such provision in any other jurisdiction.
15. Amendment; Waiver. Any amendment hereto or waiver of any
provision hereof may be made with, and only with, the written consent of Maker and Payee.
16. Assignment. This Note binds
and is for the benefit of the successors and permitted assigns of Maker and Payee. No assignment or transfer of this Note or any rights, remedies or obligations hereunder may be made by any party hereto (by operation of law or otherwise) without the
prior written consent of the other party hereto and any attempted assignment without the required consent shall be void; provided, that upon the occurrence and during the continuation of an Event of Default, Payee shall have the right to assign this
Note in its discretion without the consent of Maker. Notwithstanding anything to the contrary, Payee may transfer this Note in whole or in part to one or more of its affiliates or members; provided that Payee shall provide prompt notice of such
transfer to Maker.
[Signature page follows]
D-13
IN WITNESS WHEREOF, Maker, intending to be legally bound hereby, has caused
this Note to be duly executed by the undersigned as of the day and year first above written.
|
|
|
Abacus Life, Inc. |
|
|
By: |
|
|
|
|
Name: |
|
|
Title: |
|
|
|
ACCEPTED AND AGREED: |
|
East Sponsor, LLC |
|
|
By: |
|
|
|
|
Name: |
|
|
Title: |
D-14
ANNEX E
COMPANY SUPPORT AGREEMENT
This Company Support Agreement (this Agreement), dated as of August 30, 2022, is entered into by and among East
Resources Acquisition Company, a Delaware corporation (Parent), Longevity Market Assets, LLC, a Florida limited liability company (LMA), Abacus Settlements, LLC, a Florida limited liability company
(Abacus and, together with LMA, the Companies), each of the members of LMA, whose names appear on the signature pages of this Agreement (each, an LMA Member and, collectively, the LMA
Members), and each of the members of Abacus, whose names appear on the signature pages of this Agreement (each, an Abacus Member and, collectively, the Abacus Members and, together with the LMA
Members, collectively, each a Member and, collectively, the Members). Parent, LMA, Abacus and the Members are sometimes individually referred to in this Agreement as a Party and collectively
as the Parties. Capitalized terms used, but not defined, in this Agreement shall have the meanings ascribed to them in the Merger Agreement (as defined below).
RECITALS
WHEREAS,
concurrently herewith, Parent, the Companies, LMA Merger Sub, LLC, a Delaware limited liability company (LMA Merger Sub), and Abacus Merger Sub, LLC, a Delaware limited liability company (Abacus Merger Sub), are
entering into an Agreement and Plan of Merger (as amended, supplemented or otherwise modified from time to time, the Merger Agreement), pursuant to which (and subject to the terms and conditions set forth therein) (i) LMA
Merger Sub will merge with and into LMA, with LMA surviving such merger (the LMA Merger) as a direct wholly owned subsidiary of Parent and (ii) Abacus Merger Sub will merge with and into Abacus, with Abacus surviving such
merger (the Abacus Merger and, together with the LMA Merger, the Mergers) as a direct wholly owned subsidiary of Parent;
WHEREAS, as of the date hereof, the LMA Members collectively own all of the issued and outstanding limited liability company interests
in LMA (the LMA Interests);
WHEREAS, as of the date hereof, the Abacus Members collectively own all of the
issued and outstanding limited liability company interests in Abacus (the Abacus Interests and, together with the LMA Interests, the Company Interests);
WHEREAS, each Member is the record owner of the number of Company Interests set forth on Schedule 1 attached hereto (such
Company Interests, together with any Company Interests issued to or otherwise acquired by the Member (including Company Interests acquired from another Member) after the date hereof, as to such Member, the Subject Interests); and
WHEREAS, as a condition and inducement to the willingness of Parent to enter into the Merger Agreement, the Companies and the
Members are entering into this Agreement.
AGREEMENT
NOW, THEREFORE, in consideration of the foregoing and the mutual covenants and agreements herein contained, and intending to be legally
bound hereby, each Party hereby agrees as follows:
1. Agreement to Vote. Each Member hereby covenants and agrees that, prior to the
Termination Date (as defined herein), each Member will, at any meeting of the members of the applicable Company (and at any adjournment or postponement thereof), however called, and in any written actions by consent of the members of the applicable
Company, cause the Subject Interests to be voted, if applicable (including via proxy), (a) in favor
E-1
of any action necessary to authorize, approve or permit the Transactions to be effected as contemplated therein, and (b) against the following actions (other than the Transactions): (i) any
extraordinary transaction, such as a merger, consolidation or other business combination involving the applicable Company or any of its Subsidiaries; (ii) any reorganization, recapitalization, dissolution or liquidation of the applicable
Company and its Subsidiaries, other than a redomestication of the applicable Company consistent with the Merger Agreement; (iii) any change in the capitalization of the applicable Company or the applicable Companys capital structure;
(iv) any sale, lease, sublease, license, sublicense or transfer of a material portion of the assets of the applicable Company; (v) any amendment to the applicable Companys Organizational Documents, except, with respect to any
redomestication of the applicable Company consistent with the Merger Agreement or as contemplated by the preceding clause (a) or otherwise agreed to in writing by Parent; and (vi) any other action, proposal, agreement or transaction which
is intended, or would reasonably be expected, to prohibit, impede, interfere with, prevent or nullify the Transactions.
2. No
Inconsistent Agreements. Each Member hereby covenants and agrees that such Member shall not (i) enter into any voting agreement or voting trust with respect to any of such Members Subject Interests that is inconsistent with such
Members obligations pursuant to this Agreement, (ii) grant a proxy or power of attorney with respect to any of such Members Subject Interests that is inconsistent with such Members obligations pursuant to this Agreement, or
(iii) enter into any agreement or undertaking that is otherwise inconsistent with, or would interfere with, or prohibit or prevent it from satisfying, its obligations pursuant to this Agreement.
3. Dissenters Rights. Each Member hereby irrevocably and unconditionally waives and agrees not to demand, perfect, assert, claim
or exercise any rights of appraisal, quasi appraisal or any dissenters rights (or similar claims) that such Member may have (whether under applicable Law or otherwise) or could potentially have or acquire in connection with the execution and
delivery of the Merger Agreement or consummation of the Transactions.
4. Termination. This Agreement shall terminate upon the
earliest of (i) such date and time as the Merger Agreement shall be terminated in accordance with its terms, (ii) as to each Member, the written agreement of such Member, Parent and each of the Companies and (iii) the expiration of
the applicable lock-up period set forth in Section 7 (such date, the Termination Date); provided, that the provisions set forth in Sections 6 and 11
through 21 shall survive the termination of this Agreement, unless the Merger Agreement has also terminated in which case these provisions shall not survive the termination of this Agreement; provided, further, that termination of this
Agreement shall not relieve any Party hereto from any liability resulting from a breach of this Agreement prior to the Termination Date or for any willful breach of, or actual fraud in connection with, this Agreement prior to such termination.
5. Representations and Warranties of the Members. Each Member hereby represents and warrants (severally and not jointly as to itself
only) to Parent as follows:
(a) Such Member is the sole record and beneficial owner of all of such Members Subject Interests and has
good and marketable title to all of the Members Subject Interests, free and clear of any encumbrances, except for any such restriction that may be imposed pursuant to (i) this Agreement and (ii) the applicable Companys
Organizational Documents. The Subject Interests listed on Schedule 1 constitute all of the Company Interests and any other equity securities of the Companies owned by such Member as of the date hereof, and such Member does not own or have the
power to vote any other membership interests or other equity securities of either of the Companies.
(b) Such Member has full voting power
with respect to all of the Subject Interests (to the extent such Subject Interests have any voting power) and full power to agree to all of the matters set forth in this Agreement, in each case with respect to all of the Subject Interests. None of
the Subject Interests are subject to any voting agreement, proxy, voting trust or other agreement, arrangement or restriction of any kind or nature with respect to the voting of the Subject Interests, other than this Agreement and the applicable
Companys Organizational Documents.
E-2
(c) Other than the filings, notices and reports pursuant to, in compliance with or required
to be made under the Exchange Act, to the Florida Office of Insurance Regulation, or to the California Department of Insurance, no filings, notices, reports, consents, registrations, approvals, permits, waivers, expirations of waiting periods or
authorizations are required to be obtained by such Member from, or to be given by such Member to, or be made by such Member with, any Governmental Entity in connection with the execution, delivery and performance by such Member of this Agreement,
the consummation of the transactions contemplated hereby or the Transactions.
(d) The execution, delivery and performance of this
Agreement by such Member does not, and the consummation of the transactions contemplated hereby and the Transactions will not, constitute or result in (i) a breach or violation of, or a default under, the Organizational Documents of such Member
(if such Member is not a natural person), (ii) with or without notice, lapse of time or both, a breach or violation of, a termination (or right of termination) of or a default under, the loss of any benefit under, the creation, modification or
acceleration of any obligations under or the creation of a Lien on any of the properties, rights or assets of such Member pursuant to any Contract binding upon such Member or under any applicable Law to which such Member is subject or (iii) any
change in the rights or obligations of any party under any Contract legally binding upon such Member, except, in the case of clause (ii) or (iii) directly above, for any such breach, violation, termination, default, creation, acceleration or
change that would not, individually or in the aggregate, reasonably be expected to prevent or materially delay or impair such Members ability to perform its obligations hereunder or to consummate the transactions contemplated hereby or the
Transactions.
(e) As of the date of this Agreement, there is no action pending against such Member or, to the knowledge of such Member,
threatened against such Member that, in any manner, questions the beneficial or record ownership of the Members Subject Interests or the validity of this Agreement, or challenges or seeks to prevent, enjoin or materially delay the performance
by such Member of its obligations under this Agreement.
(f) Such Member is, and in the event that such Member is acting on behalf of one
or more others who have an interest in the Company Interests, the Member has received confirmation from each such other to the effect that it is, an Accredited Investor, as defined in Regulation D of the Securities Act of 1933, as
amended, and is acting for either its own account or accounts of other Accredited Investors as to which it exercises sole investment discretion and has the authority to make the agreements contained herein. Such Member has executed the investor
questionnaire attached hereto as Exhibit A and shall provide to Parent an updated questionnaire reflecting any material changes thereto that arise at any time on or prior to the Closing.
(g) Such Member is a sophisticated holder of limited liability company interests and has adequate information concerning the business and
financial condition of Parent and the applicable Company to make an informed decision regarding this Agreement and the Transactions and has independently and based on such information as such Member has deemed appropriate, made its own analysis and
decision to enter into this Agreement. Such Member acknowledges that Parent and the Companies have not made and do not make any representation or warranty, whether express or implied, of any kind or character except as expressly set forth in this
Agreement. Such Member acknowledges that the agreements contained herein with respect to the Subject Interests held by such Member are irrevocable.
(h) Such Member understands and acknowledges that Parent is entering into the Merger Agreement in reliance upon such Members execution
and delivery of this Agreement and the representations, warranties, covenants and other agreements of such Member contained herein.
(i)
No investment banker, broker, finder or other intermediary is entitled to any brokers, finders, financial advisors or other similar fee or commission for which Parent or either of the Companies is or could be liable in connection
with the Merger Agreement or this Agreement or any of the respective transactions contemplated hereby or thereby, in each case based upon arrangements made by such Member in his, her or its capacity as a holder of Company Interests or, to the
knowledge of such Member, on behalf of such Member in his, her or its capacity as a holder of Company Interests.
E-3
6. Certain Covenants of the Members. Except in accordance with the terms of this
Agreement, each Member hereby covenants and agrees as follows:
(a) No Solicitation. Subject to Section 7
hereof, prior to the Termination Date, each Member shall not take, and, to the extent applicable, shall direct its Affiliates and Representatives not to take, whether directly or indirectly, any action to (i) knowingly encourage, initiate,
solicit, or facilitate any inquiries regarding or the making of offers or proposals that constitute an Acquisition Proposal (except as otherwise required by Law), (ii) engage in any discussions or negotiations with respect to an Acquisition Proposal
with, or provide any non-public information or data to, any Person that has made, or informs the Companies that it is considering making, an Acquisition Proposal, or (iii) enter into any agreement
(whether or not binding) relating to an Acquisition Proposal; provided, that, in the case of clauses (ii) and (iii), the execution, delivery and performance of this Agreement and the transactions contemplated hereby shall not be deemed a
violation of this Section 6(a). Such Member shall, and shall direct its Representatives to, immediately cease any and all existing discussions or negotiations with any Person conducted prior to the date hereof with respect
to, or which is reasonably likely to give rise to or result in, an Acquisition Proposal. If a Member or any of its Affiliates receives any inquiry or proposal regarding an Acquisition Proposal, then such Member shall (A) notify Parent and the
Companies promptly upon receipt of any Acquisition Proposal by such Member, and describe the material terms and conditions of any such Acquisition Proposal in reasonable detail and (B) keep Parent and the Companies reasonably informed on a
current basis of any modifications to such offer or information.
Notwithstanding anything in this Agreement to the contrary,
(i) such Member shall not be responsible for the actions of the applicable Company or the board of directors of the applicable Company (or any committee thereof), any subsidiary of the applicable Company, or any officers, directors (in their
capacity as such), employees and professional advisors of any of the foregoing (collectively, the Company Related Parties), (ii) such Member makes no representations or warranties with respect to the actions of any of the Company
Related Parties, and (iii) any breach by the applicable Company of its obligations under Section 5.13 of the Merger Agreement shall not be considered a breach by any Member of this Section 6(a) (it being
understood that, for the avoidance of doubt, such Member or his, her or its Representatives (other than any such Representative that is a Company Related Party) shall remain responsible for any breach by such Member or his, her or its
Representatives of this Section 6(a)).
(b) Transfer Restrictions. Each Member hereby agrees, prior to
the Termination Date, not to (except in each case pursuant to the Merger Agreement), (i) directly or indirectly, (x) Transfer (as defined below) or cause to be Transferred, or (y) enter into any Contract or option with respect to the
Transfer of, any of such Members Subject Interests or any voting rights with respect thereto, or (ii) publicly announce any intention to effect any transaction specified in clauses (x) or (y), or (iii) take any action that would
make any representation or warranty of such Member contained herein untrue or incorrect or have the effect of preventing or disabling such Member from performing its obligations under this Agreement; provided, however, that nothing herein shall
prohibit a Transfer to an Affiliate or immediate family member of such Member or to another Member of the applicable Company that is a party to this Agreement and bound by the terms and obligations hereof (a Permitted Transfer);
provided, further, that any Permitted Transfer shall be permitted only if, as a precondition to such Transfer, the transferee agrees in a writing, reasonably satisfactory in form and substance to Parent, to assume all of the obligations of such
Member under, and be bound by all of the terms of, this Agreement; provided, further, that any Transfer permitted under this Section 6(b) shall not relieve such Member of its obligations under this Agreement. Any Transfer
in violation of this Section 6(b) with respect to the Members Subject Interests shall be null and void. For purposes of this Agreement, Transfer shall mean the (i) sale of, offer to sell,
contract or agreement to sell, hypothecate, pledge, grant of any option to purchase or otherwise dispose of or agreement to dispose of, directly or indirectly, or establishment or increase of a put equivalent position or liquidation with respect to
or decrease of a call equivalent position within the meaning of Section 16 of the Exchange Act with respect to, any limited liability company interest or security, (ii) entry into any swap or other arrangement that transfers to another, in
whole or in part, any of the economic consequences of ownership of any limited liability company interest or security, whether any such transaction is to be settled by delivery of such securities, in cash or otherwise, or (iii) public
announcement of any intention to effect any transaction specified in clause (i) or (ii).
E-4
(c) Company Records. Each Member hereby authorizes the applicable Company to maintain
a copy of this Agreement at either the executive office or the registered office of the applicable Company.
(d) Confidentiality.
Each Member agrees that it understands and acknowledges that it may have had access to and may have learned (i) information proprietary to the applicable Company, (ii) other information proprietary to the applicable Company, including
trade secrets, processes, patent and trademark applications, product development, price, customer and supply lists, sales, pricing and marketing plans, policies and strategies, details of client and consultant contracts, supplier, partner, merchant,
lender, originator, processor, marketer, servicer and purchaser identities, operations methods, product development techniques, business acquisition plans and all other confidential information with respect to the businesses of the applicable
Company, and (iii) other confidential and/or proprietary information of the applicable Company obtained by such Member prior to the earlier of (x) the Effective Time and (y) the valid termination of the Merger Agreement, including the
terms of, or other facts relating to, this Agreement, the Merger Agreement, the Mergers and the other Ancillary Agreements and the other Transactions (collectively, Proprietary Information). Each Member agrees as to only that,
except for disclosures to such its counsel and accountants or in the proper performance of its duties with the applicable Company, it (i) will keep confidential all Proprietary Information, (ii) will not, directly or indirectly, disclose
any Proprietary Information to any third party or use any Proprietary Information in any way and (iii) will not, directly or indirectly, misuse, misappropriate or exploit any Proprietary Information in any way. The restrictions contained in
this Section 6(d) shall not apply to any information which (x) is at the Closing Date or thereafter (or if the Merger Agreement is terminated, at the date of termination or thereafter) becomes generally available to
the public other than as a result of a disclosure, directly or indirectly, by Member, or (y) is required to be disclosed by applicable Laws; provided that in such event, such Member shall use reasonable efforts to give reasonable advance notice
of such requirement to Parent to enable Parent to seek a protective order or other appropriate remedy with respect to such permitted disclosure. No Member or any of a Members Affiliates shall issue or make any press release or other public
announcement concerning (or otherwise disclose to any Person the existence or terms of) this Agreement, the Merger Agreement, the Ancillary Agreements or any of the Transactions, without Parents and the Companies prior written consent.
(e) Communications. Notwithstanding anything herein to the contrary, any confidentiality, nondisclosure or similar provision in
this Agreement does not prohibit or restrict a Member from initiating communications directly with, responding to any inquiry from, making disclosures that are protected under the whistleblower provisions of federal law or regulation, or providing
testimony before the Department of Justice, the Securities and Exchange Commission, the Congress, any agency Inspector General, FINRA (formerly the National Association of Securities Dealers, Inc.), any other government agency or legislative body or
any self-regulatory organizations or any other state or federal regulatory authority, in each case, without advance notice to Parent or the Companies. Pursuant to 18 U.S.C. § 1833(b), such Member will not be held criminally or civilly liable
under any Federal or State trade secret law for the disclosure of a trade secret of the applicable Company that (i) is made (A) in confidence to a Federal, State, or local government official, either directly or indirectly, or to such
Persons attorney and (B) solely for the purpose of reporting or investigating a suspected violation of law; or (ii) is made in a complaint or other document that is filed under seal in a lawsuit or other proceeding. If a Member files
a lawsuit for retaliation by Parent or the Companies for reporting a suspected violation of law, such Member may disclose the trade secret to such Persons attorney and use the trade secret information in the court proceeding, if such Person
(i) files any document containing the trade secret under seal, and (ii) does not disclose the trade secret, except pursuant to court order. Nothing in this Agreement is intended to conflict with 18 U.S.C. § 1833(b) or create liability
for disclosures of trade secrets that are expressly allowed by such section.
7. Lock-up.
(a) Each Member hereby agrees that such Member shall not Transfer (i) any Phase I Lock-up
Shares until the date that is 180 days after the Closing Date and (ii) any Phase II Lock-up Shares until the date that is 24 months after the Closing Date. For purposes of this Agreement, (x)
Phase I Lock-up Shares means, with respect to each Member, 15% of the shares of Parents Class A common stock, par value $0.0001 per share
E-5
(Parent Common Stock), received by such Member in connection with the Closing, and (y) Phase II Lock-up Shares means,
with respect to each Member, 85% of the shares of Parent Common Stock received by such Member in connection with the Closing.
(b)
Notwithstanding the provisions set forth in Section 7(a), Transfers of Phase I Lock-up Shares or Phase II Lock-up Shares, as applicable, and
that are held by a Member or any of their permitted transferees (that have complied with this Section 7(b)), are permitted (i) to officers or directors of Parent following the Closing or any affiliates or family
members of any of such officers, directors; (ii) in the case of an individual, transfers by gift to a member of the individuals immediate family, to a trust, the beneficiary of which is a member of the individuals immediate family
or an affiliate of such person, or to a charitable organization; (iii) in the case of an individual, transfers by virtue of laws of descent and distribution upon death of the individual; (iv) in the case of an individual, transfers
pursuant to a qualified domestic relations order; and (v) in the event of Parents liquidation, merger, capital stock exchange, reorganization or other similar transaction which results in all of Parents stockholders having the right
to exchange their shares of Parent Common Stock for cash, securities or other property following the Closing; provided, however, that in the case of clauses (i) through (iii), these permitted transferees must enter into a written agreement
agreeing to be bound by the restrictions contained in this Section 7.
8. Further Assurances. From time
to time, at Parents request and without further consideration, each Member shall execute and deliver such additional documents and take all such further action as may be reasonably necessary or reasonably requested to effect the actions and
consummate the Transactions and the transactions contemplated hereby. Each Member further agrees not to commence or participate in, and to take all actions necessary to opt out of any class in any class action with respect to, any action or claim,
derivative or otherwise, against Parent, Parents Affiliates, ERES Sponsor, the Companies or any of their respective successors and assigns relating to the negotiation, execution or delivery of this Agreement, the Merger Agreement or the
consummation of the transactions contemplated hereby and thereby.
9. Disclosure. Such Member hereby authorizes each of the
Companies and Parent to publish and disclose in any announcement or disclosure required by the SEC such Members identity and ownership of the Subject Interests and the nature of such Members obligations under this Agreement. Each Member
will promptly provide any information reasonably requested by Parent or the Companies for any regulatory application or filing made or approval sought in connection with the Transactions (including filings with the SEC).
10. Changes in Membership Interests. In the event (i) of any dividend in the form of Company Interests or other equity interests
in either of the Companies or any subdivision (or split), recapitalization, reclassification, combination or exchange of equity interests of either of the Companies on, of or affecting any Members Subject Interests or (ii) any Member
becomes the owner of any additional Company Interests or other equity interests of either of the Companies or other securities entitling the holder thereof to vote or give consent with respect to the matters set forth in
Section 1 hereof, the terms Company Interests and Subject Interests shall be deemed to refer to and include such additional Company Interests or other equity interests as well as any such securities
into which or for which any or all of such equity interests may be changed or exchanged or which are received in any such transaction. Each Member hereby agrees, while this Agreement is in effect, to notify Parent of the number of any new Company
Interests or other equity interests of the Companies acquired by such Member, if any, after the date hereof and Schedule 1 will be deemed amended accordingly.
11. Notices. All notices and other communications hereunder shall be in writing and shall be deemed given if delivered personally, by
email (with confirmation of receipt) or sent by a nationally recognized overnight courier service, such as Federal Express, to the Parties at the following addresses (or at such other address for a Party as shall be specified by like notice made
pursuant to this Section 11):
if to the Member, to the address or email address set forth opposite such
Members name on
E-6
Schedule 1, or in the absence of such address or email address being set forth on Schedule 1, the address (including email) set forth in each Companys books and records,
with a copy (which shall not constitute notice) to:
Locke Lord LLP
Terminus 200
3333 Piedmont Road, NE, Suite 1200
Atlanta, Georgia 30305
Attention: Brian T. Casey
E-mail: bcasey@lockelord.com
if to Abacus, to it at:
Abacus
Settlements, LLC
2101 Park Center Drive, Suite 220
Orlando, Florida 32835
Attention: Jay Jackson
E-mail: jay@abacuslife.com
with a copy (which shall not constitute notice) to:
Locke Lord LLP
Terminus 200,
Suite 1200
3333 Piedmont Road, NE
Atlanta, Georgia 30305
Attention: Brian T. Casey
E-mail: bcasey@lockelord.com
if to LMA, to it at:
Longevity
Market Assets, LLC
2101 Park Center Drive, Suite 220
Orlando, Florida 32835
Attention: Jay Jackson
E-mail: jay@abacuslife.com
with a copy (which shall not constitute notice) to:
Locke Lord LLP
Terminus 200
3333 Piedmont Road, NE, Suite 1200
Atlanta, Georgia 30305
Attention: Brian T. Casey
E-mail: bcasey@lockelord.com
if to Parent, to it at:
c/o
East Resources Acquisition Company
7777 NW Beacon Square Boulevard
Boca Raton, Florida 33487
Attention: John P. Sieminski
E-mail: jsieminski@emslp.com
with a copy (which shall not constitute notice) to:
Latham & Watkins LLP
811 Main Street, Suite 3700
Houston, Texas 77002
Attention: Ryan J. Maierson
E-mail: ryan.maierson@lw.com
E-7
12. No Ownership Interest. Nothing contained in this Agreement shall be deemed to
vest in Parent any direct or indirect ownership or incidence of ownership of or with respect to the Subject Interests of the Members. All rights, ownership and economic benefits of and relating to the Subject Interests of each Member shall remain
vested in and belong to each Member, and Parent shall have no authority to direct the Members in the voting or disposition of any of the Members Subject Interests, except as otherwise provided herein.
13. Fees and Expenses. Except as otherwise set forth in this Agreement, each party hereto shall be responsible for and pay its own
expenses incurred in connection with this Agreement and the Transactions, including all fees of its legal counsel, financial advisers and accountants; provided that if the Closing shall occur, the Surviving Companies shall pay or cause to be paid
the Parent Transaction Expenses and Company Transaction Expenses.
14. Severability. If any term or other provision of this
Agreement is invalid, illegal or incapable of being enforced by any rule of Law or public policy, all other terms, conditions and provisions of this Agreement shall nevertheless remain in full force and effect so long as the economic or legal
substance of the transactions contemplated by this Agreement is not affected in any manner materially adverse to any Party. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the Parties
shall negotiate in good faith to modify this Agreement so as to effect the original intent of the Parties as closely as possible in a mutually acceptable manner in order that the transactions contemplated by this Agreement be consummated as
originally contemplated to the fullest extent possible.
15. Binding Effect; Assignment. This Agreement and all of the provisions
hereof shall be binding upon and shall inure to the benefit of the Parties and their respective successors and permitted assigns. Neither this Agreement nor any of the rights, interests or obligations hereunder shall be assigned in whole or in part,
directly or indirectly, including by operation of law, by any Party without the prior written consent of the other Parties, and any attempted or purported assignment or delegation in violation of this Section 15 shall be
null and void.
16. No Third Party Beneficiaries. This Agreement is exclusively for the benefit of the Companies, and their
respective successors and permitted assigns, with respect to the obligations of the Parent Parties under this Agreement, and for the benefit of the Parent Parties, and their respective successors and permitted assigns, with respect to the
obligations of the Companies under this Agreement, and this Agreement shall not be deemed to confer upon or give to any other third party, including any Parent Stockholder, holders of Parent Private Warrants and holders of Parent Public Warrants any
remedy, claim, liability, reimbursement, cause of action or other right, including the right to rely upon the representations and warranties set forth in this Agreement. The representations and warranties in this Agreement are the product of
negotiations among the Parties. Any inaccuracies in such representations and warranties are subject to waiver by the Parties in accordance with Section 23. In some instances, the representations and warranties in this Agreement may represent an
allocation among the Parties of risks associated with particular matters regardless of the knowledge of any of the Parties. Consequently, Persons other than the Parties may not rely upon the representations and warranties in this Agreement as
characterizations of actual facts or circumstances as of the date of this Agreement or as of any other date.
17. Section Headings.
The Section headings contained in this Agreement are exclusively for the purpose of reference, are not part of the agreement of the Parties and shall not in any way affect the meaning or interpretation of this Agreement.
18. Consent to Jurisdiction, Etc. Each Party, and any Person asserting rights as a third party beneficiary hereunder, irrevocably
agrees that any Legal Dispute shall be brought exclusively in the courts of the State of Delaware; provided that if subject matter jurisdiction over such Legal Dispute is vested exclusively in the United States federal courts, such Legal Dispute
shall be heard in the United States District Court for the District of Delaware. Each Party, and any Person asserting rights as a third party beneficiary hereunder, hereby irrevocably
E-8
and unconditionally submits to the jurisdiction of such courts (and of the appropriate appellate courts therefrom) in any such suit, action or proceeding and irrevocably waives, to the fullest
extent permitted by Laws, any objection that it may now or hereafter have to the laying of the venue of any such suit, action or proceeding in any such court or that any such Legal Dispute that is brought in any such court has been brought in an
inconvenient forum. During the period a Legal Dispute that is filed in accordance with this Section 18 is pending before a court, all actions, suits or proceedings with respect to such Legal Dispute or any other Legal
Dispute, including any counterclaim, cross-claim or interpleader, shall be subject to the exclusive jurisdiction of such court. Each Party, and any Person asserting rights as a third party beneficiary hereunder, may bring such Legal Dispute only if
it hereby waives, and shall not assert as a defense in any Legal Dispute, that (a) such Party is not personally subject to the jurisdiction of the above named courts for any reason, (b) such action, suit or proceeding may not be brought or
is not maintainable in such court, (c) such Partys property is exempt or immune from execution, (d) such Legal Dispute is brought in an inconvenient forum or (e) the venue of such action, suit or proceeding is improper. A final
judgment in any action, suit or proceeding described in this Section 18 following the expiration of any period permitted for appeal and subject to any stay during appeal shall be conclusive and may be enforced in other
jurisdictions by suit on the judgment or in any other manner provided by applicable Laws. EACH OF THE PARTIES, AND ANY PERSON ASSERTING RIGHTS AS A THIRD PARTY BENEFICIARY HEREUNDER, MAY BRING A LEGAL DISPUTE ONLY IF IT IRREVOCABLY AND
UNCONDITIONALLY WAIVES ANY RIGHT TO TRIAL BY JURY ON ANY CLAIMS OR COUNTERCLAIMS ASSERTED IN ANY LEGAL DISPUTE RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY AND FOR ANY COUNTERCLAIM RELATING THERETO. IF THE SUBJECT MATTER OF ANY
SUCH LEGAL DISPUTE IS ONE IN WHICH THE WAIVER OF JURY TRIAL IS PROHIBITED, NO PARTY, NOR ANY PERSON ASSERTING RIGHTS AS A THIRD PARTY BENEFICIARY, SHALL ASSERT IN SUCH LEGAL DISPUTE A NONCOMPULSORY COUNTERCLAIM ARISING OUT OF OR RELATING TO THIS
AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY. FURTHERMORE, NO PARTY, NOR ANY PERSON ASSERTING RIGHTS AS A THIRD PARTY BENEFICIARY, SHALL SEEK TO CONSOLIDATE ANY SUCH LEGAL DISPUTE WITH A SEPARATE ACTION OR OTHER LEGAL PROCEEDING IN WHICH A JURY
TRIAL CANNOT BE WAIVED.
19. Entire Agreement. This Agreement constitutes the entire agreement among the Parties with respect to
the subject matter of this Agreement and supersede all other prior agreements and understandings, both written and oral, between the Parties with respect to the subject matter of this Agreement. Each Party acknowledges and agrees that, in entering
into this Agreement, such Party has not relied on any representations, warranties, promises or assurances, written or oral, that are not reflected in this Agreement.
20. Governing Law. This Agreement shall be governed by and construed in solely accordance with the laws of the State of Delaware
(regardless of the laws that might otherwise govern under applicable principles of conflicts of laws thereof) as to all matters, including matters of validity, construction, effect, performance and remedies.
21. Specific Performance. The Parties acknowledge that the rights of each Party to consummate the transactions contemplated hereby are
unique and recognize and affirm that in the event of a breach of this Agreement by any Party, money damages may be inadequate and the non breaching Party may have no adequate remedy at law. Accordingly, the Parties agree that such non-breaching Party shall have the right, in addition to any other rights and remedies existing in their favor at law or in equity, to enforce its rights and the other Partys obligations hereunder not only by
an action or actions for damages but also by an action or actions for specific performance, injunctive and/or other equitable relief (without posting of bond or other security), including any order, injunction or decree sought by such non-breaching Party to cause the other Party to perform its respective agreements and covenants contained in this Agreement. Each Party further agrees that the only permitted objection that it may raise in response
to any action for equitable relief is that it contests the existence of a breach or threatened breach of this Agreement, and that no Party shall allege, and each Party hereby irrevocably waives the defense, that there is an adequate remedy at law.
E-9
22. Counterparts. This Agreement may be executed in counterparts, each of which shall
be deemed to be an original, but all of which taken together shall constitute one and the same agreement. Signatures to this Agreement transmitted by electronic mail in .pdf form, or by any other electronic means designed to preserve the original
graphic and pictorial appearance of a document (including DocuSign or other such services), will be deemed to have the same effect as physical delivery of the paper document bearing the original signatures. No Party shall be bound until such time as
all of the Parties have executed counterparts of this Agreement.
23. Amendment; Modification; Waiver. This Agreement may be
amended, modified or supplemented at any time only by written agreement of the Parties. No failure or delay by any Party in exercising any right, power or privilege hereunder or under applicable Law shall operate as a waiver of such rights and,
except as otherwise expressly provided herein, no single or partial exercise thereof shall preclude any other or further exercise thereof or the exercise of any other right, power or privilege. The rights and remedies herein provided shall be
cumulative and not exclusive of any rights or remedies provided by Law.
24. Time of Essence. With regard to all dates and time
periods set forth in this Agreement, time is of the essence.
25. No Recourse. All claims, obligations, liabilities, or causes of
action (whether in contract or in tort, in law or in equity, or granted by statute) that may be based upon, in respect of, arise under, out or by reason of, be connected with, or relate in any manner to this Agreement, or the negotiation, execution,
or performance of this Agreement (including any representation or warranty made in, in connection with, or as an inducement to, this Agreement), may be made only against (and such representations and warranties are those solely of) the Parties, and
then only with respect to the specific obligations set forth herein with respect to such Party. No Person who is not a Party, including any current, former or future director, officer, employee, incorporator, member, partner, manager, stockholder,
equityholder, Affiliate, agent, attorney, representative or assignee of, and any financial advisor or lender to, any Party, or any current, former or future director, officer, employee, incorporator, member, partner, manager, stockholder, Affiliate,
agent, attorney, representative or assignee of, and any financial advisor or lender to, any of the foregoing (collectively, the Nonparty Affiliates), shall have any liability (whether in contract or in tort, in law or in equity, or
granted by statute) for any claims, causes of action, obligations, or liabilities arising under, out of, in connection with, or related in any manner to this Agreement or based on, in respect of, or by reason of this Agreement or its negotiation,
execution, performance or breach, and, to the maximum extent permitted by Laws, each Party hereby waives and releases all such liabilities, claims, causes of action and obligations against any such Nonparty Affiliates. Without limiting the
foregoing, to the maximum extent permitted by Laws, (a) each Party hereby waives and releases any and all rights, claims, demands or causes of action that may otherwise be available in contract or in tort, at law or in equity, or granted by
statute, to avoid or disregard the entity form of a Party or otherwise impose liability of a Party on any Nonparty Affiliate, whether granted by statute or based on theories of equity, agency, control, instrumentality, alter ego, domination, sham,
single business enterprise, piercing the veil, unfairness, undercapitalization, or otherwise, and (b) each Party disclaims any reliance upon any Nonparty Affiliates with respect to the performance of this Agreement or any representation or
warranty made in, in connection with, or as an inducement to, this Agreement.
26. Construction.
(a) Unless the context of this Agreement otherwise clearly requires, (i) references to the plural include the singular, and references to
the singular include the plural, (ii) references to one gender include the other gender, (iii) the words include, includes and including do not limit the preceding terms or words and shall be deemed to
be followed by the words without limitation, (iv) the terms hereof, herein, hereunder, hereto and similar terms in this Agreement refer to this Agreement as a whole and not to any
particular provision of this Agreement, (v) the terms day and days mean and refer to calendar day(s), (vi) any statement in this Agreement to the effect that any information, document, or other material has been
made available by
E-10
any of the Group Companies shall mean that a true, correct, and complete copy of such information, document, or other material was included in and available at the LMA Drive online
data site at least four (4) Business Days prior to the date hereof and was not removed after being included in such online data site, and (vii) the terms year and years mean and refer to calendar year(s).
(b) Unless otherwise set forth in this Agreement and for disclosure purposes only if made available to Parent, references in this Agreement to
(i) any document, instrument or agreement (including this Agreement) (A) includes and incorporates all exhibits, schedules and other attachments thereto, (B) includes all documents, instruments or agreements issued or executed in
replacement thereof and (C) means such document, instrument or agreement, or replacement or predecessor thereto, as amended, modified or supplemented from time to time in accordance with its terms and in effect at any given time, and
(ii) a particular Law means such Law, as amended, modified, supplemented or succeeded from time to time and in effect on the date hereof. All Article, Section, Exhibit and Schedule references herein are to Articles, Sections, Exhibits and
Schedules of this Agreement, unless otherwise specified.
(c) This Agreement shall not be construed as if prepared by one of the Parties,
but rather according to its fair meaning as a whole, as if all Parties had prepared it.
27. Trust Account Waiver. Notwithstanding
anything to the contrary set forth herein, each Member acknowledges that Parent has established the trust account described therein (the Trust Account) containing the proceeds of its initial public offering (the
IPO) and from certain private placements occurring simultaneously with the IPO (including interest accrued from time to time thereon) for the benefit of Parents public shareholders and certain other parties (including the
underwriters of the IPO). Accordingly, each Member (on behalf of itself and its Affiliates) hereby waives any past, present or future claim of any kind against, and any right to access, the Trust Account, any trustee of the Trust Account and Parent
to collect from the Trust Account any monies that may be owed to them by Parent or any of its affiliates for any reason whatsoever, and will not seek recourse against the Trust Account at any time for any reason whatsoever, including, without
limitation, for any knowing and intentional material breach by any of the parties to this Agreement of any of its representations or warranties as set forth in this Agreement, or such partys material breach of any of its covenants or other
agreements set forth in this Agreement, which material breach constitutes, or is a consequence of, a purposeful act or failure to act by such party with the knowledge that the taking of such act or failure to take such act would cause a material
breach of this Agreement. This Section 27 shall survive the termination of this Agreement for any reason.
28.
Non-Recourse. This Agreement may only be enforced against, and any claim or cause of action based upon, arising out of, or related to this Agreement or the transactions contemplated hereby may only be
brought against, the entities that are expressly named as parties hereto, and then only with respect to the specific obligations set forth herein with respect to such party. Except to the extent a named party to this Agreement (and then only to the
extent of the specific obligations undertaken by such named party in this Agreement), (a) no past, present or future director, officer, manager, employee, incorporator, member, partner, stockholder, affiliate, agent, attorney, advisor or
representative or affiliate of any named party to this Agreement and (b) no past, present or future director, officer, employee, incorporator, member, partner, stockholder, affiliate, agent, attorney, advisor or representative or affiliate of
any of the foregoing shall have any liability (whether in contract, tort, equity or otherwise) for any one or more of the representations, warranties, covenants, agreements or other obligations or liabilities of any one or more of Parent or the
Members under this Agreement of or for any claim based on, arising out of, or related to this Agreement or the transactions contemplated hereby.
29. Capacity as a Member or Proxy Holder. Notwithstanding anything herein to the contrary, each Member or proxy holder signs this
Agreement solely in the Members or proxy holders capacity as a member or proxy holder of the applicable Company, and not in any other capacity and this Agreement shall not limit, prevent or otherwise affect the actions of the Member,
proxy holder or any Affiliate or Representative of the Member or proxyholder, or any of their respective Affiliates in his or her capacity, if applicable, as an officer, manager or director of the applicable Company (or any Subsidiary of the
applicable Company) or any other Person, including in the exercise of his or her fiduciary duties as a director or officer of the applicable Company or any Subsidiary of the applicable Company. No Member shall be liable or responsible for any
breach, default, or violation of any
E-11
representation, warranty, covenant or agreement by any other Member that is also a Party and each Member shall solely be required to perform its obligations hereunder in its individual capacity.
[Signature Pages Follow.]
E-12
IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed (where applicable,
by their respective officers or other authorized Persons thereunto duly authorized) as of the date first written above.
|
|
|
EAST RESOURCES ACQUISITION COMPANY |
|
|
By: |
|
/s/ Gary L. Hagerman, Jr. |
Name: |
|
Gary L. Hagerman, Jr. |
Title: |
|
Chief Financial Officer and Treasurer |
[Signature Page to
Company Support Agreement]
E-13
IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed (where applicable,
by their respective officers or other authorized Persons thereunto duly authorized) as of the date first written above.
|
|
|
ABACUS SETTLEMENTS, LLC |
|
|
By: |
|
/s/ Jay Jackson |
Name: |
|
Jay Jackson |
Title: |
|
Chief Executive Officer |
|
LONGEVITY MARKET ASSETS, LLC |
|
|
By: |
|
/s/ Jay Jackson |
Name: |
|
Jay Jackson |
Title: |
|
Chief Executive Officer |
[Signature Page to
Company Support Agreement]
E-14
|
|
|
ABACUS MEMBERS |
|
|
By: |
|
/s/ T. Sean McNealy |
Name: |
|
T. Sean McNealy |
|
|
By: |
|
/s/ K. Scott Kirby |
Name: |
|
K. Scott Kirby |
|
|
By: |
|
/s/ Matthew A. Ganovsky |
Name: |
|
Matthew A. Ganovsky |
|
LMA MEMBERS |
|
|
By: |
|
/s/ T. Sean McNealy |
Name: |
|
T. Sean McNealy |
|
|
By: |
|
/s/ K. Scott Kirby |
Name: |
|
K. Scott Kirby |
|
|
By: |
|
/s/ Matthew A. Ganovsky |
Name: |
|
Matthew A. Ganovsky |
|
|
By: |
|
/s/ Jay Jackson |
Name: |
|
Jay Jackson |
[Signature Page to
Company Support Agreement]
E-15
Exhibit A
Form of Accredited Investor Questionnaire
Form of Investor Representation Letter and Questionnaire
August 30, 2022
East Resources Acquisition
Company
7777 NW Beacon Square Boulevard
Boca Raton, Florida
33487
Re: Investor Representation Letter and Questionnaire
Ladies and Gentlemen:
The undersigned (the
Holder) is an owner of the limited liability company interests (the Interests) set forth on Schedule 1 to that certain Company Support Agreement (the Company Support Agreement), dated as of
the date hereof, by and among the Holder, East Resources Acquisition Company, a Delaware corporation (Parent), Longevity Market Assets, LLC, a Florida limited liability company (LMA), Abacus Settlements, LLC, a
Florida limited liability company (Abacus and, together with LMA, the Companies), each of the members of LMA, whose names appear on the signature pages of the Company Support Agreement, and each of the members
of Abacus, whose names appear on the signature pages of the Company Support Agreement. Reference is made to that certain Agreement and Plan of Merger, dated as of the date hereof (as it may be amended from time to time in accordance with its terms,
the Merger Agreement), by and among Parent, the Companies, LMA Merger Sub, LLC, a Delaware limited liability company (LMA Merger Sub), and Abacus Merger Sub, LLC, a Delaware limited liability company
(Abacus Merger Sub), pursuant to which (and subject to the terms and conditions set forth therein) (i) LMA Merger Sub will merge with and into LMA, with LMA surviving such merger (the LMA Merger) as a
direct wholly owned subsidiary of Parent and (ii) Abacus Merger Sub will merge with and into Abacus, with Abacus surviving such merger (the Abacus Merger and, together with the LMA Merger, the Mergers) as a
direct wholly owned subsidiary of Parent. Capitalized terms used in this investor representation letter and questionnaire (this Investor Representation Letter) and not otherwise defined herein shall have the same meanings ascribed
to such terms in the Merger Agreement.
Upon the closing of the Mergers (the Closing, and the date of such Closing, the
Closing Date), Holders Interests will be converted into the right to receive a certain number of shares of Parent Common Stock, subject to and in accordance with the terms of the Merger Agreement, in a private placement
effected in reliance on the exemption from the registration requirements of the Securities Act of 1933, as amended (the Securities Act), provided by Section 4(a)(2) of the Securities Act and/or Regulation D promulgated under
the Securities Act, and exemptions from the qualification requirements of applicable state law. The Holder acknowledges and agrees that Parent is relying on the truth and accuracy of the representations and warranties made by the Holder in this
Investor Representation Letter in order to rely on the exemptions described above.
1. Representations, Warranties and Certain
Agreements of the Holder. The Holder hereby makes the following representations, warranties and agreements to Parent, each of which representations and warranties is true and correct as to the Holder as of the date hereof and will be true and
correct on and as of the Closing Date as if made on the Closing Date.
1.1 Investment Representation Authorization Letter. This
Investor Representation Letter constitutes the Holders valid and legally binding obligation, enforceable against the Holder in accordance with its terms, except as may be limited by: (a) applicable bankruptcy, insolvency, reorganization
or other laws of general application relating to or affecting the enforcement of creditors rights generally; or (b) the effect of rules of law governing the availability of equitable remedies.
E-16
1.2 Acquisition for Own Account. The shares of Parent Common Stock to be acquired by
the Holder pursuant to the Merger Agreement will be acquired for investment for the Holders own account, not as a nominee or agent, and not with a view to the public resale or distribution thereof within the meaning of the Securities Act, and
the Holder has no present intention of selling, granting any participation in, or otherwise distributing the same.
1.3 No
Solicitation. At no time was the Holder presented with or solicited by any publicly issued or circulated newspaper, mail, radio, television or other form of general advertising or solicitation in connection with the offer, sale and purchase of
the Parent Common Stock by Parent or its agents.
1.4 Accredited Investor. The Holder is an accredited investor as
defined in Rule 501(a) under the Securities Act satisfying the applicable requirements set forth on Schedule A.
1.5 Disclosure
of Information. The Holder has received or has had full access to all the information the Holder considers necessary or appropriate to make an informed investment decision with respect to the shares of Parent Common Stock. The Holder further has
had an opportunity to ask questions and receive answers from Parent regarding the terms and conditions of the offering of the shares of Parent Common Stock and to obtain additional information necessary to verify any information furnished to the
Holder or to which the Holder had access.
1.6 Understanding of Risks. The Holder is fully aware of (a) the highly speculative
nature of the shares of Parent Common Stock and (b) the financial risk involved.
1.7 Holder Qualifications. The Holder
has such knowledge and experience in financial and business matters that the Holder is capable of evaluating the merits and risks of this prospective investment, has the capacity to protect the Holders own interests in connection with this
transaction and is financially capable of bearing a total loss of the shares of Parent Common Stock.
1.8 Compliance with Securities
Laws. The Holder understands and acknowledges that, in reliance upon the representations and warranties made by the Holder herein, the shares of Parent Common Stock are not being registered with the U.S. Securities and Exchange Commission under
the Securities Act or any state securities laws, but instead are being transferred under an exemption or exemptions from the registration and qualification requirements of the Securities Act and applicable state securities laws which impose certain
restrictions on the Holders ability to transfer the shares of Parent Common Stock.
1.9 Restricted Securities. The Holder
agrees not to make any disposition of all or any portion of the shares of Parent Common Stock unless and until: (a) there is then in effect a registration statement under the Securities Act covering such proposed disposition and such
disposition is made in accordance with such registration statement; or (b) the Holder shall have furnished Parent with an opinion of counsel, in a form reasonably satisfactory to Parent, that such disposition will not require registration of
the shares of Parent Common Stock under the Securities Act and otherwise complies with applicable state securities laws. Holder understands that the Parent Common Stock is being offered in a transaction not involving any public offering within the
meaning of the Securities Act and that the Parent Common Stock has not been registered under the Securities Act. Holder understands that the Parent Common Stock may not be resold, transferred, pledged or otherwise disposed of by Holder absent an
effective registration statement under the Securities Act, except (i) to Parent or a subsidiary thereof, (ii) to non-U.S. persons pursuant to offers and sales that occur outside the United States
within the meaning of Regulation S under the Securities Act or (iii) pursuant to another applicable exemption from the registration requirements of the Securities Act, and that any certificates or book entries representing the Parent Common
Stock shall contain a legend to such effect. Holder acknowledges that the Parent Common Stock will not be eligible for resale pursuant to Rule 144A promulgated under the Securities Act. Holder understands and agrees that the Parent Common Stock will
be subject to transfer restrictions under the Securities Act and, as a result of these transfer restrictions, Holder may not be able to readily resell the Parent
E-17
Common Stock and may be required to bear the financial risk of an investment in the Parent Common Stock for an indefinite period of time. Holder understands that it has been advised to consult
legal counsel prior to making any offer, resale, pledge or transfer of any of the Parent Common Stock.
1.10
Rule 144. The Holder acknowledges that, because the shares of Parent Common Stock have not been registered under the Securities Act, such shares must be held indefinitely unless subsequently registered under the Securities
Act or unless an exemption from such registration is available. The Holder is aware of the provisions of Rule 144 promulgated under the Securities Act.
1.11 Legends. The certificates or book-entry entitlements representing the shares of Parent Common Stock shall bear the following
legend (as well as any other legends required by applicable state and federal securities laws) until such time as such legends are no longer relevant or applicable:
THE SHARES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR UNDER APPLICABLE STATE SECURITIES LAWS AND HAVE BEEN
ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH SALE OR DISTRIBUTION MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL FOR THE
COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS.
The legend shall be
removed by Parent from any certificate or book-entry entitlement evidencing the shares of Parent Common Stock upon delivery to Parent of an opinion of counsel, reasonably satisfactory in form and substance to Parent, that either: (a) a
registration statement under the Securities Act is at that time in effect with respect to the legended security; or (b) such security can be freely transferred without requiring registration thereof under the Securities Act and such transfer
otherwise complies with the applicable state securities laws.
1.12 Stop-Transfer Instructions. The Holder agrees that, in order to
ensure compliance with the restrictions imposed by this Investor Representation Letter, Parent may issue appropriate stop-transfer instructions to its transfer agent. Parent will not be required: (a) to transfer on its books any
shares of Parent Common Stock that have been sold or otherwise transferred in violation of any of the provisions of this Investor Representation Letter; or (b) to treat as owner of such shares of Parent Common Stock, or to accord the right to
vote or receive dividends, to any purchaser or other transferee to whom such shares of Parent Common Stock have been so transferred in violation of any of the provisions of this Investor Representation Letter.
2. Entire Agreement. This Investor Representation Letter, the Company Support Agreement and the Merger Agreement constitute the entire
agreement and understanding of the parties with respect to the subject matter of this Investor Representation Letter, and supersede all prior understandings and agreements, whether oral or written, between or among the parties hereto with respect to
the specific subject matter hereof.
[Signature Page Follows]
E-18
IN WITNESS WHEREOF, the Holder has entered into this Investor Representation Letter as of
the date and year first entered.
|
Very truly yours, |
|
THE HOLDER: |
|
|
(Print Name of Stockholder) |
|
|
(Signature) |
|
|
(Print name and title if signing on behalf of an
entity) |
|
|
(Print Address) |
|
|
(Print Address) |
|
|
(Print Telephone Number) |
Signature Page to
Investor Representation Letter
E-19
SCHEDULE A
ELIGIBILITY REPRESENTATIONS OF HOLDER
Rule 501(a), in relevant part, states that an accredited investor shall mean any person who comes within any of the below listed categories, or
who the issuer reasonably believes comes within any of the below listed categories, at the time of the sale of the securities to that person. Holder has indicated, by marking and initialing the appropriate box below, the provision(s) below which
apply to Holder and under which Holder accordingly qualifies as an accredited investor.
☐ Any bank, registered broker or
dealer, insurance company, registered investment company, business development company, small business investment company, or rural business investment company;
☐ Any plan established and maintained by a state, its political subdivisions, or any agency or instrumentality of a state or its
political subdivisions for the benefit of its employees, if such plan has total assets in excess of $5,000,000;
☐ Any employee
benefit plan, within the meaning of the Employee Retirement Income Security Act of 1974, if a bank, insurance company, or registered investment adviser makes the investment decisions, or if the plan has total assets in excess of $5,000,000;
☐ Any organization described in Section 501(c)(3) of the Internal Revenue Code, corporation, Massachusetts or similar business
trust, partnership, or limited liability company, not formed for the specific purpose of acquiring the securities offered, with total assets in excess of $5,000,000;
☐ Any director, executive officer, or general partner of the issuer of the securities being offered or sold, or any director, executive
officer, or general partner of a general partner of that issuer;
☐ Any natural person whose individual net worth, or joint net worth
with that persons spouse or spousal equivalent, at the time of that persons purchase exceeds $1,000,000. For purposes of calculating a natural persons net worth: (a) the persons primary residence must not be included as
an asset; (b) indebtedness secured by the persons primary residence up to the estimated fair market value of the primary residence must not be included as a liability (except that if the amount of such indebtedness outstanding at the time
of calculation exceeds the amount outstanding 60 days before such time, other than as a result of the acquisition of the primary residence, the amount of such excess must be included as a liability); and (c) indebtedness that is secured by the
persons primary residence in excess of the estimated fair market value of the residence must be included as a liability;
☐ Any
natural person who had an individual income in excess of $200,000 in each of the two most recent years or joint income with that persons spouse or spousal equivalent in excess of $300,000 in each of those years and has a reasonable expectation
of reaching the same income level in the current year;
☐ Any trust with assets in excess of $5,000,000, not formed to acquire the
securities offered, whose purchase is directed by a sophisticated person;
☐ Any entity in which all of the equity owners are
accredited investors meeting one or more of the above tests;
☐ Any entity of a type not listed in one or more of the tests above,
not formed for the specific purpose of acquiring the securities offered, owning investments (as defined in rule 2a51-1(b) of the Investment Company Act of 1940) in excess of $5,000,000;
☐ Any natural person holding in good standing one or more of the following: the General Securities Representative license (Series 7); the
Private Securities Offerings Representative license (Series 82), or the d Investment Adviser Representative license (Series 65);
☐
Any family office (as defined in rule 202(a)(11)(G)-1 under the Investment Advisers Act of 1940): (i) with assets under management in excess of $5,000,000, (ii) that is not formed for the specific
purpose of acquiring the securities offered, and (iii) whose prospective investment is directed by a person who has such
E-20
knowledge and experience in financial and business matters that such family office is capable of evaluating the merits and risks of the prospective investment; or
☐ Any family client (as defined in rule 202(a)(11)(G)-1 under the Investment Advisers
Act of 1940) of a family office meeting the requirements of the above test and whose prospective investment in the issuer is directed by such family office pursuant to clause (iii) of the above test.
E-21
ANNEX F
AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT
THIS AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this Agreement), dated as of
[ ], 202[ ], is made and entered into by and among Abacus Life, Inc., a Delaware corporation, f/k/a East Resources Acquisition Company (the
Company), East Sponsor, LLC, a Delaware limited liability company (the Sponsor), and the undersigned parties listed under Holder on the signature pages hereto (each such party, together with the Sponsor and any
person or entity who hereafter becomes a party to this Agreement pursuant to Section 5.02 of this Agreement, a Holder and collectively the Holders).
RECITALS
WHEREAS, the
Company and the Sponsor are party to that certain Registration Rights Agreement, dated as of July 30, 2020 (the Original Registration Rights Agreement), pursuant to which the Company granted the Sponsor certain registration
rights with respect to the Class A Common Stock, Class B Common Stock, Public Warrants, and Private Warrants of the Company;
WHEREAS, pursuant to that certain Agreement and Plan of Merger, dated as of August 30, 2022 (the Merger Agreement), by
and among the Company, LMA Merger Sub, LLC, a Delaware limited liability company (LMA Merger Sub), Abacus Merger Sub, LLC, a Delaware limited liability company (Abacus Merger Sub), Longevity Market Assets, LLC,
a Florida limited liability company (LMA), and Abacus Settlements, LLC, a Florida limited liability company (Abacus and, together with LMA, the Legacy Companies), on August 30, 2022, (i)
LMA Merger Sub merged with and into LMA, with LMA surviving such merger as a direct wholly owned subsidiary of the Company and (ii) Abacus Merger Sub merged with and into Abacus, with Abacus surviving such merger as a direct wholly owned
subsidiary of the Company (collectively, the Mergers and, together with the other transactions completed pursuant to the Merger Agreement, the Business Combination);
WHEREAS, in connection with the closing of the Business Combination (the Closing), [ ● ] shares of the
Companys Class A common stock, par value $0.0001 per share (the Common Stock), were issued to the holders of the limited liability company interest of each of the Legacy Companies (each such holder, a Legacy
Member) as consideration in the Mergers;
WHEREAS, in connection with the Business Combination, an aggregate of 8,625,000 shares
of the Companys Class B common stock, par value $0.0001 per share (the Founder Shares), were converted into shares of Common Stock;
WHEREAS, the Company and the Sponsor are parties to that certain Sponsor Warrants Purchase Agreement, dated as of July 2, 2020, pursuant
to which the Sponsor purchased an aggregate of 8,900,000 warrants to purchase shares of the Common Stock (the Private Placement Warrants), in a private placement transaction that occurred simultaneously with the closing of the
Companys initial public offering;
WHEREAS, in connection with the extension of the Companys time to consummate a business
combination from July 27, 2022 to January 27, 2023, on July 25, 2022, the Company issued a promissory note in the principal amount of up to $1,924,356.46 to the Sponsor, up to $1,500,000 of which is convertible into warrants for the
purchase of the Common Stock (the Conversion Warrants) at a price of $1.50 per warrant at the option of the Sponsor at the Closing;
WHEREAS, pursuant to Section 5.05 of the Original Registration Rights Agreement, the provisions, covenants and
conditions set forth therein may be amended or modified upon the written consent of the Company and the holders of at least a majority-in-interest of the Registrable
Securities (as defined in the Original Registration Rights Agreement) at the time in question; and
F-1
WHEREAS, the Company and the Sponsor, which, on the date hereof, collectively hold a majority-in-interest of the Registrable Securities under the Original Registration Rights Agreement, desire to amend and restate the Original Registration Rights Agreement in
its entirety pursuant to Section 5.05 thereof in order to provide the Holders with registration rights with respect to the Registrable Securities hereunder on the terms set forth herein.
NOW, THEREFORE, in consideration of the representations, covenants and agreements contained herein, and certain other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby agree as follows:
ARTICLE I.
DEFINITIONS
Section 1.01 Definitions. The terms defined in this Article I shall, for all purposes of this
Agreement, have the respective meanings set forth below:
Abacus shall have the meaning given in the Recitals hereto.
Abacus Merger Sub shall have the meaning given in the Recitals hereto.
Adverse Disclosure shall mean any public disclosure of material non-public
information, which disclosure, in the good faith judgment of the Chief Executive Officer or principal financial officer of the Company, after consultation with counsel to the Company, (i) would be required to be made in any Registration
Statement or Prospectus in order for the applicable Registration Statement or Prospectus not to contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements contained therein (in the case of any
prospectus and any preliminary prospectus, in the light of the circumstances under which they were made) not misleading, (ii) would not be required to be made at such time if the Registration Statement were not being filed, and
(iii) the Company has a bona fide business purpose for not making such information public.
Agreement shall have
the meaning given in the Preamble.
Business Combination shall have the meaning given in the Recitals hereto.
Closing shall have the meaning given in the Recitals hereto.
Closing Date shall have the meaning given in the Merger Agreement.
Commission shall mean the Securities and Exchange Commission.
Common Stock shall have the meaning given in the Recitals hereto.
Company shall have the meaning given in the Preamble.
Conversion Warrants shall have the meaning given in the Recitals hereto.
Demand Registration shall have the meaning given in Section 2.02(a).
Demanding Holder shall have the meaning given in Section 2.02(a).
Exchange Act shall mean the Securities Exchange Act of 1934, as it may be amended from time to time.
Form S-1 Shelf shall have the meaning given in
Section 2.01(a).
F-2
Form S-3 Shelf
shall have the meaning given in Section 2.01(a).
Founder Shares shall have the meaning given
in the Recitals hereto and shall be deemed to include the shares of Common Stock issuable upon conversion thereof.
Founder
Shares Lock-up Period shall mean (i) with respect to 15% of the shares of Common Stock received by the Sponsor upon conversion of the Founder Shares in connection with the Closing, the date that
is 180 days after the Closing Date and (ii) with respect to the remaining 85% of the shares of Common Stock received by the Sponsor upon conversion of the Founder Shares in connection with the Closing, the date that is 24 months after the
Closing Date.
Holder or Holders shall have the meaning given in the Preamble.
Insider Letter shall mean that certain letter agreement, dated as of July 23, 2020, by and among the Company, the
Sponsor and each of the Companys officers, directors and director nominees.
Legacy Companies shall have the
meaning given in the Recitals hereto.
Legacy Member shall have the meaning given in the Recitals hereto.
Legacy Member Lock-Up Period shall mean (i) with respect to 15% of the shares
of Common Stock received by any Legacy Member in connection with the Closing, the date that is 180 days after the Closing Date and (ii) with respect to the remaining 85% of the shares of Common stock received by any Legacy Member in connection
with the Closing, the date that is 24 months after the Closing Date.
LMA shall have the meaning given in the Recitals
hereto.
LMA Merger Sub shall have the meaning given in the Recitals hereto.
Maximum Number of Securities shall have the meaning given in Section 2.03(b).
Mergers shall have the meaning given in the Recitals hereto.
Minimum Takedown Threshold shall have the meaning given in Section 2.03(a).
Misstatement shall mean an untrue statement of a material fact or an omission to state a material fact required to be
stated in a Registration Statement or Prospectus, or necessary to make the statements in a Registration Statement or Prospectus in the light of the circumstances under which they were made not misleading.
Original Registration Rights Agreement shall have the meaning given in the Recitals hereto.
Permitted Transferees shall mean any person or entity to whom a Holder of Registrable Securities is permitted to transfer
such Registrable Securities prior to the expiration of the Founder Shares Lock-up Period, Private Placement Lock-up Period or Legacy Member Lock-Up Period, as the case may be, under the Insider Letter and any other applicable agreement between such Holder and the Company, and to any transferee thereafter.
Piggyback Registration shall have the meaning given in Section 2.04(a).
F-3
Private Placement Lock-up Period
shall mean, with respect to Private Placement Warrants or Common Stock for which Private Placement Warrants are exercisable that are held by the Sponsor or its Permitted Transferees, the date that is thirty (30) days after the Closing Date.
Private Placement Warrants shall have the meaning given in the Recitals hereto.
Pro Rata shall have the meaning given in Section 2.03(b).
Prospectus shall mean the prospectus included in any Registration Statement, as supplemented by any and all prospectus
supplements and as amended by any and all post-effective amendments and including all material incorporated by reference in such prospectus.
Registrable Security shall mean (a) the shares of Common Stock issued or issuable upon the conversion of any Founder
Shares, (b) the Private Placement Warrants (including any shares of Common Stock issued or issuable upon the exercise of any such Private Placement Warrants), (c) any outstanding share of Common Stock or any other equity security
(including the shares of Common Stock issued or issuable upon the exercise of any other equity security) of the Company held by a Holder as of the date of this Agreement, (d) the Conversion Warrants (including the shares of Common Stock issued
or issuable upon the exercise of any such Conversion Warrants), and (e) any other equity security of the Company issued or issuable with respect to any such share of Common Stock by way of a stock dividend or stock split or in connection with a
combination of shares, recapitalization, merger, consolidation or reorganization of the Company; provided, however, that, as to any particular Registrable Security, such securities shall cease to be Registrable Securities when:
(A) a Registration Statement with respect to the sale of such securities shall have become effective under the Securities Act and such securities shall have been sold, transferred, disposed of or exchanged by the applicable Holder in accordance
with such Registration Statement; (B) such securities shall have been otherwise transferred, new certificates for such securities not bearing (or book entry positions not subject to) a legend restricting further transfer shall have been
delivered by the Company and subsequent public distribution of such securities shall not require registration under the Securities Act; (C) such securities shall have ceased to be outstanding; (D) such securities may be sold without
registration pursuant to Rule 144 promulgated under the Securities Act (or any successor rule promulgated thereafter by the Commission) with no volume or other restrictions or limitations; or (E) such securities have been sold to, or
through, a broker, dealer or underwriter in a public distribution or other public securities transaction.
Registration
shall mean a registration effected by preparing and filing a registration statement or similar document in compliance with the requirements of the Securities Act, and the applicable rules and regulations promulgated thereunder, and such
registration statement becoming effective.
Registration Expenses shall mean the out-of-pocket expenses of a Registration, including, without limitation, the following:
(a) |
all registration and filing fees (including fees with respect to filings required to be made with the Financial
Industry Regulatory Authority, Inc.) and any securities exchange on which the Common Stock is then listed; |
(b) |
fees and expenses of compliance with securities or blue sky laws (including reasonable and customary fees and
disbursements of counsel for the Underwriters in connection with blue sky qualifications of Registrable Securities); |
(c) |
printing, messenger, telephone and delivery expenses; |
(d) |
reasonable fees and disbursements of counsel for the Company; |
(e) |
reasonable fees and disbursements of all independent registered public accountants of the Company incurred
specifically in connection with such Registration; and |
(f) |
reasonable fees and expenses of one (1) legal counsel (and any local or foreign counsel) selected by
(i) in the case of a Demand Registration pursuant to Section 2.02 or an Underwritten Shelf Takedown pursuant to |
F-4
|
Section 2.03, a majority-in-interest of the Demanding Holders initiating a Demand
Registration or Underwritten Shelf Takedown, as applicable, or (ii) in the case of a Registration under Section 2.04 initiated by the Company for its own account or that of a Company stockholder other than pursuant to
rights under this Agreement, a majority-in-interest of participating Holders. |
Registration Statement shall mean any registration statement under the Securities Act that covers the Registrable
Securities pursuant to the provisions of this Agreement, including the Prospectus included in such registration statement, amendments (including post-effective amendments) and supplements to such registration statement, and all exhibits to and all
material incorporated by reference in such registration statement.
Removed Shares shall have the meaning given
in Section 2.05.
Requesting Holder shall have the meaning given in Section 2.02(a).
Securities Act shall mean the Securities Act of 1933, as amended from time to time.
Shelf shall mean the Form S-1 Shelf, a Form
S-3 Shelf or any Subsequent Shelf Registration, as the case may be.
Shelf
Registration means a registration of securities pursuant to a registration statement filed with the Commission in accordance with and pursuant to Rule 415 promulgated under the Securities Act (or any successor rule then in effect).
Sponsor shall have the meaning given in the Preamble hereto.
Subsequent Shelf Registration shall have the meaning given in Section 2.01(b).
Underwriter shall mean a securities dealer who purchases any Registrable Securities as principal in an Underwritten
Offering and not as part of such dealers market-making activities.
Underwritten Registration or
Underwritten Offering shall mean a Registration in which securities of the Company are sold to an Underwriter in a firm commitment underwriting for distribution to the public.
Underwritten Shelf Takedown shall have the meaning given in Section 2.03(a).
Withdrawal Notice shall have the meaning given in Section 2.03(c).
ARTICLE II.
REGISTRATIONS
Section 2.01 Shelf Registration Filing.
(a) The Company shall as soon as reasonably practicable, but in any event within thirty (30) days after the Closing Date, file with the
Commission a Registration Statement for a Shelf Registration on Form S-1 (the Form S-1 Shelf) covering, subject to
Section 3.03, the public resale of all of the Registrable Securities (determined as of two business days prior to such filing) on a delayed or continuous basis and shall use its commercially reasonable efforts to cause such
Form S-1 Shelf to be declared effective as soon as practicable after the filing thereof, but in no event later than the earlier of (i) the 90th
calendar day (or as soon as reasonably practicable if the Commission notifies the Company that it will review the Registration Statement) following the Closing Date and (ii) the
10th business day after the date the Company is notified (orally or in writing, whichever is earlier) by the Commission that the Registration Statement will not be reviewed or will not
be
F-5
subject to further review. Such Shelf shall provide for the resale of the Registrable Securities included therein pursuant to any method or combination of methods legally available to, and
requested by, any Holder named therein. The Company shall maintain a Shelf in accordance with the terms hereof, and shall prepare and file with the SEC such amendments, including post-effective amendments, and supplements as may be necessary to keep
a Shelf continuously effective, available for use and in compliance with the provisions of the Securities Act until such time as there are no longer any Registrable Securities. Following the filing of a Form
S-1 Shelf, the Company shall use its commercially reasonable efforts to convert the Form S-1 Shelf (and any Subsequent Shelf Registration) to a Registration Statement on
Form S-3 (the Form S-3 Shelf) as soon as reasonably practicable after the Company is eligible to use Form S-3.
As soon as practicable following the effective date of a Registration Statement filed pursuant to this Section 2.01(a), but in any event within one (1) business day of such date, the Company shall notify the Holders of
the effectiveness of such Registration Statement. When deemed effective, a Registration Statement filed pursuant to this Section 2.01(a) (including the documents incorporated therein by reference) will comply as to form in
all material respects with all applicable requirements of the Securities Act and the Exchange Act and will not contain a Misstatement.
(b) Subsequent Shelf Registration. If any Shelf ceases to be effective under the Securities Act for any reason at any time while
Registrable Securities are still outstanding, the Company shall, subject to Section 3.04, use its commercially reasonable efforts to as promptly as is reasonably practicable cause such Shelf to again become effective under
the Securities Act (including obtaining the prompt withdrawal of any order suspending the effectiveness of such Shelf), and shall use its commercially reasonable efforts to as promptly as is reasonably practicable amend such Shelf in a manner
reasonably expected to result in the withdrawal of any order suspending the effectiveness of such Shelf or file an additional registration statement as a Shelf Registration (a Subsequent Shelf Registration) registering the resale
of all Registrable Securities (determined as of two business days prior to such filing), and pursuant to any method or combination of methods legally available to, and requested by, any Holder named therein. If a Subsequent Shelf Registration is
filed, the Company shall use its commercially reasonable efforts to (i) cause such Subsequent Shelf Registration to become effective under the Securities Act as promptly as is reasonably practicable after the filing thereof (it being agreed
that the Subsequent Shelf Registration shall be an automatic shelf registration statement (as defined in Rule 405 promulgated under the Securities Act) if the Company is a well-known seasoned issuer (as defined in Rule 405 promulgated under the
Securities Act) at the most recent applicable eligibility determination date) and (ii) keep such Subsequent Shelf Registration continuously effective, available for use and in compliance with the provisions of the Securities Act until such time
as there are no longer any Registrable Securities. Any such Subsequent Shelf Registration shall be on Form S-3 to the extent that the Company is eligible to use such form. Otherwise, such Subsequent Shelf
Registration shall be on another appropriate form. As soon as practicable following the effective date of a Subsequent Shelf Registration filed pursuant to this Section 2.01(b), but in any event within one (1) business
day of such date, the Company shall notify the Holders of the effectiveness of such Subsequent Shelf Registration. When deemed effective, a Subsequent Shelf Registration filed pursuant to this Section 2.01(b) (including the
documents incorporated therein by reference) will comply as to form in all material respects with all applicable requirements of the Securities Act and the Exchange Act and will not contain a Misstatement.
Section 2.02 Demand Registration.
(a) Subject to the provisions of Section 2.03(c) and Section 3.04 hereof, at any time and
from time to time after the Closing Date, in the event that any Holder holds Registrable Securities that are not registered for resale on a delayed or continuous basis, any Holder that holds at least five percent (5.0%) of the Registrable Securities
(such holder, the Demanding Holder), may make a written demand for Registration for all or part of such Registrable Securities on a Registration Statement, which written demand shall describe the amount and type of securities to
be included in such Registration and the intended method(s) of distribution thereof (such written demand a Demand Registration). The Company shall, promptly following the Companys receipt of a Demand Registration, notify, in
writing, all other Holders of Registrable Securities of such demand, and each Holder of Registrable Securities who thereafter wishes to include all or a portion of such Holders Registrable Securities in
F-6
a Registration pursuant to a Demand Registration (each such Holder that includes all or a portion of such Holders Registrable Securities in such Registration, a Requesting
Holder) shall so notify the Company, in writing, within five (5) days after the receipt by the Holder of the notice from the Company. For the avoidance of doubt, to the extent a Requesting Holder also separately possesses Demand
Registration rights pursuant to this Section 2.02, but is not the Holder who exercises such Demand Registration rights, the exercise by such Requesting Holder of its rights pursuant to the foregoing sentence shall not count
as the exercise by it of one of its Demand Registration rights. Upon receipt by the Company of any such written notification from a Requesting Holder(s) to the Company, subject to Section 2.03(b) below, such Requesting
Holder(s) shall be entitled to have their Registrable Securities included in a Registration pursuant to a Demand Registration and the Company shall use its commercially reasonable efforts to file a Shelf as soon thereafter as practicable, but not
more than thirty (30) days following the Companys receipt of the Demand Registration, for Registration of all Registrable Securities requested by the Demanding Holders and Requesting Holders pursuant to such Demand Registration. The
Company shall not be obligated to effect (i) more than two (2) Registrations pursuant to a Demand Registration initiated by the Sponsor, (ii) more than two (2) Registrations pursuant to a Demand Registration initiated by the
Holders (other than the Sponsor) or (iii) more than four (4) Registrations pursuant to a Demand Registration in the aggregate, in each case, in any 12-month period; provided, however,
that a Registration shall not be counted for such purposes unless a Registration Statement that may be available at such time has become effective.
(b) Effective Registration. Notwithstanding any other provision of this Agreement, a Registration pursuant to a Demand Registration
shall not count as a Registration unless and until (i) the Registration Statement filed with the Commission with respect to a Registration pursuant to a Demand Registration has been declared effective by the Commission, (ii) all of the
Registrable Securities requested by the Requesting Holders to be registered on behalf of the Demanding Holders and the Requesting Holders in such Registration have been sold, in accordance with Section 3.01 of this
Agreement and (iii) the Company has complied with all of its obligations under this Agreement with respect thereto; provided, that if, after such Registration Statement has been declared effective, an offering of Registrable Securities
in a Registration pursuant to a Demand Registration is subsequently interfered with by any stop order or injunction of the Commission, federal or state court or any other governmental agency the Registration Statement with respect to such
Registration shall be deemed not to have been declared effective unless and until (x) such stop order or injunction is removed, rescinded or otherwise terminated, and (y) a
majority-in-interest of the Demanding Holders initiating such Demand Registration thereafter affirmatively elect to continue with such Registration and accordingly
notify the Company in writing, but in no event later than five (5) days after the removal, rescission or other termination of such stop order or injunction, of such election; provided, further, that the Company shall not be
obligated or required to file another Registration Statement until the Registration Statement that has been previously filed with respect to a Registration pursuant to a Demand Registration by the same Demanding Holder becomes effective or is
subsequently terminated.
(c) Underwritten Offering. Subject to the provisions of Section 2.03(b) and
Section 3.04 hereof, if a majority-in-interest of the Demanding Holders so advise the Company as part of their Demand Registration that the
offering of the Registrable Securities pursuant to such Demand Registration shall be in the form of an Underwritten Offering, then the right of such Demanding Holder or Requesting Holder (if any) to include its Registrable Securities in such
Registration shall be conditioned upon such Holders participation in such Underwritten Offering and the inclusion of such Holders Registrable Securities in such Underwritten Offering to the extent provided herein. All such Holders
proposing to distribute their Registrable Securities through an Underwritten Offering under this Section 2.02(c), subject to Section 3.03 and Article IV, shall enter into an underwriting
agreement in customary form with the Underwriter(s) selected for such Underwritten Offering by a majority-in-interest of the Demanding Holders initiating the Demand
Registration.
Section 2.03 Underwritten Shelf Takedown.
(a) At any time and from time to time following the effectiveness of a Shelf required by Section 2.01, any Holder may
request to sell all or any portion of its or their Registrable Securities in an Underwritten Offering that
F-7
is registered pursuant to such Shelf (each, an Underwritten Shelf Takedown); provided, in each case, that the Company shall only be obligated to effect an Underwritten
Offering if such offering shall include Registrable Securities proposed to be sold by the Demanding Holder(s) with a total offering price reasonably expected to exceed, in the aggregate, $20,000,000 (the Minimum Takedown
Threshold). All requests for Underwritten Shelf Takedowns shall be made by giving written notice to the Company, which shall specify the approximate number of Registrable Securities proposed to be sold in the Underwritten Shelf Takedown
and the expected price range (net of underwriting discounts and commissions) of such Underwritten Offering. Promptly (but in any event within ten (10) days) after receipt of a request for Underwritten Shelf Takedown, the Company shall give
written notice of the Underwritten Shelf Takedown to all other Holders of Registrable Securities and, subject to the provisions of Section 2.03(b), shall include in such Underwritten Shelf Takedown all Registrable
Securities with respect to which the Company has received written requests for inclusion therein within five (5) business days after sending such notice to Holders. The Company shall enter into an underwriting agreement in a form as is
customary in Underwritten Offerings of securities by the Company with the managing Underwriter or Underwriters selected by the Holders requesting such Underwritten Shelf Takedown (which managing Underwriter or Underwriters shall be subject to
approval of the Company, which approval shall not be unreasonably withheld) and shall take all such other reasonable actions as are requested by the managing Underwriter or Underwriters in order to expedite or facilitate the disposition of such
Registrable Securities in accordance with the terms of this Agreement. In connection with any Underwritten Shelf Takedown contemplated by this Section 2.03, subject to Section 3.03 and Article
IV, the underwriting agreement into which each Holder and the Company shall enter shall contain such representations, covenants, indemnities and other rights and obligations as are customary in underwritten offerings of securities by the
Company. Notwithstanding any other provision of this Agreement to the contrary, (i) the Sponsor may demand not more than two (2) Underwritten Shelf Takedowns, (ii) the Holders (other than the Sponsor) may demand not more than two
(2) Underwritten Shelf Takedowns and (iii) the Company shall not be obligated to participate in more than four (4) Underwritten Shelf Takedowns in the aggregate, in each case, pursuant to this Section 2.03 in
any 12-month period. Notwithstanding anything to the contrary in this Agreement, the Company may effect an Underwritten Shelf Takedown pursuant to any then effective Registration Statement, including a Form S-3, that is then available for such offering.
(b) Reduction of Underwritten Offering. If the
managing Underwriter or Underwriters in an Underwritten Registration, in good faith, advises the Company, the Demanding Holders and the Requesting Holders (if any) in writing, in its or their opinion, that the dollar amount or number of Registrable
Securities that the Demanding Holders and the Requesting Holders (if any) desire to sell, taken together with all other Common Stock or other equity securities that the Company desires to sell for its own account and the shares of Common Stock, if
any, as to which a Registration has been requested pursuant to separate written contractual piggy-back registration rights held by any other stockholders of the Company, exceeds the maximum dollar amount or maximum number of equity securities that
can be sold in the Underwritten Offering without adversely affecting the proposed offering price, the timing, the distribution method, or the probability of success of such offering (such maximum dollar amount or maximum number of such securities,
as applicable, the Maximum Number of Securities), then the Company shall include in such Underwritten Offering, as follows: (i) first, the Registrable Securities of the Demanding Holders and the Requesting Holders (if any)
(pro rata based on the respective number of Registrable Securities that each Demanding Holder and Requesting Holder (if any) has requested be included in such Underwritten Registration and the aggregate number of Registrable Securities that the
Demanding Holders and Requesting Holders have requested be included in such Underwritten Registration (such proportion is referred to herein as Pro Rata)) that can be sold without exceeding the Maximum Number of Securities;
(ii) second, to the extent that the Maximum Number of Securities has not been reached under the foregoing clause (i), shares of Common Stock or other equity securities that the Company desires to sell for its own account, which can be sold
without exceeding the Maximum Number of Securities; and (iii) third, to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses (i) and (ii), shares of Common Stock or other equity securities of
other persons or entities that the Company is obligated to register in a Registration pursuant to separate written contractual arrangements with such persons and that can be sold without exceeding the Maximum Number of Securities.
F-8
(c) Withdrawal. A Demanding Holder or a Requesting Holder shall have the right to
withdraw all or a portion of its Registrable Securities included in a Demand Registration pursuant to Section 2.02 or an Underwritten Shelf Takedown pursuant to Section 2.03 for any or no reason
whatsoever upon written notification to the Company and the Underwriter or Underwriters (if any) of its intention to so withdraw (a Withdrawal Notice) at any time prior (a) in the case of a Demand Registration not involving
an Underwritten Offering, the effectiveness of the applicable Registration Statement, or (b) in the case of any Demand Registration involving an Underwritten Offering or any Underwritten Shelf Takedown, prior to the filing of the applicable
red herring prospectus or prospectus supplement used for marketing such Underwritten Offering or Underwritten Shelf Takedown; provided, however, that upon withdrawal by a majority-in-interest of the Demanding Holders initiating a Demand Registration (or, in the case of an Underwritten Shelf Takedown, withdrawal of an amount of Registrable Securities included by the Holders in
such Underwritten Shelf Takedown), the Company shall cease all efforts to secure effectiveness of the applicable Registration Statement or complete the Underwritten Offering, as applicable; provided that any Holder may elect to have the
Company continue an Underwritten Shelf Takedown if the Minimum Takedown Threshold would still be satisfied by the Registrable Securities proposed to be sold in the Underwritten Shelf Takedown by the remaining Holders. If withdrawn, such requested
Demand Registration or Underwritten Shelf Takedown shall constitute a demand for a Demand Registration or Underwritten Shelf Takedown for purposes of Section 2.02 unless either (i) the Demanding Holders have not previously
withdrawn any Demand Registration or (ii) the Demanding Holders reimburse the Company for all Registration Expenses with respect to such Underwritten Shelf Takedown; provided that, if the Sponsor or any Holder (other than the Sponsor)
elects to continue an Underwritten Shelf Takedown pursuant to the proviso in the immediately preceding sentence, such Underwritten Shelf Takedown shall instead count as an Underwritten Shelf Takedown demanded by the Sponsor or such Holder (other
than the Sponsor), as applicable, for purposes of Section 2.03. Following the receipt of any Withdrawal Notice, the Company shall promptly forward such Withdrawal Notice to any other Holders that had elected to participate
in such Underwritten Shelf Takedown. Notwithstanding anything to the contrary in this Agreement, the Company shall be responsible for the Registration Expenses incurred in connection with a Registration pursuant to a Demand Registration or an
Underwritten Shelf Takedown prior to its and including its withdrawal under this Section 2.03(c), other than if a Demanding Holder elects to pay such Registration Expenses pursuant to the second sentence of this
Section 2.03(c).
Section 2.04 Piggyback Registration.
(a) Piggyback Rights. If the Company proposes to file a Registration Statement under the Securities Act with respect to an offering of
equity securities, or securities or other obligations exercisable or exchangeable for, or convertible into equity securities, for its own account or for the account of stockholders of the Company (or by the Company and by the stockholders of the
Company including, without limitation, pursuant to Article II hereof), other than a Registration Statement (or any registered offering with respect thereto) (i) filed in connection with any employee stock option or other benefit plan,
(ii) for an exchange offer or offering of securities solely to the Companys existing stockholders or pursuant to a Registration Statement on Form S-4 (or similar form that relates to a transaction
subject to Rule 145 under the Securities Act or any successor rule thereto), (iii) for an offering of debt that is convertible into equity securities of the Company, (iv) filed in connection with an at-the-market offering or (v) for a dividend reinvestment plan or a rights offering, then the Company shall give written notice of such proposed filing to all of the Holders of Registrable
Securities (excluding the Sponsor with respect to the Registrable Securities distributed by the Sponsor to its members following the expiration of the Founder Shares Lock-up Period or Private Placement Lock-up Period, as applicable) as soon as practicable but not less than ten (10) days before the anticipated filing date of such Registration Statement, which notice shall (A) describe the amount and type
of securities to be included in such offering, the intended method(s) of distribution, (including whether such registration will be pursuant to a shelf registration statement), and the proposed price and name of the proposed managing Underwriter or
Underwriters, if any, in such offering, and (B) offer to all of the Holders of Registrable Securities the opportunity to register the sale of such number of Registrable Securities as such Holders may request in writing within five (5) days
after receipt of such written notice (such Registration a Piggyback Registration). The Company shall, in good faith,
F-9
cause such Registrable Securities identified in a Holders response notice described in the foregoing sentence to be included in such Piggyback Registration and shall use its commercially
reasonable efforts to cause the managing Underwriter or Underwriters of a proposed Underwritten Offering, if any, to permit the Registrable Securities requested by the Holders pursuant to this Section 2.04(a) to be included
in a Piggyback Registration on the same terms and conditions as any similar securities of the Company or Company stockholder(s) for whose account such Registration Statement is to be filed included in such Registration and to permit the sale or
other disposition of such Registrable Securities in accordance with the intended method(s) of distribution thereof. All such Holders proposing to distribute their Registrable Securities through an Underwritten Offering under this
Section 2.04(a), subject to Section 3.03 and Article IV, shall enter into an underwriting agreement in customary form with the Underwriter(s) selected for such Underwritten Offering by the
Company or the Holders as provided in Section 2.02(c) or Section 2.03(a). For purposes of this Section 2.04, the filing by the Company of an automatic shelf registration
statement for offerings pursuant to Rule 415(a) that omits information with respect to any specific offering pursuant to Rule 430B shall not trigger any notification or participation rights hereunder until such time as the Company amends or
supplements such Registration Statement to include information with respect to a specific offering of securities (and such amendment or supplement shall trigger the notice and participation rights provided for in this
Section 2.04).
(b) Reduction of Piggyback Registration. If the managing Underwriter or Underwriters in
an Underwritten Registration that is to be a Piggyback Registration, in good faith, advises the Company and the Holders of Registrable Securities participating in the Piggyback Registration in writing that, in such Underwriters or
Underwriters opinion, the dollar amount or number of shares of Common Stock that the Company desires to sell, taken together with (i) the shares of Common Stock, if any, as to which Registration has been demanded pursuant to separate
written contractual arrangements with persons or entities other than the Holders of Registrable Securities hereunder, (ii) the Registrable Securities as to which registration has been requested pursuant to Section 2.04
hereof, and (iii) the shares of Common Stock, if any, as to which Registration has been requested pursuant to separate written contractual piggy-back registration rights of other stockholders of the Company, exceeds the Maximum Number of
Securities, then:
(i) If the Registration is undertaken for the Companys account, the Company shall include in any
such Registration (A) first, shares of Common Stock or other equity securities that the Company desires to sell for its own account, which can be sold without exceeding the Maximum Number of Securities; (B) second, to the extent that the
Maximum Number of Securities has not been reached under the foregoing clause (A), the Registrable Securities of Holders exercising their rights to register their Registrable Securities pursuant to Section 2.04(a)
hereof, Pro Rata, which can be sold without exceeding the Maximum Number of Securities; and (C) third, to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses (A) and (B), shares of Common
Stock, if any, as to which Registration has been requested pursuant to written contractual piggyback registration rights of other stockholders of the Company, which can be sold without exceeding the Maximum Number of Securities;
(ii) If the Registration is pursuant to a request by persons or entities other than the Holders of Registrable Securities, then
the Company shall include in any such Registration (A) first, Common Stock or other equity securities, if any, of such requesting persons or entities, other than the Holders of Registrable Securities, which can be sold without exceeding the
Maximum Number of Securities; (B) second, to the extent that the Maximum Number of Securities has not been reached under the foregoing clause (A), the Registrable Securities of Holders exercising their rights to register their Registrable
Securities pursuant to Section 2.04(a), pro rata based on the number of Registrable Securities that each Holder has requested be included in such Underwritten Registration and the aggregate number of Registrable Securities
that the Holders have requested be included in such Underwritten Registration, which can be sold without exceeding the Maximum Number of Securities; (C) third, to the extent that the Maximum Number of Securities has not been reached under the
foregoing clauses (A) and (B), Common Stock or other equity securities that the Company desires to sell for its own account, which can be sold without exceeding the Maximum Number of Securities; and (D) fourth, to the extent that the
Maximum Number of Securities has not been reached under the foregoing clauses (A), (B) and (C), Common Stock or other equity securities for the account of other
F-10
persons or entities that the Company is obligated to register pursuant to separate written contractual arrangements with such persons or entities, which can be sold without exceeding the Maximum
Number of Securities.
(c) Piggyback Registration Withdrawal. Any Holder of Registrable Securities (other than a Demanding Holder,
whose right to withdraw from an Underwritten Shelf Takedown, and related obligations, shall be governed by Section 2.03(c)) shall have the right to withdraw all or any portion of its Registrable Securities in a Piggyback
Registration for any or no reason whatsoever upon written notification to the Company and the Underwriter or Underwriters (if any) of his, her or its intention to withdraw such Registrable Securities from such Piggyback Registration prior to
(a) in the case of a Piggyback Registration not involving an Underwritten Offering or Underwritten Shelf Takedown, the effectiveness of the applicable Registration Statement, or (b), in the case of any Piggyback Registration involving an
Underwritten Offering or any Underwritten Shelf Takedown, prior to the filing of the applicable red herring prospectus or prospectus supplement used to market such Underwritten Offering or Underwritten Shelf Takedown. The Company
(whether on its own good faith determination or as the result of a request for withdrawal by persons pursuant to separate written contractual obligations) may withdraw a Registration Statement filed with the Commission in connection with a Piggyback
Registration at any time prior to the effectiveness of such Registration Statement. Notwithstanding anything to the contrary in this Agreement (other than Section 2.03(c)), the Company shall be responsible for the
Registration Expenses incurred in connection with the Piggyback Registration prior to and including its withdrawal under this Section 2.04(c).
(d) Unlimited Piggyback Registration Rights. For purposes of clarity, any Registration effected pursuant to this
Section 2.04 hereof shall not be counted as a Registration pursuant to an Underwritten Shelf Takedown effected under Section 2.03(a) hereof.
Section 2.05 Rule 415; Removal. If at any time the Commission takes the position that the offering of some or all of the
Registrable Securities in a Form S-3 Shelf filed pursuant to this Article II is not eligible to be made on a delayed or continuous basis under the provisions of Rule 415 under the Securities Act
(provided, however, that the Company shall be obligated to use diligent efforts to advocate with the Commission for the registration of all of the Registrable Securities in accordance with the Commission Guidance, including without
limitation, Compliance and Disclosure Interpretation 612.09) or requires a Holder to be named as an underwriter, the Company shall promptly notify each Holder of Registrable Securities thereof (or in the case of the Commission requiring
a Holder to be named as an underwriter, such Holder) and use commercially reasonable efforts to persuade the Commission that the offering contemplated by such Registration Statement is a valid secondary offering and not an offering
by or on behalf of the issuer as defined in Rule 415. In the event that the Commission refuses to alter its position, the Company shall (a) remove from such Registration Statement such portion of the Registrable Securities (the
Removed Shares) and/or (b) agree to such restrictions and limitations on the registration and resale of the Registrable Securities as the Commission may require to assure the Companys compliance with the requirements of
Rule 415; provided, however, that the Company shall not agree to name any Holder as an underwriter in such Registration Statement without the prior written consent of such Holder and, if the Commission requires such Holder to be
named as an underwriter in such Registration Statement, notwithstanding any provision in this Agreement to the contrary, the Company shall not be under any obligation to include any Registrable Securities of such Holder in such
Registration Statement. In the event of a share removal pursuant to this Section 2.05, the Company shall give the applicable Holders at least five (5) days prior written notice along with the calculations as to
such Holders allotment. Any removal of shares of the Holders pursuant to this Section 2.05 shall first be applied to Holders other than the Holders with securities registered for resale under the applicable
Registration Statement and thereafter allocated between the Holders on a Pro Rata basis based on the aggregate amount of Registrable Securities held by such Holders. In the event of a share removal of the Holders pursuant to this
Section 2.05, the Company shall promptly register the resale of any Removed Shares pursuant to Section 2.01(b) hereof and in no event shall the filing of such Shelf filed pursuant to the terms of
Section 2.01(b) be counted as a Demand Registration hereunder.
F-11
ARTICLE III.
COMPANY PROCEDURES
Section 3.01 General Procedures. If at any time the Company is required to effect the Registration of Registrable Securities, the
Company shall use its best efforts to effect such Registration to permit the sale of such Registrable Securities in accordance with the intended plan of distribution thereof, and pursuant thereto the Company shall, as expeditiously as possible:
(a) prepare and file with the Commission as soon as practicable a Registration Statement with respect to such Registrable Securities and use
its reasonable best efforts to cause such Registration Statement to become effective and remain effective until all Registrable Securities covered by such Registration Statement have been sold;
(b) prepare and file with the Commission such amendments and post-effective amendments to the Registration Statement, and such supplements to
the Prospectus, as may be reasonably requested by the Holders of at least five percent (5%) of the Registrable Securities registered on such Registration Statement or any Underwriter of Registrable Securities or as may be required by the rules,
regulations or instructions applicable to the registration form used by the Company or by the Securities Act or rules and regulations thereunder to keep the Registration Statement effective until all Registrable Securities covered by such
Registration Statement are sold in accordance with the intended plan of distribution set forth in such Registration Statement or supplement to the Prospectus or are no longer outstanding;
(c) prior to filing a Registration Statement or Prospectus, or any amendment or supplement thereto, furnish without charge to the
Underwriters, if any, and the Holders of Registrable Securities included in such Registration, and such Holders legal counsel, copies of such Registration Statement as proposed to be filed, each amendment and supplement to such Registration
Statement (in each case including all exhibits thereto and documents incorporated by reference therein), the Prospectus included in such Registration Statement (including each preliminary Prospectus), and such other documents as the Underwriters and
the Holders of Registrable Securities included in such Registration or the legal counsel for any such Holders may reasonably request in order to facilitate the disposition of the Registrable Securities owned by such Holders; provided, that
the Company will not have any obligation to provide any document pursuant to this clause that is available on the Commissions EDGAR system;
(d) prior to any public offering of Registrable Securities, but in any case no later than the effective date of the applicable Registration
Statement, use its reasonable best efforts to (i) register or qualify the Registrable Securities covered by the Registration Statement under such securities or blue sky laws of such jurisdictions in the United States as the Holders
of Registrable Securities included in such Registration Statement (in light of their intended plan of distribution) may request to keep such registration or qualification in effect for so long as such Registration Statement remains in effect and
(ii) take such action necessary to cause such Registrable Securities covered by the Registration Statement to be registered with or approved by such other governmental authorities as may be necessary by virtue of the business and operations of
the Company or otherwise and do any and all other acts and things that may be necessary or advisable, in each case, to enable the Holders of Registrable Securities included in such Registration Statement to consummate the disposition of such
Registrable Securities in such jurisdictions; provided, however, that the Company shall not be required to qualify generally to do business in any jurisdiction where it would not otherwise be required to qualify or take any action to
which it would be subject to general service of process or taxation in any such jurisdiction where it is not then otherwise so subject;
(e) cause all such Registrable Securities to be listed on each securities exchange or automated quotation system on which similar securities
issued by the Company are then listed;
(f) provide a transfer agent or warrant agent, as applicable, and registrar for all such
Registrable Securities no later than the effective date of such Registration Statement;
F-12
(g) promptly furnish to each seller of Registrable Securities covered by such Registration
Statement such number of conformed copies of such Registration Statement and of each such amendment and supplement thereto (in each case including all exhibits), such number of copies of the Prospectus contained in such Registration Statement
(including each preliminary Prospectus and any summary Prospectus) and any other Prospectus filed under Rule 424 under the Securities Act, in conformity with the requirements of the Securities Act, and such other documents as such seller may
reasonably request;
(h) advise each seller of such Registrable Securities, promptly after it shall receive notice or obtain knowledge
thereof, of any request by the Commission that the Company amend or supplement such Registration Statement or Prospectus or of the issuance of any stop order by the Commission suspending the effectiveness of such Registration Statement or Prospectus
or the initiation or threatening of any proceeding for such purpose and promptly use its reasonable best efforts to amend or supplement such Registration Statement or Prospectus or prevent the issuance of any stop order or to obtain its withdrawal
if such stop order should be issued, as applicable;
(i) notify each Holder of Registrable Securities covered by such Registration
Statement, promptly after the Company receives notice thereof, of the time when such Registration Statement has been declared effective or a supplement to any Prospectus forming a part of such Registration Statement has been filed;
(j) at least five (5) business days prior to the filing of any Registration Statement or Prospectus or any amendment or supplement to
such Registration Statement or Prospectus or any document that is to be incorporated by reference into such Registration Statement or Prospectus, furnish a copy thereof to each seller of such Registrable Securities or its counsel;
(k) notify the Holders at any time when a Prospectus relating to such Registration Statement is required to be delivered under the Securities
Act, of the happening of any event as a result of which the Prospectus included in such Registration Statement, as then in effect, includes a Misstatement, and then to correct such Misstatement as set forth in Section 3.04
hereof;
(l) permit a representative of the Holders, the Underwriters, if any, and any attorney or accountant retained by such Holders or
Underwriter to participate, at each such persons own expense, in the preparation of any Registration Statement, and cause the Companys officers, directors and employees to supply all information reasonably requested by any such
representative, Underwriter, attorney or accountant in connection with such Registration Statement; provided, however, that such representatives or Underwriters enter into a confidentiality agreement, in form and substance reasonably
satisfactory to the Company, prior to the release or disclosure of any such information;
(m) obtain a cold comfort letter
(including a bring-down letter dated as of the date the Registrable Securities are delivered for sale pursuant to such Registration) from the Companys independent registered public accountants in the event of an Underwritten Offering, in
customary form and covering such matters of the type customarily covered by cold comfort letters as the managing Underwriter may reasonably request, and reasonably satisfactory to a majority-in-interest of the participating Holders and the managing Underwriter;
(n) on the date
the Registrable Securities are delivered for sale pursuant to such Registration, obtain an opinion and negative assurance letter, dated such date, of counsel representing the Company for the purposes of such Registration, addressed to the Holders,
the placement agent or sales agent, if any, and the Underwriters, if any, covering such legal matters with respect to the Registration in respect of which such opinion is being given as the Holders, placement agent, sales agent, or Underwriter may
reasonably request and as are customarily included in such opinions and negative assurance letters, and reasonably satisfactory to a majority-in-interest of the
participating Holders and the managing Underwriter;
(o) in the event of any Underwritten Offering, enter into and perform its obligations
under an underwriting agreement, in usual and customary form, with the managing Underwriter of such Underwritten Offering;
F-13
(p) otherwise use its commercially reasonable efforts to comply with all applicable rules
and regulations of the Commission, and to make available to its security holders, as soon as reasonably practicable, an earnings statement covering the period of at least twelve (12) months beginning with the first day of the Companys
first full calendar quarter after the effective date of the Registration Statement which satisfies the provisions of Section 11(a) of the Securities Act and the rules and regulations thereunder, including Rule 158 thereunder (or any
successor rule promulgated thereafter by the Commission);
(q) use its reasonable best efforts to make available senior executives of the
Company to participate in customary road show presentations that may be reasonably requested by the Underwriter in any Underwritten Offering; and
(r) otherwise, in good faith, cooperate reasonably with, and take such customary actions as may reasonably be requested by the Holders, in
connection with such Registration.
Section 3.02 Registration Expenses. The Registration Expenses of all Registrations shall
be borne by the Company. It is acknowledged by the Holders that the Holders shall bear all incremental selling expenses relating to the sale of Registrable Securities, such as Underwriters commissions and discounts, brokerage fees, and, other
than as set forth in the definition of Registration Expenses, all reasonable fees and expenses of any legal counsel representing the Holders.
Section 3.03 Requirements for Participation in Underwritten Offerings. No person may participate in any Underwritten Offering for
equity securities of the Company pursuant to a Registration initiated by the Company hereunder unless such person (a) agrees to sell such persons securities on the basis provided in any underwriting arrangements approved by the Company
and (b) completes and executes all customary questionnaires, powers of attorney, indemnities, lock-up agreements, underwriting agreements and other customary documents as may be reasonably required under
the terms of such underwriting arrangements.
Section 3.04 Suspension of Sales; Adverse Disclosure. Upon receipt of written
notice from the Company that a Registration Statement or Prospectus contains a Misstatement, each of the Holders shall forthwith discontinue disposition of Registrable Securities until he, she or it has received copies of a supplemented or amended
Prospectus correcting the Misstatement (it being understood that the Company hereby covenants to prepare and file such supplement or amendment as soon as practicable after the time of such notice), or until he, she or it is advised in writing by the
Company that the use of the Prospectus may be resumed. If the filing, initial effectiveness or continued use of a Registration Statement in respect of any Registration at any time would require the Company to make an Adverse Disclosure or would
require the inclusion in such Registration Statement of financial statements that are unavailable to the Company for reasons beyond the Companys control, the Company may, upon giving prompt written notice of such action to the Holders, delay
the filing or initial effectiveness of, or suspend use of, such Registration Statement for the shortest period of time, but in no event more than thirty (30) days, determined in good faith by the Company to be necessary for such purpose. In the
event the Company exercises its rights under the preceding sentence, the Holders agree to suspend, immediately upon their receipt of the notice referred to above, their use of the Prospectus relating to any Registration in connection with any sale
or offer to sell Registrable Securities. The Company shall immediately notify the Holders of the expiration of any period during which it exercised its rights under this Section 3.04.
Section 3.05 Covenants of the Company. As long as any Holder shall own Registrable Securities, the Company hereby covenants and
agrees that:
(a) The Company will not file any Registration Statement or Prospectus included therein or any other filing or document
(other than this Agreement) with the Commission that refers to any Holder of Registrable Securities by name or otherwise without the prior written approval of such Holder, which may not be unreasonably withheld, unless required by applicable law or
the Commission Guidance;
(b) As long as any Holder shall own Registrable Securities, the Company, at all times while it shall be a
reporting company under the Exchange Act, covenants to file timely (or obtain extensions in respect thereof and
F-14
file within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to Sections 13(a) or 15(d) of the Exchange Act and to promptly furnish
the Holders with true and complete copies of all such filings, provided that any documents publicly filed or furnished with the Commission pursuant to the Electronic Data Gathering Analysis and Retrieval System (or any successor thereto) shall be
deemed to have been furnished to the Holders pursuant to this Section 3.05(b). The Company further covenants that it shall take such further action as any Holder may reasonably request, all to the extent required from time
to time to enable such Holder to sell shares of Common Stock held by such Holder without registration under the Securities Act within the limitation of the exemptions provided by Rule 144 promulgated under the Securities Act (or any successor
rule promulgated thereafter by the Commission), including providing any legal opinions. Upon the request of any Holder, the Company shall deliver to such Holder a written certification of a duly authorized officer as to whether it has complied with
such requirements.
(c) Upon request of a Holder, the Company shall (i) authorize the Companys transfer agent to remove any
legend on share certificates of such Holders Common Stock, Private Placement Warrants or Conversion Warrants restricting further transfer (or any similar restriction in book entry positions of such Holder) if such restrictions are no longer
required by the Securities Act or any applicable state securities laws or any agreement with the Company to which such Holder is a party, including if such shares subject to such a restriction have been sold pursuant to a Registration Statement,
(ii) request the Companys transfer agent to issue in lieu thereof shares of Common Stock, Private Placement Warrants or Conversion Warrants without such restrictions to the Holder upon, as applicable, surrender of any stock certificates
evidencing such shares of Common Stock, or warrant certificates evidencing such Private Placement Warrants or Conversion Warrants or to update the applicable book entry position of such Holder so that it no longer is subject to such a restriction,
and (iii) use commercially reasonable efforts to cooperate with such Holder to have such Holders shares of Common Stock, Private Placement Warrants or Conversion Warrants, as the case may be, transferred into a book entry position at The
Depository Trust Company, in each case, subject to delivery of customary documentation, including any documentation required by such restrictive legend or book entry notation.
ARTICLE IV.
INDEMNIFICATION AND CONTRIBUTION
Section 4.01 Indemnification.
(a) The Company agrees to indemnify, to the extent permitted by law, each Holder of Registrable Securities, its officers and directors and
each person who controls such Holder (within the meaning of the Securities Act) against all losses, claims, damages, liabilities and expenses (including, without limitation, reasonable attorneys fees) caused by any untrue or alleged untrue
statement of material fact contained in any Registration Statement, Prospectus or preliminary Prospectus or any amendment thereof or supplement thereto or any omission or alleged omission of a material fact required to be stated therein or necessary
to make the statements therein not misleading, except insofar as the same are caused by or contained in any information furnished in writing to the Company by such Holder expressly for use therein. The Company shall indemnify the Underwriters, their
officers and directors and each person who controls such Underwriters (within the meaning of the Securities Act) to the same extent as provided in the foregoing with respect to the indemnification of the Holder.
(b) In connection with any Registration Statement in which a Holder of Registrable Securities is participating, such Holder shall furnish to
the Company in writing such information and affidavits as the Company reasonably requests for use in connection with any such Registration Statement or Prospectus and, to the extent permitted by law, shall indemnify the Company, its directors and
officers and agents and each person who controls the Company (within the meaning of the Securities Act) against any losses, claims, damages, liabilities and expenses (including without limitation reasonable attorneys fees) resulting from any
untrue statement of material fact contained in the Registration Statement, Prospectus or preliminary Prospectus or any
F-15
amendment thereof or supplement thereto or any omission of a material fact required to be stated therein or necessary to make the statements therein not misleading, but only to the extent that
such untrue statement or omission is contained in any information or affidavit so furnished in writing by such Holder expressly for use therein. The Holders of Registrable Securities shall indemnify the Underwriters, their officers, directors and
each person who controls such Underwriters (within the meaning of the Securities Act) to the same extent as provided in the foregoing with respect to indemnification of the Company. For the avoidance of doubt, the obligation to indemnify under this
Section 4.01(b) shall be several, not joint and several, among the Holders of Registrable Securities, and the total indemnification liability of a Holder under this Section 4.01(b) shall be in
proportion to and limited to the net proceeds received by such Holder from the sale of Registrable Securities pursuant to such Registration Statement.
(c) Any person entitled to indemnification herein shall (i) give prompt written notice to the indemnifying party of any claim with
respect to which it seeks indemnification (provided that the failure to give prompt notice shall not impair any persons right to indemnification hereunder to the extent such failure has not materially prejudiced the indemnifying party) and
(ii) unless in such indemnified partys reasonable judgment a conflict of interest between such indemnified and indemnifying parties may exist with respect to such claim, permit such indemnifying party to assume the defense of such claim
with counsel reasonably satisfactory to the indemnified party. If such defense is assumed, the indemnifying party shall not be subject to any liability for any settlement made by the indemnified party without its consent (but such consent shall not
be unreasonably withheld). An indemnifying party who is not entitled to, or elects not to, assume the defense of a claim shall not be obligated to pay the fees and expenses of more than one counsel for all parties indemnified by such indemnifying
party with respect to such claim, unless in the reasonable judgment of any indemnified party a conflict of interest may exist between such indemnified party and any other of such indemnified parties with respect to such claim. No indemnifying party
shall, without the consent of the indemnified party, consent to the entry of any judgment or enter into any settlement which cannot be settled in all respects by the payment of money (and such money is so paid by the indemnifying party pursuant to
the terms of such settlement) or which settlement does not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified party of a release from all liability in respect to such claim or litigation.
(d) The indemnification provided for under this Agreement shall remain in full force and effect regardless of any investigation made by or on
behalf of the indemnified party or any officer, director or controlling person of such indemnified party and shall survive the transfer of securities.
(e) If the indemnification provided under Section 4.01 hereof from the indemnifying party is unavailable or
insufficient to hold harmless an indemnified party in respect of any losses, claims, damages, liabilities and expenses referred to herein, then the indemnifying party, in lieu of indemnifying the indemnified party, shall contribute to the amount
paid or payable by the indemnified party as a result of such losses, claims, damages, liabilities and expenses in such proportion as is appropriate to reflect the relative fault of the indemnifying party and the indemnified party, as well as any
other relevant equitable considerations. The relative fault of the indemnifying party and indemnified party shall be determined by reference to, among other things, whether any action in question, including any untrue or alleged untrue statement of
a material fact or omission or alleged omission to state a material fact, was made by, or relates to information supplied by, such indemnifying party or indemnified party, and the indemnifying partys and indemnified partys relative
intent, knowledge, access to information and opportunity to correct or prevent such action; provided, however, that the liability of any Holder under this Section 4.01(e) shall be limited to the amount of the
net proceeds received by such Holder in such offering giving rise to such liability. The amount paid or payable by a party as a result of the losses or other liabilities referred to above shall be deemed to include, subject to the limitations set
forth in Section 4.01(a), Section 4.01(b) and Section 4.01(c) above, any legal or other fees, charges or expenses reasonably incurred by such party in connection with any
investigation or proceeding. The parties hereto agree that it would not be just and equitable if contribution pursuant to this Section 4.01(e) were determined by pro rata allocation or by any other method of allocation,
which does not take account of the equitable considerations referred to in this
F-16
Section 4.01(e). No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution
pursuant to this Section 4.01(e) from any person who was not guilty of such fraudulent misrepresentation.
ARTICLE V.
MISCELLANEOUS
Section 5.01 Notices. Any notice or communication under this Agreement must be in writing and given by (a) deposit in the
United States mail, addressed to the party to be notified, postage prepaid and registered or certified with return receipt requested, (b) delivery in person or by courier service providing evidence of delivery, or (c) transmission by hand
delivery, electronic mail, telecopy, telegram or facsimile. Each notice or communication that is mailed, delivered, or transmitted in the manner described above shall be deemed sufficiently given, served, sent, and received, in the case of mailed
notices, on the third business day following the date on which it is mailed and, in the case of notices delivered by courier service, hand delivery, electronic mail, telecopy, telegram or facsimile, at such time as it is delivered to the addressee
(with the delivery receipt or the affidavit of messenger) or at such time as delivery is refused by the addressee upon presentation. Any notice or communication under this Agreement must be addressed, if to the Company, to: 2101 Park Center Drive,
Suite 220, Orlando, Florida 32835, Attention: Jay Jackson, and, if to any Holder, at such Holders address or facsimile number as set forth in the Companys books and records. Any party may change its address for notice at any time and
from time to time by written notice to the other parties hereto, and such change of address shall become effective thirty (30) days after delivery of such notice as provided in this Section 5.01.
Section 5.02 Assignment; No Third Party Beneficiaries.
(a) This Agreement and the rights, duties and obligations of the Company hereunder may not be assigned or delegated by the Company in whole or
in part.
(b) Prior to the expiration of the Founder Shares Lock-up Period, the Private Placement Lock-up Period or the Legacy Member Lock-Up Period, as the case may be, no Holder may assign or delegate such Holders rights, duties or obligations under this Agreement,
in whole or in part, except in connection with a transfer of Registrable Securities by such Holder to a Permitted Transferee.
(c) This
Agreement and the provisions hereof shall be binding upon and shall inure to the benefit of each of the parties and its successors and the permitted assigns of the Holders, which shall include Permitted Transferees.
(d) This Agreement shall not confer any rights or benefits on any persons that are not parties hereto, other than as expressly set forth in
this Agreement and Section 5.02 hereof.
(e) No assignment by any party hereto of such partys rights,
duties and obligations hereunder shall be binding upon or obligate the Company unless and until the Company shall have received (i) written notice of such assignment as provided in Section 5.01 hereof and (ii) the
written agreement of the assignee, in a form reasonably satisfactory to the Company, to be bound by the terms and provisions of this Agreement (which may be accomplished by an addendum or certificate of joinder to this Agreement). Any transfer or
assignment made other than as provided in this Section 5.02 shall be null and void.
Section 5.03
Counterparts. This Agreement may be executed in multiple counterparts (including facsimile or PDF counterparts), each of which shall be deemed an original, and all of which together shall constitute the same instrument, but only one of which
need be produced.
Section 5.04 Governing Law; Venue. NOTWITHSTANDING THE PLACE WHERE THIS AGREEMENT MAY BE EXECUTED BY ANY OF
THE PARTIES HERETO, THE PARTIES EXPRESSLY AGREE THAT THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED UNDER THE LAWS OF THE STATE OF NEW YORK AS APPLIED TO AGREEMENTS AMONG NEW YORK RESIDENTS ENTERED INTO AND TO BE PERFORMED ENTIRELY WITHIN NEW
YORK, WITHOUT REGARD TO THE
F-17
CONFLICT OF LAW PROVISIONS OF SUCH JURISDICTION AND THE VENUE FOR ANY ACTION TAKEN WITH RESPECT TO THE AGREEMENT SHALL BE ANY STATE OR FEDERAL COURT IN NEW YORK COUNTY IN THE STATE OF NEW YORK.
EACH PARTY HERETO ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND
DIFFICULT ISSUES, AND, THEREFORE, EACH SUCH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT TO ANY ACTION DIRECTLY OR INDIRECTLY
ARISING OUT OF, UNDER OR IN CONNECTION WITH OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT.
Section 5.05 Amendments and Modifications. Upon the written consent of the Company and the Holders of at least a majority-in-interest of the Registrable Securities at the time in question, compliance with any of the provisions, covenants and conditions set forth in this Agreement may be
waived, or any of such provisions, covenants or conditions may be amended or modified; provided, however, that notwithstanding the foregoing, any amendment hereto or waiver hereof that adversely affects one Holder, solely in his, her
or its capacity as a holder of the shares of capital stock of the Company, in a manner that is materially different from the other Holders (in such capacity) shall require the consent of the Holder so affected. No course of dealing between any
Holder or the Company and any other party hereto or any failure or delay on the part of a Holder or the Company in exercising any rights or remedies under this Agreement shall operate as a waiver of any rights or remedies of any Holder or the
Company. No single or partial exercise of any rights or remedies under this Agreement by a party shall operate as a waiver or preclude the exercise of any other rights or remedies hereunder or thereunder by such party.
Section 5.06 Other Registration Rights. The Company represents and warrants that no person, other than a Holder of Registrable
Securities and East Asset Management, LLC as purchaser party to that certain to the Forward Purchase Agreement between the Company and East Asset Management, LLC, dated as of July 2, 2020, has any right to require the Company to register any
securities of the Company for sale or to include such securities of the Company in any Registration filed by the Company for the sale of securities for its own account or for the account of any other person. Further, the Company represents and
warrants that this Agreement supersedes any other registration rights agreement or agreement with similar terms and conditions and in the event of a conflict between any such agreement or agreements and this Agreement, the terms of this Agreement
shall prevail.
Section 5.07 Term. This Agreement shall terminate upon the earlier of (a) the tenth anniversary of the
date of this Agreement, (b) the date as of which (x) all of the Registrable Securities have been sold pursuant to a Registration Statement (but in no event prior to the applicable period referred to in Section 4(a)(3) of the
Securities Act and Rule 174 thereunder (or any successor rule promulgated thereafter by the Commission)) or (y) the Holders of all Registrable Securities are permitted to sell the Registrable Securities under Rule 144 (or any
similar provision) under the Securities Act without limitation on the amount of securities sold or the manner of sale or (c) with respect to a particular Holder, the date as of which all Registrable Securities held by such Holder have been sold
(x) pursuant to a Registration Statement (but in no event prior to the applicable period referred to in Section 4(a)(3) of the Securities Act and Rule 174 thereunder (or any successor rule promulgated thereafter by the Commission)) or
(y) under Rule 144 (or any similar provision) or another exemption from registration under the Securities Act. The provisions of Section 3.05 and Article IV shall survive any termination.
[Signature Page Follows]
F-18
IN WITNESS WHEREOF, the undersigned have caused this Agreement to be executed as of the date
first written above.
|
|
|
COMPANY: |
|
ABACUS LIFE, INC., |
|
|
By: |
|
|
Name: |
|
Gary L Hagerman, Jr. |
Title: |
|
Chief Financial Officer and Treasurer |
|
HOLDER: |
|
EAST SPONSOR, LLC, |
|
|
By: |
|
East Asset Management, LLC, |
|
|
its Managing Member |
|
|
By: |
|
|
Name: |
|
Gary L Hagerman, Jr. |
Title: |
|
Chief Financial Officer and Treasurer |
|
|
Thomas W. Corbett, Jr. |
|
|
Jay Jackson |
|
|
K. Scott Kirby |
|
|
T. Seam McNealy |
|
|
Matthew A. Ganovsky |
[Signature Page to Registration Rights Agreement]
F-19
ANNEX G
ABACUS LIFE, INC.
2023
LONG-TERM EQUITY COMPENSATION INCENTIVE PLAN
The purpose of the ABACUS LIFE, INC. 2023 LONG-TERM EQUITY COMPENSATION INCENTIVE PLAN (Plan) is to provide a means through
which Abacus Life, Inc., a Delaware corporation (Company), and its Affiliates may attract able individuals to enter the employ or to serve as Directors or Consultants of the Company and any of its Affiliates and to provide
a means whereby those individuals upon whom the responsibilities of the successful administration and management of the Company and its Affiliates rest, and whose present and potential contributions to the Company and its Affiliates are of
importance, can acquire and maintain ownership of the Companys Common Stock, thereby strengthening their concern for the welfare of the Company and its Affiliates. A further purpose of the Plan is to provide such individuals with additional
incentive and reward opportunities designed to enhance the profitable growth of the Company and its Affiliates. Accordingly, the Plan provides for granting Incentive Stock Options, Options that do not constitute Incentive Stock Options, Restricted
Stock Awards, Performance Awards, Stock Appreciation Rights, Phantom Stock Awards, Stock Awards, Restricted Stock Unit Awards, or any combination of the foregoing, as is best suited to the circumstances of the particular employee, Consultant, or
Director as provided herein.
The following definitions shall be applicable throughout the Plan unless specifically modified by any provision of the Plan:
(a) Affiliate means any entity which, directly or indirectly, controls, is controlled by, or is under common control
with, the Company. For purposes of the preceding sentence, control (including, with correlative meanings, the terms controlled by and under common control with), as used
with respect to any entity, shall mean the possession, directly or indirectly, of the power (i) to vote more than 50% of the securities having ordinary voting power for the election of directors of the controlled entity, or (ii) to direct
or cause the direction of the management and policies of the controlled entity, whether through the ownership of voting securities or by contract or otherwise.
(b) Award means any Option, Stock Appreciation Right, Restricted Stock Award, Performance Award, Phantom Stock
Award, Stock Award or Restricted Stock Unit Award granted under the Plan.
(c) Award Agreement means a
written agreement between the Company and a Participant evidencing an Award and its terms. Each Award Agreement shall designate (i) the type of Award being issued; (ii) the vesting conditions or forfeiture provisions applicable to the
Award, including any applicable Performance Goals or provisions constituting a Substantial Risk of Forfeiture; (iii) transferability restrictions; (iv) any applicable rules regarding delivery of Shares issued by the Company under the
Award; (v) subject to Section V(g) below, and to the extent applicable, provisions regarding payments by the Company of dividends or Dividend Equivalents; and (vi) any additional matters as the Committee may determine to be appropriate.
The terms and provisions of each Award Agreement need not be identical. Except as otherwise provided in the Plan, subject to the consent of the Participant, the Committee may, in its sole discretion, amend an outstanding Award Agreement from time to
time in any manner that is not inconsistent with the provisions of the Plan.
(d) Board means the Board of
Directors of the Company.
G-1
(e) Change of Control Value means the amount determined in
clause (i), (ii) or (iii), whichever is applicable, as follows:
(i) the per Share price offered to stockholders of the Company in a
Corporate Change which is a merger, consolidation, sale of assets or dissolution transaction;
(ii) the price per Share offered to
stockholders of the Company in any tender offer or exchange offer whereby a Corporate Change occurs; or
(iii) if a Corporate Change
occurs other than pursuant to a tender or exchange offer of Shares and an Award will be cancelled by or surrendered to the Committee as a result of such transaction, the Fair Market Value per share of the Shares underlying such Award, as determined
by the Committee as of the date determined by the Committee to be the date of cancellation and surrender of such Award.
In the event that the
consideration offered to stockholders of the Company in any transaction which results in a Corporate Change consists of anything other than cash, the Committee shall determine the fair cash equivalent of the portion of the consideration offered
which is other than cash.
(f) Code means the Internal Revenue Code of 1986, as amended. Reference in the Plan
to any section of the Code shall be deemed to include any amendments or successor provisions to such section and any regulations issued by the Department of Treasury under such section.
(g) Committee means a committee of the Board that is selected by the Board as provided in Section IV(a).
(h) Common Stock means the common stock, par value $.0001 per share, of the Company, or any security into which such
Common Stock may be changed by reason of any transaction or event of the type described in Section XIII.
(i)
Company means Abacus Life, Inc., a Delaware corporation.
(j) Consultant means
consultant, advisor or other person or entity that is not an Employee, in each case, that can be granted an Award that is eligible to be registered on a Form S-8 Registration Statement.
(k) Corporate Change means a transaction or event in which:
(i) the Company is not the surviving entity in any merger or consolidation or other reorganization (or survives only as a subsidiary of an
entity other than an entity that was directly or indirectly wholly owned by the Company immediately prior to such merger, consolidation or other reorganization);
(ii) the Company sells, leases or exchanges all or substantially all of its assets to any other person (other than an entity that is directly
or indirectly wholly owned by the Company);
(iii) the Company is to be dissolved;
(iv) any person, including a group as contemplated by Section 13(d)(3) of the 1934 Act, acquires or gains ownership or
control (including, power to vote) of more than 50 percent of the outstanding shares of the Companys voting stock (based on voting power);
(v) as a result of or in connection with a contested election of Directors, the individuals who were Directors of the Company before such
election shall cease to constitute a majority of the Board; or
(vi) the Company is party to any other corporate transaction (as defined
under section 424(a) of the Code and applicable Department of Treasury regulations) that is not described in clauses (i), (ii), (iii), (iv) or (v) above.
G-2
(l) Director means an individual elected or appointed to the
Board by the stockholders of the Company or by the Board under applicable corporate law.
(m) Disability means
as determined by the Committee in its discretion,
(i) in the case of an Award (other than an Incentive Stock Option) that is exempt from
the application of the requirements of Section 409A, a physical or mental condition of the Participant that would entitle the Participant to payment of disability income payments under the Companys group long-term disability insurance
policy or plan for employees as then in effect, or in the event that the Participant is a Director or is not covered (for whatever reason) under the Companys group long-term disability insurance policy or plan for employees or in the event the
Company does not maintain such a group long-term disability insurance policy, and in the case of an Incentive Stock Option, Disability means a permanent and total disability as defined in section 22(e)(3) of the Code; and
(ii) in the case of an Award that is not exempt from the application of the requirements of Section 409A, (1) the Participant
is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of not less than 12 months, or
(2) the Participant is, by reason of any medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of not less than 12 months, receiving income replacement
benefits for a period of not less than three months under an accident and health plan covering employees of the Company.
A determination of Disability
may be made by a physician selected or approved by the Committee and, in this respect, the Participant shall submit to an examination by such physician upon request by the Committee.
(n) Dividend Equivalent means a payment equivalent in amount to dividends paid to the Companys stockholders.
(o) Employee means any individual in an employment relationship with the Company or any Affiliate. Directors
who are Employees shall be considered Employees under the Plan.
(p) Entity means a corporation, limited
liability company, partnership, limited partnership or any other type of legal entity or organization.
(q) Fair Market
Value on any date means the market price of Common Stock:
(i) if the Common Stock is listed on one or more established
stock exchanges or national market systems, including without limitation the New York Stock Exchange and NASDAQ, its Fair Market Value shall be the closing sales price for such stock (or the closing bid, if no sales were reported) as quoted on the
principal exchange or system on which the Common Stock is listed on the date of determination (or, if no closing sales price or closing bid was reported on that date on the last trading date such closing sales price or closing bid was reported), as
reported by The Wall Street Journal (including through www.wsj.com) or such other source as the Committee deems reliable;
(ii) if the
Common Stock is regularly quoted on an automated quotation system (including the OTC Bulletin Board) or by a recognized securities dealer, its Fair Market Value shall be the closing sales price for such stock as quoted on such system or by such
securities dealer on the date of determination, but if selling prices are not reported, the Fair Market Value of a share of Common Stock shall be the mean between the high bid and low asked prices for the Common Stock on the date of determination
(or, if no such prices were reported on that date, on the last date such prices were reported), as reported by The Wall Street Journal (including through www.wsj.com) or such other source as the Committee deems reliable; or
G-3
(iii) in the absence of an established market for the Common Stock of the type described
in (i) and (ii), above, the Fair Market Value thereof shall be determined by the Committee in its discretion.
The Committees determination of
Fair Market Value shall be final, binding, and conclusive on all individuals.
(r) Forfeiture Restrictions has
the meaning assigned to such term in Section VIII(a).
(s) Holder means the holder of an Award, which includes
the Participant, a beneficiary, or the Immediate Family, as applicable.
(t) Immediate Family means, with
respect to a Participant, such Participants spouse, children, or grandchildren (including adopted children, stepchildren, and grandchildren).
(u) Incentive Stock Option means an incentive stock option within the meaning of section 422 of the Code.
(v) 1934 Act means the Securities Exchange Act of 1934, as amended.
(w) Mature Shares means Shares which have been held by the Participant and with respect to which any
applicable forfeiture restrictions have lapsed, in each case, for at least six months.
(x) Option means an
Award (other than a SAR) granted under Section VII and includes both Incentive Stock Options to purchase Common Stock and Options that do not constitute Incentive Stock Options to purchase Common Stock.
(y) Participant means an employee, Consultant, or Director who has been granted an Award.
(z) Performance Award means an Award granted under Section IX.
(aa) Performance Goals means the criteria the Committee selects for purposes of calculating vesting, exercisability,
and payment under a Performance Award. The Performance Goals shall be designated by the Committee in its sole discretion and may be based on (i) one or more business criteria that apply to the Participant, (ii) one or more business units
of the Company or an Affiliate, or (iii) the Company and Affiliates as a whole, and may reference to one or more of the following: Common Stock price (including adjustments for dividends), funds from operations, adjusted funds from operations,
earnings or adjusted earnings before or after interest, taxes, depletion, depreciation or amortization, earnings per share, earnings per share growth, total stockholder return, economic value added, cash return on capitalization, increased revenue,
revenue ratios (per employee or per customer), net income (before or after taxes), market share, return on equity, return on assets, return on capital, return on capital compared to cost of capital, return on capital employed, return on invested
capital, return on investment, return on sales, operating or profit margins, stockholder value, net cash flow, operating income, cash flow, cash flow from operations, cost reductions or cost savings, cost ratios (per employee or per customer),
expense control, sales, proceeds from dispositions, project completion time, budget goals, net cash flow before financing activities, customer growth, total capitalization, debt to total capitalization ratio, credit quality or debt ratings, dividend
payout, dividend growth, production volumes or safety results, or such other events or matters as the Committee determines appropriate in its sole discretion. Performance Goals may also be based on performance relative to a peer group or index of
companies. Unless otherwise stated, such a Performance Goal need not be based upon an increase or positive result under a particular business criterion and could include, for example, maintaining the status quo or limiting economic losses (measured,
in each case, by reference to specific business criteria). The Committee, in its discretion, may adjust or modify the calculation of Performance Goals for each performance period in order to prevent the dilution or enlargement of the rights of
Participants under Awards (i) in the event of, or in anticipation of, any unusual or extraordinary corporate item, transaction, event, or development affecting the Company or any Affiliate; (ii) in the event of, or in connection
G-4
with, any acquisition or divestiture of a portion of the Companys or any Affiliates business or operations; or (iii) in recognition of, or in anticipation of, any other unusual
or nonrecurring events affecting the Company or any Affiliate, or the financial statements of the Company or any Affiliate, or in response to, or in anticipation of, changes in applicable laws, regulations, accounting principles, or business
conditions affecting the Company or any Affiliate.
(bb) Person means an individual or entity.
(cc) Phantom Stock Award means an Award granted under Section X.
(dd) Plan means the Abacus Life, Inc. 2023 Long-Term Equity Compensation Incentive Plan, as it may be amended,
supplemented, or restated from time to time in accordance with its terms.
(ee) Restricted Stock Award means an
Award granted under Section VIII.
(ff) Restricted Stock Unit Award or RSU Award means
an Award granted under Section XII.
(gg) Rule 16b-3 means SEC Rule 16b-3 promulgated under the 1934 Act, as such may be amended from time to time, and any successor rule, regulation or statute fulfilling the same or a similar function.
(hh) Section 409A means section 409A of the Code and other guidance promulgated by
the Internal Revenue Service under Section 409A.
(ii) Share means a share of Common Stock.
(jj) Stock Appreciation Right or SAR means a stock appreciation right granted pursuant to
Section VII.
(kk) Stock Award means an award granted pursuant to Section XI.
(ll) Substantial Risk of Forfeiture has the meaning ascribed to that term in Section 409A.
III. |
EFFECTIVE DATE AND DURATION OF THE PLAN |
The Plan shall become effective upon the date approved by the stockholders of the Company (the Effective Date), and no Award shall be
granted under the Plan prior to such date. No Awards may be granted under the Plan after ten years from the Effective Date. The Plan shall remain in effect until all Options granted under the Plan have been exercised or expired, all Restricted Stock
Awards granted under the Plan have fully vested or been entirely forfeited, and all Performance Awards, Phantom Stock Awards and RSU Awards have been fully satisfied or expired.
(a) Composition of Committee. The Plan shall be administered by a committee of, and appointed by, the Board that shall be
comprised solely of two or more independent Directors (within the meaning of the term Non-Employee Director as defined in Rule 16b-3). Unless otherwise
provided by the Board, the Committee shall be the Compensation Committee of the Board.
(b) Powers. Subject to the terms and
provisions of the Plan, the Committee, at any time, and from time to time, may grant Awards under the Plan to eligible individuals in such amounts and upon such terms as the Committee shall determine. Subject to the express provisions of the Plan,
the Committee shall have authority, in its discretion, to determine which employees, Consultants or Directors shall receive an Award, the time or times when such Award shall be made, the type of Award that shall be made, the number of Shares to be
subject to
G-5
each Option, SAR, Stock Award or Restricted Stock Award, and the number of Shares subject to or the value of each Performance Award, RSU Award or Phantom Stock Award. In making such
determinations, the Committee shall take into account the nature of the services rendered by the respective employees, Consultants, or Directors, their present and potential contribution to the Companys success and such other factors as the
Committee in its sole discretion shall deem relevant.
(c) Additional Powers. The Committee shall have such additional
powers as are delegated to it by the other provisions of the Plan. Subject to the express provisions of the Plan, this shall include the power to construe the Plan and the respective Award Agreements executed hereunder, to prescribe rules and
regulations relating to the administration of the Plan, and to determine the terms, conditions, restrictions and provisions of each Award Agreement, including such terms, conditions, restrictions and provisions as shall be requisite in the judgment
of the Committee to cause designated Options to qualify as Incentive Stock Options, and to make all other determinations necessary or advisable for administering the Plan. The Committee may specify in any Award Agreement the effect under the
applicable Award of the occurrence of the death, Disability, retirement, or cessation of employment of the Participant with the Company and all Affiliates, the cessation of services rendered by the Participant to the Company and all Affiliates, or
the occurrence of a Corporate Change. The Committee may, in its discretion and as of a date determined by the Committee, fully vest any Award, in whole or in part. The Committee may rely on the descriptions, representations, reports and estimates
provided to it by the management of the Company or an Affiliate for determinations to be made pursuant to the Plan. The Committee may correct any defect or supply any omission or reconcile any inconsistency in the Plan or in any Award Agreement in
the manner and to the extent it shall deem expedient to carry it into effect. The determinations of the Committee on the matters referred to in this Section IV shall be final, binding, and conclusive on all individuals.
(d) Delegation of Authority. The Committee in its sole discretion and on such terms and conditions as it may provide may
delegate all or any part of its authority and powers under the Plan to one or more members of the Board and/or officers of the Company; provided, however, that the Committee may not delegate its authority or power with respect to (i) the
selection for participation in this Plan of an officer of the Company or other person subject to Section 16 of the Exchange Act or decisions concerning the timing, pricing or amount of an Award to such an officer or person; or (ii) any
Awards to a Director.
V. |
SHARES SUBJECT TO THE PLAN; AWARD LIMITS; GRANT OF AWARDS |
(a) Number of Shares Available for Awards. Subject to adjustment as provided in Section XIII, the aggregate number of Shares that
may be issued under the Plan shall be equal to 3,090,000 Shares. The Shares that are available for issuance under the Plan may be issued in any form of Award authorized under the Plan. Any Shares that are the subject of Awards under the Plan which
are forfeited or terminated, expire unexercised, are settled in cash in lieu of Shares or in a manner such that all or some of the Shares covered by an Award are not issued to a Participant (including, but not limited to, Shares withheld to satisfy
tax obligations on any Award other than an Option or an SAR), or are exchanged for Awards that do not involve Shares, shall again immediately become available to be issued pursuant to Awards granted under the Plan. If Shares are withheld to satisfy
tax obligations with respect to an Option or an SAR, such Shares shall not again be available for issuance under the Plan. If Shares are tendered in payment of an option price of an Option or the exercise price of a SAR, such Shares shall not be
available for issuance under the Plan.
(b) Incentive Stock Option Award Limit. The aggregate number of Shares with respect
to which Incentive Stock Options may be granted under the Plan is 3,090,000 Shares. This amount shall be subject to adjustment in accordance with the provisions of Section XIII.
(c) Grant of Awards. The Committee may from time to time grant Awards to one or more employees, Consultants, or Directors
determined by it to be eligible for participation in the Plan in accordance with the terms of the Plan.
G-6
(d) Director Equity Retainer Awards. The Company may, from time to time,
award shares of Common Stock to one or more non-employee Directors (the Director Equity Grant). The Committee shall designate the terms and conditions of the Director Equity Grants
granted under this Section V(d), provided, however, that unless otherwise designated by the Committee, the Awards shall be fully vested on the date of grant. The Director Equity Grants shall be paid as Stock Awards on the date of grant and shall not
require an Award Agreement. The aggregate Fair Market Value on the date of grant (computed in accordance with applicable financial accounting rules) of the Award issued to a non-employee Director during a
calendar year shall be determined by the Committee and shall not exceed $75,000 per calendar year. As of the close of business on the date of grant, the number of Stock Awards issued to each director shall be equal to (x) the designated dollar
amount of the Director Equity Grant, divided by (y) the Fair Market Value of a share of Common Stock on such day, which amount shall be rounded to the nearest whole share.
(e) Substitute Awards. The Committee may grant Awards under the Plan in substitution for stock and stock based awards held by
service providers of another entity in connection with a merger or consolidation of the service recipient entity with the Company or an Affiliate or the acquisition by the Company or an Affiliate of property or equity interests of the service
recipient entity. The Committee may direct that the substitute awards be granted on such terms and conditions as the Committee considers appropriate in the circumstances. The substitution of any outstanding stock option must satisfy the requirements
of Treasury Regulation § 1.424-1 and Section 409A. Any substitute Awards granted under the Plan shall not count against the Share limitations set forth in Sections V(a) and (b), nor shall such Shares
subject to substitute awards again be available for grant under the Plan to the extent of any forfeiture, expiration, or cash settlement under an Award.
(f) Stock Offered. Subject to the limitations set forth in Section V(a), the Shares to be offered pursuant to the grant of an
Award may be authorized but unissued Common Stock, Common Stock previously issued and outstanding and reacquired by the Company, or treasury shares. Any of such Shares which remain unissued and which are not subject to outstanding Awards at the
termination of the Plan shall cease to be subject to the Plan but, until the termination of the Plan, the Company shall at all times make available a sufficient number of Shares to meet the requirements of the Plan.
(g) Limitation on Dividends and Dividend Equivalents. The Committee may provide that Awards under this Plan shall earn dividends
or Dividend Equivalents; provided, however, that the payment of such dividends or Dividend Equivalents shall be subject to the same vesting conditions as apply to the underlying Awards, and no portion of such dividends or Dividend Equivalents shall
be paid prior to vesting or during the Forfeiture Restriction period. Prior to payment, such dividends or Dividend Equivalents shall be credited to an account maintained on the books of the Company. Any crediting of dividends or Dividend Equivalents
will be subject to such terms, conditions, limitations and restrictions as the Committee may establish, from time to time, including reinvestment in additional shares of Common Stock or common share equivalents. Dividend or Dividend Equivalent
rights shall be as specified in the Award Agreement, or pursuant to a resolution adopted by the Committee with respect to outstanding Awards. No dividends or Dividend Equivalents shall be paid on Options or Stock Appreciation Rights.
Awards may be granted only to individuals who, at the time of grant, are employees, Consultants, or Directors. An Award may be granted on more than one
occasion to the same person, and, subject to the limitations set forth in the Plan, such Award may include an Incentive Stock Option, an Option that is not an Incentive Stock Option, a Stock Award, a Restricted Stock Award, a Performance Award, a
Phantom Stock Award, a SAR or an RSU Award or any combination thereof.
G-7
VII. |
STOCK OPTIONS AND STOCK APPRECIATION RIGHTS |
(a) Option Period or Stock Appreciation Right Period. The term of each Option or SAR shall be as specified by the Committee at
the date of grant, but shall not be exercisable more than ten years after the date of grant.
(b) Limitations on Exercise of Option
or Stock Appreciation Right. An Option or SAR shall be exercisable in whole or in such installments and at such times as determined by the Committee.
(c) Special Limitations on Incentive Stock Options. Unless otherwise specified in an Award Agreement, Options granted pursuant
to the Plan shall be Options that do not constitute Incentive Stock Options. An Incentive Stock Option may be granted only to an individual who is employed by the Company or any subsidiary corporation (as defined in section 424 of the Code) at the
time the Option is granted. To the extent that the aggregate Fair Market Value (determined at the time the respective Incentive Stock Option is granted) of Common Stock with respect to which Incentive Stock Options are exercisable for the first time
by an individual during any calendar year under all incentive stock option plans of the Company and its parent and subsidiary corporations exceeds $100,000, such Incentive Stock Options shall be treated as Options which do not constitute Incentive
Stock Options. No Incentive Stock Option shall be granted to an individual if, at the time the Option is granted, such individual owns Shares possessing more than 10% of the total combined voting power of all classes of stock of the Company or of
its parent or subsidiary corporation, within the meaning of section 422(b)(6) of the Code, unless (i) at the time such Option is granted its option price is at least 110% of the Fair Market Value of the Common Stock subject to the Option and
(ii) such Option by its terms is not exercisable after the expiration of five years from the date of grant. An Incentive Stock Option shall not be transferable otherwise than by will or the laws of descent and distribution, and shall be
exercisable during the Participants lifetime only by such Participant or the Participants guardian or legal representative.
(d) Award Agreement.
(i) Each Option shall be evidenced by an Award Agreement in such form and containing such provisions not inconsistent with the provisions of
the Plan as the Committee from time to time shall approve, including provisions to qualify an Incentive Stock Option under section 422 of the Code. Each Award Agreement shall specify the effect of termination of the Participants
(1) employment with the Company or an Affiliate, (2) the consulting or advisory relationship with the Company or an Affiliate, or (3) membership on the Board, as applicable, on the exercisability of the Option. An Award Agreement may
provide for the payment by the Participant of the option price as the Committee may specify, including by the delivery of Shares by the Company to the Participant.
(ii) Each SAR shall be evidenced by an Award Agreement in such form and containing such provisions not inconsistent with the provisions of the
Plan as the Committee from time to time shall approve. Unless otherwise set forth in an Award Agreement, upon the exercise of a SAR, a Holder shall be entitled to receive payment from the Company in an amount determined by multiplying (1) the
difference between the value of a Share on the date of exercise over the Shares grant price, by (2) the number of Shares with respect to which the SAR is exercised. The per Share grant price for a SAR shall be established on the date of
grant of the SAR. At the discretion of the Committee, the payment made by the Company to a Holder upon the Holders exercise of a SAR may be in cash, in Shares or in any combination thereof. The Committees determination regarding the form
of such payment may be set out in the applicable SAR Agreement pertaining to the grant of the SAR.
(e) Restrictions on Repricing of
Options or Stock Appreciation Rights. Except as provided in Section XIII, the Committee may not, without approval of the stockholders of the Company, (i) amend any outstanding Award Agreement for an Option to lower the option price (or
cancel and replace any outstanding Award Agreement for an Option with a new Award Agreement having a lower option price), (ii) amend any outstanding Award Agreement for a SAR or to lower the SAR grant price (or cancel and replace any outstanding SAR
with a
G-8
new SAR having a lower SAR grant price), or (iii) cancel any outstanding underwater Option or SAR in exchange for cash. Further, the Committee may not lower an option price of an
Option (or cancel and replace any outstanding Award Agreement with a new Award Agreement having a lower option price) or lower the SAR grant price (or cancel and replace any outstanding SAR with a new Award Agreement having a lower SAR grant price)
to the extent that doing so would subject the Holder to additional taxes under Section 409A.
(f) Option Price and
Payment. The price at which a Share may be purchased upon exercise of an Option by its Holder shall be determined by the Committee but, subject to adjustment as provided in Section XIII, such purchase price shall not be less than the Fair
Market Value of a Share on the date such Option is granted. The Option or portion thereof may be exercised by delivery of an irrevocable notice of exercise by the Holder to the Company, as specified by the Committee. The purchase price of the Option
or portion thereof shall be paid by the Holder to the Company in full in the manner prescribed by the Committee. Separate stock certificates shall be issued by the Company for those Shares acquired by a Holder pursuant to the Holders exercise
of an Incentive Stock Option and for those Shares acquired by a Holder pursuant to the Holders exercise of any Option that does not constitute an Incentive Stock Option, or should the Shares be represented by book or electronic entry rather
than certificates, such Shares shall be accounted for separately in such book or electronic entry.
(g) Method of Exercise of
Option.
(i) General Method of Exercise. Subject to the terms and provisions of the Plan and the applicable Award
Agreement, Options may be exercised in whole or in part from time to time by the delivery of written notice in the manner designated by the Committee stating (1) that the Holder wishes to exercise such Option on the date such notice is so
delivered, (2) the number of Shares with respect to which the Option is to be exercised, and (3) the address to which any certificate representing such Shares should be mailed or delivered. Except in the case of exercise by a third party
broker as provided below, in order for the notice to be effective the notice must be accompanied by payment of the option price by any combination of the following: (A) cash, certified check, bank draft or postal or express money order for an
amount equal to the option price under the Option, (B) an election to make a cashless exercise through a registered broker-dealer (if approved in advance by the Committee or an executive officer of the Company), or (C) any other form of
payment which is acceptable to the Committee.
(ii) Exercise Through Third-Party Broker. The Committee may permit a Holder to elect
to pay the option price and any applicable tax withholding resulting from such exercise by authorizing a third-party broker to sell all or a portion of the Shares acquired upon the Holders exercise of the Option and remit to the Company a
sufficient portion of the sale proceeds to pay the option price and any applicable tax withholding resulting from such exercise.
(iii)
Options and Stock Appreciation Rights in Substitution for Options Granted by Other Employers. Options and SARs may be granted under the Plan from time to time in substitution for options held by individuals who become employees, Consultants,
or Directors as a result of a merger or consolidation or other business transaction with the Company or any Affiliate. The repricing prohibitions of Sections VII(e) and XIV shall apply to substitution awards granted pursuant to this Section VII(g).
VIII. |
RESTRICTED STOCK AWARDS |
(a) Forfeiture Restrictions To Be Established by the Committee. Shares that are the subject of a Restricted Stock Award shall be
subject to restrictions on disposition by the Participant and an obligation of the Participant to forfeit and surrender the Shares to the Company under certain circumstances (Forfeiture Restrictions). The Forfeiture
Restrictions shall be determined by the Committee in its sole discretion, and the Committee may provide that the Forfeiture Restrictions shall lapse upon (i) the attainment by the Participant of one or more performance measures established by
the Committee, (ii) the Participants continued employment or service with the Company or an Affiliate for a specified period of time, or (iii) the occurrence or non-occurrence of any event or
the satisfaction of any other condition specified by the Committee in its sole discretion. Each Restricted Stock Award may have different Forfeiture Restrictions, in the discretion of the Committee.
G-9
(b) Other Terms and Conditions. Shares awarded pursuant to a Restricted
Stock Award shall be represented by (i) a stock certificate registered in the name of the Participant, (ii) book or electronic entry or (iii) any other reasonable alternative form for evidencing or representing the issuance of Common
Stock. Unless provided otherwise in an Award Agreement, the Participant shall have the right to vote Common Stock subject thereto and to enjoy all other stockholder rights, except that (A) the Participant shall not be entitled to delivery of a
stock certificate until the Forfeiture Restrictions have lapsed, (B) the Company shall retain custody of the Common Stock until the Forfeiture Restrictions have lapsed, (C) the Participant may not sell, transfer, pledge, exchange,
hypothecate or otherwise dispose of the Shares until all the Forfeiture Restrictions have lapsed, and (D) a breach of the terms and conditions established by the Committee pursuant to the Award Agreement shall cause a forfeiture of the
Restricted Stock Award. At the time of such Award, the Committee may, in its sole discretion, prescribe additional terms, conditions or restrictions relating to Restricted Stock Awards, including rules pertaining to the termination of employment
with or service as a Consultant to the Company or an Affiliate or Director (by retirement, Disability, death or otherwise) of a Participant prior to expiration of all the Forfeitures Restrictions. Such additional terms, conditions or restrictions
shall be set forth in the Award Agreement made in conjunction with the Award.
(c) Payment for Restricted Stock. The
Committee shall determine the amount and form of any payment for Common Stock received pursuant to a Restricted Stock Award, provided that in the absence of such a determination, a Participant shall not be required to make any payment for Common
Stock received pursuant to a Restricted Stock Award, except to the extent otherwise required by applicable law.
(a) Performance Awards Based Upon Satisfaction of Performance Goals. Subject to the terms and provisions of the Plan, the
Committee, at any time, and from time to time, may grant Performance Awards under the Plan to eligible individuals in such amounts and upon such terms as the Committee shall determine. The amount of, the vesting and the transferability restrictions
applicable to any Performance Award shall be based upon the Participants attainment of such Performance Goals as the Committee may determine when a Performance Award is made.
(b) Form of Payment Under Performance Award. Payment made by the Company to the Holder under a Performance Award shall be made
in cash or Shares as specified in the Holders Award Agreement.
(c) Certification by Committee In Connection with
Payment. In connection with the payment of any compensation by the Company to a Holder based on the Participants achievement of Performance Goals, the Committee must certify in writing that applicable Performance Goals and any of the
material terms thereof were, in fact, satisfied by the Participant.
(d) Time of Payment Under Performance Award. Unless a
Performance Award is structured as a current issuance of Shares subject to a risk of forfeiture in the event Performance Goals are not achieved, payment under a Performance Award shall be made at such time as is specified in the applicable Award
Agreement. The Award Agreement shall specify that such payment will be made (i) by a date that is no later than the date that is two and one-half (2 1/2) months after the end of the calendar year in which
the Performance Award payment is no longer subject to a Substantial Risk of Forfeiture or (ii) at a time that is permissible under Section 409A.
(a) Phantom Stock Awards. Phantom Stock Awards are rights to receive the value of Shares which vest over a period of time as
established by the Committee, without satisfaction of any performance criteria or objectives by the Participant. The Committee may, in its discretion, require payment or other conditions of the Participant respecting any Phantom Stock Award.
G-10
(b) Award Period. The Committee shall establish, with respect to and at
the time of grant of each Phantom Stock Award, a period over which the Award shall vest with respect to the Participant.
(c) Awards
Criteria. In determining the value of Phantom Stock Awards, the Committee shall take into account a Participants responsibility level, performance, potential, other Awards, and such other considerations as it deems appropriate.
(d) Payment. Following the end of the vesting period for a Phantom Stock Award (or at such other time as the applicable Phantom
Stock Award Agreement may provide), the Holder of a Phantom Stock Award shall be entitled to receive payment of an amount, not exceeding the maximum value of the Phantom Stock Award, based on the then vested value of the Award. Payment of a Phantom
Stock Award may be made in cash, Common Stock, or a combination thereof as determined by the Committee.
(e) Termination of
Award. A Phantom Stock Award shall terminate if the Participant does not remain continuously in the employ of the Company or an Affiliate or does not continue to perform services as a Consultant or a Director for the Company or an Affiliate
at all times during the applicable vesting period, except as may be otherwise determined by the Committee.
(a) Stock Awards. Stock Awards are rights to receive Shares, which vest immediately, without satisfaction of any performance
criteria or objectives by the Participant. The Committee may, in its discretion, require payment, partial payment or other conditions of the Participant respecting any Stock Award.
(b) Awards Criteria. In determining the number of Shares subject to a Stock Award to be granted, the Committee may take into
account a Participants employment or service responsibility level, performance, potential, other Awards, and such other considerations as the Committee deems appropriate.
(c) Payment. A Participant who receives a Stock Award shall be entitled to receive immediate payment of such Award in Common
Stock.
XII. |
RESTRICTED STOCK UNIT AWARDS |
(a) RSU Awards. An RSU Award shall be similar in nature to a Restricted Stock Award except that no Shares or cash shall be
transferred to the Holder until all the applicable vesting restrictions lapse or performance conditions have been fully satisfied by the Participant. The amount of, and the vesting and the transferability restrictions applicable to, any RSU Award
shall be determined by the Committee in its sole discretion. The Committee shall maintain a bookkeeping ledger account which reflects the number of RSUs credited under the Plan for the benefit of a Holder.
(b) Form of Payment Under RSU Award. Payment under an RSU Award shall be made in cash or Shares as specified in the applicable
Award Agreement.
(c) Time of Payment Under RSU Award. Payment to a Holder under an RSU Award shall be made at such time as
is specified in the applicable Award Agreement. The Award Agreement shall specify that the payment will be made (i) by a date that is no later than the date that is two and one-half (2 1/2) months after
the end of the fiscal year in which the RSU Award payment is no longer subject to a Substantial Risk of Forfeiture, or (ii) at a time that is permissible under Section 409A.
XIII. |
RECAPITALIZATION; REORGANIZATION AND CORPORATE CHANGES |
(a) No Effect on Right or Power. The existence of the Plan and the Awards granted hereunder shall not affect in any way the right
or power of the Board or the stockholders of the Company to make or authorize any
G-11
adjustment, recapitalization, reorganization or other change in the Companys or any Affiliates capital structure or its business, any merger or consolidation of the Company or any
Affiliate, any issue of debt or equity securities ahead of or affecting Common Stock or the rights thereof, the dissolution or liquidation of the Company or any Affiliate or any sale, lease, exchange or other disposition of all or any part of its
assets or business or any other corporate act or proceeding, whether of a similar character or otherwise.
(b) Adjustment
Clause. In the event of any change in the outstanding Shares of the Company by reason of any stock dividend, split, spinoff, recapitalization, merger, consolidation, combination, extraordinary dividend, exchange of shares or other
change affecting the outstanding Shares as a class without the Companys receipt of consideration, or other equity restructuring of the Companys equity within the meaning of Financial Accounting Standards Board (FASB) Accounting Standards
Codification (ASC) Topic 718, Stock Compensation (formerly, FASB Statement 123R), adjustments shall be made by the Committee to (i) the terms, the number of Shares and/or the exercise price per Share relating to any outstanding Awards, and
(ii) the share limitations set forth in Section V hereof, with such adjustments being appropriate and equitable to prevent dilution or enlargement of rights of Participants; provided, however, that the number of Shares subject to any Award
shall always be a whole number. The Committee shall also make appropriate adjustments described in the previous sentence in the event of any distribution by the Company of its assets to stockholders other than a normal cash dividend. Adjustments, if
any, and any determination or interpretations, made by the Committee shall be final, binding, and conclusive on all individuals. Conversion of any convertible securities of the Company shall be deemed to have been effected for adequate
consideration. Except as expressly provided herein, no issuance by the Company of shares of any class or securities convertible into shares of any class, shall affect, and no adjustment by reason thereof shall be made with respect to, the number or
price of Shares subject to an Award.
(c) Corporate Changes. If a Corporate Change occurs, the Committee, without limitation
or the consent or approval of any Participant (subject to any restrictions or limitations in an individual Award Agreement or any other written agreement entered into between the Company and a Participant), shall effect one or more of the following
alternatives, as selected by the Committee in its sole discretion, which alternatives may vary among individual Participants and which may vary among Awards held by any individual Participant:
(i) for any award of Options or SARs, either (A) accelerate the time at which the Options and SARs then outstanding may be exercised so
that such Options or SARs may be exercised in full for a limited period of time on or before a specified date (before or after such Corporate Change) fixed by the Committee, after which specified date all unexercised Options and SARs and all rights
of the Participants thereunder shall terminate; or (B) require the mandatory surrender to the Company by all or selected Participants of some or all of the outstanding Options and SARs held by such Participants (irrespective of whether such
Awards are then exercisable under the provisions of the Plan or the applicable Award Agreements) as of a date, before or after such Corporate Change, specified by the Committee, in which event the Committee shall thereupon cancel such Awards and the
Company shall pay (or cause to be paid) to each Participant an amount of cash per Share equal to the excess, if any, of the Change in Control Value of the Shares subject to such Option over the exercise price(s) under such Option for such Shares or
the grant date values of the SARs with respect to such Shares (provided, however, that such Awards may, in the Committees discretion, be cancelled for no consideration if there is no excess amount);
(ii) for any Award, with respect to all or selected Participants, have some or all of their then outstanding Awards (whether vested or
unvested) assumed or have a new award of a similar nature substituted for some or all of their then outstanding Awards under the Plan (whether vested or unvested) by an entity or subsidiary of such entity which is a party to the transaction
resulting in such Corporate Change and which is then (or will be upon completion of the Corporate Change transaction) employing, or receiving services as a Consultant from, such Participant or which is (or will be upon completion of the Corporate
Change transaction) affiliated or associated with such Participant in the same or a substantially similar manner as the Company prior to the Corporate Change, or a parent or subsidiary of such entity, provided that (A) such assumption or
substitution is on a basis where the aggregate Fair Market Value of the Common Stock subject to the Award
G-12
immediately after the assumption or substitution is equal to the aggregate Fair Market Value of all Common Stock subject to the Award immediately before such assumption or substitution, and
(B) the assumed rights under such existing Award or the substituted rights under such new award, as the case may be, will have substantially the same terms and conditions as the rights under the existing Award assumed or substituted for, as the
case may be;
(iii) make such adjustments to Awards then outstanding as the Committee deems appropriate to reflect such Corporate Change
(provided, however, that the Committee may determine in its sole discretion that no adjustment is necessary to Awards then outstanding), including adjusting an Award to provide that the number and class of Shares covered by such Award shall be
adjusted so that such Award shall thereafter cover securities of the surviving or acquiring corporation or other property (including cash) as determined by the Committee in its sole discretion; or
(iv) except as otherwise provided in Section XV(h) or an Award Agreement, then, in addition to the foregoing provisions of this Section
XIII(c), upon the occurrence of a Corporate Change, the Committee, acting in its sole discretion without the consent or approval of any Participant, may require the mandatory surrender to the Company by Participants selected by the Committee of some
or all of the outstanding Awards, as of a date, before or after such Corporate Change, specified by the Committee, in which event the Committee shall thereupon cancel such Awards and the Company shall pay (or cause to be paid) to each Participant an
amount of cash equal to the maximum value of such Award which, in the event the applicable performance or vesting period set forth in such Award has not been completed, shall be multiplied by a fraction, the numerator of which is the number of days
during the period beginning on the first day of the applicable performance or vesting period and ending on the date of the surrender, and the denominator of which is the aggregate number of days in the applicable performance or vesting period.
(d) Other Changes in the Common Stock. In the event of changes in the outstanding Common Stock by reason of recapitalizations,
reorganizations, mergers, consolidations, combinations, split-ups, split-offs, spin-offs, exchanges or other relevant changes in capitalization of the Company or distributions made by the Company to the
holders of Common Stock occurring after the date of the grant of any Award and not otherwise provided for by this Section XIII, such Award and any agreement evidencing such Award shall be subject to adjustment by the Committee at its sole discretion
as to the number and price of Shares or other consideration subject to such Award. In the event of any such change in the outstanding Common Stock or distribution to the holders of Common Stock, the aggregate number of Shares then available for
issuance under the Plan under Section V(a) may be appropriately adjusted by the Committee, whose determination shall be conclusive.
(e)
Section 409A Limitations. The following provisions shall apply with respect to any action taken under this Section XIII:
(i) any adjustments made to Awards that are considered deferred compensation within the meaning of Section 409A shall be made
in compliance with the requirements of Section 409A unless the Participant consents otherwise;
(ii) any adjustments made to Awards
that are not considered deferred compensation subject to Section 409A shall be made in such a manner as to ensure that after such adjustment, the Awards either continue not to be subject to Section 409A or comply with the
requirements of Section 409A unless the Participant consents otherwise; and
(iii) in any circumstance or transaction in which
compensation resulting from or in respect of an Award would result in the imposition of an additional tax under Section 409A if the Plans definition of Corporate Change were to apply, but would not result in the imposition of
any additional tax if the term Corporate Change were defined herein to mean a change in control event within the meaning of Treasury Regulation Section 1.409A-3(i)(5), then
Corporate Change shall mean a change in control event within the meaning of
G-13
Treasury Regulation Section 1.409A-3(i)(5), but only to the extent necessary to prevent such compensation from becoming subject to an additional tax
under Section 409A.
(f) No Adjustments Unless Otherwise Provided. Except as hereinbefore expressly provided, the
issuance by the Company of shares of its capital stock of any class or securities convertible into shares of stock of any class, for cash, property, labor or services, upon direct sale, upon the exercise of rights or warrants to subscribe therefor,
or upon conversion of shares or obligations of the Company convertible into such shares or other securities, and in any case whether or not for fair value, shall not affect, and no adjustment by reason thereof shall be made with respect to, the
number of Shares subject to Awards theretofore granted or the purchase price per share, if applicable.
XIV. |
AMENDMENT AND TERMINATION OF THE PLAN |
The Board in its discretion may terminate the Plan at any time with respect to any Shares for which Awards have not theretofore been granted. The Board shall
have the right to alter or amend the Plan or any part thereof from time to time; provided that no change in the Plan may be made that would impair the rights of a Participant with respect to an Award theretofore granted without the consent of the
Participant, and provided, further, that the Board may not, without approval of the stockholders of the Company, (a) amend the Plan to increase the maximum aggregate number of Shares that may be issued under the Plan or change the class of
individuals eligible to receive Awards under the Plan, or (b) amend or eliminate Section VII(e).
(a) No Right To An Award. Neither the adoption of the Plan nor any action of the Board or of the Committee shall be deemed to
give any individual any right to be granted an Award or any other rights hereunder except as may be evidenced by an Award Agreement duly executed on behalf of the Company, and then only to the extent and on the terms and conditions expressly set
forth therein.
(b) Unfunded Plan. The Plan is and shall be unfunded. The Company shall not be required to establish any
special or separate fund or to make any other segregation of its or any Affiliates funds or assets to assure the performance of its obligations under any Award.
(c) No Employment/Membership Rights Conferred. Nothing contained in the Plan shall (i) confer upon any employee or
Consultant any right with respect to continuation of employment or of a consulting or advisory relationship with the Company or any Affiliate or (ii) interfere in any way with the right of the Company or any Affiliate to terminate his or her
employment or consulting or advisory relationship at any time. Nothing contained in the Plan shall confer upon any Director any right with respect to continuation of membership on the Board.
(d) Other Laws. The Company shall not be obligated to issue any Common Stock pursuant to any Award granted under the Plan at any
time when the Shares covered by such Award have not been registered under the Securities Act of 1933, as amended, and such other state and federal laws, rules and regulations as the Company or the Committee deems applicable and, in the opinion of
legal counsel for the Company, there is no exemption from the registration requirements of such laws, rules and regulations available for the issuance and sale of such Shares.
(e) No Fractional Shares. No fractional Shares shall be delivered by the Company to any Participant, nor shall any cash in lieu
of fractional Shares be paid by the Company to any Participant.
(f) Withholding. The Company or any Affiliate shall be
entitled to deduct from any other compensation payable to each Holder any sums required by federal, state, local or foreign tax law to be withheld with respect to an Award including the vesting or exercise of an Award. Alternatively, the Company or
any Affiliate may require
G-14
the Holder (or other person validly exercising the Award on behalf of a Holder) to pay such sums for taxes directly to the Company or Affiliate in cash or by check upon the vesting or exercise.
Alternatively, in the discretion of the Committee, the Company may reduce the number of Shares issued to the Holder upon the exercise or vesting of a Holders Award to satisfy the tax withholding obligations of the Company or an Affiliate. The
Committee may, in its discretion, allow a Holder to use Mature Shares to satisfy the Companys or Affiliates tax withholding obligations with respect to an Award. The Company shall have no obligation upon vesting or exercise of any Award
until the Company or an Affiliate has received payment sufficient to satisfy the Companys or Affiliates tax withholding obligations with respect to that vesting or exercise. Neither the Company nor any Affiliate shall be obligated to
advise a Holder of the existence of the tax or the amount which it will be required to withhold.
(g) No Restriction on Corporate
Action. Nothing contained in the Plan shall be construed to prevent the Company or any Affiliate from taking any action which is deemed by the Company or such Affiliate to be appropriate or in its best interest, whether or not such action
would have an adverse effect on the Plan or any Award made under the Plan. No Participant, beneficiary of a Participant, or other person shall have any claim against the Company or any Affiliate as a result of any such action.
(h) Restrictions on Transfer. An Award (other than an Incentive Stock Option, which shall be subject to the transfer
restrictions set forth in Section VII(c)) shall not be transferable by a Holder otherwise than (i) by will or the laws of descent and distribution, (ii) pursuant to a qualified domestic relations order (as defined by the Code, or the rules
thereunder) binding upon a Participant, (iii) with respect to Awards of Options which do not constitute Incentive Stock Options, if such transfer is permitted in the sole discretion of the Committee, by transfer by a Participant to a member of
the Participants Immediate Family, to a trust solely for the benefit of the Participant and the Participants Immediate Family, or to a partnership or limited liability company whose only partners or members, as applicable, are the
Participant and members of the Participants Immediately Family, or (iv) with the prior written consent of the Committee; provided, however, no Award shall be transferred for value by a Participant without the approval of the
Companys stockholders.
(i) Exemptions from Section 16(b) Liability. It is the intent
of the Company that the grant of any Awards to or other transaction by a Participant who is subject to section 16 of the Exchange Act shall be exempt from such section pursuant to an applicable exemption (except for transactions acknowledged in
writing to be non-exempt by such Participant). Accordingly, if any provision of this Plan or any Award Agreement does not comply with the requirements of Rule 16b-3 as
then applicable to any such transaction, such provision shall be construed or deemed amended to the extent necessary to conform to the applicable requirements of Rule 16b-3 so that such Participant shall avoid
liability under section 16(b) of the Exchange Act.
(j) Compliance With Section 409A.
Awards shall be designed, granted and administered in such a manner that they are either exempt from the application of, or comply with, the requirements of Section 409A. Each Award Agreement for an Award that is intended to comply with the
requirements of Section 409A shall be construed and interpreted in accordance with such intention. If the Committee determines that an Award, an Award Agreement, payment, distribution, deferral election, transaction, or any other action or
arrangement contemplated by the provisions of the Plan would, if undertaken or implemented, cause a Holder to become subject to additional taxes under Section 409A, then unless the Committee specifically provides otherwise, such Award, Award
Agreement, payment, distribution, deferral election, transaction or other action or arrangement shall not be given effect to the extent it causes such result and the related provisions of the Plan or Award Agreement will be deemed modified, or, if
necessary, suspended in order to comply with the requirements of Section 409A to the extent determined appropriate by the Committee, in each case without the consent of or notice from the Company to the Holder. The exercisability of an Option
shall not be extended to the extent that such extension would subject the Holder to additional taxes under Section 409A.
(k)
Restrictions. If the Committee imposes vesting or transferability restrictions on a Holders rights with respect to an Award, the Committee may issue such instructions to the Companys stock transfer agent in
G-15
connection therewith as it deems appropriate. The Committee may also cause the certificate for Shares issued pursuant to an Award to be imprinted with any legend which counsel for the Company
considers advisable with respect to the restrictions or, should the Shares be represented by book or electronic entry rather than a certificate, the Company may take such steps to restrict transfer of the Shares as counsel for the Company considers
necessary or advisable to comply with applicable law.
(l) Rights As a Stockholder. Subject to the terms and conditions of
the Plan and the applicable Award Agreements, each Holder of an Award shall have all the rights of a stockholder with respect to Shares issued to the Holder pursuant to the Award during any period in which such issued Shares are subject to
forfeiture and restrictions on transfer, including the right to vote such Shares. In no event shall a Holder have any rights of a stockholder of the Company with respect to an Award before Shares are issued to the Holder pursuant to the Award.
(m) Recoupment. All Awards granted under the Plan will be subject to
recoupment in accordance with any recoupment policy that the Company has adopted or adopts (i) pursuant to the requirements of the listing standards of any national securities exchange or association on which the Companys securities are
listed or as is otherwise required by the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, as amended, or other applicable law, or (ii) that otherwise imposes recoupment provisions in the event of (1) a restatement by the
Company of its financial statements, or (2) misconduct that causes financial or reputational harm to the Company.
(n)
Individuals Residing Outside of the United States. Notwithstanding any provision of the Plan to the contrary, in order to comply with the laws in other countries in which the Company or any of its Affiliates operates or has employees,
the Committee, in its sole discretion, shall have the power and authority to (i) determine which Affiliates shall be covered by the Plan; (ii) determine which individuals employed or hired outside the United States are eligible to
participate in the Plan; (iii) amend or vary the terms and provisions of the Plan and the terms and conditions of any Award granted to individuals who reside outside the United States; (iv) establish subplans and modify exercise procedures
and other terms and procedures to the extent such actions may be necessary or advisable (and any subplans and modifications to Plan terms and procedures established under this Section XV(l) by the Committee shall be attached to the Plan document as
Appendices); and (v) take any action, before or after an Award is made, that it deems advisable to obtain or comply with any necessary local government regulatory exemptions or approvals. Notwithstanding the above, the Committee may not take
any actions hereunder, and no Awards shall be granted, that would violate the 1934 Act, the Code, any securities law or governing statute or any other applicable law.
(o) Right of Offset. The Company will have the right to offset against its obligation to deliver to a Participant any
Shares (or other property, including cash) under the Plan or any Award Agreement any outstanding amounts (including, without limitation, travel and entertainment or advance account balances, loans, repayment obligations under any Awards, or amounts
repayable by such Participant to the Company or any Affiliate pursuant to tax equalization, housing, automobile or other employee programs) that the Participant then owes to the Company or any Affiliate and any amounts the Committee otherwise deems
appropriate pursuant to any tax equalization policy or agreement; provided, however, that no such offset shall be permitted if it would constitute an acceleration of a payment hereunder within the meaning of Section 409A. This right
of offset shall not be an exclusive remedy and the Companys election not to exercise the right of offset with respect to any amount payable to a Participant shall not constitute a waiver of this right of offset with respect to any other amount
payable to the Participant by the Company or any Affiliate or any other right or remedy of the Company or any Affiliate.
(p)
Electronic Delivery and Signatures. Any reference in an Award Agreement or the Plan to a written document includes without limitation any document delivered electronically or posted on the Companys or an Affiliates intranet
or other shared electronic medium controlled by the Company or an Affiliate. The Committee and any Participant may use facsimile, PDF or other electronic signatures in signing any Award or Award
G-16
Agreement, in exercising any Option or Stock Appreciation Right, or in any other written document in the Plans administration. The Committee and each Participant are bound by facsimile, PDF
and other electronic signatures, and acknowledge that the other party relies on facsimile and PDF signatures.
(q) No Guarantee of
Tax Treatment. Notwithstanding anything herein to the contrary, a Participant shall be solely responsible for the taxes imposed on such Participant relating to the grant or vesting of, or payment pursuant to, any Award, and none of the
Company, any Affiliate, the Board or the Committee (or any of their respective members, officers or employees) guarantees any particular tax treatment with respect to any Award.
(r) Governing Law. The Plan shall be governed by, and construed solely in accordance with, the laws of the State of Delaware,
without regard to conflicts of laws principles thereof or the application of any law of any other jurisdiction.
(s)
Interpretation. The term including means including without limitation. The term or means and/or unless clearly indicated otherwise. The term vest includes the lapse of
restrictions on Awards, including Forfeiture Restrictions. Reference herein to a Section shall be to a section of the Plan unless indicated otherwise.
G-17
ANNEX H
August 29, 2022
Board of
Directors of
East Resources Acquisition Company
7777 NW
Beacon Square Boulevard
Boca Raton, FL 33487
Dear Members
of the Board of Directors:
We understand that East Resources Acquisition Company, a Delaware corporation (ERES),
proposes to enter into an Agreement and Plan of Merger, dated as of August 30, 2022 (the Merger Agreement), by and among ERES, LMA Merger Sub, LLC, a Delaware limited liability company and wholly owned subsidiary of ERES
(LMA Merger Sub), Abacus Merger Sub, LLC, a Delaware limited liability company and wholly owned subsidiary of ERES (Abacus Merger Sub and, together with LMA Merger Sub and ERES, the ERES
Parties), Longevity Market Assets, LLC, a Florida limited liability company (LMA), and Abacus Settlements, LLC, a Florida limited liability company (Abacus and, together with LMA, the
Companies), under which (1) LMA Merger Sub shall merge with and into LMA, with LMA surviving such merger (the LMA Merger) as a direct wholly owned subsidiary of ERES (the LMA Surviving
Company), and (2) Abacus Merger Sub shall merge with and into Abacus, with Abacus surviving such merger (the Abacus Merger and, together with the LMA Merger, the Mergers) as a direct wholly
owned subsidiary of ERES (the Abacus Surviving Company and, together with the LMA Surviving Company, the Surviving Companies). In connection with the Mergers, the limited liability company interests in LMA
(LMA Interests) and the limited liability company interests in Abacus (Abacus Interests) will be converted into the right to receive the Aggregate Merger Consideration. The transactions contemplated by the
Merger Agreement are collectively referred to herein as the Transaction.
The terms of the Transaction are more fully
set forth in the Merger Agreement and capitalized terms used but not defined herein have the meanings ascribed to such terms in the Merger Agreement.
You have requested our opinion as to (i) the fairness, from a financial point of view, to ERES and its unaffiliated Public Stockholders
of the consideration paid by ERES to the equityholders of the Companies pursuant to the Merger Agreement, and (ii) whether the Companies have an aggregate fair market value equal to at least 80 percent of the balance of funds in
ERESs trust account (excluding deferred underwriting commissions and taxes payable and subject to proportionate adjustments related to Nasdaqs 80 percent test) (each an Opinion and, together, the
Opinions).
In connection with our review of the Transaction and in arriving at our Opinions, we have made such
reviews, analyses, and inquiries as we have deemed necessary and appropriate under the circumstances. Among other things, we have reviewed:
|
1. |
the draft of the Merger Agreement, dated August 27, 2022; |
|
2. |
certain documents filed by ERES with the U.S. Securities and Exchange Commission (the SEC),
including the registration statement on Form S-1 initially filed July 2, 2020 and amendments thereto, and the related Rule 424(b)(4) final prospectus filed with the SEC on July 24, 2020 and various reports
filed with the SEC pursuant to the U.S. Securities Act of 1934; |
H-1
|
3. |
certain publicly available business and financial information relating to ERES and the Companies that we deemed
to be relevant; |
|
4. |
the Companies historical financial statements for the calendar years ended December 31, 2019, December
31, 2020 and December 31, 2021; |
|
5. |
certain non-public financial and business information provided to us by ERES, the Companies, and their
respective advisors; |
|
6. |
certain information relating to the historical, current and future operations, financial condition and
prospects of the Companies made available to us by the Companies and ERES, including financial projections for the years ending December 31, 2022, December 31, 2023 and December 31, 2024 prepared by the management of the Companies relating to the
Companies; |
|
7. |
certain industry and research reports relevant to the industry in which the Companies operate;
|
|
8. |
the reported historical price and trading activity for the securities of ERES, compared to certain financial
stock market information for ERES with certain other publicly traded companies, and reviewed the financial terms of certain recent business combinations, and other studies and analyses it deemed appropriate; and |
|
9. |
other documents made available in the Companies virtual data room. |
We have spoken with certain members of the respective management teams of ERES and the Companies and certain of their respective
representatives and advisors regarding the business, operations, financial condition and prospects of the Companies, the Transaction and related matters. We participated in financial and business diligence calls with executive management of ERES and
the Companies, regarding, among other things, certain financial projections prepared by the Companies, the business and financial results and outlook of the Companies and the Transaction structure and background. We have also compared the financial
and operating performance of the Companies with that of companies with publicly traded equity securities that we deemed to be relevant. In addition, we have conducted such other analyses, examinations, and inquiries and considered such other
financial, economic and market criteria as we have deemed necessary and appropriate in arriving at our Opinions.
With your consent, we
have relied upon and assumed, without independent verification, the accuracy and completeness of all data, material and other information furnished, or otherwise made available, to us, discussed with or reviewed by us, or publicly available, and
assume no responsibility to independently verify such data, material, and other information. In addition, ERESs and the Companies respective management teams have advised us, and we have assumed with your permission, that the financial
projections provided to us have been reasonably prepared in good faith on bases reflecting the best available estimates and judgments of ERESs and the Companies respective management teams as to the future financial results and condition
of the Companies and we express no opinion regarding such projections or the assumptions on which they are based. We have relied upon ERES to advise us promptly if any information provided became inaccurate or had to be updated during the period of
our review. If the foregoing assumptions are inaccurate, our Opinions could be materially affected. ERES does not publicly disclose internal financial information of the type provided to us in connection with our review of the Transaction. As a
result, such information was prepared for financial planning purposes and was not prepared with the expectation of public disclosure.
We
have relied upon and assumed, without independent verification, that there has been no change in the business, assets, liabilities, financial condition, results of operations, cash flows or prospects of since the respective dates of the most recent
financial statements and other information, financial or otherwise, provided to us that would be material to our analyses or our Opinions, and there is no information or any facts that would make the information reviewed by us incomplete or
misleading.
We have assumed, with your consent, there will be no cash redemptions paid to existing ERES stockholders from ERESs
trust account. We have assumed that the final form of the Merger Agreement will be substantially
H-2
similar to the draft we reviewed, dated August 27, 2022 without modification of material terms or conditions. We have assumed that the Transaction will be consummated under the terms of the
Merger Agreement without material amendments or waivers of any material terms or conditions or obligations thereunder. We have relied upon and assumed, without independent verification, that (a) the representations and warranties of the parties
to the Merger Agreement and all other related documents and instruments referred to therein are true and correct, (b) each party to the Merger Agreement and such other related documents and instruments will fully and timely perform all of the
covenants and agreements required to be performed by such party and (c) all conditions to the consummation of the Transaction will be satisfied without waiver thereof. In arriving at our Opinions, we have assumed, with your consent, all the
regulatory approvals and consents required for the Transaction to be consummated pursuant to the terms of the Merger Agreement will be obtained in a manner that will not adversely affect ERES or the Companies or materially alter the terms of the
Transaction.
At your direction, we have assumed that all projections and estimates provide a reasonable basis on which to evaluate the
Companies and the Transaction and we have, at your direction, used and relied upon such projections and estimates for purposes of our analyses and in arriving at our Opinions. You and the Companies have advised us that no projections or estimates
will need to be revised or adjusted based on the final redemptions from the ERES trust account. We express no view or opinion with respect to any projections or estimates or the assumptions on which they are based.
For purposes of our financial analyses and our Opinions, with your consent, we (i) did not perform any financial analyses to evaluate the
value of ERES or to derive valuation references ranges for any shares of ERES for purposes of comparison with the Aggregate Merger Consideration or otherwise, and (ii) have assumed that the value of each share of ERES capital stock (including,
without limitation, each share of ERES Class A Common Stock and each share of ERES Class B Common Stock) is equal to the original issue price per share of ERES Class A Common Stock (which is equal to $10.00 per share pursuant to the
terms of the Merger Agreement), notwithstanding the different voting rights and other non-financial terms of such shares that could impact their value.
In arriving at our Opinions, we have performed no appraisals or valuations of any specific assets or liabilities (fixed, contingent, or other)
of the Companies, including any intellectual property for which the Companies might receive royalty or licensing fees, and we have not been furnished with any such appraisals or valuations, and have made no physical inspection of the property or
assets of the Companies. We express no opinion regarding the liquidation value of any entity. In arriving at the Opinions, we have undertaken no independent analysis of any pending or threatened litigation, governmental proceedings or
investigations, possible unasserted claims or other contingent liabilities, to which any of the Companies or their affiliates is a party or may be subject and at the Companies direction and with its consent, in arriving at our Opinions, we
have made no assumption about and therefore have not considered, the possible assertion of claims, outcomes, damages, or recoveries arising out of any such matters.
None of the companies or transactions we may have used in any analysis for purposes of comparison is identical to the Companies or the
Transaction. Accordingly, our analysis of the results of the comparisons is not mathematical; rather, it involves complex considerations and judgments about differences in the companies and transactions to which the Companies and the Transaction
were compared and other factors that could affect the public trading value or transaction value of the companies or transactions. We also have considered no potential judicial, legislative, or regulatory changes pending or being considered or that
may be adopted by any judicial, governmental, or regulatory bodies or any potential changes in accounting methods or generally accepted accounting principles that may be adopted.
The Opinions are based upon the financial, market, economic, and other conditions that exist on, and the information made available to us as
of, the date hereof. As you are aware, the credit, financial, and stock markets have from time-to-time experienced unusual volatility, and we express no opinion or view
as to any potential effects of such volatility on the Transaction and the Opinions do not address potential developments in any such
H-3
markets. In addition, we express no opinion or view as to any potential effects of the COVID-19 pandemic on the Transaction, ERES or the Companies. It should be understood that subsequent
developments may affect the assumptions underlying the Opinions and that we disclaim any undertaking or obligation to advise any person of any change in any fact or matter affecting the Opinions that may come or be brought to our attention after the
date of the Opinions. We have not undertaken to reaffirm or revise the Opinions or otherwise comment upon any events after the date hereof and have no obligation to update, revise or reaffirm the Opinions.
Consistent with applicable legal and regulatory requirements, we have adopted policies and procedures to establish and maintain the
independence of our research department and personnel. Our research analysts may hold opinions, make statements or recommendations, or publish research reports regarding the Companies or the Transaction and other participants in the Transaction that
differ from the views of our investment banking personnel.
The Opinions are furnished under our engagement letter dated August 17, 2022
(the Engagement Letter) and are directed to the Board of Directors of ERES (the Board) in connection with its consideration of the Transaction. The Opinions are furnished solely to be used by the Board as only
one input to consider in its process of analyzing the Transaction and is not intended to be and does not constitute a recommendation to any member of the Board or any stockholder of ERES as to how such director or stockholder should act or vote
regarding the Transaction or any other matter. Notwithstanding the foregoing, the Board may rely upon the Opinions. The Opinions delivered to the Board are subject to the conditions, scope of engagement, limitations, and understandings in this
opinion and in the Engagement Letter.
The Opinions address solely the fairness, from a financial point of view, to ERES and its
unaffiliated Public Stockholders of the consideration paid by ERES to the equityholders of the Companies pursuant to the Merger Agreement and the aggregate fair market value of the Companies. We were not requested to opine as to, and the Opinions do
not address, the basic business decision of the Board, ERES or its stockholders to proceed with or effect the Transaction, or any solvency or fraudulent conveyance consideration relating to the Transaction. We express no opinion as to the relative
merits of the Transaction as compared to any alternative business strategies or transactions that might exist for ERES or any other party or the effect of any other transaction in which ERES or any other party might engage. We express no opinion as
to the amount, nature or fairness of any consideration or compensation to be received in or because of the Transaction by securityholders, officers, directors, or employees of the Companies, or any other class of such persons, or relative to or in
comparison with the consideration to be paid by ERES to the equityholders of the Companies pursuant to the Merger Agreement. We have not been asked to consider, and the Opinions do not address, the solvency or viability of ERES to pay its
obligations when they come due. We are not rendering any financial, legal, accounting, or other advice and understand that ERES is relying on its legal counsel and accounting advisors as to legal and accounting matters in connection with the
Transaction.
We have not been requested to, and did not, (i) participate in negotiations regarding the Merger Agreement,
(ii) solicit any expressions of interest from any other parties regarding any business combination with ERES or any other alternative transaction or (iii) advise the Board or any other party regarding alternatives to the Transaction. In
addition, we were not requested to and did not provide advice regarding the structure or any other aspect of the Transaction, or to provide services other than the delivery of the Opinions. In the ordinary course of our business, we and our
affiliates may actively trade securities of ERES for our own account or the account of our customers and, accordingly, we may hold a long or short position in such securities. We may seek to be engaged for compensation in the future to perform
investment banking services for ERES or its founders, other parties to the Transaction, or the Companies and certain of its affiliates.
We, as a customary part of our investment banking business, are continually engaged in performing financial analyses regarding businesses and
their securities in connection with acquisitions, negotiated underwritings, competitive biddings, secondary distributions of listed and unlisted securities, private placements, and other transactions and for estate, corporate and other purposes. We
have been engaged by the Board to render
H-4
the Opinions and will receive a fee for rendering the Opinions. In addition, ERES has agreed to reimburse certain of our expenses arising, and indemnify us against certain liabilities that may
arise, out of our engagement relating to providing the Opinions.
On August 17, 2022, we entered into an engagement letter with ERES (the
Engagement Letter), to provide services with respect to rending an opinion in connection with the Transaction. We will receive a portion of the fees payable to us under the Engagement Letter in cash upon delivery of this letter
and will receive the remaining portion of the fees upon the closing of the Transaction.
Preparing a fairness opinion is a complex,
analytical process involving various determinations as to the most appropriate and relevant methods of financial analysis and applying those methods to the particular circumstances and is not necessarily susceptible to partial analysis or summary
description. In arriving at the Opinions, we attributed no particular weight to any particular analysis or factor considered by us, but rather made qualitative judgments as to the significance and relevance of each analysis and factor. Several
analytical methodologies were employed by us in our analyses, and no one method of analysis should be regarded as critical to the overall conclusion reached. Each analytical technique has inherent strengths and weaknesses, and the nature of the
available information may further affect the value of particular techniques. Accordingly, we believe that our analyses must be considered as a whole and that selecting portions of our analyses and of the factors considered by us, without considering
all analyses and factors in their entirety, could create a misleading or incomplete view of the evaluation process underlying the Opinions. The conclusion reached by us, therefore, is based on applying our own experience and judgment to all analyses
and factors considered by us. The Opinions were reviewed and approved by the Northland Securities Fairness Opinion Committee.
Other than
as required by applicable law, the Opinions shall not be published, disclosed, or otherwise used, nor shall any public references to us be made, without our prior written approval. This letter and a summary thereof may be filed with or included in
or with any proxy or information statement required to be filed by ERES with the SEC and delivered to the holders of ERES s securities in connection with the Transaction. However, no reference to this letter or the Opinions in the proxy or
information statement may be made without our written consent and subject to our approval of the language that references this letter or the Opinions, which consent we will not unreasonably withheld, conditioned, or delayed. By execution of the
Opinion, we hereby consent to the inclusion of the Opinion as an annex to the proxy statement relating to the Transaction and to the references to us and such opinion therein.
Based upon and subject to the foregoing and based upon such other !actors as we consider relevant, it is our opinion that, as of the
date hereof, (i) the consideration to be paid by ERES to the equityholders of the Companies pursuant to the Merger Agreement is fair, from a financial point of view, to ERES and its unaffiliated Public Stockholders and (ii) the Companies
have an aggregate fair market value equal to at least 80 percent of the balance of funds in ERESs trust account (excluding deferred underwriting commissions and taxes payable and subject to proportionate adjustments related to
Nasdaqs 80 percent test).
Sincerely,
Northland Securities, Inc.
|
|
|
By: |
|
|
H-5
ANNEX I
RESTRICTION AGREEMENT
THIS RESTRICTION
AGREEMENT, (this Agreement), dated as of [ ⚫ ], 2023 (the Effective Date), is made by and between Abacus Life, Inc. (the Company), and Jay Jackson (the
Executive or you or your).
WHEREAS, in connection with the Agreement and Plan of Merger, dated
August 30, 2022, as amended on October 14, 2022 and [ ], 2023 (collectively, Merger Agreement), by and among East Resources Acquisition Company, LMA Merger Sub, LLC, Abacus Merger Sub, LLC, Longevity
Market Assets, LLC (LMA), and Abacus Settlements, LLC (Abacus), Executive is receiving a portion of the Stock Consideration (as defined in the Merger Agreement) as one of the owners of LMA.
WHEREAS, the amount of Stock Consideration Executive is receiving is in excess of his pro rata ownership in LMA;
WHEREAS, the owners of Abacus have agreed as described in the Merger Agreement to contribute a portion of their Stock Consideration to
Executive in exchange for his provision of services to the Company post-Closing (as defined in the Merger Agreement) and subject to the forfeiture restrictions described herein (the Restricted Stock); and
WHEREAS, Executive and the Company wish to enter into this Agreement to satisfy the agreement described above.
NOW, THEREFORE, in consideration of the recitals and the mutual agreements herein contained, the parties hereto agree as follows:
ARTICLE I
RECEIPT OF
RESTRICTED STOCK
As of the Closing Date as provided in the Merger Agreement, the Executive shall receive 4,569,922 shares (the
Shares) of Restricted Stock on the terms and conditions set forth in this Agreement.
ARTICLE II
TERMS AND CONDITIONS OF RESTRICTED STOCK
The Restricted Stock provided in Article I shall be subject to the following terms, conditions and restrictions:
2.1 Certificate; Book Entry Form; Legend. The Company shall issue the Shares of Restricted Stock
either (a) in certificate form or (b) in book entry form, registered in your name, with legends, or notations, as applicable, referring to the terms, conditions and restrictions applicable to the Shares. You agree that any certificate
issued for Restricted Stock prior to the lapse of any outstanding restrictions relating thereto shall be inscribed with the following legend:
This certificate and the shares of stock represented hereby are subject to the terms and conditions, including restrictions against transfer
(the Restrictions), contained in the agreement entered into between the registered owner and the Company. Any attempt to dispose of these shares in contravention of the Restrictions, including by way of sale, assignment, transfer,
pledge, hypothecation or otherwise, shall be null and void and without effect.
I-1
2.2 Vesting Schedule; Stockholder Rights. The
Restricted Stock shall vest, and the restrictions thereon shall lapse, subject to your continued employment, with respect to (i) fifty percent (50%) of the Shares on the twenty-five (25) month anniversary of the Effective Date and
(ii) fifty percent (50%) of the Shares on the thirty (30) month anniversary of the Effective Date (the Restricted Period). Subject to the restrictions set forth in Section 2.3, as of the date of issuance you shall have all
the rights of a stockholder with respect to the Shares, including without limitation, the right to vote the Shares and to receive any dividends or other distributions paid or made with respect to such Shares; provided, however, that any dividends or
other distributions shall solely be accrued during the Restricted Period and paid once the restrictions lapse under Section 2.3. In addition, the Restricted Stock will become fully vested (and the restrictions thereon shall lapse) upon the
first to occur of one of the following events: (i) your separation from service due to Disability, (ii) your death, (iii) your separation from service without Cause; or (iv) your separation from service for Good Reason. For
purposes of this Agreement, the following definitions apply:
|
|
|
Cause shall mean (i) any act of gross negligence or willful misconduct by Executive in the
performance of his duties on behalf of the Company, including misappropriation funds, fraud, embezzlement, or theft; (ii) any conviction of, guilty plea, plea of no contest or nolo contendere, or entry of deferred adjudication to any felony or
crime involving fraud or theft by Executive; and (iii) unlawful use (including being under the influence of) or possession of illegal drugs. |
|
|
|
Disability shall mean Executives inability to perform substantially all of his duties and
responsibilities (notwithstanding the provision of any reasonable accommodation) for a period of one hundred and eighty (180) days during any period of three hundred sixty-five (365) consecutive days. If any question arises as to whether
Executive is disabled, the Executive shall, at the Companys request and expense, submit to a medical examination by a physician jointly selected by the Company and Executive to determine whether Employee is disabled. |
|
|
|
Good Reason shall mean (i) a material diminution in Executives duties, responsibilities
and authorities; (ii) a decrease in Executives compensation; (iii) the relocation of Executives primary work location more than 30 miles from Executives current work location; and (iv) a material breach by the
Company of the terms of any written agreement between Executive and the Company. To constitute Good Reason, Executive must provide notice of the event constituting Good Reason within sixty (60) days of Good Reason event, and the Company must be
allowed thirty (30) days to cure such Good Reason event. If the Company does not cure the Good Reason event, the Executive must resign within one hundred and eighty (180) days of Good Reason event. |
2.3 Restrictions on Sale or Transfer. Subject to the provisions of this Agreement, the Shares and any interest
therein may not be sold, assigned, transferred, pledged, hypothecated or otherwise disposed of during the Restricted Period. Any attempt to dispose of any Shares in contravention of the above restriction shall be null and void and without effect.
The restrictions in this Section 2.3 shall lapse with respect to the Shares in accordance with the vesting schedule in Section 2.2. Upon the lapse of restrictions relating to any Shares, the Company shall, as applicable, either remove the
notations on any such Shares issued in book-entry form or deliver to you or your personal representative a stock certificate representing a number of shares of Stock, free of the restrictive legend described in Section 2.1, equal to the number
of Shares with respect to which such restrictions have lapsed. If certificates representing such Shares shall have theretofore been delivered to you, such certificates shall be returned to the Company, complete with any necessary signatures or
instruments of transfer prior to the issuance by the Company of such unlegended Shares.
2.4 Forfeiture. Unless otherwise provided in Section 2.2, in the event of the
severance of your employment relationship between the Company and all Affiliates for any reason prior to the lapsing of restrictions in accordance with Section 2.3 with respect to any portion of the Restricted Stock, such portion of the
Restricted Stock held by you shall be automatically forfeited by you as of the date of termination for no consideration. Any Shares of Restricted Stock forfeited pursuant to this Agreement shall be transferred to, and reacquired by, the Company
without payment of any consideration by the Company, and neither you nor any of your successors,
I-2
heirs, assigns or personal representatives shall thereafter have any further rights or interests in such shares. If certificates for any such Shares containing restrictive legends shall have
theretofore been delivered to you (or your legatees or personal representative), such certificates shall be returned to the Company, complete with any necessary signatures or instruments of transfer.
2.5 Amount of Restricted Stock Received. The amount of Restricted Stock received by Executive shall not exceed
an amount of Restricted Stock that would preclude the Parties from treating the Mergers in a manner consistent with the intended tax treatment provided for within the Merger Agreement.
ARTICLE III
MISCELLANEOUS
3.1 Notices. Any and all notices, designations, consents, offers, acceptances and any other
communications provided for herein shall be given in writing and shall be delivered either personally or by registered or certified mail, postage prepaid, which shall be addressed, in the case of the Company to the Board of Directors of the Company
at the principal office of the Company and, in your case, to your address appearing on the books of the Company or to your residence or to such other address as you may designate in writing.
3.2 No Tax, Legal, or Financial Advice. The Company and its Affiliates (including East Resources
Acquisition Company) are not providing any tax, legal or financial advice, nor are the Company and such Affiliates making any recommendations regarding your acquisition or sale of the underlying shares of Stock. You should consult with your own
personal tax, legal and financial advisors. You acknowledge that the ultimate liability for all taxes related to this Agreement is and remains your responsibility. Such tax liability may exceed any amount actually withheld by the Company, if any.
3.3 No Employment or Service Obligation. Nothing contained in this Agreement shall
(a) confer upon Executive any right with respect to continuation of employment or of a consulting or advisory relationship with the Company or any Affiliate or (b) interfere in any way with the right of the Company or any Affiliate to
terminate Executives employment or consulting or advisory relationship at any time.
3.4 Successors. The terms of this Agreement shall be binding upon and inure to the benefit of the
Company, its successors and assigns, and to you and your beneficiaries, executors, administrators, heirs and successors.
3.5 Entire Agreement. This Agreement contains the entire agreement and understanding of the parties
hereto with respect to the subject matter contained herein and therein and supersede all prior communications, representations and negotiations in respect thereto.
3.6 Governing Law. The provisions of this Agreement shall be construed, administered, and governed
under the laws of the state of Delaware and applicable federal law. Notwithstanding any other provision of this Agreement, the Company shall have no liability to issue any shares under this Agreement unless such issuance would comply with all
applicable laws and the applicable requirements of any securities exchange or similar entity.
3.7 Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed an
original, but all of which together shall constitute one and the same instrument.
[Signature Page Follows]
I-3
IN WITNESS WHEREOF, this Agreement has been executed and delivered by the parties hereto
as of the day of , 2023.
|
|
|
|
|
|
|
|
|
Company:
Abacus Life, Inc. (f/k/a East Resources Acquisition
Company) |
|
|
|
Executive:
Jay Jackson |
|
|
|
|
By: |
|
|
|
|
|
|
|
|
Signature |
|
|
|
|
|
Signature |
|
|
|
|
|
Title: |
|
|
|
|
|
Date: |
|
|
|
|
|
|
|
Date: |
|
|
|
|
|
|
|
|
East Resources Acquisition (NASDAQ:ERES)
Historical Stock Chart
From Apr 2024 to May 2024
East Resources Acquisition (NASDAQ:ERES)
Historical Stock Chart
From May 2023 to May 2024